matchedPattern,context,lineNumber,columnNumber,publicationName
3.5.1.1,...6 2 2011 © The Author(s) 2011l-Asparaginase (E.C. 3.5.1.1) is used as a therapeutic agent in the tre...,3,677,3_Biotech_2011_Jul_7_1(1)_21-26.txt
4.1.2.131,...igues Int J Pharmacogn 1996 34 2 14 10.1076/phbi.34.1.2.13177,189,116,3_Biotech_2011_Jul_27_1(1)_1-9.txt
EC 3.1.1.13,...The Author(s) 2011Cholesterol ester lipase (LIPA; EC 3.1.1.13) and cholesterol 25-hydroxylase (CH25H...,3,754,3_Biotech_2011_Sep_3_1(2)_99-109.txt
EC 1.14.99.48,... 3.1.1.13) and cholesterol 25-hydroxylase (CH25H; EC 1.14.99.48) play essential role in cholesterol ...,3,806,3_Biotech_2011_Sep_3_1(2)_99-109.txt
EC 3.1.1.13,...l ester hydrolase (also called lipase A or LIPA) (EC 3.1.1.13) catalyses the hydrolysis of cholester...,12,86,3_Biotech_2011_Sep_3_1(2)_99-109.txt
EC 1.14.99.38,...roxylase (CH25H or cholesterol 25-monooxygenase) (EC 1.14.99.38) catalyses the formation of 25-hydro...,16,69,3_Biotech_2011_Sep_3_1(2)_99-109.txt
EC 3.2.1.8,"...accharide of hemicelluloses. Endo-β-1,4-xylanase (EC 3.2.1.8) and β-xylosidase (EC 3.2.1.37) are the...",9,259,3_Biotech_2011_Oct_13_1(3)_161-171.txt
EC 3.2.1.37,"...ndo-β-1,4-xylanase (EC 3.2.1.8) and β-xylosidase (EC 3.2.1.37) are the key enzymes involved in the h...",9,289,3_Biotech_2011_Oct_13_1(3)_161-171.txt
3.2.1.4,"...do-1,4-β-d-glucanase [carboxymethyl cellulase (EC.3.2.1.4)], which cleaves β-linkage randomly in the...",19,279,3_Biotech_2011_Dec_20_1(4)_207-215.txt
3.2.1.91,"...ose; exo-1,4-β-d-glucanase [cellobiohydrolase (EC.3.2.1.91)], which hydrolyzes cellobiose from eithe...",19,405,3_Biotech_2011_Dec_20_1(4)_207-215.txt
3.2.1.21,"...parts of cellulose; β-glucosidase [cellobiase (EC.3.2.1.21)], releases glucose from cellobiose and s...",19,568,3_Biotech_2011_Dec_20_1(4)_207-215.txt
EC 3.2.1.8,"...prising xylanases (β-1,4-d-xylan xylanohydrolase, EC 3.2.1.8) and β-xylosidases (β-1,4-d-xylan xyloh...",8,412,3_Biotech_2011_Dec_22_1(4)_255-259.txt
EC 3.2.1.37,"...) and β-xylosidases (β-1,4-d-xylan xylohydrolase, EC 3.2.1.37) are required. Xylanases cleave intern...",8,472,3_Biotech_2011_Dec_22_1(4)_255-259.txt
3.2.8.1,"..., has been mutated in the cell lines CHO Lec1, Lec3.2.8.1 (Stanley 1989) and HEK293S-GnTI(−) (Reeves...",42,1566,3_Biotech_2012_Jun_10_2(2)_89-113.txt
2.8.3.9,...me A: acetate/butyrate: coenzyme A-transferase (EC2.8.3.9) and in other solvent pathway Appl Environ...,115,194,3_Biotech_2012_Jun_3_2(2)_159-167.txt
EC 3.2.1.20,"...osidase; α-glucoside hydrolase; α-1,4-glucosidase EC 3.2.1.20), is involved in the exo-hydrolysis of...",3,770,3_Biotech_2012_Sep_25_2(3)_225-231.txt
EC 3.2.1.20,"...osidase; α-glucoside hydrolase; α-1,4-glucosidase EC 3.2.1.20), is involved in the exo-hydrolysis of...",9,165,3_Biotech_2012_Sep_25_2(3)_225-231.txt
3.2.1.44,...ght fucoidans can be obtained by fucoidanase (E.C.3.2.1.44) treatment. This enzyme sourced from hepa...,157,1157,3_Biotech_2012_Sep_15_2(3)_171-185.txt
2.7.11.30,Lipase H (LIPH; E.C.2.7.11.30; also known as phosphatidic acid-selecti...,12,21,3_Biotech_2012_Dec_25_2(4)_263-275.txt
2.7.11.34,"...ted in vertebrates, including lipase I (LIPI; E.C.2.7.11.34), also known as phosphatidic acid-select...",12,1012,3_Biotech_2012_Dec_25_2(4)_263-275.txt
3.1.1.3,"...holipase domain-containing proteins (PNPLA) (E.C. 3.1.1.3) catalyse the hydrolysis of triglycerides,...",3,629,3_Biotech_2012_Dec_18_2(4)_277-286.txt
3.1.1.3,...ase domain-containing proteins (PNPLA-like) (E.C. 3.1.1.3) and genes have been reported which encode...,12,99,3_Biotech_2012_Dec_18_2(4)_277-286.txt
EC 4.1.1.49,...e enzyme phosphoenolpyruvate carboxykinase (PCK) (EC 4.1.1.49) which decarboxylates and simultaneous...,9,352,3_Biotech_2012_Dec_29_2(4)_311-318.txt
EC 3.1.2.23,Thioesterases (EC 3.1.2.23) are a large enzyme family that cataly...,9,16,3_Biotech_2013_Feb_15_3(1)_19-27.txt
EC 3.2.1.8,"...tion of xylanase (1, 4-β-d-xylan xylanohydrolase, EC 3.2.1.8) and β-xylosidase (β-d-xyloside xylohyd...",9,356,3_Biotech_2013_Jun_18_3(3)_241-246.txt
EC 3.2.1.37,"....8) and β-xylosidase (β-d-xyloside xylohydrolase, EC 3.2.1.37) (Biswas et al. 1988), of which the la...",9,414,3_Biotech_2013_Jun_18_3(3)_241-246.txt
4.81.1.87,...ations Cereal Chem 2004 81 87 90 10.1094/CCHEM.2004.81.1.87,156,171,3_Biotech_2013_Jun_18_3(3)_247-254.txt
2.79.1.45,...lavour Cereal Chem 2002 79 45 51 10.1094/CCHEM.2002.79.1.45,184,210,3_Biotech_2013_Jun_18_3(3)_247-254.txt
1.27.1.67,...actor Lab Anim Res 2011 27 1 67 71 10.5625/lar.2011.27.1.67 21826164,208,277,3_Biotech_2013_Jun_18_3(3)_173-185.txt
EC 3.2.1.8,"...oup of enzymes mainly consisting of endoxylanase (EC 3.2.1.8) which primarily cleaves β-1, 4 linked ...",9,67,3_Biotech_2013_Apr_26_3(2)_127-136.txt
EC 3.2.1.37,"...es β-1, 4 linked xylan backbone and β-xylosidase (EC 3.2.1.37) which converts xylooligomers to monom...",9,150,3_Biotech_2013_Apr_26_3(2)_127-136.txt
EC 4.2.1.84,Nitrile hydratases (EC 4.2.1.84) are metaloenzymes that contain either...,9,21,3_Biotech_2013_Aug_16_3(4)_319-330.txt
EC 3.2.1.8,"...rst presented by Viikari et al. (1994). Xylanase (EC 3.2.1.8), a hydrolytic enzyme, is being used pr...",11,440,3_Biotech_2013_Aug_10_3(4)_277-285.txt
3.87.3.297,...in Peru Plant Dis 2003 87 297 302 10.1094/PDIS.2003.87.3.297,243,177,3_Biotech_2013_Apr_8_3(2)_153-164.txt
3.87.4.329,... Uganda Plant Dis 2003 87 329 335 10.1094/PDIS.2003.87.4.329,257,150,3_Biotech_2013_Apr_8_3(2)_153-164.txt
4.2.1.84,... The Author(s) 2012Nitrile hydratase (NHase; E.C. 4.2.1.84) has been purified and characterized usin...,3,520,3_Biotech_2013_Apr_24_3(2)_165-171.txt
1.10.3.2,"...xtracellular enzyme system includes Laccase (E.C. 1.10.3.2), Manganese peroxidase (MnP, E.C. 1.11.1....",11,790,3_Biotech_2013_Apr_7_3(2)_143-152.txt
1.11.1.13,"... (E.C. 1.10.3.2), Manganese peroxidase (MnP, E.C. 1.11.1.13), Lignin peroxidase (LiP, E.C. 1.11.1.14...",11,833,3_Biotech_2013_Apr_7_3(2)_143-152.txt
1.11.1.14,"...nP, E.C. 1.11.1.13), Lignin peroxidase (LiP, E.C. 1.11.1.14) that are able to decolorize various dye...",11,874,3_Biotech_2013_Apr_7_3(2)_143-152.txt
1.10.3.2,...apan) in extracted sample. Laccase activity (E.C. 1.10.3.2) was determined by measuring the oxidatio...,38,138,3_Biotech_2013_Apr_7_3(2)_143-152.txt
1.11.1.13,"...ku et al. (1990). Manganese peroxidase (MnP, E.C. 1.11.1.13) activity was measured by oxidation of 2...",38,332,3_Biotech_2013_Apr_7_3(2)_143-152.txt
EC 1.10.3.2,Laccases (p-diphenol: dioxygen oxidoreductases; EC 1.10.3.2) are copper-containing enzymes that ca...,17,49,3_Biotech_2012_Jun_16_2(2)_149-157.txt
EC 3.2.1.21,β-Glucosidase (EC 3.2.1.21) together with endoglucanase (EC 3.2.1...,9,16,3_Biotech_2013_Oct_6_3(5)_381-388.txt
EC 3.2.1.4,...sidase (EC 3.2.1.21) together with endoglucanase (EC 3.2.1.4) and exoglucanase (EC 3.2.1.74) form a ...,9,58,3_Biotech_2013_Oct_6_3(5)_381-388.txt
EC 3.2.1.74,...with endoglucanase (EC 3.2.1.4) and exoglucanase (EC 3.2.1.74) form a cellulase complex. All three e...,9,88,3_Biotech_2013_Oct_6_3(5)_381-388.txt
1.10.3.2,"...e as they are potential producers of laccase (E.C.1.10.3.2), manganese peroxidase (MnP; E.C.1.11.1.1...",13,268,3_Biotech_2013_Oct_15_3(5)_365-372.txt
1.11.1.13,"...se (E.C.1.10.3.2), manganese peroxidase (MnP; E.C.1.11.1.13), and lignin peroxidase (LiP; E.C.1.11.1...",13,310,3_Biotech_2013_Oct_15_3(5)_365-372.txt
1.11.1.14,"...; E.C.1.11.1.13), and lignin peroxidase (LiP; E.C.1.11.1.14), enzymes that modify lignin. Various re...",13,354,3_Biotech_2013_Oct_15_3(5)_365-372.txt
1.10.3.2,... β-Glucosidase activities. Laccase activity (E.C. 1.10.3.2) was determined by monitoring the A420 ch...,34,473,3_Biotech_2013_Oct_15_3(5)_365-372.txt
1.11.1.13,"...xtract. Manganese peroxidase (MnP) activity (E.C. 1.11.1.13) was measured by oxidation of 2, 6-dimet...",34,887,3_Biotech_2013_Oct_15_3(5)_365-372.txt
EC 3.2.1.8,...min under the standard assay condition. Xylanase (EC 3.2.1.8) activity was determined according to B...,34,1479,3_Biotech_2013_Oct_15_3(5)_365-372.txt
EC 3.1.3.1,...ric monoester phosphohydrolase (alkaline optimum) EC 3.1.3.1] are a group of phosphatidylinositol-an...,10,92,3_Biotech_2013_Dec_6_3(6)_517-520.txt
EC 3.2.1.7,"...al inulinases (β-2,1-d-fructan fructanohydrolase, EC 3.2.1.7) appears to be an interesting alternati...",10,374,3_Biotech_2013_Dec_3_3(6)_509-515.txt
3.31.3.168,...Korean J Med Mycol 2003 31 168 174 10.4489/KJM.2003.31.3.168,223,168,3_Biotech_2014_Feb_19_4(1)_1-12.txt
5.33.4.235,...Nepal Mycobiology 2005 33 235 239 10.4489/MYCO.2005.33.4.235 24049507,264,138,3_Biotech_2014_Feb_19_4(1)_1-12.txt
4.37.4.466,...iochem Mol Biol 2004 37 466 473 10.5483/BMBRep.2004.37.4.466 15469735,289,209,3_Biotech_2014_Feb_19_4(1)_1-12.txt
EC 3.5.1.41,"...s over chemical process. Chitin deacetylase (CDA, EC 3.5.1.41) catalyzes the deacetylation of monome...",10,1264,3_Biotech_2014_Feb_5_4(1)_33-39.txt
3.16.8.689,... Microbe Interact 2003 16 689 698 10.1094/MPMI.2003.16.8.689 12906113,155,248,3_Biotech_2014_Feb_4_4(1)_91-95.txt
1.10.3.2,"...accases (benzenediol: oxygen oxidoreductase, E.C. 1.10.3.2) are multinuclear copper-containing enzym...",10,52,3_Biotech_2014_Feb_16_4(1)_77-84.txt
1.10.3.2,Laccase activity (E.C. 1.10.3.2) was determined by measuring the oxidatio...,28,24,3_Biotech_2014_Feb_16_4(1)_77-84.txt
EC 4.6.1.1,"Adenylyl cyclase (AC, EC 4.6.1.1) catalyzes the cyclization of ATP to fo...",152,23,3_Biotech_2015_Jun_17_5(3)_317-336.txt
4.94.8.842,...nola Phytopathology 2004 94 S116 10.1094/PHYTO.2004.94.8.84,259,161,3_Biotech_2014_Apr_17_4(2)_127-136.txt
EC 3.1.1.20,"Tannin acyl hydrolase (EC 3.1.1.20), commonly known as tannase, catalyses...",10,24,3_Biotech_2014_Apr_25_4(2)_159-166.txt
3.1.1.20,...od for determination of tannin acyl hydrolase (EC.3.1.1.20) activity Anal Biochem 2001 295 168 171 1...,347,115,3_Biotech_2014_Apr_25_4(2)_159-166.txt
3.1.1.20,...halam M   Screening of tannin acyl hydrolase (E.C.3.1.1.20) producing tannery effluent fungal isolat...,349,84,3_Biotech_2014_Apr_25_4(2)_159-166.txt
4.94.11.125,...Phytopathology 2004 94 1252 1258 10.1094/PHYTO.2004.94.11.1252 18944463,307,144,3_Biotech_2014_Jun_20_4(3)_305-315.txt
EC 3.5.4.4,... (Gayathri et al. 2010). Adenosine deaminase-ADA (EC 3.5.4.4) is a zinc-metallo enzyme involved in p...,10,343,3_Biotech_2014_Jun_7_4(3)_235-239.txt
2.40.4.231,...rea Mycobiology 2012 40 4 231 235 10.5941/MYCO.2012.40.4.231 23323047,373,177,PMC5042905.txt
EC 3.2.1.8,"...res the cumulative action of endo-β-1,4-xylanase (EC 3.2.1.8), β-xylosidase (EC 3.2.1.37), and a ser...",10,374,3_Biotech_2014_Aug_18_4(4)_345-356.txt
EC 3.2.1.37,"...f endo-β-1,4-xylanase (EC 3.2.1.8), β-xylosidase (EC 3.2.1.37), and a series of enzymes that degrade...",10,401,3_Biotech_2014_Aug_18_4(4)_345-356.txt
EC 3.5.5.1,"Nitrilase (EC 3.5.5.1), nitrile hydratase (EC 4.2.1.84) and a...",10,12,3_Biotech_2014_Aug_27_4(4)_375-381.txt
EC 4.2.1.84,"Nitrilase (EC 3.5.5.1), nitrile hydratase (EC 4.2.1.84) and amidase (EC 3.5.1.4) constitute a...",10,44,3_Biotech_2014_Aug_27_4(4)_375-381.txt
EC 3.5.1.4,"....1), nitrile hydratase (EC 4.2.1.84) and amidase (EC 3.5.1.4) constitute an important class of nitri...",10,70,3_Biotech_2014_Aug_27_4(4)_375-381.txt
3.2.1.4,"...ude: endoglucanases (carboxymethylcellulase, E.C. 3.2.1.4), exoglucanases (avicelase, E.C. 3.2.1.91)...",13,496,3_Biotech_2014_Aug_6_4(4)_411-424.txt
3.2.1.91,"...se, E.C. 3.2.1.4), exoglucanases (avicelase, E.C. 3.2.1.91), and cellobiases (β-glucosidase, E.C. 3....",13,537,3_Biotech_2014_Aug_6_4(4)_411-424.txt
3.2.1.21,".... 3.2.1.91), and cellobiases (β-glucosidase, E.C. 3.2.1.21) (Lynd et al. 2002). Among the group of c...",13,585,3_Biotech_2014_Aug_6_4(4)_411-424.txt
3.2.1.4,"The endoglucanase gene sequences (EC, 3.2.1.4) of B. subtilis were retrieved from GenBan...",46,39,3_Biotech_2014_Oct_28_4(5)_461-465.txt
1.46.2.62,...s Korean J Hematol 2011 46 2 62 64 10.5045/kjh.2011.46.2.62 21747874,210,137,3_Biotech_2014_Dec_18_4(6)_635-645.txt
EC 3.5.1.1,"l-Asparaginase (l-asparagine amidohydrolase, EC 3.5.1.1) is an important enzyme that has applic...",13,46,3_Biotech_2014_Dec_13_4(6)_647-653.txt
2.1.3.3,"...e credited.Ornithine transcarbamylase (OTC) (E.C. 2.1.3.3) is one of the enzymes in the urea cycle, ...",4,268,3_Biotech_2014_Dec_24_4(6)_621-634.txt
EC 3.2.1.29,"... β-1, 4 N-acetyl glucosaminidases. Exochitinases (EC 3.2.1.29), the objective of this study, catalyz...",12,234,3_Biotech_2016_Dec_11_6(1)_29.txt
EC 3.2.1.4,"Cellulase (EC 3.2.1.4), invertase activity (EC 3.2.1.26) and ...",71,12,3_Biotech_2015_Feb_18_5(1)_13-21.txt
EC 3.2.1.26,"Cellulase (EC 3.2.1.4), invertase activity (EC 3.2.1.26) and amylase activity (EC 3.2.1.1",71,45,3_Biotech_2015_Feb_18_5(1)_13-21.txt
EC 3.2.1.1,...tase activity (EC 3.2.1.26) and amylase activity (EC 3.2.1.1,71,80,3_Biotech_2015_Feb_18_5(1)_13-21.txt
1.91.1.35,...s  spp Phytopathol 2001 91 35 43 10.1094/PHYTO.2001.91.1.35,441,227,3_Biotech_2015_Feb_19_5(1)_45-60.txt
1.91.1.44,...cteria Phytopathol 2001 91 44 54 10.1094/PHYTO.2001.91.1.44,444,239,3_Biotech_2015_Feb_19_5(1)_45-60.txt
5.38.6.668,...iochem Mol Biol 2006 38 668 675 10.5483/BMBRep.2005.38.6.668 16336781,254,210,3_Biotech_2015_Apr_29_5(2)_129-151.txt
3.2.1.78,β-Mannanase (E.C. 3.2.1.78) is a key softwood-specific accessory enz...,16,19,3_Biotech_2015_Apr_6_5(2)_221-225.txt
3.2.1.21,...value is presented in Fig. 1. β-Glucosidase (E.C. 3.2.1.21) and β-mannosidase (E.C. 3.2.1.25) activi...,33,1112,3_Biotech_2015_Apr_6_5(2)_221-225.txt
3.2.1.25,...ucosidase (E.C. 3.2.1.21) and β-mannosidase (E.C. 3.2.1.25) activity were each measured using 10 mM ...,33,1146,3_Biotech_2015_Apr_6_5(2)_221-225.txt
EC 4.1.99.4,"...is physiological crisis, an enzyme ACC deaminase (EC 4.1.99.4) produced by many soil microflora incl...",116,64,3_Biotech_2015_Apr_12_5(2)_111-121.txt
EC 1.10.3.2,"Laccases (benzenediol:oxygen oxidoreductases; EC 1.10.3.2) are multicopper oxidases, which catal...",10,47,3_Biotech_2015_Apr_23_5(2)_175-185.txt
3.93.3.286,...s Phytopathology 2003 93 286 292 10.1094/PHYTO.2003.93.3.286 18944338,155,277,3_Biotech_2015_Jun_17_5(3)_245-252.txt
EC 3.2.1.4,"...lucanases (or 1,4-β-d-glucan-4-glucanohydrolases, EC 3.2.1.4), commonly referred to as endoglucanase...",136,65,3_Biotech_2015_Aug_21_5(4)_337-353.txt
EC 3.2.1.91,"...-glucanase (or 1,4-β-d-glucan cellobiohydrolases, EC 3.2.1.91) cleave cellobiose units from the non-...",139,62,3_Biotech_2015_Aug_21_5(4)_337-353.txt
EC 3.2.1.74,"...)-glucosidase (or 1,4-β-d-Glucan glucohydrolases, EC 3.2.1.74) cleaves glucose units successively fr...",139,210,3_Biotech_2015_Aug_21_5(4)_337-353.txt
EC 3.2.1.21,"β-glucosidase (or β-d-glucoside glucohydrolase, EC 3.2.1.21) hydrolyzes cellobiose and other very ...",142,49,3_Biotech_2015_Aug_21_5(4)_337-353.txt
2.45.1.14,...e library BMB Rep 2011 45 14 19 10.5483/BMBRep.2012.45.1.14 22281007,128,151,3_Biotech_2015_Aug_19_5(4)_553-559.txt
1.85.12.126,...robin Plant Dis 2001 85 1264 1270 10.1094/PDIS.2001.85.12.1264,194,144,3_Biotech_2016_Dec_5_6(1)_8.txt
4.94.11.127,...topathology 2004 94 11 1272 1275 10.1094/PHYTO.2004.94.11.1272 18944466,207,197,3_Biotech_2016_Dec_5_6(1)_8.txt
3.87.3.208,...ation Plant Dis 2003 87 3 208 222 10.1094/PDIS.2003.87.3.208,211,147,3_Biotech_2016_Dec_5_6(1)_8.txt
EC 3.2.1.23,"β-d-Galactosidase (EC 3.2.1.23, β-d galactoside, galactohydrolase, la...",13,20,3_Biotech_2015_Aug_15_5(4)_411-421.txt
2.8.1.1,"...nide sulfurtransferases (TST) or rhodaneses (E.C. 2.8.1.1), catalyze the transfer of a sulfane sulfu...",12,70,3_Biotech_2015_Aug_2_5(4)_513-521.txt
3.1.1.3,...of reactions under mild conditions. Lipases (E.C. 3.1.1.3) are the members of the hydrolase family a...,17,486,3_Biotech_2015_Oct_4_5(5)_847-851.txt
EC 2.5.1.47,...radford (1976) using BSA as standard. The OAS-TL (EC 2.5.1.47) activity was assayed by measuring the...,26,482,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 6.3.2.2,"...560 nm following Gaitonde (1967). Assay of γ-ECS (EC 6.3.2.2), PC synthase (PCS; EC 2.3.2.15) and LC...",26,716,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 2.3.2.15,"...). Assay of γ-ECS (EC 6.3.2.2), PC synthase (PCS; EC 2.3.2.15) and LCD (EC 4.4.1.1) was done by foll...",26,747,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 4.4.1.1,"...6.3.2.2), PC synthase (PCS; EC 2.3.2.15) and LCD (EC 4.4.1.1) was done by following Seelig and Meist...",26,769,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 4.4.1.15,"...995), and Bloem et al. (2004), respectively. DCD (EC 4.4.1.15) activity was determined in the same w...",26,896,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 1.15.1.1,...ned using BSA as a standard (Bradford 1976). SOD (EC 1.15.1.1) activity was determined by nitro blue...,29,401,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 1.11.1.11,...0 % decrease of SOD-inhibited NBT reduction. APX (EC 1.11.1.11) activity (nmol AsA oxidized min−1 mg...,29,675,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 1.8.5.1,...e absorbance at 290 nm (ε = 2.8 mM−1 cm−1). DHAR (EC 1.8.5.1) and GR (EC 1.6.4.2) activity was measu...,29,898,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 1.6.4.2,...nm (ε = 2.8 mM−1 cm−1). DHAR (EC 1.8.5.1) and GR (EC 1.6.4.2) activity was measured following the pr...,29,918,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 1.11.1.6,"...Carlberg and Mannervik (1985), respectively. CAT (EC 1.11.1.6) extraction was performed in a 50-mM T...",29,1056,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 2.5.1.18,"...25 °C, as detailed earlier (Talukdar 2013). GSTs (EC 2.5.1.18) specific activity was assayed followi...",29,1274,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 1.1.3.15,...ivity was assayed following Li et al. (1995). GO (EC 1.1.3.15) activity was assayed by the formation...,29,1349,3_Biotech_2015_Oct_4_5(5)_819-829.txt
EC 3.5.1.1,L-Asparaginase (L-asparagine amidohydrolase: EC 3.5.1.1) catalyzes the hydrolysis of L-Asn to L...,14,46,3_Biotech_2015_Oct_4_5(5)_783-789.txt
1.73.2.112,... J Vitam Nutr Res 2003 73 112 119 10.1024/0300-9831.73.2.112 12747218,178,113,3_Biotech_2015_Oct_19_5(5)_633-640.txt
EC 3.1.1.3,"... lipases. Lipases (triacylglycerol acylhydrolase, EC 3.1.1.3) are produced by microorganisms, plants...",13,610,3_Biotech_2015_Oct_7_5(5)_715-725.txt
EC 3.1.1.11,...ayani et al. 2005; Gonzalez and Rosso 2011). PME (EC 3.1.1.11) is responsible for pectin degradation...,42,973,3_Biotech_2016_Dec_31_6(1)_4.txt
3.16.4.295,... Microbe Interact 2003 16 295 305 10.1094/MPMI.2003.16.4.295 12744458,212,222,3_Biotech_2015_Dec_13_5(6)_1007-1019.txt
EC 3.2.1.8,"(1,4-β-xylan xylanohydrolase; EC 3.2.1.8), which release long and short xylo-oli...",58,31,3_Biotech_2015_Dec_3_5(6)_1053-1066.txt
EC 3.2.1.37,"...s, and β-d-xylosidase (1,4-β-xylan xylohydrolase; EC 3.2.1.37), which remove d-xylose residues from ...",59,96,3_Biotech_2015_Dec_3_5(6)_1053-1066.txt
1.10.3.2,"... Laccases (benzenediol:oxygen oxidoreductase, E.C.1.10.3.2) are copper-containing oxidoreductases pr...",17,882,3_Biotech_2015_Dec_10_5(6)_911-924.txt
3.2.1.91,"...g the synergistic action of exo-β-1, 4 glucanase (3.2.1.91), endo- β-1, 4 glucanase (3.2.1.4) and β-...",12,95,3_Biotech_2015_Dec_19_5(6)_883-892.txt
3.2.1.4,"..., 4 glucanase (3.2.1.91), endo- β-1, 4 glucanase (3.2.1.4) and β-glucosidase (3.2.1.21). Cellulolyti...",12,130,3_Biotech_2015_Dec_19_5(6)_883-892.txt
3.2.1.21,"...do- β-1, 4 glucanase (3.2.1.4) and β-glucosidase (3.2.1.21). Cellulolytic enzymes can be produced up...",12,158,3_Biotech_2015_Dec_19_5(6)_883-892.txt
3.5.1.1,...ndicate if changes were made.l-Asparaginase (E.C. 3.5.1.1) is used as an anti-neoplastic drug in the...,4,425,3_Biotech_2015_Dec_5_5(6)_975-981.txt
2.92.10.113,...Phytopathology 2002 92 1134 1141 10.1094/PHYTO.2002.92.10.1134 18944224,240,223,3_Biotech_2015_Dec_23_5(6)_1089-1100.txt
EC 3.2.1.4,...y three enzymes are involved; endo-β-d-glucanase (EC 3.2.1.4) which catalyzes the random hydrolysis ...,14,701,3_Biotech_2015_Dec_27_5(6)_1101-1106.txt
EC 3.2.1.19,...nd insoluble cellulose chains. Exo-β-d-glucanase (EC 3.2.1.19) aids in releasing cellobiose from red...,14,813,3_Biotech_2015_Dec_27_5(6)_1101-1106.txt
EC 3.2.1.37,...biose to glucose is carried out by β-glucosidase (EC 3.2.1.37) (Bhat and Bhat 1997; Bhat 2000; Sohai...,14,978,3_Biotech_2015_Dec_27_5(6)_1101-1106.txt
6.4.1.2,...1994). Acetyl-coenzyme A carboxylase (ACCase) (EC.6.4.1.2) is a key enzyme in fatty acid biosynthesi...,12,352,3_Biotech_2016_Dec_5_6(1)_12.txt
EC 1.10.3.2,"...gal laccase (benzene diol: oxygen oxidoreductase, EC 1.10.3.2) along with ferroxidases (EC 1.16.3.1)...",10,728,3_Biotech_2016_Dec_6_6(1)_15.txt
EC 1.16.3.1,"...oreductase, EC 1.10.3.2) along with ferroxidases (EC 1.16.3.1) and ascorbate oxidase (EC 1.10.3.3) f...",10,766,3_Biotech_2016_Dec_6_6(1)_15.txt
EC 1.10.3.3,...ferroxidases (EC 1.16.3.1) and ascorbate oxidase (EC 1.10.3.3) from the family of extranuclear multi...,10,802,3_Biotech_2016_Dec_6_6(1)_15.txt
EC 1.10.3.2,"Laccase (EC 1.10.3.2, p-benzenediol: oxygen oxidoreductase)...",156,10,3_Biotech_2016_Dec_6_6(1)_15.txt
3.2.1.21,...idases (β-d-glucopyrranoside glucohydrolase) [E.C.3.2.1.21] are the enzymes which hydrolyze the glyc...,10,59,3_Biotech_2016_Dec_31_6(1)_3.txt
3.2.1.4,"...nzymes: endoglucanase (endo-1, 4–β-glucanase [E.C.3.2.1.4]), exoglucanase (cellobiohydrolase) (exo-1...",10,1409,3_Biotech_2016_Dec_31_6(1)_3.txt
3.2.1.91,"...se (cellobiohydrolase) (exo-1, 4-β-glucanase [E.C.3.2.1.91]) and β-glucosidase (β-d-glucoside glycoh...",10,1480,3_Biotech_2016_Dec_31_6(1)_3.txt
3.2.1.21,... β-glucosidase (β-d-glucoside glycohydrolase [E.C.3.2.1.21]) (Teeri 1997). The endoglucanase randoml...,10,1544,3_Biotech_2016_Dec_31_6(1)_3.txt
EC 3.2.1.165,...s of chitosanase enzymes have been reported: exo-(EC 3.2.1.165) and endochitosanase (EC 3.2.1.132). ...,10,278,3_Biotech_2016_Dec_6_6(1)_13.txt
EC 3.2.1.132,"...reported: exo-(EC 3.2.1.165) and endochitosanase (EC 3.2.1.132). Endo-acting enzymes hydrolyse β-1,4...",10,313,3_Biotech_2016_Dec_6_6(1)_13.txt
2.21.4.141,...order Exp Neurobiol 2012 21 141 150 10.5607/en.2012.21.4.141 23319874,118,95,3_Biotech_2016_Dec_5_6(1)_11.txt
3.2.1.40,Naringinase (EC3.2.1.40) is a hydrolytic enzyme containing both α...,13,16,3_Biotech_2016_Dec_6_6(1)_14.txt
3.24.12.176,...Korean Chem Soc 2003 24 1763 1766 10.5012/bkcs.2003.24.12.1763,283,143,3_Biotech_2016_Dec_5_6(1)_9.txt
3.3.1.97,...sa  Future Microbiol 2008 3 97 106 10.2217/17460913.3.1.97 18230038,100,184,3_Biotech_2016_Dec_9_6(1)_18.txt
3.2.1.8,"...ving enzymes including endo-β-1, 4-xylanase (E.C. 3.2.1.8), β-D-xylosidase (E.C. 3.2.1.37), α-l-arab...",13,597,3_Biotech_2016_Dec_14_6(1)_30.txt
3.2.1.37,"..., 4-xylanase (E.C. 3.2.1.8), β-D-xylosidase (E.C. 3.2.1.37), α-l-arabinofuranosidase (E.C.3.2.1.39),...",13,628,3_Biotech_2016_Dec_14_6(1)_30.txt
3.2.1.39,"...ase (E.C. 3.2.1.37), α-l-arabinofuranosidase (E.C.3.2.1.39), acetyl xylan esterase (E.C. 3.1.1.72) a...",13,668,3_Biotech_2016_Dec_14_6(1)_30.txt
3.1.1.72,"...idase (E.C.3.2.1.39), acetyl xylan esterase (E.C. 3.1.1.72) and ferulic or p-coumaric acid esterase ...",13,707,3_Biotech_2016_Dec_14_6(1)_30.txt
3.2.1.73,....72) and ferulic or p-coumaric acid esterase (E.C.3.2.1.73) (Shallom and Shoham 2003). In recent yea...,13,762,3_Biotech_2016_Dec_14_6(1)_30.txt
EC 3.1.1.3,Lipases (EC 3.1.1.3) from different organisms were reported...,14,10,3_Biotech_2016_Dec_11_6(1)_24.txt
EC 3.5.4.17,...y was catalysed by adenosine-phosphate deaminase (EC 3.5.4.17) and adenylic acid deaminase (EC 3.5.4...,145,672,3_Biotech_2016_Dec_21_6(1)_34.txt
EC 3.5.4.6,...minase (EC 3.5.4.17) and adenylic acid deaminase (EC 3.5.4.6) (Yoshimune et al. 2005). The enzyme fr...,145,714,3_Biotech_2016_Dec_21_6(1)_34.txt
EC 3.5.4.4,"... identified as a nonspecific adenosine deaminase (EC 3.5.4.4, adenosine aminohydrolase) by Minato et...",145,845,3_Biotech_2016_Dec_21_6(1)_34.txt
3.1.1.11,"...be distinguished between pectinesterases (PE, E.C 3.1.1.11), which modify pectin esters into low met...",10,893,3_Biotech_2016_Dec_23_6(1)_36.txt
3.2.1.15,"...hanism. Both these endo types of PGs and PLs (E.C 3.2.1.15 and E.C 4.2.2.2, respectively) are recogn...",10,1517,3_Biotech_2016_Dec_23_6(1)_36.txt
4.2.2.2,"...e endo types of PGs and PLs (E.C 3.2.1.15 and E.C 4.2.2.2, respectively) are recognized as the arbit...",10,1534,3_Biotech_2016_Dec_23_6(1)_36.txt
3.2.1.67,"...ectin chain. Exo-polygalacturonases (exo-PGs, E.C 3.2.1.67) liberate monomers or dimmers from the no...",10,1653,3_Biotech_2016_Dec_23_6(1)_36.txt
4.2.2.9,"...e chain, whereas exopectate lyases (exo-PALs, E.C 4.2.2.9) discharge unsaturated dimers from the red...",10,1774,3_Biotech_2016_Dec_23_6(1)_36.txt
EC 3.2.1.15,"... pectin, which consist of endo-polygalacturonase (EC 3.2.1.15), exo-polygalacturonase (EC 3.2.1.67),...",10,1964,3_Biotech_2016_Dec_23_6(1)_36.txt
EC 3.2.1.67,"...lacturonase (EC 3.2.1.15), exo-polygalacturonase (EC 3.2.1.67), pectate lyase (EC 4.2.2.2), Exo-poly...",10,2001,3_Biotech_2016_Dec_23_6(1)_36.txt
EC 4.2.2.2,"...o-polygalacturonase (EC 3.2.1.67), pectate lyase (EC 4.2.2.2), Exo-poly α-galactouronosidase (E.C.3....",10,2030,3_Biotech_2016_Dec_23_6(1)_36.txt
3.2.1.82,"... (EC 4.2.2.2), Exo-poly α-galactouronosidase (E.C.3.2.1.82), pectin lyase (EC 4.2.2.10), Exo-pectate...",10,2078,3_Biotech_2016_Dec_23_6(1)_36.txt
EC 4.2.2.10,"...-galactouronosidase (E.C.3.2.1.82), pectin lyase (EC 4.2.2.10), Exo-pectatelyase (E.C.4.2.2.9), Endo...",10,2103,3_Biotech_2016_Dec_23_6(1)_36.txt
4.2.2.9,"...pectin lyase (EC 4.2.2.10), Exo-pectatelyase (E.C.4.2.2.9), Endopectin lyase (E.C.4.2.2.10) and pect...",10,2139,3_Biotech_2016_Dec_23_6(1)_36.txt
4.2.2.10,"...pectatelyase (E.C.4.2.2.9), Endopectin lyase (E.C.4.2.2.10) and pectin methyl esterase (EC 3.1.1.11)...",10,2171,3_Biotech_2016_Dec_23_6(1)_36.txt
EC 3.1.1.11,"... lyase (E.C.4.2.2.10) and pectin methyl esterase (EC 3.1.1.11). Depending on the pH optima, pectinas...",10,2209,3_Biotech_2016_Dec_23_6(1)_36.txt
3.2.1.15,...galacturonase/pectin depolymerase/pectinase (E.C. 3.2.1.15). A decrease in final pH of the medium wa...,99,491,3_Biotech_2016_Dec_23_6(1)_36.txt
6.1.2.13,... Int J Microbiol Res 2009 1 13 17 10.9735/0975-5276.1.2.13-17,548,274,3_Biotech_2016_Dec_23_6(1)_36.txt
3.1.1.3,Lipases are triacylglycerol hydrolases (E.C. 3.1.1.3) that catalyzes variety of conversion reac...,11,46,3_Biotech_2016_Dec_8_6(1)_49.txt
1.2.1.25,... assembled using DNASTAR SeqMan NGen 11 Version: 11.2.1.25 with default parameters and the targeted ...,32,394,3_Biotech_2016_Dec_27_6(1)_38.txt
4.15.13.545,... Prev APJCP 2013 15 13 5455 5461 10.7314/APJCP.2014.15.13.5455 25041018,391,246,3_Biotech_2016_Dec_27_6(1)_40.txt
4.15.22.996,...Cancer Prev 2014 15 22 9961 9966 10.7314/APJCP.2014.15.22.9961 25520136,415,247,3_Biotech_2016_Dec_27_6(1)_40.txt
3.1.1.11,...thylgalacturonate esterase (PMGE)	Pectin esterase	3.1.1.11	Pectin	Random cleavage of methyl ester gr...,16,57,3_Biotech_2016_Dec_8_6(1)_47.txt
3.2.1.15,Endopolygalacturonase (endo—PG)	Polygalacturonase	3.2.1.15	Pectate	Random cleavage of pectic acid	Ol...,22,51,3_Biotech_2016_Dec_8_6(1)_47.txt
3.2.1.67,...xopolygalacturonase 1 (exo—PG1)	Polygalacturonase	3.2.1.67	Pectate	Terminal cleavage from the non re...,23,52,3_Biotech_2016_Dec_8_6(1)_47.txt
3.2.1.82,...xopolygalacturonase 2 (exo—PG2)	Polygalacturonase	3.2.1.82	Pectate	Penultimate Cleavage	Di-galacturo...,24,52,3_Biotech_2016_Dec_8_6(1)_47.txt
4.2.2.2,Endo—PGL	Pectate lyase	4.2.2.2	Pectate	Random cleavage	Unsaturated oligo-...,30,24,3_Biotech_2016_Dec_8_6(1)_47.txt
4.2.2.9,Exo—PGL	Pectate lyase	4.2.2.9	Pectate	Cleavage of penultimate bonds from...,31,23,3_Biotech_2016_Dec_8_6(1)_47.txt
4.2.2.6,Oligogalacturonate lyase	Pectate lyase	4.2.2.6	Oligo-galacturonate	Terminal cleavage	Unsa...,32,40,3_Biotech_2016_Dec_8_6(1)_47.txt
4.2.2.10,Endo –PMGL	Pectin lyase	4.2.2.10	Pectin	Random cleavage	Unsaturated methyl...,34,25,3_Biotech_2016_Dec_8_6(1)_47.txt
EC 1.11.1.19,"...xidase (VP) and dye decolorizing peroxidase (DyP, EC 1.11.1.19) (Martínez et al. 2009; Sugano 2009)....",22,461,3_Biotech_2016_Dec_4_6(1)_46.txt
2.46.2.109,...ses Holzforschung 1992 46 109 115 10.1515/hfsg.1992.46.2.109,594,222,3_Biotech_2016_Dec_4_6(1)_46.txt
EC 1.1.1.34,...roxy-3-methylglutaryl coenzyme A reductase (HMGR; EC 1.1.1.34) (Rogers et al. 1983). Evidence for th...,15,885,3_Biotech_2016_Dec_7_6(1)_89.txt
EC 3.2.1.14,"...ct yields and environmental toxicity. Chitinases (EC 3.2.1.14) are widespread in several bacteria, a...",12,271,3_Biotech_2016_Dec_7_6(1)_87.txt
4.88.6.580,... Taiwan Plant Dis 2004 88 580 588 10.1094/PDIS.2004.88.6.580,385,164,3_Biotech_2016_Dec_13_6(1)_54.txt
5.18.2.173,... J Breast Cancer 2015 18 2 173 180 10.4048/jbc.2015.18.2.173 26155294,103,236,3_Biotech_2016_Dec_13_6(1)_58.txt
3.93.7.881,...t Phytopathology 2003 93 881 890 10.1094/PHYTO.2003.93.7.881 18943170,160,233,3_Biotech_2016_Dec_16_6(1)_76.txt
3.1.1.1,Phosphatase activity (E.C. 3.1.1.1,70,28,3_Biotech_2016_Dec_23_6(1)_78.txt
3.5.1.5,Urease activity (EC. 3.5.1.5,76,22,3_Biotech_2016_Dec_23_6(1)_78.txt
1.11.1.7,...idase (POD) activity. Peroxidase (POD) EC number (1.11.1.7) (mmol min−1 mg protein−1) activity was d...,30,518,3_Biotech_2016_Dec_8_6(1)_99.txt
1.15.1.1,...d Kirkham (1994). Superoxide dismutase (EC number 1.15.1.1) (IU min−1 mg protein−1) activity inhibit...,30,1220,3_Biotech_2016_Dec_8_6(1)_99.txt
2.15.6.577,... Microbe Interact 2002 15 577 586 10.1094/MPMI.2002.15.6.577 12059106,120,282,3_Biotech_2016_Dec_8_6(1)_99.txt
EC 1.10.3.2,"Laccase (benzenediol:oxygen oxidoreductase, EC 1.10.3.2) is one of the best-known multicopper ...",10,45,3_Biotech_2016_Dec_18_6(1)_107.txt
3.18.3.203,...Prev Nutr food Sci 2013 18 203 209 10.3746/pnf.2013.18.3.203 24471133,157,219,3_Biotech_2016_Dec_18_6(1)_104.txt
5.20.1.52,...e Prev Nutr food Sci 2015 20 52 59 10.3746/pnf.2015.20.1.52 25866750,205,205,3_Biotech_2016_Dec_18_6(1)_104.txt
3.18.3.196,...Prev Nutr Food Sci 2013 18 196 202 10.3746/pnf.2013.18.3.196 24471132,224,168,3_Biotech_2016_Dec_19_6(1)_109.txt
3.2.1.26,"..., and indicate if changes were made.Invertase (EC.3.2.1.26) catalyzes the hydrolysis of sucrose to a...",4,418,PMC4909026.txt
EC 3.2.1.26,Invertases [β-d-fructofuranoside fructohydrolase (EC 3.2.1.26)] are disaccharidases which belong to ...,10,51,PMC4909026.txt
3.2.1.8,"...on. Among these enzymes, endo-β-1,4-xylanases (EC.3.2.1.8) are the most important xylanolytic enzyme...",10,654,PMC4909030.txt
EC 3.1.1.3,"Lipases (triacylglycerol acylhydrolases, EC 3.1.1.3) are enzymes that catalyse the hydrolys...",12,42,PMC4909032.txt
EC 3.2.1.78,"...tion of β-mannanase (1,4-β-mannan mannohydrolases EC 3.2.1.78), which releases manno-oligosaccharide...",18,120,PMC4912962.txt
EC 3.2.1.78,"...clude β-mannanase (1,4-β-d-mannan mannohydrolase, EC 3.2.1.78), β-mannosidase (1,4-β-d-mannopyranosi...",18,280,PMC4912962.txt
EC 3.2.1.25,"...β-mannosidase (1,4-β-d-mannopyranoside hydrolase, EC 3.2.1.25), β-glucosidase (1,4-β-d-glucoside glu...",18,344,PMC4912962.txt
EC 3.2.1.21,"... β-glucosidase (1,4-β-d-glucoside glucohydrolase, EC 3.2.1.21) and α-galactosidase (1,4-α-d–galactos...",18,407,PMC4912962.txt
EC 3.2.1.22,"...actosidase (1,4-α-d–galactoside galactohydrolase, EC 3.2.1.22). Enzymatic synthesis of MOS from low-...",18,479,PMC4912962.txt
EC 3.2.1.83,"...degrade carrageenans, are called κ-carrageenases (EC 3.2.1.83), ι-carrageenases (EC 3.2.1.157), and ...",51,313,PMC4919138.txt
EC 3.2.1.157,"...d κ-carrageenases (EC 3.2.1.83), ι-carrageenases (EC 3.2.1.157), and λ-carrageenases (EC 3.2.1.162)....",51,344,PMC4919138.txt
EC 3.2.1.162,"...arrageenases (EC 3.2.1.157), and λ-carrageenases (EC 3.2.1.162). They all are endohydrolases that cl...",51,380,PMC4919138.txt
3.1.1.74,...gether via ester bonds. Cutinase/cutin hydrolase (3.1.1.74) secreted by phytopathogenic microorganis...,10,390,PMC4927439.txt
EC 1.14.18.1,...ic assay of tyrosinase catechol oxidase activity (EC 1.14.18.1) J Biol Chem 1973 248 4035 4039 41965...,124,90,3_Biotech_2013_Jun_7_3(3)_187-194.txt
1.14.99.1,"...-endoperoxide synthase (PTGS), an enzyme (EC No.: 1.14.99.1) which is responsible for the formation ...",14,2507,3_Biotech_2015_Aug_7_5(4)_541-551.txt
EC 3.2.1.91,"...f enzymatic complexes namely, cellobiohydrolases (EC 3.2.1.91), endoglucanases or CMCases (EC 3.2.1....",12,795,PMC4978645.txt
EC 3.2.1.4,"...rolases (EC 3.2.1.91), endoglucanases or CMCases (EC 3.2.1.4) and β-glucosidases (EC 3.2.1.21), acti...",12,836,PMC4978645.txt
EC 3.2.1.21,"...nases or CMCases (EC 3.2.1.4) and β-glucosidases (EC 3.2.1.21), acting synergistically to convert co...",12,868,PMC4978645.txt
EC 3.2.1.8,"...res different xylanolytic enzymes, like xylanase (EC 3.2.1.8), β-xylosidase (EC 3.2.1.37), α-l-arabi...",16,388,PMC4980835.txt
EC 3.2.1.37,"...nzymes, like xylanase (EC 3.2.1.8), β-xylosidase (EC 3.2.1.37), α-l-arabinofuranosidase (EC 3.2.1.55...",16,415,PMC4980835.txt
EC 3.2.1.55,"...ylosidase (EC 3.2.1.37), α-l-arabinofuranosidase (EC 3.2.1.55), α-d-glucuronidase (EC 3.2.1.139), an...",16,454,PMC4980835.txt
EC 3.2.1.139,"...inofuranosidase (EC 3.2.1.55), α-d-glucuronidase (EC 3.2.1.139), and acetyl xylan esterase (EC 3.1.1...",16,487,PMC4980835.txt
EC 3.1.1.72,"...nidase (EC 3.2.1.139), and acetyl xylan esterase (EC 3.1.1.72) (Beg et al. 2001). Crude enzyme prepa...",16,529,PMC4980835.txt
EC 3.2.1.8,"...terase) (Beg et al. 2001). Among them, xylanases (EC 3.2.1.8) deserve special attention as they degr...",15,518,PMC4987633.txt
2.1.1.19,"...made.Cyclodextrin glucanotransferase (CGTase, EC. 2.1.1.19) produced using new alkaliphile Microbact...",4,449,PMC4987636.txt
3.2.3.323,...s  Future Microbiol 2007 2 323 334 10.2217/17460913.2.3.323 17661706,173,145,PMC4987631.txt
EC 1.15.1.1,SOD (EC 1.15.1.1) activities were determined by measuri...,47,6,PMC4988954.txt
EC 3.2.1.26,"... sacrosidase (β-fructofuranoside fructohydrolase, EC 3.2.1.26) enzyme is given orally to facilitate ...",30,863,PMC4991975.txt
EC 4.3.1.24,"... 1999). In addition, phenylalanine ammonia lyase (EC 4.3.1.24) is used to degrade phenylalanine in g...",30,997,PMC4991975.txt
EC 3.4.21.62,"...lot busting by fibrinolytic enzymes. Nattokinase (EC 3.4.21.62), a potent fibrinolytic enzyme, is a ...",249,266,PMC4991975.txt
EC 2.4.1.2,"...987; Cho et al. 2010). Acid protease, dextranase (EC 2.4.1.2) and rhodanase (EC 2.8.1.1) may be used...",249,419,PMC4991975.txt
EC 2.8.1.1,"... protease, dextranase (EC 2.4.1.2) and rhodanase (EC 2.8.1.1) may be used to treat alimentary dyspep...",249,446,PMC4991975.txt
EC 3.1.1.3,"...e poisoning, respectively (Okafor 2007). Lipases (EC 3.1.1.3) are the most frequently used enzymes i...",249,573,PMC4991975.txt
EC 1.10.3.2,"...1999). Microbial lipases and polyphenol oxidases (EC 1.10.3.2) are involved in the synthesis of (2R,...",249,826,PMC4991975.txt
EC 1.14.18.1,"... disease), respectively (Faber 1997). Tyrosinase (EC 1.14.18.1), an important oxidase enzyme, is inv...",249,1070,PMC4991975.txt
EC 3.2.1.132,...Haq et al. 2002; Zaidi et al. 2014). Chitosanase (EC 3.2.1.132) catalyze hydrolysis of chitosan to b...,249,1437,PMC4991975.txt
EC 1.1.3.4,"...r health disorders, for example, glucose oxidase (EC 1.1.3.4) for glucose; urease (EC 3.5.1.5) and g...",293,159,PMC4991975.txt
EC 3.5.1.5,...glucose oxidase (EC 1.1.3.4) for glucose; urease (EC 3.5.1.5) and glutamate dehydrogenase (EC 1.4.1....,293,192,PMC4991975.txt
EC 1.4.1.2,"... urease (EC 3.5.1.5) and glutamate dehydrogenase (EC 1.4.1.2) for urea; lipase, carboxyl esterase, a...",293,233,PMC4991975.txt
EC 1.7.3.3,...glycerol kinase for triglycerides; urate oxidase (EC 1.7.3.3) for uric acid; creatinase (EC 3.5.3.3)...,293,336,PMC4991975.txt
EC 3.5.3.3,...e oxidase (EC 1.7.3.3) for uric acid; creatinase (EC 3.5.3.3) and sarcosine oxidases (EC 1.5.3.1) fo...,293,375,PMC4991975.txt
EC 1.5.3.1,...; creatinase (EC 3.5.3.3) and sarcosine oxidases (EC 1.5.3.1) for creatinine (Dordick 2013; Le Roes-...,293,411,PMC4991975.txt
EC 1.1.3.6,...e Roes-Hill and Prins 2016). Cholesterol oxidase (EC 1.1.3.6) has also been reported for useful biot...,293,504,PMC4991975.txt
EC 1.4.3.10,"...nd conversion of cholesterol. Putrescine oxidase (EC 1.4.3.10) is used to detect biogenic amines, su...",293,648,PMC4991975.txt
EC 3.2.1.8,"...nd shelf life. Additionally, lipase and xylanase (EC 3.2.1.8) are used for dough stability and condi...",305,394,PMC4991975.txt
EC 2.3.2.13,...gh strengthening and whiteness. Transglutaminase (EC 2.3.2.13) is used in baking industry to enhance...,305,561,PMC4991975.txt
EC 3.2.1.23,"...ency of lactase enzyme. Lactase (β-galactosidase, EC 3.2.1.23) catalyzes hydrolysis of lactose to gl...",312,140,PMC4991975.txt
EC 3.2.1.40,"...hyap et al. 2001; Garg et al. 2016). Naringinase (EC 3.2.1.40) and limoninase, debittering enzymes, ...",317,1127,PMC4991975.txt
EC 3.2.1.15,"...gulate cloudiness of juices by polygalacturonase (EC 3.2.1.15), pectin esterases (EC 3.1.1.11), pect...",317,1458,PMC4991975.txt
EC 3.1.1.11,"...olygalacturonase (EC 3.2.1.15), pectin esterases (EC 3.1.1.11), pectin lyase (EC 4.2.2.10) and vario...",317,1490,PMC4991975.txt
EC 4.2.2.10,"...5), pectin esterases (EC 3.1.1.11), pectin lyase (EC 4.2.2.10) and various arabanases (Kashyap et al...",317,1518,PMC4991975.txt
EC 1.10.3.2,"...es involved in biopolymer industries are laccase (EC 1.10.3.2), peroxidase and transglutaminase for ...",329,799,PMC4991975.txt
EC 1.15.1.1,"... (Li et al. 2012). The superoxide dismutase (SOD, EC 1.15.1.1) is used to arrest free radicals and t...",381,237,PMC4991975.txt
EC 3.1.1.74,"...ucts, respectively (Masse et al. 2001). Cutinase (EC 3.1.1.74), a hydrolytic enzyme, is used as a li...",388,156,PMC4991975.txt
EC 3.1.3.2,The activity of acid phosphatase (EC 3.1.3.2) and β-glucosidase (EC 3.2.1.21) were d...,62,35,PMC5009054.txt
EC 3.2.1.21,... acid phosphatase (EC 3.1.3.2) and β-glucosidase (EC 3.2.1.21) were determined as described by Eivaz...,62,66,PMC5009054.txt
EC 3.4.21.19,The activity of protease (EC 3.4.21.19) was measured using tyrosine as stand...,64,27,PMC5009054.txt
EC 1.10.3.2,"Laccases (benzenediol:oxygen oxidoreductases, EC 1.10.3.2) are blue multicopper oxidases that ca...",14,47,PMC5010537.txt
6.1.2.9,...nt J Microbiol Res 2009 1 2 09 12 10.9735/0975-5276.1.2.9-12,244,299,PMC5010537.txt
EC 3.2.1.15,Polygalacturonases (PGs) (EC 3.2.1.15) are important member of pectinases wh...,10,27,PMC5033773.txt
3.2.1.15,"...e substrate, PGs are classified as endo-PGs (E.C. 3.2.1.15) and exo-PGs (EC 3.2.1.67). The endo-PGs ...",10,264,PMC5033773.txt
EC 3.2.1.67,"...assified as endo-PGs (E.C. 3.2.1.15) and exo-PGs (EC 3.2.1.67). The endo-PGs cleave the α-1,4-D-gala...",10,287,PMC5033773.txt
3.2.1.21,β-glucosidase (E.C.3.2.1.21) comes from widespread sources including ...,16,20,PMC5047857.txt
1.14.14.1,"...Cytochrome P450 1A2 (CYP1A2), a monooxygenase [EC:1.14.14.1], catalyzes the conversion of caffeine t...",190,99,PMC5116299.txt
1.39.3.174,...UK-10 Mycobiology 2011 39 174 181 10.5941/MYCO.2011.39.3.174 22783100,790,222,PMC5055877.txt
3.6.5.24,...id Inf Technol 2013 6 5 255 268 10.14257/ijhit.2013.6.5.2,220,156,PMC5065543.txt
EC 3.2.1.4,"...tain endoglucanases [endo-1,4-β-glucanases (EGs); EC 3.2.1.4], exoglucanases [exo-1,4-β-glucanases (...",13,1248,PMC5095100.txt
EC 3.2.1.91,"...1.4], exoglucanases [exo-1,4-β-glucanases (CBHs); EC 3.2.1.91], and β-glucosidases [β-d-glucohydrola...",13,1305,PMC5095100.txt
EC 3.2.1.21,"..., and β-glucosidases [β-d-glucohydrolases (BGLs); EC 3.2.1.21] (Garvey et al. 2013). EGs and CBHs sy...",13,1367,PMC5095100.txt
EC 1.11.1.11,APX (EC 1.11.1.11) activity was determined in a reactio...,61,6,PMC5110483.txt
EC 1.11.1.6,CAT (EC 1.11.1.6) activity was assayed in the presence ...,63,6,PMC5110483.txt
EC 1.15.1.1,SOD (EC 1.15.1.1) activity was measured spectrophotomet...,65,6,PMC5110483.txt
4.17.5.484,... Microbe Interact 2004 17 484 490 10.1094/MPMI.2004.17.5.484 15141952,143,288,PMC5114211.txt
5.42.3.168,...J Plant Biotechnol 2015 42 168 179 10.5010/JPB.2015.42.3.168,196,234,PMC5114211.txt
3.3.2.88,...on Int J Drug Discov 2011 3 88 99 10.9735/0975-4423.3.2.88-99,239,172,PMC5234526.txt
3.2.1.22,...lactosidase (α-d-galactoside galactohydrolase EC. 3.2.1.22) is an exoglycosidase which catalyses hyd...,15,55,PMC5148754.txt
EC 3.5.1.1,l-asparaginase or l-asparagine amidohydrolase (EC 3.5.1.1) is an enzyme that catalyses the conver...,10,48,AAPS_J_2014_May_23_16(4)_784-790.txt
1.3.8.841,...rt Opin Drug Discov 2008 3 841 851 10.1517/17460441.3.8.841 23484962,206,126,AAPS_J_2012_Jan_27_14(1)_133-141.txt
5.4.10.124,...rug Metab Toxicol 2008 4 1245 1264 10.1517/17425255.4.10.1245 18798696,475,216,AAPS_J_2012_Jan_4_14(1)_87-96.txt
6.7.8.104,...in Pharmacother 2006 7 8 1041 1053 10.1517/14656566.7.8.1041 16722814,250,130,AAPS_J_2012_Mar_10_14(2)_282-295.txt
3.14.2.202,...ls Korean J Radiol 2013 14 202 212 10.3348/kjr.2013.14.2.202 23483022,127,261,Abdom_Imaging_2015_Oct_21_40(4)_776-782.txt
3.2.1.1,"...position on a 3 T static magnet (Phillips Achieva 3.2.1.1, Philips Achieva, Philips Healthcare, Best...",38,157,Abdom_Radiol_(NY)_2016_Feb_11_41_1261-1269.txt
4.47.6.523,...’s view Clin Endosc 2014 47 523 529 10.5946/ce.2014.47.6.523 25505718,155,144,Abdom_Radiol_(NY)_2016_Jul_12_41(11)_2089-2094.txt
6.36.3.296,...fe Threat Behav 2006 36 3 296 301 10.1521/suli.2006.36.3.296 16805657,156,131,Acad_Psychiatry_2016_Dec_14_40_623-629.txt
1.11.3.347,...l Public Policy Law 2005 11 3 347 10.1037/1076-8971.11.3.347,165,147,Acad_Psychiatry_2016_Dec_14_40_623-629.txt
1.14.99.3,The eukaryotic heme oxygenases (HOs) (E.C. 1.14.99.3) convert hem,14,44,Acc_Chem_Res_2014_Aug_19_47(8)_2291-2298.txt
3.3.1.1,"...(22), where PTA = 1,3,5-triaza-7-phosphatricyclo-[3.3.1.1]decane",398,73,Acc_Chem_Res_2014_Apr_15_47(4)_1174-1185.txt
4.28.12.1,"2006 , 28 , 4.28.12.1 .b Rokita S. E.  Quinone Methides ; John...",739,13,Acc_Chem_Res_2014_Dec_16_47(12)_3655-3664.txt
EC 3.1.26.4,"HI (EC 3.1.26.4, RNase H), AlkB (EC 1.14.11.33), and t...",165,5,Acc_Chem_Res_2015_Feb_17_48(2)_457-465.txt
EC 1.14.11.33,"HI (EC 3.1.26.4, RNase H), AlkB (EC 1.14.11.33), and triosephosphat",165,34,Acc_Chem_Res_2015_Feb_17_48(2)_457-465.txt
EC 5.3.1.1,"isomerase (EC 5.3.1.1, TIM), that have been studied in my lab...",166,12,Acc_Chem_Res_2015_Feb_17_48(2)_457-465.txt
EC 5.3.1.1,"The enzyme triosephosphate isomerase (EC 5.3.1.1, TIM) catalyze",388,39,Acc_Chem_Res_2015_Feb_17_48(2)_457-465.txt
2.5.1.4,"...ren G. L. ; Ellingson B. A. ; Stahl M. T.   OMEGA 2.5.1.4: OpenEye Scientific Software, Santa Fe, NM...",670,92,Acc_Chem_Res_2015_Mar_17_48(3)_752-760.txt
2.2.2.1,2.2.2.1 Road safet,49,1,Accid_Anal_Prev_2016_Jan_86_108-113.txt
2.2.2.2,2.2.2.2 Substance perceptions and us,52,1,Accid_Anal_Prev_2016_Jan_86_108-113.txt
2.2.2.3,2.2.2.3 Hospital attendanc,57,1,Accid_Anal_Prev_2016_Jan_86_108-113.txt
1.7.99.3,"...In nature, Cu-containing nitrite reductases (E.C. 1.7.99.3",88,62,ACS_Appl_Mater_Interfaces_2014_Mar_26_6(6)_3779-3783.txt
2.6.2.1,2.6.2.1 Hematoxyli,295,1,ACS_Appl_Mater_Interfaces_2014_Jul_9_6(13)_9955-9965.txt
2.6.2.2,2.6.2.2 Tartrate Resistant Acid Phosphatase (TRAP,306,1,ACS_Appl_Mater_Interfaces_2014_Jul_9_6(13)_9955-9965.txt
2.6.2.3,2.6.2.3 Histomorphometri,319,1,ACS_Appl_Mater_Interfaces_2014_Jul_9_6(13)_9955-9965.txt
6.14.6.859,"2004 , 14 , 859 –894 10.1517/13543776.14.6.859",932,37,ACS_Appl_Mater_Interfaces_2015_Aug_26_7(33)_18707-18716.txt
1.3.3.3,(Project No. 1.3.3.3). The device processing has been performed...,538,14,ACS_Appl_Mater_Interfaces_2016_Oct_5_8(39)_26198-26206.txt
4.10.2.309,"2001 , 10 , 309 –320 10.1517/13543784.10.2.309",838,37,ACS_Appl_Mater_Interfaces_2016_Sep_21_8(37)_24909-24917.txt
5.3.4.18,"was performed using Astra VI software (version 5.3.4.18), Wyatt Technologie",179,48,ACS_Biomater_Sci_Eng_2016_Jan_11_2(1)_43-55.txt
6.18.3.235,"2006 , 18 , 235 –49 10.1179/joc.2006.18.3.235 .17129833",891,36,ACS_Biomater_Sci_Eng_2016_Jan_11_2(1)_112-121.txt
1.32.10.364,"2011 , 32 10 3644 –3649 10.5012/bkcs.2011.32.10.3644",1184,41,PMC5350605.txt
EC 1.3.1.31,Yellow Enzyme (OYE) family [EC 1.3.1.31] ar,47,29,ACS_Catal_2015_Feb_6_5(2)_892-899.txt
5.3.2.1,"5.3.2.1 of the Advanced Light Source, Lawrence Ber...",101,1,ACS_Catal_2016_Apr_1_6(4)_2178-2181.txt
1.6.99.1,potential of the Old Yellow Enzyme (OYE; E.C. 1.6.99.1) family o,56,47,ACS_Catal_2013_Mar_1_3(3)_370-379.txt
6.1.1.149,"1999 , 1 , 149 –156 10.1517/14656566.1.1.149 .11249557",638,36,ACS_Cent_Sci_2016_Mar_23_2(3)_154-161.txt
1.7.4.5,"version 1.7.4.5, OpenEye Scientific Software, Inc., Santa ...",872,9,ACS_Cent_Sci_2015_Jul_22_1(4)_168-180.txt
EC 4.2.1.22,"namely, (i) cystathionine β-synthase (CBS; EC 4.2.1.22), (ii",42,44,ACS_Cent_Sci_2016_Apr_27_2(4)_242-252.txt
EC 4.4.1.1,"cystathionine γ-lyase (CSE; EC 4.4.1.1), and (iii) 3-mercaptopyruvat",43,29,ACS_Cent_Sci_2016_Apr_27_2(4)_242-252.txt
EC 2.8.1.2,sulfurtransferase (3-MST; EC 2.8.1.2). CBS and CSE eliminate H2S from l-cyst...,44,27,ACS_Cent_Sci_2016_Apr_27_2(4)_242-252.txt
3.2.1.20,"maltase) (E.C. 3.2.1.20) is a retaining α-glucosidase, whic",42,16,ACS_Cent_Sci_2016_May_25_2(5)_351-358.txt
3.34.7.206,"2013 , 34 , 2063 –2066 10.5012/bkcs.2013.34.7.2063",954,40,ACS_Cent_Sci_2016_Jul_27_2(7)_445-455.txt
6.1.4.13,"2006 , 1 , 13 –44 10.1162/itgg.2006.1.4.13",1264,35,ACS_Cent_Sci_2016_Oct_26_2(10)_687-701.txt
2.7.1.40,"2.7.1.40, 475 units mg–1), l-lactate dehydrogenas",449,1,ACS_Cent_Sci_2016_Nov_23_2(11)_843-849.txt
EC 1.1.1.27,"recombinant from Escherichia coli (LDH, EC 1.1.1.27",450,41,ACS_Cent_Sci_2016_Nov_23_2(11)_843-849.txt
EC 1.11.1.6,"3750 units mg–1, EC 1.11.1.6), glucose oxidase from Aspergillus nig...",452,18,ACS_Cent_Sci_2016_Nov_23_2(11)_843-849.txt
1.1.3.4,"...xidase from Aspergillus niger type II, (GOx, E.C. 1.1.3.4) lyophilize",452,91,ACS_Cent_Sci_2016_Nov_23_2(11)_843-849.txt
EC 1.1.3.2,"oxidase from Pediococcus species (LO, EC 1.1.3.2",457,39,ACS_Cent_Sci_2016_Nov_23_2(11)_843-849.txt
2.7.1.1,"2.7.1.1, 202 units mg–1) and glucose-6-phosphat",460,1,ACS_Cent_Sci_2016_Nov_23_2(11)_843-849.txt
EC 1.1.1.363,"EC 1.1.1.363, 507 units mg–1) were purchased fro",462,1,ACS_Cent_Sci_2016_Nov_23_2(11)_843-849.txt
6.4.6.889,"2003 , 4 , 889 –901 10.1517/14656566.4.6.889 .12783586",517,36,ACS_Cent_Sci_2016_Nov_23_2(11)_802-811.txt
4.3.11.3,"primary antibody (Clone 4.3.11.3, Hypoxyprobe) for 2 h, washed wit",634,25,PMC5269656.txt
3.5.54.42,"...laced into the binding site and scored using DOCK 3.5.54.42,43 The required sphere set to define the...",495,57,ACS_Chem_Biol_2013_May_17_8(5)_1044-1052.txt
3.5.54.42,"3.5.54.42,43 Ligand and receptor overlap bins were...",518,1,ACS_Chem_Biol_2013_May_17_8(5)_1044-1052.txt
EC 2.4.2.29,"guanosine(34) transglycosylase (EC 2.4.2.29) (bTGT).5,6 Two subsequent enzymatic s...",51,33,ACS_Chem_Biol_2014_Aug_15_9(8)_1812-1825.txt
EC 2.4.99.17,EC 2.4.99.17) and QueG (tRNA epoxyqueuosine(34) re...,52,1,ACS_Chem_Biol_2014_Aug_15_9(8)_1812-1825.txt
EC 4.1.3.3,N-Acetyl-d-neuraminic acid lyase (NAL) (EC 4.1.3.3) is a pyruvate-dependen,62,41,ACS_Chem_Biol_2014_Apr_18_9(4)_1025-1032.txt
EC 1.1.1.100,3-Oxo-acyl-ACP reductase (FabG; EC 1.1.1.100) catalyzes th,59,33,ACS_Chem_Biol_2013_Nov_15_8(11)_2518-2527.txt
EC 3.2.1.4,"include endoglucanases (EC 3.2.1.4), cellobiohydrolases (EC 3.2.1.91)",62,25,ACS_Chem_Biol_2014_Sep_19_9(9)_2082-2091.txt
EC 3.2.1.91,"... endoglucanases (EC 3.2.1.4), cellobiohydrolases (EC 3.2.1.91)",62,58,ACS_Chem_Biol_2014_Sep_19_9(9)_2082-2091.txt
EC 3.2.1.21,and β-glucosidases (EC 3.2.1.21).,63,21,ACS_Chem_Biol_2014_Sep_19_9(9)_2082-2091.txt
EC 3.2.1.86,"(EC 3.2.1.86) activity had been reported, suggestin...",405,2,ACS_Chem_Biol_2014_Sep_19_9(9)_2082-2091.txt
4.2.1.3,"[EC:4.2.1.3]; ADC, aspartate 4-decarboxylase [EC:4.1.1...",562,5,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
4.1.1.12,"[EC:4.2.1.3]; ADC, aspartate 4-decarboxylase [EC:4.1.1.12]; ALDO",562,50,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
4.1.2.13,"fructose-bisphosphate aldolase [EC:4.1.2.13]; ALT, alanine transaminas",563,36,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
2.6.1.2,"[EC:2.6.1.2]; CS, citrate synthase [EC:2.3.3.1]; FBP, ...",564,5,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
2.3.3.1,"[EC:2.6.1.2]; CS, citrate synthase [EC:2.3.3.1]; FBP, fructose-1,6-bisphosphatas",564,40,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
3.1.3.11,"I [EC:3.1.3.11]; FUM, fumarate hydratase [EC:4.2.1.2]; G...",565,7,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
4.2.1.2,"I [EC:3.1.3.11]; FUM, fumarate hydratase [EC:4.2.1.2]; G6PD, glucose-6-phosphat",565,46,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
1.1.1.49,"1-dehydrogenase [EC:1.1.1.49]; GAPDH, glyceraldehyde-3-phosphate dehyd...",566,21,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
1.2.1.12,"[EC:1.2.1.12]; GLDH, glutamate dehydrogenase, [EC: 1.4...",567,5,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
1.4.1.2,"...EC:1.2.1.12]; GLDH, glutamate dehydrogenase, [EC: 1.4.1.2]; GLS",567,52,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
3.5.1.2,"glutaminase [EC: 3.5.1.2]; GOT1, aspartate aminotransferase, cytopl...",568,18,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
2.6.1.1,"[EC:2.6.1.1]; GPI, glucose-6-phosphate isomerase [EC:5...",569,5,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
5.3.1.9,"...:2.6.1.1]; GPI, glucose-6-phosphate isomerase [EC:5.3.1.9]; HK",569,54,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
2.7.1.1,"hexokinase [EC:2.7.1.1]; IDH, isocitrate dehydrogenase [EC:1.1.1....",570,16,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
1.1.1.42,"...e [EC:2.7.1.1]; IDH, isocitrate dehydrogenase [EC:1.1.1.42]",570,60,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
1.1.1.27,"LDH, l-lactate dehydrogenase [EC:1.1.1.27]; MDH, malate dehydrogenas",571,34,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
1.1.1.37,"[EC:1.1.1.37]; OGDH, 2-oxoglutarate dehydrogenase, [EC...",572,5,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
1.2.4.2,"....1.1.37]; OGDH, 2-oxoglutarate dehydrogenase, [EC:1.2.4.2]; LSC",572,56,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
6.2.1.4,"succinyl-CoA synthetase [EC:6.2.1.4 6.2.1.5]; PC, pyruvate carboxylas",573,29,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
6.2.1.5,"succinyl-CoA synthetase [EC:6.2.1.4 6.2.1.5]; PC, pyruvate carboxylas",573,37,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
6.4.1.1,"[EC:6.4.1.1]; PGD, 6-phosphogluconate dehydrogenase [E...",574,5,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
1.1.1.44,"...4.1.1]; PGD, 6-phosphogluconate dehydrogenase [EC:1.1.1.44]",574,57,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
1.2.4.1,"PDH, pyruvate dehydrogenase [EC:1.2.4.1]; PGK1, phosphoglycerate kinas",575,33,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
2.7.2.3,"[EC:2.7.2.3]; PGM, phosphoglucomutase [EC:5.4.2.2]; PF...",576,5,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
5.4.2.2,"[EC:2.7.2.3]; PGM, phosphoglucomutase [EC:5.4.2.2]; PFK, 6-phosphofructokinas",576,43,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
2.7.1.11,"1 [EC:2.7.1.11]; RPI, ribose-5-phosphate isomerase A [EC...",577,7,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
5.3.1.6,"....7.1.11]; RPI, ribose-5-phosphate isomerase A [EC:5.3.1.6]",577,58,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
1.3.5.1,"SDH, succinate dehydrogenase [EC:1.3.5.1]; TPI, triosephosphate isomeras",578,34,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
5.3.1.1,"[EC:5.3.1.1]; TAL, transaldolase [EC:2.2.1.2]; TKT, tr...",579,5,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
2.2.1.2,"[EC:5.3.1.1]; TAL, transaldolase [EC:2.2.1.2]; TKT, transketolas",579,38,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
2.2.1.1,[EC:2.2.1.1],580,5,ACS_Chem_Biol_2014_Sep_19_9(9)_2032-2048.txt
2.5.1.4,"OMEGA, 2.5.1.4 , OpenEye Scientific Software , Sant",886,8,ACS_Chem_Biol_2015_Jan_16_10(1)_269-278.txt
2.3.1.97,"...A (MCoA)/protein N-myristoyltransferase (NMT, EC: 2.3.1.97) catalyzes a",44,74,ACS_Chem_Biol_2015_Jun_19_10(6)_1425-1434.txt
6.2.6.917,"2 , 917 –927 10.1517/14656566.2.6.917 .11585008",818,29,ACS_Chem_Biol_2016_Jan_15_11(1)_139-148.txt
3.2.1.45,"2 (GBA2, nonlysosomal glucosylcerebrosidase, E.C. 3.2.1.45, bile aci",41,51,ACS_Chem_Biol_2016_Jul_15_11(7)_1891-1900.txt
3.2.1.21,β-glucosidase E.C. 3.2.1.21) is a member of a family of sequence-rela...,42,20,ACS_Chem_Biol_2016_Jul_15_11(7)_1891-1900.txt
2.1.5.61,...60 Biological processes were analyzed with ClueGo 2.1.5.6,774,141,ACS_Chem_Biol_2016_Aug_19_11(8)_2165-2176.txt
4.19.2.75,"19 , 75 –88 10.15430/JCP.2014.19.2.75 .25337575",1018,29,ACS_Chem_Biol_2016_Aug_19_11(8)_2165-2176.txt
6.52.4.247,"52 , 249 –260 10.1358/dot.2016.52.4.2470954 .27252989",865,30,PMC5320539.txt
5.6.10.100,"Bioinformatics Chapter 5 , Unit 5.6.10.1002/0471250953.bi0506s15",1335,33,ACS_Chem_Neurosci_2015_Aug_8_6(11)_1825-1837.txt
1.5.3.8,"The data were processed with MaxQuant version 1.5.3.8, and the peptide",699,47,ACS_Infect_Dis_2016_Jun_10_2(6)_427-441.txt
4.11.8.111,"11 (8 ), 1117 –1125 10.1517/13543784.11.8.1117",943,36,ACS_Infect_Dis_2016_Jun_10_2(6)_427-441.txt
4.8.1.1,"8 (1 ), 1 –6 10.5009/gnl.2014.8.1.1 .24516694",605,29,ACS_Infect_Dis_2016_Aug_12_2(8)_544-551.txt
EC 1.1.3.10,...in single-molecule experiments. Pyranose oxidase (EC 1.1.3.10) in combination with catalase (POC) wa...,14,195,ACS_Nano_2012_Jul_24_6(7)_6364-6369.txt
2.3.1.44,...iments were conducted at the SIBYLS ALS beamline 12.3.1.44 Data were analyzed and traces from 0.5 s ...,94,375,ACS_Nano_2015_Jan_27_9(1)_180-190.txt
6.1.3.253,"2006 , 1 , 253 –260 10.2147/ciia.2006.1.3.253 .18046878",1245,37,PMC5269643.txt
1.2.16.110,"...ken, NJ , 2009 ; Chapter 2: Unit 2.16 1–31, Unit 31.2.16.110.1002/0471142700.nc0216s38",2480,70,PMC5333189.txt
4.15.19.850,"2014 , 15 , 8509 –8519 10.7314/APJCP.2014.15.19.8509 .25339056",461,41,ACS_Omega_2016_Oct_31_1(4)_663-668.txt
5.39.6.355,"1985 , 39 6 355 –360 10.1515/hfsg.1985.39.6.355",884,38,ACS_Sustain_Chem_Eng_2016_Sep_6_4(9)_4974-4985.txt
2.45.6.344,"2012 , 45 , 344 –352 10.3961/jpmph.2012.45.6.344 .23230464",647,39,PMC5209756.txt
2.15.2.39,2010b38 and R 2.15.2.39 Please see Supporting Information for mo...,446,15,ACS_Synth_Biol_2013_Oct_18_2(10)_587-593.txt
1.6.2.48,library version 1.6.2.4,551,17,ACS_Synth_Biol_2014_Sep_19_3(9)_686-701.txt
3.3.2.1,3.3.2.1 TNF-α release from particle-stimulated PBM...,67,1,Acta_Biomater_2015_Sep_1_23_38-51.txt
3.3.2.2,3.3.2.2 IL-1β release from particle-stimulated PBM...,70,1,Acta_Biomater_2015_Sep_1_23_38-51.txt
3.3.2.3,3.3.2.3 IL-6 release from particle-stimulated PBMN...,73,1,Acta_Biomater_2015_Sep_1_23_38-51.txt
3.3.2.4,3.3.2.4 IL-8 release from particle-stimulated PBMN...,76,1,Acta_Biomater_2015_Sep_1_23_38-51.txt
3.3.3.1,3.3.3.1 TNF-α release from particle-stimulated PBM...,82,1,Acta_Biomater_2015_Sep_1_23_38-51.txt
3.3.3.2,3.3.3.2 IL-1β release from particle-stimulated PBM...,85,1,Acta_Biomater_2015_Sep_1_23_38-51.txt
3.3.3.3,3.3.3.3 IL-6 release from particle-stimulated PBMN...,88,1,Acta_Biomater_2015_Sep_1_23_38-51.txt
3.3.3.4,3.3.3.4 IL-8 release from particle-stimulated PBMN...,91,1,Acta_Biomater_2015_Sep_1_23_38-51.txt
2.2.2.1,2.2.2.1 Dynamic mechanical thermal analysis (DMTA,46,1,Acta_Biomater_2012_Jan_8(1)_313-320.txt
2.2.2.2,2.2.2.2 Quasi-static tes,50,1,Acta_Biomater_2012_Jan_8(1)_313-320.txt
2.2.2.3,2.2.2.3 Creep/recovery experimen,54,1,Acta_Biomater_2012_Jan_8(1)_313-320.txt
2.1.9.1,...is the standard setting for superspace group No. 62.1.9.1 in,84,494,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.9.3,"... is an alternate setting of superspace group No. 62.1.9.3, for which the standard symbol is . The au...",86,349,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.9.3,...ith the standard setting of superspace group No. 62.1.9.3,86,1141,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.9.6,"... is an alternate setting of superspace group No. 62.1.9.6 , involving a transformation of basis vect...",98,300,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.9.6,"...nts the standard setting of superspace group No. 62.1.9.6 . Alternatively, the transformation   lead...",98,1007,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.9.6,...o a non-standard setting of superspace group No. 62.1.9.6,98,1110,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.9.6,...nother alternate setting of superspace group No. 62.1.9.6 . The transformation now only involves the...,102,252,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.9.6,...hat the standard setting of superspace group No. 62.1.9.6 can also be obtained by the transformation...,102,579,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.8.5,... is an alternate setting of superspace group No. 12.1.8.5  (Table 1 ▶ and Fig. 1 ▶). In physical spa...,114,821,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
6.2.19.3,... is an alternate setting of superspace group No. 16.2.19.3  with  and . The transformation between t...,131,1163,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
1.2.6.4,...ith symmetry given by the D superspace group No. 11.2.6.4  from . Inspection of the list of superspa...,136,330,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
1.2.6.4,... of the list of superspace groups shows that No. 11.2.6.4 is the only superspace group in its Bravai...,136,406,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
1.2.6.4,...the standard BSG setting of superspace group No. 11.2.6.4 is achieved by   which implies a transform...,158,112,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
1.2.6.4,"...the standard BSG setting of superspace group No. 11.2.6.4:  Choices (i), (ii) and (iv) are arbitrary...",158,600,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
1.2.6.4,...esulting in the setting  of superspace group No. 11.2.6.4.  shows that the standard setting can be r...,158,2257,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
6.1.22.2,"...be an alternate symbol for superspace group No. 166.1.22.2,  on . Apart from the -centering of the h...",213,391,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
3.1.23.1,"...rcentered setting of the D superspace group No. 163.1.23.1,",215,424,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.7.4,... is an alternate setting of superspace group No. 12.1.7.4 . Apart from the trivial transformation of...,222,69,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
6.2.60.2,"...ic space group, like the D superspace groups No. 76.2.60.2  and No. 78.2.60.2 . Intrinsic translatio...",231,397,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
5.2.60.4,"...rspace groups. For example, superspace group No. 75.2.60.4  is not enantiomorphic ( stands for the f...",231,582,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
5.2.60.4,"... enantiomorph,  is an alternative setting of No. 75.2.60.4, and is transformed into the standard set...",231,726,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.8.5,...nce of superspace group  to superspace group No. 12.1.8.5,273,96,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.1.8.5,"...ble 1 Symmetry operators of superspace group No. 12.1.8.5 in mixed, BSG and supercentered setting",283,53,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.2.1.1,2.2.1.1,369,2,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
1.2.6.4,11.2.6.4,407,3,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
4.2.16.6,14.2.16.6,425,3,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.2.50.22,62.2.50.22,463,3,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
5.2.58.2,85.2.58.2,482,3,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
5.2.58.2,85.2.58.2,501,3,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
3.2.68.6,113.2.68.6,558,4,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
3.2.68.6,113.2.68.6,577,4,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
3.2.68.6,113.2.68.6,596,4,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
3.2.68.6,113.2.68.6,615,4,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
2.2.76.3,162.2.76.3,673,4,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
6.2.80.1,176.2.80.1,693,4,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
6.2.83.4,186.2.83.4,712,4,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
4.2.83.4,194.2.83.4,731,4,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
4.2.83.4,194.2.83.4,749,4,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
3.2.72.1,143.2.72.1,770,3,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
3.2.80.4,143.2.80.4,779,3,Acta_Crystallogr_A_2013_Jan_1_69(Pt_1)_75-90.txt
1.4.2.7,"...rnational Tables, Vol. B (Shmueli, 2001 ▸) Table A1.4.2.7, the first column, n:c, lists the space-gr...",403,65,Acta_Crystallogr_A_2011_May_1_67(Pt_3)_269-275.txt
4.1.6.3,"... to be alternate settings of superspace group No. 4.1.6.3 with standard setting  (Stokes et al., 201...",27,458,Acta_Crystallogr_B_Struct_Sci_Cryst_Eng_Mater_2015_Mar_31_71(Pt_2)_228-234.txt
4.1.2.1,"...perspace group is a non-standard setting of , No. 4.1.2.1 in Stokes et al. (2011 ▸) and van Smaalen ...",53,743,Acta_Crystallogr_B_Struct_Sci_Cryst_Eng_Mater_2016_May_26_72(Pt_3)_372-380.txt
1.9.7.1,"... the parallel tempering algorithm in FOX, Version 1.9.7.1 (Favre-Nicolin & Černý, 2002 ▸, 2004 ▸). F...",67,798,PMC5289306.txt
EC 4.1.2.13,"Fructose-1,6-bisphosphate aldolase (aldolase; EC 4.1.2.13) is a ubiquitously expressed glycolyti...",10,47,Acta_Crystallogr_D_Biol_Crystallogr_2008_May_1_64(Pt_5)_543-550.txt
EC 6.3.2.17,...itous enzyme folylpolyglutamate synthetase (FPGS; EC 6.3.2.17) catalyzes folate polyglutamylation. T...,14,348,Acta_Crystallogr_D_Biol_Crystallogr_2008_Jul_1_64(Pt_7)_745-753.txt
4.16.71.148,"...n from the Conformation Angles Database (http://144.16.71.148/cadb/; Sheik et al., 2003 ▶)",98,488,Acta_Crystallogr_D_Biol_Crystallogr_2009_Feb_1_65(Pt_2)_156-168.txt
6.1.1.4,"...tallography (2006). Vol. C, 1st online ed., Table 6.1.1.4, pp. 578–580. Chester: International Union...",125,80,Acta_Crystallogr_D_Biol_Crystallogr_2009_Jul_1_65(Pt_7)_690-696.txt
6.1.1.4,"...ables for Crystallography, Vol. C, 2nd ed., Table 6.1.1.4. Dordrecht: Kluwer Academic Publishers",485,118,Acta_Crystallogr_D_Biol_Crystallogr_2010_Apr_1_66(Pt_4)_393-408.txt
EC 4.3.2.2,"...). In this pathway, adenylosuccinate lyase (PurB; EC 4.3.2.2) catalyzes the breakdown of 5-aminoimid...",10,446,Acta_Crystallogr_D_Biol_Crystallogr_2010_Aug_1_66(Pt_8)_881-888.txt
EC 4.2.1.11,Enolase (EC 4.2.1.11) is a glycolytic enzyme that is univer...,10,10,Acta_Crystallogr_D_Biol_Crystallogr_2010_Sep_1_66(Pt_9)_1036-1040.txt
EC 3.5.2.17,"...is protein family is 5-hydroxyisourate hydrolase (EC 3.5.2.17; Hennebry et al., 2006 ▶), an enzyme t...",79,695,Acta_Crystallogr_D_Biol_Crystallogr_2011_Dec_1_67(Pt_12)_1065-1072.txt
EC 5.1.1.1,Alanine racemase (EC 5.1.1.1) is a pyridoxal-5′-phosphate (PLP) depe...,16,19,Acta_Crystallogr_D_Biol_Crystallogr_2012_Jan_1_68(Pt_1)_82-92.txt
6.1.1.4,"... Tables for Crystallography (1999). Vol. C, Table 6.1.1.4. Dordrecht: Kluwer Academic Publishers",497,64,Acta_Crystallogr_D_Biol_Crystallogr_2012_Apr_1_68(Pt_4)_454-467.txt
EC 3.4.24.28,"...tral metalloprotease from Paenibacillus polymyxa (EC 3.4.24.28), is an extracellular metalloprotease...",18,77,Acta_Crystallogr_D_Biol_Crystallogr_2013_Jan_1_69(Pt_1)_24-31.txt
EC 3.2.1.17,"...lnerable target for lytic enzymes, e.g. lysozyme (EC 3.2.1.17; also referred to as muramidase), effe...",14,812,Acta_Crystallogr_D_Biol_Crystallogr_2013_Oct_1_69(Pt_10)_1889-1900.txt
EC 2.3.2.2,γ-Glutamyltranspeptidase (GGT; EC 2.3.2.2) is involved in the degradation of γ-gl...,14,32,Acta_Crystallogr_D_Biol_Crystallogr_2014_Jan_31_70(Pt_2)_607-614.txt
EC 2.5.1.61,...en deaminase (PBGD; hydroxymethylbilane synthase; EC 2.5.1.61) catalyses a key early step in the bio...,4,271,Acta_Crystallogr_D_Biol_Crystallogr_2014_Feb_15_70(Pt_3)_744-751.txt
EC 2.5.1.61,...en deaminase (PBGD; hydroxymethylbilane synthase; EC 2.5.1.61) catalyses an early step of the tetrap...,6,75,Acta_Crystallogr_D_Biol_Crystallogr_2014_Feb_15_70(Pt_3)_744-751.txt
EC 2.5.1.61,...h is also known as hydroxy­methylbilane synthase (EC 2.5.1.61). This enzyme catalyses the polymeriza...,11,310,Acta_Crystallogr_D_Biol_Crystallogr_2014_Feb_15_70(Pt_3)_744-751.txt
EC 6.3.1.2,Glutamine synthetase (GS; EC 6.3.1.2) is a vital enzyme in the nitrogen meta...,13,27,Acta_Crystallogr_D_Biol_Crystallogr_2014_Mar_19_70(Pt_4)_981-993.txt
EC 3.2.1.14,"...e glycosyl hydrolase family 18 (GH18) chitinases (EC 3.2.1.14) are enzymes that hydrolyze chitin, a ...",13,53,Acta_Crystallogr_D_Biol_Crystallogr_2014_Mar_19_70(Pt_4)_932-942.txt
3.2.8.1,... human IgG1 Fc region in lectin-resistant CHO-Lec 3.2.8.1 cells using the glutamine synthetase syste...,19,133,Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1934-1943.txt
EC 5.1.1.1,Alanine racemase (Alr; EC 5.1.1.1) is the prototypical member of the fold...,17,24,Acta_Crystallogr_D_Biol_Crystallogr_2014_Jun_29_70(Pt_7)_1922-1933.txt
EC 1.14.18.1,...phenols to ortho-quinones (monophenolase activity EC 1.14.18.1 and diphenolase activity EC 1.10.3.1)...,11,249,Acta_Crystallogr_D_Biol_Crystallogr_2014_Aug_29_70(Pt_9)_2301-2315.txt
EC 1.10.3.1,...se activity EC 1.14.18.1 and diphenolase activity EC 1.10.3.1) and the oxidation of ortho-diphenols ...,11,287,Acta_Crystallogr_D_Biol_Crystallogr_2014_Aug_29_70(Pt_9)_2301-2315.txt
EC 1.10.3.1,"...o the respective o-quinones (diphenolase activity EC 1.10.3.1), are solely catalyzed by tyrosinases ...",11,388,Acta_Crystallogr_D_Biol_Crystallogr_2014_Aug_29_70(Pt_9)_2301-2315.txt
EC 3.2.1.4,"...ulases have been recognized: endoglucanases (EGs; EC 3.2.1.4), cellobiohydrolases (CBHs; EC 3.2.1.91...",16,542,Acta_Crystallogr_D_Biol_Crystallogr_2014_Aug_29_70(Pt_9)_2356-2366.txt
EC 3.2.1.91,"...ases (EGs; EC 3.2.1.4), cellobiohydrolases (CBHs; EC 3.2.1.91 and 3.2.1.176) and β-glucosidases (Bgl...",16,581,Acta_Crystallogr_D_Biol_Crystallogr_2014_Aug_29_70(Pt_9)_2356-2366.txt
3.2.1.176,"...2.1.4), cellobiohydrolases (CBHs; EC 3.2.1.91 and 3.2.1.176) and β-glucosidases (Bgls; EC 3.2.1.21)....",16,597,Acta_Crystallogr_D_Biol_Crystallogr_2014_Aug_29_70(Pt_9)_2356-2366.txt
EC 3.2.1.21,...3.2.1.91 and 3.2.1.176) and β-glucosidases (Bgls; EC 3.2.1.21). EGs hydrolyse cellulose chains inter...,16,634,Acta_Crystallogr_D_Biol_Crystallogr_2014_Aug_29_70(Pt_9)_2356-2366.txt
EC 3.1.3.1,Alkaline phosphatases (EC 3.1.3.1) are periplasmic enzymes that are found...,13,24,Acta_Crystallogr_D_Biol_Crystallogr_2014_Feb_22_70(Pt_3)_811-820.txt
EC 1.1.1.169,"Ketopantoate reductase (KPR; EC 1.1.1.169), an enzyme involved in the biosynthe...",12,30,Acta_Crystallogr_D_Biol_Crystallogr_2007_Jan_16_63(Pt_2)_171-178.txt
EC 1.1.1.86,Acetohydroxyacid isomeroreductase (AHIR; EC 1.1.1.86) catalyses the conversion of acetohydr...,78,42,Acta_Crystallogr_D_Biol_Crystallogr_2007_Jan_16_63(Pt_2)_171-178.txt
EC 2.6.1.18,...pyruvate. The β-­alanine:pyruvate ATs (β-A:PyATs; EC 2.6.1.18) are a group of ωATs which catalyse am...,17,143,Acta_Crystallogr_D_Biol_Crystallogr_2013_Mar_14_69(Pt_4)_564-576.txt
EC 3.2.1.86,"...lucoside is cleaved by 6-P-β-glucosidase (6PβGlu; EC 3.2.1.86), releasing 6-P-β-glucose (BG6; glycon...",13,1607,Acta_Crystallogr_D_Biol_Crystallogr_2013_Feb_16_69(Pt_3)_451-463.txt
EC 3.2.1.86,"...nzymatic activities including 6-P-β-glucosidases (EC 3.2.1.86), β-glucosidases (EC 3.2.1.21), β-gala...",85,341,Acta_Crystallogr_D_Biol_Crystallogr_2013_Feb_16_69(Pt_3)_451-463.txt
EC 3.2.1.21,"...6-P-β-glucosidases (EC 3.2.1.86), β-glucosidases (EC 3.2.1.21), β-galactosidases (EC 3.2.1.23) and 6...",85,371,Acta_Crystallogr_D_Biol_Crystallogr_2013_Feb_16_69(Pt_3)_451-463.txt
EC 3.2.1.23,"..., β-glucosidases (EC 3.2.1.21), β-galactosidases (EC 3.2.1.23) and 6-P-β-galactosidases (EC 3.2.1.85...",85,403,Acta_Crystallogr_D_Biol_Crystallogr_2013_Feb_16_69(Pt_3)_451-463.txt
EC 3.2.1.85,"...tosidases (EC 3.2.1.23) and 6-P-β-galactosidases (EC 3.2.1.85), amongst others. The tertiary structu...",85,442,Acta_Crystallogr_D_Biol_Crystallogr_2013_Feb_16_69(Pt_3)_451-463.txt
EC 3.10.1.1,...sulfamate sulfohydrolase and heparan N-sulfatase; EC 3.10.1.1) and represents one of the most freque...,15,786,Acta_Crystallogr_D_Biol_Crystallogr_2014_Apr_30_70(Pt_5)_1321-1335.txt
EC 1.10.3.2,Laccases (EC 1.10.3.2; benzenediol:oxygen oxidoreductases) b...,12,11,Acta_Crystallogr_D_Biol_Crystallogr_2014_Oct_23_70(Pt_11)_2913-2923.txt
4.3.2.2,"...ystallography, Vol. C, edited by E. Prince, Table 4.3.2.2. Dordecht: Kluwer Academic Publishers",372,154,Acta_Crystallogr_D_Biol_Crystallogr_2015_Jan_1_71(Pt_1)_136-153.txt
EC 2.5.1.10,Farnesyl pyrophosphate synthase (FPPS; EC 2.5.1.10) is a promising antibiotic drug target...,14,40,Acta_Crystallogr_D_Biol_Crystallogr_2015_Feb_26_71(Pt_3)_721-731.txt
EC 3.6.1.1,"...say couples the FPPS activity to pyrophosphatase (EC 3.6.1.1), producing free orthophosphate from th...",61,186,Acta_Crystallogr_D_Biol_Crystallogr_2015_Feb_26_71(Pt_3)_721-731.txt
EC 3.6.3.44,"...nes. The transporter P-glycoprotein (P-gp; ABCB1; EC 3.6.3.44) is expressed in the intestines, liver...",13,158,Acta_Crystallogr_D_Biol_Crystallogr_2015_Feb_26_71(Pt_3)_732-741.txt
EC 4.2.1.11,"...served across the three domains of life, enolase (EC 4.2.1.11) is an essential enzyme that catalyses...",13,66,Acta_Crystallogr_D_Biol_Crystallogr_2015_Feb_26_71(Pt_3)_417-426.txt
1.6.3.1,"...e AM1BCC Hamiltonian as implemented in QuacPac (v.1.6.3.1; OpenEye Scientific Software, Santa Fe, Ne...",45,253,Acta_Crystallogr_D_Biol_Crystallogr_2015_Feb_26_71(Pt_3)_710-720.txt
2.5.1.4,"...SA) and conformers were enumerated using Omega (v.2.5.1.4; OpenEye Scientific Software, Santa Fe, Ne...",45,364,Acta_Crystallogr_D_Biol_Crystallogr_2015_Feb_26_71(Pt_3)_710-720.txt
2.1.97.100,...h the data-analysis module of the IQ5 software (v.2.1.97.1001; Bio-Rad). All measurements were perfo...,46,956,Acta_Crystallogr_D_Biol_Crystallogr_2015_Feb_26_71(Pt_3)_494-504.txt
EC 1.5.1.6,...rmyltetrahydrofolate dehydrogenase (FDH; ALDH1L1; EC 1.5.1.6) converts 10-formyltetrahydrofolate (10...,11,593,Acta_Crystallogr_D_Biol_Crystallogr_2015_Mar_27_71(Pt_4)_1006-1021.txt
EC 3.13.1.4,...pionyl-coenzyme A (3SP-CoA) desulfinase (AcdDPN7; EC 3.13.1.4) was identified during investigation o...,6,63,Acta_Crystallogr_D_Biol_Crystallogr_2015_May_23_71(Pt_6)_1360-1372.txt
EC 3.13.1.4,"...009 ▶). Recently, the isolation of a desulfinase (EC 3.13.1.4) catalyzing sulfur abstraction from 3S...",11,702,Acta_Crystallogr_D_Biol_Crystallogr_2015_May_23_71(Pt_6)_1360-1372.txt
EC 4.4.1.16,"...P)-dependent cysteine sulfinate desulfinase (CSD; EC 4.4.1.16) from Escherichia coli, which has sele...",15,288,Acta_Crystallogr_D_Biol_Crystallogr_2015_May_23_71(Pt_6)_1360-1372.txt
EC 4.1.1.12,"...ond is a PLP-dependent aspartate β-decarboxylase (EC 4.1.1.12), which can accept cysteine sulfinate ...",15,478,Acta_Crystallogr_D_Biol_Crystallogr_2015_May_23_71(Pt_6)_1360-1372.txt
EC 3.13.1.3,"...ernandez et al., 2012 ▶). The third enzyme, DszB (EC 3.13.1.3), catalyzes the hydrolysis of a sulfin...",15,627,Acta_Crystallogr_D_Biol_Crystallogr_2015_May_23_71(Pt_6)_1360-1372.txt
EC 1.14.13.162,"..., 2,5-diketocamphane 1,2-monooxygenase (2,5-DKMO; EC 1.14.13.162) and 3,6-diketocamphane 1,6-monooxy...",17,381,Acta_Crystallogr_D_Biol_Crystallogr_2015_Oct_31_71(Pt_11)_2344-2353.txt
EC 3.2.1.21,β-d-Glucosidases (EC 3.2.1.21) are classical glycoside hydrolases (r...,23,19,Acta_Crystallogr_D_Struct_Biol_2016_Jan_28_72(Pt_2)_254-265.txt
EC 3.1.3.11,"Fructose-1,6-bisphosphatase (FBPase; EC 3.1.3.11), which catalyzes the hydrolysis of fr...",12,38,Acta_Crystallogr_D_Struct_Biol_2016_Mar_30_72(Pt_4)_536-550.txt
EC 3.2.1.4,"... endoglucanases [endo-(1,4)-β-d-glucanhydrolases; EC 3.2.1.4], which randomly cleave the β-1,4 linka...",15,1410,Acta_Crystallogr_D_Struct_Biol_2016_Jun_23_72(Pt_7)_860-870.txt
EC 3.2.1.91,"...ohydrolases [(1,4)-β-d-glucan cellobiohydrolases; EC 3.2.1.91], which processively release the disac...",15,1581,Acta_Crystallogr_D_Struct_Biol_2016_Jun_23_72(Pt_7)_860-870.txt
EC 3.2.1.21,"...g or the non­reducing end of a polymer, and BGLs (EC 3.2.1.21), which hydrolyse cellobiose into gluc...",15,1723,Acta_Crystallogr_D_Struct_Biol_2016_Jun_23_72(Pt_7)_860-870.txt
4.4.1.13,"...e reaction involving 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD) and naph­thalen-2-ol in...",14,222,Acta_Crystallogr_E_Crystallogr_Commun_2015_Feb_7_71(Pt_3)_258-260.txt
4.4.1.13,"...uingly, reactions of 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD) with naphthalen-2-ol ma...",14,399,Acta_Crystallogr_E_Crystallogr_Commun_2015_Feb_7_71(Pt_3)_258-260.txt
4.4.1.13,"...mixture of 1 mmol of 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD) and 2 mmol of naphthale...",32,273,Acta_Crystallogr_E_Crystallogr_Commun_2015_Feb_7_71(Pt_3)_258-260.txt
4.4.1.13,"...from reactions between 1,3,6,8-tetra­zatri­cyclo­[4.4.1.13,8]dodecane (TATD) and phenols or naphthol...",11,232,Acta_Crystallogr_E_Crystallogr_Commun_2015_Feb_25_71(Pt_3)_312-314.txt
4.4.1.13,"A mixture of 1,3,6,8-tetra­zatri­cyclo­[4.4.1.13,8]dodecane (0.100 g, 0.6 mmol) and 4-chlo...",32,41,Acta_Crystallogr_E_Crystallogr_Commun_2015_Feb_25_71(Pt_3)_312-314.txt
4.4.1.13,"...o-crystalline adduct 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD)–4-bromo­phenol (1/2) C8...",3,362,Acta_Crystallogr_E_Crystallogr_Commun_2015_Apr_9_71(Pt_5)_463-465.txt
4.4.1.13,"...rystalline adduct of 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane is presented. In the crystal, ...",4,302,Acta_Crystallogr_E_Crystallogr_Commun_2015_Apr_9_71(Pt_5)_463-465.txt
4.4.1.13,"...id-state reaction of 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD) and 4-bromo­phenol, has...",6,133,Acta_Crystallogr_E_Crystallogr_Commun_2015_Apr_9_71(Pt_5)_463-465.txt
4.4.1.13,"...e reaction involving 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8] dodecane (TATD) (II) with phenols whic...",11,238,Acta_Crystallogr_E_Crystallogr_Commun_2015_Apr_9_71(Pt_5)_463-465.txt
4.4.1.13,"...ne half-mol­ecule of 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD) and one mol­ecule of 4-...",15,109,Acta_Crystallogr_E_Crystallogr_Commun_2015_Apr_9_71(Pt_5)_463-465.txt
4.4.1.13,"... database search for 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane yielded only three hits, two d...",25,52,Acta_Crystallogr_E_Crystallogr_Commun_2015_Apr_9_71(Pt_5)_463-465.txt
4.4.1.13,"...ile the mol­ecules of 1,3,6,8-tetra­aza­tri­cyclo[4.4.1.13,8]dodecane itself have 2m symmetry, the m...",25,311,Acta_Crystallogr_E_Crystallogr_Commun_2015_Apr_9_71(Pt_5)_463-465.txt
4.4.1.13,"... the other hand, the 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane mol­ecule displays",25,513,Acta_Crystallogr_E_Crystallogr_Commun_2015_Apr_9_71(Pt_5)_463-465.txt
4.4.1.13,"1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD) (0.21g, 1.25 mmol) and ...",29,30,Acta_Crystallogr_E_Crystallogr_Commun_2015_Apr_9_71(Pt_5)_463-465.txt
4.4.1.13,"...o-crystalline adduct 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD)–4-chloro-3,5-di­methyl­...",3,362,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"...stalline adduct, the 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD) and 4-chloro-3,5-di­met...",4,281,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"..., we have found that 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD) shows an inter­esting r...",12,155,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"...▸) and the 1:2 adduct 1,3,6,8-tetra­aza­tri­cyclo[4.4.1.13,8]dodecane (TATD)-4-bromo­phenol (Rivera,...",12,1102,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"...o-crystalline adduct 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD)–4-chloro-3,5-di­methyl­...",15,100,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"... compound contains a 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD) and a 4-chloro-3,5-di­m...",18,236,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"...nd 1.505 (3) Å]. For 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane, two comparable structures wer...",26,406,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"...e that contains only 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (Rivera et al., 2014 ▸) gives ...",26,591,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"...tion of 0.048 Å with 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane of (I) and a least-squares fit...",26,706,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"...least-squares fit of 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane co-crystallized with hydro­qui...",26,789,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"...tion of 0.051 Å with 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane of (I). Thus, it can be conclu...",26,939,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"...rmational freedom of 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane is rather limited",26,1057,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.3,"A mixture of 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.3,8]dodecane (TATD) (168 mg, 1 mmol) and 4-c...",29,43,Acta_Crystallogr_E_Crystallogr_Commun_2015_Jun_3_71(Pt_7)_737-740.txt
4.4.1.13,"...he macrocyclic aminal 1,3,6,8-tetra­aza­tri­cyclo[4.4.1.13,8]dodecane (TATD) with hindered meta-disu...",11,1317,Acta_Crystallogr_E_Crystallogr_Commun_2015_Aug_26_71(Pt_9)_1089-1092.txt
4.3.1.1,"...en the cyclic aminal 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.1.3,8]undecane (TATU) with 2-naphthol solven...",11,1622,Acta_Crystallogr_E_Crystallogr_Commun_2015_Aug_26_71(Pt_9)_1089-1092.txt
4.3.1.13,"...(144 mg, 1 mmol) and 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane (TATU) (154 mg, 1 mmol) were m...",24,62,Acta_Crystallogr_E_Crystallogr_Commun_2015_Aug_26_71(Pt_9)_1089-1092.txt
4.3.1.13,"...stal structure of the 1,3,6,8-tetra­aza­tri­cyclo[4.3.1.13,8]undecane (TATU)–4-nitro­phenol (1/2) ad...",3,339,Acta_Crystallogr_E_Crystallogr_Commun_2015_Oct_24_71(Pt_11)_1356-1360.txt
4.3.1.13,"...ted the synthesis of 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane (TATU), (II) (Rivera et al. 20...",15,2166,Acta_Crystallogr_E_Crystallogr_Commun_2015_Oct_24_71(Pt_11)_1356-1360.txt
3.3.1.13,"... similar to those in 1,3,5,7-tetra­aza­tri­cyclo­[3.3.1.13,7]decane [(III), also known as urotropine...",15,2594,Acta_Crystallogr_E_Crystallogr_Commun_2015_Oct_24_71(Pt_11)_1356-1360.txt
4.4.1.13,"... similar to those in 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane [(IV), TATD]. We have previous...",15,2755,Acta_Crystallogr_E_Crystallogr_Commun_2015_Oct_24_71(Pt_11)_1356-1360.txt
4.3.1.13,"...y four structures of 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane derivatives in the Cambridge S...",36,75,Acta_Crystallogr_E_Crystallogr_Commun_2015_Oct_24_71(Pt_11)_1356-1360.txt
4.3.1.13,"...­magnesium dibromide 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane tetra­hydrate (Rivera et al., ...",36,254,Acta_Crystallogr_E_Crystallogr_Commun_2015_Oct_24_71(Pt_11)_1356-1360.txt
4.3.1.13,"...era et al., 2014 ▸), 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane hydro­quinone (Rivera et al. 2...",36,342,Acta_Crystallogr_E_Crystallogr_Commun_2015_Oct_24_71(Pt_11)_1356-1360.txt
4.3.1.13,"... al. 2007 ▸) and 3,6,8-tri­aza-1-azoniatri­cyclo­[4.3.1.13,8]undecane penta­chloro­phenolate monohyd...",36,436,Acta_Crystallogr_E_Crystallogr_Commun_2015_Oct_24_71(Pt_11)_1356-1360.txt
4.3.1.13,"... al., 2011 ▸). Since 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane is a rigid mol­ecule, the tors...",36,551,Acta_Crystallogr_E_Crystallogr_Commun_2015_Oct_24_71(Pt_11)_1356-1360.txt
4.3.1.13,"... title compound from 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]dodecane (TATU) (0.15 g, 1.00 mmol) and...",39,89,Acta_Crystallogr_E_Crystallogr_Commun_2015_Oct_24_71(Pt_11)_1356-1360.txt
2.6.1.1,"2.6.1.1), and acts as a competitive inhibitor in t...",163,1,Acta_Crystallogr_E_Crystallogr_Commun_2015_Sep_12_71(Pt_10)_o731-o732.txt
EC 1.14.17.3,"...l peptidylglycine α-amidating monooxygenase (PAM, EC 1.14.17.3) (Klinman, 2006 ▸; McIntyre et al., 2...",11,874,Acta_Crystallogr_E_Crystallogr_Commun_2015_Sep_12_71(Pt_10)_1136-1139.txt
1.3.1.11,"...yl-3,16-dioxa-9,22,28,31-tetra­thia­hepta­cyclo­[21.3.1.11,5.14,8.110,14.114,18.117,21]dotriaconta-4...",3,396,Acta_Crystallogr_E_Crystallogr_Commun_2015_Sep_26_71(Pt_10)_o778-o779.txt
4.1.47.35,"...tal structures of two 2,9-di­thia-13-aza­dispiro­[4.1.47.35]tetra­decan-6-ones C26H31NO3S2 and C32H3...",3,340,Acta_Crystallogr_E_Crystallogr_Commun_2015_Nov_21_71(Pt_12)_1516-1520.txt
4.1.47.35,"...ethyl-1,8-di-p-tolyl-2,9-di­thia-13- aza­dispiro­[4.1.47.35]tetra­decan-6-one, C26H31NO3S2, (I), and...",6,94,Acta_Crystallogr_E_Crystallogr_Commun_2015_Nov_21_71(Pt_12)_1516-1520.txt
4.1.47.35,"...is­(4-methyl­phen­yl)-2,9-di­thia-13-aza­dispiro­[4.1.47.35]tetradecan-6-one, C32H35NO3S2, (II), the...",6,226,Acta_Crystallogr_E_Crystallogr_Commun_2015_Nov_21_71(Pt_12)_1516-1520.txt
4.1.47.35,"crystal structure2,9-di­thia-13-aza­dispiro­[4.1.47.35]]tetra­decan-6-onethio­phenepiperidinedi...",10,46,Acta_Crystallogr_E_Crystallogr_Commun_2015_Nov_21_71(Pt_12)_1516-1520.txt
4.1.47.35,"...e synthesized two new 2,9-di­thia-13-aza­dispiro­[4.1.47.35]tetra­decan-6-one derivatives, each inco...",17,961,Acta_Crystallogr_E_Crystallogr_Commun_2015_Nov_21_71(Pt_12)_1516-1520.txt
4.1.47.35,"...for the sub-structure 2,9-di­thia-13-aza­dispiro­[4.1.47.35]tetra­decan-6-one gave zero hits",36,157,Acta_Crystallogr_E_Crystallogr_Commun_2015_Nov_21_71(Pt_12)_1516-1520.txt
2.1.2.1,"...piro­[2.5]octane building unit, namely. tris­piro(2.1.2.1.2.1)dodecane-4,8,12-trione (DAZVEF; Hoffma...",23,569,Acta_Crystallogr_E_Crystallogr_Commun_2016_Jan_30_72(Pt_2)_266-268.txt
4.3.1.13,"...f a 1:2 co-crystal of 1,3,6,8-tetra­aza­tri­cyclo[4.3.1.13,8]undecane (TATU) and 4-chloro-3,5-dimeth...",3,377,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1651-1653.txt
4.3.1.13,"...nt-free treatment of 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecano (TATU) with 4-chloro-3,5-di­me...",11,56,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1651-1653.txt
4.3.1.13,"...en the cyclic aminal 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane (TATU) and 4-chloro-3,5-di­met...",16,942,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1651-1653.txt
4.4.1.13,"...h the related aminal 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane (TATD) for example (Riddell & ...",19,235,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1651-1653.txt
4.3.1.13,"... al. 2016 ▸), namely 1,3,6,8-tetra-aza­tri­cyclo­(4.3.1.13,8)undecane hydro­quinone (HICTOD; Rivera ...",29,141,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1651-1653.txt
4.3.1.13,"...et al., 2007 ▸), 3,6,8-tri­aza-1-azoniatri­cyclo­[4.3.1.13,8]undecane penta­chloro­phenolate monohyd...",29,241,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1651-1653.txt
4.3.1.13,"..., and 4-nitro­phenol 1,3,6,8-tetra-aza­tri­cyclo­[4.3.1.13,8]undecane (VUXMEI; Rivera et al., 2015 ▸...",29,377,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1651-1653.txt
4.3.1.13,"A mixture of 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecano (TATU) (154 mg, 1 mmol) and 4-...",32,43,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1651-1653.txt
4.3.1.13,"...he 1:2 co-crystal of 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane (TATU) and 4-chloro­phenol (1/...",3,350,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1648-1650.txt
4.3.1.13,"...l mol­ecules and one 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane (TATU) mol­ecule in the asymme...",11,167,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1648-1650.txt
4.3.1.13,"...een the aminal cage, 1,3,6,8-tetra­aza­tri­cyclo [4.3.1.13,8]undecane (TATU), with 4-chloro­phenol u...",19,187,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1648-1650.txt
4.3.1.13,"...l mol­ecules and one 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane (TATU) mol­ecule. The phenols ...",25,207,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1648-1650.txt
4.3.1.13,"...l., 2016 ▸),, namely 1,3,6,8-tetra-aza­tri­cyclo­(4.3.1.13,8)undecane hydro­quinone (HICTOD; Rivera ...",35,143,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1648-1650.txt
4.3.1.13,"...et al., 2007 ▸), 3,6,8-tri­aza-1-azoniatri­cyclo­[4.3.1.13,8]undecane penta­chloro­phenolate monohyd...",35,243,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1648-1650.txt
4.3.1.13,"...) and 4-nitro­phenol 1,3,6,8-tetra-aza­tri­cyclo­[4.3.1.13,8]undecane (VUXMEI; Rivera et al., 2015",35,378,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1648-1650.txt
4.3.1.13,"A mixture of 1,3,6,8-tetra­aza­tri­cyclo­[4.3.1.13,8]undecane (TATU) (154 mg, 1 mmol) and 4-...",39,43,Acta_Crystallogr_E_Crystallogr_Commun_2016_Oct_25_72(Pt_11)_1648-1650.txt
EC 1.14.18.1,Tyrosinases (EC 1.14.18.1 and 1.10.3.1) are type 3 copper enzym...,11,14,Acta_Crystallogr_F_Struct_Biol_Commun_2014_Jan_23_70(Pt_2)_263-266.txt
1.10.3.1,Tyrosinases (EC 1.14.18.1 and 1.10.3.1) are type 3 copper enzymes that are widel...,11,31,Acta_Crystallogr_F_Struct_Biol_Commun_2014_Jan_23_70(Pt_2)_263-266.txt
EC 3.5.1.54,Allophanate hydrolase (EC 3.5.1.54) from Pseudomonas sp. strain ADP (AtzF...,13,24,Acta_Crystallogr_F_Struct_Biol_Commun_2014_Feb_19_70(Pt_3)_310-315.txt
EC 3.5.1.5,"...isms, the nickel-containing metalloenzyme urease (EC 3.5.1.5) provides a single-step hydrolysis of u...",15,74,Acta_Crystallogr_F_Struct_Biol_Commun_2014_Feb_19_70(Pt_3)_310-315.txt
EC 3.5.2.15,... opened by cyanuric acid hydrolase (AtzD or TrzD; EC 3.5.2.15) forming the unstable metabolite carbo...,17,196,Acta_Crystallogr_F_Struct_Biol_Commun_2014_Feb_19_70(Pt_3)_310-315.txt
EC 3.5.1.84,...s produced from biuret by AtzE (biuret hydrolase; EC 3.5.1.84) via a single deamination (Martinez et...,17,423,Acta_Crystallogr_F_Struct_Biol_Commun_2014_Feb_19_70(Pt_3)_310-315.txt
EC 1.14.18.1,Tyrosinases (EC 1.14.18.1 and 1.10.3.1) are type 3 copper enzym...,11,14,Acta_Crystallogr_F_Struct_Biol_Commun_2014_May_28_70(Pt_6)_832-834.txt
1.10.3.1,Tyrosinases (EC 1.14.18.1 and 1.10.3.1) are type 3 copper enzymes that are widel...,11,31,Acta_Crystallogr_F_Struct_Biol_Commun_2014_May_28_70(Pt_6)_832-834.txt
EC 1.14.18.1,...to o-diphenols (cresolase/monophenolase activity; EC 1.14.18.1) and the subsequent oxidation of o-di...,11,473,Acta_Crystallogr_F_Struct_Biol_Commun_2014_May_28_70(Pt_6)_832-834.txt
EC 1.10.3.1,"...ing o-quinones (catecholase/diphenolase activity; EC 1.10.3.1), which are precursors for the biosynt...",11,598,Acta_Crystallogr_F_Struct_Biol_Commun_2014_May_28_70(Pt_6)_832-834.txt
EC 1.10.3.1,... to o-quinones (catecholase/diphenolase activity; EC 1.10.3.1) but lack cresolase/monophenolase acti...,11,942,Acta_Crystallogr_F_Struct_Biol_Commun_2014_May_28_70(Pt_6)_832-834.txt
EC 1.14.18.1,...0.3.1) but lack cresolase/monophenolase activity (EC 1.14.18.1). Laccases (EC 1.10.3.2) are multi-co...,11,998,Acta_Crystallogr_F_Struct_Biol_Commun_2014_May_28_70(Pt_6)_832-834.txt
EC 1.10.3.2,.../monophenolase activity (EC 1.14.18.1). Laccases (EC 1.10.3.2) are multi-copper enzymes that oxidize...,11,1023,Acta_Crystallogr_F_Struct_Biol_Commun_2014_May_28_70(Pt_6)_832-834.txt
EC 5.1.1.1,Alanine racemase (EC 5.1.1.1) is a pyridoxal 5′-phosphate (PLP)-depe...,16,19,Acta_Crystallogr_F_Struct_Biol_Commun_2014_Aug_29_70(Pt_9)_1199-1205.txt
EC 3.2.1.4,...chaeon Pyrococcus furiosus (EGPf; Gene ID PF0854; EC 3.2.1.4) catalyzes the hydrolytic cleavage of t...,6,128,Acta_Crystallogr_F_Struct_Biol_Commun_2014_Jun_18_70(Pt_7)_878-883.txt
EC 3.2.1.55,"...ce similarity to other GH43 arabinofuranosidases (EC 3.2.1.55), the gene encoding the H. orenii glyc...",15,1109,Acta_Crystallogr_F_Struct_Biol_Commun_2015_Feb_19_71(Pt_3)_338-345.txt
EC 1.14.18.1,... type III copper enzymes and include tyrosinases (EC 1.14.18.1) and catechol oxidases (EC 1.10.3.1)....,12,74,Acta_Crystallogr_F_Struct_Biol_Commun_2015_May_22_71(Pt_6)_746-751.txt
EC 1.10.3.1,...tyrosinases (EC 1.14.18.1) and catechol oxidases (EC 1.10.3.1). Tyrosinases catalyze the ortho-hydro...,12,111,Acta_Crystallogr_F_Struct_Biol_Commun_2015_May_22_71(Pt_6)_746-751.txt
EC 3.2.1.46,"...ctose by the enzyme β-galactocerebrosidase (GALC; EC 3.2.1.46; Morimoto et al., 1989 ▸; Harzer et al...",11,1375,Acta_Crystallogr_F_Struct_Biol_Commun_2015_Jun_27_71(Pt_7)_895-900.txt
1.7.4.2,"...le of the align algorithm implemented in PyMOL (v.1.7.4.2; DeLano, 2002 ▸). Domain motions were comp...",43,154,Acta_Crystallogr_F_Struct_Biol_Commun_2015_Sep_23_71(Pt_10)_1292-1299.txt
EC 2.2.1.1,The generic transketolase (EC 2.2.1.1; Tkt) is a ubiquitous enzyme that catal...,15,28,Acta_Crystallogr_F_Struct_Biol_Commun_2015_Sep_23_71(Pt_10)_1327-1334.txt
EC 1.10.3.2,Laccases (EC 1.10.3.2; benzenediol:oxygen oxidoreductases) b...,12,11,Acta_Crystallogr_F_Struct_Biol_Commun_2015_Nov_18_71(Pt_12)_1465-1469.txt
EC 1.2.1.70,"...e NADPH-dependent glutamyl-tRNA reductase (GluTR; EC 1.2.1.70; Moser et al., 1999 ▸), and GSA is the...",12,714,Acta_Crystallogr_F_Struct_Biol_Commun_2016_May_23_72(Pt_6)_448-456.txt
EC 5.4.3.8,"...y glutamate-1-semialdehyde-2,1-aminomutase (GSAM; EC 5.4.3.8; Ilag & Jahn, 1992 ▸). ALA formation is...",12,835,Acta_Crystallogr_F_Struct_Biol_Commun_2016_May_23_72(Pt_6)_448-456.txt
EC 4.2.1.25,l-Arabinonate dehydratase (EC 4.2.1.25) and d-xylonate dehydratase (EC 4.2.1....,14,28,Acta_Crystallogr_F_Struct_Biol_Commun_2016_Jul_13_72(Pt_8)_604-608.txt
EC 4.2.1.82,...dratase (EC 4.2.1.25) and d-xylonate dehydratase (EC 4.2.1.82) are two enzymes that are involved in ...,14,69,Acta_Crystallogr_F_Struct_Biol_Commun_2016_Jul_13_72(Pt_8)_604-608.txt
EC 4.2.1.25,"... ▸). In both pathways, l-arabinonate dehydratase (EC 4.2.1.25) catalyzes the removal of one water mo...",21,1037,Acta_Crystallogr_F_Struct_Biol_Commun_2016_Jul_13_72(Pt_8)_604-608.txt
EC 4.2.1.82,"a). Similarly, d-xylonate dehydratase (EC 4.2.1.82) catalyzes the removal of one water mo...",22,40,Acta_Crystallogr_F_Struct_Biol_Commun_2016_Jul_13_72(Pt_8)_604-608.txt
EC 4.1.1.1,Pyruvate decarboxylase (PDC; EC 4.1.1.1) is a thiamine pyrophosphate- and Mg2+ ...,12,30,Acta_Crystallogr_F_Struct_Biol_Commun_2016_Aug_26_72(Pt_9)_700-706.txt
EC 4.1.1.1,Pyruvate decarboxylase (PDC; EC 4.1.1.1) catalyses the non-oxidative decarboxyl...,20,30,Acta_Crystallogr_F_Struct_Biol_Commun_2016_Aug_26_72(Pt_9)_700-706.txt
EC 3.2.1.4,"...s of cellulases, namely endo-(1,4)-β-d-glucanase (EC 3.2.1.4; carboxymethylcellulase or CMCase), exo...",17,309,Acta_Crystallogr_F_Struct_Biol_Commun_2016_Nov_25_72(Pt_12)_870-876.txt
EC 3.2.1.91,"...hylcellulase or CMCase), exo-(1,4)-β-d-glucanase (EC 3.2.1.91; cellobiohydrolase, avicelase, microcr...",17,381,Acta_Crystallogr_F_Struct_Biol_Commun_2016_Nov_25_72(Pt_12)_870-876.txt
EC 3.2.1.21,"...e cellulase or β-exoglucanase) and β-glucosidase (EC 3.2.1.21), which must act synergistically to ac...",17,489,Acta_Crystallogr_F_Struct_Biol_Commun_2016_Nov_25_72(Pt_12)_870-876.txt
EC 3.7.1.5,hydrolase from rat liver (EC 3.7.1.5) all have aliphatic side chains.(Davey ...,131,27,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o15.txt
2.5.1.15,"...-Methyl-6-methyl­ene-10,16,18-trioxa­hexa­cyclo­[12.5.1.15,8.01,11.02,8.017,20]henicosane-7,9-dione:...",3,319,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2007_Dec_6_64(Pt_1)_o79.txt
4.2.1.12,"anti-Tricyclo­[4.2.1.12,5]deca-3,7-diene-9-endo,10-endo-diol C10H...",4,31,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Nov_8_64(Pt_12)_o2270.txt
3.3.1.1,"...rs1-Methyl-1-azonia-3,5-diaza-7-phospha­tricyclo­[3.3.1.1]decane 7-oxide triiodide C7H15N3OP+·I3−Kir...",3,277,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jan_23_64(Pt_2)_o496-o497.txt
3.3.1.1,"...e 1-methyl-1-azonia-3,5-diaza-7-phospha­tricyclo­[3.3.1.1]decane 7-oxide cation and a triiodide anio...",4,220,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jan_23_64(Pt_2)_o496-o497.txt
4.2.2.4,"...001785Organic Papers6,10,16,19-Tetra­oxatrispiro­[4.2.2.4.2.2]nona­deca­ne C15H24O4Wang Ji-Kui aWang...",3,259,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jan_23_64(Pt_2)_o498.txt
3.2.1.40,α-L-Rhamnosidases (E.C. 3.2.1.40) catalyze the hydrolysis o,128,25,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jan_9_64(Pt_2)_o379.txt
2.1.1.307,...inistry of Science and Education (project No. RNP 2.1.1.3077),123,198,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Aug_9_64(Pt_9)_m1145.txt
3.3.1.13,"...ers1-Methyl-1-azonia-3,5-diaza-7-phosphatricyclo­[3.3.1.13,7]decane tetra­fluoro­borate C7H15N3P+·BF...",3,276,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Feb_6_64(Pt_3)_o556.txt
5.3.1.13,"...Organic Papers8-Methyl-5-methyl­ene-2-oxotricyclo[5.3.1.13,9]dodecan-endo-8-ol C14H20O2Chan Isa Y. H...",3,265,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_16_64(Pt_5)_o841.txt
5.3.1.13,"5-Methylidenetricyclo[5.3.1.13,9]dodecane-2,8-dione (Yue et al.",139,23,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Apr_16_64(Pt_5)_o841.txt
3.3.1.13,"N-(2-Hydroxy­ethyl)-N-(tricyclo­[3.3.1.13,7]dec-2-yl)benzamide C19H25NO2Boyle Grant...",4,49,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_10_64(Pt_6)_o1029.txt
3.3.1.13,"To a stirred solution of 2-(tricyclo[3.3.1.13,7]dec-2-ylamino)-ethanol (1 g, 5.1 mmol) ...",144,38,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_10_64(Pt_6)_o1029.txt
5.3.1.13,"tricyclo[5.3.1.13,9]dodecane ring system, the chemistry of ...",131,10,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_10_64(Pt_6)_o1055.txt
5.3.1.13,"3,7-bis(methoxycarbonyl)-5-methylidenetricyclo[5.3.1.13,9]dodecane-2,8-dion",150,48,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_May_10_64(Pt_6)_o1055.txt
2.2.1.16,"...1,6,7,8,9,14,15,16,17,17-Decachloro­penta­cyclo­[12.2.1.16,9.02,13.05,10]octa­deca-7,15-diene C18H14...",3,308,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_13_64(Pt_7)_o1249.txt
2.2.1.16,"decachloropentacyclo[12.2.1.16,9.02,13.05,10]-octadeca-7,15-diene] and a...",132,23,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_13_64(Pt_7)_o1249.txt
2.2.1.16,"decachloropentacyclo[12.2.1.16,9.02,13.05,10]-octadeca-7,15-diene",134,23,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_13_64(Pt_7)_o1249.txt
2.2.1.16,"12.2.1.16,9.02,13.05,10]-octadeca-7,15-diene (compo...",150,2,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_13_64(Pt_7)_o1249.txt
3.3.1.13,"...1ACSEBHS1600536808016851Organic Papers2-(Tricyclo[3.3.1.13,7]dec-2-ylamino)ethanol hemihydrate C12H2...",3,241,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_7_64(Pt_7)_o1228.txt
2.2.1.16,"...8,9,14,15,16,17,17,18-Undeca­chloro­penta­cyclo­[12.2.1.16,9.02,13.05,10]octa­deca-7,15-diene C18H13...",3,318,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_13_64(Pt_7)_o1250.txt
2.2.1.16,"undecachloropentacyclo[12.2.1.16,9.02,13.05,10]-octadeca-7,15-diene",131,25,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jun_13_64(Pt_7)_o1250.txt
3.3.1.13,"...apersA new polymorph of N-(prop-2-yn­yl)tricyclo­[3.3.1.13,7]decane-1-carbox­amide C14H19NOFrey Wolf...",3,274,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2008_Jul_16_64(Pt_8)_o1495.txt
4.2.1.12,"anti-Tricyclo­[4.2.1.12,5]deca-3,7-diene-9,10-dione C10H8O2Gidaly...",4,31,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Mar_11_65(Pt_4)_o729.txt
3.3.1.1,"...0-Tetra­kis(4-fluoro­phen­yl)-1,3-diaza­tricyclo­[3.3.1.1]decan-6-one C32H24F4N2ONatarajan S. aPriya...",3,286,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_10_65(Pt_7)_o1530.txt
5.2.5.2,"...3,12,12-Tetra­methyl-1,5,10,14-tetra­oxa­dispiro­[5.2.5.2]hexa­deca­ne C16H28O4He Yong-Jun aXie Min-...",3,281,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jun_13_65(Pt_7)_o1559.txt
5.3.1.13,"...0536809016547Organic Papers2,8-Dimethyl­tricyclo­[5.3.1.13,9]dodecane-syn-2,syn-8-diol–propanoic aci...",3,252,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1241.txt
5.3.1.13,"2,8-dimethyltricyclo[5.3.1.13,9]dodecane-syn-2,syn-8-diol wa",153,22,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_14_65(Pt_6)_o1241.txt
3.3.1.111,"...3,27-Dichloro-3,6,9,17,20,23-hexa­azatetracyclo­[23.3.1.111,15.02,6]triaconta-1(29),9,11,13,15(30),1...",3,287,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_May_7_65(Pt_6)_m614.txt
4.44.54.63,...a complex network with point symbol {34.412.512}{34.44.54.63}2. Both of the bridging water mol­ecule...,3,1832,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_30_65(Pt_10)_m1265-m1266.txt
6.3.3.3,"...bulated in International Tables C (1992 ▶), Table 6.3.3.3, were interpolated with Lagrange’s method ...",54,125,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_26_65(Pt_10)_i72.txt
6.3.3.3,"C (1992\bbr00), Table 6.3.3.3, were interpolated with Lagrange's metho",174,23,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_26_65(Pt_10)_i72.txt
2.2.2.211,"...48Organic Papers3,6,9,16,19,22-Hexaaza­tricyclo­[22.2.2.211,14]­triaconta-1(27),11 (30),12,14(29),24...",3,263,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_9_65(Pt_10)_o2405-o2406.txt
5.2.1.12,"...,10,11-Heptaphenyl-3,6,9,10,11-penta­azatricyclo­[5.2.1.12,5]undecane-4,8-diamine C48H43N7Taheri Ami...",6,73,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Sep_5_65(Pt_10)_o2337.txt
6.3.3.3,"...tabulated in International Tables C (1992), Table 6.3.3.3, were interpolated with Lagrange’s method ...",53,126,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_3_65(Pt_11)_i73.txt
6.3.3.3,"C (1992), Table 6.3.3.3, were interpolated with Lagrange's metho",170,17,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_3_65(Pt_11)_i73.txt
5.2.2.5,"...040884Organic Papers7,11,18,21-Tetra­oxatrispiro­[5.2.2.5.2.2]heneicosa­ne C17H28O4Shi Jiang-Hua aYu...",3,259,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_10_65(Pt_11)_o2712.txt
4.2.2.4,"...rystal structure of 6,10,16,19-tetra­oxatrispiro­[4.2.2.4.2.2]nona­decane, see: Wang et al. (2008 ▶)...",6,167,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Oct_10_65(Pt_11)_o2712.txt
5.3.1.112,"...-Di-tert-butyl-3,10,18,25-tetra­azatpenta­cyclo­[25.3.1.112,16.04,9.019,24]dotriaconta-1(31),4,6,8,1...",3,293,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Jul_25_65(Pt_8)_m985.txt
2.62.62.62,"B) nodes is 62.62.62.62.62.62, while 62.62.62.62.62.6",149,14,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_9_66(Pt_2)_i4.txt
2.62.62.62,"B) nodes is 62.62.62.62.62.62, while 62.62.62.62.62.6",149,39,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_9_66(Pt_2)_i4.txt
2.62.62.62,"for the P nodes, giving the net symbol (62.62.62.62.62.62)",150,42,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_9_66(Pt_2)_i4.txt
6.3.3.3,"p. 523,Tab. 6.3.3.3 for values of muR in the range 0–2.5, and ...",204,13,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_25_65(Pt_5)_m564.txt
4.2.5.2,"...l)-2,11,11-trimethyl-1,4,10,12-tetra­oxa­dispiro­[4.2.5.2]penta­decane-9,13-dione C26H26Br2O6Peng Ju...",3,302,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_30_65(Pt_5)_o1151.txt
4.2.5.2,"...n­yl)-11,11-dimethyl-1,4,10,12-tetra­oxa­dispiro­[4.2.5.2]penta­decane-9,13-dione C27H30O8Zhang Jinp...",3,301,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Apr_18_65(Pt_5)_o1076.txt
6.3.3.3,"...ated in International Tables Vol. C (1992), Table 6.3.3.3, were interpolated with Lagrange’s method ...",51,131,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_13_66(Pt_2)_i6.txt
6.3.3.3,"Vol. C (1992), Table 6.3.3.3, were interpolated with Lagrange's metho",149,22,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_13_66(Pt_2)_i6.txt
3.3.1.13,"...971Organic Papers(3aRS,4SR,7RS,7aSR)-2-(Tricyclo­[3.3.1.13,7]decan-1-yl)-4,5,6,7-tetra­hydro-4,7-epo...",3,262,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_May_15_66(Pt_6)_o1374.txt
6.3.3.3,"1992, p. 523, Table 6.3.3.3) for values of µR in the range 0–2.5, and",199,21,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_27_66(Pt_2)_o447.txt
4.5.5.5,"... title compound, C20H34O2Si, a cis,trans,cis,cis-[4.5.5.5]fenestrane derivative, the geometry of the...",4,934,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_13_66(Pt_2)_o340.txt
4.5.5.5,"in compound (4), the cis,trans,cis,cis [4.5.5.5]fenestrane without th",145,41,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_13_66(Pt_2)_o340.txt
4.5.5.5,"cis,trans,cis,cis[4.5.5.5.]fenestrene (5), bearing only one bridgehe...",149,19,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_13_66(Pt_2)_o340.txt
6.3.3.3,"...olation using  Int.Tab. Vol. C (1992) p. 523,Tab. 6.3.3.",202,71,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jan_16_66(Pt_2)_o375.txt
4.3.1.13,"...c Papers5-Bromo­spiro­[1,2-dioxane-4,4′-tricyclo­[4.3.1.13,8]undeca­ne]-3′-ol C14H21BrO3Robinson Ton...",3,271,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Dec_24_66(Pt_1)_o247.txt
4.2.1.112,"...30-oxa-29-thia-3,10,17,24-tetra­aza­penta­cyclo­[24.2.1.112,15.04,9.018,23]triaconta-5,7,9(4),10,12,...",3,305,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Feb_20_66(Pt_3)_o660-o661.txt
5.6.5.6,"...xolan-4-yl]-3,16-dimethyl­ene-8,20-diaza­dispiro­[5.6.5.6]tetra­cosa-7,19-diene C34H54N2O4Guéret Sté...",3,335,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_26_66(Pt_7)_o1778-o1779.txt
EC 4.2.1.1,"Carbonic anhydrases (CAs, EC 4.2.1.1) are widespread metalloenzymes i",133,27,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1596.txt
6.3.3.3,"...ation using  Int. Tab. Vol. C (1992) p. 523, Tab. 6.3.3.",225,59,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_23_66(Pt_7)_m826-m827.txt
EC 4.2.1.1,"enzyme carbonic anhydrase (CA, EC 4.2.1.1) with sulfonamides may be exploite",130,32,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jun_5_66(Pt_7)_o1559-o1560.txt
2.2.1.16,"...hen­yl)-3,7,11,15-tetra­oxa-8,16-diaza­tricyclo­[12.2.1.16,9]octa­deca-1(16),6(18),8,14(17)-tetra­en...",3,297,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_24_66(Pt_8)_o2120.txt
2.2.1.16,"...chloro­dispiro­[1,3-dioxolane-2,17′-penta­cyclo­[12.2.1.16,9.02,13.05,10]octa­decane-18′,2′′-1,3-dio...",4,103,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Jul_3_66(Pt_8)_o1882.txt
3.7.1.19,"...omo­phen­yl)-14-hy­droxy-3,13-diaza­hepta­cyclo­[13.7.1.19,13.02,9.02,14.03,7.019,23]tetra­cosa-1(22...",3,316,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_23_66(Pt_11)_o2926-o2927.txt
2.2.1.16,"...   syn-Dispiro­[1,3-dioxolane-2,17′-penta­cyclo­[12.2.1.16,9.02,13.05,10]octa­decane-18′,2′′-[1,3]di...",4,63,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Oct_20_66(Pt_11)_o2880.txt
3.7.1.19,"...ne]-14-hy­droxy-8-phenyl-3,13-diaza­hepta­cyclo­[13.7.1.19,13.02,9.02,14.03,7.019,23]tetra­cosa-1(22...",3,297,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Nov_6_66(Pt_12)_o3045.txt
3.3.1.13,"... [systematic name: 3,5,7-triaza-1-azoniatricyclo­[3.3.1.13,7]decane (E)-3-carb­oxy­prop-2-enoate], C...",3,1034,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2010_Dec_24_67(Pt_1)_o214.txt
4.4.4.4,...odal four-connected two-dimensional network of a (4.4.4.4.6.6) topology. Further weak C—H⋯O inter­ac...,6,112,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Jan_15_67(Pt_2)_o414-o415.txt
4.4.3.1,"...hoxo-bis­{[μ-3,10,18,25-tetra­aza­penta­cyclo­[17.4.4.3.1.1]triconta-1(31),2,4(9),5,7,10,12,14,16(32...",3,294,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Feb_23_67(Pt_3)_m368.txt
3.3.1.13,"...-Organic PapersBis(3,5,7-triaza-1-azoniatricyclo­[3.3.1.13,7]deca­ne) bis­(1,2-dicyano­ethene-1,2-di...",3,270,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_m730.txt
3.3.1.13,"...2], comprises one 1-azonia-3,5,7-triaza­tricyclo­[3.3.1.13,7]decane cation and one half of an [Ni(mn...",3,1092,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_m730.txt
3.3.1.13,"1-azonia-3,5,7-triaza-tricyclo[3.3.1.13,7]decane cation and one half of",138,32,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_May_7_67(Pt_6)_m730.txt
EC 3.2.1.23,"potent inhibitors of β-galactosidase (EC 3.2.1.23) (De Bruyne,et al.",129,39,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Aug_11_67(Pt_9)_o2308-o2309.txt
EC 3.1.1.3,(EC 3.1.1.3) are the most used biocatalyst for this...,139,2,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_30_67(Pt_10)_o2778.txt
4.3.1.13,"...Organic Papers1-Heptyl-1,3,6,8-tetraaza­tricyclo­[4.3.1.13,8]undecan-1-ium iodide C14H29N4+·I−Rivera...",3,265,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2629.txt
4.3.1.13,"...damanzane-type aminal 1,3,6,8-tetra­aza­tricyclo­[4.3.1.13,8]undecane with heptyl iodide. In the cat...",4,115,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2629.txt
4.3.1.13,"1,3,6,8-tetraazatricyclo[4.3.1.13,8]undecane with an alkyl halide. In th",136,26,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2629.txt
4.3.1.13,"1-heptyl-1,3,6,8-tretraazatricyclo[4.3.1.13,8]undeca-1-ium iodide, i",138,36,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2629.txt
4.3.1.13,"a 1-heptyl-1,3,6,8-tretraazatricyclo[4.3.1.13,8]undeca-1-ium cation and on",143,38,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2629.txt
4.4.1.13,"1,3,6,8-tetraazatricyclo[4.4.1.13,8]dodecane (Rivera et al.",132,26,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2581.txt
4.3.1.13,"1,3,6,8-tetraazatricyclo[4.3.1.13,8]undecane. Recrystallization fro",148,26,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Sep_14_67(Pt_10)_o2581.txt
1.3.1.115,"...yl]-2,5,8,11,14,20,23,26,29,32-deca­oxatricyclo­[31.3.1.115,19]octa­triaconta-1(37),15,17,19 (38),33...",3,1082,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_9_67(Pt_12)_o3244.txt
2.2.1.16,"...681104493XOrganic PapersDibenzo[a,e]penta­cyclo­[12.2.1.16,9.02,13.05.10]octa­deca-2(13),5(10)-diene...",3,255,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Nov_5_67(Pt_12)_o3209.txt
3.7.1.19,"...meth­oxy­phen­yl)-5-thia-3,13-diaza­hepta­cyclo­[13.7.1.19,13.02,9.02,14.03,7.019,23]tetra­cosa-1(22...",3,329,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_8_67(Pt_11)_o2881-o2882.txt
2.1.1.1,... the European Regional Development Fund (No. 2DP/ 2.1.1.1.0/10/APIA/VIAA/066),118,77,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Oct_5_67(Pt_11)_o2851.txt
4.3.1.13,"...Organic Papers1-Hexyl-1,3,6,8-tetra­aza­tricyclo­[4.3.1.13,8]undecan-1-ium iodide C13H27N4+·I−Rivera...",3,265,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_3_68(Pt_1)_o17.txt
4.3.1.13,"1,3,6,8-tetraazatricyclo[4.3.1.13,8]undecane by alkylation with alky",138,26,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_3_68(Pt_1)_o17.txt
2.2.1.111,"...5-dithia-3,6,9,16,19,22,27,28-octa­aza­tricyclo­[22.2.1.111,14]octa­cosa-1(26),11(28),13,24(27)-tetr...",3,1079,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_10_68(Pt_1)_o54-o55.txt
5.14.10.13,"...,32,35,38,41-Octa­oxa-5,9,13-triaza­penta­cyclo­[15.14.10.13,30.17,11.115,19]tetra­tetra­conta-1,3(4...",3,290,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2011_Dec_14_68(Pt_1)_o107.txt
4.4.1.13,"the aminal cage 1,3,6,8-tetrazatricyclo[4.4.1.13,8]dodecane an",145,41,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jan_11_68(Pt_2)_o312-o313.txt
4.4.4.4,"(4.4.4.4.4.4.4.4.4.4.4.4.*.*.*.) (Braga & Grepioni,...",173,2,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o866.txt
4.4.4.4,"(4.4.4.4.4.4.4.4.4.4.4.4.*.*.*.) (Braga & Grepioni, 2007",173,10,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o866.txt
4.4.4.4,"(4.4.4.4.4.4.4.4.4.4.4.4.*.*.*.) (Braga & Grepioni, 2007",173,18,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o866.txt
4.4.4.4,"(4.4.4.4.4.4.4.4.6.6.6.6.6.6.6.) (Figs. 4, 5)",178,2,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o866.txt
4.4.4.4,"(4.4.4.4.4.4.4.4.6.6.6.6.6.6.6.) (Figs. 4, 5)",178,10,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o866.txt
6.6.6.6,"(4.4.4.4.4.4.4.4.6.6.6.6.6.6.6.) (Figs. 4, 5)",178,18,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o866.txt
4.4.4.4,Fig. 4. The (4.4.4.4.4.4.4.4.6.6.6.6.6.6.6.) topological diagra...,205,14,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o866.txt
4.4.4.4,Fig. 4. The (4.4.4.4.4.4.4.4.6.6.6.6.6.6.6.) topological diagram of (I)...,205,22,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o866.txt
6.6.6.6,Fig. 4. The (4.4.4.4.4.4.4.4.6.6.6.6.6.6.6.) topological diagram of (I) through...,205,30,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Feb_29_68(Pt_3)_o866.txt
3.3.1.13,"...0536812012597Organic Papers4-Nitro-2-{[(tricyclo­[3.3.1.13,7]decan-1-yl)iminium­yl]meth­yl}phenolate...",3,293,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_28_68(Pt_4)_o1221.txt
3.3.1.13,"For the crystal structure of 2-[(tricyclo­[3.3.1.13,7]decan-1-yl­imino)­meth­yl]phenol, see: ...",9,44,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_28_68(Pt_4)_o1221.txt
3.3.1.13,"2-[(tricyclo[3.3.1.13,7]decan-1-ylimino)methyl]phenol with simi...",144,14,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Mar_28_68(Pt_4)_o1221.txt
4.3.1.14,"...-1-yl)-3-(3-methyl­but-3-en-1-yl)-11-oxatricyclo­[4.3.1.14,10]undecane-7,9-dione} is a naturally occ...",7,634,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1451-o1452.txt
4.3.1.14,"isoprenylated derivative of 11-oxatricyclo[4.3.1.14,10]undecane-7,9-dione",171,44,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_21_68(Pt_5)_o1451-o1452.txt
3.3.1.13,"...of the related zwitterion, 4-nitro-2-{[(tricyclo­[3.3.1.13,7]decan-1-yl)iminium­yl]meth­yl}phenolate...",9,77,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_18_68(Pt_5)_o1399.txt
3.3.1.13,"4-nitro-2-{[(tricyclo[3.3.1.13,7]decan-1-yl)iminiumyl]methyl}phenolate (...",139,23,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Apr_18_68(Pt_5)_o1399.txt
5.3.1.15,"...2079XOrganic Papers2,4-Dioxa-λ6-thia­tetra­cyclo­[5.3.1.15,9.01,5]dodecane-3,3-dione C9H12O4SIoannou...",3,301,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_May_16_68(Pt_6)_o1719.txt
3.7.1.19,"...hy­droxy-8-phenyl-6-thia-3,13-diaza­hepta­cyclo­[13.7.1.19,13.02,9.02,14.03,7.019,23]tetra­cosa-1(22...",3,345,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_13_68(Pt_7)_o2013-o2014.txt
3.7.1.19,"...n­yl)-14-hy­droxy-6-thia-3,13-diaza­hepta­cyclo­[13.7.1.19,13.02,9.02,14.03,7.019,23]tetra­cosa-1(22...",3,366,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jun_13_68(Pt_7)_o2094-o2095.txt
4.4.1.1,"1,3,6,8-tetraazatricyclo[4.4.1.1.3,8]dodecane (Rivera et al.",146,26,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_14_68(Pt_8)_o2440.txt
1.2.2.213,"...droxy­methyl-10-meth­oxy-17,22-dioxapenta­cyclo­[21.2.2.213,16.13,7.011,30]triaconta-1(25),3,5,7(30)...",3,325,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Jul_28_68(Pt_8)_o2598-o2599.txt
6.6.1.13,Williams (1976) is Ca0.98Zn1.96Si1.84O6.6.1.13H2O,239,39,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_8_68(Pt_10)_i73.txt
4.24.5.151,"...27,34,37,40,43,50-Dodeca­oxa-56-aza­hepta­cyclo­[24.24.5.151,55.03,8.019,24.028,33.044,49]hexa­penta...",3,336,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_12_68(Pt_10)_o2913.txt
EC 3.4.21.36,"PPE (EC 3.4.21.36, ≈200 U/mg) and HLE (EC 3.4.21.37, ≈3...",335,6,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_19_68(Pt_10)_o2951-o2952.txt
EC 3.4.21.37,"PPE (EC 3.4.21.36, ≈200 U/mg) and HLE (EC 3.4.21.37, ≈34 U/mg",335,40,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Sep_19_68(Pt_10)_o2951-o2952.txt
2.1.1.1,...pean Regional Development Fund (No. 2011/0014/2DP/2.1.1.1.0/10/APIA/VIAA/092),129,86,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Oct_13_68(Pt_11)_o3136.txt
6.2.1.13,"endo,endo-Tetra­cyclo­[6.2.1.13,6.02,7]dodeca-9-en-anti-11-yl 4-bromo­ben...",4,24,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_9_69(Pt_2)_o202-o203.txt
3.3.1.13,"...,9-pentathia-1λ5,3λ5,5λ5,7λ5-tetraphosphatricyclo(3.3.1.13,7)decanide [Cambridge Structural Databas",153,85,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jan_12_69(Pt_2)_m95.txt
6.2.1.13,"...,24-tetra­thia-2,7,12,17-tetra­germapenta­cyclo­[16.2.1.13,6.18,11.113,16]tetra­cosa-3,5,8,10,13,15,...",3,366,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2012_Dec_12_69(Pt_1)_m37.txt
EC 3.1.1.7,Acetylcholinesterase (AChE; EC 3.1.1.7) is a key enzyme in the nervous system,155,29,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Feb_2_69(Pt_3)_o326-o327.txt
5.13.7.17,"...tetra-tert-butyl-19,29-dioxa-24-thia­hexa­cyclo­[15.13.7.17,11.132,36.05,30.013,18]nona­triaconta-1(...",3,1098,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Apr_10_69(Pt_5)_o690.txt
6.3.3.3,"...polation using Int.Tab. Vol. C (1992) p. 523,Tab. 6.3.3.",220,56,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_12_69(Pt_7)_o1083-o1084.txt
6.3.3.3,"6.3.3.3 for values of muR in the range 0-2.5, and ...",215,1,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_29_69(Pt_7)_o1170.txt
6.3.3.3,"...polation using International Tables Vol. C, Table 6.3.3.3",231,56,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_15_69(Pt_7)_o1097.txt
6.3.3.3,"International Tables Vol C, Table 6.3.3.3",224,35,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_29_69(Pt_7)_o1169.txt
2.28.8.83,"...ene 15,20,46,51,64,69,74,79-octa­oxatridecacyclo[32.28.8.83,28.113,53.122,44.09,14.021,26.038,70.040...",3,1170,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Jun_8_69(Pt_7)_o1001-o1002.txt
1.6.1.117,"...s2,15-Dioxa-7,18,19,20,23-penta­aza­hepta­cyclo­[21.6.1.117,20.01,8.03,7.09,14.024,29]hentriaconta-9...",3,319,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Oct_12_69(Pt_11)_o1637.txt
5.3.1.15,"thiatetracyclo[5.3.1.15,9.01,5]dodecane-3,3-dione (Ioannou & Mous...",175,16,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Aug_23_69(Pt_9)_o1464-o1465.txt
2.2.2.211,"6,21-diaza-3,9,18,24-tetraazoniatricyclo[22.2.2.211,14",170,43,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Nov_16_69(Pt_12)_o1782-o1783.txt
2.1.1.1,...pean Regional Development Fund (No. 2011/0014/2DP/2.1.1.1.0/10/APIA/ VIAA/092),137,86,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2013_Oct_19_69(Pt_11)_o1677.txt
2.1.1.2,...niversity’ for a scholarship and ERDF project 2DP/2.1.1.2.0/10/APIA/VI4AA/003 for the opportunity to...,119,176,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jan_4_70(Pt_2)_o108-o109.txt
4.4.1.13,"...rsRedetermination of 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodeca­ne C8H16N4Rivera Augusto a*Ríos-...",3,318,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_8_70(Pt_3)_o266.txt
4.4.1.1,"1,3,6,8-tetraazatricyclo[4.4.1.1^3,8^]dodecane (TATD) was synthesized fro",183,26,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_8_70(Pt_3)_o266.txt
4.4.1.13,"... 2-methyl­phenol and 1,3,6,8-tetra­aza­tri­cyclo­[4.4.1.13,8]dodecane, the imidazolidine ring adopts...",4,312,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Feb_5_70(Pt_3)_o243.txt
1.13.1.15,"...mplex C42H48·2C6N4 {systematic name: hepta­cyclo[21.13.1.15,19.16,18.110,14.124,36.128,32]do­tetra­c...",4,259,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Apr_30_70(Pt_5)_o625-o626.txt
6.3.3.3,"...polation using Int.Tab. Vol. C (1992) p. 523,Tab. 6.3.3.",94,56,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Jul_31_70(Pt_8)_111-114.txt
6.2.1.12,"...ro­phen­yl)-16,21,22,23,24-pentaaza­penta­cyclo­[16.2.1.12,5.17,10.112,15]tetra­cosa-1,3,5,7,9,11,13...",14,704,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Sep_24_70(Pt_10)_242-245.txt
1.13.1.15,"...ound {systematic name: 12,30-di­aza­hepta­cyclo­[21.13.1.15,19.16,18.110,14.124,36.128,32]do­tetra­c...",4,261,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_31_70(Pt_11)_447-450.txt
1.13.1.15,"...H46N2 {systematic name: 12,30-di­aza­hepta­cyclo[21.13.1.15,19.16,18.110,14.124,36.128,32]do­tetra­c...",6,74,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_31_70(Pt_11)_447-450.txt
1.13.1.15,"...elated to the four-layered [3.3]MCP, hepta­cyclo[21.13.1.15,19.16,18.110,14.124,36.128,32]dotetra­co...",21,82,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_31_70(Pt_11)_447-450.txt
1.1.1.2,...as supported by the European Social Fund (No. 1DP/1.1.1.2.0/13/APIA/VIAA/011),60,63,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2014_Oct_24_70(Pt_11)_379-381.txt
3.8.8.43,"(13.8.8.43,13.06,34.010,33)pentatriaconta-3,5,10,12,...",239,3,Acta_Crystallogr_Sect_E_Struct_Rep_Online_2009_Nov_4_65(Pt_12)_m1509-m1510.txt
EC 5.4.2.3,...      N-Acetylglucosamine-phosphate mutase (AGM1; EC 5.4.2.3) is an essential enzyme in the synthesi...,17,57,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2006_Mar_25_62(Pt_4)_419-421.txt
EC 5.4.99.5,"...an (Trp) (Haslam, 1993 ▶). Chorismate mutase (CM; EC 5.4.99.5) is located at the branch point of the...",13,396,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2006_Apr_12_62(Pt_5)_441-445.txt
EC 4.2.1.1,Carbonic anhydrases (CAs; EC 4.2.1.1) catalyze the interconversion of carbon...,14,27,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2006_Jun_10_62(Pt_7)_618-622.txt
EC 3.2.1.1,"α-Amylases (α-1,4-glucan-4-glucanohydrolases; EC 3.2.1.1) are monomeric enzymes that catalyse th...",12,47,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2006_Aug_26_62(Pt_9)_849-854.txt
EC 3.2.1.1,"Recombinant B. halmapalus α-amylase (EC 3.2.1.1) was provided by Novozymes A/S, Bagsvae...",21,38,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2006_Aug_26_62(Pt_9)_849-854.txt
EC 5.1.3.2,...ependent oxidoreductase UDP-glucose-4′-epimerase (EC 5.1.3.2; GalE) encoded by the TbGalE gene that ...,13,1737,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2006_Aug_11_62(Pt_9)_829-834.txt
EC 2.7.4.8,"... S. aureus guanylate monophosphate kinase (SaGMK; EC 2.7.4.8), the structure of which we describe in...",15,109,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2006_Sep_19_62(Pt_10)_949-953.txt
EC 1.19.3.2,Laccases (benzenediol oxygen oxidoreductases; EC 1.19.3.2) are widely distributed in higher plan...,14,47,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2006_Sep_19_62(Pt_10)_954-957.txt
EC 4.2.1.43,... l-­2-­Keto-3-deoxyarabonate (l-KDA) dehydratase (EC 4.2.1.43; encoded by the AraD gene; GenBank acc...,18,128,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2007_Apr_6_63(Pt_5)_393-395.txt
EC 2.6.1.13,"... et al., 1993 ▶). Subgroup II contains ornithine (EC 2.6.1.13), 4-aminobutyrate (EC 2.6.1.19), acety...",17,154,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2007_Jan_17_63(Pt_2)_117-119.txt
EC 2.6.1.19,"...ontains ornithine (EC 2.6.1.13), 4-aminobutyrate (EC 2.6.1.19), acetylornithine (EC.2.6.1.11), diami...",17,185,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2007_Jan_17_63(Pt_2)_117-119.txt
2.6.1.11,"...-aminobutyrate (EC 2.6.1.19), acetylornithine (EC.2.6.1.11), diaminopelargonate (EC.2.6.1.62) and ω-...",17,219,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2007_Jan_17_63(Pt_2)_117-119.txt
2.6.1.62,"...ylornithine (EC.2.6.1.11), diaminopelargonate (EC.2.6.1.62) and ω-amino acid:pyruvate transaminases ...",17,253,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2007_Jan_17_63(Pt_2)_117-119.txt
EC 2.6.1.18,"....6.1.62) and ω-amino acid:pyruvate transaminases (EC 2.6.1.18). Within this subgroup, the distal ami...",17,304,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2007_Jan_17_63(Pt_2)_117-119.txt
EC 3.5.2.3,Dihydroorotase (DHOase; EC 3.5.2.3) is a zinc metalloenzyme that catalyzes...,14,25,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2007_Feb_13_63(Pt_3)_154-161.txt
EC 3.6.1.23,...ridine triphosphate nucleotidohydrolase (dUTPase; EC 3.6.1.23) catalyzes the hydrolysis of deoxyurid...,14,79,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2007_Apr_14_63(Pt_5)_409-411.txt
EC 3.6.1.23,dUTPase (EC 3.6.1.23) is a ubiquitous enzyme (Cedergren-Zep...,14,10,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Sep_25_65(Pt_10)_1030-1034.txt
3.2.8.1,"...terminus. We transfected the plasmid into CHO Lec 3.2.8.1 cells (Stanley, 1989 ▶) by electroporation...",18,578,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Jun_30_65(Pt_7)_739-742.txt
3.2.8.1,"...ential N-glycosylation sites, we used the CHO Lec 3.2.8.1 cell line for stable expression. This cell...",28,329,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Jun_30_65(Pt_7)_739-742.txt
EC 5.3.99.2,"... haematopoietic prostaglandin D synthase (H-PGDS; EC 5.3.99.2) produces prostaglandin D2, an allergi...",5,56,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Jun_24_66(Pt_7)_846-850.txt
EC 3.1.4.39,"...ho­lipase D) activity (Umezu-Goto et al., 2002 ▶; EC 3.1.4.39). Autotaxin converts extracellular lys...",16,365,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Aug_31_66(Pt_9)_1130-1135.txt
EC 3.6.1.23,"...v et al., 2000 ▶). dUTP pyrophosphatase (dUTPase; EC 3.6.1.23) catalyzes the hydrolysis of dUTP to d...",10,431,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Aug_4_66(Pt_10)_1237-1244.txt
EC 6.1.1.2,... of TmTrpRS (tryptophanyl-tRNA synthetase; TrpRS; EC 6.1.1.2) reveals an iron–sulfur [4Fe–­4S] clust...,5,264,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Sep_23_66(Pt_10)_1326-1334.txt
EC 6.1.1.2,"...s preferred. Tryptophanyl-tRNA synthetase (TrpRS; EC 6.1.1.2) belongs to the class I AARSs and, as i...",13,1170,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Sep_23_66(Pt_10)_1326-1334.txt
EC 2.3.1.9,...ciation with members of the thiolase superfamily (EC 2.3.1.9) that are involved in condensation of a...,59,511,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Mar_5_66(Pt_10)_1160-1166.txt
EC 1.2.99.5,"...s of molybdenum formylmethanofuran dehydrogenase (EC 1.2.99.5), an enzyme that is involved in microb...",5,319,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Aug_4_66(Pt_10)_1335-1346.txt
EC 1.2.99.5,"...tic subunits of formylmethanofuran dehydrogenase (EC 1.2.99.5) has been reported (Hochheimer et al.,...",10,326,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Aug_4_66(Pt_10)_1335-1346.txt
EC 4.1.1.50,"... including S-adenosyl-l-methionine decarboxylase (EC 4.1.1.50), an enzyme implicated in the urea cyc...",10,1409,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Oct_27_66(Pt_10)_1205-1210.txt
EC 4.1.1.50,... S-adenosyl­methionine decarboxylases (AdoMetDCs; EC 4.1.1.50) were also observed. Superposition of ...,40,99,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Oct_27_66(Pt_10)_1205-1210.txt
EC 2.8.1.7,"...idase (LP2181, score 0.64). Cysteine desulfurase (EC 2.8.1.7) catalyzes the production of alanine fr...",54,260,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Oct_27_66(Pt_10)_1205-1210.txt
EC 3.2.2.16,"...cysteine, while methylthioadenosine nucleosidase (EC 3.2.2.16) also participates in the metabolism o...",54,363,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Oct_27_66(Pt_10)_1205-1210.txt
EC 5.4.99.5,"...encodes a bifunctional enzyme, chorismate mutase (EC 5.4.99.5)/prephenate dehydrogenase (EC 1.3.1.12...",22,100,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Jul_31_66(Pt_10)_1317-1325.txt
EC 1.3.1.12,"...te mutase (EC 5.4.99.5)/prephenate dehydrogenase (EC 1.3.1.12) (CM/PDH), with a molecular weight of ...",22,139,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Jul_31_66(Pt_10)_1317-1325.txt
EC 5.4.99.5,"...eria, fungi and higher plants, chorismate mutase (EC 5.4.99.5) catalyzes the isomerization of choris...",12,668,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Mar_5_66(Pt_10)_1182-1189.txt
3.2.8.1,"...Davis et al., 1995 ▶), from mutant CHO-derived Lec3.2.8.1 cells whose ability to process glycans bey...",36,752,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
3.2.8.1,"...verely limited (Davis et al., 1993 ▶) and from Lec3.2.8.1 cells treated with NB-DNJ (Butters et al.,...",36,883,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
3.2.8.1,"...rees of sensitivity, with protein expressed in Lec3.2.8.1 cells and in CHO-K1 cells, both with NB-DN...",36,1107,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
3.2.8.1,"...pressed in the presence of kifunensine, and in Lec3.2.8.1 cells only, exhibited similar intermediate...",37,81,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
3.2.8.1,For glycans derived from CHO Lec3.2.8.1 cells in the presence of 0.5 mM NB-DNJ (Fi...,46,33,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
3.2.8.1,...lycans released from CTLA-4ex expressed in CHO Lec3.2.8.1 cells (Fig. 2,50,1270,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
3.2.8.1,"...K1 cells with 10 µM kifunensine; sample 4, CHO Lec3.2.8.1 cells only; sample 5, CHO Lec3.2.8.1 cells...",67,612,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
3.2.8.1,"...le 4, CHO Lec3.2.8.1 cells only; sample 5, CHO Lec3.2.8.1 cells with 0.5 mM NB-DNJ. In (b) crystals ...",67,649,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
3.2.8.1,"...ed in CHO-K1 cells with 1.5 mM NB-DNJ (a), CHO Lec3.2.8.1 cells with 0.5 mM NB-DNJ (b), CHO-K1 cells...",69,151,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
3.2.8.1,"..., CHO-K1 cells with 10 µM kifunensine (c), CHO Lec3.2.8.1 cells (d) and CHO-K1 cells (e). A trace am...",69,237,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
3.2.8.1,...Ac2 glycans was detected in the spectra of CHO Lec3.2.8.1 but was obscured by contaminating peaks (n...,69,378,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Jun_30_67(Pt_7)_785-789.txt
EC 1.1.1.21,Aldose reductases (EC 1.1.1.21) are ubiquitous NADPH-dependent oxidor...,19,20,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1113-1117.txt
EC 4.2.1.2,...zekii strain Madrid E (NCBI NP_221027; fumC gene; EC 4.2.1.2; UniProt Q9ZCQ4) spanning the full-leng...,26,69,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1123-1128.txt
EC 4.1.2.13,...glycolytic enzyme fructose bisphosphate aldolase (EC 4.1.2.13) catalyzes the aldol cleavage of fruct...,14,373,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_13_67(Pt_9)_1055-1059.txt
EC 4.1.2.13,...culi (NCBI 6035; UniProt Q8SSM8; Pfam ID PF00274; EC 4.1.2.13) spanning the full-length protein from...,21,101,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_13_67(Pt_9)_1055-1059.txt
EC 4.1.2.13,...glycolytic enzyme fructose bisphosphate aldolase (EC 4.1.2.13) catalyzes the aldol cleavage of fruct...,14,277,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_13_67(Pt_9)_1051-1054.txt
EC 2.5.1.48,"... of this pathway, cystathionine γ-­synthase (CGS; EC 2.5.1.48) catalyzes the reaction between",13,214,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1154-1158.txt
EC 2.5.1.48,...CBI YP_904423.1; UniProt A0PKT3; Pfam ID PF01053; EC 2.5.1.48) was amplified from M. ulcerans Agy99 ...,25,147,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1154-1158.txt
EC 2.7.7.3,...BURPS1710B_0748; UniProt Q3JW91; Pfam ID PF01467; EC 2.7.7.3) spanning the full-length protein from ...,20,153,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_13_67(Pt_9)_1032-1037.txt
EC 1.20.4.1,...41.1; UniProt Q2YLN2 and Q6G5J5; Pfam ID PF00462; EC 1.20.4.1) were cloned into a pAVA vector (Choi ...,21,121,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1141-1147.txt
EC 5.4.2.1,...lycerate-dependent phosphoglycerate mutase (PGAM; EC 5.4.2.1) to accomplish this reaction in glycoly...,11,225,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_13_67(Pt_9)_1044-1050.txt
EC 5.4.2.4,...n erythrocytes bisphospho­glycerate mutase (BPGM; EC 5.4.2.4) is the predominant form. PGAM converts...,11,341,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_13_67(Pt_9)_1044-1050.txt
EC 1.3.99.7,"...ike other flavoproteins within this family, GCDH (EC 1.3.99.7) performs α,β-dehydrogenation as well ...",10,309,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_13_67(Pt_9)_1060-1069.txt
EC 1.1.1.100,...fabG gene RP762; UniProt P50941; Pfam ID PF00106; EC 1.1.1.100) spanning the full-length protein fro...,21,108,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2011_Aug_16_67(Pt_9)_1118-1122.txt
EC 1.5.1.33,...ehydrogenase/reductase pteridine reductase (PTR1; EC 1.5.1.33). This enzyme is unique to trypanosoma...,17,393,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2010_Dec_21_67(Pt_1)_33-37.txt
EC 5.4.99.9,"...rejo et al., 1971 ▶; Nassau et al., 1996 ▶). UGM (EC 5.4.99.9) is a flavo-containing enzyme that cat...",16,655,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2012_May_23_68(Pt_6)_705-708.txt
EC 2.5.1.47,... phosphate (PLP)-dependent cysteine synthase (CS; EC 2.5.1.47). This de novo pathway for cysteine bi...,14,1301,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2012_Jun_22_68(Pt_7)_738-743.txt
EC 1.1.1.44,...he enzyme 6-phosphogluconate dehydrogenase (6PDH; EC 1.1.1.44) catalyzes the conversion of 6-phospho...,17,52,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2009_Apr_24_65(Pt_5)_450-454.txt
EC 1.1.1.205,Inosine 5′-monophosphate dehydrogenase (IMPDH; EC 1.1.1.205) catalyzes the first committed reacti...,12,48,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2013_Feb_22_69(Pt_3)_243-247.txt
EC 3.5.4.26,...ohydroxyphosphoribosylaminopyrimi­dine deaminase (EC 3.5.4.26)/5-amino-6-(5-phosphoribosylamino)­ura...,14,1579,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2013_May_23_69(Pt_6)_611-617.txt
EC 1.1.1.193,"...amino-6-(5-phosphoribosylamino)­uracil reductase (EC 1.1.1.193), called RibD, in this pathway as a p...",14,1644,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2013_May_23_69(Pt_6)_611-617.txt
EC 3.5.4.26,... RibD. A total of 550 sequences annotated as both EC 3.5.4.26 and EC 1.1.1.193 in the UniProt databa...,133,84,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2013_May_23_69(Pt_6)_611-617.txt
EC 1.1.1.193,...f 550 sequences annotated as both EC 3.5.4.26 and EC 1.1.1.193 in the UniProt database (http://www.u...,133,100,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2013_May_23_69(Pt_6)_611-617.txt
EC 2.5.1.61,...en deaminase (PBGD; hydroxymethylbilane synthase; EC 2.5.1.61) catalyses a key early step in the bio...,5,271,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2013_Jul_27_69(Pt_8)_906-908.txt
EC 2.5.1.61,...en deaminase (PBGD; hydroxymethylbilane synthase; EC 2.5.1.61) catalyses an early step of the tetrap...,7,75,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2013_Jul_27_69(Pt_8)_906-908.txt
EC 2.5.1.61,"...ch is also known as hydroxymethylbilane synthase (EC 2.5.1.61), catalyses an early step of the tetra...",12,99,Acta_Crystallogr_Sect_F_Struct_Biol_Cryst_Commun_2013_Jul_27_69(Pt_8)_906-908.txt
6.9.3.405,...t Opin Pharmacother 2008 9 405 420 10.1517/14656566.9.3.405 18220491,137,195,Acta_Diabetol_2011_Mar_21_48(1)_71-77.txt
1.6.1.138,... Ann Periodontol 2001 6 138 145 10.1902/annals.2001.6.1.138 11887456,242,182,Acta_Diabetol_2011_Dec_2_48(4)_257-273.txt
3.20.5.341,...dy Health Psychol 2001 20 341 350 10.1037/0278-6133.20.5.341 11570648,206,217,Acta_Diabetol_2013_Mar_15_50(5)_721-726.txt
4.41.2.86,...Clin Exp Reprod Med 2014 41 86 91 10.5653/cerm.2014.41.2.86 25045633,278,273,Acta_Diabetol_2016_May_12_53_227-236.txt
6.99.1.3,...Mayr) J comp psychol 1985 99 3 14 10.1037/0735-7036.99.1.3,204,152,Acta_Ethol_2010_May_4_13(1)_23-31.txt
4.50.3.559,...ers Soc Psychol 1986 50 3 559 570 10.1037/0022-3514.50.3.559,104,110,PMC5243905.txt
4.72.2.346,...ers Soc Psychol 1997 72 2 346 361 10.1037/0022-3514.72.2.346 9107005,107,150,PMC5243905.txt
EC 3.4.21.4,"... the sections were pretreated in 10 U/ml trypsin (EC 3.4.21.4, type 1, Sigma) in PBS. After washing ...",20,581,Acta_Histochem_Cytochem_2007_Aug_30_40(4)_123-130.txt
EC 2.7.4.3,"...n reported. AK1, AK2 (ATP:AMP phosphotransferase, EC 2.7.4.3), and AK3 (GTP:AMP phosphotransferase, ...",12,96,Acta_Histochem_Cytochem_2009_Apr_28_42(2)_55-64.txt
EC 2.7.4.10,"...EC 2.7.4.3), and AK3 (GTP:AMP phosphotransferase, EC 2.7.4.10) were the first to be described [4, 6,...",12,146,Acta_Histochem_Cytochem_2009_Apr_28_42(2)_55-64.txt
EC 5.3.99.3,...rization of PGH2 to PGE2 by PGE2 synthase (PGES) [EC 5.3.99.3] (Fig. 1). COX-2 and PGES collaborativ...,8,498,Acta_Histochem_Cytochem_2009_Aug_29_42(4)_105-109.txt
2.1.3.5,...fibrillar Adenosine Tri-phosphatase (mATPase (E.C.2.1.3.5.7.9.1) activity was determined after pre-i...,21,179,Acta_Histochem_Cytochem_2011_Apr_28_44(2)_43-50.txt
2.6.1.44,"Human alanine:glyoxylate aminotransferase (AGT; EC2.6.1.44), localized to liver peroxisomes, has a b...",8,51,Acta_Histochem_Cytochem_2012_Apr_26_45(2)_121-129.txt
EC 2.3.1.6,"... (acetyl-CoA, choline-O-acetyl-transferase, ChAT; EC 2.3.1.6). In previous studies, protein expressi...",8,139,Acta_Histochem_Cytochem_2013_Apr_30_46(2)_59-64.txt
1.19.68.79,...ta Inform Med 2011 19 2 68 79 doi: 10.4555/aim.2011.19.68.79,572,156,Acta_Inform_Med_2012_Jun_20(2)_72-84.txt
1.19.68.79,doi: 10.4555/aim.2011.19.68.79,337,21,Acta_Inform_Med_2013_Mar_21(1)_67-70.txt
1.19.68.79,doi: 10.4555/aim.2011.19.68.79,202,21,Acta_Inform_Med_2013_Mar_21(1)_55-59.txt
4.22.6.10,...a Inform Med 2014 2 22 1 6 10 doi. 10.5455 aim/2014.22.6.10,80,239,Acta_Inform_Med_2014_Feb_25_22(1)_44-48.txt
4.22.6.10,...ta Inform Med 2014 2 22 1 6 10 doi: 10.5455aim/2014.22.6.10,58,237,Acta_Inform_Med_2014_Feb_25_22(1)_68-70.txt
3.14.2.734,...rch 2013 14 2 193 202 DOI: 10.5829/idosi.mejsr.2013.14.2.734,124,192,Acta_Inform_Med_2015_Feb_22_23(1)_33-38.txt
6.24.99.102,...Inform Med 2016 4 24 2 99 102 doi: 10.5455/aim.2016.24.99.102 2714779,93,249,Acta_Inform_Med_2016_Jul_16_24(4)_296-298.txt
2.3.1.1,2.3.1.1 Segmentation of aluminide,24,1,Acta_Mater_2011_Sep_59(16)_6420-6432.txt
2.3.1.2,2.3.1.2 Segmentation of S,27,1,Acta_Mater_2011_Sep_59(16)_6420-6432.txt
EC 3.2.1.20,"... the enzyme acid alpha-glucosidase (acid maltase, EC 3.2.1.20, Swiss) which originates lysosomal gly...",11,266,Acta_Myol_2013_Oct_32(2)_95-99.txt
EC 3.1.8.1,"...rs in the blood stream. Plasma paraoxonase (PON1; EC 3.1.8.1) displays an arylesterase activity, and...",25,203,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 3.1.1.8,"...terase activity, and butyrylcholinesterase (BChE; EC 3.1.1.8) — that has broad esterase specificity ...",25,283,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 3.1.1.7,...olinesterases (ChEs): acetylcholinesterase (AChE; EC 3.1.1.7) and butyrylcholinesterase (Fig. 2). AC...,30,199,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 3.1.1.1,...alized by tissues (liver) carboxylesterases (CaE; EC 3.1.1.1) and oxidized by oxidases such as cytoc...,38,69,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 2.5.1.18,...and peroxidases. Glutathione S-transferases (GST; EC 2.5.1.18) are 20-30kDa enzymes that catalyze gl...,38,220,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 3.1.8.1,"...acterial enzymes called phosphotriesterases (PTE; EC 3.1.8.1), or sometimes organophosphorus hydrola...",72,419,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 3.1.8.1,...l phosphotriesterases - Phosphotriesterases (PTE; EC 3.1.8.1) are encoded by the organophosphate deg...,74,59,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 3.1.8.2,...such as organophosphorus acid anhydrolases (OPAA; EC 3.1.8.2) and organophosphate-degrading agents (...,116,123,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 3.4.13.9,...ophosphate-degrading agents (OpdA) or prolidases (EC 3.4.13.9). Prolidases were first isolated from ...,116,194,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 3.4.11.9,... discovered human cytosolic aminopeptidase (AMPP; EC 3.4.11.9) could also be a valuable catalytic bi...,118,507,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 1.10.3.2,Laccases (EC 1.10.3.2) are fungal phenol oxidoreductases tha...,120,11,Acta_Naturae_2009_Apr_1(1)_68-79.txt
EC 3.2.1.18,Neuraminidase is an exosialidase (EC 3.2.1.18) which cleaves α-ketosidic linkage bet...,11,35,Acta_Naturae_2009_Jul_1(2)_26-32.txt
6.4.1.2,Biotin		Carboxylases. E.C. 6.4.1.2; 6.4.1.3. Carboxylation. Transfer of a sin...,22,28,Acta_Naturae_2009_Oct_1(3)_29-51.txt
6.4.1.3,Biotin		Carboxylases. E.C. 6.4.1.2; 6.4.1.3. Carboxylation. Transfer of a single carbo...,22,37,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.3.1.12,Lipoate		Acyltransferases. E.C. 2.3.1.12. Reduction-oxidation. Transfer of carbon ...,23,33,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.3.1.85,Panthotenate		Acyltransferases. E.C. 2.3.1.85. Transacylation. Transfer of an acyl frag...,24,38,Acta_Naturae_2009_Oct_1(3)_29-51.txt
1.9.3.1,Heme		cytochrome c oxidase. E.C. 1.9.3.1. Reduction-oxidation. Transfer of electron...,26,34,Acta_Naturae_2009_Oct_1(3)_29-51.txt
1.3.99.1,FAD		Oxidoreductases. E.C. 1.3.99.1. Reduction-oxidation. Oxidation of the -C...,27,28,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.6.1.1,"Aspartate aminotransferase (C.E. 2.6.1.1), which catalyses the transamination of ox...",31,34,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.7.10.2,...hey add the phosphate into tyrosine kinases (E.C. 2.7.10.2) and serine/threonine kinases (E.C. 2.7.1...,40,523,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.7.11.1,"...E.C. 2.7.10.2) and serine/threonine kinases (E.C. 2.7.11.1) [5]. Also, histidine kinases are often f...",40,568,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.7.11.24,"Mitogen-activated kinases (MAPK, E.C. 2.7.11.24) respond to extracellular stimuli (mitog...",58,39,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.7.7.6,...; for instance eukaryotic RNA polymerase II (E.C. 2.7.7.6) [28]. The C-terminus of this enzyme's maj...,62,333,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.3.1.48,...ious forms of the histone acetyltransferase (E.C. 2.3.1.48) catalyze the acetylation of lysine resid...,69,54,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.1.1.43,... residue (histone-lysine methyltransferases (E.C. 2.1.1.43) and histone-arginine methyltransferases ...,112,219,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.1.1.125,...43) and histone-arginine methyltransferases (E.C. 2.1.1.125)) and the position of this residue in th...,112,275,Acta_Naturae_2009_Oct_1(3)_29-51.txt
1.5.3.4,"...+ ions, Alpha;-ketoglutarate, and ascorbate (E.C. 1.5.3.4) [37, 65, 66, 82, 83]. For schematic repre...",116,599,Acta_Naturae_2009_Oct_1(3)_29-51.txt
3.5.3.15,"A nuclear peptidylarginine deiminase (E.C. 3.5.3.15) can demethylate arginine residues, turni...",120,44,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.5.1.58,"...ngeranyl-geranyl transferases, respectively (E.C. 2.5.1.58 and E.C. 2.5.1.59 or E.C. 2.5.1.60; Type ...",127,339,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.5.1.59,"...ransferases, respectively (E.C. 2.5.1.58 and E.C. 2.5.1.59 or E.C. 2.5.1.60; Type I and II geranyl-g...",127,357,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.5.1.60,...ectively (E.C. 2.5.1.58 and E.C. 2.5.1.59 or E.C. 2.5.1.60; Type I and II geranyl-geranyl transferas...,127,374,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.1.1.100,...osprenyl-cysteine-carboxymethyl transferase (E.C. 2.1.1.100) [84-87] (Fig. 12),131,1203,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.4.1.119,...culum. The oligosaccaryl transferase enzyme (E.C. 2.4.1.119) transfers a branched tetradecasaccharid...,145,228,Acta_Naturae_2009_Oct_1(3)_29-51.txt
3.2.1.106,"...hich are catalyzed by glucosidases I and II (E.C. 3.2.1.106) that cleave away two glucose residues, ...",153,168,Acta_Naturae_2009_Oct_1(3)_29-51.txt
3.2.1.130,"...away two glucose residues, and mannosidases (E.C. 3.2.1.130) that cleave away 6 mannose residues. Th...",153,241,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.7.8.19,...DP-glucose:glycoprotein glucosyltransferase (E.C. 2.7.8.19) returns a glucose residue back onto the ...,153,929,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.4.1.94,...into the protein by an 0-GlcNAc-transferase (E.C. 2.4.1.94) and can be cleaved by the appropriate hy...,161,309,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.8.2.20,"...is catalyzed by the sulfotransferase enzyme (E.C. 2.8.2.20) [103, 104]",166,255,Acta_Naturae_2009_Oct_1(3)_29-51.txt
3.1.5.6,...lpha; chemokine. An enzyme called sulfatase (E.C. 3.1.5.6) was found in lysosomes and was able to ca...,170,434,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.4.2.31,"...nd is cleaved by the ADP-ribosyltransferase (E.C. 2.4.2.31) and forms a ribo-oxocarbene cation, whic...",175,138,Acta_Naturae_2009_Oct_1(3)_29-51.txt
1.8.1.7,...of NAD(P)H and of the glutathione reductase (E.C. 1.8.1.7) and thioredoxinreductase (E.C. 1.8.1.9) e...,204,341,Acta_Naturae_2009_Oct_1(3)_29-51.txt
1.8.1.9,...ase (E.C. 1.8.1.7) and thioredoxinreductase (E.C. 1.8.1.9) enzymes lead to the reduction of oxidized...,204,381,Acta_Naturae_2009_Oct_1(3)_29-51.txt
1.14.99.20,"...e is catalyzed by the γ-glutamilcarboxylase (E.C. 1.14.99.20), which uses the reduced (dihydronaphto...",238,92,Acta_Naturae_2009_Oct_1(3)_29-51.txt
1.1.4.1,"...l form is catalyzed by 2,3-epoxydereductase (E.C. 1.1.4.1), which is associated in a complex with pr...",238,712,Acta_Naturae_2009_Oct_1(3)_29-51.txt
1.8.4.2,...fide isomerase in the endoplasmic reticulum (E.C. 1.8.4.2) [167],238,823,Acta_Naturae_2009_Oct_1(3)_29-51.txt
3.3.1.1,... is hydrolyzed by the adensylhomocysteinase (E.C. 3.3.1.1) enzyme into adenosine and homocysteine. T...,267,180,Acta_Naturae_2009_Oct_1(3)_29-51.txt
6.1.1.1,...tion catalyzed by methionyl-tRNA synthetase (E.C. 6.1.1.1) turns homocysteine into thiolactone (this...,267,288,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.1.1.77,"...tein isoaspartyl-O-methyltransferase (PIMT) (E.C. 2.1.1.77), a widespread cellular enzyme [211, 212,...",288,298,Acta_Naturae_2009_Oct_1(3)_29-51.txt
2.3.2.13,...ansamidiation catalyzed by transglutaminase (E.C. 2.3.2.13,296,62,Acta_Naturae_2009_Oct_1(3)_29-51.txt
EC 1.2.1.2,"...s are NAD+-dependent formate dehydrogenases (FDH, EC 1.2.1.2), which oxidize formate coupled with re...",14,312,Acta_Naturae_2009_Oct_1(3)_89-93.txt
EC 1.2.1.2,"Formate dehydrogenase (EC 1.2.1.2, FDH), a NAD+–dependent enzyme, catalys...",28,24,Acta_Naturae_2010_Apr_2(1)_97-102.txt
EC 2.4.2.1,"(PNP; EC 2.4.2.1), which hydrolyzed inosine or guanosine...",240,7,Acta_Naturae_2010_Jul_2(2)_36-59.txt
EC 2.4.2.4,Thymidine phosphorylase (TP; EC 2.4.2.4) reversibly catalyzes the phosphorolysi...,269,30,Acta_Naturae_2010_Jul_2(2)_36-59.txt
EC 2.4.2.3,"–uracil, whereas uridine phosphorylase (UP; EC 2.4.2.3) does not distinguish betwee",272,45,Acta_Naturae_2010_Jul_2(2)_36-59.txt
EC 2.4.2.6,purine(pyrimidine)deoxyribosyl transferases; EC 2.4.2.6) represent another type of enzymes,624,46,Acta_Naturae_2010_Jul_2(2)_36-59.txt
EC 1.2.1.2,"NAD+–dependent formate dehydrogenase (EC 1.2.1.2, FDH",20,39,Acta_Naturae_2010_Jul_2(2)_82-88.txt
EC 3.5.1.11,"Penicillin acylase (PA, EC 3.5.1.11) was discovered 60 years ago as a cata...",9,25,Acta_Naturae_2010_Jul-Sep_2(3)_47-61.txt
1.11.1.7,1.11.1.7]) with antigens or antibodies,28,1,Acta_Naturae_2011_Jul-Sep_3(3)_85-92.txt
EC 1.2.1.2,"... cited.NAD+-dependent formate dehydrogenase (FDH, EC 1.2.1.2) widely occur",7,59,Acta_Naturae_2011_Oct-Dec_3(4)_38-54.txt
1.2.1.2,...AD + -dependent formate dehydrogenases (FDHs) [EC 1.2.1.2] belong to the family of enzymes catalyzin...,21,52,Acta_Naturae_2011_Oct-Dec_3(4)_38-54.txt
EC 1.5.1.3,DHFR ‑ dihydrofolate reductase (EC 1.5.1.3,466,33,Acta_Naturae_2012_Jan-Mar_4(1)_93-100.txt
EC 1.1.1.205,"Inosine monophosphate dehydrogenase (IMPDH, [EC 1.1.1.205]) is one of the key enzymes in a de n...",21,46,Acta_Naturae_2012_Oct-Dec_4(4)_73-77.txt
EC 3.1.1.8,...tyrylcholinesterase (BChE) is a serine hydrolase (EC 3.1.1.8) which can b,9,53,Acta_Naturae_2013_Jan-Mar_5(1)_73-84.txt
EC 3.1.1.8,...tyrylcholinesterase (BChE) is a serine hydrolase [EC 3.1.1.8] that has bee,26,53,Acta_Naturae_2013_Jan-Mar_5(1)_73-84.txt
EC 1.1.3.6,"...ed by a fluorescence change. Cholesterol oxidase (EC 1.1.3.6) [29], which catalyses cholesterol oxid...",380,60,Acta_Naturae_2012_Apr-Jun_4(2)_36-43.txt
EC 4.4.1.11,Methionine γ-lyase (MGL) [EC 4.4.1.11] is a pyridoxal 5’-phosphate-dependen,31,27,Acta_Naturae_2013_Jul-Sep_5(3)_92-98.txt
EC 3.4.24.7,MMP1interstitial collagenase (EC 3.4.24.7,599,31,Acta_Naturae_2013_Oct-Dec_5(4)_110-117.txt
EC 3.1.1.43,"Alpha-amino acid ester hydrolase (EC 3.1.1.43, AEH) is a promising biocatalys",9,35,Acta_Naturae_2013_Oct-Dec_5(4)_62-70.txt
3.1.1.43,3.1.1.43]). Penicillin acylases have been isolated...,68,1,Acta_Naturae_2013_Oct-Dec_5(4)_62-70.txt
EC 1.6.4.2,peroxidase (GR [EC 1.6.4.2.]; GP [EC 1.11.1.9.]) system performs t...,70,17,Acta_Naturae_2014_Apr-Jun_6(2)_110-118.txt
EC 1.11.1.9,peroxidase (GR [EC 1.6.4.2.]; GP [EC 1.11.1.9.]) system performs th,70,35,Acta_Naturae_2014_Apr-Jun_6(2)_110-118.txt
EC 1.1.1.49,with glucose- 6-phosphate dehydrogenase (G6PDG [EC 1.1.1.49.]) being its ke,75,49,Acta_Naturae_2014_Apr-Jun_6(2)_110-118.txt
EC 1.1.1.42,"by NADP-isocitrate dehydrogenase (NADP-IDG [EC 1.1.1.42.]), which includes th",79,45,Acta_Naturae_2014_Apr-Jun_6(2)_110-118.txt
EC 1.4.3.3,"Trigonopsis variabilis (TvDAAO, EC 1.4.3.3). As a result o",14,33,Acta_Naturae_2014_Jul-Sep_6(3)_76-88.txt
EC 1.4.3.3,"D-amino acid oxidase (DAAO, [EC 1.4.3.3]) belongs to a class of FAD-containin",33,30,Acta_Naturae_2014_Jul-Sep_6(3)_76-88.txt
3.3.1.111,35 Methodological Guidelines MU 3.3.1.1113-02 (approved by the Main State Health O...,709,33,Acta_Naturae_2015_Jan-Mar_7(1)_102-108.txt
EC 1.2.1.2,"NAD+-dependent formate dehydrogenases (EC 1.2.1.2., FDH) fro",11,40,Acta_Naturae_2015_Jan-Mar_7(1)_60-69.txt
EC 1.2.1.2,[EC 1.2.1.2] (FDH). In all bacterial FDHs (except f...,66,2,Acta_Naturae_2015_Jan-Mar_7(1)_60-69.txt
EC 3.2.1.49,α-N-Acetylgalactosaminidases (EC 3.2.1.49) catalyze the removal o,33,31,Acta_Naturae_2015_Jan-Mar_7(1)_117-120.txt
1.2.1.2,"NAD(P)+-dependent formate dehydrogenases ([1.2.1.2], FDHs) have bee",32,44,Acta_Naturae_2015_Jul-Sep_7(3)_55-64.txt
EC 4.4.1.11,γ-lyase (MGL) [EC 4.4.1.11] from Citrobacter freundi,49,16,Acta_Naturae_2015_Oct-Dec_7(4)_128-135.txt
EC 4.4.1.4,is catalyzed by PLP-dependent alliinase [EC 4.4.1.4] [16] upon crushing of garlic. The anti...,89,42,Acta_Naturae_2015_Oct-Dec_7(4)_128-135.txt
1.14.11.29,"oxygen oxidoreductase, [1.14.11.29]; PDB code: 2G19) in a complex with th",164,25,Acta_Naturae_2016_Jan-Mar_8(1)_82-89.txt
EC 2.4.2.30,EC 2.4.2.30) are a group of eukaryotic proteins wi...,34,1,Acta_Naturae_2016_Apr-Jun_8(2)_108-115.txt
1.1.8.3,"Vekton, Russia; fetal calf serum (1.1.8.3.), RPMI-1640 (1.3.4) and DME",97,35,Acta_Naturae_2016_Jul-Sep_8(3)_136-146.txt
1.3.5.1,"(1.3.5.1.) culture media for cell cultures, Biolot,...",98,2,Acta_Naturae_2016_Jul-Sep_8(3)_136-146.txt
EC 3.4.21.26,endopeptidase (PREP [EC 3.4.21.26]) or prolyl carboxypeptidase (PRCP [E...,780,22,Acta_Naturae_2016_Jul-Sep_8(3)_136-146.txt
3.4.16.2,3.4.16.2]) could be one of these enzymes. They cle...,781,1,Acta_Naturae_2016_Jul-Sep_8(3)_136-146.txt
6.21.5.5,...ymphoma Neurosurg Focus 2006 21 E4 10.3171/foc.2006.21.5.5 17134120,62,119,Acta_Neurochir_(Wien)_2010_Jan_4_152(1)_163-168.txt
6.21.5.4,...roaches Neurosurg Focus 2006 21 E3 10.3171/foc.2006.21.5.4 17134119,66,252,Acta_Neurochir_(Wien)_2010_Jan_4_152(1)_163-168.txt
6.21.3.2,...ence? Neurosurg Focus 2006 21 3 E2 10.3171/foc.2006.21.3.2 17029341,130,166,Acta_Neurochir_(Wien)_2010_Feb_4_152(2)_251-255.txt
6.21.3.8,...ement Neurosurg Focus 2006 21 3 E8 10.3171/foc.2006.21.3.8 1702934,131,126,Acta_Neurochir_(Wien)_2010_Feb_4_152(2)_251-255.txt
6.5.1.33,...s J Neurosurg Spine 2006 5 1 33 45 10.3171/spi.2006.5.1.33 16850954,94,261,Acta_Neurochir_(Wien)_2010_Apr_14_152(4)_655-661.txt
4.46.4.839,... Pers Soc Psychol 1984 46 839 852 10.1037/0022-3514.46.4.839 6737195,247,139,Acta_Neurochir_(Wien)_2010_Aug_5_152(8)_1375-1382.txt
3.98.6.126,...on J Neurosurg 2003 98 6 1263 1270 10.3171/jns.2003.98.6.1263 12816274,128,243,Acta_Neurochir_(Wien)_2010_Aug_15_152(8)_1367-1373.txt
2.6.3.6,"5	F/62	Acromegalic features, BTH	3.3 × 2.6.3.6	III E	AIH	Sublabial	STR	460",54,40,Acta_Neurochir_(Wien)_2011_Jul_30_153(7)_1401-1408.txt
1.95.6.108,...gery J Neurosurg 2001 95 1083 1096 10.3171/jns.2001.95.6.1083 11765830,153,149,Acta_Neurochir_(Wien)_2011_Jul_30_153(7)_1401-1408.txt
3.15.2.15,...rature Neurosurg Focus 2003 15 E15 10.3171/foc.2003.15.2.15 15350046,124,194,Acta_Neurochir_(Wien)_2011_Jul_12_153(7)_1427-1434.txt
2.97.6.136,...ry J Neurosurg 2002 97 6 1367 1372 10.3171/jns.2002.97.6.1367 12507135,139,159,Acta_Neurochir_(Wien)_2010_Sep_30_152(9)_1603-1609.txt
3.99.6.107,...tute J Neurosurg 2003 99 1070 1076 10.3171/jns.2003.99.6.1070 14705736,188,180,Acta_Neurochir_(Wien)_2011_Nov_9_153(11)_2241-2250.txt
3.98.6.125,...ocus J Neurosurg 2003 98 1255 1262 10.3171/jns.2003.98.6.1255 12816273,205,246,Acta_Neurochir_(Wien)_2011_Sep_6_153(9)_1739-1749.txt
2.97.6.127,...trol J Neurosurg 2002 97 1276 1281 10.3171/jns.2002.97.6.1276 12507123,228,279,Acta_Neurochir_(Wien)_2012_Sep_16_154(9)_1669-1677.txt
3.98.6.121,...odel J Neurosurg 2003 98 1217 1221 10.3171/jns.2003.98.6.1217 12816267,218,253,Acta_Neurochir_(Wien)_2013_Feb_11_155(2)_323-333.txt
1.16.4.652,... J Bone Miner Res 2001 16 652 659 10.1359/jbmr.2001.16.4.652 11315992,132,234,Acta_Neurochir_(Wien)_2013_Mar_13_155(3)_421-427.txt
4.19.10.170,... Bone Miner Res 2004 19 1706 1711 10.1359/jbmr.2004.19.10.1706 15355566,134,251,Acta_Neurochir_(Wien)_2013_Mar_13_155(3)_421-427.txt
6.38.3.139,...l Cancer Res Treat 2006 38 139 143 10.4143/crt.2006.38.3.139 19771274,179,193,Acta_Neurochir_(Wien)_2014_Feb_11_156(6)_1135-1142.txt
3.98.6.117,...ct J Neurosurg 2003 98 6 1175 1181 10.3171/jns.2003.98.6.1175 12816260,242,362,Acta_Neurochir_(Wien)_2014_Aug_2_156(10)_1855-1863.txt
5.5.4.509,...ert Rev Neurother 2005 5 4 509 514 10.1586/14737175.5.4.509 16026234,245,132,Acta_Neurochir_(Wien)_2014_Aug_2_156(10)_1855-1863.txt
6.5.3.183,...e J Neurosurg Spine 2006 5 183 190 10.3171/spi.2006.5.3.183 16961078,193,157,Acta_Neurochir_(Wien)_2016_Nov_17_158_147-154.txt
4.56.5.428,...ean Neurosurg Soc 2014 56 428 430 10.3340/jkns.2014.56.5.428 25535522,119,215,Acta_Neurochir_(Wien)_2016_Jun_30_158_1731-1740.txt
6.38.2.177,...pital trauma VASA 2009 38 177 180 10.1024/0301-1526.38.2.177 19588307,135,160,Acta_Neurochir_(Wien)_2016_Jun_30_158_1731-1740.txt
2.97.5.101,...tion J Neurosurg 2002 97 1018 1022 10.3171/jns.2002.97.5.1018 12450021,148,184,Acta_Neurochir_(Wien)_2016_Jul_5_158_1807-1811.txt
1.2.4.239,...ant Korean J Radiol 2001 2 239 242 10.3348/kjr.2001.2.4.239 11754333,32,180,Acta_Neurol_Belg_2012_Dec_15_112(4)_425-426.txt
1.12.4.2,"...g image analysis and base calling by Illumina RTA 1.12.4.2, demultiplexing by CASAVA 1.8 (Illumina I...",91,115,Acta_Neurol_Scand_2016_Jul_12_134(1)_67-75.txt
5.4.6.973,...xpert Rev Neurother 2004 4 973 984 10.1586/14737175.4.6.973 Thom M (2004) Recent advances in the neu...,240,131,Acta_Neuropathol_2008_Jun_4_115(6)_683-696.txt
4.3.3.265,... both? Future Virol 2008 3 265 277 10.2217/17460794.3.3.265 19763230,221,161,Acta_Neuropathol_2010_Sep_13_120(3)_403-417.txt
6.19.8.104,...Drug News Perspect 2006 19 453 460 10.1358/dnp.2006.19.8.1043961 17160145,160,168,Acta_Neuropathol_2011_Jan_16_121(1)_5-20.txt
6.3.2.2,"...ate–cysteine ligase catalytic subunit (GCLc, E.C. 6.3.2.2); (2) rat glutamate–cysteine ligase modula...",20,127,Acta_Neuropathol_2011_Apr_30_121(4)_475-485.txt
1.8.1.7,"...Lm); and (3) rat glutathione reductase (GSR, E.C. 1.8.1.7). Control shRNAs were: EGFP-shRNA, Lucifer...",20,243,Acta_Neuropathol_2011_Apr_30_121(4)_475-485.txt
5.4.5.879,...xpert Rev Neurother 2004 4 879 893 10.1586/14737175.4.5.879 15853514,171,160,Acta_Neuropathol_2012_Sep_3_124(3)_439-447.txt
5.22.2.159,...Neuropsychology 2008 22 2 159 168 10.1037/0894-4105.22.2.159 18331158,192,188,Acta_Neuropathol_2014_Nov_22_127(2)_189-201.txt
5.7.7.887,...xpert Rev Neurother 2007 7 887 900 10.1586/14737175.7.7.887 17610395,415,156,Acta_Neuropathol_2014_Sep_24_128(5)_665-677.txt
3.6.2.8,"...C-173, PE-Cy7), mouse IgG1, κ (eBioscience, USA, P3.6.2.8.1, FITC), mouse IgG2a, κ (BD, USA; G155-17...",42,1412,Acta_Neuropathol_2014_Oct_5_128(5)_651-663.txt
1.1.2.760,"... 20× magnification. Imagescope software (version 11.1.2.760; Aperio, CA, USA) was used to view, deli...",61,154,Acta_Neuropathol_2014_Feb_16_127(5)_667-683.txt
1.1.2.760,"...he positive pixel algorithm (Imagescope, version 11.1.2.760; Aperio, CA, USA) and expressed as the p...",61,622,Acta_Neuropathol_2014_Feb_16_127(5)_667-683.txt
3.22.3.149,...tem Exp Neurobiol 2013 22 3 149 157 10.5607/en.2013.22.3.149 24167410,233,225,Acta_Neuropathol_2015_Oct_17_129_81-96.txt
5.7.3.227,...xpert Rev Neurother 2007 7 227 239 10.1586/14737175.7.3.227 17341170,137,121,Acta_Neuropathol_2015_Mar_27_129(5)_639-652.txt
5.8.3.433,...xpert Rev Neurother 2008 8 433 455 10.1586/14737175.8.3.433 18345973,138,137,Acta_Neuropathol_2015_Mar_27_129(5)_639-652.txt
3.98.6.117,...toma J Neurosurg 2003 98 1170 1174 10.3171/jns.2003.98.6.1170 12816259,120,223,Acta_Neuropathol_2015_Mar_20_129(6)_775-788.txt
5.17.1.2,...thophysiology J Stroke 2015 17 2 6 10.5853/jos.2015.17.1.2 25692102,125,128,Acta_Neuropathol_2016_Dec_28_131_645-658.txt
4.11.7.991,...in Investig Drugs 2002 11 991 1002 10.1517/13543784.11.7.991 12084009,240,132,Acta_Neuropathol_2016_Dec_28_131_645-658.txt
3.9.2.125,...ence? J Clin Neurol 2013 9 125 129 10.3988/jcn.2013.9.2.125 23626651,229,210,Acta_Neuropathol_2016_Mar_12_132_127-144.txt
1.4.1.2,...[96]. Raw data were analyzed by MaxQuant (version 1.4.1.2) [12] as described in the Supplementary Ma...,31,611,Acta_Neuropathol_2016_May_10_132_175-196.txt
2.7.3.972,... mode equipped with the Leica LAS-AF software (v. 2.7.3.9723),32,1230,Acta_Neuropathol_2016_Jul_8_132_453-473.txt
1.5.2.8,"...000 at m/z 200. MS data were analyzed by MaxQuant 1.5.2.8 [19], which includes the MaxLFQ algorithm ...",58,818,Acta_Neuropathol_2016_Jul_8_132_453-473.txt
1.4.1.14,"...les were analyzed using Proteome Discoverer (ver. 1.4.1.14) (Thermo Fisher Scientific, Rockford, IL,...",65,57,Acta_Neuropathol_2016_Jul_8_132_453-473.txt
5.24.1.1,... the key? Exp Neurobiol 2015 24 1 7 10.5607/en.2015.24.1.1 25792864,192,148,PMC5209403.txt
2.6.3.387,...t Opin Ther Targets 2002 6 387 399 10.1517/14728222.6.3.387 12223075,329,185,PMC5250671.txt
5.4.6.697,...rug Metab Toxicol 2008 1 6 697 720 10.1517/17425255.4.6.697 18611112,196,184,Acta_Neuropathol_Commun_2013_May_9_1_10.txt
4.-1.3.-20,"...rg, Limburg Sterk Merk and Alma-in-Silico (EMR INT4.-1.3.-2008-03/003)",132,275,Acta_Neuropathol_Commun_2013_Aug_2_1_43.txt
2.7.1.35,...ert Opin Ther Targets 2003 1 35 48 10.1517/14728222.7.1.35 12556201,147,156,Acta_Neuropathol_Commun_2013_Jun_4_1_21.txt
6.7.7.108,... Pharmacogenomics 2006 1 1087 1094 10.2217/14622416.7.7.1087 17054418,214,190,Acta_Neuropathol_Commun_2013_Jun_27_1_28.txt
2.6.3.275,...t Opin Ther Targets 2002 2 275 289 10.1517/14728222.6.3.275 10.1517/14728222.6.3.275 12223069,181,128,Acta_Neuropathol_Commun_2014_Jan_8_2_5.txt
2.6.3.275,...2 275 289 10.1517/14728222.6.3.275 10.1517/14728222.6.3.275 12223069,181,153,Acta_Neuropathol_Commun_2014_Jan_8_2_5.txt
EC 1.3.99.7,"... deficiency of glutaryl-coenzyme-A dehydrogenase (EC 1.3.99.7; GCDH), inherited as an autosomal rece...",17,285,Acta_Neuropathol_Commun_2014_Jan_27_2_13.txt
1.90.-2.10,"...(samples were excluded when ratio was outside the 1.90.-2.10 range). When RNA quality was approved, ...",130,554,Acta_Neuropathol_Commun_2014_Aug_23_2_98.txt
3.2.3.151,...a were exported using AGCC Scan Control software v3.2.3.1515. Subsequently data processing and analy...,70,314,Acta_Neuropathol_Commun_2014_Dec_11_2_168.txt
2.7.4.513,...Opin Ther Targets 2003 7 4 513 522 10.1517/14728222.7.4.513 12885270,160,157,Acta_Neuropathol_Commun_2014_Jun_5_2_62.txt
EC 1.4.3.4,"...nsmitter-degrading enzyme monoamine oxidase (Mao, EC 1.4.3.4). The existence of Mao in platelets was...",536,139,Acta_Neuropathol_Commun_2014_Jun_16_2_65.txt
EC 3.1.1.4,"...brane physiology are the phospholipases A2 (PLA2, EC 3.1.1.4) which play an important role especiall...",573,88,Acta_Neuropathol_Commun_2014_Jun_16_2_65.txt
1.7.1.10,...odels J Clin Neurol 2011 7 1 10 18 10.3988/jcn.2011.7.1.10 21519521,266,166,Acta_Neuropathol_Commun_2014_Jun_10_2_64.txt
2.11.2.161,...Opin Ther Targets 2007 11 2 161 79 10.1517/14728222.11.2.161 17227232,298,182,Acta_Neuropathol_Commun_2015_Apr_3_3_18.txt
5.24.1.1,...he Key? Exp Neurobiol 2015 24 1 1 7 10.5607/en.2015.24.1.1 25792864,188,150,Acta_Neuropathol_Commun_2015_Jul_28_3_47.txt
5.20.3.489,... Korean Med Sci 2005 20 3 489 494 10.3346/jkms.2005.20.3.489 15953875,211,188,Acta_Neuropathol_Commun_2015_Aug_19_3_50.txt
4.16.4.8,...terature Neurosurg Focus 2004 16 4 10.3171/foc.2004.16.4.8 15191336,223,119,Acta_Neuropathol_Commun_2015_Aug_19_3_50.txt
5.17.1.17,...ng concepts J Stroke 2015 17 17 30 10.5853/jos.2015.17.1.17 25692104,152,101,Acta_Neuropathol_Commun_2015_Nov_10_3_70.txt
1.1.1.27,...activity of lactate dehydrogenase (LDH; EC number 1.1.1.27) and αKG dehydrogenase (αKGDH; EC number ...,76,139,Acta_Neuropathol_Commun_2015_Dec_4_3_79.txt
1.2.4.2,...1.1.1.27) and αKG dehydrogenase (αKGDH; EC number 1.2.4.2). Quantitative enzyme activity experiments...,76,189,Acta_Neuropathol_Commun_2015_Dec_4_3_79.txt
6.8.6.597,...cs Pharmacogenomics 2007 8 597 608 10.2217/14622416.8.6.597 17559349,175,167,Acta_Neuropathol_Commun_2015_Dec_15_3_85.txt
4.23.4.292,...ranes Exp Neurobiol 2014 23 292 313 10.5607/en.2014.23.4.292 25548530,244,133,Acta_Neuropathol_Commun_2016_Mar_30_4_27.txt
5.24.1.8,...elopment Exp Neurobiol 2015 24 8 16 10.5607/en.2015.24.1.8 25792865,225,136,Acta_Neuropathol_Commun_2016_Mar_31_4_30.txt
6.85.6.109,...s J of Neurosurg 1996 85 1091 1094 10.3171/jns.1996.85.6.1091 8929500,239,169,Acta_Neuropathol_Commun_2016_Aug_31_4(1)_93.txt
2.3.1.600,... were loaded into Aperio eSlide Manager (version 12.3.1.6002) and regions of interest were drawn usi...,71,533,Acta_Neuropathol_Commun_2016_Oct_27_4_111.txt
2.3.2.503,...rest were drawn using Aperio ImageScope (version 12.3.2.5030) around the cortex and hippocampus in s...,71,614,Acta_Neuropathol_Commun_2016_Oct_27_4_111.txt
1.1.2.760,...rio Slide Scanner and analyzed using ImageScope v11.1.2.760 software (Aperio),83,2876,Acta_Neuropathol_Commun_2016_Nov_28_4_125.txt
5.48.7.218,...RNA-seq BMB Rep 2015 48 388 394 10.5483/BMBRep.2015.48.7.218 25603796,353,176,PMC5251221.txt
EC 3.1.1.3,".... A lipase solution from Thermomyces lanuginosus (EC 3.1.1.3., minimum 105 units/g) was purchased fr...",29,340,Acta_Orthop_2009_Oct_1_80(5)_514-519.txt
3.99.25.8,"...ed using Visual 3-D Professional software version 3.99.25.8 (C-Motion Inc., Germantown, MD), consist...",58,1367,Acta_Orthop_2011_Apr_5_82(2)_171-176.txt
1.5.1.4,"...mages were reconstructed using NRecon (Skyscan v. 1.5.1.4; Aarteselar), by correcting for ring artif...",50,433,Acta_Orthop_2011_Oct_24_82(5)_628-632.txt
1.5.1.4,...truction was performed (SkyScan NRecon package v. 1.5.1.4) by correcting for ring artifacts and beam...,47,270,Acta_Orthop_2013_Feb_26_84(1)_106-111.txt
6.3.1.381,"...ation using software connected to the PACS (IMPAX 6.3.1.3811; Agfa, Mortsel, Belgium). The mechanica...",77,733,Acta_Orthop_2013_Apr_18_84(2)_202-206.txt
6.7.1.2,"...lyzed with the ASIPRO VM software package version 6.7.1.2 (Concorde Microsystems; Siemens, Germany)....",61,64,Acta_Orthop_2014_Jun_16_85(3)_305-313.txt
1.1.1.1,...es with the highest value registry reports type A.1.1.1.1. (Labek et al. 2011c). Data collection in ...,24,886,Acta_Orthop_2015_Feb_22_86(1)_58-62.txt
6.5.3.117,"...s were analyzed using DICOM software (Agfa IMPAX v6.5.3.117; Agfa HealthCare, Mortsel, Belgium). Rad...",59,65,Acta_Orthop_2016_Apr_15_87(2)_100-105.txt
2.2.2.178,"...sing gamma coefficients (Epidata Analysis version 2.2.2.178), including 95% CI and p-values",103,117,PMC4967280.txt
1.4.2.1,"...ur cameras motion analysis system (MaxPro version 1.4.2.1, INNOVISION Systems, USA), with 60 Hz samp...",69,84,Acta_Ortop_Bras_2016_Mar-Apr_24(2)_73-76.txt
5.49.71.14,"...ia della Balduina 88, 00136 Roma. Tel.: +39 (0)6 35.49.71.14 – Fax: +39 (0)6 35.34.15.35 – E-mail: c...",82,266,Acta_Otorhinolaryngol_Ital_2011_Oct_31(5)_341-346.txt
5.34.15.35,...Roma. Tel.: +39 (0)6 35.49.71.14 – Fax: +39 (0)6 35.34.15.35 – E-mail: corte@jaka.it – Site: www.jak...,82,294,Acta_Otorhinolaryngol_Ital_2011_Oct_31(5)_341-346.txt
5.49.71.14,"...ia della Balduina 88, 00136 Roma. Tel.: +39 (0)6 35.49.71.14 – Fax: +39 (0)6 35.34.15.35 – E-mail: c...",106,266,Acta_Otorhinolaryngol_Ital_2011_Dec_31(6)_402-409.txt
5.34.15.35,...Roma. Tel.: +39 (0)6 35.49.71.14 – Fax: +39 (0)6 35.34.15.35 – E-mail: corte@jaka.it – Site: www.jak...,106,294,Acta_Otorhinolaryngol_Ital_2011_Dec_31(6)_402-409.txt
3.7.1.1,"...was also calculated using Pallas software (Pallas 3.7.1.1; CompuDrug International, Sedona, AZ, USA)...",116,306,Acta_Pharmacol_Sin_2013_Oct_7_34(10)_1337-1348.txt
3.1.1.7,"...sterase (AChE, acetylcholine acetylhydrolase, E C 3.1.1.7) is a pivotal enzyme that terminates nerve...",18,82,Acta_Pharmacol_Sin_2010_Mar_8_31(3)_313-328.txt
EC 2.1.1.77,... protein L-isoaspartyl O-methyltransferase (PIMT; EC 2.1.1.77) on the secretion of Aβ peptides,4,73,Acta_Pharmacol_Sin_2011_Mar_4_32(3)_288-294.txt
2.1.1.77,"...rotein L-isoaspartyl O-methyltransferase (PIMT, EC2.1.1.77), an enzyme that catalyzes the transfer o...",20,1054,Acta_Pharmacol_Sin_2011_Mar_4_32(3)_288-294.txt
EC 3.2.3.1,"... enzyme myrosinase (thioglucoside glycohydrolase, EC 3.2.3.1). The thioglycosidic bond is hydrolyzed...",15,301,Acta_Pharmacol_Sin_2009_May_5_30(5)_501-512.txt
EC 1.13.11.34,"5-Lipoxygenase (5-LOX, EC 1.13.11.34) is a key enzyme in catalyzing the c...",18,24,Acta_Pharmacol_Sin_2010_Feb_5_31(2)_137-144.txt
EC 6.4.1.3,18	gi|92654|	Propionyl-CoA carboxylase (EC 6.4.1.3) alpha chain	2.43	12	6.3/78.22,130,41,Acta_Pharmacol_Sin_2011_Sep_15_32(9)_1116-1127.txt
EC 5.3.4.1,133	gi|1083311|	Protein disulfide-isomerase (EC 5.3.4.1) ERp61 precursor	2.00	22	6.1/56.95,245,46,Acta_Pharmacol_Sin_2011_Sep_15_32(9)_1116-1127.txt
EC 4.2.1.11,140	gi|109803|	Phosphopyruvate hydratase (EC 4.2.1.11) alpha	2.43	24	6.4/47.45,252,43,Acta_Pharmacol_Sin_2011_Sep_15_32(9)_1116-1127.txt
EC 5.3.4.1,142	gi|1083311|	Protein disulfide-isomerase (EC 5.3.4.1) ERp61 precursor	2.30	27	6.1/56.95,254,46,Acta_Pharmacol_Sin_2011_Sep_15_32(9)_1116-1127.txt
2.1.1.77,"...rotein L-isoaspartyl O-methyltransferase (PIMT, EC2.1.1.77) is a widely distributed enzyme that cata...",20,52,Acta_Pharmacol_Sin_2011_Sep_15_32(9)_1165-1172.txt
3.1.1.47,"...t-activating factor acetylhydrolase (PAF-AH; E.C. 3.1.1.47), is a Ca2+-independent, 45 kDa secreted ...",22,87,Acta_Pharmacol_Sin_2011_Oct_15_32(10)_1253-1258.txt
EC 3.1.1.7,acetylcholinesterases (AChEs; EC 3.1.1.7) and butyrylcholinesterases (BChEs; EC ...,52,31,Acta_Pharmacol_Sin_2012_Jul_11_33(7)_964-978.txt
EC 3.1.1.8,...s; EC 3.1.1.7) and butyrylcholinesterases (BChEs; EC 3.1.1.8),52,78,Acta_Pharmacol_Sin_2012_Jul_11_33(7)_964-978.txt
EC 4.4.1.5,"Glyoxalase I (GLOI, EC 4.4.1.5) is the first and the rate-limiting glu...",18,21,Acta_Pharmacol_Sin_2015_Sep_17_36(9)_1145-1150.txt
EC 3.1.1.7,"...c-eel AChE (Torpedo californica type VI-S, Sigma, EC 3.1.1.7), horse-serum BChE (EC 3.1.1.8), acetyl...",35,152,Acta_Pharmacol_Sin_2015_Jul_4_36(7)_879-886.txt
EC 3.1.1.8,"... type VI-S, Sigma, EC 3.1.1.7), horse-serum BChE (EC 3.1.1.8), acetylthiocholine iodide (ATCh), buty...",35,183,Acta_Pharmacol_Sin_2015_Jul_4_36(7)_879-886.txt
6.3.2.2,...viations: GCS: γ-glutamylcysteine synthetase (EC: 6.3.2.2); GS: glutathione synthetase (EC: 6.3.2.3)...,126,149,Acta_Pharmacol_Sin_2014_May_17_35(5)_697-706.txt
6.3.2.3,...se (EC: 6.3.2.2); GS: glutathione synthetase (EC: 6.3.2.3); GATM: glycine amidinotransferase (EC: 2....,126,191,Acta_Pharmacol_Sin_2014_May_17_35(5)_697-706.txt
2.1.4.1,...: 6.3.2.3); GATM: glycine amidinotransferase (EC: 2.1.4.1); GAMT: guanidinoacetate N-methyltransfera...,126,239,Acta_Pharmacol_Sin_2014_May_17_35(5)_697-706.txt
2.1.2.2,...; GAMT: guanidinoacetate N-methyltransferase (EC: 2.1.2.2); CK: Creatine kinase (EC: 2.7.3.2); Creat...,126,297,Acta_Pharmacol_Sin_2014_May_17_35(5)_697-706.txt
2.7.3.2,...ansferase (EC: 2.1.2.2); CK: Creatine kinase (EC: 2.7.3.2); Creatinase (EC: 3.5.3.3); Pcr: Phosphocr...,126,332,Acta_Pharmacol_Sin_2014_May_17_35(5)_697-706.txt
3.5.3.3,...K: Creatine kinase (EC: 2.7.3.2); Creatinase (EC: 3.5.3.3); Pcr: Phosphocreatine. The abbreviations ...,126,358,Acta_Pharmacol_Sin_2014_May_17_35(5)_697-706.txt
EC 2.3.2.13,...e-2 (TG2) belongs to the transglutaminase family (EC 2.3.2.13) and has a molecular mass of 77–85 kDa...,20,99,PMC5260835.txt
EC 3.4.11.2,"Bauvois B, Dauzonne D. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological eva...",148,47,PMC5342666.txt
EC 1.14.18.1,"Tyrosinase (EC 1.14.18.1), also known as polyphenol oxidase (P...",14,13,Acta_Pharm_Sin_B_2014_Apr_21_4(2)_141-145.txt
2.3.1.1,2.3.1.1 Photon correlation spectroscop,37,1,Acta_Pharm_Sin_B_2014_Apr_2_4(2)_151-160.txt
2.3.1.2,2.3.1.2 Zeta potentia,40,1,Acta_Pharm_Sin_B_2014_Apr_2_4(2)_151-160.txt
2.3.1.3,"2.3.1.3 pH, viscosity and gelling temperatur",43,1,Acta_Pharm_Sin_B_2014_Apr_2_4(2)_151-160.txt
2.3.1.4,2.3.1.4 Percentage transmittanc,46,1,Acta_Pharm_Sin_B_2014_Apr_2_4(2)_151-160.txt
2.3.1.5,2.3.1.5 Stability assessmen,49,1,Acta_Pharm_Sin_B_2014_Apr_2_4(2)_151-160.txt
2.3.7.1,2.3.7.1 Animal studie,68,1,Acta_Pharm_Sin_B_2014_Apr_2_4(2)_151-160.txt
2.3.7.2,2.3.7.2 Analytical procedure,73,1,Acta_Pharm_Sin_B_2014_Apr_2_4(2)_151-160.txt
2.3.7.3,2.3.7.3 Data analysi,80,1,Acta_Pharm_Sin_B_2014_Apr_2_4(2)_151-160.txt
2.3.7.4,2.3.7.4 Statistical analysi,83,1,Acta_Pharm_Sin_B_2014_Apr_2_4(2)_151-160.txt
3.1.1.7,"...he inhibition of acetylcholinesterase (AChE, E.C. 3.1.1.7), which is responsible for the breakdown o...",15,52,Acta_Pharm_Sin_B_2014_Dec_22_4(6)_430-437.txt
3.1.1.7,AChE (E.C. 3.1.1.7) was extracted from rat cortex (Sprague Da...,27,12,Acta_Pharm_Sin_B_2014_Dec_22_4(6)_430-437.txt
3.1.1.8,...ted from rat cortex (Sprague Dawley). BuChE (E.C. 3.1.1.8) was obtained from human plasma (purchased...,27,81,Acta_Pharm_Sin_B_2014_Dec_22_4(6)_430-437.txt
2.1.2.1,2.1.2.1 Microarray-in-a-tub,38,1,Acta_Pharm_Sin_B_2015_Jan_12_5(1)_38-46.txt
2.1.2.2,2.1.2.2 GNP technolog,43,1,Acta_Pharm_Sin_B_2015_Jan_12_5(1)_38-46.txt
2.1.2.3,2.1.2.3 A nucleic acid amplification test strip me...,50,1,Acta_Pharm_Sin_B_2015_Jan_12_5(1)_38-46.txt
3.1.1.7,"Acetylcholinesterase (AChE, E.C. 3.1.1.7, from Electric Eel), butyrylcholinesterase...",46,34,Acta_Pharm_Sin_B_2015_Jan_23_5(1)_67-73.txt
3.1.1.8,"... Electric Eel), butyrylcholinesterase (BChE, E.C. 3.1.1.8, from equine serum), 5,5′-dithiobis-(2-nit...",46,97,Acta_Pharm_Sin_B_2015_Jan_23_5(1)_67-73.txt
2.1.1.1,2.1.1.1 Integrin,30,1,Acta_Pharm_Sin_B_2015_Sep_8_5(5)_402-418.txt
2.1.1.2,2.1.1.2 Cadherin,37,1,Acta_Pharm_Sin_B_2015_Sep_8_5(5)_402-418.txt
2.1.1.3,2.1.1.3 Selectin,46,1,Acta_Pharm_Sin_B_2015_Sep_8_5(5)_402-418.txt
2.1.1.4,2.1.1.4 The immunoglobulin superfamily (IgSF,49,1,Acta_Pharm_Sin_B_2015_Sep_8_5(5)_402-418.txt
2.1.1.5,2.1.1.5 CD44 member,52,1,Acta_Pharm_Sin_B_2015_Sep_8_5(5)_402-418.txt
3.2.1.1,3.2.1.1 N-cadherin inhibitor,130,1,Acta_Pharm_Sin_B_2015_Sep_8_5(5)_402-418.txt
3.2.1.2,3.2.1.2 Integrin antagonist,133,1,Acta_Pharm_Sin_B_2015_Sep_8_5(5)_402-418.txt
3.2.1.3,3.2.1.3 Selectin inhibitor,144,1,Acta_Pharm_Sin_B_2015_Sep_8_5(5)_402-418.txt
3.2.1.4,3.2.1.4 CD44 antagonist,147,1,Acta_Pharm_Sin_B_2015_Sep_8_5(5)_402-418.txt
4.1.1.1,"4.1.1.1 12-N-p-Chlorobenzyl sophoridinic-4′,4-chlo...",51,1,Acta_Pharm_Sin_B_2016_May_14_6(3)_222-228.txt
4.1.1.2,"4.1.1.2 12-N-p-Chlorobenzyl sophoridinic-4′,4-fluo...",54,1,Acta_Pharm_Sin_B_2016_May_14_6(3)_222-228.txt
4.1.2.1,"4.1.2.1 -4′,4′ dimethyl sophoridinol (6",58,1,Acta_Pharm_Sin_B_2016_May_14_6(3)_222-228.txt
4.1.2.2,"4.1.2.2 12-N-p-Chlorobenzyl-4′,4′-di-4-fluoropheny...",61,1,Acta_Pharm_Sin_B_2016_May_14_6(3)_222-228.txt
4.1.2.3,"4.1.2.3 -4′,4′-diethyl sophoridinene bihydrochlori...",64,1,Acta_Pharm_Sin_B_2016_May_14_6(3)_222-228.txt
4.1.7.1,4.1.7.1 12-N-p-Chlorobenzyl-4′-(4-chloro-3-trifluo...,80,1,Acta_Pharm_Sin_B_2016_May_14_6(3)_222-228.txt
4.1.7.2,4.1.7.2 12-N-p-Chlorobenzyl-4′-(N-methypiperazine)...,83,1,Acta_Pharm_Sin_B_2016_May_14_6(3)_222-228.txt
5.1.2.1,5.1.2.1 Active-sites theor,62,1,Acta_Pharm_Sin_B_2016_Jul_4_6(4)_308-318.txt
5.1.2.2,5.1.2.2 Agglomeration theor,65,1,Acta_Pharm_Sin_B_2016_Jul_4_6(4)_308-318.txt
5.1.2.3,5.1.2.3 Fluidization theor,68,1,Acta_Pharm_Sin_B_2016_Jul_4_6(4)_308-318.txt
5.1.2.4,5.1.2.4 Buffer hypothesi,71,1,Acta_Pharm_Sin_B_2016_Jul_4_6(4)_308-318.txt
5.1.2.5,5.1.2.5 Case-dependent theor,74,1,Acta_Pharm_Sin_B_2016_Jul_4_6(4)_308-318.txt
EC 2.3.1.5,"NATs (EC 2.3.1.5, N-acetyltransferase, arylamine N-acety...",31,7,Acta_Pharm_Sin_B_2016_Sep_3_6(5)_384-392.txt
EC 3.5.1.4,"Amidases (EC 3.5.1.4, acylamidases, acylases, or acylamide a...",40,11,Acta_Pharm_Sin_B_2016_Sep_3_6(5)_384-392.txt
2.5.1.18,"Glutathione S-transferases (GSTs, E.C. 2.5.1.18) comprise a multi-gene family of phase II...",56,40,Acta_Pharm_Sin_B_2016_Sep_3_6(5)_384-392.txt
4.1.2.1,4.1.2.1 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-1...,61,1,PMC5343109.txt
4.1.2.2,4.1.2.2 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-1...,64,1,PMC5343109.txt
4.1.2.3,4.1.2.3 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-1...,67,1,PMC5343109.txt
4.1.2.4,4.1.2.4 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-1...,70,1,PMC5343109.txt
4.1.2.5,4.1.2.5 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-1...,73,1,PMC5343109.txt
4.1.2.6,4.1.2.6 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-1...,76,1,PMC5343109.txt
4.1.2.7,4.1.2.7 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-1...,79,1,PMC5343109.txt
4.1.2.8,4.1.2.8 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-1...,82,1,PMC5343109.txt
4.1.2.9,4.1.2.9 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-1...,85,1,PMC5343109.txt
4.1.2.10,4.1.2.10 4-Nitrophenyl 4-[5-(4-(benzyloxy)phenyl)-...,88,1,PMC5343109.txt
4.1.2.11,4.1.2.11 4-Nitrophenyl 4-[5-(4-(benzyloxy)phenyl)-...,91,1,PMC5343109.txt
4.1.2.12,4.1.2.12 4-Nitrophenyl 4-[5-(4-(benzyloxy)phenyl)-...,94,1,PMC5343109.txt
4.1.2.13,4.1.2.13 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-...,97,1,PMC5343109.txt
4.1.2.14,4.1.2.14 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-...,100,1,PMC5343109.txt
4.1.2.15,4.1.2.15 4-Nitrophenyl-4-[5-(4-(benzyloxy)phenyl)-...,103,1,PMC5343109.txt
4.1.3.1,4.1.3.1 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(2-chlorop...,109,1,PMC5343109.txt
4.1.3.2,4.1.3.2 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(3-chlorop...,112,1,PMC5343109.txt
4.1.3.3,4.1.3.3 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(4-chlorop...,115,1,PMC5343109.txt
4.1.3.4,"4.1.3.4 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(3,4-dichl...",118,1,PMC5343109.txt
4.1.3.5,4.1.3.5 1-[4-[5-(4-(benzyloxy)phenyl)-1-(4-fluorop...,121,1,PMC5343109.txt
4.1.3.6,4.1.3.6 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(3-chloro-...,124,1,PMC5343109.txt
4.1.3.7,4.1.3.7 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(4-bromoph...,127,1,PMC5343109.txt
4.1.3.8,4.1.3.8 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(4-nitroph...,130,1,PMC5343109.txt
4.1.3.9,"4.1.3.9 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(2,4-dinit...",133,1,PMC5343109.txt
4.1.3.10,4.1.3.10 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(2-methyl...,136,1,PMC5343109.txt
4.1.3.11,4.1.3.11 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(3-methyl...,139,1,PMC5343109.txt
4.1.3.12,4.1.3.12 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(4-methyl...,142,1,PMC5343109.txt
4.1.3.13,"4.1.3.13 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(2,6-dime...",145,1,PMC5343109.txt
4.1.3.14,4.1.3.14 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(2-methox...,148,1,PMC5343109.txt
4.1.3.15,4.1.3.15 1-[4-[5-(4-(Benzyloxy)phenyl)-1-(4-methox...,151,1,PMC5343109.txt
3.2.1.-,...ety by the action of specific β-glycosidases (EC. 3.2.1.-). The resulting cyanohydrins are relativel...,15,124,Acta_Physiol_Plant_2013_Oct_12_35(3)_781-789.txt
4.1.2.-,"...reaction catalysed by α-hydroxynitrile lyase (EC. 4.1.2.-) to an aldehyde or a ketone, and free HCN ...",15,290,Acta_Physiol_Plant_2013_Oct_12_35(3)_781-789.txt
4.4.1.9,"...ing enzymes. β-Cyanoalanine synthase (β-CAS), (EC.4.4.1.9), plays pivotal role in detoxification of ...",15,494,Acta_Physiol_Plant_2013_Oct_12_35(3)_781-789.txt
4.2.1.65,"...action catalysed by β-cyanoalanine hydrolase (EC. 4.2.1.65), (Wurtele et al. 1984)",15,755,Acta_Physiol_Plant_2013_Oct_12_35(3)_781-789.txt
1.1.4.1,... W.  Eschman A.  Zuccolotto A.   E-Prime (version 1.1.4.1) [computer software and manual] reference ...,468,60,Acta_Psychol_(Amst)_2012_Sep_141(1)_54-66.txt
3.5.2.1,"... arteries using commercial software (Aquaris ver. 3.5.2.1; TeraRecon, SanMateo, Calif., USA)",33,222,Acta_Radiol_2010_Nov_16_51(9)_982-989.txt
6.7.2.3,"...e cancer. European Association of Urology, update 6.7.2.3 March 2015. Available at: http://uroweb.or...",211,146,Acta_Radiol_Open_2016_Aug_17_5(8)_2058460116663046.txt
1.1.2.1,...n Social Funds in Latvia (grant no. 2009/0147/1DP/1.1.2.1.2/09/IPIA/VIAA/009). Special gratitude to ...,83,90,Acta_Radiol_Short_Rep_2013_Apr_24_2(3)_2047981613486099.txt
3.67.2.169,...ed 2002) Mammalia 2003 68 169 178 10.1515/mamm.2003.67.2.169,144,217,Acta_Theriol_(Warsz)_2011_Apr_22_56(2)_117-122.txt
3.5.1.3,.... Linkage disequilibria were computed in Arlequin 3.5.1.3 (Excoffier and Lischer 2010); none were fo...,58,617,Acta_Theriol_(Warsz)_2012_Jul_28_57(3)_195-204.txt
3.5.1.3,Arlequin3.5.1.3 software was used to calculate the basic g...,64,9,Acta_Theriol_(Warsz)_2012_Jul_28_57(3)_195-204.txt
3.1.3.2," Acid phosphatase (ACP, 3.1.3.2)	B	2.30",43,25,Acta_Trop_2006_Dec_100(3)_246-251.txt
4.1.2.13," Aldolase (ALD, 4.1.2.13)	B	2.00",44,17,Acta_Trop_2006_Dec_100(3)_246-251.txt
3.1.1.1," Esterase (EST, 3.1.1.1)	B	2.00",45,17,Acta_Trop_2006_Dec_100(3)_246-251.txt
3.1.3.11," Fructose-1,6-diphosphatase (FDP, 3.1.3.11)b	B	2.30",46,35,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.49," Glucose-6-phosphate dehydrogenase (G6PD, 1.1.1.49)b	B, C	2.30",47,43,Acta_Trop_2006_Dec_100(3)_246-251.txt
5.3.1.9," Glucose-phosphate isomerase (GPI, 5.3.1.9)	B, C	2.30",48,36,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.30," β-Hydroxybutyrate dehydrogenase (HBDH, 1.1.1.30)	B	1.30",49,41,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.42," Isocitrate dehydrogenase (IDH, 1.1.1.42)b	A, B	2.30",50,33,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.4.2.1," Nucleoside phosphorylase (NP, 2.4.2.1)	B	1.30",51,32,Acta_Trop_2006_Dec_100(3)_246-251.txt
3.4.11.4," Peptidase leucine-glycine-glycine (PEP-B, 3.4.11.4)	B	2.30",52,44,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.7.5.3," Phosphoglycerate mutase (PGAM, 2.7.5.3)b	C	2.30",55,33,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.44," 6-Phosphogluconate dehydrogenase (6PGD, 1.1.1.44)	B	1.30",56,42,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.7.1.40," Pyruvate kinase (PK, 2.7.1.40)b	C	2.30",57,23,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.7.1.48," Uridine monophosphate kinase (UMPK, 2.7.1.48)	C	2.30",58,38,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.7.3.2," Creatine kinase (CK, 2.7.3.2)	B, C	2.30",63,23,Acta_Trop_2006_Dec_100(3)_246-251.txt
4.2.1.2," Fumarate hydratase (FUM, 4.2.1.2)	B	2.30",64,27,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.4.1.3," Glutamate dehydrogenase (GDH, 1.4.1.3)	B	1.30",65,32,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.27," Lactate dehydrogenase (LDH, 1.1.1.27)	B	1.30",66,30,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.40," Malic enzyme (ME, 1.1.1.40)	B, C	2.30",67,20,Acta_Trop_2006_Dec_100(3)_246-251.txt
3.4.13.11," Purine peptidase valine-leucine (PEP-A, 3.4.13.11)	B, C	2.00",68,42,Acta_Trop_2006_Dec_100(3)_246-251.txt
4.2.1.3," Aconitate hydratase (ACON, 4.2.1.3)	B	1.30",73,29,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.7.4.3," Adenylate kinase (AK, 2.7.4.3)	B	2.30",74,24,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.6.1.2," Alanine aminotransferase (GPT, 2.6.1.2)	B	2.00",75,33,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.6.1.1," Aspartate aminotransferase (GOT, 2.6.1.1)	B	2.00",76,35,Acta_Trop_2006_Dec_100(3)_246-251.txt
4.2.1.11," Enolase (ENOL, 4.2.1.11)	A, B	2.00",77,17,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.7.1.1," Hexokinase (HK, 2.7.1.1)	B, C	2.30",78,18,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.37," Malate dehydrogenase (MDH, 1.1.1.37)	B, C	2.30",79,29,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.7.5.1," Phosphoglucomutase (PGM, 2.7.5.1)	B, C	2.30",80,27,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.7.4.6," Nucleotide diphosphate kinase (NDPK, 2.7.4.6)	B	2.30",85,39,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.2.1.12," Glyceraldehyde-3-phosphate dehydrogenase (GAPD, 1.2.1.12)	B	2.30",90,50,Acta_Trop_2006_Dec_100(3)_246-251.txt
5.3.1.1," Triose-phosphate isomerase (TPI, 5.3.1.1)	B	2.00",91,35,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.1,"...horesis and staining: alcohol dehydrogenase (ADH, 1.1.1.1), aldehyde dehydrogenase (ALDH, 1.2.1.5), ...",94,143,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.2.1.5,"...ase (ADH, 1.1.1.1), aldehyde dehydrogenase (ALDH, 1.2.1.5), alkaline phosphatase (AP, 3.1.3.1), diap...",94,183,Acta_Trop_2006_Dec_100(3)_246-251.txt
3.1.3.1,"...genase (ALDH, 1.2.1.5), alkaline phosphatase (AP, 3.1.3.1), diaphorase (DIA, 1.6.*.*), glucose dehyd...",94,219,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.47,"...rase (DIA, 1.6.*.*), glucose dehydrogenase (GLDH, 1.1.1.47), glycollate oxidase (GOX, 1.1.3.1), glyc...",94,285,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.3.1,"...genase (GLDH, 1.1.1.47), glycollate oxidase (GOX, 1.1.3.1), glycerol-3-phosphate dehydrogenase (GPD,...",94,321,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.8,"....1.3.1), glycerol-3-phosphate dehydrogenase (GPD, 1.1.1.8), leucine aminotransferase (LAP, 3.4.11.1)...",94,372,Acta_Trop_2006_Dec_100(3)_246-251.txt
3.4.11.1,"...se (GPD, 1.1.1.8), leucine aminotransferase (LAP, 3.4.11.1), mannose-phosphate isomerase (MPI, 5.3.1...",94,413,Acta_Trop_2006_Dec_100(3)_246-251.txt
5.3.1.8,"...LAP, 3.4.11.1), mannose-phosphate isomerase (MPI, 5.3.1.8), phosphoglycerate kinase (PGK, 2.7.2.3), ...",94,458,Acta_Trop_2006_Dec_100(3)_246-251.txt
2.7.2.3,"...ase (MPI, 5.3.1.8), phosphoglycerate kinase (PGK, 2.7.2.3), superoxide dismutase (SOD, 1.15.1.1), so...",94,498,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.15.1.1,"...kinase (PGK, 2.7.2.3), superoxide dismutase (SOD, 1.15.1.1), sorbital dehydrogenase (SORDH, 1.1.1.14...",94,535,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.1.1.14,"...e (SOD, 1.15.1.1), sorbital dehydrogenase (SORDH, 1.1.1.14) and xanthine oxidase (XO, 1.2.3.2)",94,577,Acta_Trop_2006_Dec_100(3)_246-251.txt
1.2.3.2,"...enase (SORDH, 1.1.1.14) and xanthine oxidase (XO, 1.2.3.2)",94,613,Acta_Trop_2006_Dec_100(3)_246-251.txt
EC 3.6.1.37,"...-embedded (Na++K+)-activated ATPase (Na,K-ATPase, EC 3.6.1.37) of mammalian cells is usually suppose...",8,70,Acta_Vet_Scand_2001_Jun_30_42(2)_261-270.txt
3.1.6.2,"...tical calculations (Software program JMP, version 3.1.6.2, SAS Institute)",17,130,Acta_Vet_Scand_2003_Dec_31_44(4)_199-202.txt
4.5.1.143,...v Vaccines 2006 5 143 163 16451116 10.1586/14760584.5.1.143,156,169,Acta_Vet_Scand_2009_Mar_19_51(1)_11.txt
1.72.5.583,...riodontol 2001 72 583 589 11394392 10.1902/jop.2001.72.5.583,110,254,Acta_Vet_Scand_2009_Mar_24_51(1)_12.txt
5.4.6.6,"...ty areas Food Quality and Safety (FP6, FOOD-2004-T5.4.6.6), and FORMAS (220-2007-1616) and the lingu...",40,124,Acta_Vet_Scand_2010_Oct_13_52(Suppl_1)_S25.txt
EC 4.2.1.1,"Carbonic anhydrase (CA; EC 4.2.1.1), a well-characterized enzyme, catalyze...",16,25,Acta_Vet_Scand_2011_Mar_7_53(1)_16.txt
3.18.3.553,... J Bone Miner Res 2003 18 553 560 10.1359/jbmr.2003.18.3.553 12619941,121,170,Acta_Vet_Scand_2011_Aug_31_53(1)_49.txt
2.95.69.15,"Law on Zoonoses, SFS 2006:811 http://62.95.69.15/cgi-bin/thw?%24{HTML}=sfst_lst&%24{OOHT...",97,39,Acta_Vet_Scand_2011_Oct_5_53(1)_51.txt
2.95.69.15,"Ordinance on Zoonoses, SFS 2006:820 http://62.95.69.15/cgi-bin/thw?%24{HTML}=sfst_lst&%24{OOHT...",98,45,Acta_Vet_Scand_2011_Oct_5_53(1)_51.txt
EC 3.6.1.5,"...ke the majority of so far characterised NTPDases [EC 3.6.1.5] and NPPases [EC 3.6.1.9], acted optima...",226,391,Acta_Vet_Scand_2011_Oct_13_53(1)_54.txt
EC 3.6.1.9,"... characterised NTPDases [EC 3.6.1.5] and NPPases [EC 3.6.1.9], acted optimally in alkaline condition...",226,416,Acta_Vet_Scand_2011_Oct_13_53(1)_54.txt
5.23.3.167,...lus J Perinat Med 1995 23 167 174 10.1515/jpme.1995.23.3.167 8568608,252,208,Acta_Vet_Scand_2011_Oct_13_53(1)_54.txt
EC 4.2.1.1,"Carbonic anhydrase (CA; EC 4.2.1.1), a well-characterized enzyme, catalyze...",16,25,Acta_Vet_Scand_2011_Nov_26_53(1)_63.txt
3.47.4.463,"...evon, UK Mammalia 1983 47 463 476 10.1515/mamm.1983.47.4.463",60,110,Acta_Vet_Scand_2012_Feb_24_54(Suppl_1)_S9.txt
2.17.8.154,... Bone Miner Res 2002 17 1545 1554 10.1359/jbmr.2002.17.8.1545 12162508,234,216,Acta_Vet_Scand_2012_Jul_13_54(1)_41.txt
EC 3.6.1.3,"...ke and starvation on the magnitude of Na,KATPase (EC 3.6.1.3) dependent respiration in duodenal muco...",163,96,Acta_Vet_Scand_2013_Feb_5_55(1)_9.txt
1.16.8.155,...one Mineral Res 2001 16 1556 1563 10.1359/jbmr.2001.16.8.1556,111,218,Acta_Vet_Scand_2013_Feb_1_55(1)_8.txt
4.37.2.139,...iochem Mol Biol 2004 37 139 143 10.5483/BMBRep.2004.37.2.139 15469687,238,144,Acta_Vet_Scand_2013_Mar_2_55(1)_18.txt
2.6.1.3,... in rats Nutr Res Pract 2012 6 3 8 10.4162/nrp.2012.6.1.3 22413034,264,136,Acta_Vet_Scand_2013_Mar_2_55(1)_18.txt
4.5.1.143,...pert Revi Vaccines 2006 56 143 163 10.1586/14760584.5.1.143,197,161,Acta_Vet_Scand_2014_Apr_15_56(1)_22.txt
3.18.10.172,... Bone Miner Res 2003 18 1725 1736 10.1359/jbmr.2003.18.10.1725 14584880,210,314,Acta_Vet_Scand_2014_May_27_56(1)_34.txt
2.6.3.2,"... the ADC map at an Extended MR Workspace (Version 2.6.3.2 HF 3 2010, Philips Medical Systems). The F...",21,647,Acta_Vet_Scand_2013_Apr_24_55(1)_36.txt
2.6.3.2,"...as performed on an Extended MR workspace (Version 2.6.3.2 HF 3 2010, Philips Medical Systems) with t...",58,1955,Acta_Vet_Scand_2013_Apr_24_55(1)_36.txt
6.21.2.219,...iability Anim Welf 2012 21 219 231 10.7120/09627286.21.2.219,160,203,Acta_Vet_Scand_2013_Oct_18_55(1)_72.txt
4.4.1.89,... Expert Rev Vaccines 2005 4 89 101 10.1586/14760584.4.1.89 15757476,169,123,Acta_Vet_Scand_2013_Nov_12_55(1)_78.txt
1.16.8.155,... Bone Miner Res 2001 16 1556 1563 10.1359/jbmr.2001.16.8.1556 11499879,115,216,Acta_Vet_Scand_2013_Nov_17_55(1)_81.txt
3.18.3.553,... J Bone Miner Res 2003 18 553 560 10.1359/jbmr.2003.18.3.553 12619941,183,180,Acta_Vet_Scand_2014_Sep_24_56(1)_64.txt
3.14.1.55,... Physiol Pharmacol 2003 14 55 76 10.1515/JBCPP.2003.14.1.55 12901446,239,195,Acta_Vet_Scand_2014_Sep_24_56(1)_64.txt
2.3.2.477,...eindeer parasites Rangifer 1983 3 2 19 38 10.7557/2.3.2.477,120,186,Acta_Vet_Scand_2014_Nov_25_56(1)_76.txt
2.4.2.497,...deer [in Swedish] Rangifer 1984 4 2 10 15 10.7557/2.4.2.497,121,150,Acta_Vet_Scand_2014_Nov_25_56(1)_76.txt
2.16.3.120,...ntering reindeer Rangifer 1996 16 147 150 10.7557/2.16.3.1209,140,152,Acta_Vet_Scand_2014_Nov_25_56(1)_76.txt
5.59.2.229,...enaica ) Mammalia 1995 59 229 235 10.1515/mamm.1995.59.2.229,331,127,Acta_Vet_Scand_2014_Dec_10_56(1)_83.txt
4.8.2.205,...Expert Rev Vaccines 2009 8 205 213 10.1586/14760584.8.2.205 19196200,346,221,Acta_Vet_Scand_2014_Dec_10_56(1)_83.txt
4.2.4.525,...astroenterol Hepatol. 2008 2 525 9 10.1586/17474124.2.4.525 19072400,579,180,Acta_Vet_Scand_2015_Feb_28_57(1)_11.txt
4.19.19.208,...rosurveillance 2014 19 2 5 10.2807/1560-7917.ES2014.19.19.20804,201,179,Acta_Vet_Scand_2015_Jun_6_57(1)_28.txt
5.3.1.-,...Austria) with the multi-species software (version 5.3.1.-MS). The ADVIA™ system has recently been ev...,43,142,Acta_Vet_Scand_2015_Jun_14_57(1)_30.txt
2.13.3.311,...icropigs J Vet Sci 2012 13 311 314 10.4142/jvs.2012.13.3.311 23000588,191,159,Acta_Vet_Scand_2015_Nov_25_57_80.txt
2.15.1.115,...ted reindeer calves Rangifer 1995 15 9 14 10.7557/2.15.1.1151,204,166,Acta_Vet_Scand_2016_Apr_12_58_22.txt
2.13.4.112,...way and Svalbard Rangifer 1993 13 215 219 10.7557/2.13.4.1120,225,164,Acta_Vet_Scand_2016_Apr_12_58_22.txt
2.25.2.255,"...m Finnmark, Norway Rangifer 2005 25 75 83 10.7557/2.25.2.25",226,235,Acta_Vet_Scand_2016_Apr_12_58_22.txt
6.22.2.199,... factors Anim Welf 2013 22 199 218 10.7120/09627286.22.2.199,281,203,Acta_Vet_Scand_2016_May_21_58_31.txt
6.22.2.219,... factors Anim Welf 2013 22 219 238 10.7120/09627286.22.2.219,291,206,Acta_Vet_Scand_2016_May_21_58_31.txt
6.23.4.435,...position Anim Welf 2014 23 435 443 10.7120/09627286.23.4.43,298,168,Acta_Vet_Scand_2016_May_21_58_31.txt
2.28.1.61,...isease Lab Anim Res. 2012 28 61 66 10.5625/lar.2012.28.1.61 22474476,182,162,Acta_Vet_Scand_2016_Jul_7_58_46.txt
2.36.4.573,...da Ann Rehabil Med 2012 36 573 577 10.5535/arm.2012.36.4.573 22977787,129,180,Acta_Vet_Scand_2016_Jul_8_58_47.txt
3.14.3.465,...ature Kor J Radiol 2013 14 465 469 10.3348/kjr.2013.14.3.465,130,184,Acta_Vet_Scand_2016_Jul_8_58_47.txt
5.16.4.413,...regnancy J Vet Sci 2015 16 413 421 10.4142/jvs.2015.16.4.413 26243597,105,195,Acta_Vet_Scand_2016_Sep_8_58(1)_52.txt
2.16.6.437,...hysiol Pharmacol. 2012 16 437 446 10.4196/kjpp.2012.16.6.437 23269907,174,212,Acta_Vet_Scand_2016_Oct_6_58_72.txt
5.20.12.210,...uro Surveill 2015 20 21 32 10.2807/1560-7917.ES2015.20.12.21069 25719964,195,292,Acta_Vet_Scand_2016_Oct_22_58_74.txt
4.19.50.209,...uro Surveill 2014 19 20996 10.2807/1560-7917.ES2014.19.50.20996 25597538,203,236,Acta_Vet_Scand_2016_Oct_22_58_74.txt
5.16.2.225,...al study J Vet Sci 2015 16 225 231 10.4142/jvs.2015.16.2.225 26124697,143,198,Acta_Vet_Scand_2016_Dec_19_58_86.txt
3.28.5.744,... J Korean Med Sci 2013 28 744 749 10.3346/jkms.2013.28.5.744 23678267,272,259,PMC5346197.txt
2.2.2.404,...gifer tarandus  L.) Rangifer. 1982 2 2 21 10.7557/2.2.2.404,171,159,PMC5353846.txt
2.10.3.868,...ress in reindeer Rangifer. 1990 3 267 288 10.7557/2.10.3.868,172,82,PMC5353846.txt
2.16.3.120,...abomasal lesions Rangifer. 1996 3 109 117 10.7557/2.16.3.1204,174,265,PMC5353846.txt
2.4.1.483,...angifer tarandus  L.) Rangifer 1984 4 2 8 10.7557/2.4.1.483,177,178,PMC5353846.txt
2.15.2.116,...ransport distance Rangifer. 1995 15 47 54 10.7557/2.15.2.1166,178,209,PMC5353846.txt
2.21.1.152,...rted reindeer bulls Rangifer 2001 21 3 12 10.7557/2.21.1.1522,180,223,PMC5353846.txt
2.27.3.272,...d healthy?] Rangifer Report 2007 12 71 77 10.7557/2.27.3.272,181,180,PMC5353846.txt
2.16.1.118,...eer during winter Rangifer. 1996 16 21 30 10.7557/2.16.1.1182,187,165,PMC5353846.txt
3.21.6.441,1993 ;21 :441 –52 . doi:10.1515/jpme.1993.21.6.4418006770,185,41,Acupunct_Med_2015_Oct_11_33(5)_413-419.txt
2.17.3.394,2002 ;17 :394 –405 . doi:10.1359/jbmr.2002.17.3.39411878304,183,42,Acupunct_Med_2015_Dec_5_33(6)_465-471.txt
2.31.7.729,... Soc Clin Psychol 2012 31 729 745 10.1521/jscp.2012.31.7.729,246,174,Addict_Sci_Clin_Pract_2012_Dec_7_7(1)_25.txt
2.76.2.226,...Orthopsychiatry 2006 76 2 226 237 10.1037/0002-9432.76.2.226 16719642,226,217,Addict_Sci_Clin_Pract_2015_Feb_24_10(1)_5.txt
5.24.6.811,...tp://guilfordjournals.com/doi/abs/10.1521/jscp.2005.24.6.811,251,197,Addict_Sci_Clin_Pract_2015_Sep_3_10_18.txt
6.57.7.992,...ts Psychiatr Serv 2006 57 7 992 999 10.1176/ps.2006.57.7.992 16816284,361,174,Addict_Sci_Clin_Pract_2015_Aug_5_10_17.txt
3.10.5.360,... Health Psychol 1991 10 5 360 365 10.1037/0278-6133.10.5.360 1935872,258,169,Addict_Sci_Clin_Pract_2016_Mar_15_11_4.txt
4.63.4.596,...ers Soc Psychol 1992 63 4 596 612 10.1037/0022-3514.63.4.596,290,169,Addict_Sci_Clin_Pract_2016_Mar_31_11_6.txt
3.22.2.156,... Health Psychol 2003 22 2 156 165 10.1037/0278-6133.22.2.156 12683736,247,209,Addict_Sci_Clin_Pract_2016_Apr_18_11_8.txt
2.6.3.343,... Rev Cardiovasc Ther 2008 6 343 68 10.1586/14779072.6.3.343 18327995,217,259,Adipocyte_2012_Oct_1_1(4)_215-229.txt
5.3.5.545,...eling Future Lipidol 2008 3 545 56 10.2217/17460875.3.5.545 18978945,94,153,Adipocyte_2013_Apr_1_2(2)_67-73.txt
3.37.1.22,...mans Diabetes Metab J 2013 37 22 9 10.4093/dmj.2013.37.1.22 23441053,71,139,Adipocyte_2014_Jan_1_3(1)_4-9.txt
EC 1.1.1.42,"...on are: cytosolic isocitrate dehydrogenase (IDH), EC 1.1.1.42, cytosolic NADP malic enzyme, EC1.1.1....",11,378,Adipocyte_2014_Jan_1_3(1)_30-38.txt
1.1.1.40,"...IDH), EC 1.1.1.42, cytosolic NADP malic enzyme, EC1.1.1.40, enzyme of pentose phosphate shunt, gluco...",11,422,Adipocyte_2014_Jan_1_3(1)_30-38.txt
EC 1.1.1.49,"...shunt, glucose-6-phosphate dehydrogenase (G6PDH), EC 1.1.1.49, and 6-phosphogluconate dehydrogenase,...",11,510,Adipocyte_2014_Jan_1_3(1)_30-38.txt
1.1.1.44,"... and 6-phosphogluconate dehydrogenase, (6PGDH), EC1.1.1.44. The last two enzymes are the main NADPH ...",11,572,Adipocyte_2014_Jan_1_3(1)_30-38.txt
EC 1.1.1.49,...00 g for 45 min. Duplicate measurements of G6PDH (EC 1.1.1.49) activities were performed photometric...,86,266,Adipocyte_2014_Jan_1_3(1)_30-38.txt
4.29.4.410,...; PMID:25559569; http://dx.doi.org/10.3803/EnM.2014.29.4.410 25559569,716,69,Adipocyte_2015_Dec_10_5(2)_982-118.txt
4.39.1.97,"...actice, Training 2002 39 1 97 102 10.1037/0033-3204.39.1.97",198,204,Adm_Policy_Ment_Health_2010_May_26_37(3)_221-229.txt
1.1.5.807,...t Mental Health 2009 21 29 38 10.2989/JCAMH.2009.21.1.5.807,170,167,Adm_Policy_Ment_Health_2011_Sep_26_38(5)_356-367.txt
4.41.2.83,"... Practice, Training 2004 41 83 96 10.1037/0033-3204.41.2.83",332,225,Adm_Policy_Ment_Health_2010_May_10_37(3)_230-244.txt
4.41.2.83,"... Practice, Training 2004 41 83 96 10.1037/0033-3204.41.2.83",170,225,Adm_Policy_Ment_Health_2010_May_12_37(3)_208-220.txt
EC 3.1.13.-,"...tion, ie, probable exosome complex exonuclease 2 (EC 3.1.13.-)/tRNA nucleotidyltransferase (N2), pro...",23,437,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 3.4.25.1,"...ucleotidyltransferase (N2), proteasome subunit α (EC 3.4.25.1) (N3), probable exosome complex RNA-bi...",23,506,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 3.1.26.5,"...nuclease P (tRNA processing) protein component 3 (EC 3.1.26.5) (N8), ribonuclease P protein componen...",23,719,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 3.1.26.5,"...1.26.5) (N8), ribonuclease P protein component 2 (EC 3.1.26.5) (N9), prefoldin, chaperonin cofactor ...",23,774,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 2.1.1.-,...am and a gene for tRNA/RNA cytosine-C5-methylase (EC 2.1.1.-) is immediately upstream from the human...,27,405,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 3.1.13.-,"...ologs), 2-probable exosome complex exonuclease 2 (EC 3.1.13.-)/tRNA nucleotidyltransferase, 3-protea...",64,404,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 3.4.25.1,"...A nucleotidyltransferase, 3-proteasome subunit α (EC 3.4.25.1), 4-probable exosome complex RNA-bindi...",64,470,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 3.1.26.5,"...nuclease P (tRNA processing) protein component 3 (EC 3.1.26.5), 9-ribonuclease P protein component 2...",64,672,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 3.1.26.5,"... 3.1.26.5), 9-ribonuclease P protein component 2 (EC 3.1.26.5), 10-prefoldin, chaperonin cofactor, a...",64,724,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 2.7.11.1,"...ual specificity testis-specific protein kinase 2 (EC 2.7.11.1), and 8-RABX5 (NP_001185988.1). 200 kb...",68,524,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 2.1.1.-,...7340	70503	6838	−	tRNA/RNA cytosine-C5-methylase (EC 2.1.1.-),79,72,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 2.7.11.1,"...	94790	77229	17562	−	Protein kinase C, beta type (EC 2.7.11.1)",80,70,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 2.7.7.7,...1.peg.1987	467450	461400	6051	−	DNA polymerase I (EC 2.7.7.7),91,61,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 2.1.1.-,... ribosomal RNA small subunit methyltransferase J (EC 2.1.1.-),94,101,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 3.6.1.23,...idine 5 and 39;-triphosphate nucleotidohydrolase (EC 3.6.1.23),106,97,Adv_Appl_Bioinform_Chem_2011_Sep_21_4_43-50.txt
EC 2.4.2.1,...g assay with purine nucleoside phosphorylase (PNP EC 2.4.2.1) and 2-amino-6-mercapto-7-methylpurine ...,37,180,Adv_Appl_Bioinform_Chem_2013_Feb_7_6_1-13.txt
1.5.4.10,...oltzmann Solver (ABPS) with AutoDockTools release 1.5.4.10 Molecular graphics images were produced u...,18,602,Adv_Appl_Bioinform_Chem_2013_Aug_19_6_47-53.txt
4.2.5.1,AutoDock v.4.2.5.1 was used in the study since its previous v...,24,12,Adv_Appl_Bioinform_Chem_2014_Sep_2_7_23-36.txt
EC 6.3.2.10,"...development of new antibiotics.56 Moreover, murF; EC 6.3.2.10 was the only enzyme present in peptido...",73,469,Adv_Appl_Bioinform_Chem_2015_Dec_8_8_49-63.txt
EC 2.7.2.1,"...ethane metabolism (KEGG Pathway: map00680), AckA; EC 2.7.2.1 was found to be uniquely present. Metha...",75,55,Adv_Appl_Bioinform_Chem_2015_Dec_8_8_49-63.txt
1.3.1.38,"...he mitochondrial trans-2-enoyl-CoA reductase (EC: 1.3.1.38). Within KEGG, when this component is cli...",53,93,Adv_Bioinformatics_2013_Jan_29_2013_527295.txt
1.2.4.1,1.2.4.1	Pyruvate dehydrogenase E1,77,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
1.1.1.38,1.1.1.38	Malic enzyme,80,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
1.1.1.37,1.1.1.37	Malate dehydrogenase,83,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
2.7.9.1,2.7.9.1	Pyruvate phosphate dikinase,86,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
2.7.1.40,2.7.1.40	Pyruvate kinase,89,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
4.1.1.31,4.1.1.31	PEP carboxylase,92,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
6.4.1.1,6.4.1.1	Pyruvate kinase II,95,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
4.1.1.3,4.1.1.3	Pyruvate carboxylase subunit,98,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
2.3.1.8,2.3.1.8	Phosphate acetyltransferase,101,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
2.7.2.1,2.7.2.1	Acetate kinase,104,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
2.3.3.9,2.3.3.9	Malate synthase G,107,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
6.2.1.13,6.2.1.13	Acetyl-CoA synthase,110,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
1.2.1.10,1.2.1.10	Acetaldehyde dehydrogenase,113,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
6.2.1.1,6.2.1.1	Acetyl-coenzyme A synthetase,116,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
2.3.1.169,2.3.1.16,120,1,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
1.2.99.2,1.2.99.2	Carbon-monoxide dehydrogenase,124,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
1.2.1.2,1.2.1.2	Formate dehydrogenase-O,127,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
1.2.99.5,1.2.99.5	Tungsten formylmethanofuran dehydrogenase...,130,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
1.2.99.5,1.2.99.5	Formylmethanofuran dehydrogenase,133,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
1.12.7.2,1.12.7.2	Ni/Fe hydrogenase large subunit,136,2,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
2.7.1.40,R 9	2.7.1.40	Pyruvate kinase,149,5,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
6.4.1.1,R 11	6.4.1.1	Pyruvate carboxylase,152,6,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
1.1.1.37,R 7	1.1.1.37	Malate dehydrogenase,155,5,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
2.3.3.9,R 15	2.3.3.9	Malate synthase,162,6,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
2.7.1.40,R 9	2.7.1.40	Pyruvate kinase,168,5,Adv_Bioinformatics_2014_Apr_16_2014_928038.txt
6.42.7.973,...06 42 7 481 489 2-s2.0-33747104566 10.1358/dot.2006.42.7.973588 16894402,290,143,Adv_Bioinformatics_2014_Dec_17_2014_324753.txt
2.7.10.1,"...rd and EC number search (“tyrosine kinase” AND EC:2.7.10.1 AND reviewed: yes). Furthermore, to exclu...",23,338,Adv_Bioinformatics_2015_Aug_11_2015_528097.txt
2.7.10.1,...rd and EC number search (“tyrosine kinase” AND EC:2.7.10.1 AND reviewed: yes). To exclude redundancy...,66,246,Adv_Bioinformatics_2015_Aug_11_2015_528097.txt
EC 3.8.1.2,2-Haloalkanoic acid dehalogenase enzymes (EC 3.8.1.2) are present in many bacteria and fungi...,16,43,Adv_Bioinformatics_2016_Jan_6_2016_8701201.txt
2.7.7.24,"...hat is, α-D-Glc-1-P thymidylyltransferase (RmlA) (2.7.7.24), in the dTDP-Rha pathway of Mtb. It cata...",20,2443,Adv_Bioinformatics_2016_Feb_14_2016_9841250.txt
3.19.2.121,...matics Research  2013 19 2 121 129 10.4258/hir.2013.19.2.121 2-s2.0-84880061591 23882417,283,213,Adv_Bioinformatics_2016_Feb_29_2016_8150784.txt
4.5.1.11,...urnal of Radiology  2004 5 1 11 18 10.3348/kjr.2004.5.1.11 2-s2.0-2342446592 15064554,174,178,Adv_Bioinformatics_2016_May_24_2016_5614058.txt
EC 3.1.1.8,"... EC numbers. As a result, the profile HMM for the EC 3.1.1.8 used with default parameters selects se...",14,821,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.1.1.4,"...rofiles, for example the 7 subgroups of EC number 3.1.1.4 were designated as 3.1.1.4_1 through 3.1.1...",29,310,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.1.1.4,...subgroups of EC number 3.1.1.4 were designated as 3.1.1.4_1 through 3.1.1.4_7 and converted into sep...,29,337,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.1.1.4,...mber 3.1.1.4 were designated as 3.1.1.4_1 through 3.1.1.4_7 and converted into separate HMMs. There ...,29,355,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
EC 2.7.7.6,...ot sequences for the DNA-directed RNA polymerase (EC 2.7.7.6) into 14 subgroups (PRIAM has 51 separa...,71,393,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
EC 2.7.7.6,... 14 subgroups (PRIAM has 51 separate profiles for EC 2.7.7.6). We tested the ModEnzA profiles for EC...,71,459,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
EC 2.7.7.6,...r EC 2.7.7.6). We tested the ModEnzA profiles for EC 2.7.7.6 on a set of sequences of the structural...,71,507,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
EC 3.4.22.32,...with the nearest cysteine endopetidase bromelain (EC 3.4.22.32) but it is gratifying to note that th...,93,717,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
EC 3.4.23.2,... same first three digits. Only one EC assignment (EC 3.4.23.2) has more than 1 digit mismatch with t...,93,1019,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
EC 2.7.7.6,...bclusters or subgroups of the ModEnzA profile for EC 2.7.7.6 (DNA-directed RNA polymerase) and its s...,105,103,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
EC 3.1.1.8,...selected from the EC groups by the HMM profile of EC 3.1.1.8,109,216,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
1.1.5.3,1.1.5.3	PFC0275w	FAD-dependent glycerol-3-phosphat...,163,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
1.17.7.1,1.17.7.1	PF10_0221	(E)-4-Hydroxy-3-methylbut-2-eny...,164,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
1.3.1.8,1.3.1.8	PF11_0370	—	—,165,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
1.3.5.2,1.3.5.2	PFF0160c	—	Uridine-5′-phosphate biosynthes...,166,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.1.1.48,2.1.1.48	PF14_0156	—	—,167,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.3.1.180,2.3.1.180	PFB0505c	3-Oxoacyl-(acyl carrier protein...,168,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.3.1.181,2.3.1.181	MAL8P1.37	Lipoyl(octanoyl) transferase	—...,169,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.4.1.141,"2.4.1.141	MAL8P1.133	Beta-1,4-N-acetylglucosaminyl...",170,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.7.12.1,2.7.12.1	PF14_0431	dual-specificity kinase	—,171,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.7.1.90,2.7.1.90	PFI0755c	6-phosphofructokinase	ATP-depend...,172,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.7.7.64,2.7.7.64	PFE0875c	—	—,173,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.8.1.8,2.8.1.8	MAL13P1.220	Lipoic acid synthetase	—,174,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.1.13.4,"3.1.13.4	MAL8P1.104, PFE0980c	—	—",175,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.1.21.2,3.1.21.2	PF13_0176	—	—,176,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.21.10,"3.4.21.10	PFE0340c, PF11_0149, MAL8P1.16, PF14_011...",177,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.5.1.88,3.5.1.88	PFI0380c	—	—,178,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.6.1.1,"3.6.1.1	PF14_0541, PFL1700c, PFC0710w-a, PFC0710w-...",179,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.6.1.7,3.6.1.7	PF11_0121	—	—,180,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.6.3.44,"3.6.3.44	PFE1150w	—	ABC transporter, putative",181,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.6.4.3,3.6.4.3	PF14_0548	—	—,182,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.6.4.6,3.6.4.6	PFC0140c	Vesicle-fusing ATPase	—,183,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.6.5.5,3.6.5.5	PF10_0368	Dynamin GTPase	—,184,1,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.1.3.-,"PF07_0059	4-nitrophenylphosphatase, putative	3.1.3.-(Phosphoric monoester hydrolases.); 3.1.3.4...",190,46,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.1.3.41,...tative	3.1.3.-(Phosphoric monoester hydrolases.); 3.1.3.41 (4-nitrophenylphosphatase)	T2-3.1.3.41	4-...,190,89,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.1.3.41,...rolases.); 3.1.3.41 (4-nitrophenylphosphatase)	T2-3.1.3.41	4-nitrophenylphosphatase,190,128,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.1,"PF08_0108	Pepsinogen, putative	3.4.23.1	T2-3.4.23.2	Pepsin B",191,32,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.2,"PF08_0108	Pepsinogen, putative	3.4.23.1	T2-3.4.23.2	Pepsin B",191,44,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.2,"...partyl protease, putative; Plasmepsin VII	None	T2-3.4.23.2	Pepsin B",192,63,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.22.-,"PF11_0161	Falcipain-2 precursor, putative	3.4.22.-	T3-3.4.22.32	Stem bromelain",193,43,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.22.32,"..._0161	Falcipain-2 precursor, putative	3.4.22.-	T3-3.4.22.32	Stem bromelain",193,55,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.22.-,PF11_0162	Falcipain-3	3.4.22.-	T3-3.4.22.32	Stem bromelain,194,23,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.22.32,PF11_0162	Falcipain-3	3.4.22.-	T3-3.4.22.32	Stem bromelain,194,35,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.22.-,PF11_0165	Falcipain 2 precursor	3.4.22.-	T3-3.4.22.32	Stem bromelain,195,33,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.22.32,PF11_0165	Falcipain 2 precursor	3.4.22.-	T3-3.4.22.32	Stem bromelain,195,45,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.5.1.10,"...11_0295	Farnesyl pyrophosphate synthase, putative	2.5.1.10 Geranyltranstransferase; 2.5.1.1 Dimethyl...",196,53,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.5.1.1,"...thase, putative	2.5.1.10 Geranyltranstransferase; 2.5.1.1 Dimethylallyltranstransferase	T2-2.5.1.67	...",196,87,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.5.1.67,...sferase; 2.5.1.1 Dimethylallyltranstransferase	T2-2.5.1.67	Chrysanthemyl diphosphate synthase,196,128,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.38,"PF14_0075	Plasmepsin, putative	3.4.23.38 (Plasmepsin I)	T2-3.4.23.39	Plasmepsin I...",197,32,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.39,"...	Plasmepsin, putative	3.4.23.38 (Plasmepsin I)	T2-3.4.23.39	Plasmepsin II",197,60,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.38,PF14_0076	Plasmepsin 1 precursor	3.4.23.38 (Plasmepsin I)	T2-3.4.23.39	Plasmepsin I...,198,34,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.39,...lasmepsin 1 precursor	3.4.23.38 (Plasmepsin I)	T2-3.4.23.39	Plasmepsin II,198,62,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.39,PF14_0077	Plasmepsin 2	3.4.23.39 (Plasmepsin II)	T2-3.4.23.39	Plasmepsin ...,199,24,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.39,...14_0077	Plasmepsin 2	3.4.23.39 (Plasmepsin II)	T2-3.4.23.39	Plasmepsin II,199,53,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.-,PF14_0078	HAP protein; Plasmepsin III	3.4.23.-Aspartic endopeptidases	T2-3.4.23.39	Plasm...,200,39,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.39,...Plasmepsin III	3.4.23.-Aspartic endopeptidases	T2-3.4.23.39	Plasmepsin II,200,74,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.2,"PF14_0281	Aspartyl protease, putative	None	T2-3.4.23.2	Pepsin B",201,47,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
1.4.7.1,"...34	NAD(P)H-dependent glutamate synthase, putative	1.4.7.1 Glutamate synthase (ferredoxin);1.4.1.14 -...",202,58,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
1.4.1.14,... putative	1.4.7.1 Glutamate synthase (ferredoxin);1.4.1.14 -Glutamate synthase (NADH)	T2-1.4.1.14	Gl...,202,98,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
1.4.1.14,...erredoxin);1.4.1.14 -Glutamate synthase (NADH)	T2-1.4.1.14	Glutamate synthase,202,137,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.22.32,PF14_0553	Cysteine proteinase falcipain-1	None	T3-3.4.22.32	Stem bromelain,203,51,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.2.3,PF14_0625	Hypothetical protein	3.4.2.3; Transferred entry: 3.4.17.4	T2-3.4.23.2	P...,204,32,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.17.4,...	Hypothetical protein	3.4.2.3; Transferred entry: 3.4.17.4	T2-3.4.23.2	Pepsin B,204,60,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.2,...l protein	3.4.2.3; Transferred entry: 3.4.17.4	T2-3.4.23.2	Pepsin B,204,72,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.-,"PFC0495w	Aspartyl protease, putative	3.4.23.- Aspartic endopeptidases	T2-3.4.23.2	Pepsi...",205,38,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
3.4.23.2,"...ase, putative	3.4.23.- Aspartic endopeptidases	T2-3.4.23.2	Pepsin B",205,74,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.2.1.1,"PFF0530w	Transketolase, putative	2.2.1.1 Transketolase	T2-2.2.1.3	Formaldehyde tran...",206,34,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.2.1.3,"...	Transketolase, putative	2.2.1.1 Transketolase	T2-2.2.1.3	Formaldehyde transketolase",206,59,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
1.1.1.100,"...xoacyl-(acyl-carrier protein) reductase, putative	1.1.1.100 (3-oxoacyl-[acyl-carrier-protein] reduct...",207,63,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
2.3.1.85,...100 (3-oxoacyl-[acyl-carrier-protein] reductase); 2.3.1.85 (Fatty-acid synthase)	T2-1.1.1.140	Sorbit...,207,119,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
1.1.1.140,...in] reductase); 2.3.1.85 (Fatty-acid synthase)	T2-1.1.1.140	Sorbitol-6-phosphate 2-dehydrogenase,207,153,Adv_Bioinformatics_2011_Mar_29_2011_743782.txt
EC 2.7.1.149,"...sphatidylinositol 5-phosphate 4-kinases (PI5P4Ks, EC 2.7.1.149) are a family of three in most verteb...",9,58,Adv_Biol_Regul_2015_Jan_57_193-202.txt
EC 3.5.1.1,L-Asparaginases (EC 3.5.1.1) are the enzymes catalyzing the convers...,18,18,Adv_Biomed_Res_2014_Feb_28_3_82.txt
EC 2.7.1.40,"...e kinase (PK, ATP-pyruvate-O-phospho transferase, EC 2.7.1.40), which plays a metabolic role in bact...",24,58,Adv_Biomed_Res_2014_Dec_31_3_260.txt
1.11.1.7,"...roxidases (PODs) (donor: H2O2 oxidoreductase, EC: 1.11.1.7) belong to a large family of enzymes whic...",18,53,Adv_Biomed_Res_2015_Jul_27_4_159.txt
3.90.70.117,...12 Nov 10 New Delhi Available from: http://www. 203.90.70.117/searoftp/WROIND/whoindia/linkfiles/NMH...,60,147,Adv_Biomed_Res_2015_Aug_31_4_187.txt
3.2.1.18,...assistants in 1983 [Figure 2]. Neuraminidase (EC: 3.2.1.18) has an important role in the influenza v...,28,128,Adv_Biomed_Res_2015_Oct_7_4_219.txt
3.2.1.18,"...related to the classification of Neuraminidase (EC3.2.1.18), the weight of subtype 200KD,[1011121314...",36,71,Adv_Biomed_Res_2015_Oct_7_4_219.txt
1.11.1.9,"GPx (EC1.11.1.9 GPx) is a tetrameric enzyme, which utiliz...",176,8,Adv_Biomed_Res_2015_Oct_29_4_241.txt
1.11.1.7,"Lactoperoxidase (LPO) (EC.1.11.1.7), a peroxidase enzyme, is present in exoc...",18,27,Adv_Biomed_Res_2016_Nov_28_5_189.txt
2.1.1.1,2.1.1.1 Penicillin,25,1,Adv_Drug_Deliv_Rev_2014_Jun_30_73(100)_127-139.txt
2.1.1.2,2.1.1.2 Cephalosporin,32,1,Adv_Drug_Deliv_Rev_2014_Jun_30_73(100)_127-139.txt
2.1.1.3,2.1.1.3 Carbapenem,41,1,Adv_Drug_Deliv_Rev_2014_Jun_30_73(100)_127-139.txt
EC 2.7.1.68,"...ate (PtdIns(4,5)P2) (Fig. 1). The Type I enzymes (EC 2.7.1.68) are now known to catalyze the major r...",6,736,Adv_Enzyme_Regul_2010_50(1)_12-18.txt
EC 2.7.1.149,"...4P 5-kinases Iα, Iβ and Iγ). The Type II enzymes (EC 2.7.1.149) are 4-kinases (Rameh et al., 1997), ...",6,986,Adv_Enzyme_Regul_2010_50(1)_12-18.txt
EC 3.1.3.78,"...b of two isoforms of PtdIns(4,5)P2 4-phosphatase (EC 3.1.3.78) (Ungewickell et al., 2005; Zou et al....",10,514,Adv_Enzyme_Regul_2010_50(1)_12-18.txt
EC 3.1.3.36,"...cance of a PTEN homologue that is a 5-phosphatse (EC 3.1.3.36), but very specific for PtdIns5P (Pagl...",10,1344,Adv_Enzyme_Regul_2010_50(1)_12-18.txt
EC 2.7.1.68,"...rated here. EC Numbers: Type I PtdIns4P 5-kinase, EC 2.7.1.68; Type II PtdIns5P 4-kinase, EC 2.7.1.1...",54,180,Adv_Enzyme_Regul_2010_50(1)_12-18.txt
EC 2.7.1.149,"...5-kinase, EC 2.7.1.68; Type II PtdIns5P 4-kinase, EC 2.7.1.149; PtdIns(4,5)P2 4-phosphatase, EC 3.1....",54,220,Adv_Enzyme_Regul_2010_50(1)_12-18.txt
EC 3.1.3.78,"...inase, EC 2.7.1.149; PtdIns(4,5)P2 4-phosphatase, EC 3.1.3.78",54,263,Adv_Enzyme_Regul_2010_50(1)_12-18.txt
EC 2.7.1.127,"...5-trisphosphate (Ins(1,4,5)P3) in the 3-position (EC 2.7.1.127) was discovered 20 yr ago (Batty et a...",8,96,Adv_Enzyme_Regul_2006_46(1)_314-323.txt
EC 3.1.3.56,"...3 can be inactivated by a specific 5-phosphatase (EC 3.1.3.56) (Downes et al., 1982), it was somethi...",8,474,Adv_Enzyme_Regul_2006_46(1)_314-323.txt
EC 2.7.1.151,"...; Irvine, 2005), either as ‘InsP3 multi-kinases’ (EC 2.7.1.151, i.e., inositol phosphate kinases tha...",13,284,Adv_Enzyme_Regul_2006_46(1)_314-323.txt
EC 2.7.4.21,"...sphorylate several substrates), or InsP6 kinases (EC 2.7.4.21). Together these enzymes form a major ...",13,393,Adv_Enzyme_Regul_2006_46(1)_314-323.txt
3.6.3.6,...the Interconversion of Folate Derviatives Chapter 3.6.3.6 EcoSal—Escherichia coli and Salmonella: Ce...,97,211,Adv_Enzyme_Res_2014_Mar_2(1)_39-48.txt
2.5.2.1,"...on 5, and the more robust elastic data of Section 2.5.2.1, it seems possible that there is thermal h...",60,267,Adv_Funct_Mater_2014_May_1_24(20)_2993-3002.txt
2.5.2.1,2.5.2.1. Low Temperatur,67,1,Adv_Funct_Mater_2014_May_1_24(20)_2993-3002.txt
2.5.2.2,2.5.2.2. High Temperatur,75,1,Adv_Funct_Mater_2014_May_1_24(20)_2993-3002.txt
4.40.3.562,...Social Psychology 1981 40 562 572 10.1037/0022-3514.40.3.562,179,185,Adv_Health_Sci_Educ_Theory_Pract_2010_Aug_23_15(3)_303-313.txt
4.72.5.116,...al Psychology 1997 72 5 1161 1176 10.1037/0022-3514.72.5.1161 9150590,202,217,Adv_Health_Sci_Educ_Theory_Pract_2010_Aug_23_15(3)_303-313.txt
3.84.4.429,...tional Psychology 1992 84 429 434 10.1037/0022-0663.84.4.429,252,185,Adv_Health_Sci_Educ_Theory_Pract_2010_Oct_7_15(4)_517-532.txt
3.81.3.392,...tional Psychology 1989 81 392 399 10.1037/0022-0663.81.3.392,291,134,Adv_Health_Sci_Educ_Theory_Pract_2010_Dec_9_15(5)_695-715.txt
3.95.4.667,...tional Psychology 2003 95 667 696 10.1037/0022-0663.95.4.667,306,183,Adv_Health_Sci_Educ_Theory_Pract_2010_Dec_9_15(5)_695-715.txt
4.52.5.890,...cial Psychology 1987 52 5 890 898 10.1037/0022-3514.52.5.890 3585701,197,190,Adv_Health_Sci_Educ_Theory_Pract_2011_May_16_16(2)_183-195.txt
3.15.6.116,"..., and Cognition 1989 15 1166 1174 10.1037/0278-7393.15.6.1166",189,220,Adv_Health_Sci_Educ_Theory_Pract_2011_May_30_16(2)_151-165.txt
4.53.3.550,...cial Psychology 1987 53 3 550 562 10.1037/0022-3514.53.3.550,175,161,Adv_Health_Sci_Educ_Theory_Pract_2011_Mar_25_16(1)_5-16.txt
4.77.6.112,...cial Psychology 1999 77 1121 1134 10.1037/0022-3514.77.6.1121 10626367,197,218,Adv_Health_Sci_Educ_Theory_Pract_2011_Aug_30_16(3)_311-329.txt
3.94.3.545,...onal Psychology 2002 94 3 545 561 10.1037/0022-0663.94.3.545,142,182,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_18_16(4)_465-479.txt
4.48.2.393,...cial Psychology 1985 48 2 393 399 10.1037/0022-3514.48.2.393,144,175,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_18_16(4)_465-479.txt
3.88.4.715,...onal Psychology 1996 88 4 715 730 10.1037/0022-0663.88.4.715,152,210,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_18_16(4)_465-479.txt
4.40.1.1,... Social Psychology 1981 40 1 1 10 10.1037/0022-3514.40.1.1,159,179,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_18_16(4)_465-479.txt
4.59.5.916,...cial Psychology 1990 59 5 916 924 10.1037/0022-3514.59.5.916,164,202,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_18_16(4)_465-479.txt
3.80.4.514,...onal Psychology 1988 80 4 514 523 10.1037/0022-0663.80.4.514,172,178,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_18_16(4)_465-479.txt
3.88.2.203,...onal Psychology 1996 88 2 203 214 10.1037/0022-0663.88.2.203,174,202,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_18_16(4)_465-479.txt
3.82.1.33,...tional Psychology 1990 82 1 33 40 10.1037/0022-0663.82.1.33,175,175,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_18_16(4)_465-479.txt
4.50.3.550,...cial Psychology 1986 50 3 550 558 10.1037/0022-3514.50.3.550,182,228,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_18_16(4)_465-479.txt
4.72.5.116,...al Psychology 1997 72 3 1161 1176 10.1037/0022-3514.72.5.1161 9150590,188,224,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_18_16(4)_465-479.txt
3.93.4.659,...onal Psychology 2001 93 4 659 676 10.1037/0022-0663.93.4.659,384,231,PMC5306423.txt
3.81.4.610,...onal Psychology 1989 81 4 610 619 10.1037/0022-0663.81.4.610,175,243,Adv_Health_Sci_Educ_Theory_Pract_2011_Oct_16_16(4)_449-464.txt
4.77.6.112,...cial Psychology 1999 77 1121 1134 10.1037/0022-3514.77.6.1121 10626367,150,218,Adv_Health_Sci_Educ_Theory_Pract_2011_Dec_25_16(5)_579-590.txt
3.82.2.189,...tional Psychology 1990 82 189 200 10.1037/0022-0663.82.2.189,171,137,Adv_Health_Sci_Educ_Theory_Pract_2011_Dec_5_16(5)_553-567.txt
4.77.6.112,...cial Psychology 1999 77 1121 1134 10.1037/0022-3514.77.6.1121 10626367,156,218,Adv_Health_Sci_Educ_Theory_Pract_2012_Mar_6_17(1)_15-26.txt
3.33.4.704,"...ry, and Cognition 2007 33 704 719 10.1037/0278-7393.33.4.704",128,247,Adv_Health_Sci_Educ_Theory_Pract_2012_Mar_27_17(1)_27-37.txt
4.52.5.890,...cial Psychology 1987 52 5 890 898 10.1037/0022-3514.52.5.890 3585701,166,190,Adv_Health_Sci_Educ_Theory_Pract_2012_Dec_1_17(5)_743-757.txt
3.87.3.406,...onal Psychology 1995 87 3 406 423 10.1037/0022-0663.87.3.406,205,160,Adv_Health_Sci_Educ_Theory_Pract_2012_Dec_1_17(5)_743-757.txt
4.52.5.890,...cial Psychology 1987 52 5 890 898 10.1037/0022-3514.52.5.890 3585701,197,190,Adv_Health_Sci_Educ_Theory_Pract_2013_Mar_22_18(1)_57-69.txt
3.96.1.68,...cational Psychology 2004 96 68 84 10.1037/0022-0663.96.1.68,203,229,Adv_Health_Sci_Educ_Theory_Pract_2013_Mar_22_18(1)_57-69.txt
3.99.4.734,...onal Psychology 2007 99 4 734 746 10.1037/0022-0663.99.4.734,206,216,Adv_Health_Sci_Educ_Theory_Pract_2013_Mar_22_18(1)_57-69.txt
3.97.3.468,...onal Psychology 2005 97 3 468 483 10.1037/0022-0663.97.3.468,216,198,Adv_Health_Sci_Educ_Theory_Pract_2013_Mar_22_18(1)_57-69.txt
4.69.6.106,...al Psychology 1995 69 6 1069 1086 10.1037/0022-3514.69.6.1069,270,185,Adv_Health_Sci_Educ_Theory_Pract_2013_May_23_18(3)_343-363.txt
3.32.5.113,...and Cognition 2006 32 5 1133 1145 10.1037/0278-7393.32.5.1133,280,218,Adv_Health_Sci_Educ_Theory_Pract_2013_May_23_18(3)_343-363.txt
3.87.1.33,...tional Psychology 1995 87 1 33 46 10.1037/0022-0663.87.1.33,281,163,Adv_Health_Sci_Educ_Theory_Pract_2013_May_23_18(3)_343-363.txt
4.91.5.797,...Social Psychology 2006 91 797 813 10.1037/0022-3514.91.5.797 17059302,213,202,Adv_Health_Sci_Educ_Theory_Pract_2015_Sep_4_20(2)_499-513.txt
4.77.6.112,...cial Psychology 1999 77 1121 1134 10.1037/0022-3514.77.6.1121 10626367,206,220,Adv_Health_Sci_Educ_Theory_Pract_2015_Sep_11_20(3)_611-626.txt
3.93.4.659,...onal Psychology 2001 93 4 659 676 10.1037/0022-0663.93.4.659,184,223,Adv_Health_Sci_Educ_Theory_Pract_2016_May_29_21_93-104.txt
3.90.2.224,...onal Psychology 1998 90 2 224 235 10.1037/0022-0663.90.2.224,207,153,Adv_Health_Sci_Educ_Theory_Pract_2016_May_29_21_93-104.txt
3.81.3.329,...onal Psychology 1989 81 3 329 339 10.1037/0022-0663.81.3.329,208,144,Adv_Health_Sci_Educ_Theory_Pract_2016_May_29_21_93-104.txt
4.92.6.108,...cial Psychology 2007 92 1087 1101 10.1037/0022-3514.92.6.1087 17547490,344,185,Adv_Health_Sci_Educ_Theory_Pract_2016_May_8_21_33-49.txt
3.21.6.160,...and Cognition 1995 21 6 1608 1623 10.1037/0278-7393.21.6.1608,218,174,Adv_Health_Sci_Educ_Theory_Pract_2016_Jul_31_21_189-205.txt
3.90.2.312,...tional Psychology 1998 90 312 320 10.1037/0022-0663.90.2.312,62,191,Adv_Health_Sci_Educ_Theory_Pract_2016_Nov_7_21(5)_983-990.txt
4.54.6.106,...al Psychology 1988 54 6 1063 1070 10.1037/0022-3514.54.6.1063 339786,262,210,PMC5306429.txt
5.35.6.563,...ratory Medicine  2015 35 6 563 569 10.3343/alm.2015.35.6.563 2-s2.0-84942233474 26354343,253,179,PMC5339490.txt
3.48.1.51,...dia Blood Research  2013 48 1 51 54 10.5045/br.2013.48.1.51 2-s2.0-84890673537 23589796,147,190,Adv_Hematol_2014_Oct_16_2014_749218.txt
3.39.9.799,... Drugs of Today  2003 39 9 665 672 10.1358/dot.2003.39.9.799475 2-s2.0-0242427463 14586482,138,130,Adv_Hematol_2014_Dec_8_2014_735751.txt
EC 1.15.1.1,"2.5. Superoxide Dismutase (SOD, EC 1.15.1.1",39,33,Adv_Hematol_2015_Aug_9_2015_961049.txt
EC 1.11.1.6,"2.6. Catalase (CAT, EC 1.11.1.6",42,21,Adv_Hematol_2015_Aug_9_2015_961049.txt
5.20.1.31,... Medical Science  2005 20 1 31 35 10.3346/jkms.2005.20.1.31 2-s2.0-14844336911 15716598,283,207,Adv_Hematol_2015_Sep_3_2015_920838.txt
EC 1.15.1.1,"2.13. Superoxide Dismutase (SOD, EC 1.15.1.1",57,34,Adv_Hematol_2016_Feb_2_2016_4091461.txt
EC 1.11.1.6,"2.14. Catalase (CAT, EC 1.11.1.6",60,22,Adv_Hematol_2016_Feb_2_2016_4091461.txt
5.22.4.469,...2008 22 469 484 http://dx.doi.org/10.1037/0894-4105.22.4.469  18590359,284,245,Adv_J_Mol_Imaging_2014_Oct_4(4)_43-57.txt
5.83.6.101,... Neurosurgery  1995 83 6 1017 1022 10.3171/jns.1995.83.6.1017 2-s2.0-0029621163 7490615,155,220,Adv_Med_2014_Aug_27_2014_943648.txt
3.14.3.203,... Prevention  2013 14 3 2037 2042 10.7314/APJCP.2013.14.3.2037 2-s2.0-84880429005 23679315,291,205,Adv_Med_2014_Sep_7_2014_238045.txt
5.9.1.99,...2009 9 1 99 107 2-s2.0-58149232453 10.1586/14737175.9.1.99 19102672,360,206,Adv_Med_2014_Jun_11_2014_317980.txt
1.35.3.309,...tation Medicine  2011 35 3 309 315 10.5535/arm.2011.35.3.309 22506138,302,220,Adv_Med_2015_Apr_30_2015_916735.txt
2.73.11.129,... 73 11 1292 1298 2-s2.0-0036867429 10.1902/jop.2002.73.11.1292 12479633,141,211,Adv_Med_2014_Jun_15_2014_487903.txt
2.73.10.111,... 73 10 1118 1125 2-s2.0-0036776001 10.1902/jop.2002.73.10.1118 12416768,151,239,Adv_Med_2014_Jun_15_2014_487903.txt
3.74.10.141,... 74 10 1415 1422 2-s2.0-0344442767 10.1902/jop.2003.74.10.1415 14653386,198,232,Adv_Med_2014_Jun_15_2014_487903.txt
3.14.2.941,...er Prevention  2013 14 2 941 946 10.7314/APJCP.2013.14.2.941 2-s2.0-84877683468 23621265,259,258,Adv_Med_2015_Oct_7_2015_109593.txt
4.3.2.142,...trition Research  2014 3 2 142 149 10.7762/cnr.2014.3.2.142 25136542,248,200,Adv_Med_2016_Oct_13_2016_2675345.txt
4.29.9.121,...ical Science  2014 29 9 1212 1216 10.3346/jkms.2014.29.9.1212 2-s2.0-84929156561 25246738,121,360,Adv_Med_2016_Oct_19_2016_8639041.txt
5.16.6.252,... Prevention  2015 16 6 2527 2530 10.7314/apjcp.2015.16.6.2527 2-s2.0-84929180150 25824791,125,270,Adv_Med_2016_Oct_19_2016_8639041.txt
3.54.7.433,...rnal of Urology  2013 54 7 433 436 10.4111/kju.2013.54.7.433 2387868,135,242,Adv_Med_2016_Oct_19_2016_8639041.txt
3.18.2.248,...edical Science  2003 18 2 248 254 10.3346/jkms.2003.18.2.248 2-s2.0-0348147396 12692424,138,254,PMC5220387.txt
5.1.74.556,...ew Pharmacotherapy  2005 25 1 74 85 10.1592/phco.25.1.74.55620 2-s2.0-11144221727 15767223,143,156,Adv_Orthop_2016_Sep_5_2016_5646529.txt
2.32.8.376,...sical Therapy  2002 32 8 376 379 10.2519/jospt.2002.32.8.376 2-s2.0-0035991798 12168955,159,160,Adv_Orthop_2016_Oct_23_2016_3817270.txt
2.32.8.405,...sical Therapy  2002 32 8 405 414 10.2519/jospt.2002.32.8.405 2-s2.0-0035991783 12168959,174,207,Adv_Orthop_2016_Oct_23_2016_3817270.txt
6.8.4.180,...ysical Therapy  1986 8 4 180 184 10.2519/jospt.1986.8.4.180 2-s2.0-0023039321 18802227,181,182,Adv_Orthop_2016_Oct_23_2016_3817270.txt
2.32.9.447,...sical Therapy  2002 32 9 447 460 10.2519/jospt.2002.32.9.447 2-s2.0-0036715271 12322811,189,193,Adv_Orthop_2016_Oct_23_2016_3817270.txt
4.8.5.565,...an Spine Journal  2014 8 5 565 570 10.4184/asj.2014.8.5.565 2-s2.0-84921028641 25346808,191,266,Adv_Orthop_2016_Oct_23_2016_3817270.txt
1.41.5.218,...1 41 5 218 226 2-s2.0-84859766447 10.5051/jpis.2011.41.5.218 22087412,137,353,Adv_Orthop_2014_Nov_6_2014_791539.txt
3.18.9.162,...ral Research  2003 18 9 1622 1631 10.1359/jbmr.2003.18.9.1622 12968671,141,268,Adv_Orthop_2014_Nov_6_2014_791539.txt
5.22.5.216,...sical Therapy  1995 22 5 216 222 10.2519/jospt.1995.22.5.216 2-s2.0-0028871384 8580949,68,159,Adv_Orthop_2014_Dec_7_2014_806363.txt
4.32.4.213,...ncology Journal  2014 32 4 213 220 10.3857/roj.2014.32.4.213 25568849,310,131,Adv_Orthop_2015_Feb_24_2015_525363.txt
2.17.8.154,...ral Research  2002 17 8 1545 1554 10.1359/jbmr.2002.17.8.1545 2-s2.0-0035992661 12162508,250,259,Adv_Orthop_2015_Oct_19_2015_912790.txt
4.6.1.1,... Orthopedic Surgery  2014 6 1 1 8 10.4055/cios.2014.6.1.1 2-s2.0-84895166481 24605183,146,167,Adv_Orthop_2016_Jan_4_2016_4961846.txt
EC 3.2.1.1,....006 M NaCl) containing hog pancreatic α-amylase (EC 3.2.1.1) (0.5 mg/mL) were incubated at 25°C for...,52,137,Adv_Pharmacol_Sci_2013_Nov_21_2013_926047.txt
5.2.4.493,...m and Toxicology  2006 2 4 493 503 10.1517/17425255.2.4.493 2-s2.0-33747834655 16859400,213,176,Adv_Pharmacol_Sci_2016_Nov_20_2016_3094783.txt
5.1.3.389,...ism & Toxicology  2005 1 3 389 397 10.1517/17425255.1.3.389 2-s2.0-29544446150 16863451,215,176,Adv_Pharmacol_Sci_2016_Nov_20_2016_3094783.txt
6.28.7.100,...cal Pharmacology  2006 28 7 423 431 10.1358/mf.2006.28.7.1003580 2-s2.0-33750023151 17003847,236,218,Adv_Pharmacol_Sci_2016_Nov_20_2016_3094783.txt
EC 1.3.99.1,...mitochondrial succinate: acceptor oxidoreductase (EC 1.3.99.1) was determined by standard protocol b...,49,55,Adv_Pharmacol_Sci_2014_Feb_24_2014_809438.txt
1.35.2.243,...inseng Research  2011 35 2 243 249 10.5142/jgr.2011.35.2.243 2-s2.0-79959886636 23717067,318,225,Adv_Pharmacol_Sci_2014_Nov_20_2014_373295.txt
4.10.3.439,...igational Drugs  2001 10 3 439 454 10.1517/13543784.10.3.439 2-s2.0-0035110957 11227044,173,196,Adv_Pharmacol_Sci_2015_Aug_20_2015_418673.txt
4.47.3.149,... & Cell Biology  2014 47 3 149 156 10.5115/acb.2014.47.3.149 25276473,164,177,Adv_Pharmacol_Sci_2015_Sep_7_2015_384750.txt
1.49.1.17,...l of Parasitology  2011 49 1 17 23 10.3347/kjp.2011.49.1.17 2-s2.0-79953284018 21461264,101,204,Adv_Pharmacol_Sci_2016_Feb_28_2016_8195381.txt
5.30.1.34,... Medical Science  2015 30 1 34 43 10.3346/jkms.2015.30.1.34 25552881,175,233,Adv_Pharmacol_Sci_2016_Mar_6_2016_4608979.txt
3.46.11.207,...BMB Reports  2013 46 11 519 526 10.5483/bmbrep.2013.46.11.207 2-s2.0-84890203127 24238362,114,135,Adv_Pharmacol_Sci_2016_Mar_20_2016_7238679.txt
2.2.3.1,2.2.3.1 Timer mechanisms and polarizatio,332,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
2.2.3.2,2.2.3.2 Competitive and cooperative bindin,343,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
2.2.3.3,2.2.3.3 Force feedbac,354,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
2.2.3.4,2.2.3.4 Structure feedbac,363,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
3.1.1.1,3.1.1.1 Probing technique,440,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
3.1.1.2,3.1.1.2 Rheological measurement,461,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
3.1.2.1,3.1.2.1 Linear viscoelasticit,493,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
3.1.2.2,3.1.2.2 Tensegrit,500,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
3.1.2.3,3.1.2.3 Soft glassy rheolog,505,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
3.3.3.1,3.3.3.1 Leading edge protrusio,622,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
3.3.3.2,3.3.3.2 Self-organization into oriented branche,672,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
3.3.3.3,3.3.3.3 Regulation of the actin dynamic,683,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
3.3.4.1,"3.3.4.1 Contractility, retraction, disassembl",701,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
3.3.4.2,3.3.4.2 Substrate adhesio,716,1,Adv_Phys_2013_Jan_6_62(1)_1-112.txt
EC 3.2.1.1,....006 M NaCl) containing Hog pancreatic α-amylase (EC 3.2.1.1) (0.5 mg/mL) were incubated at 25°C for...,55,160,Adv_Prev_Med_2014_Jan_16_2014_534082.txt
5.14.3.260,...7 14 3 260 274 2-s2.0-34548822196 10.1037/1072-5245.14.3.260,311,186,Adv_Prev_Med_2015_Mar_19_2015_749417.txt
3.6.2.73,...of Histotechnology  1983 6 2 73 76 10.1179/his.1983.6.2.73 2-s2.0-0020956655,313,195,Adv_Prev_Med_2015_Jul_28_2015_183728.txt
4.52.3.596,...ial Psychology  1987 52 3 596 604 10.1037/0022-3514.52.3.596 2-s2.0-0023304222 3572727,313,225,Adv_Prev_Med_2015_Oct_12_2015_467498.txt
2.13.2.705,...er Prevention  2012 13 2 705 714 10.7314/apjcp.2012.13.2.705 2-s2.0-84866440464 22524848,255,281,Adv_Prev_Med_2015_Oct_13_2015_639239.txt
3.76.1.80,... and Motor Skills  1993 76 1 80 82 10.2466/pms.1993.76.1.80 2-s2.0-0027546079 8451153,384,233,Adv_Prev_Med_2015_Dec_6_2015_614723.txt
4.35.4.173,...amily Medicine  2014 35 4 173 181 10.4082/kjfm.2014.35.4.173 2-s2.0-84906891492 25120888,355,194,Adv_Prev_Med_2015_Dec_8_2015_352547.txt
2.13.12.596,...Prevention  2012 13 12 5969 5973 10.7314/apjcp.2012.13.12.5969 2-s2.0-84877013688 23464387,212,279,Adv_Prev_Med_2016_Jan_3_2016_4018023.txt
1.10.1.31,...ins were rendered with the software USCF Chimera V1.10.1.31 As there is no structural data set of th...,153,575,Adv_Sci_(Weinh)_2016_May_27_3(10)_1600046.txt
1.38.47.201,"...R Grant No. 09-05-91000-ANF-a, by SPSU grant No. 11.38.47.2011, and by the European Union Seventh Fr...",47,133,Adv_Space_Res_2011_Nov_1_48(9)_1531-1536.txt
EC 3.1.1.3,...mmercial suppliers and used as received. Lipases (EC 3.1.1.3) were from Amano Enzyme Inc. or Sigma–A...,49,81,Adv_Synth_Catal_2014_Mar_24_356(5)_987-992.txt
EC 4.1.1.35,... UDP-Xyl is produced by UDP-xylose synthase (UXS; EC 4.1.1.35) via oxidative decarboxylation of UDP-...,8,567,Adv_Synth_Catal_2014_Nov_24_356(17)_3575-3584.txt
EC 1.1.1.22,... (UDP-GlcUA).[2] UDP-glucose dehydrogenase (UGDH; EC 1.1.1.22) synthesizes UDP-GlcUA in a NAD+-depen...,8,682,Adv_Synth_Catal_2014_Nov_24_356(17)_3575-3584.txt
1.2.1.30,...ading eventually to its classification as an E.C. 1.2.1.30 enzyme. These E.C. 1.2.1.30 type CARs are...,29,1356,Adv_Synth_Catal_2016_Nov_3_358(21)_3414-3421.txt
1.2.1.30,...sification as an E.C. 1.2.1.30 enzyme. These E.C. 1.2.1.30 type CARs are comprised of three domains:...,29,1384,Adv_Synth_Catal_2016_Nov_3_358(21)_3414-3421.txt
1.2.1.30,The family of E.C.1.2.1.30 carboxylate reductase enzymes (CARs) was ...,121,19,Adv_Synth_Catal_2016_Nov_3_358(21)_3414-3421.txt
6.2.4.417,... Clin Risk Manag 2006 2 4117 4134 10.2147/tcrm.2006.2.4.417,247,136,Adv_Ther_2013_Jun_25_30(6)_630-643.txt
5.5.4.525,...xpert Rev Neurother 2005 5 525 539 10.1586/14737175.5.4.525 16026236,383,157,Adv_Ther_2014_Dec_27_31(1)_44-65.txt
2.1.1.43,...t Rev Cardiovasc Ther 2003 1 43 50 10.1586/14779072.1.1.43 15030296,222,177,Adv_Ther_2014_Jan_11_31(2)_217-233.txt
5.5.2.153,...xpert Rev Neurother 2005 5 153 164 10.1586/14737175.5.2.153 15853486,132,107,Adv_Ther_2014_Sep_3_31(9)_915-931.txt
1.47.12.170,...rugs Today (Barc). 2011 47 883 890 10.1358/dot.2011.47.12.1709243 22348913,198,149,Adv_Ther_2014_Sep_27_31(10)_1059-1071.txt
6.9.3.479,...Opin Pharmacother 2008 9 3 479 490 10.1517/14656566.9.3.479 18220498,79,242,Adv_Ther_2015_Apr_7_32(4)_285-292.txt
1.47.1.35,...n J Am Pharm Assoc. 2007 47 35 41 10.1331/1544-3191.47.1.35.Stumpf,132,196,Adv_Ther_2015_May_31_32(6)_485-495.txt
5.13.4.546,...city Neuropsychology 1999 13 4 11 10.1037/0894-4105.13.4.546,1330,191,Adv_Ther_2015_Nov_7_32(11)_983-1028.txt
5.51.1.26,...ome Chonnam Med J. 2015 51 1 26 32 10.4068/cmj.2015.51.1.26 25914877,226,208,Adv_Ther_2016_Mar_17_33_532-552.txt
6.2.3.203,...Health Risk Manag. 2006 2 203 212 10.2147/vhrm.2006.2.3.203 17326327,181,180,Adv_Ther_2016_Apr_12_33_848-861.txt
5.76.1.154,...rt J Periodontol 2005 76 1 154 160 10.1902/jop.2005.76.1.154 15830652,911,196,Adv_Ther_2016_Jun_10_33_910-958.txt
3.18.5.495,...de Health Psychol 1999 18 495 505 10.1037/0278-6133.18.5.495 10519466,212,214,Adv_Ther_2016_Apr_30_33_959-981.txt
5.21.5.409,...re Spec Pharm. 2015 21 5 409 423 10.18553/jmcp.2015.21.5.409 25943002,266,322,Adv_Ther_2016_Jul_4_33_1360-1373.txt
2.24.2.126,...ase Ann Dermatol. 2012 24 2 126 135 10.5021/ad.2012.24.2.126 22577261,160,173,Adv_Ther_2016_Jul_18_33(9)_1481-1501.txt
2.2.5.523,...xpert Rev Dermatol. 2007 6 523 531 10.1586/17469872.2.5.523,207,135,Adv_Ther_2016_Jul_18_33(9)_1481-1501.txt
6.7.5.783,...pe Pharmacogenomics 2006 7 783 792 10.2217/14622416.7.5.783 16886902,343,268,Adv_Ther_2016_Jul_12_33(9)_1461-1480.txt
6.2.4.317,...ns Pharmacogenomics 2001 2 317 327 10.1517/14622416.2.4.317 11722282,381,148,Adv_Ther_2016_Jul_12_33(9)_1461-1480.txt
6.7.1.49,...ting Pharmacogenomics 2006 7 49 59 10.2217/14622416.7.1.49 16354124,394,180,Adv_Ther_2016_Jul_12_33(9)_1461-1480.txt
5.6.9.124,...ert Rev Neurother 2006 6 1249 1265 10.1586/14737175.6.9.1249 17009913,156,143,Adv_Ther_2016_Oct_7_33(11)_1853-1866.txt
5.19.3.190,... Int Neurourol J 2015 19 3 190 196 10.5213/inj.2015.19.3.190 26620902,142,204,PMC5126182.txt
4.9.1.39,...rt Opin Emerg Drugs 2004 9 1 39 53 10.1517/14728214.9.1.39 15155135,203,169,PMC5216065.txt
2.6.3.391,...ev Cardiovasc Ther. 2008 6 391 409 10.1586/14779072.6.3.391 18327998,336,225,PMC5331085.txt
4.2.1.2,4.2.1.2.) [35]. FH consists of ten exon,409,1,Adv_Urol_2008_Nov_9_2008_720840.txt
EC 1.15.1.1,Total (Cu-Zn and Mn) SOD (EC 1.15.1.1) activity was determined according to ...,69,27,Adv_Urol_2013_Sep_8_2013_836121.txt
2.53.9.614,...rnal of Urology  2012 53 9 614 618 10.4111/kju.2012.53.9.614 2-s2.0-84866994001 23060998,119,271,Adv_Urol_2015_Oct_1_2015_656459.txt
5.56.7.478,...rnal of Urology  2015 56 7 478 486 10.4111/kju.2015.56.7.478 26175866,121,156,Adv_Urol_2015_Oct_7_2015_476390.txt
5.56.2.164,...rnal of Urology  2015 56 2 164 167 10.4111/kju.2015.56.2.164 2-s2.0-84922595437 25685305,79,221,Adv_Urol_2015_Oct_21_2015_397936.txt
1.52.7.485,...11 52 7 485 488 2-s2.0-79961235958 10.4111/kju.2011.52.7.485 21860770,164,245,Adv_Urol_2015_Dec_14_2015_592175.txt
2.53.5.304,...rnal of Urology  2012 53 5 304 309 10.4111/kju.2012.53.5.304 2-s2.0-84861876438 22670188,144,274,Adv_Urol_2016_Jan_14_2016_5751647.txt
2.13.6.247,... Prevention  2012 13 6 2477 2479 10.7314/apjcp.2012.13.6.2477 2-s2.0-84874039949 22938407,148,239,Adv_Urol_2016_Jan_14_2016_5751647.txt
4.4.5.637,... Future Oncology  2008 4 5 637 645 10.2217/14796694.4.5.637 2-s2.0-55249096718 18922121,42,156,Adv_Urol_2016_Jun_27_2016_3140372.txt
4.15.10.417,...Prevention  2014 15 10 4175 4179 10.7314/APJCP.2014.15.10.4175 2-s2.0-84903550446 24935366,127,247,Adv_Urol_2016_Jul_17_2016_2075021.txt
6.17.1.1,...Veterinary Science  2016 17 1 1 11 10.4142/jvs.2016.17.1.1 2-s2.0-84962734451 27051334,178,153,PMC5278201.txt
3.4.21.98,...yme Commission (EC) classification with EC number 3.4.21.98. It is a bifunctional enzyme that has tw...,28,279,Adv_Virol_2015_Oct_26_2015_972067.txt
3.13.5.163,...s Immune Network  2013 13 5 163 167 10.4110/in.2013.13.5.163 24198740,258,186,Adv_Virol_2016_May_4_2016_3605302.txt
2.44.4.1,...of Science  2012 44 4 297 307 10.5614/itbj.sci.2012.44.4.1 2-s2.0-84899059702,80,203,Adv_Virol_2015_Dec_31_2015_675921.txt
4.51.2.288,...inking Social Problems 51 2 288 304 10.1525/sp.2004.51.2.288,117,138,AERA_Open_2015_Oct-Dec_1(4)_10_1177_2332858415613055.txt
5.12.3.105,...ical Immunology 2002 12 3 105 109 10.1027/0838-1925.12.3.105,166,228,Aerobiologia_(Bologna)_2011_Sep_29_27(3)_229-238.txt
3.93.9.107,...Phytopathology 2003 93 1073 1081 10.1094/PHYTO.2003.93.9.1073 18944090,150,237,Aerobiologia_(Bologna)_2016_Sep_14_32_39-51.txt
4.6.3.222,...unology Research 2014 6 3 222 227 10.4168/aair.2014.6.3.222,244,232,Aerobiologia_(Bologna)_2016_Mar_11_32(3)_571-580.txt
4.2.89.165,"...t Orbital Reconstr Surg 2001 4 89 93 10.1076/otoo.4.2.89.16580 Bosniak S, Cantisano-Zilkha M (2001) ...",161,162,Aesthetic_Plast_Surg_2009_May_12_33(3)_274-282.txt
6.8.8.105,...Opin Pharmacother 2007 8 1059 1072 10.1517/14656566.8.8.1059 De Boulle KLV (2007) Botulinum neurotox...,145,123,Aesthetic_Plast_Surg_2008_Sep_29_32(5)_724-730.txt
2.39.5.452,...el Arch Plast Surg 2012 39 452 456 10.5999/aps.2012.39.5.452 23094238,241,214,Aesthetic_Plast_Surg_2014_Jul_2_38(5)_849-860.txt
3.40.5.603,...le Arch Plast Surg 2013 40 603 609 10.5999/aps.2013.40.5.603 24086817,135,151,Aesthetic_Plast_Surg_2016_Mar_22_40_343-348.txt
4.29.4.462,... Korean Med Sci 2014 29 4 462 467 10.3346/jkms.2014.29.4.462 24753692,117,136,Aesthetic_Plast_Surg_2016_Apr_21_40_428-434.txt
2.39.1.51,...on Arch Plast Surg 2012 39 1 51 54 10.5999/aps.2012.39.1.51 22783492,119,200,Aesthetic_Plast_Surg_2016_Apr_21_40_428-434.txt
2.12.1.9,...ogical Association 2002 12 1 9 29 10.1525/ap3a.2002.12.1.9,150,197,Afr_Archaeol_Rev_2016_Mar_4_33_13-27.txt
6.1.1.11,...6 ;(1 ):1 –31 . http://dx.doi.org/10.2147/ciia.2006.1.1.1,211,127,Afr_J_Prim_Health_Care_Fam_Med_2015_Apr_21_7(1)_780.txt
2.23.23.42,... (23 ):42 –46 . http://dx.doi.org/10.7748/ns2009.02.23.23.42.c6800,305,128,Afr_J_Prim_Health_Care_Fam_Med_2014_Jun_6_6(1)_640.txt
6.1.2.106,...(2 ):106 –122 . http://dx.doi.org/10.1162/itgg.2006.1.2.106,493,193,Afr_J_Prim_Health_Care_Fam_Med_2014_Jan_31_6(1)_560.txt
2.76.1.103,"...(1 ):103 –108 . http://dx.doi.org/10.1037/0002-9432.76.1.103,  PMid:, PMCid:16569133",219,173,Afr_J_Prim_Health_Care_Fam_Med_2013_Sep_13_5(1)_497.txt
6.7.1.28,...06 ;7 :28 –30 . http://dx.doi.org/10.1383/anes.2006.7.1.28,149,102,Afr_J_Prim_Health_Care_Fam_Med_2015_Jul_23_7(1)_835.txt
6.17.3.28,...7 (3 ):28 –34 . http://dx.doi.org/10.7748/nm2010.06.17.3.28.c780,231,58,Afr_J_Prim_Health_Care_Fam_Med_2015_Jun_26_7(1)_753.txt
3.10.3.155,...(3 ):155 –163 . http://dx.doi.org/10.1037/0278-6133.10.3.1551879387,246,77,Afr_J_Prim_Health_Care_Fam_Med_2015_Oct_22_7(1)_847.txt
4.12.1.7,...12 (1 ): 7 –18 . http://dx.doi.org/10.5049/EBP.2014.12.1.,322,121,Afr_J_Prim_Health_Care_Fam_Med_2015_Dec_17_49(1)_875.txt
1.16.9.435,...9 ):435 –440 . http://dx.doi.org/10.12968/bjcn.2011.16.9.435 22067953,169,162,Afr_J_Prim_Health_Care_Fam_Med_2016_May_24_8(2)_997.txt
3.15.97.252,...13 ;15 :1 –9 . http://dx.doi.org/10.11604/pamj.2013.15.97.252423847698,356,230,Afr_J_Prim_Health_Care_Fam_Med_2016_Nov_29_8(1)_1230.txt
5.20.5.529,...(5 ):529 –547 . http://dx.doi.org/10.1891/vivi.2005.20.5.52916248489,228,234,Afr_J_Prim_Health_Care_Fam_Med_2016_Nov_29_8(1)_1209.txt
2.17.5.817,...J Bone Min Res 2002 17 817 25 doi:10.1359/jbmr.2002.17.5.817,206,179,Age_Ageing_2011_Jan_15_40(1)_14-23.txt
5.4.1.79,"... Expert Rev Neurother 2004 4 79 86 10.1586/14737175.4.1.79 Carro E, Torres-Aleman I (2004) Insulin-l...",92,152,Age_(Dordr)_2006_Jun_13_28(2)_181-189.txt
2.17.6.104,... Bone Miner Res 2002 17 1044 1050 10.1359/jbmr.2002.17.6.1044 12054159,132,201,Age_(Dordr)_2011_Sep_7_33(3)_247-260.txt
4.12.1.12,...ging? Psychol Aging 1997 12 12 21 10.1037/0882-7974.12.1.12 9100264,134,220,Age_(Dordr)_2012_Feb_14_34(1)_1-10.txt
4.18.1.149,...ory Psychol Aging 2003 18 149 160 10.1037/0882-7974.18.1.149 12641319,162,211,Age_(Dordr)_2012_Feb_14_34(1)_1-10.txt
4.7.2.185,...ints Psychol Aging 1992 7 185 193 10.1037/0882-7974.7.2.185 1610506,174,179,Age_(Dordr)_2012_Feb_14_34(1)_1-10.txt
5.11.1.3,...ease Neuropsychology 1997 11 3 12 10.1037/0894-4105.11.1.3 9055265,111,200,Age_(Dordr)_2012_Feb_19_34(1)_67-73.txt
3.21.3.451,...m Percept Perform 1995 21 451 468 10.1037/0096-1523.21.3.451 7790827,114,141,Age_(Dordr)_2012_Feb_19_34(1)_67-73.txt
4.7.4.594,...arch Psychol Aging 1992 7 594 601 10.1037/0882-7974.7.4.594 1466828,117,145,Age_(Dordr)_2012_Feb_19_34(1)_67-73.txt
5.16.2.254,...n Neuropsychology 2002 16 254 274 10.1037/0894-4105.16.2.254 11949718,124,147,Age_(Dordr)_2012_Feb_19_34(1)_67-73.txt
3.25.3.661,...m Percept Perform 1999 25 661 676 10.1037/0096-1523.25.3.661 1038598,132,169,Age_(Dordr)_2012_Feb_19_34(1)_67-73.txt
5.77.1.139,...report Psychol Rep 1995 77 139 142 10.2466/pr0.1995.77.1.139 7501752,119,196,Age_(Dordr)_2012_Feb_22_34(1)_111-120.txt
3.4.3.219,...s Health Psychol 1985 4 3 219 247 10.1037/0278-6133.4.3.219 4029106,141,163,Age_(Dordr)_2012_Apr_7_34(2)_461-468.txt
4.67.6.106,...s Soc Psychol 1994 67 6 1063 1078 10.1037/0022-3514.67.6.1063 7815302,142,226,Age_(Dordr)_2012_Apr_7_34(2)_461-468.txt
4.22.2.291,...pan Psychol Aging 2007 22 291 299 10.1037/0882-7974.22.2.291 17563184,234,142,Age_(Dordr)_2012_Aug_22_34(4)_1001-1009.txt
1.16.11.210,... Bone Miner Res 2001 16 2103 2110 10.1359/jbmr.2001.16.11.2103 11697807,144,263,Age_(Dordr)_2012_Aug_4_34(4)_845-861.txt
4.7.3.331,...eory Psychol Aging 1992 7 331 338 10.1037/0882-7974.7.3.331 1388852,214,151,Age_(Dordr)_2014_Feb_2_36(1)_445-456.txt
4.80.1.136,... Pers Soc Psychol 2001 80 136 151 10.1037/0022-3514.80.1.136 11195886,217,167,Age_(Dordr)_2014_Feb_2_36(1)_445-456.txt
4.86.1.130,... Pers Soc Psychol 2004 86 130 147 10.1037/0022-3514.86.1.130 14717632,223,216,Age_(Dordr)_2014_Feb_2_36(1)_445-456.txt
4.15.3.511,...udy Psychol Aging 2000 15 511 526 10.1037/0882-7974.15.3.511 11014714,237,211,Age_(Dordr)_2014_Feb_2_36(1)_445-456.txt
3.19.6.586,... Health Psychol 2000 19 6 586 592 10.1037/0278-6133.19.6.586 11129362,185,243,Age_(Dordr)_2014_Apr_3_36(2)_923-931.txt
2.32.7.347,...orts Phys Ther 2002 32 7 347 356 10.2519/jospt.2002.32.7.347 12113469,264,180,Age_(Dordr)_2014_Jun_19_36(3)_9652.txt
4.86.1.130,...ers Soc Psychol 2004 86 1 130 147 10.1037/0022-3514.86.1.130 14717632,131,218,Age_(Dordr)_2014_Jun_21_36(3)_9638.txt
2.9.1.8,...ew Psychiatr Investig 2012 9 1 8 16 10.4306/pi.2012.9.1.8,141,155,Age_(Dordr)_2014_Jun_21_36(3)_9638.txt
4.19.2.367,...932 Psychol Aging 2004 19 367 371 10.1037/0882-7974.19.2.367 15222832,260,201,Age_(Dordr)_2014_Aug_30_36(4)_9673.txt
4.86.1.130,... Pers Soc Psychol 2004 86 130 147 10.1037/0022-3514.86.1.130 14717632,261,197,Age_(Dordr)_2014_Aug_30_36(4)_9673.txt
5.7.1.66,...Cognitive Neurosci 1995 7 1 66 80 10.1162/jocn.1995.7.1.66,141,126,Age_(Dordr)_2014_Aug_9_36(4)_9671.txt
4.14.3.427,...emory Psychol Aging 1999 14 3 427 10.1037/0882-7974.14.3.427 10509697,145,196,Age_(Dordr)_2014_Aug_9_36(4)_9671.txt
4.9.1.90,...d aging Psychol Aging 1994 9 1 90 10.1037/0882-7974.9.1.90 8185873,162,90,Age_(Dordr)_2014_Aug_9_36(4)_9671.txt
2.7.2.336,...ntrol theory Emotion 2007 7 2 336 10.1037/1528-3542.7.2.336 17516812,165,146,Age_(Dordr)_2014_Aug_9_36(4)_9671.txt
3.22.2.342,...Percept Perform 1996 22 2 342 354 10.1037/0096-1523.22.2.342 8934848,226,125,Age_(Dordr)_2014_Aug_9_36(4)_9671.txt
5.20.2.215,...y Neuropsychology 2006 20 215 223 10.1037/0894-4105.20.2.215 16594782,214,176,Age_(Dordr)_2014_Aug_5_36(4)_9682.txt
4.20.4.695,...? Psychol Aging 2005 20 4 695 709 10.1037/0882-7974.20.4.695 16420143,183,232,Age_(Dordr)_2014_Aug_30_36(4)_9688.txt
4.18.3.443,...s Psychol Aging 2003 18 3 443 460 10.1037/0882-7974.18.3.443 14518807,214,149,Age_(Dordr)_2014_Aug_30_36(4)_9688.txt
3.34.4.834,...sychol Learn Mem Cogn 2008 34 834 10.1037/0278-7393.34.4.834 18605872,272,153,Age_(Dordr)_2015_Jun_9_37(3)_53.txt
5.17.6.685,...come J Chemother 2005 17 6 685 692 10.1179/joc.2005.17.6.685 16433202,181,279,Age_(Dordr)_2015_Dec_3_37(6)_112.txt
5.16.3.111,... Cancer Prev 2015 16 3 1117 1122 10.7314/APJCP.2015.16.3.1117 25735341,188,203,Age_(Dordr)_2015_Dec_3_37(6)_112.txt
4.16.4.600,...ent Psychol Aging 2001 16 600 614 10.1037/0882-7974.16.4.600 11766915,297,185,Age_(Dordr)_2016_Feb_28_38(1)_3.txt
4.17.1.56,...ife span Psychol Aging 2002 17 56 10.1037/0882-7974.17.1.56 11931287,318,148,Age_(Dordr)_2016_Feb_28_38(1)_3.txt
3.31.2.237,...m Behav Process 2005 31 2 237 246 10.1037/0097-7403.31.2.237 15839779,339,185,Age_(Dordr)_2016_Feb_4_38(1)_6.txt
4.15.1.126,...g Psychol Aging 2000 15 1 126 147 10.1037/0882-7974.15.1.126 10755295,346,114,Age_(Dordr)_2016_Feb_4_38(1)_6.txt
3.21.3.451,...Percept Perform 1995 21 3 451 468 10.1037/0096-1523.21.3.451 7790827,350,144,Age_(Dordr)_2016_Feb_4_38(1)_6.txt
4.15.21.921,...ac J Cancer Prev 2014 15 9217 23 10.7314/APJCP.2014.15.21.9217 25422204,158,282,PMC5182073.txt
3.2.2.5,"...ni EN   The enzyme cd38 (a nad glycohydrolase, ec 3.2.2.5) is necessary for the development of diet-...",109,119,Aging_(Albany_NY)_2011_Aug_31_3(8)_794-802.txt
1.2.1.3,...yme variations in acetaldehyde dehydrogenase (e.c.1.2.1.3) in human tissues Human genetics 1978 44 1...,204,92,Aging_(Albany_NY)_2015_Sep_28_7(9)_718-733.txt
EC 2.7.1.1,"...kinase (HK) (ATP: D-hexose-6-phospho-transferase, EC 2.7.1.1) converts glucose to glucose-6-phosphat...",12,55,Aging_(Albany_NY)_2016_Feb_7_8(2)_245-258.txt
1.4.1.2,...escribed [63]. Raw files were searched using MQ v 1.4.1.2 against a recent mouse reference proteome ...,101,247,Aging_(Albany_NY)_2016_Feb_16_8(3)_441-454.txt
3.4.24.3,"...lagenase from Clostridium histoliticum (EC number 3.4.24.3; Sigma), while the other half was left un...",124,764,Aging_(Albany_NY)_2016_Jul_12_8(8)_1650-1668.txt
1.5.1.2,...and label-free quantitation with MaxQuant version 1.5.1.2 [32] as described [33] using the set of ra...,181,1719,Aging_(Albany_NY)_2016_Aug_9_8(8)_1735-1753.txt
2.13.5.180,...ac J Cancer Prev 2012 13 1809 17 10.7314/APJCP.2012.13.5.1809 22901127,183,179,Aging_(Albany_NY)_2016_Sep_28_8(9)_2204-2217.txt
4.86.1.130,...J Pers Soc Psychol 2004 86 130 47 10.1037/0022-3514.86.1.130 14717632,208,218,Aging_(Albany_NY)_2016_Sep_19_8(9)_2039-2051.txt
1.13.8.1,...energy of 50 kV and 456 μA. NRecon v1.6 and CTAn v1.13.8.1 software were used to reconstruct and ana...,102,247,Aging_(Albany_NY)_2016_Sep_14_8(9)_2006-2019.txt
4.19.4.301,...etry J Cancer Prev 2014 19 301 08 10.15430/JCP.2014.19.4.301 25574465,459,221,Aging_(Albany_NY)_2016_Aug_29_8(9)_1896-1915.txt
1.5.9.1,"...0th passage in Biolot (Saint-Petersburg, Russia, #1.5.9.1). Cells were cultured in 75 cm2 Nunc EasYF...",140,137,Aging_(Albany_NY)_2016_Sep_24_8(9)_2127-2141.txt
4.38.5.321,...on Diabetes Metab J 2014 38 321 29 10.4093/dmj.2014.38.5.321 25349818,103,129,Aging_(Albany_NY)_2016_Oct_30_8(10)_2590-2600.txt
1.12.3.195,... Rev Neurosci 2001 12 195 215 10.1515/REVNEURO.2001.12.3.195 11560368,228,137,Aging_(Albany_NY)_2016_Oct_15_8(10)_2463-2483.txt
2.17.1.14,...re converted to fastq files using the bcl2fastq (v2.17.1.14) program. The processed fastq files were...,92,583,PMC5191890.txt
1.4.2.293,... medicine Regen Med 2009 4 293 319 10.2217/17460751.4.2.293 19317647,158,155,PMC5191876.txt
4.4.6.815,...ri F    Future Oncol 2008 4 815 24 10.2217/14796694.4.6.815 19086848,46,61,PMC5191891.txt
4.30.4.235,...n cancer Toxicol Res 2014 30 235 42 10.5487/TR.2014.30.4.235 25584142,147,98,PMC5191864.txt
4.7.2.118,...s Int J Stem Cells 2014 7 118 26 10.15283/ijsc.2014.7.2.118 25473449,195,200,PMC5270684.txt
2.13.12.626,...ac J Cancer Prev 2012 13 6269 72 10.7314/APJCP.2012.13.12.6269 23464443,204,214,PMC5270670.txt
6.18.2.227,...an J Cogn Neurosci 2006 18 227 41 10.1162/jocn.2006.18.2.227 16494683,330,180,PMC5270666.txt
2.2.1.1,...ana” and EU Funded CM1001 and FRAILOMIC-HEALTH.2012.2.1.1-2 (To J.V) APM-03/15 from Conselleria de S...,174,370,PMC5270663.txt
4.16.2.272,...lder Psychol Aging 2001 16 272 80 10.1037/0882-7974.16.2.272 11405315,145,188,PMC5310666.txt
2.17.7.121,... J Bone Miner Res 2002 17 1219 29 10.1359/jbmr.2002.17.7.1219 12096835,328,261,PMC5310667.txt
1.5.2.150,...drome Nutr Res Pract 2011 5 150 56 10.4162/nrp.2011.5.2.150 21556229,359,229,PMC5310667.txt
3.18.6.108,... J Bone Miner Res 2003 18 1088 98 10.1359/jbmr.2003.18.6.1088 12817763,381,237,PMC5310667.txt
1.16.4.788,...b J Bone Miner Res 2001 16 788 93 10.1359/jbmr.2001.16.4.788 11316008,382,195,PMC5310667.txt
EC 3.4.24.3,"... removed and placed into 0.4% type I collagenase (EC 3.4.24.3) (Sigma–Aldrich Co., St Louis, MO, USA...",108,168,Aging_Cell_2010_Dec_9(6)_979-990.txt
EC 3.4.24.3,"...r 1.5 h at 37°C in 0.4% (w/v) Type I collagenase (EC 3.4.24.3; Sigma Chemical Co., Poole, Dorset, UK...",106,256,Aging_Cell_2011_Oct_6_10(5)_749-760.txt
3.2.1.17,"...chnology, Danvers, MA, USA), lysozyme (Dako, # EC.3.2.1.17), chromogranin A (Immunostar, #20085), PC...",125,414,Aging_Cell_2015_Feb_6_14(1)_139-147.txt
3.1.2.1,"...s were acquired using axiovision software version 3.1.2.1 (Carl Zeiss Ltd, Welwyn Garden City, UK)",100,391,Aging_Cell_2015_Aug_23_14(4)_558-568.txt
3.1.2.1,...tive coelomocytes was quantified using axiovision 3.1.2.1 software. A defined area (± 10%) of a coel...,118,713,Aging_Cell_2015_Aug_23_14(4)_558-568.txt
1.17.21.3,...alling was performed using Illumina’s RTA version 1.17.21.3. The RNA-Seq data were analyzed using ma...,84,555,Aging_Cell_2015_Oct_25_14(5)_734-743.txt
EC 1.6.5.3,"... Fe‐S‐binding sites (Hinchliffe & Sazanov, 2005) (EC 1.6.5.3, 1.6.99.3). In EDL, 6 of 7 core protein...",103,1338,Aging_Cell_2016_Feb_25_15(1)_89-99.txt
1.6.99.3,"...g sites (Hinchliffe & Sazanov, 2005) (EC 1.6.5.3, 1.6.99.3). In EDL, 6 of 7 core proteins encoded by...",103,1350,Aging_Cell_2016_Feb_25_15(1)_89-99.txt
1.5.1.1,"...as performed using Feature Extraction software (v11.5.1.1, Agilent Technologies, Santa Clara, CA, US...",79,701,Aging_Cell_2015_Apr_25_14(2)_209-218.txt
6.1.2.107,...lin Interv Aging 2006 1 2 107 113 10.2147/ciia.2006.1.2.107 18044107,229,129,Aging_Clin_Exp_Res_2014_Aug_20_26(1)_77-88.txt
5.16.3.309,...n Neuropsychology 2002 16 309 321 10.1037/0894-4105.16.3.309 1214667,155,222,Aging_Clin_Exp_Res_2016_Nov_25_28(5)_909-915.txt
5.21.5.540,...g Neuropsychology 2007 21 540 548 10.1037/0894-4105.21.5.540 17784802,103,161,Aging_Clin_Exp_Res_2016_May_26_28(5)_959-964.txt
4.15.3.417,...age Psychol Aging 2000 15 417 436 10.1037/0882-7974.15.3.417 11014706,104,176,Aging_Clin_Exp_Res_2016_May_26_28(5)_959-964.txt
5.19.1.18,...sts Neuropsychology 2005 19 18 27 10.1037/0894-4105.19.1.18 15656759,107,180,Aging_Clin_Exp_Res_2016_May_26_28(5)_959-964.txt
4.18.3.443,...sis Psychol Aging 2003 18 443 460 10.1037/0882-7974.18.3.443 14518807,117,141,Aging_Clin_Exp_Res_2016_May_26_28(5)_959-964.txt
4.84.4.822,...ty and Social Psychology  822 848 10.1037/0022-3514.84.4.822 12703651,152,186,Aging_Ment_Health_2015_Mar_4_19(3)_2012-206.txt
4.83.2.261,...y & Social Psychology  2 261 270 10.1037//0022-3514.83.2.261 12150226,265,183,Aging_Ment_Health_2015_Aug_3_19(8)_6671-678.txt
4.15.2.187,...is Psychology and Aging  187 224 10.1037//0882-7974.15.2.187 10879576,375,203,Aging_Ment_Health_2016_May_3_20(5)_5299-542.txt
3.2.3.1,3.2.3.1 Source of cattl,147,1,PMC5312657.txt
3.2.3.2,3.2.3.2 Transport of cattl,152,1,PMC5312657.txt
3.2.3.3,3.2.3.3 Transactions of live cattle within the mar...,155,1,PMC5312657.txt
3.2.3.4,3.2.3.4 Slaughtering and transaction of beef produ...,162,1,PMC5312657.txt
3.2.3.5,3.2.3.5 Beef meat chain,171,1,PMC5312657.txt
3.2.3.6,"3.2.3.6 Beef offal, heads and legs chain",176,1,PMC5312657.txt
3.2.3.7,3.2.3.7 Product transportatio,179,1,PMC5312657.txt
3.2.5.1,3.2.5.1 Source of product,212,1,PMC5312657.txt
3.2.5.2,3.2.5.2 Beef meat distributio,215,1,PMC5312657.txt
3.2.5.3,3.2.5.3 Transport of beef mea,220,1,PMC5312657.txt
3.2.7.1,3.2.7.1 Source of cattl,231,1,PMC5312657.txt
3.2.7.2,3.2.7.2 Cattle transportation and slaughterin,234,1,PMC5312657.txt
3.2.7.3,3.2.7.3 Value additio,237,1,PMC5312657.txt
3.2.7.4,3.2.7.4 Distribution of beef product,240,1,PMC5312657.txt
3.2.7.5,3.2.7.5 Transport of beef mea,243,1,PMC5312657.txt
5.20.46.300,... . doi: http://dx.doi.org/10.2807/1560-7917.ES.2015.20.46.30065,346,71,AIDS_2016_Feb_20_30(4)_645-656.txt
5.17.5.430,"...on and Prevention 2005 17 430 443 10.1521/aeap.2005.17.5.430 Operario, D., & Nemoto, T. (2005). Sexu...",243,184,AIDS_Behav_2009_Oct_6_13(5)_902-913.txt
5.17.5.430,"...on and Prevention,17, 430–443. doi:10.1521/aeap2005.17.5.430. 16255639",243,393,AIDS_Behav_2009_Oct_6_13(5)_902-913.txt
4.1.1.243,"...ucation and Prevention 2002 14 1 16 10.1521/aeap.14.1.1.24331 Kirshenbaum, S. B., & Nevid, J. S. (20...",228,171,AIDS_Behav_2009_Dec_9_13(6)_1253-1261.txt
4.1.1.243,"...cation and Prevention,14, 1–16. doi:10.1521/aeap.14.1.1.24331. 11900106",228,373,AIDS_Behav_2009_Dec_9_13(6)_1253-1261.txt
3.27.1.4,... Health Psychology 2008 27 1 4 14 10.1037/0278-6133.27.1.4 18230008,182,234,AIDS_Behav_2010_Apr_7_14(2)_339-350.txt
6.69.3.191,...sonal Processes 2006 69 3 191 203 10.1521/psyc.2006.69.3.191,193,189,AIDS_Behav_2010_Apr_7_14(2)_339-350.txt
3.27.2.129,...alth Psychology 2008 27 2 129 139 10.1037/0278-6133.27.2.129 18377131,215,216,AIDS_Behav_2010_Apr_7_14(2)_339-350.txt
3.25.4.462,... Health Psychol 2006 25 4 462 473 10.1037/0278-6133.25.4.462 16846321,195,183,AIDS_Behav_2010_Jun_22_14(3)_580-589.txt
3.22.2.223,... Health Psychol 2003 22 2 223 228 10.1037/0278-6133.22.2.223 1268374,199,219,AIDS_Behav_2010_Jun_22_14(3)_580-589.txt
4.54.6.980,...ers Soc Psychol 1988 54 6 980 988 10.1037/0022-3514.54.6.980,327,155,AIDS_Behav_2010_Oct_25_14(5)_1032-1044.txt
4.84.2.365,...Social Psychology 2003 84 365 376 10.1037/0022-3514.84.2.365 12585810,200,284,AIDS_Behav_2010_Aug_6_14(4)_769-777.txt
3.23.4.413,...alth Psychology 2004 23 4 413 418 10.1037/0278-6133.23.4.413 15264978,203,230,AIDS_Behav_2010_Aug_6_14(4)_769-777.txt
4.54.6.106,...al Psychology 1988 54 6 1063 1070 10.1037/0022-3514.54.6.1063 3397865,230,207,AIDS_Behav_2010_Aug_6_14(4)_769-777.txt
3.24.4.385,...alth Psychology 2005 24 4 385 392 10.1037/0278-6133.24.4.385 16045374,231,256,AIDS_Behav_2010_Aug_6_14(4)_769-777.txt
3.17.3.224,...on Health Psychol 1998 17 224 231 10.1037/0278-6133.17.3.224 9619471,305,197,AIDS_Behav_2011_Jan_11_15(1)_45-57.txt
3.18.3.281,... Health Psychol 1999 18 3 281 287 10.1037/0278-6133.18.3.281 10357509,332,152,AIDS_Behav_2011_Jan_11_15(1)_45-57.txt
4.51.6.117,...ers Soc Psychol 1986 51 1173 1182 10.1037/0022-3514.51.6.1173 3806354,127,209,AIDS_Behav_2011_Jan_28_15(1)_179-185.txt
6.18.5.390,... AIDS Educ Prev 2006 18 5 390 405 10.1521/aeap.2006.18.5.390 17067251,194,232,AIDS_Behav_2011_Feb_12_15(2)_365-375.txt
3.23.5.525,... Health Psychol 2004 23 5 525 532 10.1037/0278-6133.23.5.525 15367072,65,253,AIDS_Behav_2011_Apr_15_15(Suppl_1)_51-56.txt
5.17.5.418,... AIDS Educ Prev 2005 17 5 418 429 10.1521/aeap.2005.17.5.418 16255638,71,262,AIDS_Behav_2011_Apr_15_15(Suppl_1)_51-56.txt
5.1.15.238,...aine AIDS Educ Prev 2003 15 1 15 32 10.1521/aeap.15.1.15.23843 12627741,103,179,AIDS_Behav_2011_Apr_15_15(Suppl_1)_51-56.txt
6.18.5.461,... AIDS Educ Prev 2006 18 5 461 473 10.1521/aeap.2006.18.5.461 17067256,124,172,AIDS_Behav_2011_Apr_15_15(Suppl_1)_51-56.txt
2.49.1.11,...pulations Soc Probl 2002 49 1 11 34 10.1525/sp.2002.49.1.11,273,176,AIDS_Behav_2011_Apr_7_15(3)_626-634.txt
5.1.49.238,...ed? AIDS Educ Prev. 2003 15 1 49 69 10.1521/aeap.15.1.49.23844 12627743,205,146,AIDS_Behav_2011_Jul_16_15(5)_930-937.txt
3.14.1.6,...rs Health Psychol. 1995 14 1 6 12 10.1037/0278-6133.14.1.6 7737075,259,204,AIDS_Behav_2011_Aug_17_15(6)_1140-1152.txt
3.18.3.281,...s Health Psychol. 1999 18 281 287 10.1037/0278-6133.18.3.281 10357509,281,146,AIDS_Behav_2011_Aug_17_15(6)_1140-1152.txt
3.26.1.40,...us Health Psychol 2007 26 1 40 49 10.1037/0278-6133.26.1.40 17209696,215,218,AIDS_Behav_2011_Aug_24_15(6)_1187-1196.txt
3.21.3.229,... Health Psychol 2002 21 3 229 236 10.1037/0278-6133.21.3.229 12027028,281,165,AIDS_Behav_2011_Oct_26_15(7)_1347-1358.txt
3.26.6.787,... Health Psychol 2007 26 6 787 793 10.1037/0278-6133.26.6.787 18020852,283,201,AIDS_Behav_2011_Oct_26_15(7)_1347-1358.txt
5.1.15.238,...aine AIDS Educ Prev 2003 15 1 15 32 10.1521/aeap.15.1.15.23843 12627741,299,179,AIDS_Behav_2011_Oct_26_15(7)_1347-1358.txt
4.51.6.117,...s Soc Psychol 1986 51 6 1173 1182 10.1037/0022-3514.51.6.1173 3806354,146,211,AIDS_Behav_2011_Oct_1_15(7)_1546-1553.txt
3.22.4.332,...Health Psychology 2003 22 332 339 10.1037/0278-6133.22.4.332 12940388,213,173,AIDS_Behav_2011_Oct_16_15(7)_1309-1318.txt
3.13.3.238,...s Health Psychol. 1994 13 238 250 10.1037/0278-6133.13.3.238 8055859,317,230,AIDS_Behav_2011_Nov_5_15(8)_1732-1744.txt
3.12.6.481,... Health Psychol 1993 12 6 481 488 10.1037/0278-6133.12.6.481 8293732,225,173,AIDS_Behav_2010_Jun_11_14(3)_618-628.txt
3.26.4.418,... Health Psychol 2007 26 4 418 427 10.1037/0278-6133.26.4.418,181,199,AIDS_Behav_2012_Jan_11_16(1)_159-167.txt
3.25.1.74,... J Health Psychol 2006 25 1 74 81 10.1037/0278-6133.25.1.74,183,217,AIDS_Behav_2012_Jan_11_16(1)_159-167.txt
3.24.6.617,... Health Psychol 2005 24 6 617 622 10.1037/0278-6133.24.6.617 16287408,214,157,AIDS_Behav_2012_Jan_11_16(1)_159-167.txt
3.19.2.124,... J Health Psychol 2000 19 124 133 10.1037/0278-6133.19.2.124,216,222,AIDS_Behav_2012_Jan_11_16(1)_159-167.txt
3.12.3.215,... J Health Psychol 1993 12 215 219 10.1037/0278-6133.12.3.215,217,233,AIDS_Behav_2012_Jan_11_16(1)_159-167.txt
3.26.4.488,... Health Psychol 2007 26 4 488 495 10.1037/0278-6133.26.4.488 17605569,168,264,AIDS_Behav_2012_Jul_25_16(5)_1308-1315.txt
3.25.5.595,...s Health Psycho 2006 25 5 595 603 10.1037/0278-6133.25.5.595,215,279,AIDS_Behav_2012_May_23_16(4)_934-942.txt
3.26.2.146,... Health Psychol 2007 26 2 146 151 10.1037/0278-6133.26.2.146 17385965,144,189,AIDS_Behav_2012_May_22_16(4)_1075-1083.txt
2.49.1.11,...pulations Soc Probl 2002 49 1 11 34 10.1525/sp.2002.49.1.11,976,177,AIDS_Behav_2012_May_15_16(4)_797-806.txt
5.17.6.568,... AIDS Educ Prev 2005 17 6 568 589 10.1521/aeap.2005.17.6.568 16398578,178,195,AIDS_Behav_2012_Oct_15_16(7)_1753-1760.txt
6.7.2.135,...Opin Pharmacother 2006 7 2 135 143 10.1517/14656566.7.2.135 16433579,302,179,AIDS_Behav_2013_Jan_20_17(1)_181-192.txt
3.17.3.269,... Health Psychol 1998 17 3 269 276 10.1037/0278-6133.17.3.269 9619477,326,182,AIDS_Behav_2013_Jan_20_17(1)_181-192.txt
1.1.3.86,...thods Behav Soc Sci 2005 13 86 92 10.1027/1614-2241.1.3.86,366,145,AIDS_Behav_2013_Jun_4_17(5)_1645-1654.txt
3.27.1.4,...ing Health Psychol 2008 27 1 4 14 10.1037/0278-6133.27.1.4 18230008,243,230,AIDS_Behav_2013_Jun_9_17(5)_1612-1625.txt
3.27.2.129,... Health Psychol 2008 27 2 129 139 10.1037/0278-6133.27.2.129 18377131,246,220,AIDS_Behav_2013_Jun_9_17(5)_1612-1625.txt
3.22.4.332,... Health Psychol 2003 22 4 332 339 10.1037/0278-6133.22.4.332 12940388,201,179,AIDS_Behav_2013_Jul_11_17(6)_2075-2083.txt
4.7.53.238,...S Educ Prev 2002 14 5 Suppl B 53 64 10.1521/aeap.14.7.53.23865 12413193,188,179,AIDS_Behav_2013_May_4_17(8)_2695-2702.txt
6.7.6.665,...pin Pharmacother. 2006 7 6 665 675 10.1517/14656566.7.6.665 16556084,253,165,AIDS_Behav_2013_Jun_26_17(9)_3108-3119.txt
2.24.5.408,... AIDS Educ Prev 2012 24 5 408 421 10.1521/aeap.2012.24.5.408 23016502,288,220,AIDS_Behav_2014_Jul_30_18(2)_195-216.txt
3.22.4.332,... Health Psychol 2003 22 4 332 339 10.1037/0278-6133.22.4.332 12940388,241,179,AIDS_Behav_2014_Aug_22_18(3)_464-472.txt
1.23.5.397,... AIDS Educ Prev 2011 23 5 397 411 10.1521/aeap.2011.23.5.397 22010804,246,203,AIDS_Behav_2014_Aug_22_18(3)_464-472.txt
3.22.2.166,...Health Psychol. 2003 22 2 166 177 10.1037/0278-6133.22.2.166 12683737,657,233,AIDS_Behav_2014_Jan_19_18(5)_885-904.txt
2.49.1.11,...populations Soc Probl 2002 49 11 34 10.1525/sp.2002.49.1.11,333,176,AIDS_Behav_2015_Sep_19_19(2)_393-404.txt
2.49.1.11,...pulations Soc Probl 2002 49 1 11 34 10.1525/sp.2002.49.1.11,327,179,AIDS_Behav_2015_Nov_15_19(Suppl_1)_24-35.txt
3.22.4.332,... Health Psychol 2003 22 4 332 339 10.1037/0278-6133.22.4.332 12940388,355,179,AIDS_Behav_2015_Nov_15_19(Suppl_1)_24-35.txt
5.1.5.39,...duc Prev 2003 15 Supplement A 39 52 10.1521/aeap.15.1.5.39.23613 12630598,520,288,AIDS_Behav_2015_Aug_1_19(6)_996-1004.txt
2.49.1.11,...populations Soc Probl 2002 49 11 34 10.1525/sp.2002.49.1.11,535,176,AIDS_Behav_2015_Aug_1_19(6)_996-1004.txt
5.1.5.53,...duc Prev 2003 15 Supplement A 53 65 10.1521/aeap.15.1.5.53.23609 12630599,548,244,AIDS_Behav_2015_Aug_1_19(6)_996-1004.txt
4.51.6.117,...s Soc Psychol 1986 51 6 1173 1182 10.1037/0022-3514.51.6.1173 3806354,250,212,AIDS_Behav_2015_Dec_2_19(7)_1247-1262.txt
3.20.5.369,... Health Psychol 2001 20 5 369 376 10.1037/0278-6133.20.5.369 11570651,267,255,AIDS_Behav_2015_Dec_2_19(7)_1247-1262.txt
6.18.6.546,... AIDS Educ Prev 2006 18 6 546 559 10.1521/aeap.2006.18.6.546 17166080,373,260,AIDS_Behav_2015_Mar_3_19(9)_1720-1734.txt
4.1.29.243,...dren AIDS Educ Prev 2002 14 1 29 40 10.1521/aeap.14.1.29.24332 11900108,377,244,AIDS_Behav_2015_Mar_3_19(9)_1720-1734.txt
3.25.1.25,...en AIDS Educ Prev 2013 25 1 25 37 10.1521/aeap.2013.25.1.25 2338794,427,224,AIDS_Behav_2015_Mar_3_19(9)_1720-1734.txt
1.6.8.1,...edian price (IQR) MSM $ 6.5 (3.0.11.3) FSW $ 4.8 (1.6.8.1)	9.3 % paid < $ 8 1.2 % paid > $ 50 	Media...,136,77,AIDS_Behav_2015_Jun_9_19(11)_1949-1965.txt
4.51.6.117,...s Soc Psychol 1986 51 6 1173 1182 10.1037/0022-3514.51.6.1173 3806354,268,213,AIDS_Behav_2016_Aug_19_20_776-787.txt
2.24.2.148,... AIDS Educ Prev 2012 24 2 148 162 10.1521/aeap.2012.24.2.148 22468975,2181,200,AIDS_Behav_2016_Nov_13_20_880-918.txt
2.24.6.574,... AIDS Educ Prev 2012 24 6 574 581 10.1521/aeap.2012.24.6.574 23206205,2186,245,AIDS_Behav_2016_Nov_13_20_880-918.txt
3.7.4.355,...s Health Psychol 1988 7 4 355 386 10.1037/0278-6133.7.4.355 3049068,2251,101,AIDS_Behav_2016_Nov_13_20_880-918.txt
5.56.1.179,...ppeals Psychol Rep 1985 56 179 182 10.2466/pr0.1985.56.1.179,2253,121,AIDS_Behav_2016_Nov_13_20_880-918.txt
3.13.6.548,... Health Psychol 1994 13 6 548 555 10.1037/0278-6133.13.6.548 7889910,2256,195,AIDS_Behav_2016_Nov_13_20_880-918.txt
4.66.4.742,... J Pers Soc Psychol 1994 66 4 742 10.1037/0022-3514.66.4.742,2289,200,AIDS_Behav_2016_Nov_13_20_880-918.txt
3.10.6.432,...vior Health Psychol 1991 10 6 432 10.1037/0278-6133.10.6.432 1765039,2298,179,AIDS_Behav_2016_Nov_13_20_880-918.txt
3.16.5.468,...STDs Health Psychol 1997 16 5 468 10.1037/0278-6133.16.5.468 9302544,2299,228,AIDS_Behav_2016_Nov_13_20_880-918.txt
5.1.81.238,...th men AIDS Educ Prev 2003 15 81 92 10.1521/aeap.15.1.81.23842 12627745,331,199,AIDS_Behav_2016_Jun_16_20_1478-1488.txt
3.20.4.291,... Health Psychol 2001 20 4 291 299 10.1037/0278-6133.20.4.291 11515741,123,168,AIDS_Behav_2011_Feb_7_15(2)_499-506.txt
2.49.1.11,...pulations Soc Probl 2002 49 1 11 34 10.1525/sp.2002.49.1.11,152,177,AIDS_Behav_2011_Feb_7_15(2)_499-506.txt
4.51.6.117,...ers Soc Psych 1986 51 6 1173 1182 10.1037/0022-3514.51.6.1173,211,209,AIDS_Behav_2012_Aug_25_16(6)_1681-1689.txt
3.19.2.134,... Health Psychol 2000 19 2 134 145 10.1037/0278-6133.19.2.134 10762097,381,244,AIDS_Behav_2016_Mar_9_20(12)_2812-2826.txt
3.16.30.187,...igeria Pan Afr Med J. 2013 16 30 10.11604/pamj.2013.16.30.1877 24570791,369,168,PMC5288435.txt
3.25.1.14,...frica AIDS Educ Prev 2013 25 1 14 10.1521/aeap.2013.25.1.14 23387948,214,190,PMC5288443.txt
3.25.1.74,...py Health Psychol 2006 25 1 74 81 10.1037/0278-6133.25.1.74 16448300,372,217,PMC5288444.txt
3.23.4.413,... Health Psychol 2004 23 4 413 418 10.1037/0278-6133.23.4.413 15264978,374,237,PMC5288444.txt
3.25.4.462,... Health Psychol 2006 24 4 462 473 10.1037/0278-6133.25.4.462,377,187,PMC5288444.txt
3.23.2.207,... Health Psychol 2004 23 2 207 218 10.1037/0278-6133.23.2.207 15008666,389,143,PMC5288444.txt
4.26.1.13,...n and Prevention. 2014 26 1 13 27 10.1521/aeap.2014.26.1.13 24450275,263,176,PMC5306183.txt
3.24.2.198,... Health Psychol 2005 24 2 198 208 10.1037/0278-6133.24.2.198 15755234,251,225,PMC5136346.txt
3.21.2.177,... Health Psychol 2002 21 2 177 186 10.1037/0278-6133.21.2.177 11950108,254,224,PMC5136346.txt
3.15.2.114,... Health Psychol 1996 15 2 114 123 10.1037/0278-6133.15.2.114 8681919,279,279,PMC5136346.txt
3.20.4.281,... Health Psychol 2001 20 4 281 290 10.1037/0278-6133.20.4.281 11515740,280,252,PMC5136346.txt
3.13.3.238,... Health Psychol 1994 13 3 238 250 10.1037/0278-6133.13.3.238 805585,294,248,PMC5136346.txt
4.68.4.671,...cial Psychology 1995 68 4 671 686 10.1037/0022-3514.68.4.671,95,228,AIDS_Care_2014_May_10_26(5)_582-586.txt
4.4.27.238,...cation and Prevention 2002 14 27 37 10.1521/aeap.14.4.27.23886 12092934,246,282,AIDS_Care_2013_Jun_9_25(Suppl_1)_S7-S19.txt
1.23.4.367,...Education and Prevention  367 381 10.1521/aeap.2011.23.4.367 21966746,173,248,AIDS_Care_2014_Dec_2_26(12)_155517-1561.txt
4.51.6.117,... and Social Psychology  1173 1182 10.1037/0022-3514.51.6.1173 3806354,172,237,AIDS_Care_2015_Nov_2_27(sup1)_284-35.txt
1.23.4.382,...Education and Prevention  382 392 10.1521/aeap.2011.23.4.382 21861610,330,249,AIDS_Care_2015_Nov_2_27(sup1)_365-46.txt
4.57.4.723,...ty and Social Psychology  723 730 10.1037/0022-3514.57.4.723 2795439,312,218,AIDS_Care_2015_Nov_2_27(sup1)_183-27.txt
3.12.3.215,...ection Health Psychology  215 219 10.1037/0278-6133.12.3.215 8500451,324,305,AIDS_Care_2015_Nov_2_27(sup1)_183-27.txt
1.93.3.693,...rceptual and Motor Skills  693 703 10.2466/pms.2001.93.3.693 11806588,337,243,AIDS_Care_2015_Nov_2_27(sup1)_183-27.txt
6.18.1.56,...S Education and Prevention  56 67 10.1521/aeap.2006.18.1.56 16539576,224,224,AIDS_Care_2015_Nov_2_27(sup1)_9011-98.txt
1.23.4.382,...Education and Prevention  382 392 10.1521/aeap.2011.23.4.382 21861610,252,246,AIDS_Care_2015_Nov_2_27(sup1)_9011-98.txt
3.25.4.462,...rapy Health Psychology  4 462 473 10.1037/0278-6133.25.4.462 16846321,275,196,AIDS_Care_2016_Mar_24_28(sup1)_6813-75.txt
4.89.4.623,... and Social Psychology  4 623 642 10.1037/0022-3514.89.4.623 16287423,241,258,AIDS_Care_2016_Mar_24_28(sup1)_164-25.txt
5.17.4.386,...Education and Prevention  386 399 10.1521/aeap.2005.17.4.386 16178707,100,190,AIDS_Care_2016_Mar_24_28(sup1)_11119-113.txt
4.26.6.521,...ucation and Prevention  6 521 537 10.1521/aeap.2014.26.6.521 25490733,233,171,AIDS_Care_2016_Mar_24_28(sup1)_12422-131.txt
2.31.2.123,...nd Clinical Psychology  2 123 150 10.1521/jscp.2012.31.2.123 22611302,261,239,AIDS_Care_2016_Mar_24_28(sup1)_12422-131.txt
3.17.4.423,...al Anthropology Quarterly  423 441 10.1525/maq.2003.17.4.423,209,163,AIDS_Care_2016_Mar_24_28(sup1)_8415-91.txt
4.51.6.117,...nd Social Psychology  6 1173 1182 10.1037/0022-3514.51.6.1173 3806354,126,239,AIDS_Care_2016_Mar_24_28(sup1)_9917-105.txt
4.91.4.730,... and Social Psychology  4 730 749 10.1037/0022-3514.91.4.730 17014296,156,232,AIDS_Care_2016_Mar_24_28(sup1)_9917-105.txt
2.49.1.11,...opulations Social Problems  1 11 34 10.1525/sp.2002.49.1.11,202,181,AIDS_Care_2016_Mar_24_28(sup1)_14024-147.txt
5.1.81.238,...S Education and Prevention  1 81 92 10.1521/aeap.15.1.81.23842 12627745,215,214,AIDS_Care_2016_Mar_24_28(sup1)_14024-147.txt
3.25.6.468,...ucation and Prevention  6 468 479 10.1521/aeap.2013.25.6.468 24245594,365,272,AIDS_Care_2016_Jul_2_28(7)_8577-865.txt
4.51.6.117,...nd Social Psychology  6 1173 1182 10.1037/0022-3514.51.6.1173 3806354,142,241,AIDS_Care_2016_May_26_28(sup2)_16120-167.txt
4.54.6.106,...nd Social Psychology  6 1063 1070 10.1037/0022-3514.54.6.1063 3397865,172,213,AIDS_Care_2016_May_26_28(sup2)_16120-167.txt
3.5.6.503,...ples Health Psychology  6 503 529 10.1037/0278-6133.5.6.503 3492372,174,160,AIDS_Care_2016_May_26_28(sup2)_16120-167.txt
5.1.49.238,...ned? AIDS Education and Prevention  10.1521/aeap.15.1.49.23844,184,154,AIDS_Care_2016_May_26_28(sup2)_346-41.txt
3.25.4.462,...chological Association  4 462 473 10.1037/0278-6133.25.4.462,190,288,AIDS_Care_2016_May_26_28(sup2)_346-41.txt
3.25.4.462,...chological Association  4 462 473 10.1037/0278-6133.25.4.462,170,288,AIDS_Care_2016_May_26_28(sup2)_609-65.txt
4.4.1.1,"...ase. Search results were imported into Scaffold (v4.4.1.1; Proteome Software, Portland, OR) to filte...",28,814,AIDS_Res_Hum_Retroviruses_2016_Nov_1_32(10-11)_1005-1015.txt
2.2.5.717,...Infec Ther 2006 2 717 132 15482235 10.1586/14789072.2.5.717,149,152,AIDS_Res_Ther_2006_Oct_23_3_28.txt
4.10.8.144,...g Drugs 2001 10 1443 1456 11772261 10.1517/13543784.10.8.1443,126,155,AIDS_Res_Ther_2007_Jun_27_4_14.txt
4.10.8.144,...g Drugs 2001 10 1443 1456 11772261 10.1517/13543784.10.8.1443,171,155,AIDS_Res_Ther_2007_Jul_16_4_16.txt
2.10.1.87,...er Targets 2006 10 87 118 16441231 10.1517/14728222.10.1.87,143,214,AIDS_Res_Ther_2008_Dec_22_5_25.txt
3.6.10.660,...tory of HIV/AIDS Medicine 2005 33 6 10.1383/medc.33.6.10.66008,227,86,AIDS_Res_Ther_2009_Apr_28_6_7.txt
4.1.6.717,...bitors Future Virol 2006 1 717 731 10.2217/17460794.1.6.71,169,127,AIDS_Res_Ther_2009_Jun_29_6_14.txt
4.15.5.541,...tig Drugs 2006 15 541 552 16634692 10.1517/13543784.15.5.541,109,192,AIDS_Res_Ther_2009_Aug_21_6_19.txt
4.11.8.107,...n Investig Drugs 2002 11 1077 1097 10.1517/13543784.11.8.1077 12150703,155,168,AIDS_Res_Ther_2009_Nov_5_6_23.txt
4.10.10.181,...nvestig Drugs 2001 10 10 1819 1830 10.1517/13543784.10.10.1819 11772288,113,183,AIDS_Res_Ther_2009_Nov_19_6_25.txt
4.14.4.457,...pin Investig Drugs 2005 14 457 477 10.1517/13543784.14.4.457 15882121,175,178,AIDS_Res_Ther_2010_Mar_24_7_7.txt
6.8.6.547,...ro Pharmacogenomics 2007 8 547 558 10.2217/14622416.8.6.547 17559344,198,196,AIDS_Res_Ther_2010_Mar_26_7_8.txt
6.1.3.11,...Human Research Ethics 2006 1 11 26 10.1525/jer.2006.1.3.11 19385819,305,221,AIDS_Res_Ther_2010_Apr_23_7_10.txt
6.8.5.679,...t Opin Pharmacother 2007 8 679 688 10.1517/14656566.8.5.679 17376022,126,254,AIDS_Res_Ther_2010_Jun_23_7_18.txt
6.8.5.679,...t Opin Pharmacother 2007 8 679 688 10.1517/14656566.8.5.679 17376022,145,254,AIDS_Res_Ther_2010_May_26_7_13.txt
6.1.19.277,...tion and Prevention 2004 16 1 19 30 10.1521/aeap.16.1.19.27721 15058708,211,232,AIDS_Res_Ther_2010_Jun_17_7_17.txt
5.3.3.347,...rug Metab Toxicol 2007 3 3 347 361 10.1517/17425255.3.3.347 17539743,114,247,AIDS_Res_Ther_2010_Jul_28_7_27.txt
3.23.2.207,...s Health Psychol 2004 23 2 207 18 10.1037/0278-6133.23.2.207 15008666,383,136,AIDS_Res_Ther_2010_Oct_30_7_39.txt
3.1.29.319,...ction Pharmacotherapy 2003 23 29 43 10.1592/phco.23.1.29.31915 12523458,121,172,AIDS_Res_Ther_2010_Oct_11_7_37.txt
4.15.12.150,...n Investig Drugs 2006 15 1507 1522 10.1517/13543784.15.12.1507 17107277,169,155,AIDS_Res_Ther_2010_Dec_14_7_44.txt
2.8.3.121,...dicitis Swiss Surg 2002 8 121 122 10.1024/1023-9332.8.3.121 1212533,156,118,AIDS_Res_Ther_2010_Dec_29_7_47.txt
3.4.7.2,5.1	3.4.7.2.9	89	48	-	-	54	15	-	-	91	53	-	-	58	15	-	-,74,5,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.4.7.2,5.2b	3.4.7.2.0	n/a	n/a	-	-	n/a	n/a	-	-	94	57	-	-	57	23	...,75,6,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.9.2,5.3	3.8.9.2.7	92	49	-	-	40	13	-	-	94	54	-	-	41	15	-	-,76,5,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.5.9,5.4b	3.8.5.9.0	n/a	n/a	-	-	n/a	n/a	-	-	95	64	-	-	58	20	...,77,6,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.5.2,5.5	3.8.5.2.9	92	53	-	-	48	12	-	-	94	59	-	-	54	13	-	-,78,5,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.5.2,5.6b	3.8.5.2.1	n/a	n/a	-	-	n/a	n/a	-	-	97	65	-	-	53	10	...,79,6,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.4.7.2,6.2b	3.4.7.2.0.5	n/a	n/a	n/a	-	n/a	n/a	n/a	-	100	89	51	...,80,6,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.9.2,6.3	3.8.9.2.7.6	100	86	46	-	65	26	4	-	99	89	49	-	67	23...,81,5,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.5.9,6.4b	3.8.5.9.0.6	n/a	n/a	n/a	-	n/a	n/a	n/a	-	100	88	60	...,82,6,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.5.2,6.5b	3.8.5.2.9.0	n/a	n/a	n/a	-	n/a	n/a	n/a	-	99	94	58	-...,83,6,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.5.2,6.6	3.8.5.2.9.7	99	87	43	-	68	31	9	-	98	92	47	-	73	34	...,84,5,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.5.2,6.7b	3.8.5.2.1.7	n/a	n/a	n/a	-	n/a	n/a	n/a	-	100	94	53	...,85,6,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.4.7.2,6.8b	3.4.7.2.0.6	n/a	n/a	n/a	-	n/a	n/a	n/a	-	99	88	52	-...,86,6,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.4.7.2,6.9	3.4.7.2.9.5	98	84	43	-	75	45	9	-	98	87	47	-	79	50	...,87,5,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.9.2,7.3b	3.8.9.2.7.6.0	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	100	...,88,6,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.5.2,7.5	3.8.5.2.9.7.6	100	99	81	41	84	56	18	3	100	98	84	44...,89,5,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.4.7.2,7.7	3.4.7.2.9.5.6	100	96	80	40	86	64	31	3	100	94	83	43...,90,5,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.4.7.2,"...reporter used (C). For example, combinations 6.2 (3.4.7.2.0.5), 6.8 (3.4.7.2.0.6) and 6.9 (3.4.7.2.9...",113,892,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.4.7.2,"...For example, combinations 6.2 (3.4.7.2.0.5), 6.8 (3.4.7.2.0.6) and 6.9 (3.4.7.2.9.5) in position 2 w...",113,911,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.4.7.2,"...ons 6.2 (3.4.7.2.0.5), 6.8 (3.4.7.2.0.6) and 6.9 (3.4.7.2.9.5) in position 2 were assayed with the P...",113,933,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.9.2,"...rter (matched to shRNA #4), and combinations 6.3 (3.8.9.2.7.6) - 6.7 (3.8.5.2.1.7) were assayed with...",113,1045,AIDS_Res_Ther_2011_Jan_13_8_1.txt
3.8.5.2,"...NA #4), and combinations 6.3 (3.8.9.2.7.6) - 6.7 (3.8.5.2.1.7) were assayed with the Vpu reporter (m...",113,1065,AIDS_Res_Ther_2011_Jan_13_8_1.txt
6.8.5.679,...t Opin Pharmacother 2007 7 679 688 10.1517/14656566.8.5.679 17376022,94,223,AIDS_Res_Ther_2010_Jul_14_7_23.txt
1.46.4.253,...a Korean J Hematol 2011 11 253 257 10.5045/kjh.2011.46.4.253 22259631,35,264,AIDS_Res_Ther_2014_Feb_7_11_11.txt
3.1.29.319,...ction Pharmacotherapy 2003 23 29 43 10.1592/phco.23.1.29.31915 12523458,198,180,AIDS_Res_Ther_2014_Nov_10_11_35.txt
3.33.6.420,...boratory Medicine. 2013 33 420 425 10.3343/alm.2013.33.6.420 24205491,97,221,AIDS_Res_Ther_2016_Jan_5_13_1.txt
2.6.2.235,...f Ghana Gut Liver 2012 6 2 235 240 10.5009/gnl.2012.6.2.235 22570754,175,235,AIDS_Res_Ther_2016_May_17_13_23.txt
4.26.5.429,... AIDS Educ Prev 2014 26 5 429 444 10.1521/aeap.2014.26.5.429 25299807,144,317,AIDS_Res_Ther_2016_Nov_8_13_35.txt
4.26.6.521,... AIDS Educ Prev 2014 26 6 521 537 10.1521/aeap.2014.26.6.521 25490733,151,160,AIDS_Res_Ther_2016_Nov_8_13_35.txt
2.3.1.4,"...nalyzed using DNASTAR Lasergene Software Suite v.12.3.1.4 (Madison, WI)",123,242,PMC5359922.txt
2.3.1.4,"... SeqMan NGen (DNASTAR Lasergene Software Suite v.12.3.1.4), and the assemblies analyzed using SeqMan...",129,157,PMC5359922.txt
2.3.1.4,...g SeqMan Pro (DNASTAR Lasergene Software Suite v.12.3.1.4). Full-length HIV-1 consensus sequences we...,129,249,PMC5359922.txt
4.26.6.521,...and Prevention  2014 26 6 521 537 10.1521/aeap.2014.26.6.521 2-s2.0-84925883405 25490733,299,177,AIDS_Res_Treat_2016_Aug_16_2016_9510172.txt
3.14.10.137,"...cal Journal  2013 14, article 10 10.11604/pamj.2013.14.10.1373",361,271,AIDS_Res_Treat_2014_Nov_13_2014_731848.txt
4.17.88.326,"...7, article 88 2-s2.0-84893700218 10.11604/pamj.2014.17.88.3262",279,285,AIDS_Res_Treat_2015_Mar_4_2015_148769.txt
3.22.2.223,...lth Psychology  2003 22 2 223 228 10.1037/0278-6133.22.2.223 2-s2.0-0037336043 12683743,312,238,AIDS_Res_Treat_2015_Dec_1_2015_879052.txt
3.21.2.177,...th Psychology  2002 21 2 177 186 10.1037//0278-6133.21.2.177 2-s2.0-0036194302 11950108,314,240,AIDS_Res_Treat_2015_Dec_1_2015_879052.txt
2.31.2.123,...cal Psychology  2012 31 2 123 150 10.1521/jscp.2012.31.2.123 2-s2.0-8486588421,273,242,AIDS_Res_Treat_2016_Mar_8_2016_5323256.txt
4.48.1.150,...ial Psychology  1985 48 1 150 170 10.1037/0022-3514.48.1.150 2-s2.0-0021775234 2980281,258,221,AIDS_Res_Treat_2016_Mar_17_2016_3015468.txt
4.61.6.102,...l Psychology  1991 61 6 1028 1039 10.1037/0022-3514.61.6.1028 2-s2.0-0026263751 1774625,263,229,AIDS_Res_Treat_2016_Mar_17_2016_3015468.txt
3.25.3.179,...and Prevention  2013 25 3 179 189 10.1521/aeap.2013.25.3.179 2-s2.0-84879311217 23631713,280,232,AIDS_Res_Treat_2016_Jun_2_2016_5015707.txt
3.22.5.533,...lth Psychology  2003 22 5 533 540 10.1037/0278-6133.22.5.533 2-s2.0-0141919709 14570537,281,232,AIDS_Res_Treat_2016_Jun_2_2016_5015707.txt
6.8.8.113,...harmacotherapy  2007 8 8 1137 1145 10.1517/14656566.8.8.1137 2-s2.0-34250682204 17516877,136,97,AIDS_Res_Treat_2015_Oct_13_2015_570316.txt
4.18.1.460,... Medical Journal  2014 18 1 10.11604/pamj.supp.2014.18.1.4608,278,212,PMC5346378.txt
2.3.4.5,"...specific and UV detection (Pinheiro et al. 2004), 2.3.4.5.6-PENTAFLUOROBENZYLHYDROXYLAMINE derivatiz...",15,277,Air_Qual_Atmos_Health_2010_Oct_21_4(3-4)_211-220.txt
1.26.2.166,... Korean Med Sci 2011 26 2 166 173 10.3346/jkms.2011.26.2.166 21286005,159,204,Air_Qual_Atmos_Health_2014_May_10_7(4)_459-466.txt
1.3.8.2,"...l of Air quality and Chemistry (GEM-MACH) version 1.3.8.2, has been used to produce the “first-guess...",37,156,Air_Qual_Atmos_Health_2016_Jan_7_9(7)_743-759.txt
2.7.3.15,...n Human Research Ethics  7 3 15 28 10.1525/jer.2012.7.3.15 22850140,288,175,AJOB_Empir_Bioeth_2016_Jan_2_7(1)_315-38.txt
3.22.1.79,... Health Psychol 2003 22 79 87 doi:10.1037/0278-6133.22.1.79  12558205,261,184,Alcohol_Alcohol_2012_Mar_2_47(2)_169-177.txt
EC 1.2.1.3,"...rial low km form of aldehyde dehydrogenase (ALDH: EC 1.2.1.3). Of these, 3-hydroxykynurenine (3-HK),...",18,272,Alcohol_Alcohol_2016_Jan_29_51(1)_20-26.txt
6.3.1.131,...cogenomics 2002 3 131 144 11966409 10.1517/14622416.3.1.131,140,127,Algorithms_Mol_Biol_2006_Apr_19_1_6.txt
3.25.3.5,"200	3.25.3.5, 4, 7, ∞	3.75, 4, 4.25, 4.5, 5, 8, ∞	4.75...",384,5,Algorithms_Mol_Biol_2007_Jul_11_2_9.txt
3.25.3.5,"300	3.25.3.5, 4, 7, ∞	3.75, 4, 4.25, 4.5, 5, 8, ∞	4.75...",385,5,Algorithms_Mol_Biol_2007_Jul_11_2_9.txt
3.25.3.5,"400	3.25.3.5, 3.75, 4, 4.25, 5, 8,∞	3.75, 4, 4.25, 4.5...",386,5,Algorithms_Mol_Biol_2007_Jul_11_2_9.txt
6.1.1.15,...macogenomics 2000 1 15 26 11258593 10.1517/14622416.1.1.15,234,144,Algorithms_Mol_Biol_2009_Aug_11_4_11.txt
6.2.1.11,...macogenomics 2001 2 11 24 11258193 10.1517/14622416.2.1.11,235,146,Algorithms_Mol_Biol_2009_Aug_11_4_11.txt
5.1.93.151,...urnal on Computing 2003 15 1 93 113 10.1287/ijoc.15.1.93.15155,277,101,Algorithms_Mol_Biol_2009_Dec_30_4_16.txt
4.6.2.181,...ural Computation 1994 6 2 181 214 10.1162/neco.1994.6.2.181,235,125,Algorithms_Mol_Biol_2010_Jan_4_5_10.txt
4.7.9.143,...in Investig Drugs 1998 7 1439 1452 10.1517/13543784.7.9.1439 15992042,138,154,Algorithms_Mol_Biol_2011_May_31_6_14.txt
1.1.85.419,...http://citeseerx.ist.psu.edu/viewdoc/summary?] 10.1.1.85.4196,269,263,Algorithms_Mol_Biol_2013_Jul_5_8_17.txt
3.2.2.15,...ysis was performed using the metafor package in R 3.2.2.15 Proportions were used as the measure of e...,126,60,Aliment_Pharmacol_Ther_2016_Apr_19_43(8)_910-923.txt
3.39.6.799,...Drugs Today (Barc) 2003 39 451 468 10.1358/dot.2003.39.6.799450 12944997,378,277,Allergo_J_Int_2014_May_9_23(3)_87-95.txt
6.7.14.198,...Opin Pharmacother 2006 7 1989 2001 10.1517/14656566.7.14.1989 17020424,419,160,Allergo_J_Int_2014_May_9_23(3)_87-95.txt
5.15.2.73,...gy Clin Immunol Int 2003 15 73 78 10.1027/0838-1925.15.2.73,156,151,Allergo_J_Int_2014_Feb_19_23(1)_17-23.txt
4.2.3.1,4.2.3.1. Grass polle,273,1,Allergo_J_Int_2014_Dec_23_23(8)_282-319.txt
4.2.3.2,4.2.3.2. Tree polle,276,1,Allergo_J_Int_2014_Dec_23_23(8)_282-319.txt
4.2.3.3,4.2.3.3. House dust mite,279,1,Allergo_J_Int_2014_Dec_23_23(8)_282-319.txt
4.2.3.4,4.2.3.4. Animal allergen,284,1,Allergo_J_Int_2014_Dec_23_23(8)_282-319.txt
4.2.3.5,4.2.3.5. Other allergen source,287,1,Allergo_J_Int_2014_Dec_23_23(8)_282-319.txt
4.3.3.1,4.3.3.1. Grass polle,322,1,Allergo_J_Int_2014_Dec_23_23(8)_282-319.txt
4.3.3.2,4.3.3.2. Tree polle,329,1,Allergo_J_Int_2014_Dec_23_23(8)_282-319.txt
4.3.3.3,4.3.3.3. House dust mite,334,1,Allergo_J_Int_2014_Dec_23_23(8)_282-319.txt
4.3.3.4,4.3.3.4. Efficacy of SLIT with other allergen extr...,341,1,Allergo_J_Int_2014_Dec_23_23(8)_282-319.txt
2.4.5.264,...y Asthma Immunol Res 2012 4 264 9 10.4168/aair.2012.4.5.264 22950031,333,118,Allergo_J_Int_2014_Sep_29_23(6)_172-178.txt
4.2.1.1,4.2.1.1. Indication for IgE determinatio,461,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
4.2.1.2,4.2.1.2. Definitions and concepts for allergen sel...,490,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
4.2.1.3,4.2.1.3. Foodstuffs as allergen sources and their ...,632,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
4.2.1.4,4.2.1.4. Important plant protein families and thei...,635,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
4.2.1.4,4.2.1.4.1. Other allergens in plant derived food,775,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
4.2.1.5,4.2.1.5. Common animal food allergen,782,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
4.2.1.6,4.2.1.6. Interpreting serological IgE diagnostic m...,801,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
4.4.1.1,4.4.1.1. Use of therapeutic infant formula during ...,942,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
4.4.2.1,4.4.2.1. Decision-making criteria and influencing ...,948,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
4.4.2.2,4.4.2.2. Performing and interpreting oral food cha...,977,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
4.4.2.3,4.4.2.3. Safety aspect,1010,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
5.2.1.1,5.2.1.1. Core question,1083,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
5.2.1.2,5.2.1.2. Treatment of IgE-mediated food allergie,1088,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
5.2.1.3,5.2.1.3. Treatment of acute reaction,1097,1,Allergo_J_Int_2015_Nov_7_24_256-293.txt
5.5.1.3,...Asia Pac Allergy 2015 5 3 16 10.5415/apallergy.2015.5.1.3 25653915,146,156,Allergo_J_Int_2016_Mar_23_25_55-62.txt
6.6.8.134,...t Opin Pharmacother 2005 6 1349 71 10.1517/14656566.6.8.1349 16013985,289,107,Allergo_J_Int_2015_Mar_14_24(2)_58-66.txt
4.50.1.31,... Marken Diagnostica 2004 50 31 38 10.1026/0012-1924.50.1.31,185,123,PMC5288410.txt
5.77.2.475,...format Psychol Rep 1995 77 475 480 10.2466/pr0.1995.77.2.475 8559872,194,207,PMC5288410.txt
1.2.1.1,"...r the Seventh Framework Programme, Topic ENV.2007.1.2.1.1. ‘Indoor air pollution in Europe: An emerg...",179,495,Allergy_2014_Aug_13_69(8)_1092-1101.txt
2.5.3.1,...racted using in-house developed software Quanti v 2.5.3.1 11. For quantitative purposes only reliabl...,120,83,Allergy_2014_Jan_11_69(1)_104-112.txt
2.5.3.1,...uded from the analysis. The results from Quanti v 2.5.3.1 are reported as a set of relative protein ...,120,618,Allergy_2014_Jan_11_69(1)_104-112.txt
6.8.13.208,... Opin Pharmacother 2007 8 2089 107 10.1517/14656566.8.13.2089 17714062,226,152,Allergy_Asthma_Clin_Immunol_2009_Oct_22_5(1)_4.txt
6.9.5.859,... Opin Pharmacother 2008 9 5 859 67 10.1517/14656566.9.5.859 18345961,47,150,Allergy_Asthma_Clin_Immunol_2009_Dec_17_5(1)_14.txt
3.21.6.531,...del Health Psychol 2002 21 531 41 10.1037/0278-6133.21.6.531 12433005,135,184,Allergy_Asthma_Clin_Immunol_2008_Mar_15_4(1)_29-36.txt
EC 3.4.14.5,"... a selective dipeptidylpeptidase-4 (DPP IV, CD26, EC 3.4.14.5) inhibitor indicated for the treatment...",6,65,Allergy_Asthma_Clin_Immunol_2010_May_12_6(1)_8.txt
5.19.1.35,...lin Allergy Immunol 2007 19 35 53 10.1027/0838-1925.19.1.35 17153006,159,163,Allergy_Asthma_Clin_Immunol_2010_May_12_6(1)_8.txt
4.91.9.353,...in old age Praxis 2002 91 9 353 8 10.1024/0369-8394.91.9.353 11902099,279,76,Allergy_Asthma_Clin_Immunol_2010_May_13_6(1)_10.txt
3.2.1.1,3.2.1.1. 'Classical' short-term prophylaxi,67,1,Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_18.txt
3.2.1.2,3.2.1.2. 'Alternative' short-term prophylaxi,72,1,Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_18.txt
4.15.9.107,...n Investig Drugs 2006 15 1077 1090 10.1517/13543784.15.9.1077 16916274,179,169,Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_18.txt
6.2.7.107,...Opin Pharmacother 2001 2 1073 1083 10.1517/14656566.2.7.1073 11583058,155,152,Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_23.txt
4.17.5.697,...pin Investig Drugs 2008 17 697 706 10.1517/13543784.17.5.697 18447596,187,140,Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_23.txt
6.9.13.238,...Opin Pharmacother 2008 9 2383 2390 10.1517/14656566.9.13.2383 18710362,200,130,Allergy_Asthma_Clin_Immunol_2010_Jul_28_6(1)_23.txt
4.17.12.160,... Endocrinol Metab 2004 17 1607 12 10.1515/JPEM.2004.17.12.1607 15645694,298,144,Allergy_Asthma_Clin_Immunol_2011_Aug_25_7(1)_13.txt
6.21.6.110,...dical Science 2006 21 6 1108 1110 10.3346/jkms.2006.21.6.1108 17179696,118,218,Allergy_Asthma_Clin_Immunol_2011_Oct_3_7(1)_16.txt
4.6.5.699,...n Expet Rev Vaccine 2007 6 699 710 10.1586/14760584.6.5.699,126,162,Allergy_Asthma_Clin_Immunol_2012_Mar_2_8(1)_2.txt
5.16.6.231,...World Allergy Org 2004 16 231 236 10.1027/0838-1925.16.6.231,258,126,Allergy_Asthma_Clin_Immunol_2013_Feb_7_9(1)_5.txt
2.27.7.788,...a J Korean Med Sci 2012 9 788 793 10.3346/jkms.2012.27.7.788 22787376,278,270,Allergy_Asthma_Clin_Immunol_2013_Dec_27_9(1)_50.txt
2.4.6.357,...unology Research 2012 4 6 357 361 10.4168/aair.2012.4.6.357,112,204,Allergy_Asthma_Clin_Immunol_2014_May_7_10(1)_24.txt
3.5.1.3,...gy Asthma Immunol Res 2013 5 3 15 10.4168/aair.2013.5.1.3 23277873,87,136,Allergy_Asthma_Clin_Immunol_2014_Jan_17_10(1)_3.txt
3.5.1.3,... Asthma Immunol Res 2013 5 1 3 15 10.4168/aair.2013.5.1.3 23277873,237,138,Allergy_Asthma_Clin_Immunol_2014_Feb_20_10(1)_7.txt
6.9.3.349,... Pharmacogenomics 2008 9 3 349 358 10.2217/14622416.9.3.349 18303970,230,130,Allergy_Asthma_Clin_Immunol_2014_Feb_5_10(1)_8.txt
6.6.7.713,... Pharmacogenomics 2005 6 7 713 719 10.2217/14622416.6.7.713 16207148,268,173,Allergy_Asthma_Clin_Immunol_2014_Feb_5_10(1)_8.txt
3.18.5.913,... J Bone Miner Res 2003 18 913 918 10.1359/jbmr.2003.18.5.913 12733732,788,158,Allergy_Asthma_Clin_Immunol_2013_Aug_15_9(1)_30.txt
1.1.3.157,...a Pac allergy 2011 1 157 167 10.5415/apallergy.2011.1.3.157 22053313,185,140,Allergy_Asthma_Clin_Immunol_2013_Oct_11_9(1)_40.txt
1.3.1.3,...gy Asthma Immunol Res 2011 1 3 10 10.4168/aair.2011.3.1.3 21217919,329,149,Allergy_Asthma_Clin_Immunol_2014_Dec_11_10(1)_64.txt
3.7.1.3,...kwheat Nutr Res Pract 2013 7 1 3 8 10.4162/nrp.2013.7.1.3 23423876,20,147,Allergy_Asthma_Clin_Immunol_2014_Dec_18_10(Suppl_2)_A38.txt
4.75.3.108,...sses Psychol Rep 1994 75 1089 1090 10.2466/pr0.1994.75.3.1089 7892372,384,206,Allergy_Asthma_Clin_Immunol_2014_Dec_21_10(1)_67.txt
3.2.1.76,... cases Clin Nutr Res. 2013 2 76 79 10.7762/cnr.2013.2.1.76 23429235,158,188,Allergy_Asthma_Clin_Immunol_2015_Jul_25_11(1)_22.txt
3.7.5.347,...s Nutr Res Pract. 2013 7 5 347 351 10.4162/nrp.2013.7.5.347 24133612,163,162,Allergy_Asthma_Clin_Immunol_2015_Jul_25_11(1)_22.txt
1.1.3.145,...a Pac Allergy 2011 1 145 151 10.5415/apallergy.2011.1.3.145 22053311,381,176,Allergy_Asthma_Clin_Immunol_2015_Aug_25_11(1)_24.txt
4.18.3.39,...ure Paediatr Nurs 2006 18 39 43 10.7748/paed2006.04.18.3.39.c8136 16634384,123,171,Allergy_Asthma_Clin_Immunol_2015_Sep_4_11(1)_25.txt
2.11.6.737,... Opin Ther Targets 2007 11 737 743 10.1517/14728222.11.6.737 17504012,282,210,Allergy_Asthma_Clin_Immunol_2015_Nov_19_11_33.txt
5.36.2.60,...Korean J Fam Med. 2015 36 2 60 71 10.4082/kjfm.2015.36.2.60 25802687,135,167,Allergy_Asthma_Clin_Immunol_2016_Jan_22_12_5.txt
2.2.2.93,... Pac Allergy 2012 2 2 93 100 10.5415/apallergy.2012.2.2.93 22701858,423,138,Allergy_Asthma_Clin_Immunol_2016_Apr_11_12_13.txt
2.17.1.116,... Korean Med Sci 2002 17 1 116 120 10.3346/jkms.2002.17.1.116 11850600,438,263,Allergy_Asthma_Clin_Immunol_2016_May_24_12_27.txt
1.3.2.67,...Asthma Immunol Res 2011 3 2 67 73 10.4168/aair.2011.3.2.67,357,176,Allergy_Asthma_Clin_Immunol_2016_Jul_26_12_31.txt
1.26.3.262,...n J Intern Med. 2011 26 3 262 273 10.3904/kjim.2011.26.3.262 22016586,119,118,Allergy_Asthma_Clin_Immunol_2016_Oct_19_12_51.txt
5.7.4.359,...sthma Immun Res. 2015 7 4 359 366 10.4168/aair.2015.7.4.359,122,239,Allergy_Asthma_Clin_Immunol_2016_Oct_19_12_51.txt
3.5.4.211,...thma Immunol Res 2013 5 4 211 215 10.4168/aair.2013.5.4.211 23814674,444,167,Allergy_Asthma_Clin_Immunol_2016_Oct_19_12_52.txt
1.26.9.116,...orean Med Sci 2011 26 9 1165 1172 10.3346/jkms.2011.26.9.1165 21935271,179,159,Allergy_Asthma_Clin_Immunol_2016_Oct_24_12_56.txt
2.2.2.144,...Pac Allergy 2012 2 2 144 148 10.5415/apallergy.2012.2.2.144 22701865,184,167,Allergy_Asthma_Clin_Immunol_2016_Oct_24_12_56.txt
3.5.3.162,...thma Immunol Res 2013 5 3 162 169 10.4168/aair.2013.5.3.162 23638315,192,196,Allergy_Asthma_Clin_Immunol_2016_Oct_24_12_56.txt
1.26.9.116,...orean Med Sci 2011 26 9 1165 1172 10.3346/jkms.2011.26.9.1165 21935271,148,150,Allergy_Asthma_Clin_Immunol_2016_Nov_15_12_58.txt
2.27.7.788,... Korean Med Sci 2012 27 7 788 793 10.3346/jkms.2012.27.7.788 22787376,262,187,Allergy_Asthma_Clin_Immunol_2016_Dec_2_12_62.txt
1.3.1.1,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.1.1EditorialLessons Learned from the Prevalenc...,3,229,Allergy_Asthma_Immunol_Res_2011_Jan_13_3(1)_1-2.txt
1.3.1.11,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.1.11ReviewUpdate in the Mechanisms of Allergen...,3,229,Allergy_Asthma_Immunol_Res_2011_Jan_16_3(1)_11-20.txt
1.3.1.27,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.1.27Original ArticleChanges in the Prevalence ...,3,229,Allergy_Asthma_Immunol_Res_2011_Jan_14_3(1)_27-33.txt
1.3.1.62,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.1.62Case ReportA Case of Chlorpheniramine Male...,3,229,Allergy_Asthma_Immunol_Res_2011_Jan_29_3(1)_62-64.txt
1.3.1.39,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.1.39Original ArticleBronchiectasis in Children...,3,229,Allergy_Asthma_Immunol_Res_2011_Jan_14_3(1)_39-45.txt
1.3.1.53,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.1.53Original ArticleNutritional Status Accordi...,3,229,Allergy_Asthma_Immunol_Res_2011_Jan_23_3(1)_53-57.txt
1.3.1.34,...y and Respiratory Disease 2022467610.4168/aair.2011.3.1.34Original ArticleThe Financial Burden of As...,3,237,Allergy_Asthma_Immunol_Res_2011_Jan_1_3(1)_34-38.txt
1.3.1.46,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.1.46Original ArticleSkills in Handling Turbuha...,3,229,Allergy_Asthma_Immunol_Res_2011_Jan_17_3(1)_46-52.txt
1.3.1.3,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.1.3ReviewAspirin-Exacerbated Respiratory Disea...,3,229,Allergy_Asthma_Immunol_Res_2011_Jan_20_3(1)_3-10.txt
1.3.1.58,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.1.58Brief CommunicationIn vitro Biphasic Effec...,3,229,Allergy_Asthma_Immunol_Res_2011_Jan_17_3(1)_58-61.txt
1.3.1.21,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.1.21ReviewBiomarkers Predicting Isocyanate-Ind...,3,229,Allergy_Asthma_Immunol_Res_2011_Jan_29_3(1)_21-26.txt
1.3.2.123,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.123Original ArticleRole of Toll-like Recepto...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_14_3(2)_123-127.txt
1.3.2.81,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.81ReviewIL-33 and Airway Inflammation Oboki ...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_15_3(2)_81-88.txt
1.3.2.111,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.111Original ArticleAirway Measurement for Ai...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_1_3(2)_111-117.txt
1.3.2.67,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.67ReviewThe Atopic March: Progression from A...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_14_3(2)_67-73.txt
1.3.2.132,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.132Case ReportNew Sensitization to House Dus...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_14_3(2)_132-134.txt
1.3.2.135,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.135Case ReportAbsence of Hyper-Responsivenes...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_14_3(2)_135-137.txt
1.3.2.141,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.141Case ReportA Case of Autoimmune Progester...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_9_3(2)_141-144.txt
1.3.2.138,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.138Case ReportA Rare Association Between Leu...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_9_3(2)_138-140.txt
1.3.2.128,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.128Case ReportTwo Cases of H2-Receptor Antag...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_6_3(2)_128-131.txt
1.3.2.89,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.89Original ArticleLong-term Efficacy of Intr...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_14_3(2)_89-95.txt
1.3.2.118,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.118Original ArticleChallenge Test Results in...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_14_3(2)_118-122.txt
1.3.2.74,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.74ReviewGender-Specific Asthma Treatment Cho...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_8_3(2)_74-80.txt
1.3.2.65,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.65EditorialUse of Intravenous Immunoglobulin...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_21_3(2)_65-66.txt
1.3.2.103,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.103Original ArticleTherapeutic Effects of Fe...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_14_3(2)_103-110.txt
1.3.2.96,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.2.96Original ArticlePseudoceramide-Containing ...,3,229,Allergy_Asthma_Immunol_Res_2011_Apr_14_3(2)_96-102.txt
1.3.3.157,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.157ReviewOccupational Asthma: Etiologies and...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_20_3(3)_157-167.txt
1.3.3.178,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.178Original ArticlePersonal Factors Affectin...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_18_3(3)_178-185.txt
1.3.3.194,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.194Original ArticleVancomycin-Associated Spo...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_19_3(3)_194-198.txt
1.3.3.212,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.212Case ReportOccupational Asthma Induced by...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_9_3(3)_212-214.txt
1.3.3.199,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.199Original ArticleThe Role of Plasmacytoid ...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_23_3(3)_199-204.txt
1.3.3.205,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.205Original ArticleMesenchymal Stem Cell Tra...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_17_3(3)_205-211.txt
1.3.3.186,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.186Original ArticleIncreased Expression and ...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_17_3(3)_186-193.txt
1.3.3.168,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.168ReviewRegulatory B Cells and Allergic Dis...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_30_3(3)_168-177.txt
1.3.3.146,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.146EditorialRole of TSLP in Nasal Polyp Infl...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_20_3(3)_146-147.txt
1.3.3.145,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.145EditorialCongratulations are due to Aller...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_21_3(3)_145.txt
1.3.3.148,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.3.148ReviewManagement of Rhinitis: Allergic an...,3,229,Allergy_Asthma_Immunol_Res_2011_Jul_20_3(3)_148-156.txt
1.3.4.226,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.226ReviewChronic Rhinosinusitis: Therapeutic...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_1_3(4)_226-235.txt
1.3.4.217,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.217ReviewCurrent Control and Future Risk in ...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_21_3(4)_217-225.txt
1.3.4.215,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.215EditorialAssessment of Bronchodilator Res...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_1_3(4)_215-216.txt
1.3.4.236,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.236ReviewThe Search for Genetic Variants and...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_30_3(4)_236-244.txt
1.3.4.265,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.265Original ArticleAsthma-Predictive Genetic...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_18_3(4)_265-272.txt
1.3.4.251,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.251Original ArticleThe Relationship Between ...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_13_3(4)_251-255.txt
1.3.4.245,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.245Original ArticleAssessment of Bronchodila...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_20_3(4)_245-250.txt
1.3.4.256,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.256Original ArticleDiagnostic Value of Clini...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_1_3(4)_256-264.txt
1.3.4.280,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.280Case ReportBronchospasm and Anaphylactic ...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_1_3(4)_280-282.txt
1.3.4.277,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.277Case ReportAcute Urticaria Induced by Ora...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_26_3(4)_277-279.txt
1.3.4.273,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.273Brief CommunicationPolymorphisms of Aspir...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_1_3(4)_273-276.txt
1.3.4.283,...c Allergy and Respiratory Disease 10.4168/aair.2011.3.4.283ErratumErratum: Changes in the Prevalence...,3,229,Allergy_Asthma_Immunol_Res_2011_Oct_13_3(4)_283.txt
1.3.1.27,doi: 10.4168/aair.2011.3.1.2,11,22,Allergy_Asthma_Immunol_Res_2011_Oct_13_3(4)_283.txt
2.4.1.31,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.31Original ArticleInvolvement of Human Hista...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_10_4(1)_31-36.txt
2.4.1.2,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.2EditorialAngiogenic Factors Play a Signific...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_12_4(1)_2-4.txt
2.4.1.49,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.49Case ReportA Case of Occupational Rhinitis...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_11_4(1)_49-51.txt
2.4.1.52,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.52Case ReportMeloxicam-Induced Rhabdomyolysi...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_10_4(1)_52-54.txt
2.4.1.5,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.5ReviewThe Revised Edition of Korean Calenda...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_3_4(1)_5-11.txt
2.4.1.46,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.46Case ReportA Case of Propofol-Induced Orop...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_18_4(1)_46-48.txt
2.4.1.55,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.55Case ReportFulminant and Fatal Multiple Or...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_25_4(1)_55-57.txt
2.4.1.24,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.24Original ArticleDecreased Expression of FO...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_9_4(1)_24-30.txt
2.4.1.37,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.37Original ArticleRole of Angiogenic Factors...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_1_4(1)_37-45.txt
2.4.1.12,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.12ReviewEpidermal Barrier in Atopic Dermatit...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_21_4(1)_12-16.txt
2.4.1.17,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.17Original ArticleThe Efficacy of the Uprigh...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_11_4(1)_17-23.txt
2.4.1.1,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.1.1EditorialCongratulations to All are in orde...,3,229,Allergy_Asthma_Immunol_Res_2012_Jan_30_4(1)_1.txt
2.4.2.107,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.2.107Case ReportA Fatal Case of Intravascular ...,3,229,Allergy_Asthma_Immunol_Res_2012_Mar_18_4(2)_107-109.txt
2.4.2.59,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.2.59EditorialThe Role of Mycoplasma pneumoniae...,3,229,Allergy_Asthma_Immunol_Res_2012_Mar_21_4(2)_59-61.txt
2.4.2.85,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.2.85Original ArticleIgE Sensitization to Cepha...,3,229,Allergy_Asthma_Immunol_Res_2012_Mar_25_4(2)_85-91.txt
2.4.2.80,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.2.80Original ArticlePredisposing Factors Assoc...,3,229,Allergy_Asthma_Immunol_Res_2012_Mar_15_4(2)_80-84.txt
2.4.2.98,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.2.98Original ArticleRole of Adipokines and Hor...,3,229,Allergy_Asthma_Immunol_Res_2012_Mar_29_4(2)_98-103.txt
2.4.2.92,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.2.92Original ArticleMycoplasma pneumoniae Infe...,3,229,Allergy_Asthma_Immunol_Res_2012_Mar_9_4(2)_92-97.txt
2.4.2.110,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.2.110Case ReportA Case of Korean Ginseng-Induc...,3,229,Allergy_Asthma_Immunol_Res_2012_Mar_19_4(2)_110-111.txt
2.4.2.62,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.2.62ReviewAsthma and Rhinitis in South America...,3,229,Allergy_Asthma_Immunol_Res_2012_Mar_9_4(2)_62-67.txt
2.4.2.104,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.2.104Case ReportOccupational Rhinitis Induced ...,3,229,Allergy_Asthma_Immunol_Res_2012_Mar_16_4(2)_104-106.txt
2.4.2.68,"...c Allergy and Respiratory Disease 10.4168/aair.2012.4.2.68ReviewEosinophil Development, Regulation o...",3,229,Allergy_Asthma_Immunol_Res_2012_Mar_25_4(2)_68-79.txt
2.4.3.122,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.3.122ReviewInfluence of Asthma Epidemiology on...,3,255,Allergy_Asthma_Immunol_Res_2012_May_27_4(3)_122-131.txt
2.4.3.165,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.3.165Case ReportThe First Probable Case of Her...,3,255,Allergy_Asthma_Immunol_Res_2012_May_10_4(3)_165-167.txt
2.4.3.113,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.3.113EditorialImmune Tolerance by Induced Regu...,3,255,Allergy_Asthma_Immunol_Res_2012_May_22_4(3)_113-115.txt
2.4.3.116,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.3.116ReviewUpdates in the Relationship Between...,3,255,Allergy_Asthma_Immunol_Res_2012_May_18_4(3)_116-121.txt
2.4.3.132,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.3.132Original ArticleGenetic Variations in TXN...,3,255,Allergy_Asthma_Immunol_Res_2012_May_10_4(3)_132-136.txt
2.4.3.161,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.3.161Case ReportA Case of Hypereosinophilic Sy...,3,255,Allergy_Asthma_Immunol_Res_2012_May_28_4(3)_161-164.txt
2.4.3.150,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.3.150Original ArticleAsthma Prevention by Lact...,3,255,Allergy_Asthma_Immunol_Res_2012_May_8_4(3)_150-156.txt
2.4.3.157,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.3.157Brief CommunicationChanges in Major Peanu...,3,255,Allergy_Asthma_Immunol_Res_2012_May_13_4(3)_157-160.txt
2.4.3.137,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.3.137Original ArticleFlow Cytometry-Assisted B...,3,255,Allergy_Asthma_Immunol_Res_2012_May_14_4(3)_137-142.txt
2.4.3.143,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.3.143Original ArticleThe HLA-DRB1 Polymorphism...,3,255,Allergy_Asthma_Immunol_Res_2012_May_7_4(3)_143-149.txt
2.4.4.240,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.240Case ReportTwo Series of Familial Cases W...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_9_4(4)_240-244.txt
2.4.4.184,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.184Original ArticleEffectiveness of Same Ver...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_6_4(4)_184-191.txt
2.4.4.199,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.199Original ArticleWDR46 is a Genetic Risk F...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_23_4(4)_199-205.txt
2.4.4.169,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.169EditorialIs It Possible to Achieve Better...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_11_4(4)_169-170.txt
2.4.4.171,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.171ReviewRecent Developments in United Airwa...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_8_4(4)_171-177.txt
2.4.4.231,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.231Original ArticleExpression and Roles of M...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_12_4(4)_231-239.txt
2.4.4.206,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.206Original ArticleAsian Sand Dust Enhances ...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_9_4(4)_206-213.txt
2.4.4.222,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.222Original ArticleRoles of Periostin in Sym...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_8_4(4)_222-230.txt
2.4.4.214,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.214Original ArticleTherapeutic Effects of My...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_19_4(4)_214-221.txt
2.4.4.178,"...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.178ReviewDiesel Exhaust Exposure, Wheezing a...",3,255,Allergy_Asthma_Immunol_Res_2012_Jul_16_4(4)_178-183.txt
2.4.4.192,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.192Original ArticleSeasonal Factors Influenc...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_24_4(4)_192-198.txt
2.4.4.245,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.4.245Case ReportPlasmapheresis in a Patient Wi...,3,255,Allergy_Asthma_Immunol_Res_2012_Jul_14_4(4)_245-247.txt
2.4.5.284,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.5.284Original ArticleClinical Features and the...,3,255,Allergy_Asthma_Immunol_Res_2012_Sep_26_4(5)_284-289.txt
2.4.5.270,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.5.270Original ArticleThe Predictors of Poorly ...,3,255,Allergy_Asthma_Immunol_Res_2012_Sep_27_4(5)_270-276.txt
2.4.5.309,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.5.309Case ReportA Case of Allopurinol-Induced ...,3,255,Allergy_Asthma_Immunol_Res_2012_Sep_29_4(5)_309-310.txt
2.4.5.305,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.5.305Brief CommunicationClinical Features of A...,3,255,Allergy_Asthma_Immunol_Res_2012_Sep_30_4(5)_305-308.txt
2.4.5.295,"...c Allergy and Respiratory Disease 10.4168/aair.2012.4.5.295Original ArticleTLR4, 5, and 9 Agonists I...",3,255,Allergy_Asthma_Immunol_Res_2012_Sep_8_4(5)_295-304.txt
2.4.5.290,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.5.290Original ArticleEvaluation of Atorvastati...,3,255,Allergy_Asthma_Immunol_Res_2012_Sep_21_4(5)_290-294.txt
2.4.5.251,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.5.251ReviewImmunologic Evaluation of Drug Alle...,3,255,Allergy_Asthma_Immunol_Res_2012_Sep_30_4(5)_251-263.txt
2.4.5.249,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.5.249EditorialAtopic Sensitization is Associat...,3,255,Allergy_Asthma_Immunol_Res_2012_Sep_16_4(5)_249-250.txt
2.4.5.264,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.5.264ReviewThe Cockroach and Allergic Diseases...,3,255,Allergy_Asthma_Immunol_Res_2012_Sep_22_4(5)_264-269.txt
2.4.5.277,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.5.277Original ArticleIncreased Prevalence of H...,3,255,Allergy_Asthma_Immunol_Res_2012_Sep_2_4(5)_277-283.txt
2.4.6.313,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.6.313ReviewHouse Dust Mite Allergy in Korea: T...,3,255,Allergy_Asthma_Immunol_Res_2012_Nov_27_4(6)_313-325.txt
2.4.6.332,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.6.332Original ArticleMost Highly Cytokinergic ...,3,255,Allergy_Asthma_Immunol_Res_2012_Nov_25_4(6)_332-340.txt
2.4.6.351,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.6.351Original ArticleElevated Serum Levels of ...,3,255,Allergy_Asthma_Immunol_Res_2012_Nov_29_4(6)_351-356.txt
2.4.6.357,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.6.357Original ArticleEffects of Omalizumab Tre...,3,255,Allergy_Asthma_Immunol_Res_2012_Nov_20_4(6)_357-361.txt
2.4.6.362,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.6.362Brief CommunicationABCC2 Haplotype is Ass...,3,255,Allergy_Asthma_Immunol_Res_2012_Nov_24_4(6)_362-366.txt
2.4.6.346,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.6.346Original ArticleStandardization of House ...,3,255,Allergy_Asthma_Immunol_Res_2012_Nov_12_4(6)_346-350.txt
2.4.6.367,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.6.367Brief CommunicationImmunologic Evaluation...,3,255,Allergy_Asthma_Immunol_Res_2012_Nov_15_4(6)_367-369.txt
2.4.6.326,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.6.326ReviewTreatment of Chronic Spontaneous Ur...,3,255,Allergy_Asthma_Immunol_Res_2012_Nov_14_4(6)_326-331.txt
2.4.6.311,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.6.311EditorialHighly Cytokinergic IgE Antibodi...,3,255,Allergy_Asthma_Immunol_Res_2012_Nov_9_4(6)_311-312.txt
2.4.6.341,...c Allergy and Respiratory Disease 10.4168/aair.2012.4.6.341Original ArticleBronchial Hyperresponsive...,3,255,Allergy_Asthma_Immunol_Res_2012_Nov_27_4(6)_341-345.txt
3.5.1.48,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.1.48Original ArticleIn Vitro Induction of Alle...,3,255,Allergy_Asthma_Immunol_Res_2013_Jan_27_5(1)_48-54.txt
3.5.1.59,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.1.59Case ReportA Case of Hereditary Angioedema...,3,255,Allergy_Asthma_Immunol_Res_2013_Jan_23_5(1)_59-61.txt
3.5.1.62,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.1.62Case ReportSuccessful Treatment of Steroid...,3,255,Allergy_Asthma_Immunol_Res_2013_Jan_16_5(1)_62-64.txt
3.5.1.1,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.1.1EditorialComorbid Diseases in Adult Asthma ...,3,255,Allergy_Asthma_Immunol_Res_2013_Jan_12_5(1)_1-2.txt
3.5.1.55,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.1.55Brief CommunicationClinical Features of Im...,3,255,Allergy_Asthma_Immunol_Res_2013_Jan_29_5(1)_55-58.txt
3.5.1.3,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.1.3ReviewOral Immunotherapy for Food Allergy: ...,3,255,Allergy_Asthma_Immunol_Res_2013_Jan_28_5(1)_3-15.txt
3.5.1.16,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.1.16Original ArticleDiseases Concomitant With ...,3,255,Allergy_Asthma_Immunol_Res_2013_Jan_25_5(1)_16-25.txt
3.5.1.26,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.1.26Original ArticleRatio of Leukotriene E4 to...,3,255,Allergy_Asthma_Immunol_Res_2013_Jan_10_5(1)_26-33.txt
3.5.1.34,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.1.34Original ArticleAssociation Analysis Betwe...,3,255,Allergy_Asthma_Immunol_Res_2013_Jan_25_5(1)_34-41.txt
3.5.1.42,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.1.42Original ArticleThe Influence of the Prese...,3,255,Allergy_Asthma_Immunol_Res_2013_Jan_24_5(1)_42-47.txt
3.5.2.110,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.110Case ReportAnaphylaxis to Topically Appli...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_2_5(2)_110-112.txt
3.5.2.116,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.116ErratumErratum: Involvement of Human Hist...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_21_5(2)_116.txt
2.4.1.31,http://dx.doi.org/10.4168/aair.2012.4.1.3,7,35,Allergy_Asthma_Immunol_Res_2013_Mar_21_5(2)_116.txt
3.5.2.68,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.68ReviewThe Innate Immune Response in House ...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_24_5(2)_68-74.txt
3.5.2.88,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.88Original ArticleClinical Predictors of Pri...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_2_5(2)_88-95.txt
3.5.2.75,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.75Original ArticleSeasonal Specificity of Se...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_27_5(2)_75-80.txt
3.5.2.81,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.81Original ArticleAssociation of Antioxidant...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_7_5(2)_81-87.txt
3.5.2.102,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.102Original ArticlePreparation and Character...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_7_5(2)_102-105.txt
3.5.2.106,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.106Brief CommunicationIL-5 Promoter Polymorp...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_20_5(2)_106-109.txt
3.5.2.96,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.96Original ArticleThe Influence of the Time ...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_2_5(2)_96-101.txt
3.5.2.113,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.113Case ReportA Case of Levofloxacin-Induced...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_7_5(2)_113-115.txt
3.5.2.65,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.2.65EditorialClassification of Allergic Rhinit...,3,255,Allergy_Asthma_Immunol_Res_2013_Mar_12_5(2)_65-67.txt
3.5.3.170,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.3.170Brief CommunicationThe Age Impact on Seru...,3,255,Allergy_Asthma_Immunol_Res_2013_May_15_5(3)_170-174.txt
3.5.3.138,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.3.138Original ArticleThe Clinical Usefulness o...,3,255,Allergy_Asthma_Immunol_Res_2013_May_7_5(3)_138-142.txt
3.5.3.143,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.3.143Original ArticleImpact of Atopy on Asthma...,3,255,Allergy_Asthma_Immunol_Res_2013_May_31_5(3)_143-149.txt
3.5.3.162,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.3.162Original ArticleAssessment of Total/Speci...,3,255,Allergy_Asthma_Immunol_Res_2013_May_19_5(3)_162-169.txt
3.5.3.150,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.3.150Original ArticleEvaluation of Banana Hype...,3,255,Allergy_Asthma_Immunol_Res_2013_May_4_5(3)_150-154.txt
3.5.3.129,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.3.129ReviewManagement of Insect Sting Hypersen...,3,255,Allergy_Asthma_Immunol_Res_2013_May_25_5(3)_129-137.txt
3.5.3.175,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.3.175Case ReportImprovement of Eosinophilic Ot...,3,255,Allergy_Asthma_Immunol_Res_2013_May_1_5(3)_175-178.txt
3.5.3.155,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.3.155Original ArticleRelationships Between Exh...,3,255,Allergy_Asthma_Immunol_Res_2013_May_6_5(3)_155-161.txt
3.5.3.119,"...c Allergy and Respiratory Disease 10.4168/aair.2013.5.3.119ReviewVitamin D, the Cutaneous Barrier, A...",3,255,Allergy_Asthma_Immunol_Res_2013_May_4_5(3)_119-128.txt
3.5.3.117,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.3.117EditorialCan Allergen-Specific IgE Antibo...,3,255,Allergy_Asthma_Immunol_Res_2013_May_5_5(3)_117-118.txt
3.5.4.197,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.197Original ArticleEffects of Interleukin-9 ...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_7_5(4)_197-206.txt
3.5.4.216,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.216Original ArticleRhinovirus-Infected Epith...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_27_5(4)_216-223.txt
3.5.4.224,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.224Original ArticleEffect of Prostaglandin E...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_27_5(4)_224-231.txt
3.5.4.207,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.207Original ArticleCorrelation Between Serum...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_13_5(4)_207-210.txt
3.5.4.189,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.189ReviewImmunopathogenesis of Allergic Asth...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_12_5(4)_189-196.txt
3.5.4.242,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.242Case ReportAcute Eosinophilic Pneumonia L...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_5_5(4)_242-244.txt
3.5.4.245,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.245Case ReportA Case of Idiopathic Anaphylax...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_7_5(4)_245-247.txt
3.5.4.239,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.239Brief CommunicationBreastfeeding Might Ha...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_12_5(4)_239-241.txt
3.5.4.181,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.181ReviewRelationship Between Atopy and Bron...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_27_5(4)_181-188.txt
3.5.4.179,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.179EditorialThe Clinical Impact of Vitamin D...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_26_5(4)_179-180.txt
3.5.4.232,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.232Original ArticleRhinitis Patients With Sp...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_3_5(4)_232-238.txt
3.5.4.211,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.4.211Original ArticleMutations in the Filaggri...,3,255,Allergy_Asthma_Immunol_Res_2013_Jul_20_5(4)_211-215.txt
3.5.5.301,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.301Original ArticleSeasonal Variation in Ski...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_7_5(5)_301-308.txt
3.5.5.295,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.295Original ArticleAssociation Between Pet O...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_25_5(5)_295-300.txt
3.5.5.329,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.329Original ArticleSuppression of Heme Oxyge...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_7_5(5)_329-336.txt
3.5.5.337,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.337Case ReportA Case of Fixed Drug Eruption ...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_7_5(5)_337-339.txt
3.5.5.309,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.309Original ArticleThe Allergenic Potency of...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_19_5(5)_309-314.txt
3.5.5.283,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.283Original ArticleVitamin D Insufficiency a...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_24_5(5)_283-288.txt
3.5.5.289,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.289Original ArticleThe Effect of Vitamin D S...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_12_5(5)_289-294.txt
3.5.5.315,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.315Original ArticleAllergic Diseases in Pres...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_1_5(5)_315-321.txt
3.5.5.258,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.258ReviewUnraveling the Genetic Basis of Asp...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_27_5(5)_258-276.txt
3.5.5.249,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.249EditorialPractice Patterns of Allergen Im...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_23_5(5)_249-250.txt
3.5.5.322,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.322Original ArticleUsefulness of Colored 3D ...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_24_5(5)_322-328.txt
3.5.5.251,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.251ReviewChanging Prevalence of Allergic Dis...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_18_5(5)_251-257.txt
3.5.5.277,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.5.277Original ArticleA Survey of the Prescript...,3,255,Allergy_Asthma_Immunol_Res_2013_Sep_25_5(5)_277-282.txt
3.5.6.402,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.402Original ArticleEffect of Cholesterol Dep...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_9_5(6)_402-408.txt
3.5.6.397,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.397Original ArticleThe Effects of Storage Co...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_19_5(6)_397-401.txt
3.5.6.415,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.415Case ReportA Case of Sulfasalazine-Induce...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_2_5(6)_415-417.txt
3.5.6.377,"...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.377Original ArticleIL-13 R110Q, a Naturally ...",3,255,Allergy_Asthma_Immunol_Res_2013_Nov_7_5(6)_377-382.txt
3.5.6.341,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.341EditorialIntermittent to Mild Asthma: The...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_25_5(6)_341-342.txt
3.5.6.365,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.365Original ArticleRespiratory Effects of th...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_9_5(6)_365-370.txt
3.5.6.357,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.357Original ArticleLost to Follow-Up in Asth...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_27_5(6)_357-364.txt
3.5.6.409,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.409Original ArticleThe Influence of IgE on C...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_27_5(6)_409-414.txt
3.5.6.343,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.343ReviewMechanisms of Asthma and Implicatio...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_25_5(6)_343-347.txt
3.5.6.389,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.389Original ArticleMRI Reveals Edema in Lary...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_2_5(6)_389-396.txt
3.5.6.371,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.371Original ArticleIL-4 Receptor α Polymorph...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_2_5(6)_371-376.txt
3.5.6.383,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.383Original ArticleThreshold for Positivity ...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_7_5(6)_383-388.txt
3.5.6.348,...c Allergy and Respiratory Disease 10.4168/aair.2013.5.6.348ReviewDiagnosis and Management of Grain-I...,3,255,Allergy_Asthma_Immunol_Res_2013_Nov_25_5(6)_348-356.txt
4.6.1.27,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.27Original ArticleFractional Exhaled Nitric ...,4,70,Allergy_Asthma_Immunol_Res_2014_Jan_22_6(1)_27-32.txt
4.6.1.1,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.1EditorialEmbarking on a New Journey With th...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_13_6(1)_1-2.txt
4.6.1.95,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.95Case ReportA Case of Codeine Induced Anaph...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_3_6(1)_95-97.txt
4.6.1.6,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.6ReviewHistamine-Releasing Factor and Immuno...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_2_6(1)_6-12.txt
4.6.1.55,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.55Original ArticleGene-Gene Interaction Betw...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_26_6(1)_55-60.txt
4.6.1.66,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.66Original ArticleStimulated Bronchial Epith...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_28_6(1)_66-74.txt
4.6.1.98,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.98Case ReportA Case of Idiopathic Hypereosin...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_27_6(1)_98-101.txt
4.6.1.22,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.22Original ArticleEffects of Methylprednisol...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_15_6(1)_22-26.txt
4.6.1.89,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.89Brief CommunicationAutologous Immunoglobul...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_8_6(1)_89-94.txt
4.6.1.39,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.39Original ArticleEosinophilic Airway Inflam...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_30_6(1)_39-46.txt
4.6.1.61,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.61Original ArticleBioactive Lysophosphatidyl...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_5_6(1)_61-65.txt
4.6.1.75,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.75Original ArticleA Quantitative Study of Ai...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_26_6(1)_75-82.txt
4.6.1.83,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.83Original ArticleA Novel Synthetic Mycolic ...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_23_6(1)_83-88.txt
4.6.1.3,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.3EditorialThe Efficacy of Glucocorticoid on ...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_23_6(1)_3-5.txt
4.6.1.13,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.13ReviewMolecular Genetic Mechanisms of Chro...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_30_6(1)_13-21.txt
4.6.1.33,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.33Original ArticleCan Fecal Calprotectin Lev...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_8_6(1)_33-38.txt
4.6.1.47,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.1.47Original ArticleVariability of Offending A...,3,255,Allergy_Asthma_Immunol_Res_2014_Jan_10_6(1)_47-54.txt
4.6.2.131,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.131Original ArticlePrevalence of Immediate-T...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_28_6(2)_131-136.txt
4.6.2.163,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.163Original ArticleReceptor Interacting Prot...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_30_6(2)_163-168.txt
4.6.2.179,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.179Case ReportA Case of Eosinophilic Fasciit...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_12_6(2)_179-182.txt
4.6.2.126,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.126Original ArticleThe Effects of Inhaled Al...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_126-130.txt
4.6.2.175,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.175Brief CommunicationPotential Masking of A...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_5_6(2)_175-178.txt
4.6.2.114,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.114ReviewIntegrating Evidence for Managing A...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_17_6(2)_114-120.txt
4.6.2.149,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.149Original ArticleEffects of Fungi and Eosi...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_27_6(2)_149-155.txt
4.6.2.169,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.169Original ArticleReference Values and Dete...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_15_6(2)_169-174.txt
4.6.2.142,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.142Original ArticlePolymorphisms of ATF6B Ar...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_28_6(2)_142-148.txt
4.6.2.137,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.137Original ArticleThe Interaction Between A...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_23_6(2)_137-141.txt
4.6.2.183,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.183Case ReportA Case of Serum Sickness-Like ...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_27_6(2)_183-185.txt
4.6.2.103,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.103EditorialThe Usefulness of Component-Reso...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_19_6(2)_103-104.txt
4.6.2.121,"...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.121Original ArticleUsefulness of nBos d 4, 5...",3,255,Allergy_Asthma_Immunol_Res_2014_Mar_8_6(2)_121-125.txt
4.6.2.156,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.156Original ArticleCross-reactivity to Aceta...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_13_6(2)_156-162.txt
4.6.2.105,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.2.105ReviewPrevalence of Allergic Rhinitis in ...,3,255,Allergy_Asthma_Immunol_Res_2014_Mar_12_6(2)_105-113.txt
4.6.3.263,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.263Brief CommunicationThe Prevalence of Seru...,3,255,Allergy_Asthma_Immunol_Res_2014_May_10_6(3)_263-266.txt
4.6.3.187,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.187EditorialImmunomodulating Approach to Ast...,3,255,Allergy_Asthma_Immunol_Res_2014_May_23_6(3)_187-188.txt
4.6.3.234,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.234Original ArticleHighly Protective Associa...,3,255,Allergy_Asthma_Immunol_Res_2014_May_12_6(3)_234-241.txt
4.6.3.257,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.257Brief CommunicationMite and Booklouse Fau...,3,255,Allergy_Asthma_Immunol_Res_2014_May_2_6(3)_257-262.txt
4.6.3.267,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.267Case ReportLaryngeal Spasm Mimicking Asth...,3,255,Allergy_Asthma_Immunol_Res_2014_May_14_6(3)_267-269.txt
4.6.3.208,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.208Original ArticleEfficacy of Probiotic The...,3,255,Allergy_Asthma_Immunol_Res_2014_May_12_6(3)_208-215.txt
4.6.3.196,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.196ReviewCurrent Status of Standardization o...,3,255,Allergy_Asthma_Immunol_Res_2014_May_21_6(3)_196-200.txt
4.6.3.216,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.216Original ArticleComparison of Diagnostic ...,3,255,Allergy_Asthma_Immunol_Res_2014_May_6_6(3)_216-221.txt
4.6.3.228,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.228Original ArticleClinical Characteristics ...,3,255,Allergy_Asthma_Immunol_Res_2014_May_21_6(3)_228-233.txt
4.6.3.252,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.252Brief Communicationp53 Codon 72 Genetic P...,3,255,Allergy_Asthma_Immunol_Res_2014_May_13_6(3)_252-256.txt
4.6.3.270,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.270Case ReportDrug Rash With Eosinophilia an...,3,255,Allergy_Asthma_Immunol_Res_2014_May_10_6(3)_270-272.txt
4.6.3.201,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.201Original ArticleBacillus Calmette-Guérin ...,3,255,Allergy_Asthma_Immunol_Res_2014_May_23_6(3)_201-207.txt
4.6.3.189,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.189ReviewIs There a Link Between Obesity and...,3,255,Allergy_Asthma_Immunol_Res_2014_May_7_6(3)_189-195.txt
4.6.3.222,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.222Original ArticleA Nationwide Survey of In...,3,255,Allergy_Asthma_Immunol_Res_2014_May_5_6(3)_222-227.txt
4.6.3.242,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.3.242Original ArticleSmall Airway Impairment a...,3,255,Allergy_Asthma_Immunol_Res_2014_May_11_6(3)_242-251.txt
4.6.4.288,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.288ReviewCysteinyl Leukotrienes and Their Re...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_27_6(4)_288-295.txt
4.6.4.276,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.276ReviewEpidermal Permeability Barrier Defe...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_21_6(4)_276-287.txt
4.6.4.304,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.304Original ArticleThe Utility of Serum Tryp...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_21_6(4)_304-309.txt
4.6.4.316,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.316Original ArticleSystemic Inflammation in ...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_10_6(4)_316-324.txt
4.6.4.333,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.333Original ArticleGene - Gene Interactions ...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_7_6(4)_333-340.txt
4.6.4.362,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.362Brief CommunicationClinical Characteristi...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_29_6(4)_362-365.txt
4.6.4.273,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.273EditorialCurrent Specific Immunotherapy f...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_19_6(4)_273-275.txt
4.6.4.341,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.341Original ArticlePerinatal Immunization Wi...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_21_6(4)_341-349.txt
4.6.4.370,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.370Case ReportWheat - Dependent Exercise-Ind...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_20_6(4)_370-372.txt
4.6.4.366,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.366Case ReportIdentification of a Novel Muta...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_20_6(4)_366-369.txt
4.6.4.325,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.325Original ArticleSpecific B-cell Epitope o...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_25_6(4)_325-332.txt
4.6.4.296,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.296Original ArticleTrends in Specific Immuno...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_13_6(4)_296-303.txt
4.6.4.310,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.310Original ArticleInfluence of Chronic Sinu...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_21_6(4)_310-315.txt
4.6.4.357,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.357Brief CommunicationPredictive Value of th...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_5_6(4)_357-361.txt
4.6.4.350,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.4.350Original ArticleMaternal Genetic Variants...,3,255,Allergy_Asthma_Immunol_Res_2014_Jul_20_6(4)_350-356.txt
4.6.5.428,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.428Original ArticleSerial Changes in Serum E...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_4_6(5)_428-433.txt
4.6.5.470,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.470Case ReportOccupational Rhinoconjunctivit...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_12_6(5)_470-473.txt
4.6.5.421,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.421Original ArticleExploring Household-level...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_27_6(5)_421-427.txt
4.6.5.434,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.434Original ArticleChanges in Allergen Sensi...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_9_6(5)_434-443.txt
4.6.5.449,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.449Original ArticleProstaglandin E2 Induces ...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_4_6(5)_449-457.txt
4.6.5.401,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.401Original ArticleCapsaicin cough sensitivi...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_28_6(5)_401-408.txt
4.6.5.376,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.376ReviewSmall Airways Dysfunction in Asthma...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_18_6(5)_376-388.txt
4.6.5.409,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.409Original ArticleAllergic Diseases and Mul...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_21_6(5)_409-414.txt
4.6.5.373,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.373EditorialNow is the Right Time to Establi...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_27_6(5)_373-375.txt
4.6.5.415,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.415Original ArticleClinical Features of Fixe...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_26_6(5)_415-420.txt
4.6.5.444,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.444Original ArticleIncreased Th2-like Invari...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_27_6(5)_444-448.txt
4.6.5.389,"...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.389ReviewEnvironmental Changes, Microbiota, ...",3,255,Allergy_Asthma_Immunol_Res_2014_Sep_23_6(5)_389-400.txt
4.6.5.467,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.467Case ReportFlare Up Reaction During Provo...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_7_6(5)_467-469.txt
4.6.5.458,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.458Brief CommunicationIntradermal Tests for ...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_18_6(5)_458-462.txt
4.6.5.463,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.5.463Brief CommunicationThe Impact of Asthma C...,3,255,Allergy_Asthma_Immunol_Res_2014_Sep_19_6(5)_463-466.txt
4.6.6.475,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.475EditorialRole of Murine Asthma Model in D...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_29_6(6)_475-477.txt
4.6.6.485,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.485ReviewDiagnosis and Management of Immedia...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_15_6(6)_485-495.txt
4.6.6.541,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.541Original ArticleDevelopment of a Question...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_541-547.txt
4.6.6.558,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.558Original ArticleThe Serine Protease Inhib...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_24_6(6)_558-566.txt
4.6.6.504,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.504Original ArticleReference Ranges and Dete...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_31_6(6)_504-510.txt
4.6.6.511,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.511Original ArticleFood Hypersensitivity in ...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_9_6(6)_511-516.txt
4.6.6.517,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.517Original ArticleRelationship Between Indo...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_11_6(6)_517-524.txt
4.6.6.525,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.525Original ArticleThe Importance of Allerge...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_27_6(6)_525-534.txt
4.6.6.567,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.567Original ArticleHistamine Promotes the Re...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_28_6(6)_567-572.txt
4.6.6.573,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.573Case ReportA Case of Chronic Cough Caused...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_4_6(6)_573-576.txt
4.6.6.577,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.577Case ReportMunchausen Stridor-A Strong Fa...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_10_6(6)_577-579.txt
4.6.6.496,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.496Original ArticleNovel genes in Human Asth...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_496-503.txt
4.6.6.478,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.478ReviewThe Effects of Environmental Toxins...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_15_6(6)_478-484.txt
4.6.6.535,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.535Original ArticleLong-term Effects of Spec...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_27_6(6)_535-540.txt
4.6.6.548,...c Allergy and Respiratory Disease 10.4168/aair.2014.6.6.548Original ArticleOral Lovastatin Attenuate...,3,255,Allergy_Asthma_Immunol_Res_2014_Nov_19_6(6)_548-557.txt
5.7.2.148,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.148Original ArticlePrevalence of Allergic Rh...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_25_7(2)_148-157.txt
5.7.2.195,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.195Case ReportAn IgE-Mediated Allergic React...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_26_7(2)_195-198.txt
5.7.2.186,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.186Brief CommunicationButter Tolerance in Ch...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_5_7(2)_186-189.txt
5.7.2.175,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.175Original ArticleThe Association of GSDMB ...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_18_7(2)_175-185.txt
5.7.2.130,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.130Original ArticleAssociation of Single Nuc...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_5_7(2)_130-140.txt
5.7.2.99,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.99EditorialOutcome of Sublingual Immunothera...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_23_7(2)_99-100.txt
5.7.2.190,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.190Brief CommunicationEosinophils Modulate C...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_25_7(2)_190-194.txt
5.7.2.118,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.118Original ArticleThree-Year Follow-up Resu...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_30_7(2)_118-123.txt
5.7.2.101,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.101ReviewNatural History and Risk Factors of...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_25_7(2)_101-105.txt
5.7.2.124,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.124Original ArticleIn Vitro Evaluation of Al...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_18_7(2)_124-129.txt
5.7.2.158,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.158Original ArticleComparison of Intranasal ...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_18_7(2)_158-166.txt
5.7.2.141,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.141Original ArticleThe Quality of Health Inf...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_5_7(2)_141-147.txt
5.7.2.106,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.106ReviewEndoplasmic Reticulum Stress and th...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_17_7(2)_106-117.txt
5.7.2.199,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.2.199Case ReportToxic Epidermal Necrolysis in ...,3,255,Allergy_Asthma_Immunol_Res_2015_Mar_19_7(2)_199-201.txt
5.7.2.167,...y and Respiratory Disease 2572962410.4168/aair.2015.7.2.167Original ArticleAssociation Between Antib...,3,263,Allergy_Asthma_Immunol_Res_2015_Mar_16_7(2)_167-174.txt
5.7.3.249,...y and Respiratory Disease 2574978010.4168/aair.2015.7.3.249Original ArticleAssociation of Single Nuc...,3,263,Allergy_Asthma_Immunol_Res_2015_May_5_7(3)_249-255.txt
5.7.3.203,...y and Respiratory Disease 2584070910.4168/aair.2015.7.3.203EditorialIs Your Cough Getting Better? ht...,3,263,Allergy_Asthma_Immunol_Res_2015_May_3_7(3)_203-204.txt
5.7.3.241,...y and Respiratory Disease 2584071110.4168/aair.2015.7.3.241Original ArticleInteractions Between Inna...,3,263,Allergy_Asthma_Immunol_Res_2015_May_18_7(3)_241-248.txt
5.7.3.256,...y and Respiratory Disease 2574977810.4168/aair.2015.7.3.256Original ArticleAntiallergic Function of ...,3,263,Allergy_Asthma_Immunol_Res_2015_May_5_7(3)_256-264.txt
5.7.3.276,...y and Respiratory Disease 2574977910.4168/aair.2015.7.3.276Original ArticleInhibitory Effect of Delp...,3,263,Allergy_Asthma_Immunol_Res_2015_May_5_7(3)_276-282.txt
5.7.3.290,...y and Respiratory Disease 2574976210.4168/aair.2015.7.3.290Brief CommunicationAssociation Between PT...,3,263,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
5.7.3.205,...y and Respiratory Disease 2584071010.4168/aair.2015.7.3.205ReviewMold Allergens in Respiratory Aller...,3,263,Allergy_Asthma_Immunol_Res_2015_May_11_7(3)_205-220.txt
5.7.3.230,...y and Respiratory Disease 2574976110.4168/aair.2015.7.3.230Original ArticleReliability and Validity ...,3,263,Allergy_Asthma_Immunol_Res_2015_May_18_7(3)_230-233.txt
5.7.3.234,...y and Respiratory Disease 2574977010.4168/aair.2015.7.3.234Original ArticleNovel Risk Factors for Al...,3,263,Allergy_Asthma_Immunol_Res_2015_May_23_7(3)_234-240.txt
5.7.3.265,...y and Respiratory Disease 2574976010.4168/aair.2015.7.3.265Original ArticleCopy Number Variation Bur...,3,263,Allergy_Asthma_Immunol_Res_2015_May_18_7(3)_265-275.txt
5.7.3.304,...y and Respiratory Disease 2574978510.4168/aair.2015.7.3.304Case ReportSorafenib Induces Delayed-Onse...,3,263,Allergy_Asthma_Immunol_Res_2015_May_5_7(3)_304-307.txt
5.7.3.221,...y and Respiratory Disease 2574975810.4168/aair.2015.7.3.221ReviewSpecific Immunotherapy in Atopic De...,3,263,Allergy_Asthma_Immunol_Res_2015_May_25_7(3)_221-229.txt
5.7.3.283,...y and Respiratory Disease 2574975910.4168/aair.2015.7.3.283Original ArticleAllergenic Characterizati...,3,263,Allergy_Asthma_Immunol_Res_2015_May_18_7(3)_283-289.txt
5.7.3.295,...y and Respiratory Disease 2574978210.4168/aair.2015.7.3.295Brief CommunicationJapanese Cedar (Crypto...,3,263,Allergy_Asthma_Immunol_Res_2015_May_27_7(3)_295-300.txt
5.7.3.301,...y and Respiratory Disease 2574976310.4168/aair.2015.7.3.301Case ReportImmunologic Evaluation of Pati...,3,263,Allergy_Asthma_Immunol_Res_2015_May_8_7(3)_301-303.txt
5.7.1.22,...y and Respiratory Disease 2555325910.4168/aair.2015.7.1.22Original ArticlePredictors of the Severity...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_19_7(1)_22-29.txt
5.7.1.51,...y and Respiratory Disease 2555326310.4168/aair.2015.7.1.51Original ArticleWork-Related Asthma in Kor...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_19_7(1)_51-59.txt
5.7.1.44,...y and Respiratory Disease 2555326210.4168/aair.2015.7.1.44Original ArticleThe Burden of Rhinitis and...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_15_7(1)_44-50.txt
5.7.1.1,...y and Respiratory Disease 2555325610.4168/aair.2015.7.1.1EditorialPredictors of Anaphylaxis in Korea...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_16_7(1)_1-2.txt
5.7.1.69,...y and Respiratory Disease 2555326510.4168/aair.2015.7.1.69Original ArticleJuvenile Obesity Aggravate...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_9_7(1)_69-75.txt
5.7.1.30,...y and Respiratory Disease 2555326010.4168/aair.2015.7.1.30Original ArticlePhysician-prescribed Asthm...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_16_7(1)_30-36.txt
5.7.1.60,...y and Respiratory Disease 2555326410.4168/aair.2015.7.1.60Original ArticleCross-Reactivity Between t...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_11_7(1)_60-68.txt
5.7.1.14,...y and Respiratory Disease 2555325810.4168/aair.2015.7.1.14ReviewChitotriosidase in the Pathogenesis ...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_5_7(1)_14-21.txt
5.7.1.92,...y and Respiratory Disease 2555326910.4168/aair.2015.7.1.92Case ReportDelayed Anaphylaxis to Red Meat...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_9_7(1)_92-94.txt
5.7.1.3,...y and Respiratory Disease 2555325710.4168/aair.2015.7.1.3ReviewClinical Application of Exhaled Nitri...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_19_7(1)_3-13.txt
5.7.1.76,...y and Respiratory Disease 2555326610.4168/aair.2015.7.1.76Original ArticleAn Intratracheal Challenge...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_17_7(1)_76-82.txt
5.7.1.95,...y and Respiratory Disease 2555327010.4168/aair.2015.7.1.95Case ReportA Case of Anaphylaxis Induced b...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_26_7(1)_95-97.txt
5.7.1.88,...y and Respiratory Disease 2555326810.4168/aair.2015.7.1.88Brief CommunicationSuperoxide Dismutase Ge...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_25_7(1)_88-91.txt
5.7.1.37,"...y and Respiratory Disease 2555326110.4168/aair.2015.7.1.37Original ArticleSignificance of 40-, 45-, ...",3,263,Allergy_Asthma_Immunol_Res_2015_Jan_26_7(1)_37-43.txt
5.7.1.83,...y and Respiratory Disease 2555326710.4168/aair.2015.7.1.83Brief CommunicationClinical Factors Affect...,3,263,Allergy_Asthma_Immunol_Res_2015_Jan_25_7(1)_83-87.txt
5.7.4.404,...y and Respiratory Disease 2574978310.4168/aair.2015.7.4.404Brief CommunicationFractional Exhaled Nit...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_27_7(4)_404-408.txt
5.7.4.332,...y and Respiratory Disease 2574978110.4168/aair.2015.7.4.332Original ArticleDiagnostic Decision Point...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_23_7(4)_332-338.txt
5.7.4.359,...y and Respiratory Disease 2593691110.4168/aair.2015.7.4.359Original ArticleEffect of Traffic-Related...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_10_7(4)_359-366.txt
5.7.4.321,...y and Respiratory Disease 2574976910.4168/aair.2015.7.4.321ReviewLocal Immunoglobulin E in the Nasal...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_21_7(4)_321-331.txt
5.7.4.384,...y and Respiratory Disease 2574977410.4168/aair.2015.7.4.384Original ArticleIgE Reactivity of the Dog...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_21_7(4)_384-392.txt
5.7.4.346,...y and Respiratory Disease 2593691010.4168/aair.2015.7.4.346Original ArticleDistinct Inflammatory Pro...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_21_7(4)_346-358.txt
5.7.4.409,...y and Respiratory Disease 2574978410.4168/aair.2015.7.4.409Brief CommunicationImmunomodulatory Effec...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_18_7(4)_409-413.txt
5.7.4.309,...y and Respiratory Disease 2593690910.4168/aair.2015.7.4.309EditorialDiagnostic Decision Points of Sp...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_29_7(4)_309-311.txt
5.7.4.312,...y and Respiratory Disease 2574976810.4168/aair.2015.7.4.312ReviewSeven Steps to the Diagnosis of NSA...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_21_7(4)_312-320.txt
5.7.4.376,...y and Respiratory Disease 2574977210.4168/aair.2015.7.4.376Original ArticleIgE-Binding Epitope Mappi...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_21_7(4)_376-383.txt
5.7.4.367,...y and Respiratory Disease 2574977110.4168/aair.2015.7.4.367Original ArticleTMEM16A-Mediated Mucin Se...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_24_7(4)_367-375.txt
5.7.4.416,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.4.416Letter to the EditorBasophil Activation T...,3,255,Allergy_Asthma_Immunol_Res_2015_Jul_18_7(4)_416-417.txt
5.7.4.414,...c Allergy and Respiratory Disease 10.4168/aair.2015.7.4.414Letter to the EditorBasophil Activation T...,3,255,Allergy_Asthma_Immunol_Res_2015_Jul_9_7(4)_414-415.txt
5.7.4.393,...y and Respiratory Disease 2574977510.4168/aair.2015.7.4.393Original ArticleDer p2 Internalization by...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_10_7(4)_393-403.txt
5.7.4.339,...y and Respiratory Disease 2574977610.4168/aair.2015.7.4.339Original ArticleThe Association of Lung F...,3,263,Allergy_Asthma_Immunol_Res_2015_Jul_23_7(4)_339-345.txt
5.7.5.419,...y and Respiratory Disease 2612250110.4168/aair.2015.7.5.419EditorialMore Effective Strategies are Ne...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_25_7(5)_419-420.txt
5.7.5.489,...y and Respiratory Disease 2612250810.4168/aair.2015.7.5.489Original ArticleHuman Rhinovirus-induced ...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_26_7(5)_489-496.txt
5.7.5.518,...y and Respiratory Disease 2574976510.4168/aair.2015.7.5.518Case ReportHypersensitivity Pneumonitis C...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_25_7(5)_518-522.txt
5.7.5.458,...y and Respiratory Disease 2574977710.4168/aair.2015.7.5.458Original ArticleExpression and Regulation...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_22_7(5)_458-466.txt
5.7.5.507,...y and Respiratory Disease 2612251010.4168/aair.2015.7.5.507Brief CommunicationProgress and Prospect:...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_15_7(5)_507-512.txt
5.7.5.513,...y and Respiratory Disease 2574976410.4168/aair.2015.7.5.513Case ReportBee Pollen-Induced Anaphylaxis...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_15_7(5)_513-517.txt
5.7.5.449,...y and Respiratory Disease 2612250510.4168/aair.2015.7.5.449Original ArticleAltered microRNA Expressi...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_14_7(5)_449-457.txt
5.7.5.476,...y and Respiratory Disease 2612250710.4168/aair.2015.7.5.476Original ArticleActivation of the Intrins...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_22_7(5)_476-482.txt
5.7.5.421,...y and Respiratory Disease 2612250210.4168/aair.2015.7.5.421ReviewChronic Rhinosinusitis and the Coag...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_12_7(5)_421-430.txt
5.7.5.440,...y and Respiratory Disease 2612250410.4168/aair.2015.7.5.440Original ArticleAddition of Montelukast t...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_7_7(5)_440-448.txt
5.7.5.467,...y and Respiratory Disease 2612250610.4168/aair.2015.7.5.467Original ArticleThe Prevalence of Toxocar...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_4_7(5)_467-475.txt
5.7.5.497,...y and Respiratory Disease 2612250910.4168/aair.2015.7.5.497Original ArticleEnhanced Allergic Inflamm...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_26_7(5)_497-506.txt
5.7.5.483,...y and Respiratory Disease 2574977310.4168/aair.2015.7.5.483Original ArticleProfiles of IgE Sensitiza...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_30_7(5)_483-488.txt
5.7.5.431,...y and Respiratory Disease 2612250310.4168/aair.2015.7.5.431ReviewChallenges in the Management of Ast...,3,263,Allergy_Asthma_Immunol_Res_2015_Sep_10_7(5)_431-439.txt
5.7.6.538,...y and Respiratory Disease 2633370010.4168/aair.2015.7.6.538Original ArticleIs Folate Status a Risk F...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_14_7(6)_538-546.txt
5.7.6.547,...y and Respiratory Disease 2633370110.4168/aair.2015.7.6.547Original ArticlePrevalence and Clinical I...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_5_7(6)_547-556.txt
5.7.6.557,...y and Respiratory Disease 2633370210.4168/aair.2015.7.6.557Original ArticleToxoplasma gondii Infecti...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_29_7(6)_557-564.txt
5.7.6.565,...y and Respiratory Disease 2633370310.4168/aair.2015.7.6.565Original ArticlePerformance of the PROTIA...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_26_7(6)_565-572.txt
5.7.6.583,...y and Respiratory Disease 2633370510.4168/aair.2015.7.6.583Original ArticleBlocking of Histamine Rel...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_25_7(6)_583-589.txt
5.7.6.525,...y and Respiratory Disease 2633369810.4168/aair.2015.7.6.525ReviewModels of Respiratory Infections: V...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_7_7(6)_525-533.txt
5.7.6.534,...y and Respiratory Disease 2633369910.4168/aair.2015.7.6.534ReviewMechanisms of Glucocorticoid Action...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_20_7(6)_534-537.txt
5.7.6.573,...y and Respiratory Disease 2633370410.4168/aair.2015.7.6.573Original ArticlePrenatal Particulate Matt...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_25_7(6)_573-582.txt
5.7.6.523,...y and Respiratory Disease 2633369710.4168/aair.2015.7.6.523EditorialGene-Environment Interactions Sh...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_2_7(6)_523-524.txt
5.7.6.599,...y and Respiratory Disease 2633370710.4168/aair.2015.7.6.599Brief CommunicationAttenuated Allergenic ...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_7_7(6)_599-604.txt
5.7.6.590,...y and Respiratory Disease 2633370610.4168/aair.2015.7.6.590Original ArticleEffect of Retinoic Acid i...,3,263,Allergy_Asthma_Immunol_Res_2015_Nov_2_7(6)_590-598.txt
6.8.1.32,...y and Respiratory Disease 2654049910.4168/aair.2016.8.1.32Original ArticleGIS-based Association Betw...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_25_8(1)_32-40.txt
6.8.1.79,...y and Respiratory Disease 2654050510.4168/aair.2016.8.1.79Brief CommunicationPrevalence of Atopic De...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_30_8(1)_79-83.txt
6.8.1.84,...y and Respiratory Disease 2654050610.4168/aair.2016.8.1.84Letter to the EditorsInflammation Markers ...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_7_8(1)_84-85.txt
6.8.1.22,"...y and Respiratory Disease 2654049810.4168/aair.2016.8.1.22Original ArticlePrevalence, Severity, and ...",3,263,Allergy_Asthma_Immunol_Res_2016_Jan_27_8(1)_22-31.txt
6.8.1.69,...y and Respiratory Disease 2654050410.4168/aair.2016.8.1.69Original ArticleAlternative Method for Pri...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_16_8(1)_69-78.txt
6.8.1.3,...y and Respiratory Disease 2654049610.4168/aair.2016.8.1.3ReviewUpdate on Advances in Research on Idi...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_3_8(1)_3-11.txt
6.8.1.41,...y and Respiratory Disease 2654050010.4168/aair.2016.8.1.41Original ArticleThe Interaction Between Pr...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_30_8(1)_41-48.txt
6.8.1.55,...y and Respiratory Disease 2654050210.4168/aair.2016.8.1.55Original ArticleEffect of Amino Acid Polym...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_14_8(1)_55-62.txt
6.8.1.86,...y and Respiratory Disease 2654050710.4168/aair.2016.8.1.86Letter to the EditorCow's Milk Allergy: th...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_23_8(1)_86-87.txt
6.8.1.1,...y and Respiratory Disease 2654049510.4168/aair.2016.8.1.1EditorialThe Prevalence of Atopic Dermatiti...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_30_8(1)_1-2.txt
6.8.1.12,...y and Respiratory Disease 2654049710.4168/aair.2016.8.1.12ReviewExhaled NO: Determinants and Clinica...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_2_8(1)_12-21.txt
6.8.1.49,...y and Respiratory Disease 2654050110.4168/aair.2016.8.1.49Original ArticleRelationship Between Aller...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_15_8(1)_49-54.txt
6.8.1.63,...y and Respiratory Disease 2654050310.4168/aair.2016.8.1.63Original ArticleAlternaria Induces Product...,3,263,Allergy_Asthma_Immunol_Res_2016_Jan_21_8(1)_63-68.txt
6.8.2.178,...c Allergy and Respiratory Disease 10.4168/aair.2016.8.2.178ErratumErratum: Butter Tolerance in Child...,3,255,Allergy_Asthma_Immunol_Res_2016_Mar_31_8(2)_178.txt
5.7.2.186,"...h;7(2):186-189, http://dx.doi.org/10.4168/aair.2015.7.2.186 as follows",5,323,Allergy_Asthma_Immunol_Res_2016_Mar_31_8(2)_178.txt
6.8.2.101,...y and Respiratory Disease 2673940210.4168/aair.2016.8.2.101ReviewShellfish and House Dust Mite Aller...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_14_8(2)_101-106.txt
6.8.2.89,...y and Respiratory Disease 2673940010.4168/aair.2016.8.2.89EditorialAssociations of Atopic Dermatitis...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_31_8(2)_89-91.txt
6.8.2.132,...y and Respiratory Disease 2673940610.4168/aair.2016.8.2.132Original ArticleIncreased Expression of m...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_22_8(2)_132-140.txt
6.8.2.141,...y and Respiratory Disease 2673940710.4168/aair.2016.8.2.141Original ArticleThe Potential for Poverty...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_18_8(2)_141-145.txt
6.8.2.156,...y and Respiratory Disease 2673940910.4168/aair.2016.8.2.156Original ArticleDiagnostic Value of Speci...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_2_8(2)_156-160.txt
6.8.2.107,...y and Respiratory Disease 2673940310.4168/aair.2016.8.2.107Original ArticleAssociation Between Obesi...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_16_8(2)_107-114.txt
6.8.2.124,"...y and Respiratory Disease 2673940510.4168/aair.2016.8.2.124Original ArticleMimotopes for Api g 5, a ...",3,263,Allergy_Asthma_Immunol_Res_2016_Mar_16_8(2)_124-131.txt
6.8.2.146,...y and Respiratory Disease 2673940810.4168/aair.2016.8.2.146Original ArticleDefining Chronic Cough: A...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_18_8(2)_146-155.txt
6.8.2.92,...y and Respiratory Disease 2673940110.4168/aair.2016.8.2.92ReviewEnvironmental Exposure and Genetic P...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_21_8(2)_92-100.txt
6.8.2.115,...y and Respiratory Disease 2673940410.4168/aair.2016.8.2.115Original ArticlePrognostic Factors for Ch...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_10_8(2)_115-123.txt
6.8.2.161,...y and Respiratory Disease 2673941010.4168/aair.2016.8.2.161Original ArticleAdministration of Pigment...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_2_8(2)_161-169.txt
6.8.2.170,...y and Respiratory Disease 2673941110.4168/aair.2016.8.2.170Case ReportPapain Induced Occupational As...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_2_8(2)_170-173.txt
6.8.2.174,...y and Respiratory Disease 2673941210.4168/aair.2016.8.2.174Case ReportThe Hidden Culprit: A Case of ...,3,263,Allergy_Asthma_Immunol_Res_2016_Mar_10_8(2)_174-177.txt
6.8.3.179,...y and Respiratory Disease 2692292610.4168/aair.2016.8.3.179EditorialExtracellular Vesicle: An Unknow...,3,263,Allergy_Asthma_Immunol_Res_2016_May_25_8(3)_179-180.txt
6.8.3.257,...y and Respiratory Disease 2692293610.4168/aair.2016.8.3.257Original ArticleInduction of Bronchial To...,3,263,Allergy_Asthma_Immunol_Res_2016_May_22_8(3)_257-263.txt
6.8.3.246,...y and Respiratory Disease 2692293510.4168/aair.2016.8.3.246Original ArticleLong-Term Effects of Dies...,3,263,Allergy_Asthma_Immunol_Res_2016_May_16_8(3)_246-256.txt
6.8.3.181,...y and Respiratory Disease 2692292710.4168/aair.2016.8.3.181ReviewA Comprehensive Review of the Treat...,3,263,Allergy_Asthma_Immunol_Res_2016_May_14_8(3)_181-190.txt
6.8.3.230,...y and Respiratory Disease 2692293310.4168/aair.2016.8.3.230Original ArticleIntroduction of the Relia...,3,263,Allergy_Asthma_Immunol_Res_2016_May_8_8(3)_230-238.txt
6.8.3.206,...y and Respiratory Disease 2692293010.4168/aair.2016.8.3.206Original ArticleFlagellin Modulates the F...,3,263,Allergy_Asthma_Immunol_Res_2016_May_13_8(3)_206-215.txt
6.8.3.216,...y and Respiratory Disease 2692293110.4168/aair.2016.8.3.216Original ArticleAllergen-Dependent Differ...,3,263,Allergy_Asthma_Immunol_Res_2016_May_30_8(3)_216-222.txt
6.8.3.276,...y and Respiratory Disease 2692293810.4168/aair.2016.8.3.276Case ReportA Case of Pranlukast-Induced A...,3,263,Allergy_Asthma_Immunol_Res_2016_May_13_8(3)_276-278.txt
6.8.3.198,...y and Respiratory Disease 2692292910.4168/aair.2016.8.3.198Original ArticleIgG Sensitization to Extr...,3,263,Allergy_Asthma_Immunol_Res_2016_May_22_8(3)_198-205.txt
6.8.3.223,...y and Respiratory Disease 2692293210.4168/aair.2016.8.3.223Original ArticleSeasonal Patterns of Asth...,3,263,Allergy_Asthma_Immunol_Res_2016_May_30_8(3)_223-229.txt
6.8.3.191,"...y and Respiratory Disease 2692292810.4168/aair.2016.8.3.191ReviewAllergen Immunotherapy: Past, Prese...",3,263,Allergy_Asthma_Immunol_Res_2016_May_16_8(3)_191-197.txt
6.8.3.239,"...y and Respiratory Disease 2692293410.4168/aair.2016.8.3.239Original ArticleAntibody Production, Anap...",3,263,Allergy_Asthma_Immunol_Res_2016_May_1_8(3)_239-245.txt
6.8.3.264,...y and Respiratory Disease 2692293710.4168/aair.2016.8.3.264Original ArticleCpG Oligodeoxynucleotide ...,3,263,Allergy_Asthma_Immunol_Res_2016_May_8_8(3)_264-275.txt
6.8.4.305,"...y and Respiratory Disease 2712672310.4168/aair.2016.8.4.305Original ArticleA Double-Blind, Randomize...",3,263,Allergy_Asthma_Immunol_Res_2016_Jul_4_8(4)_305-311.txt
6.8.4.282,...y and Respiratory Disease 2712672110.4168/aair.2016.8.4.282ReviewAllergic Bronchopulmonary Aspergill...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_17_8(4)_282-297.txt
6.8.4.353,...y and Respiratory Disease 2712672910.4168/aair.2016.8.4.353Original ArticleCharacteristics of Anaphy...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_25_8(4)_353-361.txt
6.8.4.329,...y and Respiratory Disease 2712672610.4168/aair.2016.8.4.329Original ArticleDetection of Allergen Spe...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_17_8(4)_329-337.txt
6.8.4.298,...y and Respiratory Disease 2712672210.4168/aair.2016.8.4.298ReviewUpdate on the Management of Aspirin...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_8_8(4)_298-304.txt
6.8.4.319,...y and Respiratory Disease 2712672510.4168/aair.2016.8.4.319Original ArticleOmalizumab Improves Quali...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_18_8(4)_319-328.txt
6.8.4.338,...y and Respiratory Disease 2712672710.4168/aair.2016.8.4.338Original ArticleAge-Related Changes in Im...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_13_8(4)_338-345.txt
6.8.4.362,...y and Respiratory Disease 2712673010.4168/aair.2016.8.4.362Original ArticleHouse Dust Mite-Derived C...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_28_8(4)_362-374.txt
6.8.4.375,...y and Respiratory Disease 2712673110.4168/aair.2016.8.4.375Brief CommunicationAutologous Immunoglobu...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_23_8(4)_375-382.txt
6.8.4.279,...y and Respiratory Disease 2712672010.4168/aair.2016.8.4.279EditorialIs Montelukast Benefical in Chil...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_15_8(4)_279-281.txt
6.8.4.312,...y and Respiratory Disease 2712672410.4168/aair.2016.8.4.312Original ArticleNo Concentration Decrease...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_22_8(4)_312-318.txt
6.8.4.346,...y and Respiratory Disease 2712672810.4168/aair.2016.8.4.346Original ArticleResponse to Nonallergenic...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_4_8(4)_346-352.txt
6.8.4.383,...y and Respiratory Disease 2712673210.4168/aair.2016.8.4.383Brief CommunicationNew Allergic and Hyper...,3,263,Allergy_Asthma_Immunol_Res_2016_Jul_17_8(4)_383-388.txt
6.8.5.445,...y and Respiratory Disease 2733478310.4168/aair.2016.8.5.445Original ArticleSynergistic Effect of Der...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_29_8(5)_445-456.txt
6.8.5.466,...y and Respiratory Disease 2733478610.4168/aair.2016.8.5.466Brief CommunicationGenes Involved in Inte...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_26_8(5)_466-470.txt
6.8.5.412,"...y and Respiratory Disease 2733477910.4168/aair.2016.8.5.412Original ArticleShort-, Intermediate-, an...",3,263,Allergy_Asthma_Immunol_Res_2016_Sep_4_8(5)_412-420.txt
6.8.5.391,...y and Respiratory Disease 2733477610.4168/aair.2016.8.5.391ReviewClimate Change and Air Pollution: E...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_29_8(5)_391-395.txt
6.8.5.396,...y and Respiratory Disease 2733477710.4168/aair.2016.8.5.396ReviewGuideline of Chronic Urticaria Beyo...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_21_8(5)_396-403.txt
6.8.5.438,...y and Respiratory Disease 2733478210.4168/aair.2016.8.5.438Original ArticleVacuolar Serine Protease ...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_28_8(5)_438-444.txt
6.8.5.421,...y and Respiratory Disease 2733478010.4168/aair.2016.8.5.421Original ArticleSystemic Reactions to Dus...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_28_8(5)_421-427.txt
6.8.5.471,...y and Respiratory Disease 2733478710.4168/aair.2016.8.5.471Brief CommunicationDynamics of Gut Microb...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_2_8(5)_471-477.txt
6.8.5.389,...y and Respiratory Disease 2733477510.4168/aair.2016.8.5.389EditorialDoes Specific Fungal Allergen Re...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_16_8(5)_389-390.txt
6.8.5.428,...y and Respiratory Disease 2733478110.4168/aair.2016.8.5.428Original ArticleOrthologous Allergens and...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_28_8(5)_428-437.txt
6.8.5.457,...y and Respiratory Disease 2733478410.4168/aair.2016.8.5.457Brief CommunicationPeriostin and Interleu...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_21_8(5)_457-460.txt
6.8.5.461,...y and Respiratory Disease 2733478510.4168/aair.2016.8.5.461Brief CommunicationSoluble CD93 as a Nove...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_25_8(5)_461-465.txt
6.8.5.404,...y and Respiratory Disease 2733477810.4168/aair.2016.8.5.404Original ArticleDoes Spore Count Matter i...,3,263,Allergy_Asthma_Immunol_Res_2016_Sep_26_8(5)_404-411.txt
6.8.6.541,...y and Respiratory Disease 2758240610.4168/aair.2016.8.6.541Brief CommunicationThe Basophil Activatio...,3,263,Allergy_Asthma_Immunol_Res_2016_Nov_28_8(6)_541-544.txt
6.8.6.479,...y and Respiratory Disease 2758239710.4168/aair.2016.8.6.479EditorialFactors Predicting Recovery From...,3,263,Allergy_Asthma_Immunol_Res_2016_Nov_25_8(6)_479-480.txt
6.8.6.499,...y and Respiratory Disease 2758240010.4168/aair.2016.8.6.499Original ArticleFactors Affecting Recover...,3,263,Allergy_Asthma_Immunol_Res_2016_Nov_25_8(6)_499-504.txt
6.8.6.505,...y and Respiratory Disease 2758240110.4168/aair.2016.8.6.505Original ArticleClinical Significance of ...,3,263,Allergy_Asthma_Immunol_Res_2016_Nov_25_8(6)_505-511.txt
6.8.6.491,...y and Respiratory Disease 2758239910.4168/aair.2016.8.6.491ReviewUsing Periostin as a Biomarker in t...,3,263,Allergy_Asthma_Immunol_Res_2016_Nov_18_8(6)_491-498.txt
6.8.6.522,...y and Respiratory Disease 2758240310.4168/aair.2016.8.6.522Original ArticlePlasma Levels of Matrix M...,3,263,Allergy_Asthma_Immunol_Res_2016_Nov_18_8(6)_522-526.txt
6.8.6.527,...y and Respiratory Disease 2758240410.4168/aair.2016.8.6.527Original ArticleBurden of Respiratory Dis...,3,263,Allergy_Asthma_Immunol_Res_2016_Nov_16_8(6)_527-534.txt
6.8.6.535,...y and Respiratory Disease 2758240510.4168/aair.2016.8.6.535Original ArticleA Multicenter Retrospecti...,3,263,Allergy_Asthma_Immunol_Res_2016_Nov_12_8(6)_535-540.txt
6.8.6.512,...y and Respiratory Disease 2758240210.4168/aair.2016.8.6.512Original ArticleEmergency Department Visi...,3,263,Allergy_Asthma_Immunol_Res_2016_Nov_8_8(6)_512-521.txt
6.8.6.481,...y and Respiratory Disease 2758239810.4168/aair.2016.8.6.481ReviewEicosanoid Mediators in the Airway ...,3,263,Allergy_Asthma_Immunol_Res_2016_Nov_25_8(6)_481-490.txt
5.7.2.124,"...h;7(2):124-129, http://dx.doi.org/10.4168/aair.2015.7.2.124 as follows",5,427,PMC5266121.txt
2.4.2.1,2.4.2.1 Determine the independent effects of T2D s...,46,1,Alzheimers_Dement_(Amst)_2015_Sep_2_1(4)_395-402.txt
2.4.3.1,2.4.3.1 Determine the interactive effects of T2D s...,50,1,Alzheimers_Dement_(Amst)_2015_Sep_2_1(4)_395-402.txt
2.4.1.1,2.4.1.1 PiB burde,49,1,Alzheimers_Dement_(Amst)_2015_Dec_20_2_27-38.txt
2.4.1.2,2.4.1.2 Regional A,54,1,Alzheimers_Dement_(Amst)_2015_Dec_20_2_27-38.txt
2.4.2.1,2.4.2.1 PiB burde,60,1,Alzheimers_Dement_(Amst)_2015_Dec_20_2_27-38.txt
2.4.2.2,2.4.2.2 Regional A,65,1,Alzheimers_Dement_(Amst)_2015_Dec_20_2_27-38.txt
2.2.1.1,2.2.1.1 MRI acquisitio,33,1,Alzheimers_Dement_(Amst)_2015_Dec_28_2_58-67.txt
2.2.1.2,2.2.1.2 Measurements of cortical thicknes,36,1,Alzheimers_Dement_(Amst)_2015_Dec_28_2_58-67.txt
2.2.1.3,2.2.1.3 Cluster analyse,39,1,Alzheimers_Dement_(Amst)_2015_Dec_28_2_58-67.txt
2.2.2.1,2.2.2.1 PET acquisitio,43,1,Alzheimers_Dement_(Amst)_2015_Dec_28_2_58-67.txt
2.2.2.2,2.2.2.2 PET analyse,46,1,Alzheimers_Dement_(Amst)_2015_Dec_28_2_58-67.txt
2.1.2.1,2.1.2.1 Medicatio,41,1,Alzheimers_Dement_(Amst)_2016_Apr_19_2_95-104.txt
2.1.2.2,2.1.2.2 Apolipoprotein E (APOE) genotypin,44,1,Alzheimers_Dement_(Amst)_2016_Apr_19_2_95-104.txt
2.2.1.1,2.2.1.1 “Old” group: 9–19 months ol,31,1,Alzheimers_Dement_(Amst)_2016_Feb_3_2_39-48.txt
2.2.1.2,2.2.1.2 “Young” group: 2–6 months ol,34,1,Alzheimers_Dement_(Amst)_2016_Feb_3_2_39-48.txt
2.3.1.1,2.3.1.1 Cortical mappin,58,1,Alzheimers_Dement_(Amst)_2016_Feb_15_2_113-122.txt
2.3.1.2,2.3.1.2 Region of interest measure,63,1,Alzheimers_Dement_(Amst)_2016_Feb_15_2_113-122.txt
3.2.1.1,3.2.1.1 Acute infarctio,51,1,PMC5198884.txt
3.2.1.2,3.2.1.2 Chronic macroinfarct,54,1,PMC5198884.txt
3.2.1.3,3.2.1.3 Microinfarct,57,1,PMC5198884.txt
2.2.1.1,2.2.1.1 Amyloid depositio,36,1,PMC5257031.txt
2.2.1.2,2.2.1.2 Tau depositio,39,1,PMC5257031.txt
3.1.1.59,...isease Biomarkers Med 2007 1 59 78 10.2217/17520363.1.1.59,106,168,Alzheimers_Res_Ther_2010_Mar_29_2(2)_7.txt
4.7.4.622,...list Psychol Aging 1992 7 622 631 10.1037/0882-7974.7.4.622 1466831,298,169,Alzheimers_Res_Ther_2010_Aug_26_2(4)_24.txt
5.7.1.41,...tion Neuropsychology 1993 7 41 52 10.1037/0894-4105.7.1.41,144,178,Alzheimers_Res_Ther_2010_Oct_15_2(5)_29.txt
6.18.7.693,... Opin Ther Patents 2008 18 693 703 10.1517/13543776.18.7.693,221,179,Alzheimers_Res_Ther_2010_Dec_29_2(6)_36.txt
2.8.1.7,... Ther Targets 2004 8 7 14 14996614 10.1517/14728222.8.1.7,103,161,Alzheimers_Res_Ther_2009_Jul_9_1(1)_3.txt
5.21.6.706,...ychology 2007 21 706 712 17983284 10.1037/0894-4105.21.6.706,140,201,Alzheimers_Res_Ther_2009_Jul_9_1(1)_4.txt
5.7.11.152,...eurother 2007 7 1527 1533 17997701 10.1586/14737175.7.11.1527,97,127,Alzheimers_Res_Ther_2009_Jul_9_1(1)_2.txt
5.8.5.691,...xpert Rev Neurother 2008 8 691 693 10.1586/14737175.8.5.691 18457525,268,139,Alzheimers_Res_Ther_2011_Dec_9_3(6)_35.txt
EC 3.1.4.2,"...GPC accumulation. However, GPC phosphodiesterase (EC 3.1.4.2, EC 3.1.4.46), another enzyme that meta...",26,1120,Alzheimers_Res_Ther_2012_Feb_1_4(1)_5.txt
EC 3.1.4.46,"...tion. However, GPC phosphodiesterase (EC 3.1.4.2, EC 3.1.4.46), another enzyme that metabolizes GPC,...",26,1132,Alzheimers_Res_Ther_2012_Feb_1_4(1)_5.txt
EC 3.1.1.4,"...acids by the 2-acyl hydrolases, phospholipase A2 (EC 3.1.1.4) and acylglycerol lipase (EC 3.1.1.23) ...",31,672,Alzheimers_Res_Ther_2012_Feb_1_4(1)_5.txt
EC 3.1.1.23,"...holipase A2 (EC 3.1.1.4) and acylglycerol lipase (EC 3.1.1.23) and reacylation, with alternative fat...",31,709,Alzheimers_Res_Ther_2012_Feb_1_4(1)_5.txt
EC 3.5.1.23,"... paralleled by increases in both acid ceramidase (EC 3.5.1.23) [46,48] and galactosylceramidase (EC ...",46,83,Alzheimers_Res_Ther_2012_Feb_1_4(1)_5.txt
EC 3.2.1.46,"...e (EC 3.5.1.23) [46,48] and galactosylceramidase (EC 3.2.1.46) [49]. Augmentation of brain ceramidas...",46,130,Alzheimers_Res_Ther_2012_Feb_1_4(1)_5.txt
6.2.3.327,...sychiatr Dis Treat 2006 2 327 339 10.2147/nedt.2006.2.3.327 19412479,130,306,Alzheimers_Res_Ther_2013_Jan_25_5(1)_3.txt
5.8.4.599,...xpert Rev Neurother 2008 5 599 610 10.1586/14737175.8.4.599 18416662,338,95,Alzheimers_Res_Ther_2013_Sep_26_5(5)_42.txt
2.7.2.70,...ir Res Hum Res Ethics 2012 6 70 79 10.1525/jer.2012.7.2.70 22565585,275,237,Alzheimers_Res_Ther_2014_Feb_28_6(1)_9.txt
3.98.5.107,...umans J Neurosurg 2003 6 1072 1077 10.3171/jns.2003.98.5.1072 12744368,119,154,Alzheimers_Res_Ther_2014_Jan_15_6(1)_4.txt
2.8.3.190,...study J Clin Neurol 2012 5 190 197 10.3988/jcn.2012.8.3.190 23091528,237,233,Alzheimers_Res_Ther_2013_Aug_7_5(4)_35.txt
5.7.11.149,...ert Rev Neurother 2007 4 1499 1516 10.1586/14737175.7.11.1499 17997699,114,135,Alzheimers_Res_Ther_2012_Apr_30_4(2)_11.txt
5.7.11.149,...ert Rev Neurother 2007 6 1499 1516 10.1586/14737175.7.11.1499 17997699,125,135,Alzheimers_Res_Ther_2014_Apr_25_6(2)_21.txt
1.7.4.215,...sease J Clin Neurol 2011 7 215 222 10.3988/jcn.2011.7.4.215 22259618,127,202,Alzheimers_Res_Ther_2014_May_7_6(3)_25.txt
4.7.9.147,...in Investig Drugs 1998 7 1475 1482 10.1517/13543784.7.9.1475 15992044,236,132,Alzheimers_Res_Ther_2014_May_12_6(3)_26.txt
3.22.1.14,...tia J Psychophysiol 2008 22 14 19 10.1027/0269-8803.22.1.14,222,223,Alzheimers_Res_Ther_2014_Nov_10_6(9)_74.txt
4.18.4.658,...ts Psychol Ageing. 2003 18 658 71 10.1037/0882-7974.18.4.658,173,147,Alzheimers_Res_Ther_2015_Mar_18_7(1)_31.txt
5.14.2.224,...w Neuropsychology. 2000 14 224 32 10.1037/0894-4105.14.2.224 10791862,501,173,Alzheimers_Res_Ther_2015_May_15_7(1)_27.txt
5.21.6.684,...n Neuropsychology. 2007 21 684 95 10.1037/0894-4105.21.6.684 17983282,531,274,Alzheimers_Res_Ther_2015_May_15_7(1)_27.txt
4.17.2.179,...ons Psychol Aging. 2002 17 179 93 10.1037/0882-7974.17.2.179 12061405,221,200,Alzheimers_Res_Ther_2015_Jun_5_7(1)_38.txt
2.1.43.172,...ity Clin Neuropsychol 1998 12 43 55 10.1076/clin.12.1.43.1726,275,198,Alzheimers_Res_Ther_2015_Oct_15_7_61.txt
6.1.1.239,... Clin Exp Neuropsychol 2004 26 1 10 10.1076/jcen.26.1.1.23940 14972689,280,228,Alzheimers_Res_Ther_2015_Oct_15_7_61.txt
5.7.1.41,...ion Neuropsychology. 1993 7 41 52 10.1037/0894-4105.7.1.41,320,189,Alzheimers_Res_Ther_2015_Jan_8_7_1.txt
3.6.2.174,...sychol Hum Learn 1980 6 2 174 215 10.1037/0278-7393.6.2.174 7373248,231,205,PMC5244569.txt
5.11.2.132,...ease J Clin Neurol. 2015 11 132 41 10.3988/jcn.2015.11.2.132 25851891,324,272,Alzheimers_Res_Ther_2016_Feb_8_8_6.txt
6.17.6.635,... Rev Neurosci. 2006 17 635 42 10.1515/REVNEURO.2006.17.6.635 17283608,336,156,Alzheimers_Res_Ther_2016_Feb_8_8_6.txt
5.17.1.82,...ype Neuropsychology 2003 17 82 92 10.1037/0894-4105.17.1.82 12597076,364,185,Alzheimers_Res_Ther_2016_Feb_22_8_9.txt
5.20.1.11,...se Neuropsychology. 2006 20 11 20 10.1037/0894-4105.20.1.11 16460218,526,176,Alzheimers_Res_Ther_2016_Mar_16_8_10.txt
4.29.7.903,... J Korean Med Sci. 2014 29 903 12 10.3346/jkms.2014.29.7.903 25045221,278,184,Alzheimers_Res_Ther_2016_Jul_30_8_23.txt
4.12.1.183,...e Psychol Aging 1997 12 1 183 188 10.1037/0882-7974.12.1.183 9100279,397,141,Alzheimers_Res_Ther_2016_Jul_30_8_26.txt
6.25.8.875,... Soc Clin Psychol 2006 25 875 884 10.1521/jscp.2006.25.8.875,216,170,Alzheimers_Res_Ther_2016_Oct_26_8_45.txt
6.17.3.140,... Cancer Prev 2016 17 3 1405 1410 10.7314/APJCP.2016.17.3.1405 27039780,239,270,Alzheimers_Res_Ther_2016_Oct_26_8_45.txt
4.17.1.85,...odel Psychol Aging 2002 17 85 100 10.1037/0882-7974.17.1.85 11931290,315,127,Alzheimers_Res_Ther_2016_Dec_8_8_56.txt
4.52.1.81,...s J Pers Soc Psychol 1987 52 1 81 10.1037/0022-3514.52.1.81 3820081,327,165,PMC5290611.txt
5.19.3.267,... Neuropsychology 2005 19 3 267 77 10.1037/0894-4105.19.3.267 15910113,298,238,PMC5336665.txt
4.35.9.645,"... Psychology , 35 , 645 -655 . doi:10.1037/0022-3514.35.9.645",253,188,Am_Behav_Sci_2016_Nov_22_60(12)_1458-1474.txt
EC 4.4.1.4,...depending on the C-S lyase activity of alliinase (EC 4.4.1.4) on (+)-alliin ((+)-S-allyl-L-cysteine ...,6,545,AMB_Express_2011_Mar_28_1_2.txt
EC 4.4.1.6,"...fore distinguished from S-alkyl-L-cysteine lyase (EC 4.4.1.6), which simply exhibits C-S lyase activ...",6,780,AMB_Express_2011_Mar_28_1_2.txt
EC 4.4.1.6,"...ally distinguished from S-alkyl L-cysteine lyase (EC 4.4.1.6), which stoichiometrically converts S-a...",134,305,AMB_Express_2011_Mar_28_1_2.txt
EC 1.14.14.1,Cytochrome P450s (EC 1.14.14.1; P450 or CYP) are remarkably diverse ...,6,19,AMB_Express_2011_Mar_28_1_1.txt
4.37.2.199,...chem Mol Biol 2004 37 2 199 205 10.5483/BMBRep.2004.37.2.199 15469696,169,190,AMB_Express_2011_Sep_30_1_26.txt
4.37.5.574,...ochem Mol Biol 2004 37 5 574 81 10.5483/BMBRep.2004.37.5.574 15479621,170,200,AMB_Express_2011_Sep_30_1_26.txt
EC 1.11.2.1,...ic peroxygenase (APO) or unspecific peroxygenase (EC 1.11.2.1; http://www.chem.qmul.ac.uk/iubmb/enzy...,10,297,AMB_Express_2011_Oct_11_1_31.txt
EC 1.11.1.7,Production of a classic peroxidase (EC 1.11.1.7) by Coprinopsis (Coprinus) cinerea UAM...,149,37,AMB_Express_2011_Oct_11_1_31.txt
EC 1.6.8.1,"...urned out to be a FMN-coupled NADH-dehydrogenase [EC 1.6.8.1], while the second subunit was claimed ...",8,759,AMB_Express_2011_Jun_23_1_13.txt
EC 4.4.1.15,"...enzyme having a cysteine desulfuhydrase activity (EC 4.4.1.15, EC 4.4.1.1). This mechanism is in acc...",148,1058,AMB_Express_2011_Nov_2_1_36.txt
EC 4.4.1.1,"... a cysteine desulfuhydrase activity (EC 4.4.1.15, EC 4.4.1.1). This mechanism is in accordance with ...",148,1071,AMB_Express_2011_Nov_2_1_36.txt
1.14.10.114,...icrobe Interact 2001 14 1149 1157 10.1094/MPMI.2001.14.10.1149 11605954,117,269,AMB_Express_2012_Jan_24_2_7.txt
EC 2.6.1.1,"...the reaction mechanism of aspartate transaminase (EC 2.6.1.1) has been studied extensively, which is...",31,579,AMB_Express_2012_Jan_31_2_11.txt
EC 2.6.1.14,"...nsaminase, e.g. asparagine:oxo-acid transaminase (EC 2.6.1.14). As of January 2012 81 different subg...",34,1636,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.1,I and II	00155	I	aspartate TA	L-aspartate	α-KG	2.6.1.1	α,39,48,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.57,I	aromatic TA	L-phenylalanine	α-KG	2.6.1.57	α,40,38,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.11,...I	00202	I	acetylornithine TA	acetylornithine	α-KG	2.6.1.11	ω,41,53,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.13,I	ornithine TA	ornithine	α-KG	2.6.1.13	ω,42,33,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.18,I	β-alanine:pyruvate TA	β-alanine	PYR	2.6.1.18	ω,43,41,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.19,I	4-aminobutyrate TA	4-aminobutyrate	α-KG	2.6.1.19	ω,45,45,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.21,IV	01063	IV	D-alanine TA	D-alanine	α-KG	2.6.1.21	α,46,41,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.42,IV	branched-chain amino-acid TA	leucine	α-KG	2.6.1.42	α,47,48,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.52,V	00266	I	phosphoserine TA	phosphoserine	α-KG	2.6.1.52	Α,48,47,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.87,...	I	ArnB	UDP-4-amino-4-deoxy-beta-L-arabinose	α-KG	2.6.1.87	α,49,59,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.18,...owards β-amino acids. β-Alanine:pyruvate TAs (E.C.2.6.1.18) and β-aminoisobutyrate:α-ketoglutarate T...,54,118,AMB_Express_2012_Jan_31_2_11.txt
2.6.1.22,"...) and β-aminoisobutyrate:α-ketoglutarate TAs (E.C.2.6.1.22) are abundant in living cells, because th...",54,176,AMB_Express_2012_Jan_31_2_11.txt
1.91.2.173,...r Phytopathology 2001 91 173 180 10.1094/PHYTO.2001.91.2.173 18944391,276,227,AMB_Express_2011_Dec_14_1_46.txt
EC 1.4.1.16,"...r meso-diaminopimelate dehydrogenase (meso-DAPDH, EC 1.4.1.16), which catalyzes the NAD(P)-dependent...",3,1383,AMB_Express_2011_Nov_25_1_43.txt
EC 1.4.1.16,"...-2,6-D-diaminopimerate dehydrogenase, meso-DAPDH, EC 1.4.1.16) catalyzes the NADP-dependent oxidativ...",8,91,AMB_Express_2011_Nov_25_1_43.txt
3.1.1.20,"...nges were made.Tannase (tannin acyl hydrolase E.C 3.1.1.20) is an inducible, largely extracellular e...",4,439,AMB_Express_2016_Jul_13_6_46.txt
3.1.1.20,...y for determination of tannin acyl hydrolase (E.C.3.1.1.20) activity Anal Biochem 2001 295 168 171 1...,268,109,AMB_Express_2016_Jul_13_6_46.txt
3.1.1.20,...halam M   Screening of tannin acyl hydrolase (E.C.3.1.1.20) producing tannery effluent fungal isolat...,270,84,AMB_Express_2016_Jul_13_6_46.txt
EC 3.2.1.132,Chitosanase (EC 3.2.1.132) is a member of glycosyl hydrolase fa...,12,14,AMB_Express_2012_Feb_16_2_13.txt
2.46.3.225,...y Holzforschung 1992 46 3 225 232 10.1515/hfsg.1992.46.3.225,128,201,AMB_Express_2012_Mar_12_2_15.txt
EC 1.13.11.12,"Lipoxygenases (EC 1.13.11.12, EC 1.13.11.34 and EC 1.13.11.33) ar...",6,16,AMB_Express_2012_Mar_26_2_17.txt
EC 1.13.11.34,"Lipoxygenases (EC 1.13.11.12, EC 1.13.11.34 and EC 1.13.11.33) are non-heme, iro...",6,31,AMB_Express_2012_Mar_26_2_17.txt
EC 1.13.11.33,"Lipoxygenases (EC 1.13.11.12, EC 1.13.11.34 and EC 1.13.11.33) are non-heme, iron or manganese con...",6,49,AMB_Express_2012_Mar_26_2_17.txt
3.2.1.14,...nd N-acetyl-β-D-glucosaminidase. Chitinases (E.C. 3.2.1.14) catalyze the hydrolysis of the linear po...,16,127,AMB_Express_2012_Mar_30_2_22.txt
EC 1.14.13.7,"... hydroxyl group by the enzyme phenol hydroxylase (EC 1.14.13.7) resulting in catechol, which is in t...",90,217,AMB_Express_2012_Mar_27_2_18.txt
EC 1.13.11.1,"...s cleaved by the catechol 1,2-dioxygenase enzyme (EC 1.13.11.1), leading to the initial formation of...",90,412,AMB_Express_2012_Mar_27_2_18.txt
EC 1.14.13.7,"...enol and derivatives, such as phenol hydroxylase (EC 1.14.13.7) (78 reads) and enzymes involved in t...",96,184,AMB_Express_2012_Mar_27_2_18.txt
EC 1.13.11.1,"...ol degradation, such as catechol 1,2-dioxygenase (EC 1.13.11.1) (9 reads) and catechol 2,3- dioxygen...",96,557,AMB_Express_2012_Mar_27_2_18.txt
EC 1.13.11.2,"...13.11.1) (9 reads) and catechol 2,3- dioxygenase (EC 1.13.11.2) (23 reads), respectively",96,612,AMB_Express_2012_Mar_27_2_18.txt
EC 3.2.1.91,...BSA) as a standard (Bradford 1976). Exoglucanase (EC 3.2.1.91) activity was measured using 1% Avicel...,40,862,AMB_Express_2012_Mar_15_2_16.txt
EC 3.2.1.21,"... of crude protein. The activity of β-glucosidase (EC 3.2.1.21), β-xylosidase (EC 3.2.1.37), endogluc...",40,1112,AMB_Express_2012_Mar_15_2_16.txt
EC 3.2.1.37,"...ity of β-glucosidase (EC 3.2.1.21), β-xylosidase (EC 3.2.1.37), endoglucanase (EC 3.2.1.4) and endox...",40,1140,AMB_Express_2012_Mar_15_2_16.txt
EC 3.2.1.4,"...1.21), β-xylosidase (EC 3.2.1.37), endoglucanase (EC 3.2.1.4) and endoxylanase (EC 3.2.1.8) in the s...",40,1169,AMB_Express_2012_Mar_15_2_16.txt
EC 3.2.1.8,"...37), endoglucanase (EC 3.2.1.4) and endoxylanase (EC 3.2.1.8) in the supernatant was determined as d...",40,1199,AMB_Express_2012_Mar_15_2_16.txt
EC 1.1.1.1,"When assaying alcohol dehydrogenase (ADH) (EC 1.1.1.1) activity, SSC was conducted as describ...",42,44,AMB_Express_2012_Mar_15_2_16.txt
EC 3.2.1.4,"...raw/bran. Specific activity of (A) endoglucanase (EC 3.2.1.4), (B) exoglucanase (EC 3.2.1.91), (C) β...",73,205,AMB_Express_2012_Mar_15_2_16.txt
EC 3.2.1.91,"...(A) endoglucanase (EC 3.2.1.4), (B) exoglucanase (EC 3.2.1.91), (C) β-glucosidase (EC 3.2.1.21), (D)...",73,236,AMB_Express_2012_Mar_15_2_16.txt
EC 3.2.1.21,"...B) exoglucanase (EC 3.2.1.91), (C) β-glucosidase (EC 3.2.1.21), (D) endoxylanase (EC 3.2.1.8), (E) β...",73,269,AMB_Express_2012_Mar_15_2_16.txt
EC 3.2.1.8,"...C) β-glucosidase (EC 3.2.1.21), (D) endoxylanase (EC 3.2.1.8), (E) β-xylosidase (EC 3.2.1.37) and (F...",73,301,AMB_Express_2012_Mar_15_2_16.txt
EC 3.2.1.37,"... (D) endoxylanase (EC 3.2.1.8), (E) β-xylosidase (EC 3.2.1.37) and (F) alcohol dehydrogenase (ADH) (...",73,332,AMB_Express_2012_Mar_15_2_16.txt
EC 1.1.1.1,...EC 3.2.1.37) and (F) alcohol dehydrogenase (ADH) (EC 1.1.1.1) as determined for F. oxysporum strains...,73,382,AMB_Express_2012_Mar_15_2_16.txt
EC 3.4.21.9,"...tag (bold) and the enteropeptidase (enterokinase, EC 3.4.21.9) restriction site (italic). Subsequent...",65,446,AMB_Express_2012_Mar_27_2_19.txt
EC 1.10.3.2,"Laccases (benzenediol:oxygen oxidoreductases, EC 1.10.3.2.) and related copper-containing protei...",8,47,AMB_Express_2011_Jun_24_1_14.txt
EC 1.14.18.1,"...ster, Pennsylvania, USA). Lyophilized tyrosinase (EC 1.14.18.1) from mushroom (A. bisporus) and a no...",46,392,AMB_Express_2011_Jun_24_1_14.txt
EC 3.4.11.9,"...ork is properly cited.The aminopeptidase P (PepP, EC 3.4.11.9) gene from Lactococcus lactis ssp. lac...",3,1011,AMB_Express_2012_Aug_1_2_39.txt
EC 3.4.11.9,Aminopeptidase P (PepP; EC 3.4.11.9) is an exopeptidase that removes the N...,8,25,AMB_Express_2012_Aug_1_2_39.txt
EC 3.4.11.5,...ses as auxiliary enzymes (proline iminopeptidase; EC 3.4.11.5 or dipeptidyl peptidase IV; EC 3.4.14....,45,248,AMB_Express_2012_Aug_1_2_39.txt
EC 3.4.14.5,...eptidase; EC 3.4.11.5 or dipeptidyl peptidase IV; EC 3.4.14.5) and substrates such as Gly-Pro-pNA or...,45,288,AMB_Express_2012_Aug_1_2_39.txt
EC 3.4.14.11,"...epX activity (X-prolyl dipeptidyl aminopeptidase; EC 3.4.14.11), which is common in lactic acid bact...",163,890,AMB_Express_2012_Aug_1_2_39.txt
EC 3.4.11.2,...h the activity of a general aminopeptidase (PepN; EC 3.4.11.2) ([FitzGerald and O'Cuinn 2006]). PepX...,171,866,AMB_Express_2012_Aug_1_2_39.txt
EC 3.2.1.1,"...able α-amylase (1,4-α-D-glucan glucanohydrolase) (EC 3.2.1.1). from Bacillus licheniformis, 240 KNU-...",36,253,AMB_Express_2012_Sep_28_2_53.txt
EC 3.2.1.91,"...re cellobiohydrolases (or exo-1, 4-β-glucanases) (EC 3.2.1.91), endo-1, 4-β-glucanases (EC 3.2.1.4),...",8,505,AMB_Express_2012_Sep_14_2_49.txt
EC 3.2.1.4,"...lucanases) (EC 3.2.1.91), endo-1, 4-β-glucanases (EC 3.2.1.4), and β-glucosidases (EC 3.2.1.21) (Beg...",8,543,AMB_Express_2012_Sep_14_2_49.txt
EC 3.2.1.21,"... 4-β-glucanases (EC 3.2.1.4), and β-glucosidases (EC 3.2.1.21) (Beguin and Aubert 1994). The endo-1,...",8,576,AMB_Express_2012_Sep_14_2_49.txt
EC 3.2.1.21,"...n the colonies were inoculated on β-glucosidases (EC 3.2.1.21) screening agar containing 1% of CMC, ...",19,207,AMB_Express_2012_Sep_14_2_49.txt
EC 2.3.1.9,"...of the pathway is acetyl-CoA C-acetyltransferase [EC 2.3.1.9], encoded by phaA, which catalyzes the ...",8,901,AMB_Express_2012_Sep_25_2_52.txt
EC 1.1.1.36,...zed by NADPH-dependent acetoacetyl-CoA reductase [EC 1.1.1.36] encoded by phaB (Peoples and Sinskey ...,8,1189,AMB_Express_2012_Sep_25_2_52.txt
EC 2.3.1.-,"...eoples and Sinskey 1989b). Finally, PHA synthase [EC 2.3.1.-] encoded by phaC, catalyzes the polymer...",8,1270,AMB_Express_2012_Sep_25_2_52.txt
EC 3.5.2.2,Hydantoinases (EC 3.5.2.2) were thought to be the microbial count...,9,16,AMB_Express_2012_Jun_27_2_33.txt
EC 3.2.1.4,"...olytic enzyme, including five endoglucanases (EG [EC 3.2.1.4]) (Pere et al",279,126,AMB_Express_2012_Dec_7_2_65.txt
EC 3.2.1.91,"2004), two cellobiohydrolases (CBH [EC 3.2.1.91]) (Bayer et al",281,37,AMB_Express_2012_Dec_7_2_65.txt
EC 3.2.1.21,"1998), and two β-glucosidases (BGL [EC 3.2.1.21]) (Sang-Mok and Ko",282,37,AMB_Express_2012_Dec_7_2_65.txt
EC 1.11.1.14,"...zymes typically includes lignin peroxidases (LiP, EC 1.11.1.14), laccases (EC 1.10.3.2), manganese p...",14,847,AMB_Express_2012_Nov_29_2_62.txt
EC 1.10.3.2,"...lignin peroxidases (LiP, EC 1.11.1.14), laccases (EC 1.10.3.2), manganese peroxidases (MnP, EC 1.11....",14,872,AMB_Express_2012_Nov_29_2_62.txt
EC 1.11.1.13,"...ccases (EC 1.10.3.2), manganese peroxidases (MnP, EC 1.11.1.13), versatile peroxidases (VP, EC 1.11....",14,914,AMB_Express_2012_Nov_29_2_62.txt
EC 1.11.1.16,"...s (MnP, EC 1.11.1.13), versatile peroxidases (VP, EC 1.11.1.16) and other accessory enzymes",14,956,AMB_Express_2012_Nov_29_2_62.txt
EC 1.14.12.3,"...ts it with a Rieske-type benzene 1,2-dioxygenase (EC 1.14.12.3) to benzene cis-dihydrodiol, which is...",8,371,AMB_Express_2013_Jan_17_3_5.txt
EC 1.14.12.11,...a side reaction catalyzed by toluene dioxygenase (EC 1.14.12.11) from the same bacterium. The former...,8,477,AMB_Express_2013_Jan_17_3_5.txt
EC 1.14.13.-,"...r example, the four-component enzymes found under EC 1.14.13.-, some of which can oxidize benzene an...",8,771,AMB_Express_2013_Jan_17_3_5.txt
EC 1.14.13.25,...r aromatics. Soluble methane monooxygenase (sMMO; EC 1.14.13.25) is an example of such a monooxygena...,8,877,AMB_Express_2013_Jan_17_3_5.txt
EC 1.14.14.1,...s hydroxylated by cytochrome P450 monooxygenases (EC 1.14.14.1) using a similar reaction mechanism a...,8,1140,AMB_Express_2013_Jan_17_3_5.txt
EC 1.11.2.1,...erred to as aromatic or unspecific peroxygenases (EC 1.11.2.1) (Hofrichter et al. 2010). The most de...,10,183,AMB_Express_2013_Jan_17_3_5.txt
EC 1.11.1.10,"... chloroperoxidase from Caldariomyces fumago (CPO; EC 1.11.1.10), APOs are able to peroxygenate/hydro...",10,892,AMB_Express_2013_Jan_17_3_5.txt
EC 1.1.1.274,"...-didehydrogluconate reductase; 2,5-DKG reductase; EC 1.1.1.274) is an NAD(P)(H)-dependent oxidoreduc...",8,113,AMB_Express_2013_Jan_28_3_7.txt
1.42.8.485,...J Periodontology 1971 42 8 485 496 10.1902/jop.1971.42.8.485,120,129,AMB_Express_2012_Jul_13_2_35.txt
EC 1.14.19.1,...ncoding the enzyme delta-9 fatty acid desaturase (EC 1.14.19.1). This enzyme introduces a double bon...,208,275,AMB_Express_2012_Dec_5_2_64.txt
EC 3.2.1.52,...20A is a β-N-acetylhexosaminidase classified into EC 3.2.1.52. The maximum LeHex20A activity was obs...,3,1536,AMB_Express_2012_Jun_1_2_29.txt
EC 3.2.1.14,"...lytic enzyme system. One component is chitinases (EC 3.2.1.14), which hydrolyze β-1,4 linkages in ch...",8,242,AMB_Express_2012_Jun_1_2_29.txt
EC 3.2.1.52,"...l. 2001). The other is β-N-acetylhexosaminidases (EC 3.2.1.52), which typically have no activity aga...",8,460,AMB_Express_2012_Jun_1_2_29.txt
EC 3.2.1.75,...20A is a β-N-acetylhexosaminidase classified into EC 3.2.1.75. While some β-N-acetylhexosaminidases ...,46,295,AMB_Express_2012_Jun_1_2_29.txt
EC 3.2.1.52,"...010). Indeed, only six β-N-acetylhexosaminidases (EC 3.2.1.52) that are able to degrade chitin polym...",85,649,AMB_Express_2012_Jun_1_2_29.txt
EC 1.4.1.2,... principal enzymes: glutamate dehydrogenase (Gdh; EC 1.4.1.2 and EC 1.4.1.4) and glutamine synthetas...,38,709,AMB_Express_2013_Mar_28_3_19.txt
EC 1.4.1.4,...mes: glutamate dehydrogenase (Gdh; EC 1.4.1.2 and EC 1.4.1.4) and glutamine synthetase (GS; EC 6.3.1...,38,724,AMB_Express_2013_Mar_28_3_19.txt
EC 6.3.1.2,...1.2 and EC 1.4.1.4) and glutamine synthetase (GS; EC 6.3.1.2). Fungal ammonium assimilation is repor...,38,766,AMB_Express_2013_Mar_28_3_19.txt
EC 3.2.1.30,"...ction, the activity β-N-Acetyl-D-glucosaminidase (EC 3.2.1.30) (NAGase) from Aspergillus niger MYA 1...",12,588,AMB_Express_2013_May_20_3_27.txt
EC 1.11.1.7,Peroxidases (EC 1.11.1.7) are enzymes that oxidize various hydr...,8,14,AMB_Express_2013_Feb_12_3_14.txt
EC 1.10.3.2,Laccases (EC 1.10.3.2) are polyphenol oxidases that catalyse...,10,11,AMB_Express_2013_Oct_24_3_63.txt
3.36.2.185,...Biochem Mol Biol 2003 3 185 189 10.5483/BMBRep.2003.36.2.185 12689517,86,149,AMB_Express_2013_Jan_29_3_8.txt
1.10.3.2,Laccases (E.C. 1.10.3.2) are well-known enzymes that were first i...,8,16,AMB_Express_2013_Aug_28_3_49.txt
EC 3.2.1.37,"...antarel et al. 2009) encompassing β-d-xylosidase (EC 3.2.1.37), β-1,3-xylosidase (EC 3.2.1.-), α-l-a...",12,108,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.-,"...g β-d-xylosidase (EC 3.2.1.37), β-1,3-xylosidase (EC 3.2.1.-), α-l-arabinofuranosidase (EC 3.2.1.55)...",12,140,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.55,"...xylosidase (EC 3.2.1.-), α-l-arabinofuranosidase (EC 3.2.1.55), endo-arabinanase (EC 3.2.1.99), xyla...",12,178,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.99,"...binofuranosidase (EC 3.2.1.55), endo-arabinanase (EC 3.2.1.99), xylanase (EC 3.2.1.8), and galactan ...",12,210,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.8,"....1.55), endo-arabinanase (EC 3.2.1.99), xylanase (EC 3.2.1.8), and galactan 1,3-β-galactosidase (EC ...",12,234,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.145,"...e (EC 3.2.1.8), and galactan 1,3-β-galactosidase (EC 3.2.1.145) of which some are central in biomass...",12,281,AMB_Express_2013_Sep_11_3_56.txt
3.2.1.37,...ion β-d-xylosidase-α-l-arabinofuranosidases (E.C. 3.2.1.37 / 3.2.1.55) accommodating at subsite −1 d...,12,679,AMB_Express_2013_Sep_11_3_56.txt
3.2.1.55,...osidase-α-l-arabinofuranosidases (E.C. 3.2.1.37 / 3.2.1.55) accommodating at subsite −1 d-xylopyrano...,12,690,AMB_Express_2013_Sep_11_3_56.txt
3.2.1.37,...tarel et al. 2009) includes β-d-xylosidases (E.C. 3.2.1.37) and α-l-arabinofuranosidases (E.C. 3.2.1...,49,250,AMB_Express_2013_Sep_11_3_56.txt
3.2.1.55,...E.C. 3.2.1.37) and α-l-arabinofuranosidases (E.C. 3.2.1.55) and the phylogenetic tree of 92 GH43 enz...,49,295,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.145,"...roup I consists of galactan 1,3-β-galactosidases (EC 3.2.1.145), group II mainly of α-l-arabinofuran...",49,582,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.55,"...45), group II mainly of α-l-arabinofuranosidases (EC 3.2.1.55), while group III and IV are divided i...",49,642,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.55,...ominately extracellular α-l-arabinofuranosidases (EC 3.2.1.55) and the other intracellular β-d-xylos...,49,786,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.37,....55) and the other intracellular β-d-xylosidases (EC 3.2.1.37). Group V is solely composed of endo-a...,49,844,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.99,... Group V is solely composed of endo-arabinanases (EC 3.2.1.99),49,907,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.37,"...ities have been abbreviated as X: β-d-xylosidase (EC 3.2.1.37). X13: β-1,3-xylosidase (EC 3.2.1.-). ...",51,307,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.-,"...-xylosidase (EC 3.2.1.37). X13: β-1,3-xylosidase (EC 3.2.1.-). A: α-l-arabinofuranosidase (EC 3.2.1....",51,344,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.55,"...osidase (EC 3.2.1.-). A: α-l-arabinofuranosidase (EC 3.2.1.55). eA: endo-arabinanase (EC 3.2.1.99), ...",51,385,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.99,"...furanosidase (EC 3.2.1.55). eA: endo-arabinanase (EC 3.2.1.99), eX: endo-xylanase (EC 3.2.1.8). G: g...",51,421,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.8,"...ndo-arabinanase (EC 3.2.1.99), eX: endo-xylanase (EC 3.2.1.8). G: galactan 1,3-β-galactosidase (EC 3...",51,454,AMB_Express_2013_Sep_11_3_56.txt
EC 3.2.1.145,"...se (EC 3.2.1.8). G: galactan 1,3-β-galactosidase (EC 3.2.1.145). The entries are numbered and furthe...",51,500,AMB_Express_2013_Sep_11_3_56.txt
EC 4.2.1.1,...ysiological functioning. Carbonic anhydrase (CA) (EC 4.2.1.1) catalyzes the interconversion between ...,8,239,AMB_Express_2014_Jan_10_4_2.txt
3.2.1.4,"...e found, including endo-1,4-β-D-glucanases (entry 3.2.1.4; BA: 72 and RJ: 90), 1,4-β-cellobiosidases...",170,101,AMB_Express_2013_Oct_26_3_65.txt
3.2.1.91,"...2.1.4; BA: 72 and RJ: 90), 1,4-β-cellobiosidases (3.2.1.91; BA: 4 and RJ: 3), and β-glucosidases (3....",170,153,AMB_Express_2013_Oct_26_3_65.txt
3.2.1.21,"... (3.2.1.91; BA: 4 and RJ: 3), and β-glucosidases (3.2.1.21; BA: 279 and RJ: 228). Sequences classifi...",170,201,AMB_Express_2013_Oct_26_3_65.txt
3.2.1.37,"...s classified as putative xylan-degrading enzymes (3.2.1.37, 1,4-β-xylosidases; BA: 23 and RJ: 9) wer...",170,291,AMB_Express_2013_Oct_26_3_65.txt
4.3.1.2,...tion of methylaspartate ammonia-lyase (EC number: 4.3.1.2). This enzyme produces ammonia as a subpro...,178,298,AMB_Express_2013_Oct_26_3_65.txt
4.3.1.3,"... well represented by histidine ammonia-lyase (EC: 4.3.1.3), L-tryptophan indole-lyase (EC: 4.1.99.1)...",178,499,AMB_Express_2013_Oct_26_3_65.txt
4.1.99.1,"...ase (EC: 4.3.1.3), L-tryptophan indole-lyase (EC: 4.1.99.1), D-amino-acid dehydrogenase (EC: 1.4.99....",178,540,AMB_Express_2013_Oct_26_3_65.txt
1.4.99.1,"...e (EC: 4.1.99.1), D-amino-acid dehydrogenase (EC: 1.4.99.1), and L-cystathionine L-homocysteine-lyas...",178,583,AMB_Express_2013_Oct_26_3_65.txt
4.4.1.8,"...1), and L-cystathionine L-homocysteine-lyase (EC: 4.4.1.8). These enzymes were found at higher abund...",178,640,AMB_Express_2013_Oct_26_3_65.txt
1.1.1.1,"...of 202 and 183 alcohol dehydrogenases (EC number: 1.1.1.1) in BA and RJ samples, respectively, which...",182,136,AMB_Express_2013_Oct_26_3_65.txt
1.14.13.1,"...-monooxygenases from the same pathway (EC number: 1.14.13.1) were found in the BA and RJ samples, re...",182,321,AMB_Express_2013_Oct_26_3_65.txt
4.94.2.147,...ola Phytopathol 2004 4 2 147 153 10.1094/PHYTO.2004.94.2.147,133,262,AMB_Express_2014_May_29_4_45.txt
EC 3.2.1.8,"...zlewood [1993]). Xylanases (endo-1,4-β-xylanases; EC 3.2.1.8) catalyze the hydrolysis of the β-1,4 b...",8,560,AMB_Express_2014_Apr_1_4_27.txt
EC 4.1.1.15,Glutamate decarboxylase (GAD; EC 4.1.1.15) catalyzes the conversion of L-glutama...,10,31,AMB_Express_2014_Apr_1_4_20.txt
EC 2.7.11.1,"...OdhI and serine/threonine protein kinase G (PknG, EC 2.7.11.1) (Schultz et al. [2009]). PknG catalyz...",14,778,AMB_Express_2014_Apr_1_4_20.txt
EC 3.2.1.4,"...llulases traditionally grouped as endoglucanases (EC 3.2.1.4), exoglucanases (EC 3.2.1.91 and 3.2.1....",10,148,AMB_Express_2014_Apr_25_4_36.txt
EC 3.2.1.91,"...ed as endoglucanases (EC 3.2.1.4), exoglucanases (EC 3.2.1.91 and 3.2.1.176) and β-glucosidases (EC ...",10,176,AMB_Express_2014_Apr_25_4_36.txt
3.2.1.176,"...ases (EC 3.2.1.4), exoglucanases (EC 3.2.1.91 and 3.2.1.176) and β-glucosidases (EC 3.2.1.21) (Lynd ...",10,192,AMB_Express_2014_Apr_25_4_36.txt
EC 3.2.1.21,...s (EC 3.2.1.91 and 3.2.1.176) and β-glucosidases (EC 3.2.1.21) (Lynd et al. [2002]; Saharay et al. [...,10,223,AMB_Express_2014_Apr_25_4_36.txt
3.2.1.8,"...lar xylanase (1,4-β-D-xylan xylanohydrolase; E.C. 3.2.1.8) and β-xylosidase (1,4-β-D-xylan xylohydro...",8,1068,AMB_Express_2014_Jul_9_4_55.txt
3.2.1.37,"...d β-xylosidase (1,4-β-D-xylan xylohydrolase; E.C. 3.2.1.37); the studied action of these two enzymes...",8,1129,AMB_Express_2014_Jul_9_4_55.txt
2.92.3.255,...liae Phytopathol 2002 92 255 264 10.1094/PHYTO.2002.92.3.255,208,169,AMB_Express_2014_Sep_30_4_74.txt
1.2.2.5,Mass spectra were analyzed by MaxQuant v1.2.2.5 (Cox and Mann [2008]) for protein identifi...,49,41,AMB_Express_2014_Aug_29_4_71.txt
EC 1.1.1.28,"...dependent d- and l-lactate dehydrogenases (d-LDH, EC 1.1.1.28; and l-LDH, EC 1.1.1.27) reduce pyruva...",9,55,AMB_Express_2014_Oct_28_4_76.txt
EC 1.1.1.27,"...te dehydrogenases (d-LDH, EC 1.1.1.28; and l-LDH, EC 1.1.1.27) reduce pyruvate to d- and l-lactate, ...",9,79,AMB_Express_2014_Oct_28_4_76.txt
1.46.6.130,...a Limnol Oceanogr 2001 46 1309 1318 10.4319/lo.2001.46.6.1309,254,148,AMB_Express_2014_Aug_30_4_60.txt
EC 4.2.1.17,"...fused polypeptide exhibiting enoyl-CoA hydratase (EC 4.2.1.17), epimerase (EC 5.1.2.3) and isomerase...",10,1416,AMB_Express_2014_Aug_28_4_69.txt
EC 5.1.2.3,"...ing enoyl-CoA hydratase (EC 4.2.1.17), epimerase (EC 5.1.2.3) and isomerase/3-hydroxyacyl-CoA dehydr...",10,1441,AMB_Express_2014_Aug_28_4_69.txt
EC 1.1.1.35,"...3) and isomerase/3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35; EC 5.3.3.8) activities. FadBEc forms,...",10,1500,AMB_Express_2014_Aug_28_4_69.txt
EC 5.3.3.8,"...ase/3-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.35; EC 5.3.3.8) activities. FadBEc forms, together wit...",10,1513,AMB_Express_2014_Aug_28_4_69.txt
1.1.1.36,"...DPH-dependent acetoacetyl-CoA reductase, PhaB (EC.1.1.1.36; Haywood et al. [1988a]). The third step ...",12,435,AMB_Express_2014_Aug_28_4_69.txt
3.74.11.164,...J Periodontol 2003 74 11 1647 1651 10.1902/jop.2003.74.11.1647 14682662,170,226,AMB_Express_2015_Jan_24_5(1)_6.txt
5.50.4.117,...y Limnol Oceanogr 2005 50 1172 1180 10.4319/lo.2005.50.4.1172,324,226,AMB_Express_2015_Feb_1_5_8.txt
3.12.10.265,...ro  J Wound Care 2003 12 413 418 10.12968/jowc.2003.12.10.26552 14648968,344,210,AMB_Express_2015_Feb_1_5_8.txt
3.2.1.4,"... glucose molecule. First, endo-β-glucanases (E.C. 3.2.1.4) cleave the cellulose backbone at internal...",13,541,AMB_Express_2015_Feb_25_5_15.txt
3.2.1.91,...reating numerous ends where exo-β-glucanases (E.C.3.2.1.91) attack to release short-chain glucose ol...,13,692,AMB_Express_2015_Feb_25_5_15.txt
3.2.1.21,... to single glucose units by a β-glucosidase (E.C. 3.2.1.21) (Singh and Hayashi 1995; Teeri 1997),13,1062,AMB_Express_2015_Feb_25_5_15.txt
EC 1.1.1.283,The NADPH-dependent methylglyoxal reductase (EC 1.1.1.283) in Saccharomyces cerevisiae is terme...,9,46,AMB_Express_2015_Mar_3_5_17.txt
EC 1.10.3.2,"Laccases (Lcc, EC 1.10.3.2) are found across kingdoms of life (e....",11,16,AMB_Express_2015_Mar_11_5_19.txt
4.94.11.124,...hytopathology 2004 94 11 1249 51 10.1094/PHYTO.2004.94.11.1249 18944462,153,87,AMB_Express_2015_Apr_17_5_24.txt
4.42.3.305,...ure Mycobiology 2014 42 3 305 309 10.5941/MYCO.2014.42.3.305 25346612,116,227,AMB_Express_2015_May_1_5_25.txt
EC 4.2.1.7,"...C. cellulovorans uses pectin lyase (Clocel_2259) (EC 4.2.1.7), which showed elevated levels in our a...",163,2411,AMB_Express_2015_May_23_5_29.txt
EC 1.14.14.11,Styrene monooxygenases (SMO; EC 1.14.14.11) are two-component flavoenzymes comp...,13,30,AMB_Express_2015_Jun_4_5_30.txt
EC 3.2.1.4,"...use of a portfolio of cellulases: endoglucanases (EC 3.2.1.4) randomly cleave internal β-1,4-glycosi...",13,1000,AMB_Express_2015_Jun_10_5_33.txt
EC 3.2.1.91,"...,4-glycosidic linkages, while cellobiohydrolases (EC 3.2.1.91) produce cellobiose by hydrolyzing cha...",13,1090,AMB_Express_2015_Jun_10_5_33.txt
EC 3.2.1.21,"...and polysaccharides, and finally, β-glucosidases (EC 3.2.1.21) produce glucose from cellobiose (Klip...",13,1208,AMB_Express_2015_Jun_10_5_33.txt
EC 3.2.1.37,"...zed xylan to xylose and neither had β-xylosidase (EC 3.2.1.37) activity, indicating that they are en...",4,1440,AMB_Express_2015_Jun_12_5_36.txt
EC 3.2.1.8,"...ivity, indicating that they are endo-β-xylanases (EC 3.2.1.8). With these results, we expect that Pa...",4,1506,AMB_Express_2015_Jun_12_5_36.txt
EC 3.2.1.8,"... secrete xylanases from xylose. Endo-β-xylanases (EC 3.2.1.8), which hydrolyze xylopyranosyl linkage...",16,202,AMB_Express_2015_Jun_12_5_36.txt
EC 3.2.1.8,"...re endoxylanases (1,4-β-d-xylan xylanohydrolases (EC 3.2.1.8)). Since these PaXyns did not have any ...",172,370,AMB_Express_2015_Jun_12_5_36.txt
3.45.1.22,...ns Infect Chemother 2013 45 1 22 31 10.3947/ic.2013.45.1.22 24265947,148,148,AMB_Express_2015_Jun_26_5_38.txt
5.3.4.19,"...analysis were carried out using ASTRA software (v 5.3.4.19, Wyatt). Based on numerous measurements o...",42,720,AMB_Express_2015_Aug_4_5_45.txt
3.23.3.399,...  Stems J Life Sci 2013 23 399 405 10.5352/JLS.2013.23.3.399,193,181,AMB_Express_2015_Aug_12_5_49.txt
4.42.3.305,...lture Mycobiology 2014 42 305 309 10.5941/MYCO.2014.42.3.305 25346612,108,225,AMB_Express_2015_Aug_14_5_51.txt
EC 1.10.3.2,"Laccases (benzenediol: oxygen oxidoreductase, EC 1.10.3.2) are multicopper oxidases that catalyz...",9,47,AMB_Express_2015_Jan_16_5_1.txt
4.1.1.15,"...ependent enzyme glutamate decarboxylase (Gad, EC: 4.1.1.15). Direct synthesis of GABA from glucose i...",12,168,AMB_Express_2016_Aug_22_6_55.txt
EC 3.2.1.8,"...s the coordinated action of endo-β-1,4-xylanases (EC 3.2.1.8) and β-xylosidases (EC 3.2.1.37). The e...",17,1075,AMB_Express_2016_Sep_15_6_73.txt
EC 3.2.1.37,"...o-β-1,4-xylanases (EC 3.2.1.8) and β-xylosidases (EC 3.2.1.37). The endoxylanases cleave the xylan t...",17,1106,AMB_Express_2016_Sep_15_6_73.txt
EC 3.2.1.37,"β-Xylosidase (β-d-xylan xylohydrolase, EC 3.2.1.37) activity was estimated using pNPX as ...",29,40,AMB_Express_2016_Sep_15_6_73.txt
EC 1.10.3.2,Laccases (EC 1.10.3.2) belong to a group of polyphenol oxida...,15,11,AMB_Express_2015_Sep_17_5_63.txt
EC 1.1.1.47,Glucose dehydrogenase (GluDH; EC 1.1.1.47) catalyzes the oxidation of β-d-glucos...,12,31,AMB_Express_2015_Nov_4_5_68.txt
EC 3.2.1.55,α-l-arabinofuranosidases (α-l-AFases) (EC 3.2.1.55) take part in the hydrolysis of hemice...,10,40,AMB_Express_2015_Dec_21_5_79.txt
EC 3.5.2.2,...s of enantiopure β-amino acids. The hydantoinase (EC 3.5.2.2) from Arthrobacter crystallopoietes DSM...,4,630,AMB_Express_2015_Dec_24_5_85.txt
EC 3.5.1.77,...worthwhile to detect an appropriate carbamoylase (EC 3.5.1.77; EC 3.5.1.87) realizing this reaction ...,112,396,AMB_Express_2015_Dec_24_5_85.txt
EC 3.5.1.87,... detect an appropriate carbamoylase (EC 3.5.1.77; EC 3.5.1.87) realizing this reaction to gain β-ami...,112,409,AMB_Express_2015_Dec_24_5_85.txt
EC 3.5.1.6,...ction to gain β-amino acids. β-Ureidopropionases (EC 3.5.1.6) may also be prospect enzymes since the...,112,490,AMB_Express_2015_Dec_24_5_85.txt
4.17.7.711,... Microbe Interact 2004 17 711 719 10.1094/MPMI.2004.17.7.711 15242165,270,246,AMB_Express_2016_Feb_17_6_12.txt
EC 3.2.14.4,"...classification are as follow: (a) endoglucanases (EC 3.2.14.4 1,4-β-d-glucan-4-glucanohydrolase): pr...",14,99,AMB_Express_2016_Mar_1_6_17.txt
EC 3.2.1.91,"...o other enzymatic attack; (b) cellobiohydrolases (EC 3.2.1.91 1,4-β-d-glucancellobiohydrolases): exo...",14,359,AMB_Express_2016_Mar_1_6_17.txt
EC 3.2.1.21,"...erminal portion of the chains; (c) β-glucosidase (EC 3.2.1.21): cellobiose hydrolysis and, in some c...",14,541,AMB_Express_2016_Mar_1_6_17.txt
EC 3.2.1.8,"...anases are as follow: (a) endo-1,4-β-d-xylanases (EC 3.2.1.8): hydrolysis of β-1,4 linkage of xylan ...",16,87,AMB_Express_2016_Mar_1_6_17.txt
EC 3.2.1.37,...erization degree of the substrate; β-xylosidases (EC 3.2.1.37): small xylo-oligosaccharide hydrolysi...,16,215,AMB_Express_2016_Mar_1_6_17.txt
EC 3.2.1.55,...drolysis to xylose; (c) α-l-arabinofuranosidases (EC 3.2.1.55): hydrolysis of α-l-arabinofuranosyl t...,16,308,AMB_Express_2016_Mar_1_6_17.txt
EC 3.2.1.1,"...ofuranosyl terminal groups; (d) α-glucoronidases (EC 3.2.1.1): hydrolysis of α-1,2 glycosidic linkag...",16,396,AMB_Express_2016_Mar_1_6_17.txt
EC 3.1.1.72,"... and glucuronic acid; (e) acetyl xylan esterases (EC 3.1.1.72): hydrolysis of xylose, acetic acid an...",16,513,AMB_Express_2016_Mar_1_6_17.txt
EC 3.1.1.73,...ic acid and ferulic acid; (f) feruloyl esterases (EC 3.1.1.73): increment of the hydrolytic enzyme a...,16,603,AMB_Express_2016_Mar_1_6_17.txt
EC 2.1.3.3,"...rginine operon (L-ornithine carbamoyltransferase (EC 2.1.3.3) argF, argininosuccinate synthetase (EC...",87,483,AMB_Express_2014_Dec_10_4_85.txt
EC 6.3.4.5,"... (EC 2.1.3.3) argF, argininosuccinate synthetase (EC 6.3.4.5) argG, and L-arginine biosynthesis oper...",87,531,AMB_Express_2014_Dec_10_4_85.txt
EC 2.7.2.8,"...back-resistant N-acetyl L-glutamate kinase (NAGK, EC 2.7.2.8). When grown in minimal medium with 2% ...",100,296,AMB_Express_2014_Dec_10_4_85.txt
EC 3.4.99.11,...nus Bacillus (Gobinath et al. 2014). Keratinases (EC 3.4.99.11) are serine- or metalloproteases (Gup...,12,976,AMB_Express_2016_Jun_30_6_42.txt
2.2.3.1,...sing the Basic Local Alignment Search Tool Blastp 2.2.3.1 available at NCBI,37,212,AMB_Express_2016_Jun_30_6_42.txt
2.2.3.1,...1 with proteases of Bacillus strains using Blastp 2.2.3.,82,358,AMB_Express_2016_Jun_30_6_42.txt
2.2.3.1,...2 with proteases of Bacillus strains using Blastp 2.2.3.,203,103,AMB_Express_2016_Jun_30_6_42.txt
3.4.22.32,"A member of papain family, stem bromelain (E.C.3.4.22.32) contains 212 amino acid residues includ...",12,48,AMB_Express_2012_Feb_15_2_12.txt
3.4.22.33,"...Maurer, 2001). In contrast, fruit bromelain (E.C. 3.4.22.33) is genetically distinct from stem brome...",12,721,AMB_Express_2012_Feb_15_2_12.txt
4.88.7.688,...ium wilt Plant Dis 2004 3 688 694 10.1094/PDIS.2004.88.7.688,160,164,AMB_Express_2013_Aug_17_3_46.txt
3.2.1.4,"...the synergistic action among endoglucanases (E.C. 3.2.1.4), cellobiohydrolases (E.C. 3.2.1.91), and ...",9,421,AMB_Express_2015_Jan_24_5(1)_3.txt
3.2.1.91,"...ucanases (E.C. 3.2.1.4), cellobiohydrolases (E.C. 3.2.1.91), and β-glucosidases (BGLs, E.C. 3.2.1.21...",9,456,AMB_Express_2015_Jan_24_5(1)_3.txt
3.2.1.21,"...s (E.C. 3.2.1.91), and β-glucosidases (BGLs, E.C. 3.2.1.21, Woodward 1991). However it has been know...",9,498,AMB_Express_2015_Jan_24_5(1)_3.txt
EC 3.2.1.21,"...wn that GH family 3 is composed of β-glucosidase (EC 3.2.1.21), glucan 1,3-β-glucosidase (EC 3.2.1.5...",158,60,AMB_Express_2015_Jan_24_5(1)_3.txt
EC 3.2.1.58,"...cosidase (EC 3.2.1.21), glucan 1,3-β-glucosidase (EC 3.2.1.58), glucan 1,4-β-glucosidase (EC 3.2.1.7...",158,100,AMB_Express_2015_Jan_24_5(1)_3.txt
EC 3.2.1.74,"...cosidase (EC 3.2.1.58), glucan 1,4-β-glucosidase (EC 3.2.1.74), exo-1,3-1,4-glucanase (EC 3.2.1.-), ...",158,140,AMB_Express_2015_Jan_24_5(1)_3.txt
EC 3.2.1.-,"...glucosidase (EC 3.2.1.74), exo-1,3-1,4-glucanase (EC 3.2.1.-), xylan 1,4-β-xylosidase (EC 3.2.1.37),...",158,177,AMB_Express_2015_Jan_24_5(1)_3.txt
EC 3.2.1.37,"...4-glucanase (EC 3.2.1.-), xylan 1,4-β-xylosidase (EC 3.2.1.37), β-N-acetylhexosaminidase (EC 3.2.1.5...",158,214,AMB_Express_2015_Jan_24_5(1)_3.txt
EC 3.2.1.52,"...losidase (EC 3.2.1.37), β-N-acetylhexosaminidase (EC 3.2.1.52), α-L-arabinofuranosidase (EC 3.2.1.55...",158,254,AMB_Express_2015_Jan_24_5(1)_3.txt
EC 3.2.1.55,"...aminidase (EC 3.2.1.52), α-L-arabinofuranosidase (EC 3.2.1.55). In addition, BGLs are divided into t...",158,293,AMB_Express_2015_Jan_24_5(1)_3.txt
EC 4.2.1.10,"...chorismate. 3-Dehydroquinate dehydratase (DHQase, EC 4.2.1.10) catalyzes the third step, i.e., rever...",9,398,AMB_Express_2015_Feb_1_5_7.txt
3.4.15.5,1	0.065	1y79A	0.419	6.15	0.074	0.719	3.4.15.5 	NA,179,38,AMB_Express_2015_Aug_27_5_59.txt
3.1.1.7,2	0.065	1maaD	0.404	6.29	0.048	0.704	3.1.1.7 	NA,180,38,AMB_Express_2015_Aug_27_5_59.txt
2.3.1.54,3	0.065	1h16A	0.416	6.33	0.042	0.727	2.3.1.54 	NA,181,38,AMB_Express_2015_Aug_27_5_59.txt
3.1.1.7,4	0.065	1b41A	0.345	6.35	0.030	0.623	3.1.1.7 	NA,182,38,AMB_Express_2015_Aug_27_5_59.txt
3.1.1.8,5	0.065	2pm8A	0.406	6.39	0.046	0.727	3.1.1.8 	NA,183,38,AMB_Express_2015_Aug_27_5_59.txt
EC 3.2.1.4,"... similarity (59–94 %) to endo-1,4-β-d-glucanases (EC 3.2.1.4) from the glycoside hydrolase family 8 ...",4,862,AMB_Express_2016_Aug_31_6(1)_63.txt
EC 3.2.1.4,"...erization of cellulose, are mainly endoglucanase (EC 3.2.1.4), exoglucanase (EC 3.2.1.176) (EC 3.2.1...",12,429,AMB_Express_2016_Aug_31_6(1)_63.txt
EC 3.2.1.176,"... mainly endoglucanase (EC 3.2.1.4), exoglucanase (EC 3.2.1.176) (EC 3.2.1.91) and β-glucosidase (EC ...",12,456,AMB_Express_2016_Aug_31_6(1)_63.txt
EC 3.2.1.91,"...canase (EC 3.2.1.4), exoglucanase (EC 3.2.1.176) (EC 3.2.1.91) and β-glucosidase (EC 3.2.1.21). Endo...",12,471,AMB_Express_2016_Aug_31_6(1)_63.txt
EC 3.2.1.21,...e (EC 3.2.1.176) (EC 3.2.1.91) and β-glucosidase (EC 3.2.1.21). Endoglucanases hydrolyze glycosidic ...,12,503,AMB_Express_2016_Aug_31_6(1)_63.txt
EC 3.2.1.4,"... cel8A), encoding for an endoglucanase precursor (EC 3.2.1.4). The spr cel8A gene from S. proteamacu...",87,310,AMB_Express_2016_Aug_31_6(1)_63.txt
EC 1.15.1.1,Classification of superoxide dismutase (EC 1.15.1.1) isoforms was performed by non-denatur...,55,41,AMB_Express_2016_Sep_13_6(1)_70.txt
EC 1.11.1.6,Catalase (EC 1.11.1.6) activity was observed after protein s...,61,11,AMB_Express_2016_Sep_13_6(1)_70.txt
3.46.8.237,...croglia BMB Rep 2013 46 398 403 10.5483/BMBRep.2013.46.8.237 23977987,107,186,AMB_Express_2016_Sep_13_6(1)_71.txt
3.2.1.55,"...es in six classes-(i) α-l-Arabinofuranosidase (EC 3.2.1.55), which is not active with polymers (Koma...",98,192,AMB_Express_2016_Oct_3_6_82.txt
3.2.1.99,"(vi) endo-1, 5-α-l-Arabinanase (EC 3.2.1.99) (Voragen et al. 1987)",108,36,AMB_Express_2016_Oct_3_6_82.txt
2.20.4.371,...her (Seoul) 2012 20 371 379 10.4062/biomolther.2012.20.4.371 2400982,294,179,AMB_Express_2016_Oct_3_6_82.txt
3.5.3.6,The enzyme arginine deiminase (ADI; E.C. 3.5.3.6) catalyses the irreversible deamination of...,10,42,AMB_Express_2016_Oct_3_6_84.txt
2.35.4.428,...iochem Mol Biol 2002 35 428 431 10.5483/BMBRep.2002.35.4.428 12297004,395,133,AMB_Express_2016_Oct_3_6_84.txt
EC 3.1.1.20,...rom tannin. Tannase enzyme (Tannin acyl hydrolase EC 3.1.1.20) hydrolyzes ester bonds in tannin to p...,12,398,AMB_Express_2016_Oct_4_6_89.txt
EC 1.10.3.2,"Laccases (benzenediol: oxygen oxidoreductases, EC 1.10.3.2) are glycoproteins classified as multi...",17,48,AMB_Express_2016_Oct_7_6_93.txt
3.16.2.71,...nterol Hepatol Nutr 2013 16 71 79 10.5223/pghn.2013.16.2.71 24010110,232,150,AMB_Express_2016_Oct_21_6_100.txt
EC 1.11.1.14,"...inolytic enzymes include lignin peroxidases (LiP, EC 1.11.1.14), manganese peroxidases (MnP, EC 1.11...",14,59,AMB_Express_2016_Nov_4_6_104.txt
EC 1.11.1.13,"... (LiP, EC 1.11.1.14), manganese peroxidases (MnP, EC 1.11.1.13) and laccase (Lcc, EC 1.10.3.2). Thes...",14,102,AMB_Express_2016_Nov_4_6_104.txt
EC 1.10.3.2,"...peroxidases (MnP, EC 1.11.1.13) and laccase (Lcc, EC 1.10.3.2). These enzymes can be induced by lign...",14,134,AMB_Express_2016_Nov_4_6_104.txt
5.30.10.150,... Korean Med Sci 2015 30 1503 1508 10.3346/jkms.2015.30.10.1503 26425050,167,220,AMB_Express_2016_Nov_9_6_109.txt
3.20.6.886,...n J Food Preserv 2013 20 886 893 10.11002/kjfp.2013.20.6.886,261,301,AMB_Express_2016_Nov_8_6_105.txt
3.20.5.744,...n J Food Preserv 2013 20 744 750 10.11002/kjfp.2013.20.5.744,262,255,AMB_Express_2016_Nov_8_6_105.txt
EC 4.1.2.9,Phosphoketolase (Xfpk; EC 4.1.2.9 and EC 4.1.2.22) plays a key role in th...,23,24,AMB_Express_2016_Nov_15_6_115.txt
EC 4.1.2.22,Phosphoketolase (Xfpk; EC 4.1.2.9 and EC 4.1.2.22) plays a key role in the metabolism of...,23,39,AMB_Express_2016_Nov_15_6_115.txt
EC 2.3.1.8,"...mon bacterial enzyme, phosphotransacetylase (Pta; EC 2.3.1.8), without requiring any energy input (C...",23,1018,AMB_Express_2016_Nov_15_6_115.txt
3.2.1.14,Chitinase (E.C. 3.2.1.14) is a glycosyl hydrolase which catalyzes ...,10,17,AMB_Express_2016_Nov_14_6_114.txt
3.2.1.17,Lysozyme (EC.3.2.1.17) widely exists in eukaryotes and prokaryo...,10,14,AMB_Express_2016_Nov_10_6_110.txt
3.46.8.251,...chicken Bmb Rep 2013 46 404 409 10.5483/BMBRep.2013.46.8.251 23977988,215,240,AMB_Express_2016_Nov_10_6_110.txt
6.3.3.148,...nt J Microbiol Res 2011 3 148 156 10.9735/0975-5276.3.3.148-156,244,133,PMC5209304.txt
3.2.1.8,"... is played by xylanase (endo-1,4-β-xylanase, E.C. 3.2.1.8), which catalyzes the random hydrolysis of...",10,789,PMC5209306.txt
3.2.1.37,"...nzyme, β-xylosidase (xylan-1,4-β-xylosidase, E.C. 3.2.1.37), completes the process of decomposition ...",10,930,PMC5209306.txt
3.2.1.139,"...o enzymes: glucuronidase (α-glucosiduronase, E.C. 3.2.1.139) and acetylxylan esterase (E.C. 3.1.1.72...",10,1172,PMC5209306.txt
3.1.1.72,"...e, E.C. 3.2.1.139) and acetylxylan esterase (E.C. 3.1.1.72) (Subramaniyan and Prema 2002). According...",10,1214,PMC5209306.txt
1.39.2.103,...ies Mycobiology 2011 39 2 103 108 10.4489/MYCO.2011.39.2.103 22783085,133,142,PMC5209310.txt
2.62.8.9,...logists Bioscience 2012 62 765 768 10.1525/bio.2012.62.8.9,158,132,PMC5209313.txt
1.4.1.3,...tudy may exhibit alcohol dehydrogenase and GDH (EC1.4.1.3) activity for activity towards glutamate a...,245,683,PMC5209314.txt
6.5.2.390,... J Microbiol Res 2013 5 2 390 398 10.9735/0975-5276.5.2.390-398,402,151,PMC5209330.txt
3.2.1.26,"...ertase). Invertase, Enzyme Commission (EC) Number 3.2.1.26 was purchased from sigma Aldrich Korea. 0...",39,427,PMC5218947.txt
4.9.3.130,...ate Environ Eng Res 2004 9 130 142 10.4491/eer.2004.9.3.130,297,180,PMC5256632.txt
3.2.1.4,"3.2.1.4), cellobiohydrolases (EC 3.2.1.91) and β-g...",31,1,PMC5302012.txt
EC 3.2.1.91,"3.2.1.4), cellobiohydrolases (EC 3.2.1.91) and β-glucosidases (EC 3.2.1.21) whic...",31,31,PMC5302012.txt
EC 3.2.1.21,...lobiohydrolases (EC 3.2.1.91) and β-glucosidases (EC 3.2.1.21) whic,31,64,PMC5302012.txt
EC 3.2.1.14,Chitinases (EC 3.2.1.14) are carbohydrate degrading enzymes th...,16,13,PMC5328894.txt
2.62.7.6,...orestry BioScience 2012 62 633 645 10.1525/bio.2012.62.7.6,244,153,Ambio_2013_Mar_10_42(2)_201-214.txt
2.62.8.7,...agement BioScience 2012 62 744 756 10.1525/bio.2012.62.8.7,146,233,Ambio_2013_Mar_10_42(2)_116-128.txt
2.62.1.2,...ble science BioScience 2012 62 5 6 10.1525/bio.2012.62.1.2,230,108,Ambio_2013_Mar_10_42(2)_116-128.txt
2.62.7.6,...orestry BioScience 2012 62 633 645 10.1525/bio.2012.62.7.6,234,153,Ambio_2013_Mar_10_42(2)_229-240.txt
2.62.1.2,...ion science BioScience 2012 62 5 6 10.1525/bio.2012.62.1.2,261,104,Ambio_2013_Mar_10_42(2)_241-253.txt
2.62.8.7,...agement BioScience 2012 62 744 756 10.1525/bio.2012.62.8.7,197,233,Ambio_2013_Mar_10_42(2)_215-228.txt
4.1.1.726,...f Aquatic Science 2009 34 1 14 10.2989/AJAS.2009.34.1.1.726,179,236,Ambio_2013_Sep_14_42(5)_549-565.txt
1.56.3.107,... and Oceanography 2011 56 1075 1092 10.4319/lo.2011.56.3.1075,176,222,Ambio_2014_Feb_12_43(1)_26-36.txt
1.56.6.201,... and Oceanography 2011 56 2018 2026 10.4319/lo.2011.56.6.2018,182,235,Ambio_2014_Feb_12_43(1)_26-36.txt
4.49.5.147,... and Oceanography 2004 49 1471 1481 10.4319/lo.2004.49.5.1471,197,187,Ambio_2014_Feb_12_43(1)_26-36.txt
1.61.8.7,...roversy BioScience 2011 61 614 618 10.1525/bio.2011.61.8.7,225,251,Ambio_2014_Dec_15_43(Suppl_1)_19-29.txt
5.50.6.202,... and Oceanography 2005 50 2022 2031 10.4319/lo.2005.50.6.2022,249,180,Ambio_2014_Dec_15_43(Suppl_1)_19-29.txt
1.61.8.7,...roversy BioScience 2011 63 614 618 10.1525/bio.2011.61.8.7,201,251,Ambio_2014_Dec_15_43(Suppl_1)_77-90.txt
1.46.5.102,... and Oceanography 2001 46 1021 1033 10.4319/lo.2001.46.5.1021,191,148,Ambio_2014_Dec_15_43(Suppl_1)_113-125.txt
6.21.1.1,...ironmental Health 2006 21 1 1 23 10.1515/REVEH.2006.21.1.1 16700427,320,161,Ambio_2014_Dec_15_43(Suppl_1)_45-57.txt
1.56.4.151,... and Oceanography 2011 56 1513 1524 10.4319/lo.2011.56.4.1513,447,213,Ambio_2016_Sep_17_45(5)_516-537.txt
4.49.5.187,... and Oceanography 2004 49 1871 1883 10.4319/lo.2004.49.5.1871,170,248,Ambio_2015_Jan_9_44(Suppl_1)_6-16.txt
2.62.2.10,...Concord BioScience 2012 62 170 181 10.1525/bio.2012.62.2.10,168,212,Ambio_2015_Jan_9_44(Suppl_1)_69-77.txt
2.27.3.264,...in Sweden 1550-1950 Rangifer 2007 12 9 16 10.7557/2.27.3.264,239,85,Ambio_2015_Jan_9_44(Suppl_1)_39-50.txt
6.29.2.158,...hysical Geography 2008 29 158 178 10.2747/0272-3646.29.2.158,118,248,Ambio_2015_Jan_9_44(Suppl_1)_60-68.txt
6.51.5.234,... and Oceanography 2006 51 2341 2348 10.4319/lo.2006.51.5.2341,198,228,Ambio_2015_Mar_15_44(Suppl_2)_263-273.txt
4.49.6.223,... and Oceanography 2004 49 2236 2241 10.4319/lo.2004.49.6.2236,200,200,Ambio_2015_Mar_15_44(Suppl_2)_263-273.txt
2.57.4.116,... and Oceanography 2012 57 1161 1170 10.4319/lo.2012.57.4.1161,219,173,Ambio_2015_Mar_15_44(Suppl_2)_263-273.txt
1.56.3.107,... and Oceanograohy 2011 56 1075 1092 10.4319/lo.2011.56.3.1075,232,222,Ambio_2015_Mar_15_44(Suppl_2)_263-273.txt
1.61.2.6,...s cycle BioScience 2011 61 117 124 10.1525/bio.2011.61.2.6,198,188,Ambio_2015_Mar_15_44(Suppl_2)_228-240.txt
2.37.7.151,... and Oceanography 1992 37 1512 1526 10.4319/lo.1992.37.7.1512,217,193,Ambio_2015_Mar_15_44(Suppl_2)_228-240.txt
2.57.6.185,... and Oceanography 2012 57 1857 1866 10.4319/lo.2012.57.6.1857,224,144,Ambio_2015_Jun_28_44(Suppl_3)_472-483.txt
2.37.8.160,... and Oceanography 1992 37 1608 1617 10.4319/lo.1992.37.8.1608,149,185,Ambio_2015_Jun_28_44(Suppl_3)_345-356.txt
3.48.1.99,...e & Remote Sensing 2011 48 99 111 10.2747/1548-1603.48.1.99,134,181,Ambio_2015_Nov_27_44(Suppl_4)_636-647.txt
3.63.7.10,...or data BioScience 2013 63 574 585 10.1525/bio.2013.63.7.10,242,226,Ambio_2015_Nov_27_44(Suppl_4)_661-673.txt
3.63.11.8,... guides BioScience 2013 63 891 899 10.1525/bio.2013.63.11.8,253,163,Ambio_2015_Nov_27_44(Suppl_4)_661-673.txt
4.59.5.155,... and Oceanography 2014 59 1555 1569 10.4319/lo.2014.59.5.1555,179,209,Ambio_2016_Oct_13_45(6)_635-648.txt
6.41.8.175,... and Oceanography 1996 41 1758 1766 10.4319/lo.1996.41.8.1758,188,125,Ambio_2016_Oct_13_45(6)_635-648.txt
4.59.5.159,... and Oceanography 2014 59 1599 1611 10.4319/lo.2014.59.5.1599,205,268,Ambio_2016_Oct_13_45(6)_635-648.txt
1.36.7.148,... and Oceanography 1991 36 1485 1492 10.4319/lo.1991.36.7.1485,211,178,Ambio_2016_Oct_13_45(6)_635-648.txt
4.49.4.109,... and Oceanography 2004 49 1095 1107 10.4319/lo.2004.49.4.1095,243,235,Ambio_2016_Oct_13_45(6)_635-648.txt
2.62.9.10,... debate BioScience 2012 62 835 842 10.1525/bio.2012.62.9.10,233,187,Ambio_2016_Feb_12_45(1)_29-41.txt
3.17.5.445,...Health Psychology 1998 17 445 453 10.1037/0278-6133.17.5.445 9776003,202,226,Ambio_2016_Feb_21_45(1)_52-62.txt
2.62.1.9,... richness BioScience 2012 62 47 55 10.1525/bio.2012.62.1.9,254,252,Ambio_2014_May_17_43(4)_480-491.txt
1.16.3.113,...ing Research (EER) 2011 16 113 119 10.4491/eer.2011.16.3.113,212,215,Ambio_2014_Dec_15_43(Suppl_1)_3-18.txt
6.51.6.279,... and Oceanography 2006 51 2794 2807 10.4319/lo.2006.51.6.2794,160,297,Ambio_2014_Dec_15_43(Suppl_1)_91-103.txt
5.5.3.2,"...nd air pollution effects, risks and trends, chap. 5.5.3.2, pp. V.60–63. United Nations Convention on...",174,274,Ambio_2014_Dec_15_43(Suppl_1)_91-103.txt
2.37.6.131,... and Oceanography 1992 37 1313 1318 10.4319/lo.1992.37.6.1313,196,168,Ambio_2014_Dec_15_43(Suppl_1)_91-103.txt
2.62.7.6,...pective BioScience 2012 62 633 645 10.1525/bio.2012.62.7.6,151,210,Ambio_2016_Feb_7_45(Suppl_2)_140-151.txt
2.10.3.835,...usbandry in Sweden Rangifer 1990 10 83 88 10.7557/2.10.3.835,200,134,Ambio_2016_Dec_22_45(Suppl_3)_352-362.txt
3.17.4.459,...ropology Quarterly 2003 17 459 482 10.1525/maq.2003.17.4.459 14716919,288,150,Ambio_2016_Dec_22_45(Suppl_3)_263-275.txt
1.15.2.171,...ropology Quarterly 2001 15 171 188 10.1525/maq.2001.15.2.171 11452626,323,160,Ambio_2016_Dec_22_45(Suppl_3)_263-275.txt
4.59.4.109,... and Oceanography 2014 59 1097 1111 10.4319/lo.2014.59.4.1097,223,204,PMC5258664.txt
4.59.5.176,... and Oceanography 2014 59 1764 1778 10.4319/lo.2014.59.5.1764,286,275,PMC5258664.txt
4.59.5.176,... and Oceanography 2014 59 1764 1778 10.4319/lo.2014.59.5.1764,230,274,PMC5258668.txt
1.28.2.245,...of Natural History 2001 28 245 255 10.3366/anh.2001.28.2.245,130,136,PMC5316321.txt
1.28.2.245,...of Natural History 2001 28 245 255 10.3366/anh.2001.28.2.245,134,130,PMC5316322.txt
1.3.1.1,"... Attribute, A2.2.1 Laboratory or Test Result, or B1.3.1.1 Laboratory Procedure. Procedure is a UMLS ...",97,290,AMIA_Jt_Summits_Transl_Sci_Proc_2014_Apr_7_2014_9-15.txt
1.3.1.1,"...n the B1.3.1 Health Activity branch, but is not a 1.3.1.1 Laboratory Procedure. Problem is a concept...",97,407,AMIA_Jt_Summits_Transl_Sci_Proc_2014_Apr_7_2014_9-15.txt
2.2.1.2,... Problem is a concept with a semantic type under B2.2.1.2 Pathologic function or A2.2.2 Sign or symp...,97,486,AMIA_Jt_Summits_Transl_Sci_Proc_2014_Apr_7_2014_9-15.txt
2.2.1.1,...tion within the recently defined variant subclade 2.2.1.1. published by WHO.1,15,425,AMIA_Jt_Summits_Transl_Sci_Proc_2014_Apr_7_2014_23-28.txt
2.2.1.1,"... populations to the viral diffusion of H5N1 clade 2.2.1.1 in Egypt (figure 1). Most notably, avian p...",48,97,AMIA_Jt_Summits_Transl_Sci_Proc_2014_Apr_7_2014_23-28.txt
2.2.1.1,...nen Y    Phylogeography of Influenza A H5N1 Clade 2.2.1.1 in Egypt Unpublished 2013,75,78,AMIA_Jt_Summits_Transl_Sci_Proc_2014_Apr_7_2014_23-28.txt
2.2.1.1,19. Arafa A   Egypt Clade 2.2.1.1. [online]. E-mail to Matthew Scotch (matth...,82,27,AMIA_Jt_Summits_Transl_Sci_Proc_2014_Apr_7_2014_23-28.txt
2.2.1.1,...nen Y    Phylogeography of influenza a H5N1 clade 2.2.1.1 in Egypt BMC Genomics 2013 14 1 871 243256...,111,76,AMIA_Jt_Summits_Transl_Sci_Proc_2015_Mar_23_2015_212-216.txt
EC 2.6.1.2,"...vate and glutamate into alanine and oxoglutarate (EC 2.6.1.2), thereby linking primary carbon metabo...",9,536,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,"... least two sequences encoding for true AlaAT (E.C.2.6.1.2) enzymes, whereas two homologues that clus...",15,221,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.4,...act as glutamate:glyoxylate aminotransferase (E.C.2.6.1.4; Igarashi et al. 2003). Subcellular fracti...,15,389,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
EC 2.6.1.2,The AlaAT enzyme activity (EC 2.6.1.2) was determined in various tissues of s...,32,28,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
EC 2.6.1.2,...tion was specifically assayed for AlaAT activity (EC 2.6.1.2) essentially as described by Good and M...,34,74,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,"...ion and by determining the activity of AlaAT (E.C.2.6.1.2.) in nodules, leaves and pods of both nodu...",52,139,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,...rate that was specific to the AlaAT reaction (E.C.2.6.1.2) only. Activity appeared to be similar in ...,56,102,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,...s (Fig. 4b). No difference in AlaAT activity (E.C.2.6.1.2) was observed between control plants (befo...,65,145,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,...N supply has on the change in AlaAT activity (E.C.2.6.1.2) during waterlogging,65,766,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,"...ed plants. Upon waterlogging, AlaAT activity (E.C.2.6.1.2) in roots of both nodulated and non-nodula...",72,171,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,The changes in AlaAT activity (E.C.2.6.1.2) as induced by waterlogging and the subseq...,83,36,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,"The regulation of AlaAT enzyme activity (E.C. 2.6.1.2) was investigated in soybean. First, the s...",88,47,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,"...ed to encode true alanine aminotransferases (E.C. 2.6.1.2), whereas two others (AtGGAT1 and AtGGAT2)...",90,350,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.4,...:glyoxylate aminotransferase (GGAT) activity (EC. 2.6.1.4; Igarashi et al. 2003; Liepman and Olsen 2...,90,479,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.4,...utamate:glyoxylate aminotransferase reaction (E.C.2.6.1.4) rather than being alanine aminotransferas...,90,787,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,"... rather than being alanine aminotransferases (E.C.2.6.1.2). However, this prediction of enzyme funct...",90,845,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,... subfamily. Changes in the activity of AlaAT (E.C.2.6.1.2) in roots correlated well with the level o...,92,303,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
2.6.1.2,... with true alanine aminotransferase activity (E.C.2.6.1.2) as was suggested earlier for Arabidopsis ...,92,512,Amino_Acids_2010_Oct_23_39(4)_1043-1053.txt
6.16.4.445,...pert Opin Ther Pat 2006 16 445 458 10.1517/13543776.16.4.445,108,128,Amino_Acids_2011_Feb_4_40(2)_731-740.txt
4.1.1.17,...ibition of mammalian ornithine decarboxylase (E.C.4.1.1.17) by substrate and product analogs J Am Ch...,136,131,Amino_Acids_2012_Feb_2_42(2-3)_619-626.txt
3.5.1.5,"Urease (urea amidohydrolase, E.C. 3.5.1.5) catalyzes the hydrolysis of urea to ammon...",9,35,Amino_Acids_2012_May_11_42(5)_1937-1945.txt
1.26.12.156,...rean Med Sci 2011 26 12 1563 1568 10.3346/jkms.2011.26.12.1563 22147992,125,179,Amino_Acids_2012_Nov_4_43(5)_2027-2035.txt
2.3.2.13,.../www.brenda-enzymes.org/php/result_flat.php4?ecno=2.3.2.13,110,59,Amino_Acids_2013_Jan_1_44(1)_63-72.txt
6.19.10.106,...Drug News Perspect 2006 19 609 614 10.1358/dnp.2006.19.10.1068008 17299603,117,154,Amino_Acids_2013_Mar_19_44(3)_1085-1091.txt
6.12.9.140,...pin Ther Patents 2002 12 1403 1406 10.1517/13543776.12.9.1403,263,101,Amino_Acids_2012_Aug_29_43(2)_617-627.txt
EC 2.6.1.57,"...lyzed by an aromatic amino acid aminotransferase (EC 2.6.1.57, ArAT), which is a pirydoxal phosphate...",9,770,Amino_Acids_2013_Aug_19_45(2)_351-358.txt
EC 3.4.14.1,"Cathepsin C (DPPI, EC 3.4.14.1, dipeptidyl peptidase I) is a lysosoma...",15,20,Amino_Acids_2014_Jan_1_46(4)_931-943.txt
EC 3.4.14.1,Bovine cathepsin C (DPP I; EC 3.4.14.1) was purified from bovine spleen after...,32,28,Amino_Acids_2014_Jan_1_46(4)_931-943.txt
EC 3.3.2.6,"...rce are credited.Leukotriene A4 hydrolase (LTA4H––EC 3.3.2.6) is a bifunctional zinc metalloenzyme, ...",4,262,Amino_Acids_2014_Feb_27_46(5)_1313-1320.txt
EC 3.4.15.1,"...ypeptidase (angiotensin-converting enzyme or ACE, EC 3.4.15.1) play an important role in controlling...",14,213,Amino_Acids_2015_Nov_20_47_369-380.txt
3.4.23.1,...erformed using commercially available pepsin (EC. 3.4.23.1) from porcine stomach type A (Sigma P7012...,35,77,Amino_Acids_2015_Nov_20_47_369-380.txt
EC 3.4.15.1,"The ACE (EC 3.4.15.1; from rabbit lung, Sigma, A6778) inhib...",50,10,Amino_Acids_2015_Nov_20_47_369-380.txt
2.3.2.13,...d the source are credited.Transglutaminases (E.C. 2.3.2.13) catalyze the post-translational modifica...,6,253,Amino_Acids_2015_Jan_13_47(4)_825-838.txt
2.3.2.13,"Transglutaminases (TGases, E.C. 2.3.2.13) are intracellular and extracellular enzy...",15,33,Amino_Acids_2015_Jan_13_47(4)_825-838.txt
EC 1.13.11.27,...ase (4-hydroxyphenylpyruvate dioxygenase; 4-HPPD; EC 1.13.11.27; CAS 9029-72-5) which has been detec...,12,1381,Amino_Acids_2015_Jan_25_47(5)_917-924.txt
EC 4.2.1.17,...l-CoA by short-chain enoyl-CoA hydratase (ESCH 1; EC 4.2.1.17).Fig. 1 Metabolism of leucine in mamma...,12,1843,Amino_Acids_2015_Jan_25_47(5)_917-924.txt
EC 1.13.11.27,...ase (4-hydroxyphenylpyruvate dioxygenase; 4-HPPD; EC 1.13.11.27; CAS 9029-72-5) which has been detec...,12,2576,Amino_Acids_2015_Jan_25_47(5)_917-924.txt
EC 4.2.1.17,...l-CoA by short-chain enoyl-CoA hydratase (ESCH 1; EC 4.2.1.17,12,2954,Amino_Acids_2015_Jan_25_47(5)_917-924.txt
EC 2.1.1.43,"29,072	Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.43)	17.93	6.08",389,51,Amino_Acids_2015_Mar_24_47(7)_1319-1339.txt
3.28.1.6,...ocrinol Metab (Seoul) 2013 28 6 11 10.3803/EnM.2013.28.1.6 24396643,561,123,Amino_Acids_2015_Jun_1_47_2037-2063.txt
1.9.2.45,...ectrolyte Blood Press 2011 9 45 49 10.5049/EBP.2011.9.2.45,144,144,Amino_Acids_2016_Feb_27_48_1423-1432.txt
6.25.1.1,...orders Exp Neurobiol 2016 25 1 1 13 10.5607/en.2016.25.1.1 26924928,248,185,PMC5241332.txt
2.3.2.13,"...in Ca2+-dependent transglutaminases (TGases, E.C. 2.3.2.13) activity was apparent (Serafini-Fracassi...",17,2171,PMC5241338.txt
EC 4.1.1.19,"...L. senescing leaves, arginine decarboxylase (ADC, EC 4.1.1.19) activity decreased progressively, whi...",19,104,PMC5241338.txt
EC 4.1.1.17,"...rogressively, while ornithine decarboxylase (ODC, EC 4.1.1.17) activity was high and constant in agi...",19,187,PMC5241338.txt
EC 4.1.1.50,"...2). S-adenosyl-l-methionine decarboxylase (SAMDC, EC 4.1.1.50) activity was not correlated with age ...",19,361,PMC5241338.txt
2.33.11.356,...Korean Chem Soc 2012 33 3565 3570 10.5012/bkcs.2012.33.11.3565,161,231,PMC5274654.txt
2.33.12.393,...Korean Chem Soc 2012 33 3931 3932 10.5012/bkcs.2012.33.12.3931,162,266,PMC5274654.txt
1.41.7.363,...ry Korean Circ J 2011 41 7 363 371 10.4070/kcj.2011.41.7.363 21860637,303,241,Am_J_Cardiovasc_Drugs_2013_Feb_24_13(1)_47-56.txt
2.6.3.391,...v Cardiovasc Ther 2008 6 3 391 409 10.1586/14779072.6.3.391 18327998,387,214,Am_J_Cardiovasc_Drugs_2013_Feb_17_13(1)_37-46.txt
6.8.14.224,...pin Pharmacother. 2007 8 2247 2265 10.1517/14656566.8.14.2247 17927481,289,159,Am_J_Cardiovasc_Drugs_2015_Apr_8_15(3)_195-203.txt
4.16.4.431,... Investig Drugs. 2007 16 4 431 440 10.1517/13543784.16.4.431 17371192,180,136,Am_J_Cardiovasc_Drugs_2016_Feb_29_16_171-182.txt
2.3.1.65,"...eptor [1]. Bile acid amino-transferase (BAAT, EC: 2.3.1.65) catalyzes the final reaction in the form...",46,522,Am_J_Case_Rep_2014_Feb_10_15_63-68.txt
2.3.1.65,"...pairment in bile acid aminotransferase (BAAT, EC: 2.3.1.65) is indicated. This indication was consis...",61,601,Am_J_Case_Rep_2014_Feb_10_15_63-68.txt
EC 3.2.1.22,...ed by deficiency of the enzyme α-galactosidase A (EC 3.2.1.22) (http://www.chem.qmul.ac.uk/iubmb/enz...,49,176,Am_J_Case_Rep_2016_May_9_17_315-319.txt
2.17.11.524,...J Community Nurs 2012 17 524 528 10.12968/bjcn.2012.17.11.524 23124421,184,136,Am_J_Clin_Dermatol_2014_Nov_6_15(6)_467-478.txt
EC 2.1.1.13,"...l-l-glutamate:l-homocysteine-S-methyltransferase; EC 2.1.1.13), present in the cytoplasm, converts h...",29,398,Am_J_Clin_Nutr_2011_Jul_94(1)_359S-365S.txt
EC 5.4.99.2,"...A) mutases (methylmalonyl-CoA CoA-carbonylmutase; EC 5.4.99.2), which are present in the mitochondri...",29,561,Am_J_Clin_Nutr_2011_Jul_94(1)_359S-365S.txt
3.1.9.2,Power calculations were performed with G*Power v3.1.9.2 (University of Dusseldorf). Graphs and inc...,79,49,Am_J_Clin_Nutr_2015_Oct_2_102(4)_791-800.txt
1.6.5.3,"...(H): ubiquinone reductase; Enzyme Commission (EC) 1.6.5.3], complexes II–III (succinate: cytochrome ...",49,79,Am_J_Clin_Nutr_2016_Feb_30_103(2)_579-588.txt
EC 1.3.5.1,"...plexes II–III (succinate: cytochrome c reductase; EC 1.3.5.1 + EC 1.10.2.2), and complex IV (cytochr...",49,142,Am_J_Clin_Nutr_2016_Feb_30_103(2)_579-588.txt
EC 1.10.2.2,"... (succinate: cytochrome c reductase; EC 1.3.5.1 + EC 1.10.2.2), and complex IV (cytochrome oxidase; ...",49,155,Am_J_Clin_Nutr_2016_Feb_30_103(2)_579-588.txt
EC 1.9.3.1,"...EC 1.10.2.2), and complex IV (cytochrome oxidase; EC 1.9.3.1) as well as citrate synthase (EC 1.1.1....",49,205,Am_J_Clin_Nutr_2016_Feb_30_103(2)_579-588.txt
EC 1.1.1.27,...oxidase; EC 1.9.3.1) as well as citrate synthase (EC 1.1.1.27) were assayed as described previously ...,49,246,Am_J_Clin_Nutr_2016_Feb_30_103(2)_579-588.txt
4.64.3.395,"...Social Psychology 1993 64 395 408 10.1037/0022-3514.64.3.395 Kaniasty, K., & Norris, F. H. (1993). A...",304,184,Am_J_Community_Psychol_2009_Dec_15_44(3-4)_233-248.txt
3.91.3.537,...tional Psychology 1999 91 537 548 10.1037/0022-0663.91.3.537,311,156,Am_J_Community_Psychol_2010_Jun_25_45(3-4)_381-393.txt
4.38.2.217,...Social Psychology 1980 38 217 230 10.1037/0022-3514.38.2.217 7373511,260,125,Am_J_Community_Psychol_2006_Dec_9_38(3-4)_263-274.txt
1.49.18.65,...Health of the People’s Republic of China (http://61.49.18.65/publicfiles/business/htmlfiles/mohwsyjb...,164,255,Am_J_Epidemiol_2012_May_1_175(9)_890-897.txt
4.1.1.1,...ed using the Joinpoint Regression program version 4.1.1.1 (Surveillance Epidemiology and End Results...,32,180,Am_J_Gastroenterol_2015_Dec_14_110(12)_1640-1646.txt
2.7.1.40,Human PK [E.C. nomenclature 2.7.1.40] is regulated through expression of four ...,29,29,Am_J_Hematol_2015_Sep_14_90(9)_825-830.txt
3.3.1.3,...ata was collected with the use of SpectroACQUIRE v3.3.1.3 software and visualised with the use of Ma...,21,1612,Am_J_Hum_Genet_2008_Aug_8_83(2)_254-260.txt
EC 3.2.1.46,"...ed a very low galactosylceramide β-galactosidase (EC 3.2.1.46) activity. On ECG, there were signs of...",20,1066,Am_J_Med_Genet_A_2009_Apr_6_149A(4)_613-621.txt
EC 3.1.6.8,"...ysosomal enzymes, including arylsulfatase A (ASA; EC 3.1.6.8) and galactosylceramide β-galactosidase...",29,2256,Am_J_Med_Genet_A_2009_Apr_6_149A(4)_613-621.txt
EC 3.2.1.46,"... 3.1.6.8) and galactosylceramide β-galactosidase (EC 3.2.1.46). Repeated infections, EBV positivity,...",29,2308,Am_J_Med_Genet_A_2009_Apr_6_149A(4)_613-621.txt
EC 3.2.1.45,"...duced activity of glucosylceramide β-glucosidase (EC 3.2.1.45), a more markedly reduced activity of ...",57,107,Am_J_Med_Genet_A_2009_Apr_6_149A(4)_613-621.txt
EC 3.1.4.12,"...e β-galactosidase, but a normal sphingomyelinase (EC 3.1.4.12) activity (for quantitative data, see ...",57,224,Am_J_Med_Genet_A_2009_Apr_6_149A(4)_613-621.txt
EC 3.2.1.22,"...ct SapB for its degradation by α-galactosidase A (EC 3.2.1.22) [Bradová et al., 1993] and, therefore...",116,1243,Am_J_Med_Genet_A_2009_Apr_6_149A(4)_613-621.txt
EC 3.1.6.8,ASAarylsulfatase A (EC 3.1.6.8,129,21,Am_J_Med_Genet_A_2009_Apr_6_149A(4)_613-621.txt
EC 3.2.1.76,"...a deficiency of the enzyme α-l-iduronidase (IDUA, EC 3.2.1.76; OMIM *252800). This leads to widespre...",13,160,Am_J_Med_Genet_A_2009_May_24_149A(5)_965-974.txt
3.2.1.37,... from Thermoanaerobacterium saccharolyticum (E.C. 3.2.1.37). This model showed that missense mutatio...,190,221,Am_J_Med_Genet_A_2009_May_24_149A(5)_965-974.txt
3.34.5.1,"...l of Child Studies , 34 , 1 -16 . 10.5723/KJCS.2013.34.5.1",222,160,Am_J_Mens_Health_2015_Jul_9(4)_332-339.txt
EC 3.4.24.3,"...Muscles were placed into 0.4% type I collagenase (EC 3.4.24.3; Sigma-Aldrich, Dorset, UK) solution i...",25,149,Am_J_Physiol_Regul_Integr_Comp_Physiol_2013_Aug_15_305(4)_R351-R358.txt
3.1.9.2,G-power 3.1.9.2 was used to calculate the sample size. The...,40,9,Am_J_Phys_Med_Rehabil_2016_Jul_20_95(7)_483-494.txt
3.18.2.189,...l 1999 18 2 189 http://dx.doi.org/10.1037/0278-6133.18.2.189  10194055,109,203,Am_J_Prev_Med_2016_May_50(5_Suppl_1)_S13-S19.txt
3.20.4.256,...l 2001 20 4 256 http://dx.doi.org/10.1037/0278-6133.20.4.256  11515737,110,203,Am_J_Prev_Med_2016_May_50(5_Suppl_1)_S13-S19.txt
3.5.1.2,"...ved heterozygosity HO were calculated in Arlequin 3.5.1.2 [Excoffier & Lischer, 2010]. Allelic richn...",42,342,Am_J_Primatol_2015_Aug_10_77(8)_878-889.txt
2.9.3.2,"...Allelic richness and FIS were calculated in Fstat 2.9.3.2 [Goudet, 1995]",42,429,Am_J_Primatol_2015_Aug_10_77(8)_878-889.txt
1.1.4.39,...nd data export were achieved with Java Treeview v.1.1.4.3,45,288,Am_J_Trop_Med_Hyg_2014_May_7_90(5)_923-938.txt
2.15.1.38,"...alyses using the Raster package36,37 in R version 2.15.1.38 The EVI and elevation were dichotomized ...",40,584,Am_J_Trop_Med_Hyg_2015_May_6_92(5)_913-921.txt
3.2.2.34,"...nalysis was conducted in Stata 13.1 and R version 3.2.2.34,3",22,1503,PMC5303059.txt
EC 3.5.4.1,"[13]. This gene encodes cytosine deaminase, (EC 3.5.4.1) which catalyzes the conversion of cyto...",81,46,Anaerobe_2016_Oct_41_104-112.txt
EC 3.4.21.4,"BSA, trypsin (porcine, type IX-S, EC 3.4.21.4) and 1,4-dithiothreitol (DTT) were pur...",63,35,Anal_Bioanal_Chem_2007_May_13_388(1)_195-200.txt
EC 1.1.3.4,"GOx from Aspergillus niger (EC 1.1.3.4, grade 1) and horseradish peroxidase (H...",21,29,Anal_Bioanal_Chem_2007_Nov_2_389(6)_2029-2033.txt
EC 1.11.1.7,"....1.3.4, grade 1) and horseradish peroxidase (HRP; EC 1.11.1.7, grade 1) were obtained from Roche (Al...",21,83,Anal_Bioanal_Chem_2007_Nov_2_389(6)_2029-2033.txt
1.14.18.1,"...ium(IV) isopropoxide, tyrosinase from mushroom (EC1.14.18.1; 5771 U mg−1), vanillic acid, gallic aci...",27,115,Anal_Bioanal_Chem_2016_May_21_408_5199-5210.txt
3.2.1.23,"...vation of 1, β-d-galactosidase from E. coli (E.C. 3.2.1.23, G 5635, activity 700 units (U) per milli...",29,360,Anal_Bioanal_Chem_2009_Sep_31_395(2)_437-448.txt
1.11.1.6,"...e heart cytochrome c (cyt c), catalase (CAT, E.C. 1.11.1.6, 1,990 U mg−1) and sodium molybdate were ...",33,55,Anal_Bioanal_Chem_2009_Jan_21_393(1)_225-233.txt
EC 1.4.3.6,"...aphic assay of diamine oxidase (DAO, histaminase, EC 1.4.3.6), based on a coupled peroxidase reactio...",3,874,Anal_Bioanal_Chem_2010_Feb_29_396(3)_1281-1290.txt
EC 1.4.3.6,"...nases [1], are homodimeric copper amine oxidases (EC 1.4.3.6), each subunit containing a single copp...",13,106,Anal_Bioanal_Chem_2010_Feb_29_396(3)_1281-1290.txt
EC 1.4.3.4,"...zymatic conversion by monoamine oxidase-A (MAO-A; EC 1.4.3.4), resulting in urinary excretion of 5-h...",9,678,Anal_Bioanal_Chem_2010_Apr_7_396(7)_2609-2616.txt
2.11.8.993,...Opin Ther Targets 2007 11 993 1004 10.1517/14728222.11.8.993 17665972,254,160,Anal_Bioanal_Chem_2010_Jul_21_397(6)_2367-2374.txt
4.49.5.149,...s Limnol Oceanogr 2004 49 1493 1502 10.4319/lo.2004.49.5.1493,103,169,Anal_Bioanal_Chem_2010_Aug_17_397(8)_3543-3551.txt
EC 3.4.21.4,"...-lactalbumin (bov.), trypsin (porcine, type IX-S, EC 3.4.21.4) and 1,4-dithiotreitol (DTT) were purc...",55,212,Anal_Bioanal_Chem_2011_Feb_24_399(5)_1845-1852.txt
EC 4.2.2.7,"...entific Co. (Fair Lawn, NJ). Heparinase I enzyme (EC 4.2.2.7) isolated from F. heparinum was purchas...",30,534,Anal_Bioanal_Chem_2011_Jan_4_399(2)_593-603.txt
EC 4.2.2.7,"...fonate (DSS), ammonium chloride and heparinase I (EC 4.2.2.7) were purchased from Sigma Chemical Co....",31,140,Anal_Bioanal_Chem_2011_Jan_3_399(2)_663-671.txt
6.7.5.773,...F  Pharmacogenomics 2006 7 773 782 10.2217/14622416.7.5.773 16886901,130,71,Anal_Bioanal_Chem_2009_Jun_11_394(3)_663-670.txt
EC 1.1.99.10,"...table FADGDHs have been reported [26–32]. FADGDH (EC 1.1.99.10, d-glucose: acceptor 1-oxidoreductase...",21,237,Anal_Bioanal_Chem_2012_Feb_6_402(6)_2069-2077.txt
EC 3.2.1.51,...s caused by a deficient lysosomal α-l-fucosidase (EC 3.2.1.51) and results in secretion of fucosyl-o...,12,359,Anal_Bioanal_Chem_2012_Jun_20_403(6)_1671-1683.txt
EC 3.2.1.24,"...ides [1, 2]. Deficient lysosomal α-d-mannosidase (EC 3.2.1.24) causes α-mannosidosis and excessive u...",12,470,Anal_Bioanal_Chem_2012_Jun_20_403(6)_1671-1683.txt
EC 3.2.1.18,...osis is caused by deficient acid exo-α-sialidase (EC 3.2.1.18) [6]. The urinary excretion of sialylo...,12,627,Anal_Bioanal_Chem_2012_Jun_20_403(6)_1671-1683.txt
EC 3.2.1.23,"...due to the deficient activity of β-galactosidase (EC 3.2.1.23) [8, 9]. In addition to the storage of...",12,842,Anal_Bioanal_Chem_2012_Jun_20_403(6)_1671-1683.txt
3.87.2.117,...ation Plant Dis 2003 87 2 117 128 10.1094/PDIS.2003.87.2.117,144,131,Anal_Bioanal_Chem_2012_Oct_18_404(6-7)_1759-1769.txt
EC 1.1.99.18,"...cytochrome (cellobiose:acceptor 1-oxidoreductase, EC 1.1.99.18) and is a monomeric protein consistin...",50,87,Anal_Bioanal_Chem_2013_Apr_18_405(11)_3637-3658.txt
EC 3.5.1.5,"Urease isolated from Jack bean (EC 3.5.1.5, lyophilized powder 100 U/mg) and 1-eth...",25,33,Anal_Bioanal_Chem_2015_Jan_27_407(7)_1807-1812.txt
2.4.3.1,"...cessed with the MASCOT DISTILLER program, version 2.4.3.1 (64 bits), MDRO 2.4.3.0 (MATRIX science, L...",52,668,Anal_Bioanal_Chem_2015_Mar_24_407(13)_3817-3829.txt
5.3.3.273,...lls Futur Lipidol 2008 3 3 273 300 10.2217/17460875.3.3.273,102,108,Anal_Bioanal_Chem_2015_Mar_8_407(17)_5189-5198.txt
2.32.5.319,...etry Ann Lab Med 2012 32 5 319 323 10.3343/alm.2012.32.5.319 22950066,122,210,Anal_Bioanal_Chem_2015_Mar_8_407(17)_5189-5198.txt
5.8.1.37,...xpert Rev Neurother 2008 8 1 37 49 10.1586/14737175.8.1.37 18088200,115,144,Anal_Bioanal_Chem_2015_Jul_14_407(24)_7295-7305.txt
6.7.2.177,...t Opin Pharmacother 2006 7 177 193 10.1517/14656566.7.2.177 16433583,108,133,Anal_Bioanal_Chem_2015_Jul_14_407(27)_8321-8331.txt
EC 3.2.1.4,"...delberg 2016endo-1,4-β-Glucanase (endo-cellulase, EC 3.2.1.4) is one of the most widely used enzymes...",3,613,Anal_Bioanal_Chem_2016_Apr_6_408_4159-4168.txt
EC 3.2.1.4,"endo-1,4-β-glucanase (EG, EC 3.2.1.4) finds use in a wide range of industria...",16,27,Anal_Bioanal_Chem_2016_Apr_6_408_4159-4168.txt
EC 3.2.1.4,"...ethods [11]. In the case of endo-1,4-β-glucanase (EC 3.2.1.4, EG), the native substrate cellulose is...",18,160,Anal_Bioanal_Chem_2016_Apr_6_408_4159-4168.txt
1.4.33.3,"...stem was controlled via Maestro software (version 1.4.33.3, GERSTEL) which was integrated into the C...",40,883,Anal_Bioanal_Chem_2016_Apr_26_408_4379-4388.txt
6.51.2.105,...y Limnol Oceanogr 2006 51 1054 1063 10.4319/lo.2006.51.2.1054,150,216,Anal_Bioanal_Chem_2016_May_14_408_4835-4843.txt
1.4.1.2,"...se searches were performed with Maxquant (version 1.4.1.2, http://www.maxquant.org/) against the dat...",55,57,Anal_Bioanal_Chem_2016_Jul_13_408(23)_6337-6348.txt
5.2.4.403,...ases Future Lipidol 2007 2 403 422 10.2217/17460875.2.4.403 18176634,303,121,Anal_Bioanal_Chem_2016_Aug_22_408(24)_6857-6868.txt
6.54.11.566,...atisierungstechnik 2006 54 566 73 10.1524/auto.2006.54.11.566,413,182,Anal_Bioanal_Chem_2016_Aug_15_408(24)_6517-6536.txt
3.1.2.53,"...iety data capturing software (Izon Control Suite v3.1.2.53). In all experiments, the lower fluid cel...",63,171,Anal_Bioanal_Chem_2016_Jun_10_408(21)_5757-5768.txt
1.11.1.7,"...xidase type VI, from Amoracia rusticana (HRP, E.C.1.11.1.7, RZ > 2.5), gold(III) chloride trihydrate...",23,67,Anal_Bioanal_Chem_2016_Oct_8_408(29)_8505-8513.txt
EC 1.5.1.33,"...te (H4F) by means of pteridine reductase 1 (PTR1, EC 1.5.1.33) and the bifunctional, nicotinamide ad...",16,462,Anal_Biochem_2010_Jan_15_396(2)_194-203.txt
1.5.1.4,"...late reductase–thymidylate synthase (DHFR-TS, ECs 1.5.1.4 and 2.1.1.45, respectively). Due to the au...",16,625,Anal_Biochem_2010_Jan_15_396(2)_194-203.txt
2.1.1.45,"...se–thymidylate synthase (DHFR-TS, ECs 1.5.1.4 and 2.1.1.45, respectively). Due to the auxotrophic na...",16,637,Anal_Biochem_2010_Jan_15_396(2)_194-203.txt
EC 1.3.5.1,"...doreductase (succinate dehydrogenase, complex II, EC 1.3.5.1) catalyzes the oxidation of succinate t...",8,102,Anal_Biochem_2013_Nov_1_442(1)_19-23.txt
EC 4.2.1.2,"...assay uses two enzymes: fumarate hydratase (FumC, EC 4.2.1.2) converts the fumarate product of succi...",14,175,Anal_Biochem_2013_Nov_1_442(1)_19-23.txt
EC 1.1.1.40,"...cetate decarboxylating malic dehydrogenase (MaeB, EC 1.1.1.40) couples the conversion of malate to p...",14,321,Anal_Biochem_2013_Nov_1_442(1)_19-23.txt
EC 1.1.1.38,"...ercially available decarboxylating malic enzymes (EC 1.1.1.38, -.39, or -.40) are prohibitively expe...",30,316,Anal_Biochem_2013_Nov_1_442(1)_19-23.txt
EC 1.1.1.37,"...ic studies. Alternatively, malate dehydrogenases (EC 1.1.1.37 or -.82) are much cheaper, but they ca...",30,478,Anal_Biochem_2013_Nov_1_442(1)_19-23.txt
3.47.4.316,...ology  2013 47 4 316 325 10.4132/koreanjpathol.2013.47.4.316 2-s2.0-84884582288,213,334,Anal_Cell_Pathol_(Amst)_2014_Dec_18_2014_352925.txt
4.15.6.266,... Prevention  2014 15 6 2669 2673 10.7314/apjcp.2014.15.6.2669 2-s2.0-84899887218 24761882,172,247,Anal_Cell_Pathol_(Amst)_2014_Dec_7_2014_248142.txt
2.12.7.905,...apeutic Targets  2008 12 7 905 916 10.1517/14728222.12.7.905 2-s2.0-48949116927 18554157,333,236,Anal_Cell_Pathol_(Amst)_2015_Jun_10_2015_569392.txt
4.15.23.102,...evention  2014 15 23 10225 10229 10.7314/apjcp.2014.15.23.10225 2-s2.0-84921723751 25556451,299,259,Anal_Cell_Pathol_(Amst)_2015_Aug_3_2015_828646.txt
3.14.2.963,...er Prevention  2013 14 2 963 968 10.7314/apjcp.2013.14.2.963 23621269,109,245,Anal_Cell_Pathol_(Amst)_2015_Aug_9_2015_326385.txt
3.13.1.25,...lls Immune Network  2013 13 1 25 25 10.4110/in.2013.13.1.25 23559897,128,175,Anal_Cell_Pathol_(Amst)_2015_Aug_27_2015_923614.txt
3.14.9.530,... Prevention  2013 14 9 5301 5310 10.7314/apjcp.2013.14.9.5301 2-s2.0-84887567541 24175817,130,276,Anal_Cell_Pathol_(Amst)_2015_Sep_17_2015_256182.txt
4.13.9.117,...ational Drugs  2004 13 9 1171 1182 10.1517/13543784.13.9.1171 2-s2.0-4544277194 15330748,328,177,Anal_Cell_Pathol_(Amst)_2015_Sep_21_2015_690916.txt
4.15.6.691,...igational Drugs  2006 15 6 691 702 10.1517/13543784.15.6.691 2-s2.0-33745262072 16732719,462,148,Anal_Cell_Pathol_(Amst)_2015_Sep_21_2015_690916.txt
4.34.4.165,...Medical Reviews  2014 34 4 165 172 10.7599/hmr.2014.34.4.165,306,139,Anal_Cell_Pathol_(Amst)_2015_Oct_18_2015_219206.txt
5.1.4.309,...Risk Management  2005 1 4 309 316 10.2147/vhrm.2005.1.4.309 2-s2.0-33947492733 17315603,205,215,PMC5225318.txt
2.13.10.487,...Prevention  2012 13 10 4879 4881 10.7314/apjcp.2012.13.10.4879 2-s2.0-84874014670 23244074,112,231,Anal_Cell_Pathol_(Amst)_2015_Dec_9_2015_313145.txt
5.16.6.212,... Prevention  2015 16 6 2129 2144 10.7314/apjcp.2015.16.6.2129 25824729,139,225,Anal_Cell_Pathol_(Amst)_2016_Jan_28_2016_7015659.txt
4.15.20.879,...Prevention  2014 15 20 8793 8796 10.7314/APJCP.2014.15.20.8793 2-s2.0-84911092357 25374209,162,236,Anal_Cell_Pathol_(Amst)_2016_Oct_12_2016_6074275.txt
4.8.2.131,...er Gut and Liver  2014 8 2 131 139 10.5009/gnl.2014.8.2.131 2-s2.0-84896967591 24672653,51,176,Anal_Cell_Pathol_(Amst)_2016_Nov_2_2016_6891971.txt
4.15.3.123,... Prevention  2014 15 3 1233 1239 10.7314/apjcp.2014.15.3.1233 2-s2.0-84896822245 24606446,109,248,Anal_Cell_Pathol_(Amst)_2016_Nov_22_2016_4131403.txt
4.15.7.300,... Prevention  2014 15 7 3001 3004 10.7314/APJCP.2014.15.7.3001 2-s2.0-84900869504 24815437 24815437,117,223,Anal_Cell_Pathol_(Amst)_2016_Nov_22_2016_4131403.txt
4.29.1.23,... Medical Science  2014 29 1 23 31 10.3346/jkms.2014.29.1.23 2-s2.0-84907424372 24431901,380,245,PMC5282433.txt
EC 1.1.99.18,"Cellobiose dehydrogenase (EC 1.1.99.18, CDH) is one of the redox enzymes cap...",13,27,Anal_Chem_2011_Apr_15_83(8)_3042-3049.txt
EC 1.1.99.29,...on has been drawn to pyranose dehydrogenase (PDH; EC 1.1.99.29),43,58,Anal_Chem_2013_Oct_15_85(20)_9852-9858.txt
EC 1.1.99.29,of analytical grade. Glycosylated PDH (EC 1.1.99.29; sequence UniProt: Q3L245;26 protein ...,133,40,Anal_Chem_2013_Oct_15_85(20)_9852-9858.txt
6.21.10.301,"2016 , 21 , 30159 10.2807/1560-7917.ES.2016.21.10.30159",571,43,Anal_Chem_2016_Jul_19_88(14)_7289-7294.txt
5.4.1.1,"...ile format. Following this, ChemAxon’s (ChemAxon, 5.4.1.1.",221,55,Anal_Chem_2014_Apr_15_86(8)_3985-3993.txt
4.1.5.12,...ht. Images were processed with HCImage software (v4.1.5.12,244,67,Anal_Chem_2014_Sep_2_86(17)_8814-8821.txt
1.5.2.8,(v. 1.5.2.8) with “Top MS/MS peaks per 100 Da” set t,194,5,Anal_Chem_2016_Aug_16_88(16)_8239-8247.txt
EC 3.4.11.2,"(EC 3.4.11.2, Merck, Darmstadt, Germany) reaction c...",223,2,Anal_Chem_2016_Dec_6_88(23)_11868-11876.txt
3.1.2.22,"thioesterase I (PPT1, EC3.1.2.22). Over 40 mutations of the CLN1 gene are ...",40,25,Anal_Chem_2014_Aug_5_86(15)_7962-7968.txt
EC 3.4.22.2,"Papain (2 × crystallized) [EC 3.4.22.2] from papaya latex (28 mg protein/ml, ...",19,28,Anal_Chem_Insights_2007_Nov_18_2_51-59.txt
3.1.1.3,Lipases (E.C.3.1.1.3) catalyze the hydrolysis of ester linkages...,9,14,Anal_Chem_Insights_2008_Mar_27_3_9-19.txt
2.4.1.1,2.4.1.1. Effect of tim,50,1,Anal_Chem_Insights_2011_May_29_6_37-44.txt
2.4.1.2,2.4.1.2. Effect of HCl concentratio,53,1,Anal_Chem_Insights_2011_May_29_6_37-44.txt
2.4.1.3,2.4.1.3. Effect of addition orde,58,1,Anal_Chem_Insights_2011_May_29_6_37-44.txt
2.4.1.4,2.4.1.4. Calibration curv,61,1,Anal_Chem_Insights_2011_May_29_6_37-44.txt
2.4.1.3,...and 1.0 ml of 10−3 M ABTS as mentioned in section 2.4.1.3. The mixture was incubated for two minutes...,112,148,Anal_Chem_Insights_2011_May_29_6_37-44.txt
3.5.1.5,"...inite Focus G4 (Alicona, Graz, Austria) using IFM 3.5.1.5 x 64 software (Alicona, Graz, Austria). Sp...",53,153,Anal_Methods_2015_Apr_7_7(7)_2917-2927.txt
1.44.1.1,...73Korean Association of Anatomists 10.5115/acb.2011.44.1.1Review ArticleClinical and anatomical appr...,3,106,Anat_Cell_Biol_2011_Mar_31_44(1)_1-7.txt
1.44.1.14,...73Korean Association of Anatomists 10.5115/acb.2011.44.1.14Original ArticleCell Biology & Microscopi...,3,106,Anat_Cell_Biol_2011_Mar_31_44(1)_14-24.txt
1.44.1.25,...73Korean Association of Anatomists 10.5115/acb.2011.44.1.25Original ArticleCell Biology & Microscopi...,3,106,Anat_Cell_Biol_2011_Mar_31_44(1)_25-34.txt
1.44.1.41,...73Korean Association of Anatomists 10.5115/acb.2011.44.1.41Original ArticleNeurobiologyTransient lys...,3,106,Anat_Cell_Biol_2011_Mar_31_44(1)_41-49.txt
1.44.1.35,...73Korean Association of Anatomists 10.5115/acb.2011.44.1.35Original ArticleCell Biology & Microscopi...,3,106,Anat_Cell_Biol_2011_Mar_31_44(1)_35-40.txt
1.44.1.50,...73Korean Association of Anatomists 10.5115/acb.2011.44.1.50Original ArticleNeurobiologyThe effects o...,3,106,Anat_Cell_Biol_2011_Mar_31_44(1)_50-59.txt
1.44.1.60,...73Korean Association of Anatomists 10.5115/acb.2011.44.1.60Original ArticleNeurobiologyThe expressio...,3,106,Anat_Cell_Biol_2011_Mar_31_44(1)_60-68.txt
1.44.1.8,...73Korean Association of Anatomists 10.5115/acb.2011.44.1.8Review ArticleInfrared-sensitive pit organ...,3,106,Anat_Cell_Biol_2011_Mar_31_44(1)_8-13.txt
1.44.1.79,...73Korean Association of Anatomists 10.5115/acb.2011.44.1.79Original ArticleApplied AnatomyMorphometr...,3,106,Anat_Cell_Biol_2011_Mar_31_44(1)_79-83.txt
1.44.1.69,...73Korean Association of Anatomists 10.5115/acb.2011.44.1.69Original ArticleDevelopment and Regenerat...,3,106,Anat_Cell_Biol_2011_Mar_31_44(1)_69-78.txt
1.44.2.106,...73Korean Association of Anatomists 10.5115/acb.2011.44.2.106Original ArticleNeurobiologyImmunohistoc...,3,106,Anat_Cell_Biol_2011_Jun_30_44(2)_106-115.txt
1.44.2.116,...73Korean Association of Anatomists 10.5115/acb.2011.44.2.116Original ArticleNeurobiologyExpression o...,3,106,Anat_Cell_Biol_2011_Jun_30_44(2)_116-127.txt
1.44.2.128,...73Korean Association of Anatomists 10.5115/acb.2011.44.2.128Original ArticleNeurobiologyID4 mediates...,3,106,Anat_Cell_Biol_2011_Jun_30_44(2)_128-134.txt
1.44.2.143,...73Korean Association of Anatomists 10.5115/acb.2011.44.2.143Original ArticleDevelopment and Regenera...,3,106,Anat_Cell_Biol_2011_Jun_30_44(2)_143-150.txt
1.44.2.160,...73Korean Association of Anatomists 10.5115/acb.2011.44.2.160Case ReportAccessory muscle in the forea...,3,106,Anat_Cell_Biol_2011_Jun_30_44(2)_160-163.txt
1.44.2.164,...73Korean Association of Anatomists 10.5115/acb.2011.44.2.164Case ReportBilateral origin of superior ...,3,106,Anat_Cell_Biol_2011_Jun_30_44(2)_164-167.txt
1.44.2.85,...73Korean Association of Anatomists 10.5115/acb.2011.44.2.85Original ArticleCell Biology & Microscopi...,3,106,Anat_Cell_Biol_2011_Jun_30_44(2)_85-97.txt
1.44.2.98,...73Korean Association of Anatomists 10.5115/acb.2011.44.2.98Original ArticleCell Biology & Microscopi...,3,106,Anat_Cell_Biol_2011_Jun_30_44(2)_98-105.txt
1.44.2.135,...73Korean Association of Anatomists 10.5115/acb.2011.44.2.135Original ArticleNeurobiologyCannabinoid ...,3,106,Anat_Cell_Biol_2011_Jun_30_44(2)_135-142.txt
6.49.3.221,...73Korean Association of Anatomists 10.5115/acb.2016.49.3.221Letter to EditorOn attending the 32nd An...,3,120,Anat_Cell_Biol_2016_Sep_29_49(3)_221-222.txt
6.49.3.165,...73Korean Association of Anatomists 10.5115/acb.2016.49.3.165Original ArticleCell BiologyPoly(ADP-rib...,3,120,Anat_Cell_Biol_2016_Sep_29_49(3)_165-176.txt
1.44.3.226,...73Korean Association of Anatomists 10.5115/acb.2011.44.3.226Original ArticleNeurobiologyCo-localizat...,3,106,Anat_Cell_Biol_2011_Sep_29_44(3)_226-237.txt
1.44.3.194,...73Korean Association of Anatomists 10.5115/acb.2011.44.3.194Original ArticleCell Biology & Microscop...,3,106,Anat_Cell_Biol_2011_Sep_29_44(3)_194-203.txt
1.44.3.176,...73Korean Association of Anatomists 10.5115/acb.2011.44.3.176Original ArticleCell Biology & Microscop...,3,106,Anat_Cell_Biol_2011_Sep_29_44(3)_176-185.txt
1.44.3.186,...73Korean Association of Anatomists 10.5115/acb.2011.44.3.186Original ArticleCell Biology & Microscop...,3,106,Anat_Cell_Biol_2011_Sep_29_44(3)_186-193.txt
1.44.3.204,...73Korean Association of Anatomists 10.5115/acb.2011.44.3.204Original ArticleCell Biology & Microscop...,3,106,Anat_Cell_Biol_2011_Sep_29_44(3)_204-209.txt
1.44.3.169,...73Korean Association of Anatomists 10.5115/acb.2011.44.3.169Review ArticleProapoptotic role of nucle...,3,106,Anat_Cell_Biol_2011_Sep_29_44(3)_169-175.txt
1.44.3.238,...73Korean Association of Anatomists 10.5115/acb.2011.44.3.238Case ReportBilateral asymmetric supernum...,3,106,Anat_Cell_Biol_2011_Sep_29_44(3)_238-240.txt
1.44.3.218,...73Korean Association of Anatomists 10.5115/acb.2011.44.3.218Original ArticleNeurobiologyThe high dos...,3,106,Anat_Cell_Biol_2011_Sep_29_44(3)_218-225.txt
1.44.3.241,...73Korean Association of Anatomists 10.5115/acb.2011.44.3.241Case ReportBilateral variations of the h...,3,106,Anat_Cell_Biol_2011_Sep_29_44(3)_241-243.txt
1.44.4.256,...73Korean Association of Anatomists 10.5115/acb.2011.44.4.256Review ArticleProspect of cell therapy f...,3,106,Anat_Cell_Biol_2011_Dec_30_44(4)_256-264.txt
1.44.4.274,...73Korean Association of Anatomists 10.5115/acb.2011.44.4.274Original ArticleCell Biology & Microscop...,3,106,Anat_Cell_Biol_2011_Dec_30_44(4)_274-283.txt
1.44.4.304,...73Korean Association of Anatomists 10.5115/acb.2011.44.4.304Original ArticleNeurobiologyThe use of S...,3,106,Anat_Cell_Biol_2011_Dec_30_44(4)_304-313.txt
1.44.4.324,...73Korean Association of Anatomists 10.5115/acb.2011.44.4.324Original ArticleNeurobiologyA simple tec...,3,106,Anat_Cell_Biol_2011_Dec_30_44(4)_324-330.txt
1.44.4.314,...73Korean Association of Anatomists 10.5115/acb.2011.44.4.314Original ArticleNeurobiologyMorphologica...,3,106,Anat_Cell_Biol_2011_Dec_30_44(4)_314-323.txt
1.44.4.295,...73Korean Association of Anatomists 10.5115/acb.2011.44.4.295Original ArticleNeurobiologyDifferent ex...,3,106,Anat_Cell_Biol_2011_Dec_30_44(4)_295-303.txt
1.44.4.331,...73Korean Association of Anatomists 10.5115/acb.2011.44.4.331Original ArticleDevelopment and Regenera...,3,106,Anat_Cell_Biol_2011_Dec_30_44(4)_331-336.txt
1.44.4.265,...73Korean Association of Anatomists 10.5115/acb.2011.44.4.265Original ArticleCell Biology & Microscop...,3,106,Anat_Cell_Biol_2011_Dec_30_44(4)_265-273.txt
1.44.4.245,...73Korean Association of Anatomists 10.5115/acb.2011.44.4.245Review ArticleInduced pluripotent stem c...,3,106,Anat_Cell_Biol_2011_Dec_30_44(4)_245-255.txt
1.44.4.284,...73Korean Association of Anatomists 10.5115/acb.2011.44.4.284Original ArticleCell Biology & Microscop...,3,106,Anat_Cell_Biol_2011_Dec_30_44(4)_284-294.txt
2.45.1.70,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.70Letter to EditorHarold Ellis: a surgeon's...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_70-71.txt
2.45.1.62,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.62Case ReportCoexistence of multiple anomal...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_62-65.txt
2.45.1.1,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.1Review ArticleA review on gastric leptin: ...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_1-16.txt
2.45.1.57,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.57Case ReportAbnormal patterns of the renal...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_57-61.txt
2.45.1.17,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.17Original ArticleCell Biology & Microscopi...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_17-25.txt
2.45.1.66,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.66Case ReportBipartite clavicular attachmen...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_66-69.txt
2.45.1.53,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.53Original ArticleApplied AnatomyDifferent ...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_53-56.txt
2.45.1.38,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.38Original ArticleNeurobiologyNestin expres...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_38-46.txt
2.45.1.26,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.26Original ArticleNeurobiologyEvidence of e...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_26-37.txt
2.45.1.47,...73Korean Association of Anatomists 10.5115/acb.2012.45.1.47Original ArticleNeurobiologyActivated mic...,3,120,Anat_Cell_Biol_2012_Mar_31_45(1)_47-52.txt
2.45.2.103,...73Korean Association of Anatomists 10.5115/acb.2012.45.2.103Original ArticleNeurobiologyProtective e...,3,120,Anat_Cell_Biol_2012_Jun_30_45(2)_103-113.txt
2.45.2.114,...73Korean Association of Anatomists 10.5115/acb.2012.45.2.114Original ArticleNeurobiologyArginine vas...,3,120,Anat_Cell_Biol_2012_Jun_30_45(2)_114-120.txt
2.45.2.128,...73Korean Association of Anatomists 10.5115/acb.2012.45.2.128Original ArticleApplied AnatomyThree typ...,3,120,Anat_Cell_Biol_2012_Jun_30_45(2)_128-135.txt
2.45.2.97,...73Korean Association of Anatomists 10.5115/acb.2012.45.2.97Original ArticleNeurobiologyDifferential ...,3,120,Anat_Cell_Biol_2012_Jun_30_45(2)_97-102.txt
2.45.2.79,...73Korean Association of Anatomists 10.5115/acb.2012.45.2.79Original ArticleCell Biology & Microscopi...,3,120,Anat_Cell_Biol_2012_Jun_30_45(2)_79-85.txt
2.45.2.92,...73Korean Association of Anatomists 10.5115/acb.2012.45.2.92Original ArticleNeurobiologyProtective ef...,3,120,Anat_Cell_Biol_2012_Jun_30_45(2)_92-96.txt
2.45.2.73,...73Korean Association of Anatomists 10.5115/acb.2012.45.2.73Review ArticleFrom tumor hypoxia to cance...,3,120,Anat_Cell_Biol_2012_Jun_30_45(2)_73-78.txt
2.45.2.86,...73Korean Association of Anatomists 10.5115/acb.2012.45.2.86Original ArticleCell Biology & Microscopi...,3,120,Anat_Cell_Biol_2012_Jun_30_45(2)_86-91.txt
2.45.2.136,"...73Korean Association of Anatomists 10.5115/acb.2012.45.2.136Case ReportFour-headed biceps brachii, t...",3,120,Anat_Cell_Biol_2012_Jun_30_45(2)_136-139.txt
2.45.3.185,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.185Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_185-192.txt
6.49.3.177,...73Korean Association of Anatomists 10.5115/acb.2016.49.3.177Original ArticleCell BiologyMacrophage d...,3,120,Anat_Cell_Biol_2016_Sep_29_49(3)_177-183.txt
2.45.3.178,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.178Original ArticleNeurobiologyEffects of h...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_178-184.txt
2.45.3.155,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.155Original ArticleCell Biology & Microscop...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_155-159.txt
2.45.3.141,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.141Review ArticleMechanism of experimental ...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_141-148.txt
2.45.3.149,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.149Original ArticleCell Biology & Microscop...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_149-154.txt
2.45.3.160,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.160Original ArticleCell Biology & Microscop...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_160-169.txt
2.45.3.203,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.203Original ArticleApplied AnatomyStudy on ...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_203-206.txt
2.45.3.211,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.211Case ReportVariant insertion of the tere...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_211-213.txt
2.45.3.214,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.214Letter from the Anatomical Society of In...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_214.txt
2.45.3.207,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.207Case ReportBilateral absence of musculoc...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_207-210.txt
2.45.3.170,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.170Original ArticleCell Biology & Microscop...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_170-177.txt
2.45.3.193,...73Korean Association of Anatomists 10.5115/acb.2012.45.3.193Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2012_Sep_30_45(3)_193-202.txt
2.45.4.221,...73Korean Association of Anatomists 10.5115/acb.2012.45.4.221Original ArticleCell Biology & Microscop...,3,120,Anat_Cell_Biol_2012_Dec_14_45(4)_221-228.txt
2.45.4.229,...73Korean Association of Anatomists 10.5115/acb.2012.45.4.229Original ArticleCell Biology & Microscop...,3,120,Anat_Cell_Biol_2012_Dec_14_45(4)_229-240.txt
2.45.4.241,...73Korean Association of Anatomists 10.5115/acb.2012.45.4.241Original ArticleNeurobiologyNuclear expr...,3,120,Anat_Cell_Biol_2012_Dec_14_45(4)_241-258.txt
2.45.4.215,...73Korean Association of Anatomists 10.5115/acb.2012.45.4.215Review ArticleErythropoietin and autoimm...,3,120,Anat_Cell_Biol_2012_Dec_14_45(4)_215-220.txt
2.45.4.259,...73Korean Association of Anatomists 10.5115/acb.2012.45.4.259Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2012_Dec_14_45(4)_259-267.txt
2.45.4.274,...73Korean Association of Anatomists 10.5115/acb.2012.45.4.274Original ArticleApplied AnatomyVertebral...,3,120,Anat_Cell_Biol_2012_Dec_14_45(4)_274-281.txt
2.45.4.268,...73Korean Association of Anatomists 10.5115/acb.2012.45.4.268Original ArticleApplied AnatomyThe study...,3,120,Anat_Cell_Biol_2012_Dec_14_45(4)_268-273.txt
2.45.4.282,...73Korean Association of Anatomists 10.5115/acb.2012.45.4.282Case ReportThe double retro-aortic left ...,3,120,Anat_Cell_Biol_2012_Dec_14_45(4)_282-284.txt
2.45.4.288,...73Korean Association of Anatomists 10.5115/acb.2012.45.4.288Case ReportDuplicated axillary arch musc...,3,120,Anat_Cell_Biol_2012_Dec_14_45(4)_288-290.txt
2.45.4.285,...73Korean Association of Anatomists 10.5115/acb.2012.45.4.285Case ReportThe inferior epigastric arter...,3,120,Anat_Cell_Biol_2012_Dec_14_45(4)_285-287.txt
3.46.1.32,...73Korean Association of Anatomists 10.5115/acb.2013.46.1.32Original ArticleDevelopment/RegenerationS...,3,120,Anat_Cell_Biol_2013_Mar_25_46(1)_32-38.txt
3.46.1.82,...73Korean Association of Anatomists 10.5115/acb.2013.46.1.82Case ReportA peculiar liver with surgical...,3,120,Anat_Cell_Biol_2013_Mar_25_46(1)_82-84.txt
3.46.1.39,...73Korean Association of Anatomists 10.5115/acb.2013.46.1.39Original ArticleDevelopment/RegenerationD...,3,120,Anat_Cell_Biol_2013_Mar_25_46(1)_39-48.txt
3.46.1.49,...73Korean Association of Anatomists 10.5115/acb.2013.46.1.49Original ArticleDevelopment/RegenerationQ...,3,120,Anat_Cell_Biol_2013_Mar_25_46(1)_49-56.txt
3.46.1.68,...73Korean Association of Anatomists 10.5115/acb.2013.46.1.68Original ArticleNeurobiologyExpression of...,3,120,Anat_Cell_Biol_2013_Mar_25_46(1)_68-78.txt
3.46.1.79,...73Korean Association of Anatomists 10.5115/acb.2013.46.1.79Case ReportUnilateral duplication of vas ...,3,120,Anat_Cell_Biol_2013_Mar_25_46(1)_79-81.txt
3.46.1.19,...73Korean Association of Anatomists 10.5115/acb.2013.46.1.19Review ArticleMolecular regulation of kid...,3,120,Anat_Cell_Biol_2013_Mar_25_46(1)_19-31.txt
3.46.1.1,...73Korean Association of Anatomists 10.5115/acb.2013.46.1.1Review ArticleThe immune modulating proper...,3,120,Anat_Cell_Biol_2013_Mar_25_46(1)_1-7.txt
3.46.1.57,...73Korean Association of Anatomists 10.5115/acb.2013.46.1.57Original ArticleNeurobiologyCaffeine-indu...,3,120,Anat_Cell_Biol_2013_Mar_25_46(1)_57-67.txt
3.46.1.8,...73Korean Association of Anatomists 10.5115/acb.2013.46.1.8Review ArticleGastric stem cells and gastr...,3,120,Anat_Cell_Biol_2013_Mar_25_46(1)_8-18.txt
3.46.2.93,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.93Review ArticleSurgical anatomy of the upp...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_93-100.txt
3.46.2.149,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.149Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_149-156.txt
3.46.2.122,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.122Original ArticleCell BiologyEffect of Oc...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_122-130.txt
3.46.2.131,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.131Original ArticleNeurobiologyCharacteriza...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_131-140.txt
3.46.2.167,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.167Case ReportRight-sided aortic arch with ...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_167-170.txt
3.46.2.141,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.141Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_141-148.txt
3.46.2.157,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.157Original ArticleApplied AnatomyStudents'...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_157-162.txt
3.46.2.101,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.101Original ArticleCell BiologyHeterogeneit...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_101-112.txt
3.46.2.85,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.85Review ArticleBiocompatability of carbon ...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_85-92.txt
3.46.2.163,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.163Case ReportRare multiple variations in b...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_163-166.txt
3.46.2.113,...73Korean Association of Anatomists 10.5115/acb.2013.46.2.113Original ArticleCell BiologyExpression o...,3,120,Anat_Cell_Biol_2013_Jun_30_46(2)_113-121.txt
3.46.3.210,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.210Original ArticleAnatomy EducationEvaluat...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_210-216.txt
3.46.3.177,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.177Original ArticleCell BiologyThe expressi...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_177-182.txt
3.46.3.191,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.191Original ArticleNeurobiologyStereologica...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_191-197.txt
6.49.4.241,...73Korean Association of Anatomists 10.5115/acb.2016.49.4.241Original ArticleApplied AnatomyMorphomet...,3,120,PMC5266106.txt
3.46.3.217,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.217Case ReportVascular variations of liver ...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_217-219.txt
3.46.3.171,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.171Original ArticleCell BiologyHistological...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_171-176.txt
3.46.3.220,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.220Case ReportAnterior cerebral artery aneu...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_220-222.txt
3.46.3.223,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.223Case ReportBilateral single cord of the ...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_223-227.txt
3.46.3.203,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.203Original ArticleApplied AnatomyLong bone...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_203-209.txt
3.46.3.198,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.198Original ArticleApplied AnatomyAnalysis ...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_198-202.txt
3.46.3.183,...73Korean Association of Anatomists 10.5115/acb.2013.46.3.183Original ArticleNeurobiologyNeuroprotect...,3,120,Anat_Cell_Biol_2013_Sep_30_46(3)_183-190.txt
3.46.4.299,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.299Case ReportRight sided descending and si...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_299-302.txt
3.46.4.272,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.272Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_272-284.txt
3.46.4.262,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.262Original ArticleCell BiologySuppression ...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_262-271.txt
3.46.4.229,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.229Review ArticleAdiponectin as a new parad...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_229-234.txt
3.46.4.254,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.254Original ArticleCell BiologyAscorbic aci...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_254-261.txt
3.46.4.296,"...73Korean Association of Anatomists 10.5115/acb.2013.46.4.296Case ReportSessile ileum, subhepatic cec...",3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_296-298.txt
3.46.4.239,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.239Original ArticleCell BiologyVitamin C mo...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_239-245.txt
3.46.4.291,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.291Case ReportApplied AnatomyRadiological a...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_291-295.txt
3.46.4.285,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.285Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_285-290.txt
3.46.4.246,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.246Original ArticleCell BiologyUltrastructu...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_246-253.txt
3.46.4.235,...73Korean Association of Anatomists 10.5115/acb.2013.46.4.235Review ArticleEvolution of the paranasal...,3,120,Anat_Cell_Biol_2013_Dec_24_46(4)_235-238.txt
4.47.1.12,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.12Original ArticleDevelopment/RegenerationF...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_12-17.txt
4.47.1.66,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.66Original ArticleApplied AnatomyHarris lin...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_66-72.txt
4.47.1.1,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.1Original ArticleCell BiologyThe expression...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_1-11.txt
4.47.1.18,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.18Original ArticleDevelopment/RegenerationE...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_18-27.txt
4.47.1.28,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.28Original ArticleDevelopment/RegenerationD...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_28-39.txt
4.47.1.40,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.40Original ArticleApplied AnatomyNormal str...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_40-43.txt
4.47.1.55,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.55Original ArticleApplied AnatomyTopohistol...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_55-65.txt
4.47.1.77,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.77Case ReportMultiple unilateral variations...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_77-80.txt
4.47.1.44,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.44Original ArticleApplied AnatomyNerves and...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_44-54.txt
4.47.1.73,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.73Case ReportA rare variant angioarchitectu...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_73-76.txt
4.47.1.81,...73Korean Association of Anatomists 10.5115/acb.2014.47.1.81Letter to EditorViewed relics belonging t...,3,120,Anat_Cell_Biol_2014_Mar_13_47(1)_81-82.txt
4.47.2.141,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.141Case ReportUncommon branching pattern wi...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_141-143.txt
4.47.2.135,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.135Case ReportAbsence of retromandibular ve...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_135-137.txt
4.47.2.138,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.138Case ReportAnomalous cutaneous branch of...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_138-140.txt
4.47.2.127,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.127Original ArticleApplied AnatomyPes anser...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_127-131.txt
4.47.2.91,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.91Original ArticleCell BiologyFK506 reduces...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_91-100.txt
4.47.2.83,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.83Original ArticleCell BiologyAdipogenesis ...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_83-90.txt
4.47.2.144,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.144Case ReportFascial entrapment of the sur...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_144-147.txt
4.47.2.101,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.101Original ArticleNeurobiologyRegion-speci...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_101-110.txt
4.47.2.132,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.132Case ReportDouble gallbladder completely...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_132-134.txt
4.47.2.111,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.111Original ArticleNeurobiologyChange of pe...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_111-116.txt
4.47.2.117,...73Korean Association of Anatomists 10.5115/acb.2014.47.2.117Original ArticleNeurobiologyA comparativ...,3,120,Anat_Cell_Biol_2014_Jun_20_47(2)_117-126.txt
4.47.3.180,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.180Original ArticleCell BiologyLocalization...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_180-187.txt
4.47.3.157,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.157Original ArticleCell BiologyDistribution...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_157-161.txt
4.47.3.210,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.210Case ReportAbsent portal vein bifurcatio...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_210-213.txt
4.47.3.202,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.202Original ArticleApplied AnatomyMastoid e...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_202-206.txt
4.47.3.171,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.171Original ArticleCell BiologyEffect of sa...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_171-179.txt
4.47.3.149,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.149Review ArticleNeuroprotection of antioxi...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_149-156.txt
4.47.3.196,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.196Original ArticleApplied AnatomySex deter...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_196-201.txt
4.47.3.207,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.207Case ReportSemimembranosus ganglion cyst...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_207-209.txt
4.47.3.162,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.162Original ArticleCell BiologyEffect of ni...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_162-170.txt
4.47.3.188,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.188Original ArticleApplied AnatomyVariation...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_188-195.txt
4.47.3.214,...73Korean Association of Anatomists 10.5115/acb.2014.47.3.214Case ReportEight prehilar branches of th...,3,120,Anat_Cell_Biol_2014_Sep_23_47(3)_214-216.txt
4.47.4.267,...73Korean Association of Anatomists 10.5115/acb.2014.47.4.267Case ReportUnilateral ureteric stone ass...,3,120,Anat_Cell_Biol_2014_Dec_23_47(4)_267-270.txt
4.47.4.274,...73Korean Association of Anatomists 10.5115/acb.2014.47.4.274Case ReportMultiple absences of the bran...,3,120,Anat_Cell_Biol_2014_Dec_23_47(4)_274-278.txt
4.47.4.259,...73Korean Association of Anatomists 10.5115/acb.2014.47.4.259Original ArticleApplied AnatomyOutcome-b...,3,120,Anat_Cell_Biol_2014_Dec_23_47(4)_259-266.txt
4.47.4.271,...73Korean Association of Anatomists 10.5115/acb.2014.47.4.271Case ReportUnusual morphology of the sup...,3,120,Anat_Cell_Biol_2014_Dec_23_47(4)_271-273.txt
4.47.4.217,...73Korean Association of Anatomists 10.5115/acb.2014.47.4.217Original ArticleCell BiologyMicroarray a...,3,120,Anat_Cell_Biol_2014_Dec_23_47(4)_217-226.txt
4.47.4.236,...73Korean Association of Anatomists 10.5115/acb.2014.47.4.236Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2014_Dec_23_47(4)_236-243.txt
4.47.4.227,...73Korean Association of Anatomists 10.5115/acb.2014.47.4.227Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2014_Dec_23_47(4)_227-235.txt
4.47.4.244,...73Korean Association of Anatomists 10.5115/acb.2014.47.4.244Original ArticleApplied AnatomyStable is...,3,120,Anat_Cell_Biol_2014_Dec_23_47(4)_244-252.txt
4.47.4.253,...73Korean Association of Anatomists 10.5115/acb.2014.47.4.253Original ArticleApplied AnatomyMorpholog...,3,120,Anat_Cell_Biol_2014_Dec_23_47(4)_253-258.txt
4.47.4.279,"...73Korean Association of Anatomists 10.5115/acb.2014.47.4.279Case ReportAbsence of transverse colon, ...",3,120,Anat_Cell_Biol_2014_Dec_23_47(4)_279-281.txt
5.48.1.10,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.10Review ArticleThe role of soluble common ...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_10-15.txt
5.48.1.36,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.36Original ArticleCell BiologyInnervation o...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_36-43.txt
5.48.1.81,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.81Case ReportUnduly extensive uncinate proc...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_81-83.txt
5.48.1.54,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.54Original ArticleCell BiologyExpression of...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_54-61.txt
5.48.1.62,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.62Original ArticleApplied AnatomyVariations...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_62-65.txt
5.48.1.1,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.1Review ArticleWhen morphogenetic proteins ...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_1-9.txt
5.48.1.16,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.16Review ArticleMechanistic insights into p...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_16-24.txt
5.48.1.66,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.66Original ArticleApplied AnatomyCisplatin ...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_66-74.txt
5.48.1.75,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.75Original ArticleApplied AnatomyMorphologi...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_75-80.txt
5.48.1.25,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.25Original ArticleCell BiologyNeurosphere a...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_25-35.txt
5.48.1.44,...73Korean Association of Anatomists 10.5115/acb.2015.48.1.44Original ArticleCell BiologyGlioblastoma ...,3,120,Anat_Cell_Biol_2015_Mar_20_48(1)_44-53.txt
6.49.4.254,...73Korean Association of Anatomists 10.5115/acb.2016.49.4.254Original ArticleApplied AnatomyVariation...,3,120,PMC5266101.txt
5.48.2.130,...73Korean Association of Anatomists 10.5115/acb.2015.48.2.130Original ArticleApplied AnatomyTopograph...,3,120,Anat_Cell_Biol_2015_Jun_26_48(2)_130-137.txt
5.48.2.147,...73Korean Association of Anatomists 10.5115/acb.2015.48.2.147Case ReportMultiple variations in the br...,3,120,Anat_Cell_Biol_2015_Jun_26_48(2)_147-150.txt
5.48.2.85,...73Korean Association of Anatomists 10.5115/acb.2015.48.2.85Original ArticleCell BiologyImproved adip...,3,120,Anat_Cell_Biol_2015_Jun_26_48(2)_85-94.txt
5.48.2.114,...73Korean Association of Anatomists 10.5115/acb.2015.48.2.114Original ArticleNeurobiologyComposite ne...,3,120,Anat_Cell_Biol_2015_Jun_26_48(2)_114-123.txt
5.48.2.138,...73Korean Association of Anatomists 10.5115/acb.2015.48.2.138Original ArticleApplied AnatomyPerceptio...,3,120,Anat_Cell_Biol_2015_Jun_26_48(2)_138-143.txt
5.48.2.151,...73Korean Association of Anatomists 10.5115/acb.2015.48.2.151ErratumErratum: Stable isotope analysis ...,3,120,Anat_Cell_Biol_2015_Jun_26_48(2)_151.txt
4.47.4.244,"...4;47(4):244-252, http://dx.doi.org/10.5115/acb.2014.47.4.24",5,69,Anat_Cell_Biol_2015_Jun_26_48(2)_151.txt
5.48.2.124,...73Korean Association of Anatomists 10.5115/acb.2015.48.2.124Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2015_Jun_26_48(2)_124-129.txt
5.48.2.104,...73Korean Association of Anatomists 10.5115/acb.2015.48.2.104Original ArticleNeurobiologyThe effects ...,3,120,Anat_Cell_Biol_2015_Jun_26_48(2)_104-113.txt
5.48.2.144,...73Korean Association of Anatomists 10.5115/acb.2015.48.2.144Case ReportDual left anterior interventr...,3,120,Anat_Cell_Biol_2015_Jun_26_48(2)_144-146.txt
5.48.2.95,...73Korean Association of Anatomists 10.5115/acb.2015.48.2.95Original ArticleCell BiologyA single frac...,3,120,Anat_Cell_Biol_2015_Jun_26_48(2)_95-103.txt
5.48.3.213,...73Korean Association of Anatomists 10.5115/acb.2015.48.3.213Case ReportBone tumors in pre-modern sku...,3,120,Anat_Cell_Biol_2015_Sep_22_48(3)_213-217.txt
5.48.3.170,...73Korean Association of Anatomists 10.5115/acb.2015.48.3.170Original ArticleCell BiologyDifferentiat...,3,120,Anat_Cell_Biol_2015_Sep_22_48(3)_170-176.txt
5.48.3.195,...73Korean Association of Anatomists 10.5115/acb.2015.48.3.195Original ArticleApplied AnatomyMorpholog...,3,120,Anat_Cell_Biol_2015_Sep_22_48(3)_195-200.txt
5.48.3.153,...73Korean Association of Anatomists 10.5115/acb.2015.48.3.153Review ArticleHuman cadaveric dissection...,3,120,Anat_Cell_Biol_2015_Sep_22_48(3)_153-169.txt
5.48.3.188,...73Korean Association of Anatomists 10.5115/acb.2015.48.3.188Original ArticleCell BiologyNfic regulat...,3,120,Anat_Cell_Biol_2015_Sep_22_48(3)_188-194.txt
5.48.3.205,...73Korean Association of Anatomists 10.5115/acb.2015.48.3.205Original ArticleApplied AnatomyRole of c...,3,120,Anat_Cell_Biol_2015_Sep_22_48(3)_205-212.txt
5.48.3.201,...73Korean Association of Anatomists 10.5115/acb.2015.48.3.201Original ArticleApplied AnatomyRectus an...,3,120,Anat_Cell_Biol_2015_Sep_22_48(3)_201-204.txt
5.48.3.222,...73Korean Association of Anatomists 10.5115/acb.2015.48.3.222Case ReportAbsence of the lateral and th...,3,120,Anat_Cell_Biol_2015_Sep_22_48(3)_222-224.txt
5.48.3.177,...73Korean Association of Anatomists 10.5115/acb.2015.48.3.177Original ArticleCell BiologyRegional dif...,3,120,Anat_Cell_Biol_2015_Sep_22_48(3)_177-187.txt
5.48.3.218,...73Korean Association of Anatomists 10.5115/acb.2015.48.3.218Case ReportAn anomalous portal vein cros...,3,120,Anat_Cell_Biol_2015_Sep_22_48(3)_218-221.txt
5.48.4.275,...73Korean Association of Anatomists 10.5115/acb.2015.48.4.275Original ArticleApplied AnatomyCraniomet...,3,120,Anat_Cell_Biol_2015_Dec_21_48(4)_275-283.txt
5.48.4.284,...73Korean Association of Anatomists 10.5115/acb.2015.48.4.284Original ArticleApplied AnatomyEvaluatio...,3,120,Anat_Cell_Biol_2015_Dec_21_48(4)_284-291.txt
5.48.4.225,...73Korean Association of Anatomists 10.5115/acb.2015.48.4.225Original ArticleCell BiologyRole of mast...,3,120,Anat_Cell_Biol_2015_Dec_21_48(4)_225-234.txt
6.49.3.189,...73Korean Association of Anatomists 10.5115/acb.2016.49.3.189Original ArticleCell BiologyRhus vernici...,3,120,Anat_Cell_Biol_2016_Sep_29_49(3)_189-198.txt
6.49.3.184,...73Korean Association of Anatomists 10.5115/acb.2016.49.3.184Original ArticleCell BiologyHistological...,3,120,Anat_Cell_Biol_2016_Sep_29_49(3)_184-188.txt
5.48.4.292,...73Korean Association of Anatomists 10.5115/acb.2015.48.4.292Original ArticleApplied AnatomyMorpholog...,3,120,Anat_Cell_Biol_2015_Dec_21_48(4)_292-298.txt
5.48.4.235,...73Korean Association of Anatomists 10.5115/acb.2015.48.4.235Original ArticleCell BiologyProtective e...,3,120,Anat_Cell_Biol_2015_Dec_21_48(4)_235-243.txt
5.48.4.251,...73Korean Association of Anatomists 10.5115/acb.2015.48.4.251Original ArticleCell BiologyThe influenc...,3,120,Anat_Cell_Biol_2015_Dec_21_48(4)_251-257.txt
5.48.4.258,...73Korean Association of Anatomists 10.5115/acb.2015.48.4.258Original ArticleCell BiologyHaversian sy...,3,120,Anat_Cell_Biol_2015_Dec_21_48(4)_258-261.txt
5.48.4.262,...73Korean Association of Anatomists 10.5115/acb.2015.48.4.262Original ArticleNeurobiologyWhite matter...,3,120,Anat_Cell_Biol_2015_Dec_21_48(4)_262-267.txt
5.48.4.244,...73Korean Association of Anatomists 10.5115/acb.2015.48.4.244Original ArticleCell BiologyA combinatio...,3,120,Anat_Cell_Biol_2015_Dec_21_48(4)_244-250.txt
5.48.4.268,...73Korean Association of Anatomists 10.5115/acb.2015.48.4.268Original ArticleNeurobiologyAnatomical s...,3,120,Anat_Cell_Biol_2015_Dec_21_48(4)_268-274.txt
6.49.1.1,...73Korean Association of Anatomists 10.5115/acb.2016.49.1.1Review ArticleThe association between PGC-...,3,120,Anat_Cell_Biol_2016_Mar_28_49(1)_1-6.txt
6.49.1.15,...73Korean Association of Anatomists 10.5115/acb.2016.49.1.15Original ArticleCell BiologyCorrecting of...,3,120,Anat_Cell_Biol_2016_Mar_28_49(1)_15-20.txt
6.49.1.61,...73Korean Association of Anatomists 10.5115/acb.2016.49.1.61Original ArticleDevelopment/RegenerationS...,3,120,Anat_Cell_Biol_2016_Mar_28_49(1)_61-67.txt
6.49.1.21,...73Korean Association of Anatomists 10.5115/acb.2016.49.1.21Original ArticleNeurobiologyModulation of...,3,120,Anat_Cell_Biol_2016_Mar_28_49(1)_21-33.txt
6.49.1.34,...73Korean Association of Anatomists 10.5115/acb.2016.49.1.34Original ArticleNeurobiologyProtective ef...,3,120,Anat_Cell_Biol_2016_Mar_28_49(1)_34-49.txt
6.49.1.50,...73Korean Association of Anatomists 10.5115/acb.2016.49.1.50Original ArticleDevelopment/RegenerationC...,3,120,Anat_Cell_Biol_2016_Mar_28_49(1)_50-60.txt
6.49.1.68,...73Korean Association of Anatomists 10.5115/acb.2016.49.1.68Original ArticleApplied AnatomyAnatomical...,3,120,Anat_Cell_Biol_2016_Mar_28_49(1)_68-72.txt
6.49.1.7,...73Korean Association of Anatomists 10.5115/acb.2016.49.1.7Original ArticleCell BiologyReduced immuno...,3,120,Anat_Cell_Biol_2016_Mar_28_49(1)_7-14.txt
6.49.1.73,...73Korean Association of Anatomists 10.5115/acb.2016.49.1.73Original ArticleApplied AnatomyMorphometr...,3,120,Anat_Cell_Biol_2016_Mar_28_49(1)_73-77.txt
6.49.2.88,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.88Original ArticleCell BiologyVitamin C is ...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_88-98.txt
6.49.2.107,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.107Original ArticleCell Biology5-Aza-2'-deo...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_107-115.txt
6.49.2.160,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.160Case ReportMuscular axillary arch accomp...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_160-162.txt
6.49.2.116,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.116Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_116-124.txt
6.49.2.163,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.163ErratumErratum: The association between ...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_163.txt
6.49.1.1,"... 2016;49(1):1-6, http://dx.doi.org/10.5115/acb.2016.49.1.",5,65,Anat_Cell_Biol_2016_Jun_24_49(2)_163.txt
6.49.2.151,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.151Original ArticleApplied AnatomyBinary lo...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_151-159.txt
6.49.2.125,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.125Original ArticleApplied AnatomyVertical ...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_125-131.txt
6.49.2.79,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.79Original ArticleCell BiologyPoly(ADP-ribo...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_79-87.txt
6.49.2.138,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.138Original ArticleApplied AnatomyAnatomica...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_138-142.txt
6.49.2.99,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.99Original ArticleCell BiologyChanges in ex...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_99-106.txt
6.49.2.132,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.132Original ArticleApplied AnatomyHuman nas...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_132-137.txt
6.49.2.143,...73Korean Association of Anatomists 10.5115/acb.2016.49.2.143Original ArticleApplied AnatomyIncidence...,3,120,Anat_Cell_Biol_2016_Jun_24_49(2)_143-150.txt
1.44.2.151,...73Korean Association of Anatomists 10.5115/acb.2011.44.2.151Original ArticleApplied AnatomySurface m...,3,106,Anat_Cell_Biol_2011_Jun_30_44(2)_151-159.txt
1.44.3.210,...73Korean Association of Anatomists 10.5115/acb.2011.44.3.210Original ArticleNeurobiologyModulation b...,3,106,Anat_Cell_Biol_2011_Sep_29_44(3)_210-217.txt
2.45.2.121,...73Korean Association of Anatomists 10.5115/acb.2012.45.2.121Original ArticleNeurobiologyPurkinje cel...,3,120,Anat_Cell_Biol_2012_Jun_30_45(2)_121-127.txt
6.49.3.206,...73Korean Association of Anatomists 10.5115/acb.2016.49.3.206Original ArticleApplied AnatomyReconstru...,3,120,Anat_Cell_Biol_2016_Sep_29_49(3)_206-209.txt
6.49.3.213,...73Korean Association of Anatomists 10.5115/acb.2016.49.3.213Case ReportDorsoscapularis triangularis:...,3,120,Anat_Cell_Biol_2016_Sep_29_49(3)_213-216.txt
6.49.3.199,...73Korean Association of Anatomists 10.5115/acb.2016.49.3.199Original ArticleDevelopment/Regeneration...,3,120,Anat_Cell_Biol_2016_Sep_29_49(3)_199-205.txt
6.49.3.210,...73Korean Association of Anatomists 10.5115/acb.2016.49.3.210Case ReportA rare case of persistent jug...,3,120,Anat_Cell_Biol_2016_Sep_29_49(3)_210-212.txt
6.49.3.217,...73Korean Association of Anatomists 10.5115/acb.2016.49.3.217Case ReportBilateral elongated mandibula...,3,120,Anat_Cell_Biol_2016_Sep_29_49(3)_217-220.txt
6.49.4.249,...73Korean Association of Anatomists 10.5115/acb.2016.49.4.249Original ArticleApplied AnatomyAn osteol...,3,120,PMC5266103.txt
6.49.4.273,...73Korean Association of Anatomists 10.5115/acb.2016.49.4.273Original ArticleClinical ResearchAnatomi...,3,120,PMC5266104.txt
6.49.4.231,...73Korean Association of Anatomists 10.5115/acb.2016.49.4.231Original ArticleDevelopment/Regeneration...,3,120,PMC5266102.txt
6.49.4.223,...73Korean Association of Anatomists 10.5115/acb.2016.49.4.223Review ArticleGalanin's implications for...,3,120,PMC5266107.txt
6.49.4.259,...73Korean Association of Anatomists 10.5115/acb.2016.49.4.259Original ArticleCellular and Molecular R...,3,120,PMC5266105.txt
4.3.8.1,1914.3.8.1/42	3.1	J1	1.10	1.85	2.60	8.70	3.56	1.18,167,4,Anat_Res_Int_2011_Jun_7_2011_484607.txt
5.12.26.32,1855.12.26.32/45	4.4	J1	1.12	2.10	2.94	10.30	4.07	1.3...,173,4,Anat_Res_Int_2011_Jun_7_2011_484607.txt
1.4.1.2,1931.4.1.2/64	4.4	J1	1.16	2.30	3.31	9.80	4.23	1.30,174,4,Anat_Res_Int_2011_Jun_7_2011_484607.txt
3.10.18.1,1913.10.18.1/47	5.3	J2	1.08	2.52	3.35	10.20	4.90	1.23...,180,4,Anat_Res_Int_2011_Jun_7_2011_484607.txt
4.8.6.14,1924.8.6.14/43	5.3	J2	1.22	2.23	3.11	9.80	4.17	1.39,183,4,Anat_Res_Int_2011_Jun_7_2011_484607.txt
6.10.23.11,1846.10.23.11/7	3.8	J1	1.23	1.57	2.87	8.70	3.32	1.29,204,4,Anat_Res_Int_2011_Jun_7_2011_484607.txt
6.11.18.1,1926.11.18.1/24	6	J1	1.26	2.08	3.27	10.38	3.90	1.39,208,4,Anat_Res_Int_2011_Jun_7_2011_484607.txt
1.8.9.9,1901.8.9.9/25	6	J1	1.31	1.94	3.04	11.00	3.58	1.47,209,4,Anat_Res_Int_2011_Jun_7_2011_484607.txt
2.7.1.19,...n Medical Science  1992 7 1 19 24 10.3346/jkms.1992.7.1.19 2-s2.0-0026838645 1418758,106,161,Anat_Res_Int_2016_Aug_15_2016_4106981.txt
4.1.4.253,...nd Applications  2014 1 4 253 267 10.12989/aba.2014.1.4.253,125,217,Anat_Res_Int_2015_May_24_2015_279814.txt
5.16.2.402,...al of Radiology  2015 16 2 402 409 10.3348/kjr.2015.16.2.402 25741202,144,278,Anat_Res_Int_2015_Jul_7_2015_384148.txt
1.1.31.281,...rnal of Morphology  2003 41 1 31 34 10.1076/ejom.41.1.31.28103 2-s2.0-12144289078 15121546,68,161,Anat_Res_Int_2015_Jul_9_2015_847812.txt
4.44.1.53,...ence in Dentistry  2014 44 1 53 60 10.5624/isd.2014.44.1.53 2-s2.0-84898025554 24701459,378,212,Anat_Res_Int_2015_Aug_20_2015_434083.txt
5.16.4.914,...al of Radiology  2015 16 4 914 918 10.3348/kjr.2015.16.4.914 26175593,219,233,Anat_Res_Int_2016_Mar_7_2016_6907472.txt
3.18.11.200,...al Research  2003 18 11 2002 2029 10.1359/jbmr.2003.18.11.2002 2-s2.0-0242412974 14606513,204,269,Anat_Res_Int_2016_Apr_11_2016_9295383.txt
2.17.1.162,...neral Research  2002 17 1 162 171 10.1359/jbmr.2002.17.1.162 2-s2.0-0036133362 11771664,226,258,Anat_Res_Int_2016_Apr_11_2016_9295383.txt
6.49.1.73,...my & Cell Biology  2016 49 1 73 77 10.5115/acb.2016.49.1.73 27051570,237,266,PMC5220386.txt
1.44.1.79,... and Cell Biology  2011 44 1 79 83 10.5115/acb.2011.44.1.79 21519552,243,139,PMC5220386.txt
1.1.31.281,... artery Eur J Morphol 2003 41 31 34 10.1076/ejom.41.1.31.28103 15121546,69,133,Anat_Sci_Int_2014_Dec_6_89(3)_195-198.txt
3.90.70.117,...ril 2009 cited 2012 mar 1 Disponível em: http://203.90.70.117/PDS_DOCS/B4292.pdf,1024,87,An_Bras_Dermatol_2014_May-Jun_89(3)_389-401.txt
3.1.3.2,(EC:3.1.3.2) and alkaline phosphatas,99,5,Anc_Sci_Life_1997_Jul-Sep_17(1)_41-46.txt
3.1.3.1,(EC:3.1.3.1) were estimated calorimetricall,100,5,Anc_Sci_Life_1997_Jul-Sep_17(1)_41-46.txt
1.1.1.27,"dehydrogenase (LDH, EC: 1.1.1.27) wa",102,25,Anc_Sci_Life_1997_Jul-Sep_17(1)_41-46.txt
3.2.1.31,Bernt.5  - glucuronidase (EC: 3.2.1.31,104,31,Anc_Sci_Life_1997_Jul-Sep_17(1)_41-46.txt
4.1.1.98,"treatment (Car 4.1.1.98, 116 - 117). B",347,16,Anc_Sci_Life_1987_Jan-Mar_6(3)_129-134.txt
1.1.4.7,"58. VS 1.1.17, 22, 29; 2.1.6, 7, 16; 2.2.19, 43; 1.1.4.7; 1.2.11, 13, 15; 8.5",347,50,Anc_Sci_Life_1988_Jan-Jun_7(3-4)_126-133.txt
1.5.1.3,...e malarial dihydrofolate reductase (Pf-DHFR) (E.C.1.5.1.3)[11] is the target for antifolate antimala...,32,60,Anc_Sci_Life_2015_Oct-Dec_35(2)_85-89.txt
1.8.1.121,"...w.degruyter.com/view/j/jcim.2011.8.issue1/jcim.2011.8.1.1216/jcim.2011.8.1.1216.xml?format=INT, DOI:...",118,270,Anc_Sci_Life_2016_Jan-Mar_35(3)_132-142.txt
1.8.1.121,"...w/j/jcim.2011.8.issue1/jcim.2011.8.1.1216/jcim.2011.8.1.1216.xml?format=INT, DOI:10.2202/1553-3840.1...",118,289,Anc_Sci_Life_2016_Jan-Mar_35(3)_132-142.txt
2.2.2.182,"... software (version 3.1 for data entry and version 2.2.2.182 for analysis, EpiData Association, Odens...",41,102,Anc_Sci_Life_2016_Apr-Jun_35(4)_212-216.txt
1.2.7.2,...oducts; GO enrichment analysis. R package version 1.2.7.2. Available at: http://CRAN.R-project.org/p...,171,158,Andrology_2013_Nov_28_1(6)_822-829.txt
6.37.2.104,...Medical Journal  1996 37 2 104 111 10.3349/ymj.1996.37.2.104 2-s2.0-0030018448 8711932,291,193,Anemia_2014_Oct_21_2014_503981.txt
4.18.30.404,"...cal Journal  2014 18, article 30 10.11604/pamj.2014.18.30.4043 2-s2.0-84900480237",388,194,Anemia_2015_Jan_18_2015_791498.txt
2.27.6.608,...n Hospitalaria  2012 27 6 1817 1836 10.3305/nh.2012.27.6.6087 23588429,241,261,Anemia_2015_Jul_5_2015_647930.txt
4.30.5.798,...n Hospitalaria  2014 30 5 1181 1190 10.3305/nh.2014.30.5.7982 2-s2.0-84908673640 25365025,220,254,Anemia_2016_Mar_21_2016_8454286.txt
3.14.4.732,...esearch  2013 14 4 461 470 10.5829/idosi.mejsr.2013.14.4.7321 2-s2.0-84880255086,368,283,Anemia_2016_Apr_4_2016_1729147.txt
1.73.6.423,...ition Research  2003 73 6 423 430 10.1024/0300-9831.73.6.423 2-s2.0-0348147703 14743546,256,341,Anemia_2016_Jun_13_2016_6430214.txt
5.58.1.15,...nal of Pediatrics  2015 58 1 15 19 10.3345/kjp.2015.58.1.15 2-s2.0-84921299181 25729394,257,239,Anemia_2016_Jun_13_2016_6430214.txt
1.12.1.101,"...escribe accuracy (ISO 80601-2-61, 2011, section 201.12.1.101.2.2). An * superscript is used to indic...",83,828,Anesth_Analg_2017_Jan_19_124(1)_136-145.txt
1.60.2.75,...f Anesthesiology  2011 60 2 75 77 10.4097/kjae.2011.60.2.75 2-s2.0-79952569494 21390160,155,223,Anesthesiol_Res_Pract_2014_Oct_29_2014_459432.txt
5.5.5.643,...eurotherapeutics  2005 5 5 643 651 10.1586/14737175.5.5.643 2-s2.0-26444462460 16162088,633,230,Anesthesiol_Res_Pract_2015_Jan_26_2015_956539.txt
3.65.3.254,...Anesthesiology  2013 65 3 254 256 10.4097/kjae.2013.65.3.254 24101961,186,227,Anesthesiol_Res_Pract_2015_Dec_1_2015_971059.txt
2.63.6.510,...Anesthesiology  2012 63 6 510 514 10.4097/kjae.2012.63.6.510 2-s2.0-84871817781 23277811,211,206,Anesthesiol_Res_Pract_2015_Dec_1_2015_971059.txt
3.64.5.478,...Anesthesiology  2013 64 5 478 479 10.4097/kjae.2013.64.5.478 2-s2.0-84878437932 23741578,228,237,Anesthesiol_Res_Pract_2016_Feb_1_2016_4237523.txt
4.47.2.117,...cular Surgery  2014 47 2 117 123 10.5090/kjtcs.2014.47.2.117 2-s2.0-84899630614 24782960,79,278,Anesthesiol_Res_Pract_2016_Feb_7_2016_6249483.txt
4.75.11.147,...riodontology  2004 75 11 1471 1478 10.1902/jop.2004.75.11.1471 2-s2.0-19944361817 15633323,101,281,Anesthesiol_Res_Pract_2016_Feb_29_2016_5768482.txt
1.72.7.895,... Periodontology  2001 72 7 895 900 10.1902/jop.2001.72.7.895 2-s2.0-0034913452 11495138,108,244,Anesthesiol_Res_Pract_2016_Feb_29_2016_5768482.txt
3.65.1.4,... of Anesthesiology  2013 65 1 4 8 10.4097/kjae.2013.65.1.4 2-s2.0-84880965239 23904932,465,128,Anesthesiol_Res_Pract_2016_Mar_9_2016_7172920.txt
1.52.11.769,...nal of Urology  2011 52 11 769 775 10.4111/kju.2011.52.11.769 2-s2.0-84255205673 22195267,177,275,Anesthesiol_Res_Pract_2016_Mar_27_2016_9036872.txt
1.20.9.412,...of Wound Care  2011 20 9 412 422 10.12968/jowc.2011.20.9.412 2-s2.0-80052639581 22068140,223,191,Anesthesiol_Res_Pract_2016_Jun_12_2016_4878246.txt
1.10.2.260,...al of Wound Care  2001 10 2 7 10 10.12968/jowc.2001.10.2.26054 2-s2.0-0141652858 12964220,224,161,Anesthesiol_Res_Pract_2016_Jun_12_2016_4878246.txt
6.15.5.269,...of Wound Care  2006 15 5 187 191 10.12968/jowc.2006.15.5.26907 2-s2.0-33745308306 16711170,226,197,Anesthesiol_Res_Pract_2016_Jun_12_2016_4878246.txt
2.36.4.466,...tation Medicine  2012 36 4 466 473 10.5535/arm.2012.36.4.466 2-s2.0-84867137371 22977771,90,229,Anesthesiol_Res_Pract_2016_Aug_17_2016_7198048.txt
3.64.4.301,...Anesthesiology  2013 64 4 301 307 10.4097/kjae.2013.64.4.301 2-s2.0-84877094687 23646238,109,194,Anesthesiol_Res_Pract_2016_Aug_17_2016_7198048.txt
3.4.2.2,...ner in Oncology  2013 4 2 82 88 10.6004/jadpro.2013.4.2.2,137,151,Anesthesiol_Res_Pract_2016_Aug_21_2016_2942416.txt
2.1.47.239,...erimental Hypnosis  2004 52 1 47 72 10.1076/iceh.52.1.47.23922 2-s2.0-1642567552 14768969,147,341,Anesthesiol_Res_Pract_2016_Aug_21_2016_2942416.txt
3.23.4.381,...lth Psychology  2004 23 4 381 387 10.1037/0278-6133.23.4.381 2-s2.0-3042734349 15264974,157,222,Anesthesiol_Res_Pract_2016_Aug_21_2016_2942416.txt
3.20.1.47,...alth Psychology  2001 20 1 47 63 10.1037//0278-6133.20.1.47 2-s2.0-0035174666 11199066,189,168,Anesthesiol_Res_Pract_2016_Aug_21_2016_2942416.txt
3.94.76.60,http://203.94.76.60/nihs/BEDS/2009%20Total%20Beds.pdf,92,10,Anesth_Essays_Res_2011_Jan-Jun_5(1)_28-32.txt
4.27.1.3,...ons. Korean J Pain. 2014 27 1 3 15 10.3344/kjp.2014.27.1.3 24478895,292,119,Anesth_Pain_Med_2016_Mar_7_6(2)_e26172.txt
4.27.2.178,...n. Korean J Pain. 2014 27 2 178 85 10.3344/kjp.2014.27.2.178 24748948,314,203,Anesth_Pain_Med_2016_Mar_7_6(2)_e26172.txt
4.66.2.169,...n J Anesthesiol. 2014 66 2 169 72 10.4097/kjae.2014.66.2.169 24624278,316,247,Anesth_Pain_Med_2016_Mar_7_6(2)_e26172.txt
2.63.4.302,...an J Anesthesiol. 2012 63 4 302 7 10.4097/kjae.2012.63.4.302 2311568,140,222,Anesth_Pain_Med_2013_Sep_1_3(2)_234-238.txt
1.61.1.50,...ean J Anesthesiol. 2011 61 1 50 4 10.4097/kjae.2011.61.1.50 21860751,64,227,Anesth_Pain_Med_2013_Sep_1_3(2)_256-259.txt
1.24.3.137,...y. Korean J Pain. 2011 24 3 137 40 10.3344/kjp.2011.24.3.137 21935491,174,157,Anesth_Pain_Med_2013_Dec_26_4(1)_e12162.txt
3.26.4.379,...n. Korean J Pain. 2013 26 4 379 86 10.3344/kjp.2013.26.4.379 24156005,193,199,Anesth_Pain_Med_2016_May_9_6(3)_e32172.txt
3.65.4.293,...an J Anesthesiol. 2013 65 4 293 8 10.4097/kjae.2013.65.4.293 24228140,197,241,Anesth_Pain_Med_2016_May_9_6(3)_e32172.txt
3.64.1.12,...ean J Anesthesiol. 2013 64 1 12 8 10.4097/kjae.2013.64.1.12 2337288,152,269,Anesth_Pain_Med_2014_Jan_25_4(1)_e14618.txt
2.63.6.521,...an J Anesthesiol. 2012 63 6 521 6 10.4097/kjae.2012.63.6.521 23277813,162,225,Anesth_Pain_Med_2014_Feb_15_4(1)_e14129.txt
2.63.1.54,...ean J Anesthesiol. 2012 63 1 54 8 10.4097/kjae.2012.63.1.54 22870366,175,278,Anesth_Pain_Med_2014_Feb_15_4(1)_e14129.txt
1.15.6.327,...ysiol Pharmacol. 2011 15 6 327 32 10.4196/kjpp.2011.15.6.327 22359469,185,281,Anesth_Pain_Med_2014_Feb_15_4(1)_e14129.txt
2.18.9.22,...c. Emerg Nurse J. 2011 18 9 22 25 10.7748/en2011.02.18.9.22.c8337 21384782,272,116,Anesth_Pain_Med_2014_Feb_13_4(1)_e16222.txt
2.6.4.287,...ss. Asian Spine J. 2012 6 4 287 90 10.4184/asj.2012.6.4.287 23275814,62,196,Anesth_Pain_Med_2014_Apr_6_4(2)_e7291.txt
2.18.9.22,...olic. Emerg Nurse. 2011 18 9 22 5 10.7748/en2011.02.18.9.22.c8337 21384782,207,113,Anesth_Pain_Med_2014_Mar_8_4(2)_e12912.txt
2.6.3.343,...v Cardiovasc Ther. 2008 6 3 343 68 10.1586/14779072.6.3.343 18327995,331,269,Anesth_Pain_Med_2014_May_4_4(2)_e18884.txt
3.65.1.4,...rean J Anesthesiol. 2013 65 1 4 8 10.4097/kjae.2013.65.1.4 23904932,161,115,Anesth_Pain_Med_2014_Jun_21_4(3)_e15905.txt
1.60.5.329,...n J Anesthesiol. 2011 60 5 329 33 10.4097/kjae.2011.60.5.329 21716962,166,242,Anesth_Pain_Med_2014_Jun_21_4(3)_e15905.txt
1.61.4.315,...an J Anesthesiol. 2011 61 4 315 9 10.4097/kjae.2011.61.4.315 22110885,128,244,Anesth_Pain_Med_2014_Aug_13_4(3)_e17872.txt
3.65.5.442,...an J Anesthesiol. 2013 65 5 442 8 10.4097/kjae.2013.65.5.442 24363848,139,206,Anesth_Pain_Med_2014_Jun_22_4(3)_e19529.txt
2.25.3.200,...ia. Korean J Pain. 2012 25 3 200 1 10.3344/kjp.2012.25.3.200 22787554,140,184,Anesth_Pain_Med_2014_Jun_22_4(3)_e19529.txt
1.52.2.326,...ry. Yonsei Med J. 2011 52 2 326 32 10.3349/ymj.2011.52.2.326 21319354,139,249,Anesth_Pain_Med_2014_Sep_9_4(4)_e14221.txt
5.7.6.637,...ert Rev Neurother. 2007 7 6 637 47 10.1586/14737175.7.6.637 17563247,266,106,Anesth_Pain_Med_2011_Sep_26_Autumn_1(2)_77-80.txt
4.66.3.199,... J Anesthesiol. 2014 66 3 199 203 10.4097/kjae.2014.66.3.199 24729841,127,171,Anesth_Pain_Med_2015_Jan_7_5(1)_e23409.txt
1.35.4.514,... Ann Rehabil Med. 2011 35 4 514 23 10.5535/arm.2011.35.4.514 22506167,445,172,Anesth_Pain_Med_2015_Feb_1_5(1)_e23139.txt
3.64.2.138,...n J Anesthesiol. 2013 64 2 138 42 10.4097/kjae.2013.64.2.138 23459631,132,190,Anesth_Pain_Med_2015_Feb_1_5(1)_e22372.txt
2.42.2.107,...l. Korean Circ J. 2012 42 2 107 12 10.4070/kcj.2012.42.2.107 22396698,118,251,Anesth_Pain_Med_2015_Feb_1_5(1)_e23799.txt
2.18.9.22,...olic. Emerg Nurse. 2011 18 9 22 5 10.7748/en2011.02.18.9.22.c8337 21384782,126,113,Anesth_Pain_Med_2014_Nov_8_4(5)_e20337.txt
1.24.3.158,...y. Korean J Pain. 2011 24 3 158 63 10.3344/kjp.2011.24.3.158 21935495,123,231,Anesth_Pain_Med_2015_Feb_1_5(1)_e21943.txt
3.96.1.201,...rcept Mot Skills. 2003 96 1 201 11 10.2466/pms.2003.96.1.201 12705527,145,162,Anesth_Pain_Med_2015_Apr_20_5(2)_e19333.txt
2.42.8.521,...ry. Korean Circ J. 2012 42 8 521 7 10.4070/kcj.2012.42.8.521 2297744,119,228,Anesth_Pain_Med_2015_Apr_20_5(2)_e19707.txt
6.19.1.3,...ility. Psychol Rep. 1966 19 1 3 11 10.2466/pr0.1966.19.1.3 5942109,396,127,Anesth_Pain_Med_2015_Apr_20_5(2)_e20350.txt
1.60.2.103,...an J Anesthesiol. 2011 60 2 103 8 10.4097/kjae.2011.60.2.103 2139016,157,255,Anesth_Pain_Med_2015_Aug_22_5(4)_e23565.txt
2.63.1.36,...an J Anesthesiol. 2012 63 1 36 42 10.4097/kjae.2012.63.1.36 22870363,138,221,Anesth_Pain_Med_2015_Aug_22_5(4)_e23963.txt
2.63.2.136,...n J Anesthesiol. 2012 63 2 136 41 10.4097/kjae.2012.63.2.136 22949981,147,241,Anesth_Pain_Med_2015_Aug_24_5(4)_e25111.txt
5.56.2.535,...te. Yonsei Med J. 2015 56 2 535 42 10.3349/ymj.2015.56.2.535 25684006,105,208,Anesth_Pain_Med_2015_Aug_22_5(4)_e25675.txt
4.1.3.1,4.1.3.1. Techniqu,47,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.1.3.2,4.1.3.2. Evidenc,51,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.1.4.1,4.1.4.1. Techniqu,59,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.1.4.2,4.1.4.2. Evidenc,63,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.1.5.2,4.1.5.2. Evidenc,73,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.2.1.1,4.2.1.1. Techniqu,85,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.2.1.2,4.2.1.2. Evidenc,92,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.2.2.1,4.2.2.1. Techniqu,101,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.2.2.2,4.2.2.2. Evidenc,104,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.2.3.1,4.2.3.1. Techniqu,110,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.2.3.2,4.2.3.2. Evidenc,116,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.3.1.1,4.3.1.1. Techniqu,128,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.3.1.2,4.3.1.2. Evidenc,138,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.4.1.1,4.4.1.1. Techniqu,143,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.4.1.2,4.4.1.2. Evidenc,149,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.4.2.1,4.4.2.1. Technique: (Conventional Method,153,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.4.2.2,4.4.2.2. Evidenc,159,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.4.2.3,4.4.2.3. Technique: (Simplicity III®,162,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.4.2.4,4.4.2.4. Evidenc,166,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.5.1.1,4.5.1.1. Diagnostic Discograph,171,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.5.1.1,4.5.1.1.1. Techniqu,176,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.5.1.1,4.5.1.1.2. Evidenc,198,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.1.1,4.6.1.1. Techniqu,207,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.1.2,4.6.1.2. Evidenc,210,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.2.1,4.6.2.1. Techniqu,223,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.2.2,4.6.2.2. Evidenc,233,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.3.1,4.6.3.1. Techniqu,245,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.3.2,4.6.3.2. Evidenc,248,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.4.1,4.6.4.1. Techniqu,256,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.4.2,4.6.4.2. Evidenc,267,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.5.1,4.6.5.1. Techniqu,273,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.5.2,4.6.5.2. Evidenc,276,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.6.1,4.6.6.1. Techniqu,284,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
4.6.6.2,4.6.6.2. Evidenc,287,1,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
2.36.4.480,.... Ann Rehabil Med. 2012 36 4 480 7 10.5535/arm.2012.36.4.480 22977773,335,204,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
1.35.6.833,... Ann Rehabil Med. 2011 35 6 833 43 10.5535/arm.2011.35.6.833 22506212,336,197,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
2.36.1.66,.... Ann Rehabil Med. 2012 36 1 66 71 10.5535/arm.2012.36.1.66 22506237,358,213,Anesth_Pain_Med_2015_Aug_22_5(4)_e29716.txt
1.50.3.205,...an Neurosurg Soc. 2011 50 3 205 8 10.3340/jkns.2011.50.3.205 22102950,160,286,Anesth_Pain_Med_2015_Oct_17_5(5)_e29540.txt
1.50.2.151,...an Neurosurg Soc. 2011 50 2 151 3 10.3340/jkns.2011.50.2.151 22053239,129,226,Anesth_Pain_Med_2015_Oct_10_5(5)_e29280.txt
2.25.2.75,...in. Korean J Pain. 2012 25 2 75 80 10.3344/kjp.2012.25.2.75 22514773,154,109,Anesth_Pain_Med_2015_Oct_24_5(5)_e27695.txt
6.4.4.310,... J Neurosurg Spine. 2006 4 4 310 8 10.3171/spi.2006.4.4.310 16619678,64,284,Anesth_Pain_Med_2015_Nov_28_5(6)_e28849.txt
4.8.4.400,...omy. Asian Spine J. 2014 8 4 400 4 10.4184/asj.2014.8.4.400 25187855,154,165,Anesth_Pain_Med_2015_Dec_5_5(6)_e30062.txt
3.64.3.229,...n J Anesthesiol. 2013 64 3 229 33 10.4097/kjae.2013.64.3.229 23560188,125,199,Anesth_Pain_Med_2016_Jan_10_6(1)_e27515.txt
3.26.4.374,...my. Korean J Pain. 2013 26 4 374 8 10.3344/kjp.2013.26.4.374 24156004,38,185,Anesth_Pain_Med_2016_Feb_13_6(1)_e35506.txt
4.23.1.11,...Pac J Clin Nutr. 2014 23 1 34 40 10.6133/apjcn.2014.23.1.11 24561970,213,254,Anesth_Pain_Med_2016_Feb_13_6(1)_e32648.txt
3.64.1.12,...ean J Anesthesiol. 2013 64 1 12 8 10.4097/kjae.2013.64.1.12 23372880,148,268,Anesth_Pain_Med_2016_Apr_2_6(2)_e35333.txt
1.61.2.127,...n J Anesthesiol. 2011 61 2 127 32 10.4097/kjae.2011.61.2.127 21927682,165,220,Anesth_Pain_Med_2016_Apr_2_6(2)_e35333.txt
3.64.1.61,...ort. Anesthesiology. 2013 64 1 61 10.4097/kjae.2013.64.1.61,26,212,Anesth_Pain_Med_2016_Mar_5_6(2)_e34953.txt
5.7.7.769,...ert Rev Neurother. 2007 7 7 769 81 10.1586/14737175.7.7.769 17610384,185,188,Anesth_Pain_Med_2016_May_14_6(3)_e34591.txt
3.26.4.374,...my. Korean J Pain. 2013 26 4 374 8 10.3344/kjp.2013.26.4.374 24156004,102,184,Anesth_Pain_Med_2016_May_9_6(3)_e35803.txt
3.26.4.374,...my. Korean J Pain. 2013 26 4 374 8 10.3344/kjp.2013.26.4.374 24156004,176,185,Anesth_Pain_Med_2016_Jun_18_6(3)_e36812.txt
4.27.2.178,...n. Korean J Pain. 2014 27 2 178 85 10.3344/kjp.2014.27.2.178 24748948,73,202,Anesth_Pain_Med_2016_Apr_27_6(3)_e26749.txt
5.28.2.122,...ck. Korean J Pain. 2015 28 2 122 8 10.3344/kjp.2015.28.2.122 25852834,91,229,Anesth_Pain_Med_2016_May_10_6(3)_e35340.txt
4.8.6.705,...ew. Asian Spine J. 2014 8 6 705 10 10.4184/asj.2014.8.6.705 25558311,133,223,Anesth_Pain_Med_2016_Jun_1_6(4)_e37428.txt
2.21.16.958,... pain. Br J Nurs. 2012 21 16 958 10.12968/bjon.2012.21.16.958 960-4 23123650,367,151,Anesth_Pain_Med_2016_Jul_16_6(4)_e37270.txt
1.40.4.546,...rean J Anesthesiol. 2001 40 4 546 10.4097/kjae.2001.40.4.546,38,206,Anesth_Pain_Med_2016_Jul_31_6(4)_e39262.txt
3.43.7.497,...on. Korean Circ J. 2013 43 7 497 9 10.4070/kcj.2013.43.7.497 23964298,49,186,Anesth_Pain_Med_2016_Feb_16_6(5)_e33979.txt
3.65.4.293,...an J Anesthesiol. 2013 65 4 293 8 10.4097/kjae.2013.65.4.293 24228140,176,241,Anesth_Pain_Med_2016_Aug_15_6(5)_e38943.txt
2.63.6.521,...an J Anesthesiol. 2012 63 6 521 6 10.4097/kjae.2012.63.6.521 23277813,134,225,Anesth_Pain_Med_2016_Jul_26_6(5)_e38550.txt
3.26.4.374,...my. Korean J Pain. 2013 26 4 374 8 10.3344/kjp.2013.26.4.374 24156004,146,185,Anesth_Pain_Med_2016_Jul_26_6(5)_e38550.txt
4.66.3.204,...an J Anesthesiol. 2014 66 3 204 9 10.4097/kjae.2014.66.3.204 24729842,171,207,Anesth_Pain_Med_2016_Jul_26_6(5)_e38550.txt
3.65.4.293,...an J Anesthesiol. 2013 65 4 293 8 10.4097/kjae.2013.65.4.293 2422814,176,242,Anesth_Pain_Med_2016_Jul_26_6(5)_e38550.txt
2.52.6.523,...an Neurosurg Soc. 2012 52 6 523 7 10.3340/jkns.2012.52.6.523 23346323,52,235,Anesth_Pain_Med_2016_Aug_27_6(5)_e40067.txt
1.8.4.272,.... Korean J Spine. 2011 8 4 272 82 10.14245/kjs.2011.8.4.272 26064145,53,212,Anesth_Pain_Med_2016_Aug_27_6(5)_e40067.txt
EC 1.4.3.4,"...a well-known target. Monoamine oxidases[17] (MAO, EC 1.4.3.4) are flavin adenine dinucleotide (FAD)-...",19,225,Angew_Chem_Int_Ed_Engl_2012_Jul_9_51(28)_7035-7040.txt
EC 1.14.13.22,Cyclohexanone monooxygenase (CHMO; EC 1.14.13.22) is an FAD‐ and NADPH‐dependent Baey...,24,36,PMC5213842.txt
EC 1.14.13.92,"...ne monooxygenase from Thermobifida fusca (TfPAMO; EC 1.14.13.92), shows no activity on cyclohexanone...",24,1346,PMC5213842.txt
3.2.1.1,3.2.1.1. Solid-Solution Approach: Coassembly of Mi...,102,1,Angew_Chem_Int_Ed_Engl_2015_Jun_15_54(25)_7234-7254.txt
3.2.1.2,3.2.1.2. Metal Node Vacancie,113,1,Angew_Chem_Int_Ed_Engl_2015_Jun_15_54(25)_7234-7254.txt
EC 4.3.1.24,"...n particular, phenylalanine ammonia lyases (PALs, EC 4.3.1.24), identified in various organisms, mai...",11,237,Angew_Chem_Int_Ed_Engl_2015_Apr_7_54(15)_4608-4611.txt
2.1.1.1,2.1.1.1 Macrocyclizatio,55,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.1.1.2,2.1.1.2. Turn-Inducing Amino Acid,58,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.1.1.3,2.1.1.3. N-Methylatio,61,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.1.1.4,2.1.1.4. Structural Mimetic,64,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.2.1.1,2.2.1.1. Turn Mimetics as β-Hairpin Inducer,80,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.2.1.2,"...in combination with macrocyclization, see Section 2.2.1.2).[114, 115",81,1209,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.2.1.2,2.2.1.2. Macrocyclizatio,87,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.2.1.3,2.2.1.3. β-Strand-Enforcing Amino Acid,92,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.3.1.1,2.3.1.1. Thiol-Based Cross-Link,106,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.3.1.2,2.3.1.2. Lactam Cross-Link,112,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.3.1.3,2.3.1.3. Triazole Cross-Link,115,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.3.1.4,2.3.1.4. α-Methylated Hydrocarbon Cross-Link,118,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.3.3.1,2.3.3.1. β-Peptide,131,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.3.3.2,2.3.3.2. α/β-Peptide,136,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.3.3.3,2.3.3.3. Peptoid,139,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.3.4.1,2.3.4.1. Sterically Enforced Scaffold,147,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.3.4.2,2.3.4.2. Hydrogen-Bond-Guided Scaffold,152,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
2.3.4.3,2.3.4.3. Covalently Constrained Scaffold,159,1,Angew_Chem_Int_Ed_Engl_2015_Jul_27_54(31)_8896-8927.txt
EC 1.14.18.1,"...nophenols to o-diphenols (monophenolase activity, EC 1.14.18.1) and the subsequent oxidation of o-di...",9,325,Angew_Chem_Int_Ed_Engl_2015_Dec_1_54(49)_14677-14680.txt
EC 1.10.3.1,"...e corresponding o-quinones (diphenolase activity, EC 1.10.3.1), which are both coupled to the reduct...",9,438,Angew_Chem_Int_Ed_Engl_2015_Dec_1_54(49)_14677-14680.txt
2.4.1.7,...rylase (from Leuconostoc mesenteroides; SPase; EC 2.4.1.7).13 αGlc 1‐P was then utilized directly in...,41,286,Angew_Chem_Int_Ed_Engl_2015_Dec_21_54(52)_15867-15871.txt
3.1.3.10,...oester hydrolase (glucose 1‐phosphatase (AGP); EC 3.1.3.10). The large number of phosphatases encode...,41,501,Angew_Chem_Int_Ed_Engl_2015_Dec_21_54(52)_15867-15871.txt
4.6.4.8,"...mulation was carried out for 500 ns using GROMACS 4.6.4.8 The found conformer, which represents 28.2...",75,424,Angew_Chem_Int_Ed_Engl_2016_Mar_14_55(12)_3925-3930.txt
1.1.2.16,...ng. Molecular docking was done with AutoDock Vina 1.1.2.1,41,323,Angew_Chem_Int_Ed_Engl_2016_Jun_1_55(23)_6600-6626.txt
EC 4.1.2.45,...oxybenzylidene pyruvate hydratase‐aldolase (HBPA; EC 4.1.2.45) which catalyses the aldol reaction be...,30,75,Angew_Chem_Int_Ed_Engl_2016_Jun_1_55(23)_6767-6770.txt
EC 4.2.1.19,"... of imidazoleglycerolphosphate‐dehydratase (IGPD; EC 4.2.1.19), an enzyme of histidine biosynthesis ...",28,770,Angew_Chem_Int_Ed_Engl_2016_Oct_17_55(43)_13485-13489.txt
4.1.1.1,4.1.1.1  Quinone‐Based Redox‐Active Material,162,1,PMC5248651.txt
4.1.1.2,4.1.1.2  TEMPO‐Based Redox‐Active Material,201,1,PMC5248651.txt
4.1.1.3,4.1.1.3  Alkoxybenzene‐Based Redox‐Active Material...,224,1,PMC5248651.txt
4.3.1.1,4.3.1.1  Symmetric Redox‐Flow Batteries with Bipol...,318,1,PMC5248651.txt
4.3.1.2,4.3.1.2  Asymmetric Redox‐Flow Batteries with Orga...,336,1,PMC5248651.txt
4.3.1.3,4.3.1.3  Asymmetric Redox‐Flow Batteries with Orga...,366,1,PMC5248651.txt
EC 4.3.1.24,"...n particular, phenylalanine ammonia lyases (PALs, EC 4.3.1.24), identified in various organisms, mai...",23,237,Angew_Chem_Weinheim_Bergstr_Ger_2015_Apr_7_127(15)_4691-4694.txt
6.2.2.351,"...t Opin Pharmacother 2001 2 351 361 10.1517/14656566.2.2.351 Mellish KJ, Brown SB (2001) Verteporfin:...",92,147,Angiogenesis_2008_Sep_7_11(3)_235-243.txt
4.11.4.725,"...t Opin Emerg Drugs 2006 11 725 740 10.1517/14728214.11.4.725 Augustin AJ, Offermann I (2006) Emergin...",107,137,Angiogenesis_2008_Sep_7_11(3)_235-243.txt
2.1.72.2,"... Kinases, Novartis Campus, Fabrikstrasse 16, WJS152.1.72.2, 4056 Basel, Switzerland 2 Novartis Insti...",3,541,Angiogenesis_2010_Sep_29_13(3)_259-267.txt
2.44.3.215,...t Cancer Res Treat 2012 44 215 218 10.4143/crt.2012.44.3.215 23091449,181,215,Angiogenesis_2015_Jul_23_18(4)_385-395.txt
4.85.6.116,.... Soc. Psychol. 2003 85 1161 1169 10.1037/0022-3514.85.6.1161 14674821,248,204,Animals_(Basel)_2014_Feb_27_4(1)_45-58.txt
4.36.3.313,...rs. Soc. Psychol. 1978 36 313 323 10.1037/0022-3514.36.3.313,280,110,Animals_(Basel)_2014_Feb_27_4(1)_45-58.txt
6.22.2.185,...elfare Anim. Welf. 2013 22 185 194 10.7120/09627286.22.2.185,260,173,Animals_(Basel)_2014_Jul_15_4(3)_446-462.txt
6.22.2.277,...elfare Anim. Welf. 2013 22 277 285 10.7120/09627286.22.2.277,276,148,Animals_(Basel)_2014_Jul_15_4(3)_446-462.txt
3.2.4.1,3.2.4.1. Response to Dartin,234,1,Animals_(Basel)_2014_Sep_15_4(3)_562-582.txt
3.2.4.2,3.2.4.2. Mortalit,239,1,Animals_(Basel)_2014_Sep_15_4(3)_562-582.txt
3.2.4.3,3.2.4.3. Non-Lethal Injurie,262,1,Animals_(Basel)_2014_Sep_15_4(3)_562-582.txt
3.2.4.4,3.2.4.4. Financial Costs and Resource Effor,269,1,Animals_(Basel)_2014_Sep_15_4(3)_562-582.txt
1.89.2.227,...pain Psychol. Rep. 2001 89 227 236 10.2466/pr0.2001.89.2.227 11783540,155,165,Animals_(Basel)_2014_Jun_30_4(3)_391-408.txt
1.12.2.177,...attle J. Vet. Sci. 2011 12 177 185 10.4142/jvs.2011.12.2.177 21586878,263,209,Animals_(Basel)_2013_Nov_4_3(4)_1036-1057.txt
4.74.3.715,...less Psychol. Rep. 1994 74 715 722 10.2466/pr0.1994.74.3.715 8058851,373,120,Animals_(Basel)_2014_May_7_4(2)_214-240.txt
6.21.2.257,...health Anim. Welf. 2012 21 257 271 10.7120/09627286.21.2.257,136,217,Animals_(Basel)_2013_May_16_3(2)_416-441.txt
4.48.5.129,.... Soc. Psychol. 1985 48 1290 1298 10.1037/0022-3514.48.5.1290,114,189,Animals_(Basel)_2013_Apr_11_3(2)_300-317.txt
6.21.2.185,...caques Anim. Welf. 2012 21 185 195 10.7120/09627286.21.2.185,124,232,Animals_(Basel)_2013_Apr_11_3(2)_300-317.txt
6.21.2.147,...arents Anim. Welf. 2012 21 147 155 10.7120/09627286.21.2.147,325,157,Animals_(Basel)_2015_May_20_5(2)_361-394.txt
2.14.4.557,...ag. Policy Pract. 2012 14 557 575 10.5172/impp.2012.14.4.557,1014,191,Animals_(Basel)_2015_Apr_29_5(2)_276-314.txt
3.1.2.158,...m. Behav. Process. 1975 1 158 169 10.1037/0097-7403.1.2.158,221,236,Animals_(Basel)_2016_Jan_7_6(1)_3.txt
6.21.4.477,... Samoa Anim. Welf. 2012 21 477 486 10.7120/09627286.21.4.477,138,184,Animals_(Basel)_2014_Sep_29_4(4)_599-611.txt
2.62.7.7,...es act? Bioscience 2012 62 646 657 10.1525/bio.2012.62.7.,91,182,Animals_(Basel)_2013_Aug_13_3(3)_745-753.txt
6.21.3.389,...emes Anim. Welfare 2012 21 389 396 10.7120/09627286.21.3.38,266,197,Animals_(Basel)_2013_Jul_5_3(3)_584-605.txt
2.1.5.1,"...sing the statistical computing program R, version 2.1.5.1. [17]",46,1239,Animals_(Basel)_2013_Feb_4_3(1)_85-108.txt
2.1.5.1,...nd Environment for Statistical Computing; Version 2.1.5.1 R Foundation for Statistical Computing Vie...,380,94,Animals_(Basel)_2013_Feb_4_3(1)_85-108.txt
2.15.9.840,...e Drug News Persp. 2002 15 604 611 10.1358/dnp.2002.15.9.840066,2303,93,Animals_(Basel)_2013_Mar_4_3(1)_158-227.txt
3.10.2.182,.... Behav. Process. 1984 10 182 194 10.1037/0097-7403.10.2.182,116,184,Animals_(Basel)_2016_Jan_5_6(1)_2.txt
2.3.1.1,2.3.1.1. Aggregation Assa,71,1,Animals_(Basel)_2015_Jul_22_5(3)_610-623.txt
2.3.1.2,2.3.1.2. Antimicrobial Activity Assa,74,1,Animals_(Basel)_2015_Jul_22_5(3)_610-623.txt
2.3.1.3,2.3.1.3. Determination of Bile Toleranc,77,1,Animals_(Basel)_2015_Jul_22_5(3)_610-623.txt
2.3.1.4,2.3.1.4. Tolerance of Isolates at Low p,80,1,Animals_(Basel)_2015_Jul_22_5(3)_610-623.txt
2.3.1.5,2.3.1.5. Antibiotic Susceptibility Tes,83,1,Animals_(Basel)_2015_Jul_22_5(3)_610-623.txt
6.24.3.255,...labies Anim. Welf. 2015 24 255 265 10.7120/09627286.24.3.255,326,211,Animals_(Basel)_2015_Oct_21_5(4)_1047-1071.txt
6.23.4.423,...g hens Anim. Welf. 2014 23 423 434 10.7120/09627286.23.4.423,174,183,Animals_(Basel)_2015_Nov_27_5(4)_1192-1206.txt
4.3.2.141,...xpert Rev. Vaccines 2004 3 141 149 10.1586/14760584.3.2.141 15056040,235,171,Animals_(Basel)_2015_Dec_3_5(4)_1268-1295.txt
6.22.3.385,... goats Anim. Welf. 2013 22 385 400 10.7120/09627286.22.3.385,197,167,Animals_(Basel)_2015_Sep_25_5(4)_934-950.txt
6.22.2.287,...review Anim. Welf. 2013 22 287 290 10.7120/09627286.22.2.287,132,155,Animals_(Basel)_2015_Nov_30_5(4)_1207-1219.txt
6.22.2.291,... sheep Anim. Welf. 2013 22 291 296 10.7120/09627286.22.2.29,133,195,Animals_(Basel)_2015_Nov_30_5(4)_1207-1219.txt
2.71.2.551,...ions Psychol. Rep. 1992 71 551 557 10.2466/pr0.1992.71.2.551,480,129,Animals_(Basel)_2015_Dec_10_5(4)_1311-1328.txt
4.57.5.792,...al. Soc. Psychol. 1989 57 792 807 10.1037/0022-3514.57.5.792,133,194,Animals_(Basel)_2015_Nov_24_5(4)_1169-1179.txt
6.23.3.251,...heep Anim. Welfare 2014 23 251 258 10.7120/09627286.23.3.251,220,222,Animals_(Basel)_2015_Dec_1_5(4)_1233-1251.txt
1.9.3.599,...ation Psychol. Rep. 1961 9 599 606 10.2466/pr0.1961.9.3.599,182,149,Animals_(Basel)_2016_Jan_7_6(1)_4.txt
6.24.4.497,...States Anim. Welf. 2015 24 497 506 10.7120/09627286.24.4.497,192,200,Animals_(Basel)_2016_Feb_3_6(2)_11.txt
3.26.2.136,...n Health Psychol. 2007 26 136 145 10.1037/0278-6133.26.2.136 17385964,340,247,Animals_(Basel)_2016_Feb_18_6(2)_14.txt
6.23.4.423,... cycle Anim. Welf. 2014 23 423 434 10.7120/09627286.23.4.423,204,272,Animals_(Basel)_2016_Feb_2_6(2)_10.txt
4.46.3.681,...al. Soc. Psychol. 1984 46 681 687 10.1037/0022-3514.46.3.681,124,179,Animals_(Basel)_2016_Feb_15_6(2)_12.txt
3.50.4.550,...s Needs Soc. Probl. 2003 50 550 566 10.1525/sp.2003.50.4.550,981,150,Animals_(Basel)_2016_Mar_16_6(3)_23.txt
6.24.3.307,... study Anim. Welf. 2015 24 307 317 10.7120/09627286.24.3.307,132,235,Animals_(Basel)_2016_Feb_26_6(3)_19.txt
6.21.2.219,...ility Anim. Welf. 2012 212 219 231 10.7120/09627286.21.2.219,132,213,PMC5187500.txt
6.24.3.241,...ates Anim. Welfare 2015 24 241 253 10.7120/09627286.24.3.241,243,185,Animals_(Basel)_2016_Mar_14_6(3)_21.txt
5.27.7.921,...p. Clin. Pharmacol. 2005 27 495 502 10.1358/mf.2005.27.7.921309 16258595,99,225,Animals_(Basel)_2014_Feb_3_4(1)_35-44.txt
3.5.2.1,3.5.2.1. The Christian Inquisition (1231)—Load She...,103,1,Animals_(Basel)_2013_Dec_2_3(4)_1086-1122.txt
3.5.2.2,3.5.2.2. The Formation of the ASPCA (1867)—Load Sh...,110,1,Animals_(Basel)_2013_Dec_2_3(4)_1086-1122.txt
3.5.2.3,3.5.2.3. The War on Drugs—Proceeds of Crime La,119,1,Animals_(Basel)_2013_Dec_2_3(4)_1086-1122.txt
3.9.3.320,...m. Behav. Process. 1983 9 320 334 10.1037/0097-7403.9.3.320 6886634,143,154,Animals_(Basel)_2016_Aug_3_6(8)_46.txt
3.34.3.388,.... Behav. Process. 2008 34 388 399 10.1037/0097-7403.34.3.388 18665721,153,170,Animals_(Basel)_2016_Aug_3_6(8)_46.txt
6.24.3.241,...ates Anim. Welfare 2015 24 241 253 10.7120/09627286.24.3.241,262,184,Animals_(Basel)_2016_Sep_21_6(9)_58.txt
6.25.1.125,...care Anim. Welfare 2016 25 125 134 10.7120/09627286.25.1.125,319,288,Animals_(Basel)_2016_Sep_21_6(9)_58.txt
6.24.3.241,...ates Anim. Welfare 2015 24 241 253 10.7120/09627286.24.3.241,88,185,Animals_(Basel)_2016_Sep_23_6(10)_59.txt
6.23.4.435,...sition Anim. Welf. 2014 23 435 443 10.7120/09627286.23.4.435,406,173,Animals_(Basel)_2016_Oct_11_6(10)_61.txt
6.24.3.241,...states Anim. Welf. 2015 24 241 253 10.7120/09627286.24.3.241,119,183,Animals_(Basel)_2016_Nov_11_6(11)_69.txt
6.21.3.307,...cattle Anim. Welf. 2012 21 307 318 10.7120/09627286.21.3.307,145,247,Animals_(Basel)_2016_Nov_11_6(11)_69.txt
6.25.2.171,"...in Animal Welfare, 2016 25 171 177 10.7120/09627286.25.2.171",147,194,Animals_(Basel)_2016_Nov_11_6(11)_71.txt
3.18.4.177,... Companion Anim. 2013 18 177 180 10.12968/coan.2013.18.4.177,262,105,Animals_(Basel)_2016_Nov_14_6(11)_73.txt
6.24.4.485,...celand Anim. Welf. 2015 24 485 495 10.7120/09627286.24.4.485,199,145,Animals_(Basel)_2016_Oct_25_6(11)_65.txt
6.24.4.399,...calves Anim. Welf. 2015 24 399 406 10.7120/09627286.24.4.399,304,169,Animals_(Basel)_2016_Oct_27_6(11)_67.txt
2.31.2.199,...ject Rangifer. Spec. Issue 2011 19 97 102 10.7557/2.31.2.1994,114,139,PMC5295152.txt
6.25.3.377,...estock Anim. Welf. 2016 25 377 387 10.7120/09627286.25.3.377,315,227,PMC5332927.txt
6.22.3.369,...ntions Anim. Welf. 2013 22 369 378 10.7120/09627286.22.3.369,205,209,PMC5332928.txt
3.32.1.91,... Anim Behav Process 2006 32 91 96 10.1037/0097-7403.32.1.91 Nissani M (2006) Do Asian Elephants (Ele...,111,154,Anim_Cogn_2008_Apr_18_11(2)_359-365.txt
3.29.3.233,"...xp Psychol Anim B 2003 29 233 242 10.1037/0097-7403.29.3.233 Fujita K, Kuroshima H, Asai S (2003) Ho...",163,172,Anim_Cogn_2008_Jul_9_11(3)_423-430.txt
3.25.1.82,"... Psychol Anim Behav 1999 25 82 91 10.1037/0097-7403.25.1.82 Clayton NS, Dickinson A (1999a) Memory f...",64,153,Anim_Cogn_2008_Apr_4_11(2)_367-371.txt
3.32.3.239,"...nim Behav Process 2006 32 239 252 10.1037/0097-7403.32.3.239 Barth J, Call J (2006) Tracking the dis...",186,258,Anim_Cogn_2009_Nov_27_12(6)_789-796.txt
3.32.3.239,... Anim Behav Proc 2006 32: 239 252 10.1037/0097-7403.32.3.239,177,171,Anim_Cogn_2010_Mar_4_13(2)_273-285.txt
3.21.1.82,...hol Anim Behav Proc 1995 21 82 86 10.1037/0097-7403.21.1.82,183,177,Anim_Cogn_2010_Mar_4_13(2)_273-285.txt
3.22.1.76,...hol Anim Behav Proc 1996 22 76 86 10.1037/0097-7403.22.1.76,184,197,Anim_Cogn_2010_Mar_4_13(2)_273-285.txt
3.32.1.60,...hol Anim Behav Proc 2006 32 60 70 10.1037/0097-7403.32.1.60,241,267,Anim_Cogn_2010_Mar_4_13(2)_273-285.txt
3.17.2.123,...l Anim Behav Proc 1991 17 123 129 10.1037/0097-7403.17.2.123,243,183,Anim_Cogn_2010_Mar_4_13(2)_273-285.txt
3.27.1.17,...hol Anim Behav Proc 2001 27 17 29 10.1037/0097-7403.27.1.17,144,198,Anim_Cogn_2010_Mar_27_13(2)_331-340.txt
3.29.1.14,...hol Anim Behav Proc 2003 29 14 22 10.1037/0097-7403.29.1.14,146,200,Anim_Cogn_2010_Mar_27_13(2)_331-340.txt
3.32.4.345,...sychol Anim Behav 2006 32 345 358 10.1037/0097-7403.32.4.345 17044738,181,136,Anim_Cogn_2010_Mar_27_13(2)_331-340.txt
2.4.3.232,...ry J Cogn Neurosci 1992 4 232 243 10.1162/jocn.1992.4.3.232,182,152,Anim_Cogn_2010_Mar_27_13(2)_331-340.txt
3.32.1.60,... Anim Behav Process 2006 32 60 70 10.1037/0097-7403.32.1.60 16435965,155,272,Anim_Cogn_2009_Jul_24_12(4)_567-574.txt
3.21.1.64,...xp Psych Anim Behav 1995 21 64 77 10.1037/0097-7403.21.1.64,212,195,Anim_Cogn_2010_May_13_13(3)_419-430.txt
3.29.3.199,... Psych Anim Behav 2003 29 199 210 10.1037/0097-7403.29.3.199,231,218,Anim_Cogn_2010_May_13_13(3)_419-430.txt
3.26.1.31,... Anim Behav Process 2000 26 31 49 10.1037/0097-7403.26.1.31 10650542,84,162,Anim_Cogn_2010_Sep_5_13(5)_711-719.txt
3.33.1.32,... Anim Behav Process 2007 33 32 41 10.1037/0097-7403.33.1.32 17227193,86,145,Anim_Cogn_2010_Sep_5_13(5)_711-719.txt
3.29.3.211,...nim Behav Process 2003 29 211 221 10.1037/0097-7403.29.3.211 12884680,113,199,Anim_Cogn_2010_Sep_5_13(5)_711-719.txt
3.25.2.474,... Learn Mem Cogn 1999 25 2 474 487 10.1037/0278-7393.25.2.474,204,133,Anim_Cogn_2012_Jan_13_15(1)_73-82.txt
3.7.1.70,...Anim Behav Process 1981 7 1 70 86 10.1037/0097-7403.7.1.7,229,175,Anim_Cogn_2012_Jan_13_15(1)_73-82.txt
3.15.6.104,... Learn Mem Cogn 1989 15 1047 1060 10.1037/0278-7393.15.6.1047 253030,157,143,Anim_Cogn_2012_May_28_15(3)_369-377.txt
2.74.2.651,...en Percept Mot Ski 1992 74 651 658 10.2466/pms.1992.74.2.651,171,139,Anim_Cogn_2012_Jul_24_15(4)_657-665.txt
3.24.6.133,...p Psychol Learn 1998 24 1331 1352 10.1037/0278-7393.24.6.1331,142,178,Anim_Cogn_2012_Sep_29_15(5)_979-990.txt
3.17.4.767,...Exp Psychol Learn 1991 17 767 778 10.1037/0278-7393.17.4.767,205,138,Anim_Cogn_2013_May_22_16(3)_417-427.txt
3.26.1.53,...chol Learn Mem Cogn 2000 26 53 76 10.1037/0278-7393.26.1.53 10682290,293,153,Anim_Cogn_2013_Feb_17_16(3)_493-507.txt
6.24.1.99,...tion Music Percept 2006 24 1 99 103 10.1525/mp.2006.24.1.99,226,112,Anim_Cogn_2014_Aug_30_17(1)_1-14.txt
3.33.4.361,...nim Behav Process 2007 33 361 370 10.1037/0097-7403.33.4.361 17924785,88,189,Anim_Cogn_2014_Mar_18_17(5)_1223-1226.txt
3.33.4.451,...nim Behav Process 2007 33 451 463 10.1037/0097-7403.33.4.451 17924792,280,191,Anim_Cogn_2014_May_5_17(5)_1207-1221.txt
6.38.1.163,...n rats Psychol Rep 1976 38 163 187 10.2466/pr0.1976.38.1.163 1250917,312,143,Anim_Cogn_2014_May_5_17(5)_1207-1221.txt
3.33.1.32,... Anim Behav Process 2007 33 32 41 10.1037/0097-7403.33.1.32 17227193,305,147,Anim_Cogn_2015_Jan_21_18(3)_733-745.txt
3.17.4.396,... Psychol Anim B 1991 17 4 396 410 10.1037/0097-7403.17.4.396,143,180,Anim_Cogn_2015_Mar_14_18(4)_867-874.txt
3.17.1.94,...p Psychol Anim B 1991 17 1 94 106 10.1037/0097-7403.17.1.94,149,160,Anim_Cogn_2015_Mar_14_18(4)_867-874.txt
3.34.1.178,...l Anim Behav Proc 2008 34 178 184 10.1037/0097-7403.34.1.178,364,151,Anim_Cogn_2015_Jul_19_18(6)_1267-1284.txt
3.27.4.316,...l Anim Behav Proc 2001 27 316 328 10.1037/0097-7403.27.4.316,372,247,Anim_Cogn_2015_Jul_19_18(6)_1267-1284.txt
3.34.4.486,...l Anim Behav Proc 2008 34 486 493 10.1037/0097-7403.34.4.486,374,95,Anim_Cogn_2015_Jul_19_18(6)_1267-1284.txt
3.34.4.494,...l Anim Behav Proc 2008 34 494 500 10.1037/0097-7403.34.4.494,376,178,Anim_Cogn_2015_Jul_19_18(6)_1267-1284.txt
3.32.1.80,...hol Anim Behav Proc 2006 32 80 86 10.1037/0097-7403.32.1.80,379,134,Anim_Cogn_2015_Jul_19_18(6)_1267-1284.txt
3.28.4.358,...l Anim Behav Proc 2002 28 358 368 10.1037/0097-7403.28.4.358,380,190,Anim_Cogn_2015_Jul_19_18(6)_1267-1284.txt
3.24.4.405,...l Anim Behav Proc 1998 24 405 415 10.1037/0097-7403.24.4.405,407,154,Anim_Cogn_2015_Jul_19_18(6)_1267-1284.txt
3.14.1.36,...hol Anim Behav Proc 1988 14 36 42 10.1037/0097-7403.14.1.36,415,114,Anim_Cogn_2015_Jul_19_18(6)_1267-1284.txt
3.29.3.184,...l Anim Behav Proc 2003 29 184 198 10.1037/0097-7403.29.3.184,425,194,Anim_Cogn_2015_Jul_19_18(6)_1267-1284.txt
3.23.2.157,...l Anim Behav Proc 1997 23 157 170 10.1037/0097-7403.23.2.15,427,197,Anim_Cogn_2015_Jul_19_18(6)_1267-1284.txt
3.15.4.366,...l Anim Behav Proc 1989 15 366 375 10.1037/0097-7403.15.4.366,125,117,Anim_Cogn_2016_Aug_27_19_91-107.txt
3.31.2.254,...nim Behav Process 2005 31 254 259 10.1037/0097-7403.31.2.254 15839781,127,211,Anim_Cogn_2016_Aug_27_19_91-107.txt
3.35.1.94,...man Percep Perform 2009 35 94 107 10.1037/0096-1523.35.1.94,133,162,Anim_Cogn_2016_Aug_27_19_91-107.txt
3.29.1.3,...chol Anim Behav Proc 2003 29 1 13 10.1037/0097-7403.29.1.3,154,228,Anim_Cogn_2016_Aug_27_19_91-107.txt
3.27.1.92,...um Percept Perform 2001 27 92 114 10.1037/0096-1523.27.1.92 11248943,160,169,Anim_Cogn_2016_Aug_27_19_91-107.txt
4.42.2.281,"...oc Psychol 42:281–291, 1982. doi:10.1037//0022-3514.42.2.281), we examined how the performance of a ...",4,664,Anim_Cogn_2016_Nov_28_19_417-428.txt
4.62.5.717,... Pers Soc Psychol 1992 62 717 727 10.1037/0022-3514.62.5.717,168,180,Anim_Cogn_2016_Nov_28_19_417-428.txt
4.51.6.110,...ers Soc Psychol 1986 51 1106 1115 10.1037/0022-3514.51.6.1106,179,111,Anim_Cogn_2016_Nov_28_19_417-428.txt
4.73.1.91,...J Pers Soc Psychol 1997 73 91 103 10.1037/0022-3514.73.1.91,187,141,Anim_Cogn_2016_Nov_28_19_417-428.txt
4.82.1.19,... J Pers Soc Psychol 2002 82 19 32 10.1037/0022-3514.82.1.19 11811631,198,183,Anim_Cogn_2016_Nov_28_19_417-428.txt
4.87.6.832,... Pers Soc Psychol 2004 87 832 844 10.1037/0022-3514.87.6.832 15598109,199,167,Anim_Cogn_2016_Nov_28_19_417-428.txt
4.42.2.281,... Pers Soc Psychol 1982 42 281 291 10.1037/0022-3514.42.2.281,208,127,Anim_Cogn_2016_Nov_28_19_417-428.txt
3.32.1.60,...xp Psychol Anim B 2006 32 1 60 70 10.1037/0097-7403.32.1.60,224,267,Anim_Cogn_2016_Feb_6_19_555-564.txt
3.33.4.361,...nim Behav Process 2007 33 361 370 10.1037/0097-7403.33.4.361 17924785,100,189,Anim_Cogn_2016_Mar_16_19_753-758.txt
4.40.2.290,...ers Soc Psychol 1981 40 2 290 302 10.1037/0022-3514.40.2.290,374,164,Anim_Cogn_2016_Mar_21_19_679-705.txt
4.6.2.99,...uli J Cogn Neurosci 1994 6 99 116 10.1162/jocn.1994.6.2.99 23962364,217,167,Anim_Cogn_2014_Oct_20_17(3)_559-575.txt
3.33.4.381,...nim Behav Process 2007 33 381 391 10.1037/0097-7403.33.4.381 17924787,218,177,Anim_Cogn_2014_Oct_20_17(3)_559-575.txt
3.7.4.733,...um Percept Perform 1981 7 733 740 10.1037/0096-1523.7.4.733 6457088,229,125,Anim_Cogn_2014_Oct_20_17(3)_559-575.txt
3.33.3.570,...ol Learn Mem Cogn 2007 33 570 585 10.1037/0278-7393.33.3.570 17470006,130,145,Anim_Cogn_2016_May_21_19_965-975.txt
3.29.3.233,...xp Psychol Anim B 2003 29 233 242 10.1037/0097-7403.29.3.233,162,176,Anim_Cogn_2016_Sep_17_19(6)_1195-1203.txt
3.34.1.54,... Exp Psychol Anim B 2008 34 54 62 10.1037/0097-7403.34.1.54,164,151,Anim_Cogn_2016_Sep_17_19(6)_1195-1203.txt
6.97.1.24,...rats J Comp Psychol 1983 97 24 33 10.1037/0735-7036.97.1.24,343,137,Anim_Cogn_2016_Jul_13_19(6)_1051-1069.txt
4.36.3.271,... Pers Soc Psychol 1978 36 271 279 10.1037/0022-3514.36.3.271 650384,380,181,Anim_Cogn_2016_Jul_13_19(6)_1051-1069.txt
6.98.3.257,...s) J Comp Psychol 1984 98 257 266 10.1037/0735-7036.98.3.257,429,154,Anim_Cogn_2016_Jul_13_19(6)_1051-1069.txt
6.96.6.100,...Physiol Psychol 1982 96 1000 1006 10.1037/0735-7036.96.6.1000,430,120,Anim_Cogn_2016_Jul_13_19(6)_1051-1069.txt
6.99.3.266,... J Comp Psychol 1985 99 3 266 274 10.1037/0735-7036.99.3.266,259,220,Anim_Cogn_2016_Jul_28_19(6)_1103-1114.txt
3.29.3.233,... Psychol Anim B 2003 29 3 233 242 10.1037/0097-7403.29.3.233,260,178,Anim_Cogn_2016_Jul_28_19(6)_1103-1114.txt
3.30.3.203,...xp Psychol Anim B 2004 30 203 212 10.1037/0097-7403.30.3.203,292,203,PMC5306232.txt
3.26.1.31,... Anim Behav Process 2000 26 31 49 10.1037/0097-7403.26.1.31 10650542,303,147,PMC5306232.txt
3.15.1.23,... Anim Behav Process 1989 15 23 35 10.1037/0097-7403.15.1.23 2926333,485,137,PMC5306232.txt
3.33.1.21,... Exp Psychol Anim B 2007 33 21 31 10.1037/0097-7403.33.1.21,487,187,PMC5306232.txt
3.34.3.388,...xp Psychol Anim B 2008 34 388 399 10.1037/0097-7403.34.3.388,488,145,PMC5306232.txt
3.5.1.2,...003) was used to define the haplotypes. arlequin v3.5.1.2 (Excoffier & Lischer 2010) was used to est...,84,451,Anim_Genet_2013_Aug_24_44(5)_522-532.txt
4.6.1.1,...oining network (MJN) was constructed with network 4.6.1.1 (Bandelt et al. 1999) using default parame...,30,1360,Anim_Genet_2014_Aug_21_45(4)_550-558.txt
3.5.1.2,...rentiation (Fis) were performed with ARLEQUIN ver 3.5.1.2 (Excoffier et al. 2005),53,314,Anim_Sci_J_2016_Feb_11_87(2)_190-196.txt
6.23.1.109,"...are (South Mimms, England)0962-728610.7120/09627286.23.1.109ems67514ArticleDoes the current regulati...",3,92,Anim_Welf_2014_Feb_1_23(1)_109-118.txt
6.23.4.369,"...are (South Mimms, England)0962-728610.7120/09627286.23.4.369ems67507ArticleHOW SHOULD THE WELFARE OF...",3,92,Anim_Welf_2014_Nov_1_23(4)_369-379.txt
5.12.2.164,"...nt J Stress Manag 2005 12 164 176 10.1037/1072-5245.12.2.164 Shapiro SL, Astin JA, Bishop SR, Cordov...",208,195,Ann_Behav_Med_2008_Jun_6_35(3)_331-340.txt
4.84.4.822,"... Pers Soc Psychol 2003 84 822 848 10.1037/0022-3514.84.4.822 Brown KW, Ryan RM. The benefits of bein...",216,158,Ann_Behav_Med_2008_Jun_6_35(3)_331-340.txt
4.64.1.131,"... Pers Soc Psychol 1993 64 131 140 10.1037/0022-3514.64.1.131 Cohen S, Tyrrell DA, Smith AP. Negative...",225,180,Ann_Behav_Med_2008_Jun_6_35(3)_331-340.txt
4.51.6.117,"...ers Soc Psychol 1986 51 1173 1182 10.1037/0022-3514.51.6.1173 Baron RM, Kenny DA. The moderator-medi...",233,209,Ann_Behav_Med_2008_Jun_6_35(3)_331-340.txt
3.27.5.505,"...w Health Psychol. 2008 27 505 512 10.1037/0278-6133.27.5.505 Kern ML, Friedman HS. Do conscientious ...",191,137,Ann_Behav_Med_2009_Apr_20_37(2)_154-163.txt
4.78.1.122,"...Pers Soc Psychol. 2000 78 122 135 10.1037/0022-3514.78.1.122 Rothbart MK, Ahadi SA, Evans DE. Temper...",206,138,Ann_Behav_Med_2009_Apr_20_37(2)_154-163.txt
3.26.1.121,"...s Health Psychol. 2007 26 121 125 10.1037/0278-6133.26.1.121 Hampson SE, Goldberg LR, Vogt TM, Duban...",223,223,Ann_Behav_Med_2009_Apr_20_37(2)_154-163.txt
4.68.4.696,"...s Social Psychol. 1995 68 696 703 10.1037/0022-3514.68.4.696 Friedman HS, Tucker JS, Schwartz JE, et...",225,174,Ann_Behav_Med_2009_Apr_20_37(2)_154-163.txt
4.65.1.176,"...Pers Soc Psychol. 1993 65 176 185 10.1037/0022-3514.65.1.176 Friedman HS, Tucker JS, Tomlinson-Kease...",232,178,Ann_Behav_Med_2009_Apr_20_37(2)_154-163.txt
3.26.4.428,"...e Health Psychol. 2007 26 428 436 10.1037/0278-6133.26.4.428 Martin LR, Friedman HS, Schwartz JE. Pe...",233,207,Ann_Behav_Med_2009_Apr_20_37(2)_154-163.txt
3.14.5.381,"...y Health Psychol. 1995 14 381 387 10.1037/0278-6133.14.5.381 Martin LR, Friedman HS, Tucker JS, et a...",241,147,Ann_Behav_Med_2009_Apr_20_37(2)_154-163.txt
3.15.2.94,"...ge Health Psychol. 1996 15 94 101 10.1037/0278-6133.15.2.94 Tucker JS, Friedman HS, Wingard DL, Schw...",242,217,Ann_Behav_Med_2009_Apr_20_37(2)_154-163.txt
4.73.2.381,"...Pers Soc Psychol. 1997 73 381 391 10.1037/0022-3514.73.2.381 Tucker JS, Friedman HS, Schwartz JE, et...",248,155,Ann_Behav_Med_2009_Apr_20_37(2)_154-163.txt
3.26.3.350,...rs Health Psychol 2007 26 350 360 10.1037/0278-6133.26.3.350 17500622,233,174,Ann_Behav_Med_2009_Dec_5_38(3)_225-236.txt
3.24.4.358,...on Health Psychol 2005 24 358 363 10.1037/0278-6133.24.4.358 16045371,235,186,Ann_Behav_Med_2009_Dec_5_38(3)_225-236.txt
3.22.4.429,...rs Health Psychol 2003 22 429 433 10.1037/0278-6133.22.4.429 12940400,236,196,Ann_Behav_Med_2009_Dec_5_38(3)_225-236.txt
3.21.6.601,...on Health Psychol 2002 21 601 609 10.1037/0278-6133.21.6.601 12433013,254,211,Ann_Behav_Med_2009_Dec_5_38(3)_225-236.txt
3.22.2.199,...rs Health Psychol 2003 22 199 209 10.1037/0278-6133.22.2.199 12683740,259,203,Ann_Behav_Med_2009_Dec_5_38(3)_225-236.txt
4.36.8.917,... Pers Soc Psychol 1978 36 917 927 10.1037/0022-3514.36.8.917 690806,164,154,Ann_Behav_Med_2010_Feb_10_39(1)_16-26.txt
3.20.1.20,...er Health Psychol 2001 20 1 20 32 10.1037/0278-6133.20.1.20 11199062,172,263,Ann_Behav_Med_2010_Feb_10_39(1)_16-26.txt
3.27.2.129,... Health Psychol 2008 27 2 129 139 10.1037/0278-6133.27.2.129 18377131,184,183,Ann_Behav_Med_2010_Feb_10_39(1)_16-26.txt
3.20.1.47,...ue Health Psychol 2001 20 1 47 63 10.1037/0278-6133.20.1.47 11199066,185,158,Ann_Behav_Med_2010_Feb_10_39(1)_16-26.txt
4.80.4.572,... Pers Soc Psychol 2001 80 572 584 10.1037/0022-3514.80.4.572 11316222,202,151,Ann_Behav_Med_2010_Feb_10_39(1)_16-26.txt
4.82.2.222,... Pers Soc Psychol 2002 82 222 238 10.1037/0022-3514.82.2.222 11831412,205,189,Ann_Behav_Med_2010_Feb_10_39(1)_16-26.txt
6.37.2.137,...risk factors Vasa 2008 37 137 142 10.1024/0301-1526.37.2.137 18622963,215,182,Ann_Behav_Med_2010_Jun_8_39(3)_222-231.txt
3.19.6.586,...en Health Psychol 2000 19 586 592 10.1037/0278-6133.19.6.586 11129362,235,241,Ann_Behav_Med_2010_Jun_8_39(3)_222-231.txt
3.27.2.268,...ld Health Psychol 2008 27 268 274 10.1037/0278-6133.27.2.268 18377146,237,192,Ann_Behav_Med_2010_Jun_8_39(3)_222-231.txt
3.19.6.613,...en Health Psychol 2000 19 613 618 10.1037/0278-6133.19.6.613 11129365,239,255,Ann_Behav_Med_2010_Jun_8_39(3)_222-231.txt
3.26.6.668,...en Health Psychol 2007 26 668 674 10.1037/0278-6133.26.6.668 18020837,245,162,Ann_Behav_Med_2010_Jun_8_39(3)_222-231.txt
3.6.2.173,...tus Health Psychol. 1987 6 173 82 10.1037/0278-6133.6.2.173 3830120,222,167,Ann_Behav_Med_2010_Dec_29_40(3)_313-324.txt
3.27.4.473,...on Health Psychol 2008 27 473 481 10.1037/0278-6133.27.4.473 18643005,284,240,Ann_Behav_Med_2011_Feb_29_41(1)_21-31.txt
4.11.2.207,...men Psychol Aging 1996 11 207 213 10.1037/0882-7974.11.2.207 8795049,315,203,Ann_Behav_Med_2011_Feb_29_41(1)_21-31.txt
3.24.1.49,...vida Health Psychol 2005 24 49 57 10.1037/0278-6133.24.1.49 15631562,317,197,Ann_Behav_Med_2011_Feb_29_41(1)_21-31.txt
3.21.5.444,...ealth Psychology. 2002 21 444 451 10.1037/0278-6133.21.5.444 12211511,268,197,Ann_Behav_Med_2011_Feb_28_41(1)_104-118.txt
3.13.1.39,... Health Psychology. 1994 13 39 46 10.1037/0278-6133.13.1.39 8168470,313,153,Ann_Behav_Med_2011_Feb_28_41(1)_104-118.txt
3.24.4.339,...ealth Psychology. 2005 24 339 348 10.1037/0278-6133.24.4.339 16045368,315,138,Ann_Behav_Med_2011_Feb_28_41(1)_104-118.txt
3.26.2.214,...ealth Psychology. 2007 26 214 221 10.1037/0278-6133.26.2.214 17385973,339,234,Ann_Behav_Med_2011_Feb_28_41(1)_104-118.txt
3.26.3.369,...ealth Psychology. 2007 26 369 374 10.1037/0278-6133.26.3.369 17500624,342,185,Ann_Behav_Med_2011_Feb_28_41(1)_104-118.txt
3.27.2.179,...ealth Psychology. 2008 27 179 184 10.1037/0278-6133.27.2.179 18377136,347,185,Ann_Behav_Med_2011_Feb_28_41(1)_104-118.txt
4.81.1.65,...J Pers Soc Psychol. 2001 81 65 84 10.1037/0022-3514.81.1.65 11474727,26,117,Ann_Behav_Med_2012_Jun_25_43(3)_284-285.txt
3.24.1.49,...Vida Health Psychol 2005 24 49 57 10.1037/0278-6133.24.1.49 15631562,560,197,Ann_Behav_Med_2012_Oct_6_44(2)_259-286.txt
3.23.5.503,...nts Health Psychol 2004 23 503 16 10.1037/0278-6133.23.5.503 15367070,563,266,Ann_Behav_Med_2012_Oct_6_44(2)_259-286.txt
3.26.4.401,...RIDE Health Psychol 2007 26 401 9 10.1037/0278-6133.26.4.401 17605559,601,207,Ann_Behav_Med_2012_Oct_6_44(2)_259-286.txt
5.20.4.529,... J Korean Med Sci 2005 20 529 534 10.3346/jkms.2005.20.4.529 16100439,177,180,Ann_Behav_Med_2012_Oct_27_44(2)_160-170.txt
3.27.3.327,...sm Health Psychol 2008 27 327 336 10.1037/0278-6133.27.3.327 18624597,27,146,Ann_Behav_Med_2013_Apr_30_45(2)_137-138.txt
3.27.2.179,...on Health Psychol 2008 27 179 184 10.1037/0278-6133.27.2.179 18377136,35,181,Ann_Behav_Med_2013_Apr_30_45(2)_137-138.txt
4.39.5.752,... Pers Soc Psychol 1980 39 752 766 10.1037/0022-3514.39.5.752,193,175,Ann_Behav_Med_2013_Aug_12_46(1)_96-106.txt
4.84.4.822,...nal Soc Psychol 2003 84 4 822 848 10.1037/0022-3514.84.4.822,370,166,Ann_Behav_Med_2013_May_1_46(2)_137-148.txt
4.57.6.106,...ers Soc Psychol 1989 57 1069 1081 10.1037/0022-3514.57.6.1069,372,158,Ann_Behav_Med_2013_May_1_46(2)_137-148.txt
3.26.1.113,... Health Psychol 2007 26 1 113 120 10.1037/0278-6133.26.1.113 17209704,232,161,Ann_Behav_Med_2014_Feb_6_48(2)_205-214.txt
4.61.1.115,... Pers Soc Psychol 1991 61 115 121 10.1037/0022-3514.61.1.115 1890582,216,212,Ann_Behav_Med_2014_Apr_5_48(3)_384-391.txt
3.23.5.443,...um Health Psychol 2004 23 443 451 10.1037/0278-6133.23.5.443 15367063,393,226,Ann_Behav_Med_2015_May_8_49(1)_7-17.txt
4.51.6.117,...s Soc Psychol 1986 51 6 1173 1182 10.1037/0022-3514.51.6.1173 3806354,261,212,Ann_Behav_Med_2015_Aug_21_49(1)_18-28.txt
4.9.3.372,...s over Psychol Aging 1994 9 3 372 10.1037/0882-7974.9.3.372 7999322,275,159,Ann_Behav_Med_2016_Nov_25_50_187-197.txt
4.74.5.125,...J Pers Soc Psychol 1998 74 5 1252 10.1037/0022-3514.74.5.1252 9599441,310,160,Ann_Behav_Med_2016_Nov_25_50_187-197.txt
4.15.2.187,...s Psychol Aging 2000 15 2 187 224 10.1037/0882-7974.15.2.187 10879576,197,201,Ann_Behav_Med_2016_Jan_14_50_419-426.txt
3.26.3.259,...fs Health Psychol 2007 26 259 267 10.1037/0278-6133.26.3.259 17500612,641,174,Ann_Behav_Med_2016_May_11_50_592-612.txt
4.69.3.505,... Pers Soc Psychol 1995 69 505 517 10.1037/0022-3514.69.3.505 7562392,658,126,Ann_Behav_Med_2016_May_11_50_592-612.txt
3.21.2.194,...ng Health Psychol 2002 21 194 201 10.1037/0278-6133.21.2.194 11950110,738,132,Ann_Behav_Med_2016_May_11_50_592-612.txt
3.14.3.210,...ty Health Psychol 1995 14 210 216 10.1037/0278-6133.14.3.210 7641661,269,119,Ann_Behav_Med_2016_Mar_15_50_582-591.txt
3.26.4.428,...te Health Psychol 2007 26 428 436 10.1037/0278-6133.26.4.428 17605562,171,210,PMC5250640.txt
3.27.5.505,...ew Health Psychol 2008 27 505 512 10.1037/0278-6133.27.5.505 18823176,172,139,PMC5250640.txt
2.17.8.154,"...one Miner. Res. 2002 17 1545 1554 10.1359/jbmr.2002.17.8.1545 Robling, A.G., Hinant, F.M., Burr, D.B...",112,236,Ann_Biomed_Eng_2009_Jul_5_37(7)_1263-1272.txt
2.17.8.154,"...ne Miner. Res. 17, 1545–1554. doi:10.1359/jbmr.2002.17.8.1545 12162508",112,492,Ann_Biomed_Eng_2009_Jul_5_37(7)_1263-1272.txt
1.46.12.355,...ees Biomed. Tech. 2001 46 355 361 10.1515/bmte.2001.46.12.355,283,155,Ann_Biomed_Eng_2010_Jul_23_38(7)_2418-2427.txt
3.24.4.103,... Human Percept. 1998 24 1037 1051 10.1037/0096-1523.24.4.1037 9706709,363,192,Ann_Biomed_Eng_2010_Aug_19_38(8)_2520-2531.txt
1.2.12.165,.... Drug Discov. 2007 2 12 1653 1668 10.1517/17460441.2.12.1653,285,190,Ann_Biomed_Eng_2010_Dec_8_38(12)_3777-3788.txt
6.1.4.483,... J. Nanomedicine 2006 1 4 483 495 10.2147/nano.2006.1.4.483 17722281,140,180,Ann_Biomed_Eng_2011_Apr_9_39(4)_1313-1327.txt
5.4.4.395,...rug Metab. Toxicol. 2008 4 395 411 10.1517/17425255.4.4.395,78,155,Ann_Biomed_Eng_2011_Apr_7_39(4)_1328-1334.txt
1.11.60.365,"...N508 476338 (ML), no. NN 507280736 (EP), and no. 11.11.60.365 (ML)",125,879,Ann_Biomed_Eng_2011_Aug_13_39(8)_2114-2129.txt
6.1.1.81,...ry Int. J. Nanomedicine 2006 1 81 10.2147/nano.2006.1.1.81 17722265,153,160,Ann_Biomed_Eng_2011_Sep_25_39(9)_2374-2387.txt
3.32.3.599,...Percept. Perform. 2006 32 599 609 10.1037/0096-1523.32.3.599 16822126,620,186,Ann_Biomed_Eng_2013_Aug_26_41(8)_1726-1739.txt
6.4.2.154,... Neurosurg. Spine 2006 4 2 154 159 10.3171/spi.2006.4.2.154 16506483,137,203,Ann_Biomed_Eng_2014_Jan_7_42(4)_751-762.txt
3.1.3.1,"...oric monoester 3 phosphohydrolase, alkaline; E.C. 3.1.3.1] was assayed in cell lysates by measuring ...",40,622,Ann_Biomed_Eng_2014_Sep_17_42(12)_2551-2561.txt
2.23.11.150,...Korean Chem. Soc. 2002 23 11 1507 10.5012/bkcs.2002.23.11.1507,101,156,Ann_Biomed_Eng_2015_Mar_19_43(7)_1706-1711.txt
3.28.5.725,... Korean Med. Sci. 2013 28 725 730 10.3346/jkms.2013.28.5.725 23678264,144,165,Ann_Biomed_Eng_2015_May_27_43(12)_2924-2940.txt
1.16.7.130,...e Miner. Res. 2001 16 7 1308 1317 10.1359/jbmr.2001.16.7.1308 11450707,119,230,Ann_Biomed_Eng_2010_Feb_2_38(2)_235-246.txt
2.7.1.3,"...gn information using Bulk Rename Utility (Version 2.7.1.3, TGRMN Software, www.bulkrenameutility.co....",36,143,Ann_Bot_2016_Oct_6_118(4)_655-665.txt
EC 1.11.1.6,Changes in the activity of catalase (EC 1.11.1.6) in relation to the dormancy of grapev...,271,38,Ann_Bot_2015_Sep_3_116(4)_703-711.txt
4.12.8.129,...ig Drugs 2003 12 1297 312 12882618 10.1517/13543784.12.8.1297,229,140,Ann_Clin_Microbiol_Antimicrob_2006_Feb_15_5_3.txt
4.12.4.683,...tig Drugs 2003 12 683 688 12665423 10.1517/13543784.12.4.683,189,144,Ann_Clin_Microbiol_Antimicrob_2006_Apr_6_5_8.txt
6.3.8.105,...macother 2002 3 1059 1065 12150685 10.1517/14656566.3.8.1059,167,117,Ann_Clin_Microbiol_Antimicrob_2006_Feb_17_5_4.txt
4.19.28.208,... Surveill 2014 19 28 20855 10.2807/1560-7917.ES2014.19.28.20855 25060570,91,196,Ann_Clin_Microbiol_Antimicrob_2016_Jul_22_15_42.txt
4.19.10.207,...Surveill. 2014;19(10). doi:10.2807/1560-7917.ES2014.19.10.20730,107,258,Ann_Clin_Microbiol_Antimicrob_2016_Jul_22_15_42.txt
5.1.3.351,...ab Toxicol 2005 1 351 361 16863448 10.1517/17425255.1.3.351,147,163,Ann_Clin_Microbiol_Antimicrob_2007_Oct_1_6_11.txt
6.4.8.122,...macother 2003 4 1227 1240 12877633 10.1517/14656566.4.8.1227,266,145,Ann_Clin_Microbiol_Antimicrob_2008_Jan_11_7_1.txt
3.2.3.323,... Microbiol 2007 2 323 334 17661706 10.2217/17460913.2.3.323,69,150,Ann_Clin_Microbiol_Antimicrob_2008_Apr_30_7_11.txt
3.2.5.501,... Microbiol 2007 2 501 512 17927473 10.2217/17460913.2.5.501,161,150,Ann_Clin_Microbiol_Antimicrob_2009_Jun_17_8_21.txt
1.14.18.1,"...ng the protein alignment of human tyrosinase (E.C.1.14.18.1) and C. neoformans laccase (E.C.10.32), ...",125,403,Ann_Clin_Microbiol_Antimicrob_2009_Nov_5_8_29.txt
3.45.1.62,...udy Infect Chemother. 2013 45 62 68 10.3947/ic.2013.45.1.62 24265951,124,231,PMC5240302.txt
6.2.5.813,...Opin Pharmacother 2001 2 5 813 818 10.1517/14656566.2.5.813 11336624,134,148,Ann_Clin_Microbiol_Antimicrob_2011_Jan_18_10_2.txt
6.9.12.207,... Opin Pharmacoter 2008 9 2077 2085 10.1517/14656566.9.12.2077,138,135,Ann_Clin_Microbiol_Antimicrob_2011_Jun_6_10_24.txt
1.1.22.146,...nd fungi Pharm Biol 2003 41 1 22 25 10.1076/phbi.41.1.22.14692,228,141,Ann_Clin_Microbiol_Antimicrob_2012_Feb_24_11_5.txt
1.2.12.140,...n Burkina Faso Agric Biol J N Am 10.5251/abjna.2011.2.12.1402.1408,302,314,Ann_Clin_Microbiol_Antimicrob_2012_Dec_26_11_33.txt
6.18.3.235,...update J Chemother 2006 13 235 249 10.1179/joc.2006.18.3.235 17129833,242,144,Ann_Clin_Microbiol_Antimicrob_2014_Jan_9_13_6.txt
2.45.2.111,... Korea? Clin Endosc 2012 13 111 112 10.5946/ce.2012.45.2.111 22866247,123,153,Ann_Clin_Microbiol_Antimicrob_2014_Apr_22_13_15.txt
4.17.3.297,...pin Investig Drugs 2008 17 297 302 10.1517/13543784.17.3.297 18321229,161,173,Ann_Clin_Microbiol_Antimicrob_2013_Jun_17_12_12.txt
3.2.1.14,"...d by two types of enzymes, namely chitinase (E.C. 3.2.1.14) and beta-N-acetyl hexosaminidase (E.C. 3...",22,70,Ann_Clin_Microbiol_Antimicrob_2014_Aug_12_13_35.txt
3.2.1.52,... 3.2.1.14) and beta-N-acetyl hexosaminidase (E.C. 3.2.1.52) [8],22,119,Ann_Clin_Microbiol_Antimicrob_2014_Aug_12_13_35.txt
EC 3.2.1.14,"...-acetamido-2-deoxy]-δ-glucoside glycanohydrolase, EC 3.2.1.14), which is the first important enzyme ...",73,79,Ann_Clin_Microbiol_Antimicrob_2014_Aug_12_13_35.txt
1.17.3.312,...astroenterol Motil 2011 17 312 317 10.5056/jnm.2011.17.3.312 21860825,187,114,Ann_Clin_Microbiol_Antimicrob_2014_Oct_17_13_49.txt
1.52.6.879,...ogens Yonsei Med J 2011 52 879 891 10.3349/ymj.2011.52.6.879 22028150,211,171,Ann_Clin_Microbiol_Antimicrob_2014_Jul_22_13_36.txt
3.2.3.297,...gy Future Microbiol 2007 2 297 307 10.2217/17460913.2.3.297 17661704,372,151,Ann_Clin_Microbiol_Antimicrob_2015_Mar_18_14_12.txt
4.3.1.1,"11	Tricyclo [4.3.1.1(3,8)] undecane-1-c arboxylic acid o-Anisal...",320,14,Ann_Clin_Microbiol_Antimicrob_2015_Mar_24_14_18.txt
3.8.1.79,...Acad Periodontol 2003 8 1 79 98 10.1902/annals.2003.8.1.79,121,169,Ann_Clin_Microbiol_Antimicrob_2015_Jul_17_14_36.txt
3.18.31.205,...eillance. 2013;18(31). doi:10.2807/1560-7917.ES2013.18.31.2054,217,234,Ann_Clin_Microbiol_Antimicrob_2015_Sep_11_14_42.txt
5.35.2.212,...s  spp Ann Lab Med 2015 35 212 219 10.3343/alm.2015.35.2.212 25729723,145,279,Ann_Clin_Microbiol_Antimicrob_2015_Oct_6_14_44.txt
3.18.31.205,...ill 2013 18 31 20548 20550 10.2807/1560-7917.ES2013.18.31.20548 23929227,128,221,Ann_Clin_Microbiol_Antimicrob_2015_Nov_25_14_51.txt
1.7.1.2,...visualized with the open source software PyMol (v.1.7.1.2,104,1830,Ann_Clin_Microbiol_Antimicrob_2015_Nov_26_14_52.txt
2.27.2.128,...rean J Intern Med 2012 27 128 142 10.3904/kjim.2012.27.2.128 22707882,245,142,Ann_Clin_Microbiol_Antimicrob_2016_Jan_29_15_3.txt
4.55.1.118,...nnii  Yonsei Med J 2014 55 118 125 10.3349/ymj.2014.55.1.118 24339296,136,182,Ann_Clin_Microbiol_Antimicrob_2016_Feb_24_15_11.txt
4.19.13.207,... Surveill 2014 19 13 20751 10.2807/1560-7917.ES2014.19.13.20751 24721538,35,217,Ann_Clin_Microbiol_Antimicrob_2016_Mar_3_15_13.txt
5.47.3.167,...rd Infect Chemother 2015 47 167 174 10.3947/ic.2015.47.3.167 26483990,479,200,Ann_Clin_Microbiol_Antimicrob_2016_Apr_6_15_20.txt
3.19.1.29,...s B Clin Mol Hepatol 2013 19 29 35 10.3350/cmh.2013.19.1.29 23593607,144,207,Ann_Clin_Microbiol_Antimicrob_2016_Apr_14_15_24.txt
3.33.4.283,...emia Ann Lab Med 2013 33 4 283 287 10.3343/alm.2013.33.4.283 23826566,104,168,Ann_Clin_Microbiol_Antimicrob_2016_Apr_18_15_25.txt
5.47.2.81,...  Infect Chemother. 2015 47 2 81 97 10.3947/ic.2015.47.2.81 26157586,191,196,Ann_Clin_Microbiol_Antimicrob_2016_May_23_15_35.txt
5.47.1.33,...a Infect Chemother. 2015 47 1 33 40 10.3947/ic.2015.47.1.33 25844261,193,185,Ann_Clin_Microbiol_Antimicrob_2016_May_23_15_35.txt
2.33.6.372,...orean J Fam Med 2012 33 6 372 380 10.4082/kjfm.2012.33.6.372 23267423,231,223,Ann_Clin_Microbiol_Antimicrob_2016_Aug_31_15(1)_50.txt
4.19.14.207,... Surveill 2014 19 14 20761 10.2807/1560-7917.ES2014.19.14.20761 24739982,509,226,Ann_Clin_Microbiol_Antimicrob_2016_Sep_29_15_57.txt
4.19.13.207,... Surveill 2014 19 13 20751 10.2807/1560-7917.ES2014.19.13.20751 24721538,512,195,Ann_Clin_Microbiol_Antimicrob_2016_Sep_29_15_57.txt
4.19.9.207,...o Surveill 2014 19 9 20720 10.2807/1560-7917.ES2014.19.9.20720 24626205,534,194,Ann_Clin_Microbiol_Antimicrob_2016_Sep_29_15_57.txt
4.11.4.529,...n Investig Drug. 2002 11 4 529 544 10.1517/13543784.11.4.529,184,136,Ann_Clin_Microbiol_Antimicrob_2016_Dec_9_15_60.txt
6.3.8.110,...in Pharmacother 2002 3 8 1109 1115 10.1517/14656566.3.8.1109 12150690,156,115,PMC5310009.txt
1.1.6.3,"...a SD-OCT (Heidelberg Spectralis, software version 1.1.6.3, Heidelberg Engeneering, Heidelberg, Germa...",39,145,Ann_Clin_Transl_Neurol_2015_Feb_17_2(2)_140-150.txt
EC 4.2.1.17,"...n enoyl-CoA hydratase (ECHS1, synonym: crotonase, EC 4.2.1.17), encoded by ECHS1 (cytogenetic locati...",20,61,Ann_Clin_Transl_Neurol_2015_May_13_2(5)_492-509.txt
3.9.1.6,"..., Goleta, CA, USA). For EEG analysis, Acknowledge 3.9.1.6 software was used. After recording baselin...",34,891,Ann_Clin_Transl_Neurol_2015_Jul_1_2(7)_722-738.txt
2.4.4.1,"...iments were supported by grants of EU Health-2009-2.4.4.1 (LeukoTreat), DFG Research Center Molecula...",5,76,Ann_Clin_Transl_Neurol_2015_Aug_24_2(8)_787-796.txt
1.5.1.1,...lent's Feature Extraction (FE) software (version 11.5.1.1) including a quality control based on inte...,101,1278,Ann_Clin_Transl_Neurol_2015_Sep_8_2(9)_875-893.txt
3.2.1.45,"...storage disease with glucocerebrosidase (GCase, EC3.2.1.45) deficiency caused by its gene (GBA1) mut...",76,108,Ann_Clin_Transl_Neurol_2016_Feb_2_3(3)_200-215.txt
3.29.1.5,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.5EditorialFunctional New Sphincter Ani Reco...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_5-6.txt
3.29.1.17,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.17Original ArticleFeasibility of Hand-Assis...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_17-21.txt
3.29.1.7,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.7Original ArticleFeasibility of Neurovascul...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_7-11.txt
3.29.1.12,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.12Original ArticleLaparoscopic Versus an Op...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_12-16.txt
3.29.1.31,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.31Case ReportA Large Polypoid Vascular Ecta...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_31-33.txt
3.29.1.28,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.28Case ReportRectal Perforation Caused by A...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_28-30.txt
3.29.1.1,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.1EditorialColorectal Cancer Epidemic in Kor...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_1-4.txt
3.29.1.22,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.22Original ArticleSafety and Feasibility of...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_22-27.txt
3.29.1.34,...he Korean Society of Coloproctology 10.3393/ac.2013.29.1.34Case ReportUnusual Case of Solitary Perin...,3,126,Ann_Coloproctol_2013_Feb_28_29(1)_34-37.txt
3.29.2.66,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.66Original ArticleThe Role of Diverting Sto...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_66-71.txt
3.29.2.44,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.44ReviewThe Role of Surgery for Asymptomati...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_44-54.txt
3.29.2.60,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.60Original ArticleDelorme's Procedure: An E...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_60-65.txt
3.29.2.72,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.72Original ArticleShort-term Outcomes of Ha...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_72-76.txt
3.29.2.80,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.80Case ReportLaparoscopic Surgery for an In...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_80-82.txt
3.29.2.39,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.39EditorialIntersphincteric Approach for De...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_39-40.txt
3.29.2.41,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.41EditorialRole of the Delorme Procedure fo...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_41.txt
3.29.2.77,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.77Case ReportA Stercoral Perforation of the...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_77-79.txt
3.29.2.83,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.83Case ReportAdenosquamous Carcinoma of the...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_83-86.txt
3.29.2.42,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.42EditorialShould Hand-Assisted Laparoscopi...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_42-43.txt
3.29.2.55,...he Korean Society of Coloproctology 10.3393/ac.2013.29.2.55Original ArticleManaging Deep Postanal Sp...,3,126,Ann_Coloproctol_2013_Apr_30_29(2)_55-59.txt
3.29.3.93,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.93Original ArticleExpression of Secreted Pr...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_93-99.txt
3.29.3.89,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.89EditorialClinical Significance of the Met...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_89-90.txt
3.29.3.126,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.126Case ReportIntramural Recurrence Without...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_126-129.txt
3.29.3.115,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.115Original ArticlePrognostic Significance ...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_115-122.txt
3.29.3.87,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.87EditorialSignificance of Secreted Protein...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_87-88.txt
3.29.3.100,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.100Original ArticlePrognostic Impact of the...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_100-105.txt
3.29.3.91,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.91EditorialIndividualized Cutoff Value of t...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_91-92.txt
3.29.3.123,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.123Case ReportPrimary Multiple Mesenteric L...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_123-125.txt
3.29.3.130,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.130Case ReportMucosal Schwann-Cell Hamartom...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_130-134.txt
3.29.3.106,...he Korean Society of Coloproctology 10.3393/ac.2013.29.3.106Original ArticleIndividualized Cutoff Va...,3,126,Ann_Coloproctol_2013_Jun_30_29(3)_106-114.txt
3.29.4.167,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.167Case ReportColon Cancer After Acute Dive...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_167-171.txt
3.29.4.137,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.137EditorialSerum Carcinoembryonic Antigen ...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_137.txt
3.29.4.150,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.150Original ArticleOptimal Time of Initiati...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_150-154.txt
3.29.4.172,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.172Case ReportChronic Pelvic Abscedation Af...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_172-176.txt
3.29.4.160,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.160Original ArticleMechanical Bowel Prepara...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_160-166.txt
3.29.4.135,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.135EditorialWhat Should Be Done to Increase...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_135.txt
3.29.4.144,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.144Original ArticleData on the Characterist...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_144-149.txt
3.29.4.136,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.136EditorialMechanical Bowel Preparation: K...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_136.txt
3.29.4.138,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.138EditorialTiming of Adjuvant Chemotherapy...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_138.txt
6.32.3.111,...he Korean Society of Coloproctology 10.3393/ac.2016.32.3.111Original ArticleComparison of a Hemorrho...,3,126,Ann_Coloproctol_2016_Jun_30_32(3)_111-116.txt
6.32.3.105,...he Korean Society of Coloproctology 10.3393/ac.2016.32.3.105Original ArticleSingle-Port Laparoscopic...,3,126,Ann_Coloproctol_2016_Jun_30_32(3)_105-110.txt
3.29.5.213,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.213Case ReportAcute Cholecystitis After a C...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_213-215.txt
3.29.5.177,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.177EditorialAnal Cancer Study Based on Kore...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_177.txt
3.29.5.181,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.181EditorialMesenteric Embolization: Is It ...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_181.txt
3.29.5.192,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.192Original ArticleA Phase II Study of Addi...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_192-197.txt
3.29.5.182,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.182Original ArticleCharacteristics and Surv...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_182-185.txt
3.29.5.179,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.179EditorialHistopathology and Physiologica...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_179-180.txt
3.29.5.205,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.205Original ArticleThe Safety and Efficacy ...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_205-208.txt
3.29.5.178,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.178EditorialAdditional Chemotherapy During ...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_178.txt
3.29.5.198,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.198Original ArticleCorrelation of Histopath...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_198-204.txt
3.29.5.186,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.186Original ArticleKnowledge of and Practic...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_186-191.txt
3.29.5.209,...he Korean Society of Coloproctology 10.3393/ac.2013.29.5.209Case ReportGiant Ascending Colonic Diver...,3,126,Ann_Coloproctol_2013_Oct_31_29(5)_209-212.txt
3.29.6.252,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.252Case ReportRhabdoid Carcinoma of the Rec...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_252-255.txt
3.29.6.243,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.243Original ArticleImportance of Early Foll...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_243-247.txt
3.29.6.224,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.224EditorialSham Feeding? Same Feeding? Kim...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_224.txt
3.29.6.225,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.225Original ArticleClinical Outcomes of 103...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_225-230.txt
3.29.6.219,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.219EditorialSafe Distal Resection Margin in...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_219-220.txt
3.29.6.248,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.248Original ArticleEffect of Gum Chewing on...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_248-251.txt
3.29.6.256,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.256Case ReportPneumoretroperitoneum After P...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_256-258.txt
3.29.6.223,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.223EditorialWhat Matters in Colonoscopy? Ki...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_223.txt
3.29.6.238,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.238Original ArticlePostoperative Pain Relie...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_238-242.txt
3.29.6.221,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.221EditorialPreemptive Analgesia in Single-...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_221-222.txt
3.29.6.231,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.231Original ArticleAssociation Between a Cl...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_231-237.txt
3.29.6.217,...he Korean Society of Coloproctology 10.3393/ac.2013.29.6.217EditorialWhat Is the Role of Hand-Assist...,3,126,Ann_Coloproctol_2013_Dec_31_29(6)_217-218.txt
4.30.1.47,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.47Case ReportTransanal Evisceration Caused ...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_47-49.txt
4.30.1.9,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.9EditorialNeedlescopic-Assisted Surgery: Si...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_9-10.txt
4.30.1.28,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.28Original ArticleIs Microsatellite Instabi...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_28-34.txt
4.30.1.54,"...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.54Letter to the EditorCommentary on \"Charac...",3,126,Ann_Coloproctol_2014_Feb_28_30(1)_54-55.txt
4.30.1.5,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.5EditorialIs a Microsatellite Instability S...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_5-6.txt
4.30.1.7,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.7EditorialIndividualized Treatment for a Re...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_7-8.txt
4.30.1.50,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.50Case ReportIatrogenic Rectal Diverticulum...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_50-53.txt
4.30.1.56,"...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.56Letter to the EditorReply on \"Characteris...",3,126,Ann_Coloproctol_2014_Feb_28_30(1)_56.txt
4.30.1.2,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.2EditorialSecond Primary Cancers Following ...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_2.txt
4.30.1.18,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.18Original ArticleClinical Characteristics ...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_18-22.txt
4.30.1.11,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.11Original ArticleThe Role of Hand-Assisted...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_11-17.txt
4.30.1.42,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.42Original ArticleOutcomes of a Single-Port...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_42-46.txt
4.30.1.1,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.1EditorialHand-Assisted Laparoscopic Right ...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_1.txt
4.30.1.23,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.23Original ArticlePositron Emission Tomogra...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_23-27.txt
4.30.1.3,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.3EditorialThe Role of Positron Emission Tom...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_3-4.txt
6.32.3.101,...he Korean Society of Coloproctology 10.3393/ac.2016.32.3.101Original ArticleUsefulness of Anorectal ...,3,126,Ann_Coloproctol_2016_Jun_30_32(3)_101-104.txt
6.32.3.120,...he Korean Society of Coloproctology 10.3393/ac.2016.32.3.120Case ReportPersistent Bleeding Following...,3,126,Ann_Coloproctol_2016_Jun_30_32(3)_120-122.txt
4.30.2.77,...he Korean Society of Coloproctology 10.3393/ac.2014.30.2.77Original ArticleNiti CAR 27 Versus a Conv...,3,126,Ann_Coloproctol_2014_Apr_25_30(2)_77-82.txt
4.30.2.71,...he Korean Society of Coloproctology 10.3393/ac.2014.30.2.71Original ArticleComparison of Surgical Sk...,3,126,Ann_Coloproctol_2014_Apr_25_30(2)_71-76.txt
4.30.2.97,...he Korean Society of Coloproctology 10.3393/ac.2014.30.2.97Case ReportSurgical Management of Unicent...,3,126,Ann_Coloproctol_2014_Apr_25_30(2)_97-100.txt
4.30.2.59,"...he Korean Society of Coloproctology 10.3393/ac.2014.30.2.59EditorialThe New Stapler Device Is Good, ...",3,126,Ann_Coloproctol_2014_Apr_25_30(2)_59.txt
4.30.2.88,...he Korean Society of Coloproctology 10.3393/ac.2014.30.2.88Original ArticleA Survey of Colonoscopic ...,3,126,Ann_Coloproctol_2014_Apr_25_30(2)_88-92.txt
4.30.2.60,...he Korean Society of Coloproctology 10.3393/ac.2014.30.2.60EditorialPreoperative Body Mass Index and...,3,126,Ann_Coloproctol_2014_Apr_25_30(2)_60.txt
4.30.2.93,...he Korean Society of Coloproctology 10.3393/ac.2014.30.2.93Case ReportAn Extragastrointestinal Strom...,3,126,Ann_Coloproctol_2014_Apr_25_30(2)_93-96.txt
4.30.2.61,...he Korean Society of Coloproctology 10.3393/ac.2014.30.2.61Original ArticleRole of β1-Integrin in Co...,3,126,Ann_Coloproctol_2014_Apr_25_30(2)_61-70.txt
4.30.2.83,...he Korean Society of Coloproctology 10.3393/ac.2014.30.2.83Original ArticlePreoperative Body Mass In...,3,126,Ann_Coloproctol_2014_Apr_25_30(2)_83-87.txt
4.30.3.141,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.141Case ReportTisN0M1 Sigmoid Colon Cancer:...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_141-146.txt
4.30.3.103,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.103EditorialEndless Arguments Over Diversio...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_103.txt
4.30.3.104,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.104EditorialSacral Chordoma: Challenging fo...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_104-105.txt
4.30.3.115,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.115Original ArticlePreoperative Localizatio...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_115-117.txt
4.30.3.109,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.109ReviewPelvic Floor Rehabilitation to Imp...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_109-114.txt
4.30.3.122,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.122Original ArticleThe Unresolved Case of S...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_122-131.txt
4.30.3.132,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.132Original ArticleSphincter-Preserving The...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_132-134.txt
4.30.3.107,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.107EditorialSpinal Block Anesthesia With Mo...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_107-108.txt
4.30.3.147,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.147Case ReportSurgical Strategy for Colonic...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_147-150.txt
4.30.3.153,"...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.153Letter to the EditorReply on \"Data on th...",3,126,Ann_Coloproctol_2014_Jun_23_30(3)_153.txt
4.30.3.101,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.101EditorialEfficacy of a Patient's Own Blo...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_101-102.txt
4.30.3.101,"...ulation. A larger-scale, well-designed, prospec2014.30.3.101tive study is necessary if the use of a ...",7,1625,Ann_Coloproctol_2014_Jun_23_30(3)_101-102.txt
4.30.3.151,"...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.151Letter to the EditorCommentary on \"Data ...",3,126,Ann_Coloproctol_2014_Jun_23_30(3)_151-152.txt
4.30.3.135,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.135Original ArticleMorphine Spinal Block An...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_135-140.txt
4.30.3.118,...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.118Original ArticleFeasibility and Safety o...,3,126,Ann_Coloproctol_2014_Jun_23_30(3)_118-121.txt
4.30.3.106,"...he Korean Society of Coloproctology 10.3393/ac.2014.30.3.106EditorialTreatment Option for Aged, Mult...",3,126,Ann_Coloproctol_2014_Jun_23_30(3)_106.txt
4.30.4.157,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.157EditorialPrediction and Prevention of Po...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_157-158.txt
4.30.4.157,"...ry anticoagulation discontinuation. Until now, 2014.30.4.157whether antiplatelet agents such as aspi...",9,1228,Ann_Coloproctol_2014_Aug_26_30(4)_157-158.txt
4.30.4.161,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.161EditorialAdvancement Flap for the Treatm...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_161-162.txt
4.30.4.165,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.165ReviewOverview of Radiation Therapy for ...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_165-174.txt
4.30.4.182,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.182Original ArticleOnly the Size of Resecte...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_182-185.txt
4.30.4.186,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.186Original ArticleEnhancing the Enhanced R...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_186-191.txt
4.30.4.201,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.201Case ReportRegression of Colonic Adenoma...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_201-204.txt
4.30.4.155,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.155EditorialParadigm Shift in the Treatment...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_155-156.txt
4.30.4.197,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.197Case ReportMesh-Based Transperineal Repa...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_197-200.txt
4.30.4.192,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.192Original ArticleApplication of Advanceme...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_192-196.txt
4.30.4.175,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.175Original ArticlePrognostic Implications ...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_175-181.txt
4.30.4.159,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.159EditorialEpidural Injection of Extended-...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_159-160.txt
4.30.4.159,"... postoperative analgesics. However, these case 2014.30.4.159series did highlight the advantages of e...",11,130,Ann_Coloproctol_2014_Aug_26_30(4)_159-160.txt
4.30.4.163,...he Korean Society of Coloproctology 10.3393/ac.2014.30.4.163EditorialMinimally Invasive Techniques f...,3,126,Ann_Coloproctol_2014_Aug_26_30(4)_163-164.txt
4.30.5.237,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.237Case ReportIntramedullary Spinal Cord Me...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_237-240.txt
4.30.5.216,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.216Original ArticleSafety of Nonoperative M...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_216-221.txt
6.32.3.92,...he Korean Society of Coloproctology 10.3393/ac.2016.32.3.92Original ArticlePrognostic Factors in Ter...,3,126,Ann_Coloproctol_2016_Jun_30_32(3)_92-100.txt
6.32.3.117,...he Korean Society of Coloproctology 10.3393/ac.2016.32.3.117Case ReportHematochezia due to Angiodysp...,3,126,Ann_Coloproctol_2016_Jun_30_32(3)_117-119.txt
4.30.5.206,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.206EditorialNonoperative Management of Acut...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_206.txt
4.30.5.222,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.222Original ArticleEffectiveness of Sodium ...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_222-227.txt
4.30.5.208,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.208EditorialImportance of Prompt Diagnosis ...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_208-209.txt
4.30.5.207,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.207EditorialFrustration Still Exists Kim Hy...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_207.txt
4.30.5.205,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.205EditorialSexual Function After a Proctec...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_205.txt
4.30.5.241,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.241Case ReportPerianal Paget's Disease Kim ...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_241-244.txt
4.30.5.210,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.210Original ArticleHigh Rate of Sexual Dysf...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_210-215.txt
4.30.6.248,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.248EditorialIntraoperative Peritoneal Lavag...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_248-249.txt
4.30.6.245,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.245EditorialSurgical Treatment of Obstructe...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_245-246.txt
4.30.6.274,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.274Original ArticleComparison of Compliance...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_274-279.txt
4.30.6.285,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.285Case ReportProper Management for Morbid ...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_285-289.txt
4.30.6.251,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.251Original ArticleComparative Study of Pos...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_251-258.txt
4.30.6.266,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.266Original ArticleRole of Peritoneal Lavag...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_266-273.txt
4.30.6.250,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.250EditorialEffect of Laparoscopic Surgery ...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_250.txt
4.30.6.280,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.280Case ReportAcute Peritonitis Caused by a...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_280-284.txt
4.30.6.290,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.290Case ReportAcute Hyponatremia With Seizu...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_290-293.txt
4.30.6.259,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.259Original ArticleReliability of 18F-Fluor...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_259-265.txt
4.30.6.247,...he Korean Society of Coloproctology 10.3393/ac.2014.30.6.247EditorialPreoperative Staging With Posit...,3,126,Ann_Coloproctol_2014_Dec_31_30(6)_247.txt
5.31.1.9,...he Korean Society of Coloproctology 10.3393/ac.2015.31.1.9Original ArticleClinicopathologic Signific...,3,126,Ann_Coloproctol_2015_Feb_28_31(1)_9-15.txt
5.31.1.5,...he Korean Society of Coloproctology 10.3393/ac.2015.31.1.5EditorialCan the Timing of Ileostomy Rever...,3,126,Ann_Coloproctol_2015_Feb_28_31(1)_5-6.txt
5.31.1.7,...he Korean Society of Coloproctology 10.3393/ac.2015.31.1.7EditorialEffect of a Purse-String Approxim...,3,126,Ann_Coloproctol_2015_Feb_28_31(1)_7-8.txt
5.31.1.1,...he Korean Society of Coloproctology 10.3393/ac.2015.31.1.1EditorialDoes BRAF Mutation and Extracellu...,3,126,Ann_Coloproctol_2015_Feb_28_31(1)_1-2.txt
5.31.1.16,...he Korean Society of Coloproctology 10.3393/ac.2015.31.1.16Original ArticleReduced-Port Laparoscopic...,3,126,Ann_Coloproctol_2015_Feb_28_31(1)_16-22.txt
6.32.6.208,...he Korean Society of Coloproctology 10.3393/ac.2016.32.6.208Original ArticlePrognostic Impact of Imm...,3,126,PMC5256249.txt
5.31.1.23,...he Korean Society of Coloproctology 10.3393/ac.2015.31.1.23Original ArticlePredictors of Fecal Incon...,3,126,Ann_Coloproctol_2015_Feb_28_31(1)_23-28.txt
5.31.1.37,...he Korean Society of Coloproctology 10.3393/ac.2015.31.1.37Case ReportEpidermoid Cyst of the Cecum P...,3,126,Ann_Coloproctol_2015_Feb_28_31(1)_37-39.txt
5.31.1.29,...he Korean Society of Coloproctology 10.3393/ac.2015.31.1.29Original ArticleClinical Trial on the Inc...,3,126,Ann_Coloproctol_2015_Feb_28_31(1)_29-33.txt
5.31.1.3,...he Korean Society of Coloproctology 10.3393/ac.2015.31.1.3EditorialReduced Port Laparoscopic Surgery...,3,126,Ann_Coloproctol_2015_Feb_28_31(1)_3-4.txt
5.31.1.34,...he Korean Society of Coloproctology 10.3393/ac.2015.31.1.34Case ReportLate Presentation of Anal Cana...,3,126,Ann_Coloproctol_2015_Feb_28_31(1)_34-36.txt
5.31.2.68,...he Korean Society of Coloproctology 10.3393/ac.2015.31.2.68Case ReportPrimary Extrauterine Endometri...,3,126,Ann_Coloproctol_2015_Apr_30_31(2)_68-73.txt
5.31.2.46,...he Korean Society of Coloproctology 10.3393/ac.2015.31.2.46Original ArticleDistribution of the Colon...,3,126,Ann_Coloproctol_2015_Apr_30_31(2)_46-51.txt
5.31.2.57,...he Korean Society of Coloproctology 10.3393/ac.2015.31.2.57Original ArticleColovesical Fistula: Shou...,3,126,Ann_Coloproctol_2015_Apr_30_31(2)_57-62.txt
5.31.2.41,...he Korean Society of Coloproctology 10.3393/ac.2015.31.2.41EditorialAdenoma Detection Rate in Patien...,3,126,Ann_Coloproctol_2015_Apr_30_31(2)_41-42.txt
5.31.2.43,...he Korean Society of Coloproctology 10.3393/ac.2015.31.2.43EditorialThe Wind of Change: Uncomplicate...,3,126,Ann_Coloproctol_2015_Apr_30_31(2)_43-44.txt
5.31.2.45,...he Korean Society of Coloproctology 10.3393/ac.2015.31.2.45EditorialDifferent Strategies for Treatin...,3,126,Ann_Coloproctol_2015_Apr_30_31(2)_45.txt
5.31.2.74,...he Korean Society of Coloproctology 10.3393/ac.2015.31.2.74Case ReportPeritoneal Metastatic Goblet-C...,3,126,Ann_Coloproctol_2015_Apr_30_31(2)_74-78.txt
5.31.2.52,...he Korean Society of Coloproctology 10.3393/ac.2015.31.2.52Original ArticleShort-term Intravenous An...,3,126,Ann_Coloproctol_2015_Apr_30_31(2)_52-56.txt
5.31.2.63,...he Korean Society of Coloproctology 10.3393/ac.2015.31.2.63Original ArticleInsertion of Totally Impl...,3,126,Ann_Coloproctol_2015_Apr_30_31(2)_63-67.txt
5.31.3.82,...he Korean Society of Coloproctology 10.3393/ac.2015.31.3.82EditorialStoma Creation After Surgery for...,3,126,Ann_Coloproctol_2015_Jun_30_31(3)_82.txt
6.32.3.90,...he Korean Society of Coloproctology 10.3393/ac.2016.32.3.90EditorialHave Any Changes in Pain Been No...,3,126,Ann_Coloproctol_2016_Jun_30_32(3)_90-91.txt
6.32.3.88,...he Korean Society of Coloproctology 10.3393/ac.2016.32.3.88EditorialMinimally Invasive Interval Appe...,3,126,Ann_Coloproctol_2016_Jun_30_32(3)_88-89.txt
5.31.3.110,...he Korean Society of Coloproctology 10.3393/ac.2015.31.3.110Case ReportIntestinal Malrotation With a...,3,126,Ann_Coloproctol_2015_Jun_30_31(3)_110-113.txt
5.31.3.84,...he Korean Society of Coloproctology 10.3393/ac.2015.31.3.84Original ArticleExpression of the Cancer ...,3,126,Ann_Coloproctol_2015_Jun_30_31(3)_84-91.txt
5.31.3.83,...he Korean Society of Coloproctology 10.3393/ac.2015.31.3.83EditorialAluminum Potassium Sulfate and T...,3,126,Ann_Coloproctol_2015_Jun_30_31(3)_83.txt
5.31.3.92,...he Korean Society of Coloproctology 10.3393/ac.2015.31.3.92Original ArticleERCC1 as a Predictive Mar...,3,126,Ann_Coloproctol_2015_Jun_30_31(3)_92-97.txt
5.31.3.106,...he Korean Society of Coloproctology 10.3393/ac.2015.31.3.106Case ReportInflammatory Fibroid Polyp in...,3,126,Ann_Coloproctol_2015_Jun_30_31(3)_106-109.txt
5.31.3.103,...he Korean Society of Coloproctology 10.3393/ac.2015.31.3.103Original ArticleComparison of Injection ...,3,126,Ann_Coloproctol_2015_Jun_30_31(3)_103-105.txt
5.31.3.79,...he Korean Society of Coloproctology 10.3393/ac.2015.31.3.79EditorialClinical Implication of Colorect...,3,126,Ann_Coloproctol_2015_Jun_30_31(3)_79-80.txt
5.31.4.144,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.144Original ArticleLong-term Outcomes and R...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_144-152.txt
5.31.4.123,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.123Original ArticleEfficacy and Safety of L...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_123-130.txt
5.31.4.157,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.157Case ReportColon Stricture After Ischemi...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_157-162.txt
5.31.4.165,"...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.165Letter to the EditorReply on \"What Is th...",3,126,Ann_Coloproctol_2015_Aug_31_31(4)_165-166.txt
5.31.4.115,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.115EditorialIs Low-Dose-Rate Endorectal Bra...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_115-116.txt
5.31.4.163,"...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.163Letter to the EditorCommentary on \"Inser...",3,126,Ann_Coloproctol_2015_Aug_31_31(4)_163-164.txt
5.31.4.167,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.167ErratumErratum Walma Marieke S. Kornmann...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_167.txt
5.31.1.23,"...n Coloproctol 2015;31(1):23-28, DOI 10.3393/ac.2015.31.1.23 as follows",5,418,Ann_Coloproctol_2015_Aug_31_31(4)_167.txt
5.31.4.131,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.131Original ArticleAssessment by Using a Wa...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_131-137.txt
5.31.4.117,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.117EditorialShould a Contrast Enema Be Perf...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_117-118.txt
5.31.4.119,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.119EditorialBiofeedback Therapy After Sphin...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_119-120.txt
5.31.4.138,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.138Original ArticleBiofeedback Therapy Befo...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_138-143.txt
5.31.4.121,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.121EditorialAnti-tumor Necrosis Factor Ther...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_121-122.txt
5.31.4.153,...he Korean Society of Coloproctology 10.3393/ac.2015.31.4.153Case ReportMultiple Glomus Tumors of the...,3,126,Ann_Coloproctol_2015_Aug_31_31(4)_153-156.txt
5.31.5.176,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.176Original ArticleThe Clinical Features an...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_176-181.txt
5.31.5.198,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.198Case ReportColonic Metastasis Presenting...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_198-201.txt
5.31.5.202,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.202Case ReportMetastatic Spermatic Cord Tum...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_202-204.txt
5.31.5.170,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.170EditorialSurveillance Colonoscopy After ...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_170-171.txt
5.31.5.182,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.182Original ArticleDetection of Polyps Afte...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_182-186.txt
5.31.5.187,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.187Original ArticleRisk Factors of a Pulmon...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_187-191.txt
5.31.5.192,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.192Original ArticlePredictive Factors to Di...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_192-197.txt
5.31.5.172,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.172EditorialVenous Thromboembolic Complicat...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_172-173.txt
5.31.5.174,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.174EditorialChange in the Diagnosis of Appe...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_174-175.txt
5.31.5.205,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.205ErratumErratum: Biofeedback Therapy Befo...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_205.txt
5.31.4.138,"...Coloproctol 2015;31(4):138-143, DOI 10.3393/ac.2015.31.4.138 as follows",5,421,Ann_Coloproctol_2015_Oct_31_31(5)_205.txt
5.31.5.169,...he Korean Society of Coloproctology 10.3393/ac.2015.31.5.169EditorialRisk of Repeat Surgery for Peri...,3,126,Ann_Coloproctol_2015_Oct_31_31(5)_169.txt
5.31.6.211,...he Korean Society of Coloproctology 10.3393/ac.2015.31.6.211EditorialEfforts to Prevent Surgical Sit...,3,126,Ann_Coloproctol_2015_Dec_31_31(6)_211-212.txt
5.31.6.235,...he Korean Society of Coloproctology 10.3393/ac.2015.31.6.235Original ArticleInfluence of Shorter Dur...,3,126,Ann_Coloproctol_2015_Dec_31_31(6)_235-242.txt
5.31.6.209,...he Korean Society of Coloproctology 10.3393/ac.2015.31.6.209EditorialObesity-Related Colorectal Canc...,3,126,Ann_Coloproctol_2015_Dec_31_31(6)_209-210.txt
5.31.6.246,...he Korean Society of Coloproctology 10.3393/ac.2015.31.6.246Case ReportNecrotizing Fasciitis Arising...,3,126,Ann_Coloproctol_2015_Dec_31_31(6)_246-250.txt
5.31.6.207,...he Korean Society of Coloproctology 10.3393/ac.2015.31.6.207EditorialTopical Effect of Glutamine for...,3,126,Ann_Coloproctol_2015_Dec_31_31(6)_207-208.txt
5.31.6.213,...he Korean Society of Coloproctology 10.3393/ac.2015.31.6.213Original ArticleEffects of a Glutamine E...,3,126,Ann_Coloproctol_2015_Dec_31_31(6)_213-221.txt
5.31.6.222,...he Korean Society of Coloproctology 10.3393/ac.2015.31.6.222Original ArticlePrognostic Significance ...,3,126,Ann_Coloproctol_2015_Dec_31_31(6)_222-227.txt
6.32.1.1,...he Korean Society of Coloproctology 10.3393/ac.2016.32.1.1EditorialExtralevator Abdominoperineal Res...,3,126,Ann_Coloproctol_2016_Feb_29_32(1)_1-2.txt
6.32.1.38,...he Korean Society of Coloproctology 10.3393/ac.2016.32.1.38Case ReportSpontaneous Transomental Herni...,3,126,Ann_Coloproctol_2016_Feb_29_32(1)_38-41.txt
6.32.1.20,...he Korean Society of Coloproctology 10.3393/ac.2016.32.1.20Original ArticleDistribution and Impact o...,3,126,Ann_Coloproctol_2016_Feb_29_32(1)_20-26.txt
6.32.1.3,...he Korean Society of Coloproctology 10.3393/ac.2016.32.1.3EditorialImpact of Visceral Fat Area in Co...,3,126,Ann_Coloproctol_2016_Feb_29_32(1)_3-4.txt
6.32.1.33,...he Korean Society of Coloproctology 10.3393/ac.2016.32.1.33Case ReportPrimary Retroperitoneal Mucino...,3,126,Ann_Coloproctol_2016_Feb_29_32(1)_33-37.txt
6.32.1.7,...he Korean Society of Coloproctology 10.3393/ac.2016.32.1.7ReviewVaginal Approaches Using Synthetic M...,3,126,Ann_Coloproctol_2016_Feb_29_32(1)_7-11.txt
6.32.1.12,...he Korean Society of Coloproctology 10.3393/ac.2016.32.1.12Original ArticleShort-term Outcomes of an...,3,126,Ann_Coloproctol_2016_Feb_29_32(1)_12-19.txt
6.32.1.27,...he Korean Society of Coloproctology 10.3393/ac.2016.32.1.27Original ArticleQuality of Life After a L...,3,126,Ann_Coloproctol_2016_Feb_29_32(1)_27-32.txt
6.32.1.5,...he Korean Society of Coloproctology 10.3393/ac.2016.32.1.5EditorialQuality of Life After a Low Anter...,3,126,Ann_Coloproctol_2016_Feb_29_32(1)_5-6.txt
6.32.2.45,...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.45EditorialImpact of Microsatellite Instabi...,3,126,Ann_Coloproctol_2016_Apr_30_32(2)_45-46.txt
6.32.2.58,...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.58Original ArticlePrognostic Impact of Micr...,3,126,Ann_Coloproctol_2016_Apr_30_32(2)_58-65.txt
6.32.2.73,...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.73Original ArticleSafety and Efficacy of Pe...,3,126,Ann_Coloproctol_2016_Apr_30_32(2)_73-78.txt
6.32.2.79,"...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.79Case ReportIncidentally Solitary, Synchro...",3,126,Ann_Coloproctol_2016_Apr_30_32(2)_79-82.txt
6.32.2.51,...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.51Original ArticleAssociation Between Expos...,3,126,Ann_Coloproctol_2016_Apr_30_32(2)_51-57.txt
6.32.2.66,...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.66Original ArticleEfficacy of Dose-Escalate...,3,126,Ann_Coloproctol_2016_Apr_30_32(2)_66-72.txt
6.32.2.47,...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.47EditorialDose-Escalated Radiotherapy for ...,3,126,Ann_Coloproctol_2016_Apr_30_32(2)_47-48.txt
6.32.2.43,...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.43EditorialExposure to Cigarette Smoke Cont...,3,126,Ann_Coloproctol_2016_Apr_30_32(2)_43-44.txt
6.32.6.205,...he Korean Society of Coloproctology 10.3393/ac.2016.32.6.205EditorialIntestinal Perforation: A Surge...,3,126,PMC5256246.txt
6.32.2.83,...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.83Case ReportXanthogranulomatous Appendicit...,3,126,Ann_Coloproctol_2016_Apr_30_32(2)_83-86.txt
6.32.2.49,...he Korean Society of Coloproctology 10.3393/ac.2016.32.2.49EditorialRole of Permacol Injection in th...,3,126,Ann_Coloproctol_2016_Apr_30_32(2)_49-50.txt
6.32.4.128,...he Korean Society of Coloproctology 10.3393/ac.2016.32.4.128Original ArticleEffect of Social Depriva...,3,126,Ann_Coloproctol_2016_Aug_31_32(4)_128-132.txt
6.32.4.133,...he Korean Society of Coloproctology 10.3393/ac.2016.32.4.133Original ArticleOutcomes and Risk Factor...,3,126,Ann_Coloproctol_2016_Aug_31_32(4)_133-138.txt
3.29.4.139,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.139Original ArticleInvestigation of Clinica...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_139-143.txt
3.29.4.155,...he Korean Society of Coloproctology 10.3393/ac.2013.29.4.155Original ArticleDiagnostic Accuracy of E...,3,126,Ann_Coloproctol_2013_Aug_29_29(4)_155-159.txt
4.30.1.35,...he Korean Society of Coloproctology 10.3393/ac.2014.30.1.35Original ArticleRectourethral Fistula: Sy...,3,126,Ann_Coloproctol_2014_Feb_28_30(1)_35-41.txt
4.30.2.57,...he Korean Society of Coloproctology 10.3393/ac.2014.30.2.57EditorialInvasion and Metastasis in the V...,3,126,Ann_Coloproctol_2014_Apr_25_30(2)_57-58.txt
4.30.5.228,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.228Original ArticlePrompt Management Is Mos...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_228-231.txt
4.30.5.232,...he Korean Society of Coloproctology 10.3393/ac.2014.30.5.232Case ReportMüllerian Adenosarcoma Arisin...,3,126,Ann_Coloproctol_2014_Oct_28_30(5)_232-236.txt
5.31.3.98,...he Korean Society of Coloproctology 10.3393/ac.2015.31.3.98Original ArticleMultivariate Analysis of ...,3,126,Ann_Coloproctol_2015_Jun_30_31(3)_98-102.txt
5.31.3.81,...he Korean Society of Coloproctology 10.3393/ac.2015.31.3.81EditorialERCC1 and the Prognosis for Pati...,3,126,Ann_Coloproctol_2015_Jun_30_31(3)_81.txt
5.31.6.228,...he Korean Society of Coloproctology 10.3393/ac.2015.31.6.228Original ArticleAge Over 80 is a Possibl...,3,126,Ann_Coloproctol_2015_Dec_31_31(6)_228-234.txt
5.31.6.243,...he Korean Society of Coloproctology 10.3393/ac.2015.31.6.243Case ReportPilonidal Abscess Associated ...,3,126,Ann_Coloproctol_2015_Dec_31_31(6)_243-245.txt
6.32.4.139,...he Korean Society of Coloproctology 10.3393/ac.2016.32.4.139Original ArticleOutcome of Colorectal Su...,3,126,Ann_Coloproctol_2016_Aug_31_32(4)_139-143.txt
6.32.4.150,...he Korean Society of Coloproctology 10.3393/ac.2016.32.4.150Case ReportEfficacy of Immunohistochemic...,3,126,Ann_Coloproctol_2016_Aug_31_32(4)_150-155.txt
6.32.4.144,...he Korean Society of Coloproctology 10.3393/ac.2016.32.4.144Original ArticlePurse-String Versus Line...,3,126,Ann_Coloproctol_2016_Aug_31_32(4)_144-149.txt
6.32.4.123,...he Korean Society of Coloproctology 10.3393/ac.2016.32.4.123EditorialIs A Mode of Presentation of Co...,3,126,Ann_Coloproctol_2016_Aug_31_32(4)_123.txt
6.32.4.156,...he Korean Society of Coloproctology 10.3393/ac.2016.32.4.156Case ReportBlack Anal Canal: Acute Necro...,3,126,Ann_Coloproctol_2016_Aug_31_32(4)_156-158.txt
6.32.4.124,...he Korean Society of Coloproctology 10.3393/ac.2016.32.4.124EditorialEmergent Colorectal Surgery: Wh...,3,126,Ann_Coloproctol_2016_Aug_31_32(4)_124-125.txt
6.32.4.126,...he Korean Society of Coloproctology 10.3393/ac.2016.32.4.126EditorialColorectal Surgery in Elderly P...,3,126,Ann_Coloproctol_2016_Aug_31_32(4)_126-127.txt
6.32.3.87,...he Korean Society of Coloproctology 10.3393/ac.2016.32.3.87EditorialColorectal Liver Metastases: A N...,3,126,Ann_Coloproctol_2016_Jun_30_32(3)_87.txt
6.32.5.190,...he Korean Society of Coloproctology 10.3393/ac.2016.32.5.190Case ReportSynchronous Primary Anorectal...,3,126,Ann_Coloproctol_2016_Oct_31_32(5)_190-194.txt
6.32.5.160,...he Korean Society of Coloproctology 10.3393/ac.2016.32.5.160EditorialHow Can We Ameliorate the Role ...,3,126,Ann_Coloproctol_2016_Oct_31_32(5)_160.txt
6.32.5.170,"...he Korean Society of Coloproctology 10.3393/ac.2016.32.5.170Original ArticleAnismus, Physiology, Rad...",3,126,Ann_Coloproctol_2016_Oct_31_32(5)_170-174.txt
6.32.5.175,...he Korean Society of Coloproctology 10.3393/ac.2016.32.5.175Original ArticleThe Outcomes of Manageme...,3,126,Ann_Coloproctol_2016_Oct_31_32(5)_175-183.txt
6.32.5.184,...he Korean Society of Coloproctology 10.3393/ac.2016.32.5.184Original ArticleTransmissibility of the ...,3,126,Ann_Coloproctol_2016_Oct_31_32(5)_184-189.txt
6.32.5.159,...he Korean Society of Coloproctology 10.3393/ac.2016.32.5.159EditorialCurrent Situation on the Diagno...,3,126,Ann_Coloproctol_2016_Oct_31_32(5)_159.txt
6.32.5.195,...he Korean Society of Coloproctology 10.3393/ac.2016.32.5.195Case ReportMajor Pelvic Bleeding Followi...,3,126,Ann_Coloproctol_2016_Oct_31_32(5)_195-198.txt
6.32.5.161,...he Korean Society of Coloproctology 10.3393/ac.2016.32.5.161Original ArticleUse of a Comprehensive G...,3,126,Ann_Coloproctol_2016_Oct_31_32(5)_161-169.txt
6.32.5.199,...he Korean Society of Coloproctology 10.3393/ac.2016.32.5.199ErratumErratum: Author Name Correction: ...,3,126,Ann_Coloproctol_2016_Oct_31_32(5)_199.txt
6.32.4.139,https://doi.org/10.3393/ac.2016.32.4.13,7,31,Ann_Coloproctol_2016_Oct_31_32(5)_199.txt
6.32.6.206,...he Korean Society of Coloproctology 10.3393/ac.2016.32.6.206EditorialWhat is the Difference Between ...,3,126,PMC5256248.txt
6.32.6.239,...he Korean Society of Coloproctology 10.3393/ac.2016.32.6.239Case ReportColonic Perforation Secondary...,3,126,PMC5256251.txt
6.32.6.201,...he Korean Society of Coloproctology 10.3393/ac.2016.32.6.201EditorialImpairment of Immunonutritional...,3,126,PMC5256245.txt
6.32.6.221,...he Korean Society of Coloproctology 10.3393/ac.2016.32.6.221Original ArticlePredictors of Morbidity ...,3,126,PMC5256250.txt
6.32.6.228,...he Korean Society of Coloproctology 10.3393/ac.2016.32.6.228Original ArticleManagement of Colonic Di...,3,126,PMC5256252.txt
6.32.6.234,"...he Korean Society of Coloproctology 10.3393/ac.2016.32.6.234Case ReportPneumoretroperitoneum, Pneumo...",3,126,PMC5256253.txt
6.32.6.203,...he Korean Society of Coloproctology 10.3393/ac.2016.32.6.203EditorialComparison of a Subtotal Colect...,3,126,PMC5256254.txt
6.32.6.215,...he Korean Society of Coloproctology 10.3393/ac.2016.32.6.215Original ArticleObstructive Left Colon C...,3,126,PMC5256247.txt
1.23.3.379,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.379Case ReportA Case of Myxoid Dermatofibro...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_379-381.txt
1.23.3.348,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.348Case ReportSuccessful Treatment of Cutan...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_348-351.txt
1.23.3.386,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.386Case ReportChildhood Granulomatous Perio...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_386-388.txt
1.23.3.405,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.405Case ReportBasal Cell Carcinoma on the P...,3,152,Ann_Dermatol_2011_Aug_18_23(3)_405-408.txt
1.23.3.338,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.338Case ReportSubcutaneous Myxoid and Round...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_338-341.txt
1.23.3.412,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.412Case ReportA Case of Cutaneous Side Effe...,3,152,Ann_Dermatol_2011_Aug_18_23(3)_412-414.txt
1.23.3.288,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.288Original ArticlePrevalence and Factors A...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_288-292.txt
1.23.3.276,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.276Original ArticleSubclinical Infiltration...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_276-281.txt
1.23.3.396,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.396Case ReportA Sporadic Case of Mal de Mel...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_396-399.txt
1.23.3.299,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.299Original ArticleThe Immunohistochemical ...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_299-303.txt
1.23.3.389,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.389Case ReportMultiple Nevus Sebaceous Occu...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_389-391.txt
1.23.3.400,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.400Case ReportAcral Lentiginous Melanoma De...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_400-404.txt
1.23.3.304,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.304Original ArticleIdentification of Dermat...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_304-312.txt
1.23.3.392,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.392Case ReportA Case of Cutaneous Bronchoge...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_392-395.txt
1.23.3.321,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.321Original ArticleEpidemiologic Study of M...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_321-328.txt
1.23.3.313,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.313Original ArticleExpression of Pro-inflam...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_313-320.txt
1.23.3.415,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.415Letter to the EditorIsolated Epidermolyt...,3,152,Ann_Dermatol_2011_Aug_18_23(3)_415-416.txt
1.23.3.342,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.342Case ReportParry-Romberg Syndrome with E...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_342-347.txt
1.23.3.409,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.409Case ReportErythematous Granuloma Annula...,3,152,Ann_Dermatol_2011_Aug_18_23(3)_409-411.txt
1.23.3.382,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.382Case ReportNeonatal Erythema Multiforme:...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_382-385.txt
1.23.3.293,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.293Original ArticleA Pilot Study of Q-switc...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_293-298.txt
1.23.3.352,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.352Case ReportA Case of Atrophoderma of Pas...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_352-356.txt
1.23.3.375,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.375Case ReportAn Unusual Case of Carcinoma ...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_375-378.txt
1.23.3.329,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.329Original ArticleSubcutaneous Panniculiti...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_329-337.txt
1.23.3.282,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.282Original ArticleDoes Immunotherapy of Vi...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_282-287.txt
1.23.3.265,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.265Review ArticleDermatoses of Pregnancy - ...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_265-275.txt
1.23.3.362,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.362Case ReportA Case of Assisted Reproducti...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_362-364.txt
1.23.3.369,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.369Case ReportChromoblastomycosis Caused by...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_369-374.txt
1.23.3.365,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.365Case ReportBlastomycosis-like Pyoderma w...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_365-368.txt
1.23.3.357,...ciety for Investigative Dermatology 10.5021/ad.2011.23.3.357Case ReportTreatment of Keratoacanthoma ...,3,152,Ann_Dermatol_2011_Aug_6_23(3)_357-361.txt
6.28.4.509,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.509Brief ReportScar Sarcoidosis Induced by ...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_509-510.txt
6.28.4.503,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.503Brief ReportHomozygous Deletion Mutation...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_503-505.txt
6.28.6.753,https://doi.org/10.5021/ad.2016.28.6.75,7,31,PMC5318521.txt
1.23.4.544,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.544Case ReportSibutramine (Reductil®)-Induc...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_544-547.txt
1.23.4.490,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.490Case ReportMilia-like Idiopathic Calcino...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_490-492.txt
1.23.4.481,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.481Original ArticleTreatment of Striae Dist...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_481-489.txt
1.23.4.554,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.554Letter to the EditorGianotti-Crosti Synd...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_554-555.txt
1.23.4.468,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.468Original ArticleIL-31 Serum Protein and ...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_468-473.txt
1.23.4.539,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.539Case ReportCongenital and Multiple Hobna...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_539-543.txt
1.23.4.551,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.551Case ReportSturge-Weber Syndrome Chen Li...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_551-553.txt
1.23.4.548,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.548Case ReportAnnular Plaques on the Tongue...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_548-550.txt
1.23.4.474,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.474Original ArticleNarrowband Ultraviolet B...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_474-480.txt
1.23.4.497,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.497Case ReportWells' Syndrome Associated wi...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_497-500.txt
1.23.4.504,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.504Case ReportTreatment of Disseminated Cla...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_504-507.txt
1.23.4.529,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.529Case ReportCD20 Positive T Cell Lymphoma...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_529-535.txt
1.23.4.523,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.523Case ReportPersistent Pemphigus Vulgaris...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_523-525.txt
1.23.4.439,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.439Original ArticleRetinoid Induces the Deg...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_439-447.txt
1.23.4.455,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.455Original ArticleHair Shaft Damage from H...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_455-462.txt
1.23.4.463,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.463Original ArticleSecond Intention Healing...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_463-467.txt
1.23.4.536,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.536Case ReportSquamous Cell Carcinoma Devel...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_536-538.txt
1.23.4.432,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.432Original ArticleCausality Assessment of ...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_432-438.txt
1.23.4.501,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.501Case ReportNicolau Syndrome in Patient F...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_501-503.txt
1.23.4.493,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.493Case ReportBowenoid Papulosis of the Vul...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_493-496.txt
1.23.4.526,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.526Case ReportBlack Hairy Tongue Associated...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_526-528.txt
1.23.4.448,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.448Original ArticleSkin Characteristics aft...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_448-454.txt
1.23.4.519,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.519Case ReportApocrine Carcinoma of the Gro...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_519-522.txt
1.23.4.417,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.417Original ArticleA Clinical Study of 35 C...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_417-423.txt
1.23.4.515,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.515Case ReportPrimary Localized Cutaneous N...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_515-518.txt
1.23.4.512,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.512Case ReportKissing Nevus of the Penis Yu...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_512-514.txt
1.23.4.508,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.508Case ReportBenign Cephalic Histiocytosis...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_508-511.txt
1.23.4.424,...ciety for Investigative Dermatology 10.5021/ad.2011.23.4.424Original ArticleCan Platelet-rich Plasma...,3,152,Ann_Dermatol_2011_Nov_3_23(4)_424-431.txt
2.24.1.101,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.101Letter to the EditorSolitary Neurofibrom...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_101-102.txt
2.24.1.94,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.94Short ReportEffects of Murine Dermal Cell...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_94-98.txt
2.24.1.32,"...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.32Original ArticleThe Prevalence, Genotype ...",3,152,Ann_Dermatol_2012_Feb_2_24(1)_32-38.txt
2.24.1.77,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.77Case ReportMerkel Cell Carcinoma Concurre...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_77-80.txt
2.24.1.70,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.70Case ReportDelayed Diagnosis of Scrofulod...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_70-73.txt
2.24.1.22,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.22Original ArticleA Clinical Study of Cutan...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_22-25.txt
2.24.1.45,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.45Original ArticleUsefulness of Enzyme-link...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_45-55.txt
2.24.1.66,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.66Case ReportIntravenous Immunoglobulin Tre...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_66-69.txt
2.24.1.56,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.56Original ArticleThe Effect of Photodynami...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_56-60.txt
2.24.1.61,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.61Original ArticleAssociation between IL17A...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_61-65.txt
2.24.1.39,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.39Original ArticleInhibitory Effect of Vita...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_39-44.txt
2.24.1.7,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.7Original ArticleUtility of Dermoscopy befo...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_7-10.txt
2.24.1.1,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.1Review ArticleTopical Hypopigmenting Agent...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_1-6.txt
2.24.1.74,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.74Case ReportCutaneous Sarcoidosis Clinical...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_74-76.txt
2.24.1.99,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.99Letter to the EditorEczema Confined to Be...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_99-100.txt
2.24.1.103,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.103Letter to the EditorClinicopathologic Ma...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_103-106.txt
2.24.1.26,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.26Original ArticleEffect of IGF-I on Hair G...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_26-31.txt
2.24.1.87,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.87Case ReportLichen Striatus Occurring afte...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_87-89.txt
2.24.1.90,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.90Short ReportA Simple Assay Method for Mel...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_90-93.txt
2.24.1.84,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.84Case ReportAn Acquired Anemic Patch Devel...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_84-86.txt
2.24.1.107,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.107Letter to the EditorAcute Vesico-Bullous...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_107-108.txt
2.24.1.109,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.109Letter to the EditorIs Spontaneous Disap...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_109-111.txt
2.24.1.16,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.16Original ArticleCedrol Enhances Extracell...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_16-21.txt
2.24.1.81,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.81Case ReportCould a Growth Spurt Cause Lin...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_81-83.txt
2.24.1.112,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.112Letter to the EditorNumerous Mucin Nodul...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_112-114.txt
2.24.1.11,...ciety for Investigative Dermatology 10.5021/ad.2012.24.1.11Original ArticleAnalysis of Cardiovascula...,3,152,Ann_Dermatol_2012_Feb_2_24(1)_11-15.txt
2.24.2.181,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.181Original ArticleThe Effect of Adipose-De...,3,164,Ann_Dermatol_2012_May_26_24(2)_181-188.txt
2.24.2.175,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.175Original ArticleOnychomycosis Due to Non...,3,164,Ann_Dermatol_2012_May_26_24(2)_175-180.txt
2.24.2.168,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.168Original ArticleChanges in Transepiderma...,3,164,Ann_Dermatol_2012_May_26_24(2)_168-174.txt
2.24.2.235,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.235Letter to the EditorA Case of Blastic Pl...,3,164,Ann_Dermatol_2012_May_26_24(2)_235-237.txt
2.24.2.240,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.240Letter to the EditorProximal and Lateral...,3,164,Ann_Dermatol_2012_May_26_24(2)_240-241.txt
2.24.2.238,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.238Letter to the EditorNail Change after Ch...,3,164,Ann_Dermatol_2012_May_26_24(2)_238-239.txt
2.24.2.189,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.189Original ArticleEffect of Probiotics on ...,3,164,Ann_Dermatol_2012_May_26_24(2)_189-193.txt
2.24.2.242,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.242RetractionRetraction: Basal Cell Nevus S...,3,164,Ann_Dermatol_2012_May_26_24(2)_242.txt
2.24.2.162,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.162Original ArticleEfficacy and Safety of 1...,3,164,Ann_Dermatol_2012_May_26_24(2)_162-167.txt
2.24.2.194,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.194Original ArticleThe Diagnostic Accuracy ...,3,164,Ann_Dermatol_2012_May_26_24(2)_194-199.txt
2.24.2.151,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.151Original ArticleInduction of Melanogenes...,3,164,Ann_Dermatol_2012_May_26_24(2)_151-157.txt
2.24.2.203,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.203Case ReportGranular Parakeratosis of Ecc...,3,164,Ann_Dermatol_2012_May_26_24(2)_203-205.txt
2.24.2.225,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.225Letter to the EditorSimultaneous Involve...,3,164,Ann_Dermatol_2012_May_26_24(2)_225-227.txt
2.24.2.230,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.230Letter to the EditorErythema Multiforme ...,3,164,Ann_Dermatol_2012_May_26_24(2)_230-232.txt
2.24.2.233,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.233Letter to the EditorEtanercept in the Tr...,3,164,Ann_Dermatol_2012_May_26_24(2)_233-234.txt
2.24.2.223,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.223Letter to the EditorRadiation Recall Der...,3,164,Ann_Dermatol_2012_May_26_24(2)_223-224.txt
2.24.2.200,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.200Case ReportParoxysmal Supraventricular T...,3,164,Ann_Dermatol_2012_May_26_24(2)_200-202.txt
2.24.2.228,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.228Letter to the EditorThe Diagnostic Signi...,3,164,Ann_Dermatol_2012_May_26_24(2)_228-229.txt
2.24.2.158,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.158Original ArticleCardiff Acne Disability ...,3,164,Ann_Dermatol_2012_May_26_24(2)_158-161.txt
2.24.2.206,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.206Case ReportUnilateral Nevoid Telangiecta...,3,164,Ann_Dermatol_2012_May_26_24(2)_206-208.txt
2.24.2.144,"...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.144Original ArticleA Randomized, Open-Label...",3,164,Ann_Dermatol_2012_May_26_24(2)_144-150.txt
2.24.2.214,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.214Case ReportErythromelalgia and Livedo Re...,3,164,Ann_Dermatol_2012_May_26_24(2)_214-217.txt
2.24.2.220,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.220Letter to the EditorSolitary Cutaneous M...,3,164,Ann_Dermatol_2012_May_26_24(2)_220-222.txt
2.24.2.209,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.209Case ReportOnychomycosis Caused by Scopu...,3,164,Ann_Dermatol_2012_May_26_24(2)_209-213.txt
2.24.2.218,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.218Letter to the EditorAcanthosis Nigricans...,3,164,Ann_Dermatol_2012_May_26_24(2)_218-219.txt
2.24.2.136,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.136Original ArticleParacrine Effects of Adi...,3,164,Ann_Dermatol_2012_May_26_24(2)_136-143.txt
2.24.2.115,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.115Review ArticleRole of Keratinocytes in t...,3,164,Ann_Dermatol_2012_May_26_24(2)_115-125.txt
2.24.2.126,...ciety for Investigative Dermatology 10.5021/ad.2012.24.2.126Review ArticleCathelicidin LL-37: An Ant...,3,164,Ann_Dermatol_2012_May_26_24(2)_126-135.txt
2.24.3.348,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.348Case ReportType B Pigmentary Demarcation...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_348-350.txt
2.24.3.380,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.380Letter to the EditorSuccessful Treatment...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_380-382.txt
2.24.3.373,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.373Letter to the EditorTopical Diphencypron...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_373-375.txt
2.24.3.306,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.306Original ArticleClinical Experience in t...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_306-310.txt
2.24.3.253,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.253Review ArticleLong Term Treatment Concep...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_253-260.txt
2.24.3.355,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.355Letter to the EditorDelayed Granulomatou...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_355-357.txt
2.24.3.287,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.287Original ArticleMolecular Phylogenetics ...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_287-294.txt
2.24.3.366,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.366Letter to the EditorFigurate Paraneoplas...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_366-367.txt
2.24.3.360,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.360Letter to the EditorPityriasis Rosea-Lik...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_360-362.txt
2.24.3.280,"...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.280Original ArticleAn Open-Label, Split-Fac...",3,164,Ann_Dermatol_2012_Aug_25_24(3)_280-286.txt
2.24.3.368,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.368Letter to the EditorDiagnosis of Variant...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_368-369.txt
2.24.3.261,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.261Original ArticleEpigenetic Modulation of...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_261-266.txt
2.24.3.274,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.274Original ArticleA Survey of the Awarenes...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_274-279.txt
2.24.3.267,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.267Original ArticleIntense Pulsed Light and...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_267-273.txt
2.24.3.363,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.363Letter to the EditorExtensive Pigmented ...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_363-365.txt
2.24.3.358,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.358Letter to the EditorA Rare Reason for Uv...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_358-359.txt
2.24.3.351,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.351Case ReportTwo Cases of Thrombosis of th...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_351-354.txt
2.24.3.295,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.295Original ArticleThe Efficacy and Safety ...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_295-305.txt
2.24.3.376,"...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.376Letter to the EditorComment on \"Pseudopa...",3,164,Ann_Dermatol_2012_Aug_25_24(3)_376-379.txt
2.24.3.243,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.243Review ArticleCharacteristics of Androge...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_243-252.txt
2.24.3.370,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.370Letter to the EditorEfficacy of Finaster...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_370-372.txt
2.24.3.311,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.311Original ArticleQuality of Life Assessme...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_311-318.txt
2.24.3.345,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.345Case ReportPityriasis Versicolor on Peni...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_345-347.txt
2.24.3.337,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.337Case ReportCardiac Myxoma Diagnosed by S...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_337-340.txt
2.24.3.341,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.341Case ReportSuccessful Treatment of Alope...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_341-344.txt
2.24.3.319,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.319Original ArticleClinical Features of Sys...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_319-323.txt
2.24.3.324,...ciety for Investigative Dermatology 10.5021/ad.2012.24.3.324Original ArticleEffect of Spa Spring Wat...,3,164,Ann_Dermatol_2012_Aug_25_24(3)_324-336.txt
2.24.4.480,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.480Letter to the EditorAdult Onset of Nevus...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_480-481.txt
2.24.4.478,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.478Letter to the EditorMultiple Bowen's Dis...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_478-480.txt
2.24.4.476,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.476Letter to the EditorEncephalocraniocutan...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_476-478.txt
2.24.4.398,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.398Original ArticleInterleukin-17 and Inter...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_398-405.txt
2.24.4.474,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.474Letter to the EditorAn Unusual Case of K...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_474-475.txt
2.24.4.383,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.383Review ArticleInflammatory Nodules of th...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_383-392.txt
2.24.4.393,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.393Original ArticleAcne Inversa: Evaluating...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_393-397.txt
2.24.4.484,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.484Letter to the EditorDelayed Diagnosis of...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_484-485.txt
2.24.4.488,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.488Letter to the EditorA Case of Squamous C...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_488-490.txt
2.24.4.459,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.459Case ReportFingernail Onychomycosis Due ...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_459-463.txt
2.24.4.406,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.406Original ArticleEffect of the Pruritus o...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_406-412.txt
2.24.4.420,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.420Original ArticleClinical Features and Et...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_420-425.txt
2.24.4.468,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.468Case ReportDermoscopy: A Useful Tool for...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_468-471.txt
2.24.4.426,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.426Original ArticleRelation of Nickel Aller...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_426-429.txt
2.24.4.482,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.482Letter to the EditorInduction of Vitilig...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_482-484.txt
2.24.4.464,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.464Case ReportA Wedge-Shaped Anterior Hairl...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_464-467.txt
2.24.4.486,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.486Letter to the EditorNodular Basal Cell C...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_486-487.txt
2.24.4.455,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.455Case ReportThree Cases of 'Morsicatio La...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_455-458.txt
2.24.4.472,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.472Letter to the EditorAeroallergen Prick S...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_472-474.txt
2.24.4.413,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.413Original ArticleAnalysis of Colonization...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_413-419.txt
2.24.4.438,"...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.438Original ArticleThe Clinical Efficacy, S...",3,164,Ann_Dermatol_2012_Nov_8_24(4)_438-443.txt
2.24.4.430,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.430Original ArticleThe Quality of Life and ...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_430-437.txt
2.24.4.491,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.491Letter to the EditorTripartite Motif-Con...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_491-493.txt
2.24.4.444,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.444Original ArticleSkin Characteristics in ...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_444-452.txt
2.24.4.490,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.490Letter to the EditorHydroxychloroquine-I...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_490-491.txt
2.24.4.494,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.494ErratumErratum: Figurate Paraneoplastic ...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_494.txt
2.24.3.366,...tol 24(3) 366~367 http://dx.doi.org/10.5021/ad.2012.24.3.36,5,160,Ann_Dermatol_2012_Nov_8_24(4)_494.txt
2.24.4.453,...ciety for Investigative Dermatology 10.5021/ad.2012.24.4.453Case ReportAcute Urticaria Associated wi...,3,164,Ann_Dermatol_2012_Nov_8_24(4)_453-454.txt
3.25.1.131,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.131Letter to the EditorBullous Annular Eryt...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_131-132.txt
3.25.1.120,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.120Letter to the EditorEosinophilic Pustula...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_120-122.txt
3.25.1.104,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.104Letter to the EditorUltraviolet A1 Photo...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_104-107.txt
3.25.1.61,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.61Original ArticleThe Clinical Significance...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_61-66.txt
3.25.1.73,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.73Original ArticleMolecular Biological Iden...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_73-79.txt
3.25.1.17,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.17Original ArticleThe Clinical Efficacy of ...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_17-22.txt
3.25.1.118,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.118Letter to the EditorHenoch-Schönlein Pur...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_118-120.txt
3.25.1.92,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.92Case ReportEccrine Poroma on the Postauri...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_92-94.txt
3.25.1.124,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.124Letter to the EditorLocalized Involution...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_124-126.txt
3.25.1.129,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.129Letter to the EditorIntractable Tufted A...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_129-130.txt
3.25.1.84,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.84Case ReportAn Unusual Association between...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_84-87.txt
3.25.1.88,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.88Case ReportExtramammary Paget's Disease o...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_88-91.txt
3.25.1.95,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.95Case ReportA Novel Frameshift Mutation of...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_95-98.txt
3.25.1.122,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.122Letter to the EditorMyopericytoma of the...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_122-124.txt
3.25.1.126,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.126Letter to the EditorStamp-Form Contact P...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_126-128.txt
3.25.1.12,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.12Original ArticleCombination Therapy with ...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_12-16.txt
3.25.1.67,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.67Original ArticleReliability on Intra-Labo...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_67-72.txt
3.25.1.99,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.99Case ReportCutaneous Metastasis of Gallbl...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_99-103.txt
3.25.1.23,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.23Original ArticleThe Short Stature in Atop...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_23-27.txt
3.25.1.1,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.1Original ArticleSkin Findings in Newborns ...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_1-4.txt
3.25.1.107,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.107Letter to the EditorCutaneous Metastasis...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_107-109.txt
3.25.1.54,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.54Original ArticleThe Ethnic Differences of...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_54-60.txt
3.25.1.116,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.116Letter to the EditorEruptive Penile Syri...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_116-118.txt
3.25.1.80,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.80Case ReportNew World Cutaneous Leishmania...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_80-83.txt
3.25.1.133,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.133Letter to the EditorCongenital Malalignm...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_133-134.txt
3.25.1.111,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.111Letter to the EditorMedical Concern for ...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_111-112.txt
3.25.1.113,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.113Letter to the EditorA Rapidly Regressed ...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_113-114.txt
3.25.1.114,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.114Letter to the EditorRefractory Atopic De...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_114-116.txt
3.25.1.109,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.109Letter to the EditorRare Manifestation o...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_109-110.txt
3.25.1.28,"...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.28Original ArticleClinical, Quality of Life...",3,164,Ann_Dermatol_2013_Feb_14_25(1)_28-35.txt
3.25.1.5,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.5Original ArticlePreventive Effects of Mult...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_5-11.txt
3.25.1.36,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.36Original ArticleComparison of Gene Expres...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_36-45.txt
3.25.1.46,...ciety for Investigative Dermatology 10.5021/ad.2013.25.1.46Original ArticleSafety Evaluation of Stam...,3,164,Ann_Dermatol_2013_Feb_14_25(1)_46-53.txt
3.25.2.163,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.163Original ArticleThe Effects of 830 nm Li...,3,164,Ann_Dermatol_2013_May_10_25(2)_163-167.txt
3.25.2.252,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.252Letter to the EditorSuccessful Treatment...,3,164,Ann_Dermatol_2013_May_10_25(2)_252-254.txt
3.25.2.226,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.226Case ReportTwo Cases of Vitiligo Develop...,3,164,Ann_Dermatol_2013_May_10_25(2)_226-228.txt
3.25.2.261,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.261Letter to the EditorNew Alternative Comb...,3,164,Ann_Dermatol_2013_May_10_25(2)_261-263.txt
3.25.2.135,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.135Review ArticleInsights into the Transfor...,3,164,Ann_Dermatol_2013_May_10_25(2)_135-144.txt
3.25.2.249,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.249Letter to the EditorSubcorneal Milia-Lik...,3,164,Ann_Dermatol_2013_May_10_25(2)_249-250.txt
3.25.2.145,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.145Original ArticleUp-Regulation of Cycloox...,3,164,Ann_Dermatol_2013_May_10_25(2)_145-151.txt
3.25.2.237,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.237Case ReportRapid Growing Superficial Cut...,3,164,Ann_Dermatol_2013_May_10_25(2)_237-241.txt
3.25.2.196,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.196Original ArticleFood Hypersensitivity in...,3,164,Ann_Dermatol_2013_May_10_25(2)_196-202.txt
3.25.2.152,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.152Original ArticleThe Fine Scratches of th...,3,164,Ann_Dermatol_2013_May_10_25(2)_152-155.txt
3.25.2.251,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.251Letter to the EditorMultiple Agminated A...,3,164,Ann_Dermatol_2013_May_10_25(2)_251-252.txt
3.25.2.173,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.173Original ArticlePotential Immunoinflamma...,3,164,Ann_Dermatol_2013_May_10_25(2)_173-180.txt
3.25.2.257,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.257Letter to the EditorSebaceous Hyperplasi...,3,164,Ann_Dermatol_2013_May_10_25(2)_257-258.txt
3.25.2.156,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.156Original ArticleEffectiveness of Convent...,3,164,Ann_Dermatol_2013_May_10_25(2)_156-162.txt
3.25.2.168,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.168Original ArticleA Pilot Study of 1% Pime...,3,164,Ann_Dermatol_2013_May_10_25(2)_168-172.txt
3.25.2.189,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.189Original ArticleLack of Association of P...,3,164,Ann_Dermatol_2013_May_10_25(2)_189-195.txt
3.25.2.247,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.247Letter to the EditorEccrine Poroma Clini...,3,164,Ann_Dermatol_2013_May_10_25(2)_247-248.txt
3.25.2.232,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.232Case ReportOnychomycosis Caused by Chaet...,3,164,Ann_Dermatol_2013_May_10_25(2)_232-236.txt
3.25.2.271,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.271Letter to the EditorEpoprostenol: Flushi...,3,164,Ann_Dermatol_2013_May_10_25(2)_271-272.txt
3.25.2.181,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.181Original ArticleThe Annual Changes of Cl...,3,164,Ann_Dermatol_2013_May_10_25(2)_181-188.txt
3.25.2.255,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.255Letter to the EditorSilver Woman and Sil...,3,164,Ann_Dermatol_2013_May_10_25(2)_255-256.txt
3.25.2.213,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.213Original ArticleExtramammary Paget Disea...,3,164,Ann_Dermatol_2013_May_10_25(2)_213-217.txt
3.25.2.208,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.208Original ArticleEccrine Angiomatous Hama...,3,164,Ann_Dermatol_2013_May_10_25(2)_208-212.txt
3.25.2.242,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.242Letter to the EditorA Long Term Case Ser...,3,164,Ann_Dermatol_2013_May_10_25(2)_242-245.txt
3.25.2.223,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.223Case ReportFamilial Colocalization of Li...,3,164,Ann_Dermatol_2013_May_10_25(2)_223-225.txt
3.25.2.266,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.266Letter to the EditorHigh Levels of Anti-...,3,164,Ann_Dermatol_2013_May_10_25(2)_266-268.txt
3.25.2.263,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.263Letter to the EditorSelective Elevation ...,3,164,Ann_Dermatol_2013_May_10_25(2)_263-265.txt
3.25.2.203,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.203Original ArticleMerkel Cell Polyomavirus...,3,164,Ann_Dermatol_2013_May_10_25(2)_203-207.txt
3.25.2.259,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.259Letter to the EditorLong-Term Follow-Up ...,3,164,Ann_Dermatol_2013_May_10_25(2)_259-260.txt
3.25.2.229,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.229Case ReportPsoriasis Induced by Trastuzu...,3,164,Ann_Dermatol_2013_May_10_25(2)_229-231.txt
3.25.2.245,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.245Letter to the EditorConglomerated Facial...,3,164,Ann_Dermatol_2013_May_10_25(2)_245-247.txt
3.25.2.218,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.218Original ArticleEfficacy and Safety of P...,3,164,Ann_Dermatol_2013_May_10_25(2)_218-222.txt
3.25.2.268,...ciety for Investigative Dermatology 10.5021/ad.2013.25.2.268Letter to the EditorCompletely Thrombose...,3,164,Ann_Dermatol_2013_May_10_25(2)_268-270.txt
3.25.3.382,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.382Letter to the EditorMedallion-Like Derma...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_382-384.txt
3.25.3.356,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.356Case ReportMetallic Discoloration on the...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_356-359.txt
3.25.3.278,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.278Original ArticlePrevalence and Risk Fact...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_278-284.txt
3.25.3.370,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.370Letter to the EditorThe Efficacy of Comp...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_370-373.txt
3.25.3.378,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.378Letter to the EditorLongitudinal Melanon...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_378-379.txt
5.27.1.1,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.1Review ArticleAbnormal B Lymphocyte Activa...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_1-9.txt
3.25.3.304,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.304Original ArticleEffects of Xanthium stra...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_304-309.txt
3.25.3.340,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.340Original ArticleDifferentiation of Benig...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_340-347.txt
3.25.3.396,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.396Letter to the EditorWoolly Hair Nevus In...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_396-397.txt
3.25.3.335,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.335Original ArticlePhotodynamic Therapy wit...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_335-339.txt
3.25.3.391,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.391Letter to the EditorPlasmocytoma-Induced...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_391-392.txt
3.25.3.373,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.373Letter to the EditorCarcinoma Erysipeloi...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_373-375.txt
3.25.3.400,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.400CorrigendumCorrigendum: The Effects of 8...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_400.txt
3.25.2.163,http://dx.doi.org/10.5021/ad.2013.25.2.16,7,33,Ann_Dermatol_2013_Aug_13_25(3)_400.txt
3.25.3.360,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.360Case ReportGeneralized Dowling-Degos Dis...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_360-364.txt
3.25.3.368,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.368Letter to the EditorSevere Refractory At...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_368-370.txt
3.25.3.292,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.292Original ArticleImprovement of Atopic De...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_292-297.txt
3.25.3.321,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.321Original ArticleAltered Levels of Sphing...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_321-326.txt
3.25.3.315,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.315Original ArticleA Novel Compound Rasatio...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_315-320.txt
3.25.3.385,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.385Letter to the EditorPrimary Dermal Melan...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_385-386.txt
3.25.3.387,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.387Letter to the EditorSuccessful Treatment...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_387-388.txt
3.25.3.365,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.365Case ReportAcquired Localized Hypertrich...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_365-367.txt
3.25.3.389,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.389Letter to the EditorHailey-Hailey Diseas...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_389-390.txt
3.25.3.327,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.327Original ArticleOnychomycosis in Childre...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_327-334.txt
3.25.3.348,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.348Case ReportA Case of Eccrine Porocarcino...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_348-351.txt
3.25.3.394,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.394Letter to the EditorThe Relation of Onyc...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_394-395.txt
3.25.3.273,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.273Original ArticleTotal Serum Oxidant/Anti...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_273-277.txt
3.25.3.285,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.285Original ArticleDose-Dependent Effects o...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_285-291.txt
3.25.3.298,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.298Original ArticleCoeliac Disease-Associat...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_298-303.txt
3.25.3.392,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.392Letter to the EditorCutaneous Septic Emb...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_392-394.txt
3.25.3.375,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.375Letter to the EditorGeneralized Idiopath...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_375-377.txt
3.25.3.398,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.398Letter to the EditorUnusual Manifestatio...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_398-399.txt
3.25.3.380,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.380Letter to the EditorAgminated Acquired M...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_380-382.txt
3.25.3.352,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.352Case ReportTouraine-Soulente-Golé Syndro...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_352-355.txt
3.25.3.310,...ciety for Investigative Dermatology 10.5021/ad.2013.25.3.310Original ArticleEvaluation of Expression...,3,164,Ann_Dermatol_2013_Aug_13_25(3)_310-314.txt
EC 3.1.1.3,"... The Lip1 protein belongs to triglyceride lipase (EC 3.1.1.3), which hydrolyzes the ester bond of tr...",39,735,Ann_Dermatol_2013_Aug_13_25(3)_310-314.txt
3.25.4.506,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.506Letter to the EditorPruritic Urticarial ...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_506-508.txt
3.25.4.531,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.531In MemoriamTo Memorize Late Emeritus Pro...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_531.txt
3.25.4.498,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.498Letter to the EditorElevated KAI1 Protei...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_498-500.txt
3.25.4.489,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.489Case ReportNew Onset Guttate Psoriasis F...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_489-492.txt
3.25.4.508,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.508Letter to the EditorA Novel Missense Mut...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_508-510.txt
3.25.4.471,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.471Original ArticleEarly Intervention with ...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_471-474.txt
3.25.4.502,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.502Letter to the EditorMinor Salivary Gland...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_502-504.txt
3.25.4.428,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.428Original ArticleClinical and Histologica...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_428-433.txt
3.25.4.401,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.401Original ArticleThe Pattern of Hair Dyei...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_401-404.txt
3.25.4.483,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.483Case ReportA Collodion Baby with Facial ...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_483-488.txt
3.25.4.518,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.518Letter to the EditorIncidental Focal Aca...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_518-520.txt
3.25.4.405,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.405Original ArticleAnalysis of Serum Zinc a...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_405-409.txt
3.25.4.504,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.504Letter to the EditorCetuximab Related Ey...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_504-505.txt
3.25.4.462,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.462Original ArticleTherapeutic Effects and ...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_462-470.txt
3.25.4.524,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.524Letter to the EditorGeneralized Schamber...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_524-525.txt
3.25.4.528,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.528Letter to the EditorTick Bite on Glans P...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_528-530.txt
3.25.4.522,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.522Letter to the EditorActivation Markers C...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_522-523.txt
3.25.4.434,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.434Original ArticleTopical Immunotherapy wi...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_434-439.txt
3.25.4.454,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.454Original ArticleComparison of the Psycho...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_454-461.txt
3.25.4.520,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.520Letter to the EditorRecurrent Milia-Like...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_520-522.txt
3.25.4.496,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.496Letter to the EditorPsoriatic Arthritis ...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_496-497.txt
3.25.4.526,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.526Letter to the EditorPlantar Keratoderma ...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_526-528.txt
3.25.4.440,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.440Original ArticleAn Observational Study o...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_440-444.txt
3.25.4.410,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.410Original ArticleStaphylococcus aureus Co...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_410-416.txt
3.25.4.423,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.423Original ArticleDecreased Expression of ...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_423-427.txt
3.25.4.475,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.475Case ReportKaposi Sarcoma in a Patient w...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_475-478.txt
3.25.4.515,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.515Letter to the EditorCD10 Expression in C...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_515-517.txt
3.25.4.479,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.479Case ReportExtensive Psoriasis Induced b...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_479-482.txt
3.25.4.445,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.445Original ArticleTreatment of Acne Scars ...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_445-453.txt
3.25.4.512,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.512Letter to the EditorCockarde (Target-Lik...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_512-514.txt
3.25.4.493,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.493Case ReportA Granulomatous Drug Eruption...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_493-495.txt
3.25.4.500,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.500Letter to the EditorLichenoid Drug Erupt...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_500-502.txt
3.25.4.511,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.511Letter to the EditorAn Effective Modalit...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_511-512.txt
3.25.4.417,...ciety for Investigative Dermatology 10.5021/ad.2013.25.4.417Original ArticlePhotodynamic Therapy wit...,3,164,Ann_Dermatol_2013_Nov_30_25(4)_417-422.txt
4.26.1.92,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.92Case ReportCutaneous Mycobacterium massil...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_92-95.txt
4.26.1.103,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.103Case ReportElastosis Perforans Serpigino...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_103-106.txt
4.26.1.125,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.125Letter to the EditorCoinfection with Her...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_125-126.txt
4.26.1.137,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.137Letter to the EditorMyocardial Infarctio...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_137-138.txt
4.26.1.127,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.127Letter to the EditorTick Bite Jeon Woo S...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_127-128.txt
4.26.1.139,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.139Letter to the EditorVitiligo Coexistent ...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_139-140.txt
4.26.1.88,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.88Original ArticleLack of Association betwe...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_88-91.txt
4.26.1.43,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.43Original ArticleEffects of Adapalene-Benz...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_43-52.txt
4.26.1.66,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.66Original ArticleAn Educational Program Th...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_66-72.txt
4.26.1.117,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.117Letter to the EditorGrover's Disease in ...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_117-118.txt
4.26.1.73,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.73Original ArticleA Case Series Study of Ei...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_73-78.txt
4.26.1.141,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.141Letter to the EditorProminent Alopetic L...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_141-143.txt
4.26.1.26,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.26Original ArticleEpidemiology and Clinical...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_26-34.txt
4.26.1.115,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.115Letter to the EditorNasal Sinus Tract As...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_115-116.txt
4.26.1.96,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.96Case ReportWarfarin-Induced Skin Necrosis...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_96-98.txt
4.26.1.53,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.53Original ArticleCombined Treatment of Mur...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_53-60.txt
4.26.1.113,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.113Letter to the EditorSolitary Granuloma A...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_113-114.txt
4.26.1.134,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.134Letter to the EditorThe Expression of In...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_134-137.txt
4.26.1.107,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.107Case ReportFour Cases of Successfully Tr...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_107-110.txt
4.26.1.1,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.1Original ArticleSynergistic Effect of Bone...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_1-10.txt
4.26.1.121,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.121Letter to the EditorCongenital Form of I...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_121-122.txt
4.26.1.111,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.111Letter to the EditorOne Mutation of the ...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_111-113.txt
4.26.1.35,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.35Original ArticleInduction of a Hardening ...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_35-42.txt
4.26.1.129,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.129Letter to the EditorBiological Effects o...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_129-132.txt
4.26.1.99,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.99Case ReportSubdermal Coagulation Treatmen...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_99-102.txt
4.26.1.119,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.119Letter to the EditorEpstein-Barr Virus-P...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_119-121.txt
4.26.1.123,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.123Letter to the EditorSuperficial Acral Fi...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_123-124.txt
4.26.1.79,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.79Original ArticleExpression of Sfrp2 Is In...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_79-87.txt
4.26.1.132,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.132Letter to the EditorLeukotrichia in Stab...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_132-134.txt
4.26.1.17,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.17Original ArticleSpectrophotometric Measur...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_17-25.txt
4.26.1.61,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.61Original ArticleClinical Course of Segmen...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_61-65.txt
4.26.1.11,...ciety for Investigative Dermatology 10.5021/ad.2014.26.1.11Original ArticleCigarette Smoke-Induced I...,3,164,Ann_Dermatol_2014_Feb_17_26(1)_11-16.txt
4.26.2.269,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.269Letter to the EditorAllergic Contact Der...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_269-270.txt
4.26.2.283,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.283Letter to the EditorAnetoderma Developin...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_283-285.txt
4.26.2.262,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.262Letter to the EditorIdiopathic Acquired ...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_262-263.txt
4.26.2.256,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.256Letter to the EditorExpression of Cold-I...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_256-258.txt
4.26.2.214,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.214Original ArticleDermoscopic Approach to ...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_214-220.txt
4.26.2.203,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.203Original ArticleImmunohistochemical Anal...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_203-208.txt
4.26.2.241,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.241Case ReportPhotodynamic Therapy for Bowe...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_241-245.txt
4.26.2.250,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.250Case ReportSolitary Congenital Erosion i...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_250-253.txt
4.26.2.280,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.280Letter to the EditorA Clinical Study of ...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_280-283.txt
4.26.2.246,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.246Case ReportAcute Generalized Exanthemato...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_246-249.txt
4.26.2.258,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.258Letter to the EditorPemphigus Vulgaris i...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_258-260.txt
4.26.2.267,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.267Letter to the EditorTinea Incognito Simu...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_267-269.txt
4.26.2.264,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.264Letter to the EditorPiebaldism with Neur...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_264-266.txt
4.26.2.162,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.162Original ArticleA Clinicopathologic Stud...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_162-171.txt
4.26.2.195,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.195Original ArticlePrognostic and Clinicopa...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_195-202.txt
4.26.2.286,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.286Letter to the Editor'Clues' for the Hist...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_286-288.txt
4.26.2.275,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.275Letter to the EditorLevels of Serum Solu...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_275-277.txt
4.26.2.184,"...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.184Original ArticleA Prospective, Long-Term...",3,164,Ann_Dermatol_2014_Apr_30_26(2)_184-188.txt
4.26.2.273,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.273Letter to the EditorDisseminated Cryptoc...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_273-275.txt
4.26.2.236,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.236Case ReportSoft Tissue Infection Caused ...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_236-240.txt
4.26.2.271,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.271Letter to the EditorPseudo-Clubbing Comp...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_271-273.txt
4.26.2.172,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.172Original ArticleIntralesional Methotrexa...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_172-176.txt
4.26.2.177,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.177Original ArticleLong-Term Survival Analy...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_177-183.txt
4.26.2.231,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.231Case ReportA Recurrent Angiosarcoma Isol...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_231-235.txt
4.26.2.221,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.221Original ArticleImmunomodulatory Effects...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_221-230.txt
4.26.2.189,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.189Original ArticleClinical Characteristics...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_189-194.txt
4.26.2.254,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.254Letter to the EditorForeign Body Granulo...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_254-255.txt
4.26.2.260,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.260Letter to the EditorA Rare Case of Annul...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_260-261.txt
4.26.2.278,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.278Letter to the EditorInfantile Perianal P...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_278-279.txt
4.26.2.209,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.209Original ArticleEffect of Adenosine on M...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_209-213.txt
4.26.2.156,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.156Original ArticlePilot Study of the Effic...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_156-161.txt
4.26.2.145,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.145Original ArticleCorrelations between Ant...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_145-149.txt
4.26.2.150,...ciety for Investigative Dermatology 10.5021/ad.2014.26.2.150Original ArticleEffect of Emollients Con...,3,164,Ann_Dermatol_2014_Apr_30_26(2)_150-155.txt
4.26.3.399,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.399Letter to the EditorAcute Generalized Ex...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_399-400.txt
4.26.3.308,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.308Original ArticleComparative Analysis of ...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_308-313.txt
4.26.3.395,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.395Case ReportSebaceous Carcinoma of the Su...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_395-398.txt
4.26.3.426,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.426Letter to the EditorComparative Study of...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_426-428.txt
4.26.3.381,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.381Case ReportA Case of Isolated Bowenoid P...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_381-384.txt
4.26.3.417,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.417Letter to the EditorDepressed Facial Sca...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_417-418.txt
4.26.3.296,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.296Original ArticleCalcitriol May Down-Regu...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_296-302.txt
4.26.3.401,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.401Letter to the EditorRegression of Melasm...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_401-402.txt
4.26.3.424,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.424Letter to the EditorGene Mutation Analys...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_424-425.txt
4.26.3.377,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.377Case ReportThe Reverse Nasolabial Flap w...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_377-380.txt
4.26.3.385,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.385Case ReportTwo Clinically Unusual Cases ...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_385-391.txt
4.26.3.332,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.332Original ArticleNotch Intracellular Doma...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_332-337.txt
4.26.3.289,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.289Original ArticleScalded Skin of Rat Trea...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_289-295.txt
4.26.3.407,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.407Letter to the EditorAuricular Composite ...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_407-408.txt
4.26.3.419,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.419Letter to the EditorSmall Cell Melanoma ...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_419-421.txt
4.26.3.392,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.392Case ReportNeuropathic Itch of the Back:...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_392-394.txt
4.26.3.409,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.409Letter to the EditorUpdated Diagnosis Cr...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_409-410.txt
4.26.3.314,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.314Original ArticleDifferences in the Known...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_314-320.txt
4.26.3.405,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.405Letter to the EditorMultiple Epidermal C...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_405-406.txt
4.26.3.411,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.411Letter to the EditorNeutrophilic Dermato...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_411-413.txt
4.26.3.338,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.338Original ArticleIdentification of Dermat...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_338-342.txt
4.26.3.303,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.303Original ArticleElevated Serum Levels of...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_303-307.txt
4.26.3.413,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.413Letter to the EditorNipple Eczema: A Dia...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_413-414.txt
4.26.3.343,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.343Original ArticleAssociation of CYP2C9 Ge...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_343-348.txt
4.26.3.357,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.357Original ArticleInvestigation of the Deg...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_357-362.txt
4.26.3.374,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.374Case ReportA Case of Acquired Idiopathic...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_374-376.txt
4.26.3.428,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.428Letter to the EditorIntramuscular Vascul...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_428-430.txt
4.26.3.349,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.349Original ArticleA Multicenter Collaborat...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_349-356.txt
4.26.3.421,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.421Letter to the EditorGene-Gene Interactio...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_421-423.txt
4.26.3.363,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.363Original ArticleThe Effect of Imiquimod ...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_363-373.txt
4.26.3.415,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.415Letter to the EditorTransient Filiform P...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_415-416.txt
4.26.3.321,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.321Original ArticleComparative Study of Pho...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_321-331.txt
4.26.3.403,...ciety for Investigative Dermatology 10.5021/ad.2014.26.3.403Letter to the EditorClear Cell Hidradeno...,3,164,Ann_Dermatol_2014_Jun_12_26(3)_403-404.txt
4.26.4.478,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.478Original ArticleScalp Dermatoscopic Find...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_478-484.txt
4.26.4.549,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.549Letter to the EditorA Case of Mucinous N...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_549-550.txt
4.26.4.510,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.510Case ReportMyxoid Cellular Neurothekeoma...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_510-513.txt
4.26.4.545,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.545Letter to the EditorLipomatosis of the N...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_545-546.txt
4.26.4.536,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.536Letter to the EditorClinical Significanc...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_536-538.txt
4.26.4.501,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.501Case ReportTwo Concurrent Facial Epiderm...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_501-504.txt
4.26.4.514,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.514Case ReportGreen Nail Syndrome Treated w...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_514-516.txt
4.26.4.505,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.505Case ReportThree Cases of Lichen Nitidus...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_505-509.txt
4.26.4.532,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.532Letter to the EditorImatinib Mesylate-In...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_532-533.txt
4.26.4.437,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.437Original ArticleClinical Availability of...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_437-446.txt
4.26.4.524,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.524Letter to the EditorBenzoin Spray: Cause...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_524-525.txt
4.26.4.526,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.526Letter to the EditorAutohemotherapy in C...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_526-527.txt
4.26.4.557,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.557CorrigendumCorrigendum: Comparative Anal...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_557.txt
4.26.3.308,http://dx.doi.org/10.5021/ad.2014.26.3.30,8,33,Ann_Dermatol_2014_Aug_31_26(4)_557.txt
4.26.4.522,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.522Letter to the EditorDecreased Serum Leve...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_522-523.txt
4.26.4.431,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.431Original ArticleBasal Cell Carcinoma-Mim...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_431-436.txt
4.26.4.469,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.469Original ArticlePossible Existence of Me...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_469-473.txt
4.26.4.552,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.552Letter to the EditorAn Unusual Presentat...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_552-554.txt
4.26.4.520,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.520Letter to the EditorEosinophilic Pustula...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_520-521.txt
4.26.4.491,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.491Original ArticleThe Efficacy of Intense ...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_491-495.txt
4.26.4.543,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.543Letter to the EditorBilateral Eyelid Con...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_543-544.txt
4.26.4.496,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.496Case ReportIntravascular Cytotoxic T-Cel...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_496-500.txt
4.26.4.539,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.539Letter to the EditorA Case of Multiple E...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_539-540.txt
4.26.4.457,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.457Original ArticleTurkish PASE: Turkish Ve...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_457-461.txt
4.26.4.528,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.528Letter to the EditorUse of Emollients in...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_528-531.txt
4.26.4.485,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.485Original ArticleComparison of Melanoma S...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_485-490.txt
4.26.4.534,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.534Letter to the EditorCutaneous Pili Migra...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_534-535.txt
4.26.4.462,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.462Original ArticleEfficacy and Safety Resu...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_462-468.txt
4.26.4.554,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.554Letter to the EditorGiant Congenital Mel...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_554-556.txt
4.26.4.547,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.547Letter to the EditorFour Cases of Dyspla...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_547-549.txt
4.26.4.447,"...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.447Original ArticleThe Efficacy, Longevity,...",3,164,Ann_Dermatol_2014_Aug_31_26(4)_447-456.txt
4.26.4.551,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.551Letter to the EditorPacinian Neuromas Pr...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_551-552.txt
4.26.4.517,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.517Letter to the EditorTazarotene-Induced G...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_517-520.txt
4.26.4.541,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.541Letter to the EditorWells Syndrome: Resp...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_541-542.txt
4.26.4.474,...ciety for Investigative Dermatology 10.5021/ad.2014.26.4.474Original ArticleThe Use of Long Pulsed N...,3,164,Ann_Dermatol_2014_Aug_31_26(4)_474-477.txt
4.26.5.653,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.653Letter to the EditorPrimary Granulocytic...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_653-655.txt
4.26.5.647,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.647Letter to the EditorFemale Hairline Pref...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_647-649.txt
4.26.5.628,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.628Case ReportEpidermotropic Metastatic Mel...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_628-631.txt
4.26.5.645,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.645Letter to the EditorToxic Epidermal Necr...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_645-646.txt
4.26.5.639,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.639Letter to the EditorA Suspected Case and...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_639-640.txt
4.26.5.576,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.576Original ArticlePreferential Recognition...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_576-583.txt
4.26.5.649,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.649Letter to the EditorGeneralized Eruptive...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_649-650.txt
4.26.5.570,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.570Original ArticleDietary Pattern and Nutr...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_570-575.txt
4.26.5.610,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.610Original ArticleClinical and Laboratory ...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_610-614.txt
4.26.5.559,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.559Original ArticleDifferent Anatomical Dis...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_559-563.txt
4.26.5.669,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.669Letter to the EditorInjection-Site React...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_669-670.txt
4.26.5.632,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.632Case ReportDermatobia hominis: Small Mig...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_632-635.txt
4.26.5.584,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.584Original ArticleEfficacy of Microneedlin...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_584-591.txt
4.26.5.659,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.659Letter to the EditorA Case of Primary Cu...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_659-660.txt
4.26.5.661,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.661Letter to the EditorIntravenous Immunogl...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_661-663.txt
4.26.5.636,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.636Case ReportTwo Cases of Unilateral Liche...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_636-638.txt
4.26.5.592,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.592Original ArticleUsefulness of the Autolo...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_592-597.txt
4.26.5.615,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.615Original ArticleComparison of the Effect...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_615-620.txt
4.26.5.564,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.564Original ArticleThe Antimicrobial Activi...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_564-569.txt
4.26.5.621,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.621Case ReportEruptive Anetoderma in a Pati...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_621-623.txt
4.26.5.641,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.641Letter to the EditorRelative High Intere...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_641-642.txt
4.26.5.664,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.664Letter to the EditorA Case of Syringotro...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_664-666.txt
4.26.5.603,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.603Original ArticleKeloids and Hypertrophic...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_603-609.txt
4.26.5.657,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.657Letter to the EditorTreatment with the P...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_657-659.txt
4.26.5.670,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.670Letter to the EditorUpregulated Expressi...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_670-673.txt
4.26.5.624,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.624Case ReportAlopecia Neoplastica due to G...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_624-627.txt
4.26.5.666,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.666Letter to the EditorExpression of Antimi...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_666-668.txt
4.26.5.651,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.651Letter to the EditorEffective Treatment ...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_651-653.txt
4.26.5.598,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.598Original ArticleComparison between Malas...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_598-602.txt
4.26.5.655,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.655Letter to the EditorA Case of Subungual ...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_655-657.txt
4.26.5.643,...ciety for Investigative Dermatology 10.5021/ad.2014.26.5.643Letter to the EditorDermatofibrosarcoma ...,3,164,Ann_Dermatol_2014_Oct_26_26(5)_643-645.txt
4.26.6.733,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.733Original ArticleClinical Evaluation of a...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_733-738.txt
4.26.6.793,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.793Letter to the EditorMultiple Habit-Induc...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_793-795.txt
4.26.6.769,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.769Letter to the EditorHyperkeratotic Hand ...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_769-771.txt
4.26.6.773,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.773Letter to the EditorA Case of Sarcoidosi...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_773-774.txt
4.26.6.722,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.722Original ArticleDifferences in Comorbidi...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_722-726.txt
4.26.6.751,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.751Case ReportFibrin Glue Fixation for Suct...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_751-754.txt
4.26.6.766,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.766Letter to the EditorSkin Sclerosis with ...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_766-767.txt
4.26.6.762,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.762Letter to the EditorMultiple Unilateral ...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_762-763.txt
4.26.6.758,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.758Letter to the EditorAn Unsuspected Case ...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_758-759.txt
4.26.6.791,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.791Letter to the EditorPilomatricoma: An Un...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_791-792.txt
4.26.6.675,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.675Original ArticleThe Expression and Role ...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_675-680.txt
4.26.6.783,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.783Letter to the EditorA Case of Reticulate...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_783-785.txt
4.26.6.789,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.789Letter to the EditorNon-Eczematous Vesic...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_789-790.txt
4.26.6.764,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.764Letter to the EditorSegmental Vitiligo a...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_764-765.txt
4.26.6.785,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.785Letter to the EditorA Case of Psoriasis ...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_785-786.txt
4.26.6.700,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.700Original ArticleThe Suitability of Gray-...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_700-705.txt
4.26.6.781,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.781Letter to the EditorForeign Body Reactio...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_781-783.txt
4.26.6.760,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.760Letter to the EditorA Case of Orange-Bro...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_760-761.txt
4.26.6.693,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.693Original ArticleImpact of Postthyroidect...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_693-699.txt
4.26.6.713,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.713Original ArticleExpression Patterns of G...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_713-721.txt
4.26.6.768,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.768Letter to the EditorPosttraumatic Ectopi...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_768-769.txt
4.26.6.787,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.787Letter to the EditorTwo Cases of General...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_787-788.txt
4.26.6.775,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.775Letter to the EditorA Case of Vitiligo A...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_775-776.txt
4.26.6.755,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.755Case ReportMinimally Invasive Surgery fo...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_755-757.txt
4.26.6.747,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.747Case ReportPigmented Mammary Paget Disea...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_747-750.txt
4.26.6.779,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.779Letter to the EditorRecurrent Acral Lent...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_779-781.txt
4.26.6.743,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.743Case ReportPattern Alopecia during Hormo...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_743-746.txt
4.26.6.706,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.706Original ArticleThe Effect of Evening Pr...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_706-712.txt
4.26.6.727,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.727Original ArticleClinical Characteristics...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_727-732.txt
4.26.6.681,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.681Original ArticleSuperoxide Dismutase 1 I...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_681-687.txt
4.26.6.739,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.739Case ReportWeber-Cockayne Type Epidermol...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_739-742.txt
4.26.6.771,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.771Letter to the EditorSacrococcygeal Nodul...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_771-773.txt
4.26.6.777,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.777Letter to the EditorFour Cases of Onycho...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_777-778.txt
4.26.6.688,...ciety for Investigative Dermatology 10.5021/ad.2014.26.6.688Original ArticleThe Effect of Environmen...,3,164,Ann_Dermatol_2014_Dec_26_26(6)_688-692.txt
5.27.1.26,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.26Original ArticleHistopathological Finding...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_26-31.txt
5.27.1.87,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.87Case ReportCongenital Lipedematous Alopec...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_87-89.txt
5.27.1.48,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.48Original ArticlePersonality Traits and Co...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_48-52.txt
5.27.1.79,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.79Case ReportNovel Treatment of Neck Wrinkl...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_79-81.txt
5.27.1.111,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.111Letter to the EditorMethods for Locating...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_111-113.txt
5.27.1.40,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.40Original ArticleDisease Awareness and Man...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_40-47.txt
5.27.1.15,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.15Original ArticleRetrospective Clinical Tr...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_15-20.txt
5.27.1.66,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.66Original ArticleEfficacy of 5% Imiquimod ...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_66-70.txt
5.27.1.117,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.117Letter to the EditorRetiform Purpura Cau...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_117-119.txt
5.27.1.21,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.21Original ArticleAlternative Method for Cr...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_21-25.txt
5.27.1.109,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.109Letter to the EditorInterferon-Gamma Rel...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_109-110.txt
5.27.1.71,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.71Case ReportRosai-Dorfman Disease with Mas...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_71-75.txt
5.27.1.53,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.53Original ArticlePostoperative Electron Be...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_53-58.txt
5.27.1.10,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.10Original ArticleVitamin D Status and Its ...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_10-14.txt
5.27.1.32,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.32Original ArticleSynergistic Inhibition of...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_32-39.txt
5.27.1.115,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.115Letter to the EditorBilateral Segmental ...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_115-117.txt
5.27.1.119,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.119Letter to the EditorLocalized Telogen Ef...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_119-120.txt
5.27.1.94,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.94Letter to the EditorA Case of Primary Pal...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_94-96.txt
5.27.1.113,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.113Letter to the EditorCutaneous Spindle Ce...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_113-115.txt
5.27.1.59,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.59Original ArticleA Study of Awareness and ...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_59-65.txt
5.27.1.76,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.76Case ReportPhotodynamic Therapy in Bowen ...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_76-78.txt
5.27.1.104,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.104Letter to the EditorTriple Combination o...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_104-107.txt
5.27.1.92,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.92Letter to the EditorAdult Onset Dyschomat...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_92-94.txt
5.27.1.107,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.107Letter to the EditorPrayer Mark on the F...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_107-108.txt
5.27.1.102,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.102Letter to the EditorA Case of Soft Fibro...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_102-103.txt
5.27.1.90,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.90Letter to the EditorChronic Cutaneous Gra...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_90-92.txt
5.27.1.101,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.101Letter to the EditorIatrogenic Harlequin...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_101-102.txt
5.27.1.99,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.99Letter to the EditorA Case of Extramammar...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_99-100.txt
5.27.1.82,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.82Case ReportTreatment of Patients with Ref...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_82-86.txt
5.27.1.97,...ciety for Investigative Dermatology 10.5021/ad.2015.27.1.97Letter to the EditorHerpes Labialis-Induc...,3,164,Ann_Dermatol_2015_Feb_3_27(1)_97-98.txt
5.27.2.152,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.152Original ArticleMechanism of Macrophage-...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_152-156.txt
5.27.2.190,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.190Case ReportHypersensitivity Reaction as ...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_190-193.txt
5.27.2.201,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.201Case ReportAmelanotic Acral Melanoma Ass...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_201-205.txt
5.27.2.214,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.214Letter to the EditorActinic Granuloma Ar...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_214-216.txt
5.27.2.226,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.226Letter to the EditorPreoperative Evaluat...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_226-227.txt
5.27.2.233,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.233Letter to the EditorA Case of Solitary P...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_233-234.txt
5.27.2.212,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.212Letter to the EditorBasal Cell Carcinoma...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_212-214.txt
5.27.2.216,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.216Letter to the EditorTwisted and Rolled B...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_216-218.txt
5.27.2.218,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.218Letter to the EditorSegmentally Arranged...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_218-220.txt
5.27.2.222,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.222Letter to the EditorSuccessful Treatment...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_222-223.txt
5.27.2.228,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.228Letter to the EditorOral and Cutaneous L...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_228-229.txt
5.27.2.237,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.237Letter to the EditorA Case of Keratoacan...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_237-238.txt
5.27.2.128,"...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.128Original ArticleTNF, IL12B, and IFNG Gen...",3,164,Ann_Dermatol_2015_Apr_24_27(2)_128-132.txt
5.27.2.142,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.142Original ArticleEthanol Extract of Peanu...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_142-151.txt
5.27.2.194,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.194Case ReportMultiple Nuchal-Type Fibromas...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_194-196.txt
5.27.2.210,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.210Letter to the EditorFrequency of Antinuc...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_210-212.txt
5.27.2.163,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.163Original ArticleInflammatory Cytokine Ex...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_163-170.txt
5.27.2.178,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.178Original ArticleEvaluation of Advanced O...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_178-183.txt
5.27.2.184,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.184Original ArticleComparison of Treatment ...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_184-189.txt
5.27.2.206,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.206Case ReportA Case of Spitzoid Melanoma K...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_206-209.txt
5.27.2.235,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.235Letter to the EditorDegos Disease Associ...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_235-236.txt
5.27.2.121,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.121Original ArticleRetinoic Acid Promotes I...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_121-127.txt
5.27.2.133,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.133Original ArticlePeriadnexal Mucin as an ...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_133-141.txt
5.27.2.157,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.157Original ArticleIdentification of Leukoc...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_157-162.txt
5.27.2.171,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.171Original ArticleAnalysis of the Results ...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_171-177.txt
5.27.2.197,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.197Case ReportPoikiloderma Vasculare Atroph...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_197-200.txt
5.27.2.220,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.220Letter to the EditorA Case of Cutaneous ...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_220-221.txt
5.27.2.224,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.224Letter to the EditorForeign Body Reactio...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_224-225.txt
5.27.2.230,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.230Letter to the EditorInfluence of Pulse T...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_230-232.txt
5.27.2.239,...ciety for Investigative Dermatology 10.5021/ad.2015.27.2.239Letter to the EditorPreliminary Study of...,3,164,Ann_Dermatol_2015_Apr_24_27(2)_239-241.txt
5.27.3.243,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.243Original ArticleEfficacy of Slimming Cre...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_243-249.txt
5.27.3.275,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.275Original ArticleAre Podoplanin Gene Poly...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_275-282.txt
5.27.3.291,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.291Original ArticlemRNA Expression Level of...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_291-297.txt
5.27.3.315,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.315Case ReportConcurrent Drug-Induced Linea...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_315-318.txt
5.27.3.328,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.328Letter to the EditorVariable Sized Cellu...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_328-329.txt
5.27.3.334,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.334Letter to the EditorBupropion-Induced Er...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_334-335.txt
5.27.3.347,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.347Letter to the EditorA Case of Psoriasis ...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_347-348.txt
5.27.3.322,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.322Case ReportPolycyclic Annular Lesion Mas...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_322-325.txt
5.27.3.326,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.326Letter to the EditorObjective Evaluation...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_326-328.txt
5.27.3.330,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.330Letter to the EditorAcquired Dermal Mela...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_330-331.txt
5.27.3.343,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.343Letter to the EditorAblative Fractional ...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_343-345.txt
5.27.3.345,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.345Letter to the EditorA Case of Kaposi's V...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_345-356.txt
5.27.3.349,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.349Letter to the EditorInfantile Scabies Ma...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_349-351.txt
5.27.3.351,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.351Letter to the EditorNovel Treatment Usin...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_351-352.txt
5.27.3.257,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.257Original ArticleHR-1 Mice: A New Inflamm...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_257-264.txt
5.27.3.265,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.265Original ArticleScreening for Psoriatic ...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_265-268.txt
5.27.3.269,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.269Original ArticleEsterase Activity and In...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_269-274.txt
5.27.3.332,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.332Letter to the EditorPoorly Differentiate...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_332-334.txt
5.27.3.338,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.338Letter to the EditorA Pediatric Case of ...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_338-339.txt
5.27.3.340,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.340Letter to the EditorChanges in Melanin a...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_340-342.txt
5.27.3.353,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.353Letter to the EditorPhacomatosis Pigment...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_353-354.txt
5.27.3.250,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.250Original ArticleTranexamic Acid Diminish...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_250-256.txt
5.27.3.283,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.283Original ArticleUsefulness of Skin Expla...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_283-290.txt
5.27.3.298,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.298Original ArticleEconomic Impact of Atopi...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_298-305.txt
5.27.3.306,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.306Case ReportCowden Syndrome with a Novel ...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_306-309.txt
5.27.3.310,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.310Case ReportCutaneous Metastatic Undiffer...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_310-314.txt
5.27.3.319,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.319Case ReportInfundibulocystic Squamous Ce...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_319-321.txt
5.27.3.336,...ciety for Investigative Dermatology 10.5021/ad.2015.27.3.336Letter to the EditorPrimary Classic Kapo...,3,164,Ann_Dermatol_2015_Jun_29_27(3)_336-337.txt
5.27.4.439,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.439Case ReportA Case of Metastatic Gastric ...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_439-441.txt
5.27.4.423,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.423Original ArticleVitamin D as a Marker fo...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_423-430.txt
5.27.4.465,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.465Letter to the EditorCefaclor-Induced Gen...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_465-466.txt
5.27.4.458,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.458Letter to the EditorGeneralized Eosinoph...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_458-460.txt
5.27.4.376,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.376Original ArticleMagnesium Ascorbyl Phosp...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_376-382.txt
5.27.4.442,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.442Case ReportMarjolin's Ulcer Presenting w...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_442-445.txt
5.27.4.398,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.398Original ArticleAntibiotic Susceptibilit...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_398-403.txt
5.27.4.404,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.404Original ArticleCharacteristics and Clin...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_404-410.txt
5.27.4.417,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.417Original ArticleDelayed Reconstruction f...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_417-422.txt
5.27.4.431,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.431Case ReportSuccessful Treatment of Hydro...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_431-434.txt
5.27.4.435,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.435Case ReportMultiple Segmental Eccrine Sp...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_435-438.txt
5.27.4.364,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.364Original ArticleProtease-Activated Recep...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_364-370.txt
5.27.4.478,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.478Letter to the EditorScleredema of Buschk...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_478-480.txt
5.27.4.480,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.480Letter to the EditorAcral Angioosteoma C...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_480-481.txt
5.27.4.456,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.456Letter to the EditorSynchronous Onset of...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_456-457.txt
5.27.4.371,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.371Original ArticleEfficacy and Safety of C...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_371-375.txt
5.27.4.389,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.389Original ArticlePatch Testing with Denta...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_389-393.txt
5.27.4.446,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.446Case ReportErythrodermic Psoriasis Treat...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_446-449.txt
5.27.4.474,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.474Letter to the EditorMutations in EDA and...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_474-477.txt
5.27.4.472,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.472Letter to the EditorA Rare Case of Multi...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_472-473.txt
5.27.4.467,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.467Letter to the EditorA Case of Sporadic D...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_467-468.txt
5.27.4.450,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.450Letter to the EditorEffects of Topical N...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_450-451.txt
5.27.4.452,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.452Letter to the EditorAcquired Perforating...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_452-453.txt
5.27.4.383,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.383Original ArticleA Family-Engaged Educati...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_383-388.txt
5.27.4.394,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.394Original ArticleButton Osteoma: A Review...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_394-397.txt
5.27.4.462,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.462Letter to the EditorDiagnostic Pitfalls ...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_462-464.txt
5.27.4.411,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.411Original ArticleAlopecia Areata in the E...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_411-416.txt
5.27.4.469,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.469Letter to the EditorMycosis Fungoides Di...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_469-471.txt
5.27.4.482,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.482Letter to the EditorEccrine Chromhidrosi...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_482-483.txt
5.27.4.454,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.454Letter to the EditorCyclosporine-Induced...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_454-456.txt
5.27.4.460,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.460Letter to the EditorA Case of Gonadotrop...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_460-462.txt
5.27.4.355,...ciety for Investigative Dermatology 10.5021/ad.2015.27.4.355Review ArticlePersonalized Immunomodulat...,3,164,Ann_Dermatol_2015_Aug_29_27(4)_355-363.txt
5.27.5.616,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.616Letter to the EditorGeneralized Pustulos...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_616-617.txt
5.27.5.492,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.492Original ArticleQuality of Life Assessme...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_492-498.txt
5.27.5.517,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.517Original ArticleEfficacy and Safety of H...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_517-522.txt
5.27.5.620,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.620Letter to the EditorDevelopment of Vitil...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_620-621.txt
5.27.5.643,"...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.643Letter to the EditorA Giant, Deep, Benig...",3,164,Ann_Dermatol_2015_Oct_2_27(5)_643-645.txt
5.27.5.626,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.626Letter to the EditorPossible Involvement...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_626-629.txt
5.27.5.605,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.605Case ReportNodular Vasculitis That Devel...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_605-607.txt
5.27.5.485,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.485Original ArticleComparison of Low-Level ...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_485-491.txt
5.27.5.578,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.578Consensus GuidelineConsensus Guidelines ...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_578-592.txt
5.27.5.635,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.635Letter to the EditorCreeping Hair in the...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_635-636.txt
5.27.5.633,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.633Letter to the EditorA Case of Multiple E...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_633-634.txt
5.27.5.608,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.608Case ReportPreceding Annular Skin Lesion...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_608-611.txt
5.27.5.499,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.499Original ArticleTopical Corticosteroid P...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_499-506.txt
5.27.5.629,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.629Letter to the EditorA Case of Focal Eosi...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_629-630.txt
5.27.5.563,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.563Consensus GuidelineConsensus Guidelines ...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_563-577.txt
5.27.5.639,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.639Letter to the EditorMycobacterium marinu...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_639-641.txt
5.27.5.593,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.593Case ReportFolliculocystic and Collagen ...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_593-596.txt
5.27.5.631,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.631Letter to the EditorPsoriatic Arthritis ...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_631-632.txt
5.27.5.614,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.614Letter to the EditorSuccessful Treatment...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_614-615.txt
5.27.5.597,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.597Case ReportCongenital Dermatofibrosarcom...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_597-600.txt
5.27.5.523,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.523Original ArticleMaintenance Therapy of F...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_523-530.txt
5.27.5.622,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.622Letter to the EditorAdult Multiple Myofi...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_622-623.txt
5.27.5.539,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.539Original ArticleTrichoscopic Findings of...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_539-550.txt
5.27.5.612,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.612Letter to the EditorMultiple Autoimmune ...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_612-613.txt
5.27.5.624,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.624Letter to the EditorPyodermatitis-Pyosto...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_624-625.txt
5.27.5.557,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.557Original ArticleReduction of Inter-Rater...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_557-562.txt
5.27.5.551,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.551Original ArticleIn Vitro Antimicrobial A...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_551-556.txt
5.27.5.531,"...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.531Original ArticleAwareness, Knowledge, an...",3,164,Ann_Dermatol_2015_Oct_2_27(5)_531-538.txt
5.27.5.507,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.507Original ArticleOxidative Damage and Nuc...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_507-516.txt
5.27.5.618,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.618Letter to the EditorCD56-Negative Extran...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_618-620.txt
5.27.5.637,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.637Letter to the EditorHypertrichosis and H...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_637-638.txt
5.27.5.601,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.601Case ReportComposite Tumor Associating T...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_601-604.txt
5.27.5.641,...ciety for Investigative Dermatology 10.5021/ad.2015.27.5.641Letter to the EditorImatinib Mesylate-In...,3,164,Ann_Dermatol_2015_Oct_2_27(5)_641-643.txt
5.27.6.694,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.694Original ArticleTreatment of Nodular Fas...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_694-701.txt
5.27.6.709,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.709Original ArticleImpact of Different Spa ...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_709-714.txt
5.27.6.765,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.765Letter to the EditorErythema Nodosum Ass...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_765-766.txt
5.27.6.771,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.771Letter to the EditorDo Interventional Pa...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_771-774.txt
5.27.6.780,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.780Letter to the EditorDiffuse Cutaneous Me...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_780-781.txt
5.27.6.784,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.784Letter to the EditorAutologous Whole Blo...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_784-786.txt
5.27.6.791,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.791Letter to the EditorGray Hair Associated...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_791-792.txt
5.27.6.793,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.793Letter to the EditorCutaneous Metastasis...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_793-794.txt
5.27.6.647,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.647Review ArticleProgress in Malassezia Res...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_647-657.txt
5.27.6.658,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.658Review ArticleRecently Identified Forms ...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_658-666.txt
5.27.6.667,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.667Original ArticleHerbal Extracts Induce D...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_667-675.txt
5.27.6.676,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.676Original ArticleComparison of High-Dose ...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_676-681.txt
5.27.6.682,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.682Original ArticleUsefulness of Dermatosco...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_682-687.txt
5.27.6.769,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.769Letter to the EditorTreatment of Diffuse...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_769-770.txt
5.27.6.774,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.774Letter to the EditorThe Clinical Efficac...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_774-775.txt
5.27.6.778,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.778Letter to the EditorPorokeratosis Presen...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_778-779.txt
5.27.6.721,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.721Original ArticleA Study about the Cause ...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_721-726.txt
5.27.6.727,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.727Original ArticleBlastic Plasmacytoid Den...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_727-737.txt
5.27.6.738,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.738Original ArticleTissue and Serum Inflamm...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_738-743.txt
5.27.6.748,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.748Case ReportA Novel Approach for Full-Thi...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_748-750.txt
5.27.6.751,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.751Case ReportHypopigmentation Induced by F...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_751-755.txt
5.27.6.756,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.756Case ReportCombined Treatment with Botul...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_756-758.txt
5.27.6.782,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.782Letter to the EditorDysplastic Nevus wit...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_782-784.txt
5.27.6.789,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.789Letter to the EditorHydroa Vacciniforme-...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_789-791.txt
5.27.6.688,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.688Original ArticleHigh-Intensity Focused U...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_688-693.txt
5.27.6.702,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.702Original ArticleEvaluation of Arterial S...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_702-708.txt
5.27.6.715,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.715Original ArticleAntifungal Susceptibilit...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_715-720.txt
5.27.6.744,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.744Case ReportVenous Leg Ulcer in a Sarcoid...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_744-747.txt
5.27.6.759,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.759Case ReportCutaneous and Systemic Plasma...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_759-762.txt
5.27.6.763,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.763Letter to the EditorMelasma in a Male Pa...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_763-764.txt
5.27.6.767,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.767Letter to the EditorCutaneous Metastasis...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_767-768.txt
5.27.6.776,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.776Letter to the EditorIdiopathic Aquagenic...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_776-777.txt
5.27.6.787,...ciety for Investigative Dermatology 10.5021/ad.2015.27.6.787Letter to the EditorSpitz Nevus on the P...,3,164,Ann_Dermatol_2015_Dec_7_27(6)_787-788.txt
6.28.1.102,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.102Case ReportA Case of Pemphigus Herpetifo...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_102-106.txt
6.28.1.136,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.136Letter to the EditorEruptive Xanthoma wi...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_136-137.txt
6.28.1.140,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.140Letter to the EditorSingle Vesicular Pap...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_140-141.txt
6.28.1.144,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.144Letter to the EditorThe Usefulness of De...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_144-145.txt
6.28.1.22,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.22Original ArticleSelective Cannabinoid Rec...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_22-29.txt
6.28.1.45,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.45Original ArticleInteraction of Wnt5a with...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_45-54.txt
6.28.1.55,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.55Original ArticleRole of Arachidonic Acid ...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_55-64.txt
6.28.1.74,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.74Original ArticleAssociation of Adipokines...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_74-79.txt
6.28.1.90,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.90Case ReportChronic Graft-Versus-Host Dise...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_90-93.txt
6.28.1.110,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.110Letter to the EditorEvaluation of the Po...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_110-112.txt
6.28.1.117,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.117Letter to the EditorStevens-Johnson Synd...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_117-118.txt
6.28.1.123,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.123Letter to the EditorCongenital Melanocyt...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_123-124.txt
6.28.1.133,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.133Letter to the EditorPathogenesis of Plan...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_133-135.txt
6.28.1.15,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.15Original ArticleEnhancement of Human Hair...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_15-21.txt
6.28.1.30,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.30Original ArticleGenetic Risk Factors for ...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_30-39.txt
6.28.1.6,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.6Original ArticleQuality of Life and Econom...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_6-14.txt
6.28.1.65,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.65Original ArticleTopical Products for Huma...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_65-73.txt
6.28.1.115,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.115Letter to the EditorIncreasing Numbers o...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_115-116.txt
6.28.1.121,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.121Letter to the EditorErythrodermic Psoria...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_121-122.txt
6.28.1.124,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.124Letter to the EditorTreatment for Refrac...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_124-125.txt
6.28.1.126,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.126Letter to the EditorAcidic Water Bathing...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_126-129.txt
6.28.1.129,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.129Letter to the EditorEffects of Magnesium...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_129-132.txt
6.28.1.142,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.142Letter to the EditorExtensive Squamous C...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_142-143.txt
6.28.1.40,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.40Original ArticleDermatoses of the Glans P...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_40-44.txt
6.28.1.86,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.86Case ReportConsiderable Variability in th...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_86-89.txt
6.28.1.94,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.94Case ReportSevere Nail Fold Psoriasis Ext...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_94-97.txt
6.28.1.98,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.98Case ReportPiperacillin/Tazobactam-Associ...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_98-101.txt
6.28.1.1,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.1Original ArticleCurrent Status of Atopic D...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_1-5.txt
6.28.1.107,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.107Letter to the EditorEfficacy and Safety ...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_107-109.txt
6.28.1.113,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.113Letter to the EditorTreatment of Classic...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_113-114.txt
6.28.1.119,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.119Letter to the EditorA Case of Acute-Onse...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_119-120.txt
6.28.1.138,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.138Letter to the EditorSecondary Granulomat...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_138-139.txt
6.28.1.80,...ciety for Investigative Dermatology 10.5021/ad.2016.28.1.80Original ArticleAvoidance Behavior agains...,3,164,Ann_Dermatol_2016_Feb_28_28(1)_80-85.txt
6.28.2.249,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.249Letter to the EditorA Case of Segmental ...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_249-250.txt
6.28.2.262,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.262Letter to the EditorA Case of Adult Gene...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_262-264.txt
6.28.2.264,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.264Letter to the EditorMucocutaneous Telang...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_264-266.txt
6.28.2.247,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.247Letter to the EditorCutaneous Metastasis...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_247-248.txt
6.28.2.205,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.205Original ArticleThe Relation of Androgen...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_205-209.txt
6.28.2.222,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.222Original ArticleThe MARCOPOLO Study of U...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_222-231.txt
6.28.2.216,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.216Original ArticleRelation between pH in t...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_216-221.txt
6.28.2.164,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.164Original ArticleSmoking and Hand Dermati...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_164-171.txt
6.28.2.245,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.245Letter to the EditorPeriorbital Lipogran...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_245-247.txt
6.28.2.255,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.255Letter to the EditorA Case of Acinic Cel...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_255-256.txt
6.28.2.273,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.273Letter to the EditorA Case of Cutaneous ...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_273-274.txt
6.28.2.251,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.251Letter to the EditorA Case of Sporotrich...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_251-252.txt
6.28.2.192,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.192Original ArticleImmunomodulatory Effects...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_192-198.txt
6.28.2.210,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.210Original ArticleThe Importance of Collag...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_210-215.txt
6.28.2.152,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.152Original ArticleClinical and Histopathol...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_152-158.txt
6.28.2.147,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.147Review ArticleManagement of Hidradenitis...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_147-151.txt
6.28.2.199,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.199Original ArticleEffect of Levothyroxine ...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_199-204.txt
6.28.2.269,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.269Letter to the EditorSymptomless Pulmonar...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_269-270.txt
6.28.2.159,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.159Original ArticleClinical Efficacy and Sa...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_159-163.txt
6.28.2.172,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.172Original ArticleClinical Features of Cut...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_172-178.txt
6.28.2.179,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.179Original ArticlePotential Role of S100A8...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_179-185.txt
6.28.2.186,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.186Original ArticleEfficacy of Red or Infra...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_186-191.txt
6.28.2.237,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.237Case ReportOnychomatricoma: A Rare Tumor...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_237-241.txt
6.28.2.253,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.253Letter to the EditorSegmental Neurofibro...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_253-254.txt
6.28.2.275,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.275Letter to the EditorExtranodal Natural K...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_275-277.txt
6.28.2.260,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.260Letter to the EditorCoexistence of Class...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_260-261.txt
4.26.3.411,https://doi.org/10.5021/ad.2014.26.3.41,7,31,PMC5318520.txt
6.28.2.232,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.232Case ReportMelkersson-Rosenthal Syndrome...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_232-236.txt
6.28.2.242,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.242Letter to the EditorApplication of Analy...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_242-245.txt
6.28.2.257,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.257Letter to the EditorErythema Annulare Ce...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_257-259.txt
6.28.2.266,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.266Letter to the EditorLymphoplasmacytic Pl...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_266-268.txt
6.28.2.271,...ciety for Investigative Dermatology 10.5021/ad.2016.28.2.271Letter to the EditorA Case of Cyclospori...,3,164,Ann_Dermatol_2016_Apr_31_28(2)_271-272.txt
6.28.3.364,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.364Original ArticleEfficacy and Safety of A...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_364-370.txt
6.28.3.371,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.371Case ReportCD30-Positive Anaplastic Lymp...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_371-374.txt
6.28.3.375,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.375Case ReportTumoral Calcinosis as an Init...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_375-380.txt
6.28.3.381,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.381Letter to the EditorEfficacy of Omalizum...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_381-382.txt
6.28.3.411,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.411Letter to the EditorA Case of Multiple D...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_411-413.txt
6.28.3.413,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.413Letter to the EditorA Case of Terra Firm...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_413-415.txt
6.28.3.290,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.290Original ArticleTreatment of Melasma wit...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_290-296.txt
6.28.3.327,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.327Original ArticleEpigallocatechin Gallate...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_327-334.txt
6.28.3.344,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.344Original ArticleCSP0510 Lotion as a Nove...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_344-351.txt
6.28.3.360,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.360Original ArticleThe Association between ...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_360-363.txt
6.28.3.383,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.383Letter to the EditorA Case of Papular My...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_383-384.txt
6.28.3.388,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.388Letter to the EditorClassic Juvenile Pit...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_388-390.txt
6.28.3.404,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.404Letter to the EditorAcquired Unilateral ...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_404-405.txt
6.28.3.409,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.409Letter to the EditorExacerbation of Psor...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_409-411.txt
6.28.3.297,"...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.297Original ArticleA Randomized, Evaluator-...",3,164,Ann_Dermatol_2016_Jun_25_28(3)_297-303.txt
6.28.3.321,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.321Original ArticleCorrelation between Seve...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_321-326.txt
6.28.3.314,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.314Original ArticleAnalysis of Dermatologic...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_314-320.txt
6.28.3.304,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.304Original ArticleProtective Effect of Top...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_304-313.txt
6.28.3.393,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.393Letter to the EditorCutaneous Metastatic...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_393-395.txt
6.28.3.395,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.395Letter to the EditorInterstitial Granulo...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_395-397.txt
6.28.3.398,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.398Letter to the EditorA Case of Multiple C...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_398-399.txt
6.28.3.400,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.400Letter to the EditorBlue Toe Syndrome as...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_400-401.txt
6.28.3.279,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.279Review ArticleSkin Pigmentation and Pigm...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_279-289.txt
6.28.3.335,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.335Original ArticleClinical Features and Aw...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_335-343.txt
6.28.3.352,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.352Original ArticleAmpelopsis japonica Maki...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_352-359.txt
6.28.3.385,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.385Letter to the EditorA Case of Phaeohypho...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_385-387.txt
6.28.3.391,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.391Letter to the EditorHistiocytic Infiltra...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_391-393.txt
6.28.3.402,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.402Letter to the EditorDevelopment of Rheum...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_402-403.txt
6.28.3.406,...ciety for Investigative Dermatology 10.5021/ad.2016.28.3.406Letter to the EditorThe Efficacy and Pro...,3,164,Ann_Dermatol_2016_Jun_25_28(3)_406-408.txt
6.28.4.495,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.495Brief ReportFibro-Osseous Pseudotumor of...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_495-496.txt
6.28.4.501,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.501Brief ReportTransepidermal Elimination o...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_501-502.txt
6.28.4.438,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.438Original ArticleEfficacy of a Complex of...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_438-443.txt
6.28.4.451,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.451Original ArticleImmunohistochemical Comp...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_451-456.txt
6.28.4.515,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.515Brief ReportDonut Ablation Method as an ...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_515-517.txt
6.28.4.417,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.417Original ArticleClinical Characteristics...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_417-421.txt
6.28.4.529,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.529Brief ReportA Rare Cutaneous Adverse Rea...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_529-531.txt
6.28.4.528,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.528Brief ReportPeriungual Abscess Caused by...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_528-529.txt
6.28.4.433,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.433Original ArticleSingle Low-Dose Radiatio...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_433-437.txt
6.28.4.522,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.522Brief ReportPalmoplantar Pustulosis Indu...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_522-523.txt
6.28.4.507,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.507Brief ReportCutaneous Sporotrichosis Pre...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_507-508.txt
6.28.4.422,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.422Original ArticleRelation between the Per...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_422-426.txt
6.28.4.497,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.497Brief ReportExtramammary Paget's Disease...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_497-498.txt
6.28.4.513,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.513Brief ReportMultiple Acquired Periungual...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_513-514.txt
6.28.4.505,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.505Brief ReportA Case of Facial Sarcoptes s...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_505-506.txt
6.28.4.517,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.517Brief ReportAcral Persistent Papular Muc...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_517-519.txt
6.28.4.427,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.427Original ArticleHistopathological Differ...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_427-432.txt
6.28.4.444,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.444Original ArticleSafety and Tolerability ...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_444-450.txt
6.28.4.524,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.524Brief ReportThe Epidemiology of Dermatop...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_524-527.txt
6.28.4.486,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.486Case ReportIncreased Infiltration of CD8...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_486-490.txt
6.28.4.519,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.519Brief ReportCutaneous Metastasis of Rhab...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_519-521.txt
6.28.4.499,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.499Brief ReportA Unique Cutaneous Presentat...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_499-501.txt
6.28.4.491,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.491Case ReportSynchronous Occurrence of Pri...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_491-494.txt
6.28.4.511,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.511Brief ReportA Case of Late Stage Sebaceo...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_511-512.txt
6.28.4.457,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.457Original ArticleExpression of Epidermal ...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_457-463.txt
6.28.4.464,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.464Original ArticleStressful Events and Ser...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_464-469.txt
6.28.4.470,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.470Original ArticleChange in Antimicrobial ...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_470-478.txt
6.28.4.479,...ciety for Investigative Dermatology 10.5021/ad.2016.28.4.479Original ArticleImmunohistochemistry and...,3,164,Ann_Dermatol_2016_Aug_26_28(4)_479-485.txt
6.28.5.650,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.650Brief ReportA Prospective Split-Face Com...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_650-652.txt
6.28.5.579,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.579Original ArticleInduction of Interleukin...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_579-585.txt
6.28.5.600,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.600Original ArticleAcute Stress-Induced Cha...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_600-606.txt
6.28.5.562,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.562Original ArticleFood Allergy in Korean P...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_562-568.txt
6.28.5.653,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.653Brief ReportMitten-Line Hyperpigmentatio...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_653-654.txt
6.28.5.655,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.655Brief ReportOnychopapilloma: A Report of...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_655-657.txt
6.28.5.607,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.607Original ArticleProspective Comparison o...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_607-614.txt
6.28.5.665,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.665Brief ReportEffect of Vitamin D on the E...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_665-669.txt
6.28.5.637,"...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.637Brief ReportA Case of Hyperandrogenism, ...",3,164,Ann_Dermatol_2016_Oct_30_28(5)_637-639.txt
6.28.5.569,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.569Original ArticleA Comparative Study of O...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_569-574.txt
6.28.5.643,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.643Brief ReportCutaneous Amyloidoma: A Rare...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_643-645.txt
6.28.5.669,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.669Brief ReportPrimary Cutaneous Apocrine C...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_669-670.txt
6.28.5.615,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.615Original ArticleValues of a Patient and ...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_615-623.txt
6.28.5.632,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.632Case ReportCase of Pleomorphic Dermal Sa...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_632-636.txt
6.28.5.660,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.660Brief ReportA Case of Linear IgA Bullous...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_660-662.txt
6.28.5.639,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.639Brief ReportHydrofluoric Acid Burn on a ...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_639-640.txt
6.28.5.645,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.645Brief ReportA Case of the Migration of H...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_645-647.txt
6.28.5.533,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.533Original ArticleIsolation and Quantifica...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_533-539.txt
6.28.5.593,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.593Original ArticleEffects of Emollient Con...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_593-599.txt
6.28.5.657,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.657Brief ReportSubungual Verrucous Carcinom...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_657-659.txt
6.28.5.548,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.548Original ArticleExpression of Phosphatas...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_548-554.txt
6.28.5.624,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.624Case ReportPerianal and Vulvar Extramamm...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_624-628.txt
6.28.5.555,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.555Original ArticleKojic Acid Peptide: A Ne...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_555-561.txt
EC 1.14.18.1,"...es, of which tyrosinase is essential. Tyrosinase (EC 1.14.18.1) 2~7 (monophenol or o-diphenol oxygen...",27,283,Ann_Dermatol_2016_Oct_30_28(5)_555-561.txt
EC 1.14.18.1,Mushroom tyrosinase (EC 1.14.18.1) used for the bioassay was purchased ...,46,22,Ann_Dermatol_2016_Oct_30_28(5)_555-561.txt
6.28.5.586,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.586Original ArticleRepeated Microneedle Sti...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_586-592.txt
6.28.5.662,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.662Brief ReportPoor Capability of 3D-Cultur...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_662-665.txt
6.28.5.671,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.671Brief ReportGlandular Paget's Disease of...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_671-672.txt
6.28.5.641,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.641Brief ReportA Case of Tailgut Cyst as a ...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_641-642.txt
6.28.5.647,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.647Brief ReportRecurrence of Nevus of Ota a...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_647-649.txt
6.28.5.575,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.575Original ArticleInvestigating Effects of...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_575-578.txt
6.28.5.540,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.540Original ArticlePityriasis Lichenoides-l...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_540-547.txt
6.28.5.629,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.629Case ReportPedunculated Nodules as a Var...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_629-631.txt
6.28.5.673,...ciety for Investigative Dermatology 10.5021/ad.2016.28.5.673Brief ReportSuccessful Treatment of Tatt...,3,164,Ann_Dermatol_2016_Oct_30_28(5)_673-675.txt
6.28.6.718,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.718Original ArticleHistologic Evidence of N...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_718-724.txt
6.28.6.725,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.725Original ArticleAwareness of Atopic Derm...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_725-732.txt
6.28.6.775,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.775Brief ReportA Case of Premature Hair Gra...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_775-776.txt
6.28.6.783,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.783Brief ReportA Cutaneous Horn-Like Form o...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_783-784.txt
6.28.6.796,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.796Brief ReportSuperficial Basal Cell Carci...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_796-797.txt
6.28.6.765,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.765Case ReportEccrine Syringofibroadenoma i...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_765-768.txt
6.28.6.757,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.757Case ReportHerpes Zoster Duplex Unilater...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_757-761.txt
6.28.6.789,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.789Brief ReportA Case of Cutaneous Epstein-...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_789-791.txt
6.28.6.787,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.787Brief ReportPseudoaneurysm as a Post-Bio...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_787-788.txt
6.28.6.791,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.791Brief ReportLupus Miliaris Disseminatus ...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_791-794.txt
6.28.6.798,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.798Brief ReportMultiple Arteriovenous Heman...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_798-800.txt
6.28.6.704,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.704Original ArticleSerum Procalcitonin Leve...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_704-710.txt
6.28.6.690,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.690Original ArticleApplication of Topical A...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_690-696.txt
6.28.6.711,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.711Original ArticleMorphologic Changes of Z...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_711-717.txt
6.28.6.733,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.733Original ArticleEfficacy and Safety of C...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_733-739.txt
6.28.6.785,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.785Brief ReportAcquired Dermal Melanocytosi...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_785-787.txt
6.28.6.697,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.697Original ArticleClinicopathological Feat...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_697-703.txt
6.28.6.771,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.771Brief ReportProtease-Activated Receptor-...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_771-772.txt
6.28.6.749,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.749Case ReportHidden Pictures of Kaposi's S...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_749-752.txt
6.28.6.684,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.684Original ArticleFour Years Prospective S...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_684-689.txt
6.28.6.781,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.781Brief ReportEczema within a Capillary Ma...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_781-782.txt
6.28.6.740,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.740Original ArticlePretreatment of Ferulic ...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_740-748.txt
6.28.6.777,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.777Brief ReportEruptive Benign Melanocytic ...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_777-779.txt
6.28.6.769,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.769Brief ReportEosinophilic Annular Erythem...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_769-771.txt
6.28.6.753,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.753Case ReportLate-Onset Complication of Fi...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_753-756.txt
6.28.6.779,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.779Brief ReportBenefits of Screening for Or...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_779-780.txt
6.28.6.762,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.762Case ReportTick Bite by Nymphal Amblyomm...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_762-764.txt
6.28.6.794,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.794Brief ReportA Case of Acrodermatitis Con...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_794-795.txt
6.28.6.801,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.801RetractionRetraction: Ampelopsis japonic...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_801.txt
6.28.3.352,https://doi.org/10.5021/ad.2016.28.3.35,7,31,Ann_Dermatol_2016_Dec_23_28(6)_801.txt
6.28.6.677,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.677Original ArticleA Study of Intravenous A...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_677-683.txt
6.28.6.772,...ciety for Investigative Dermatology 10.5021/ad.2016.28.6.772Brief ReportBetamethasone Butyrate Propi...,3,164,Ann_Dermatol_2016_Dec_23_28(6)_772-775.txt
3.91.3.403,"...tional Psychology 1999 91 403 414 10.1037/0022-0663.91.3.403 Bus, A. G., & van IJzendoorn, M. H. (19...",390,180,Ann_Dyslexia_2009_Dec_7_59(2)_169-195.txt
3.85.1.104,"...tional Psychology 1993 85 104 111 10.1037/0022-0663.85.1.104 Byrne, B., & Fielding-Barnsley, R. (199...",391,188,Ann_Dyslexia_2009_Dec_7_59(2)_169-195.txt
3.91.3.450,"...tional Psychology 1999 91 450 476 10.1037/0022-0663.91.3.450 de Jong, P. F., & van der Leij, A. (199...",393,218,Ann_Dyslexia_2009_Dec_7_59(2)_169-195.txt
3.96.4.660,"...tional Psychology 2004 96 660 670 10.1037/0022-0663.96.4.660 Elbro, C., & Petersen, D. K. (2004). Lo...",395,210,Ann_Dyslexia_2009_Dec_7_59(2)_169-195.txt
3.97.4.687,"...onal Psychology 2005 97 4 687 704 10.1037/0022-0663.97.4.687 Hindson, B. A., Byrne, B., Fielding-Bar...",404,227,Ann_Dyslexia_2009_Dec_7_59(2)_169-195.txt
3.95.2.211,"...tional Psychology 2003 95 211 224 10.1037/0022-0663.95.2.211 Leach, M. J., Scarborough, H. S., & Res...",407,138,Ann_Dyslexia_2009_Dec_7_59(2)_169-195.txt
3.92.2.284,"...tional Psychology 2000 92 284 295 10.1037/0022-0663.92.2.284 Schneider, W., Roth, E., & Ennemoser, M...",416,242,Ann_Dyslexia_2009_Dec_7_59(2)_169-195.txt
3.92.4.668,"...tional Psychology 2000 92 668 680 10.1037/0022-0663.92.4.668 Wimmer, H., Mayringer, H., & Landerl, K...",441,188,Ann_Dyslexia_2009_Dec_7_59(2)_169-195.txt
3.95.1.22,...cation & Psychology 2003 95 22 40 10.1037/0022-0663.95.1.22,198,213,Ann_Dyslexia_2010_Dec_22_60(2)_151-174.txt
3.96.4.785,...tion & Psychology 2004 96 785 797 10.1037/0022-0663.96.4.785,217,177,Ann_Dyslexia_2010_Dec_22_60(2)_151-174.txt
3.90.3.492,...tion & Psychology 1998 90 492 505 10.1037/0022-0663.90.3.492,229,234,Ann_Dyslexia_2010_Dec_22_60(2)_151-174.txt
3.83.3.346,...tion & Psychology 1991 83 346 360 10.1037/0022-0663.83.3.346,236,144,Ann_Dyslexia_2010_Dec_22_60(2)_151-174.txt
3.84.2.174,...tion & Psychology 1992 84 174 181 10.1037/0022-0663.84.2.174,237,176,Ann_Dyslexia_2010_Dec_22_60(2)_151-174.txt
5.8.4.485,...ry Neuropsychology 1994 8 485 493 10.1037/0894-4105.8.4.485,230,115,Ann_Dyslexia_2012_Apr_11_62(1)_1-18.txt
3.96.1.31,...cational Psychology 2004 96 31 42 10.1037/0022-0663.96.1.31,235,212,Ann_Dyslexia_2012_Apr_11_62(1)_1-18.txt
3.9.4.561,"...ory, and Cognition 1983 9 561 584 10.1037/0278-7393.9.4.561",240,203,Ann_Dyslexia_2012_Apr_11_62(1)_1-18.txt
3.98.3.554,...onal Psychology 2006 98 3 554 566 10.1037/0022-0663.98.3.554,272,181,Ann_Dyslexia_2012_Apr_11_62(1)_1-18.txt
3.92.1.56,...cational Psychology 2000 92 56 62 10.1037/0022-0663.92.1.56,289,208,Ann_Dyslexia_2012_Apr_11_62(1)_1-18.txt
3.98.1.122,...onal Psychology 2006 98 1 122 133 10.1037/0022-0663.98.1.122,291,204,Ann_Dyslexia_2012_Apr_11_62(1)_1-18.txt
4.94.1.48,...d Social Psychology 2008 94 48 59 10.1037/0022-3514.94.1.48 18179317,193,144,Ann_Dyslexia_2012_Jul_30_62(2)_100-119.txt
3.95.1.22,...cational Psychology 2003 95 22 40 10.1037/0022-0663.95.1.22,401,223,Ann_Dyslexia_2015_Aug_13_65(3)_178-198.txt
3.86.1.24,...cational Psychology 1994 86 24 53 10.1037/0022-0663.86.1.24,434,236,Ann_Dyslexia_2015_Aug_13_65(3)_178-198.txt
3.91.3.415,...tional Psychology 1999 91 415 438 10.1037/0022-0663.91.3.41,446,149,Ann_Dyslexia_2015_Aug_13_65(3)_178-198.txt
1.1.1.37,...me mitochondrial de la malate deshydrogenase (E.C.1.1.1.37,12,78,Ann_Genet_Sel_Anim_1971_3(3)_235-243.txt
EC 3.1.3.1,Alkaline phosphatase (EC 3.1.3.1.) is the enzyme which catalyses the hyd...,19,23,Ann_Genet_Sel_Anim_1982_14(1)_43-48.txt
5.3.1.9,...lationsgenetik der Phosphohexoseisomerase (E.C. : 5.3.1.9) bei,5958,80,Ann_Genet_Sel_Anim_1982_14(4)_481-544.txt
4.6.4.504,...and Aging 1991 6 504 511 1777137 10.1037//0882-7974.6.4.504,218,164,Ann_Gen_Hosp_Psychiatry_2003_Dec_16_2_11.txt
3.17.3.232,...ychology 1998 17 232 240 9619472 10.1037//0278-6133.17.3.232,82,231,Ann_Gen_Hosp_Psychiatry_2004_Jun_29_3_12.txt
4.3.6.1,"...ENED99ED427 (D.V.J., N.I.) and P.D.E., E.P.A.N.-M.4.3.6.1., C.2000 SE 01330005 (D.V.J., N.I., Z.C.) ...",128,133,Ann_Gen_Hosp_Psychiatry_2004_Jan_7_3_1.txt
4.63.5.832,...c Psychol 1992 63 832 838 1447695 10.1037/0022-3514.63.5.832,244,186,Ann_Gen_Psychiatry_2006_Jan_31_5_2.txt
5.1.50.592,...Threat Behav 2005 35 50 62 15843323 10.1521/suli.35.1.50.59260,309,185,Ann_Gen_Psychiatry_2007_Mar_16_6_10.txt
4.1.66.277,...Threat Behav 2004 34 66 76 15106889 10.1521/suli.34.1.66.27770,330,212,Ann_Gen_Psychiatry_2007_Mar_16_6_10.txt
2.6.4.326,...ia J Person Disord 1992 6 326 342 10.1521/pedi.1992.6.4.32,294,154,Ann_Gen_Psychiatry_2016_Jul_29_15_17.txt
4.9.10.226,...ig Drugs 2000 9 2269 2280 11060806 10.1517/13543784.9.10.2269,180,160,Ann_Gen_Psychiatry_2005_Sep_6_4_15.txt
4.99.4.760,...Neurosci 1985 99 760 765 3040035 10.1037//0735-7044.99.4.760,129,220,Ann_Gen_Psychiatry_2005_Apr_6_4_8.txt
6.42.5.985,...ay (Barc) 2006 42 283 289 16801991 10.1358/dot.2006.42.5.985635,277,134,Ann_Gen_Psychiatry_2007_Oct_9_6_27.txt
6.8.5.649,...armacother 2007 8 649 656 17376019 10.1517/14656566.8.5.649,66,220,Ann_Gen_Psychiatry_2007_Oct_8_6_25.txt
6.7.4.401,...armacother 2006 7 401 410 16503812 10.1517/14656566.7.4.401,67,128,Ann_Gen_Psychiatry_2007_Oct_8_6_25.txt
6.5.3.76,... hospital Psychiatry 2006 5 76 80 10.1383/psyt.2006.5.3.76,165,84,Ann_Gen_Psychiatry_2007_Oct_8_6_26.txt
6.36.5.519,...at Behav 2006 36 519 532 17087631 10.1521/suli.2006.36.5.519,171,109,Ann_Gen_Psychiatry_2007_Oct_8_6_26.txt
4.85.4.594,...sonal Soc Psychol 2003 85 594 604 10.1037/0022-3514.85.4.594,589,205,Ann_Gen_Psychiatry_2008_Jul_24_7_9.txt
4.64.6.102,...c Psych 1993 64 1029 1041 8326466 10.1037/0022-3514.64.6.1029,180,146,Ann_Gen_Psychiatry_2008_Aug_21_7_14.txt
2.2.4.398,...s Emotion 2002 2 398 411 12899372 10.1037/1528-3542.2.4.398,182,135,Ann_Gen_Psychiatry_2008_Aug_21_7_14.txt
5.6.11.174,...eurother 2006 6 1741 1751 17144787 10.1586/14737175.6.11.1741,599,137,Ann_Gen_Psychiatry_2008_Aug_19_7_13.txt
4.65.2.339,...c Psychol 1993 65 339 349 8366423 10.1037/0022-3514.65.2.339,680,145,Ann_Gen_Psychiatry_2008_Aug_19_7_13.txt
4.69.1.176,...c Psychol 1995 69 176 190 7643299 10.1037/0022-3514.69.1.176,681,182,Ann_Gen_Psychiatry_2008_Aug_19_7_13.txt
4.75.1.166,...c Psychol 1998 75 166 177 9686457 10.1037/0022-3514.75.1.166,682,212,Ann_Gen_Psychiatry_2008_Aug_19_7_13.txt
4.58.3.519,...c Psychol 1990 58 519 527 2324941 10.1037/0022-3514.58.3.519,693,162,Ann_Gen_Psychiatry_2008_Aug_19_7_13.txt
4.57.6.950,...c Psychol 1989 57 950 964 2693686 10.1037/0022-3514.57.6.950,698,210,Ann_Gen_Psychiatry_2008_Aug_19_7_13.txt
4.46.5.114,...Psychol 1984 46 1142 1147 6737208 10.1037/0022-3514.46.5.1142,710,127,Ann_Gen_Psychiatry_2008_Aug_19_7_13.txt
4.48.3.746,...c Psychol 1985 48 746 754 3989668 10.1037/0022-3514.48.3.746,763,188,Ann_Gen_Psychiatry_2008_Aug_19_7_13.txt
6.8.14.230,...Opin Pharmacother 2007 8 2307 2313 10.1517/14656566.8.14.2307,280,144,Ann_Gen_Psychiatry_2008_Aug_28_7_16.txt
6.6.12.209,...macother 2005 6 2091 2101 16197361 10.1517/14656566.6.12.2091,76,98,Ann_Gen_Psychiatry_2008_Dec_23_7_26.txt
4.16.6.771,...tig Drugs 2007 16 771 775 17501690 10.1517/13543784.16.6.771,78,156,Ann_Gen_Psychiatry_2008_Dec_23_7_26.txt
6.3.10.138,...macother 2002 3 1381 1391 12387684 10.1517/14656566.3.10.1381,234,145,Ann_Gen_Psychiatry_2009_Feb_11_8_5.txt
4.57.6.106,...ers Soc Psychol 1989 57 1069 1081 10.1037/0022-3514.57.6.1069,834,151,Ann_Gen_Psychiatry_2009_May_6_8_9.txt
4.61.2.226,...c Psychol 1991 61 226 244 1920064 10.1037/0022-3514.61.2.226,835,154,Ann_Gen_Psychiatry_2009_May_6_8_9.txt
4.69.4.719,...c Psychol 1995 69 719 727 7473027 10.1037/0022-3514.69.4.719,848,131,Ann_Gen_Psychiatry_2009_May_6_8_9.txt
4.9.2.195,...chol Aging 1994 9 195 205 8054167 10.1037/0882-7974.9.2.195,849,158,Ann_Gen_Psychiatry_2009_May_6_8_9.txt
6.5.8.103,...genomics 2004 5 1037 1048 15584875 10.1517/14622416.5.8.1037,105,112,Ann_Gen_Psychiatry_2009_May_14_8_10.txt
5.6.12.177,...Exp Rev Neurother 2006 6 1777 1783 10.1586/14737175.6.12.1777,203,172,Ann_Gen_Psychiatry_2009_Jul_27_8_16.txt
4.16.6.771,... Opin Invest Drugs 2007 16 771 775 10.1517/13543784.16.6.771,208,142,Ann_Gen_Psychiatry_2009_Jul_27_8_16.txt
6.3.12.177,...Opin Pharmacother 2002 3 1773 1781 10.1517/14656566.3.12.1773,227,122,Ann_Gen_Psychiatry_2009_Jul_27_8_16.txt
6.8.7.100,...Opin Pharmacother 2007 8 1001 1009 10.1517/14656566.8.7.1001,289,180,Ann_Gen_Psychiatry_2009_Jul_27_8_16.txt
5.7.8.919,...e Exp Rev Neurother 2007 7 919 925 10.1586/14737175.7.8.91,290,191,Ann_Gen_Psychiatry_2009_Jul_27_8_16.txt
3.18.5.495,...h Psychol 1999 5 495 505 10519466 10.1037/0278-6133.18.5.495,313,267,Ann_Gen_Psychiatry_2009_Oct_13_8_23.txt
2.76.1.10,...psychiatry 2006 76 10 12 16569120 10.1037/0002-9432.76.1.10,159,107,Ann_Gen_Psychiatry_2009_Oct_13_8_24.txt
6.8.7.100,...in Pharmacother 2007 8 7 1001 1009 10.1517/14656566.8.7.1001 17472545,260,184,Ann_Gen_Psychiatry_2009_Dec_31_8_27.txt
5.7.8.919,...ert Rev Neurother 2007 7 8 919 925 10.1586/14737175.7.8.919 17678485,261,195,Ann_Gen_Psychiatry_2009_Dec_31_8_27.txt
5.6.12.177,...rotherapeutics 2006 6 12 1777 1783 10.1586/14737175.6.12.1777 17181424,277,191,Ann_Gen_Psychiatry_2009_Dec_31_8_27.txt
6.36.2.223,...Life Threat Behav 2006 36 223 238 10.1521/suli.2006.36.2.223 16704326,356,177,Ann_Gen_Psychiatry_2010_Apr_12_9_14.txt
4.77.5.106,...ers Soc Psychol 1999 77 1061 1072 10.1037/0022-3514.77.5.1061 10573880,387,146,Ann_Gen_Psychiatry_2010_Apr_12_9_14.txt
4.6.4.504,...aged Psychol Aging 1991 6 504 511 10.1037/0882-7974.6.4.504 1777137,526,143,Ann_Gen_Psychiatry_2010_Apr_12_9_14.txt
5.41.1.875,...le Drugs Today (Barc) 2005 41 5 11 10.1358/dot.2005.41.1.875774 15753965,153,161,Ann_Gen_Psychiatry_2010_Feb_15_9_8.txt
6.36.4.409,...Life Threat Behav 2006 36 409 417 10.1521/suli.2006.36.4.409 1697809,168,210,Ann_Gen_Psychiatry_2010_Jun_11_9_26.txt
5.35.3.239,...Life Threat Behav 2005 35 239 250 10.1521/suli.2005.35.3.239 16156486,190,194,Ann_Gen_Psychiatry_2010_Feb_12_9_7.txt
5.19.4.420,...J Personal Disord 2005 19 420 439 10.1521/pedi.2005.19.4.420,235,163,Ann_Gen_Psychiatry_2010_Apr_27_9_19.txt
5.6.1.73,... Expert Rev Neurother 2006 6 73 80 10.1586/14737175.6.1.73,45,174,Ann_Gen_Psychiatry_2010_May_21_9_23.txt
5.8.2.215,...xpert Rev Neurother 2008 8 215 233 10.1586/14737175.8.2.215 18271709,205,130,Ann_Gen_Psychiatry_2010_Jul_5_9_30.txt
1.8.2.134,... Psychiatry Investig 2011 8 134 140 10.4306/pi.2011.8.2.134 21852990,221,141,Ann_Gen_Psychiatry_2016_Aug_31_15(1)_23.txt
EC 3.1.8.1,Paraoxonase ((PON) (EC 3.1.8.1) aryldialkylphosphatase) is an enzyme s...,18,21,Ann_Gen_Psychiatry_2010_Oct_21_9_36.txt
4.45.5.101,...cial Psychology 1983 45 1017 1028 10.1037/0022-3514.45.5.101,20,197,Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S192.txt
4.10.4.741,...n Inveting Drugs 2001 10 4 741 752 10.1517/13543784.10.4.74,18,140,Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S118.txt
6.34.9.116,...nd Personality 2006 34 9 1161 1170 10.2224/sbp.2006.34.9.116,20,239,Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S96.txt
4.10.4.741,...n Inveting Drugs 2001 10 4 741 752 10.1517/13543784.10.4.74,18,140,Ann_Gen_Psychiatry_2010_Apr_22_9(Suppl_1)_S99.txt
5.9.1.109,...s Exp Rev Neurother 2009 9 109 136 10.1586/14737175.9.1.109,344,174,Ann_Gen_Psychiatry_2011_Jan_18_10_1.txt
3.93.3.816,...Psychol Rep 2003 93 3 Pt 1 816 818 10.2466/pr0.2003.93.3.816 14723448,289,127,PMC5290643.txt
4.15.3.257,... Opin Invest Drugs 2006 15 257 266 10.1517/13543784.15.3.257,175,156,Ann_Gen_Psychiatry_2011_Feb_28_10_5.txt
5.6.12.177,...Neurotherapeutics 2006 6 1777 1783 10.1586/14737175.6.12.1777,223,179,Ann_Gen_Psychiatry_2011_Mar_24_10_8.txt
2.76.1.10,...m J Orthopsychiatry 2006 76 10 12 10.1037/0002-9432.76.1.10 16569120,694,97,Ann_Gen_Psychiatry_2011_Apr_11_10_13.txt
5.6.1.47,... Expert Rev Neurother 2006 6 47 56 10.1586/14737175.6.1.47 16466311,156,160,Ann_Gen_Psychiatry_2011_Jun_24_10_18.txt
2.12.1.45,...rt Opin Ther Targets 2008 12 45 58 10.1517/14728222.12.1.45 18076369,55,181,Ann_Gen_Psychiatry_2011_Sep_30_10_26.txt
6.18.11.178,...J Cogn Neurosci 2006 18 1789 1798 10.1162/jocn.2006.18.11.1789 17069470,83,154,Ann_Gen_Psychiatry_2011_Nov_21_10_31.txt
1.71.5.302,... J Vitam Nutr Res 2001 71 302 305 10.1024/0300-9831.71.5.302 11725695,150,201,Ann_Gen_Psychiatry_2012_Feb_20_11_5.txt
5.69.3.220,...ll Menninger Clin 2005 69 220 236 10.1521/bumc.2005.69.3.220 16178711,199,216,Ann_Gen_Psychiatry_2012_Sep_3_11_23.txt
2.10.3.799,... Scale Psychol Rep 1962 10 799 812 10.2466/pr0.1962.10.3.799,254,100,Ann_Gen_Psychiatry_2012_Oct_30_11_27.txt
1.2.89.610,...opsychiatr Dis Treat 2005 1 2 89 108 10.2147/nedt.1.2.89.61042 18568067,461,309,Ann_Gen_Psychiatry_2013_Jan_24_12_1.txt
6.8.11.157,...n Pharmacother 2007 8 11 1579 1603 10.1517/14656566.8.11.1579 17685878,621,130,Ann_Gen_Psychiatry_2013_Jan_24_12_1.txt
4.8.4.606,...Hugo Psychol Aging 1993 9 606 616 10.1037/0882-7974.8.4.606 8292289,262,145,Ann_Gen_Psychiatry_2010_Jul_21_9_32.txt
1.10.2.138,...Adv Ment Health 2012 13 2 138 148 10.5172/jamh.2011.10.2.138,111,261,Ann_Gen_Psychiatry_2014_Jan_3_13_1.txt
6.79.3.899,...type Psychol Rep 1996 13 3 899 902 10.2466/pr0.1996.79.3.899 8969098,140,152,Ann_Gen_Psychiatry_2014_Feb_21_13_6.txt
6.5.4.115,...ders Psychiatry 2006 13 4 115 118 10.1383/psyt.2006.5.4.115,122,93,Ann_Gen_Psychiatry_2014_Apr_12_13_11.txt
3.18.4.461,...d Violence Vict 2003 18 4 461 472 10.1891/vivi.2003.18.4.461 14582866,128,149,Ann_Gen_Psychiatry_2012_Oct_29_11_26.txt
2.24.3.228,... AIDS Educ Prev 2012 24 3 228 341 10.1521/aeap.2012.24.3.228 22676462,281,191,Ann_Gen_Psychiatry_2013_Jun_11_12_18.txt
3.74.7.100,...se J Periodontol 2003 74 1007 1016 10.1902/jop.2003.74.7.1007 12931763,167,181,Ann_Gen_Psychiatry_2013_Jun_24_12_20.txt
3.96.2.421,...Percept Mot Skills 2003 96 421 422 10.2466/pms.2003.96.2.421 12776823,374,210,Ann_Gen_Psychiatry_2013_Jun_26_12_21.txt
2.10.3.799,...cale Psychol Rep 1962 10 3 799 812 10.2466/pr0.1962.10.3.799,214,102,Ann_Gen_Psychiatry_2013_Sep_11_12_28.txt
6.18.5.803,...n J Cogn Neurosci 2006 18 803 817 10.1162/jocn.2006.18.5.803 16768379,97,202,Ann_Gen_Psychiatry_2013_Mar_6_12_6.txt
6.18.6.871,...J Cogn Neurosci 2006 18 6 871 879 10.1162/jocn.2006.18.6.871 16839295,204,192,Ann_Gen_Psychiatry_2013_Mar_6_12_6.txt
1.26.1.116,... J Korean Med Sci 2011 26 116 123 10.3346/jkms.2011.26.1.116 21218039,248,239,Ann_Gen_Psychiatry_2013_Nov_27_12_38.txt
4.70.3.552,... Pers Soc Psychol 1996 70 552 566 10.1037/0022-3514.70.3.552,517,248,Ann_Gen_Psychiatry_2014_Dec_5_13_36.txt
4.82.1.89,...Pers Soc Psychol 2002 82 1 89 101 10.1037/0022-3514.82.1.89 11811638,526,225,Ann_Gen_Psychiatry_2014_Dec_5_13_36.txt
4.89.3.407,...ers Soc Psychol 2005 89 3 407 425 10.1037/0022-3514.89.3.407 1624872,552,148,Ann_Gen_Psychiatry_2014_Dec_5_13_36.txt
6.18.4.551,...atry Clin Neurosci 2006 18 4 551 2 10.1176/jnp.2006.18.4.551 17135383,45,192,Ann_Gen_Psychiatry_2015_Mar_5_14_13.txt
1.5.3.236,...ren Nutr Res Pract 2011 5 3 236 45 10.4162/nrp.2011.5.3.236 21779528,238,208,Ann_Gen_Psychiatry_2015_Mar_1_14_12.txt
2.10.4.515,...Opin Ther Targets 2006 10 4 515 31 10.1517/14728222.10.4.515 16848689,199,125,Ann_Gen_Psychiatry_2015_Apr_1_14_15.txt
2.3.2.150,... requests? Emotion 2003 3 150 166 10.1037/1528-3542.3.2.150 12899416,293,151,Ann_Gen_Psychiatry_2015_Jul_14_14_20.txt
4.64.5.723,... Pers Soc Psychol 1993 64 723 739 10.1037/0022-3514.64.5.723 8505704,297,178,Ann_Gen_Psychiatry_2015_Jul_14_14_20.txt
2.5.1.55,... or arousal? Emotion 2005 5 55 66 10.1037/1528-3542.5.1.55 15755219,319,144,Ann_Gen_Psychiatry_2015_Jul_14_14_20.txt
5.48.4.481,...ion Soc Perspect 2005 48 4 481 504 10.1525/sop.2005.48.4.481,223,104,Ann_Gen_Psychiatry_2015_Jul_17_14_21.txt
5.19.5.612,...enia Neuropsychol 2005 19 612 617 10.1037/0894-4105.19.5.612,206,193,Ann_Gen_Psychiatry_2015_Sep_3_14_24.txt
6.39.3.101,...ss Psychol Rep 1976 39 3 1011 1022 10.2466/pr0.1976.39.3.1011 1005586,283,117,Ann_Gen_Psychiatry_2015_Sep_22_14_28.txt
2.6.4.326,...ymia J Pers Disord 1992 6 326 342 10.1521/pedi.1992.6.4.326,299,150,Ann_Gen_Psychiatry_2015_Sep_22_14_28.txt
4.66.4.762,...ers Soc Psychol 1994 66 4 762 775 10.1037/0022-3514.66.4.762 8189351,319,217,Ann_Gen_Psychiatry_2015_Sep_22_14_28.txt
4.70.1.127,...ers Soc Psychol 1996 70 1 127 140 10.1037/0022-3514.70.1.127 8558406,320,241,Ann_Gen_Psychiatry_2015_Sep_22_14_28.txt
6.18.2.217,...ry Clin Neurosci 2006 18 2 217 225 10.1176/jnp.2006.18.2.217 16720799,124,206,Ann_Gen_Psychiatry_2015_Sep_22_14_27.txt
2.51.5.285,...ychiatr Assoc. 2012 51 5 285 290 10.4306/jknpa.2012.51.5.285,201,220,Ann_Gen_Psychiatry_2015_Sep_23_14_30.txt
1.52.1.1,...odology Korean J Urol. 2011 52 1 8 10.4111/kju.2011.52.1.1 21344023,236,173,Ann_Gen_Psychiatry_2015_Oct_29_14_34.txt
5.12.4.379,...nt J Stress Manag 2005 12 379 388 10.1037/1072-5245.12.4.379,245,174,Ann_Gen_Psychiatry_2015_Oct_29_14_34.txt
5.16.1.84,...er Neuropsychology. 2002 16 84 91 10.1037/0894-4105.16.1.84 11853360,275,210,Ann_Gen_Psychiatry_2015_Nov_25_14_41.txt
4.45.4.194,...an) Diagnostica. 1999 45 194 204 10.1026//0012-1924.45.4.194,280,192,Ann_Gen_Psychiatry_2015_Dec_2_14_43.txt
4.61.2.226,... Pers Soc Psychol 1991 61 226 244 10.1037/0022-3514.61.2.226 1920064,287,155,Ann_Gen_Psychiatry_2015_Dec_2_14_43.txt
2.9.4.339,...sychiatry Investig 2012 9 4 339 346 10.4306/pi.2012.9.4.339 23251197,556,196,Ann_Gen_Psychiatry_2015_Dec_1_14_42.txt
1.1.29.939,...lin Expe Neuropsychol 1999 21 29 38 10.1076/jcen.21.1.29.939,148,198,Ann_Gen_Psychiatry_2016_Jan_20_15_3.txt
6.57.11.163,...rocess Psych Serv 2006 57 1636 1639 10.1176/ps.2006.57.11.1636,137,143,Ann_Gen_Psychiatry_2016_Jan_29_15_5.txt
4.18.4.379,...ons J Pers Disord 2004 18 379 393 10.1521/pedi.2004.18.4.379 15342324,249,207,Ann_Gen_Psychiatry_2016_Mar_12_15_10.txt
4.70.1.127,...sonal Soc Psychol 1996 70 127 140 10.1037/0022-3514.70.1.127,263,243,Ann_Gen_Psychiatry_2016_Mar_12_15_10.txt
3.10.4.326,...Psychiatry Investig 2013 10 326 335 10.4306/pi.2013.10.4.326 24474980,240,216,Ann_Gen_Psychiatry_2016_Jun_8_15_14.txt
4.51.1.181,... Pers Soc Psychol 1986 51 181 190 10.1037/0022-3514.51.1.181,592,123,Ann_Gen_Psychiatry_2016_Oct_21_15_28.txt
4.64.2.221,... Pers Soc Psychol 1993 64 221 242 10.1037/0022-3514.64.2.221,607,159,Ann_Gen_Psychiatry_2016_Oct_21_15_28.txt
4.78.1.173,... Pers Soc Psychol 2000 78 173 186 10.1037/0022-3514.78.1.173 10653513,625,256,Ann_Gen_Psychiatry_2016_Oct_21_15_28.txt
3.15.5.355,... Health Psychol 1996 15 5 355 361 10.1037/0278-6133.15.5.355 8891714,236,210,Ann_Gen_Psychiatry_2016_Nov_11_15_32.txt
1.26.11.140,... Korean Med Sci 2011 26 1409 1414 10.3346/jkms.2011.26.11.1409 22065895,158,200,Ann_Gen_Psychiatry_2016_Nov_29_15_35.txt
6.6.2.115,...G2 Pharmacogenomics 2005 6 115 138 10.1517/14622416.6.2.115 15882131,135,189,Ann_Hematol_2010_Nov_8_89(11)_1133-1140.txt
6.2.1.7,...a Expert Rev Hematol 2009 2 1 7 16 10.1586/17474086.2.1.7 21082989,144,162,Ann_Hematol_2011_Aug_26_90(8)_887-899.txt
1.75.11.48,VEGF expression	26.09 ± 14.8	ND	21.75.11.48	25.15 ± 14.09	32.15 ± 16.05***,83,34,Ann_Hematol_2014_Oct_19_93(4)_635-644.txt
4.14.1.89,...rt Opin Invest Drugs 2005 14 89 91 10.1517/13543784.14.1.89,102,179,Ann_Hematol_2015_Mar_27_94(Suppl_2)_123-131.txt
6.9.2.301,...t Opin Pharmacother 2008 9 301 309 10.1517/14656566.9.2.301 18201152,148,164,Ann_Hematol_2016_Mar_30_95_893-899.txt
2.14.1.71,study J Chemother 2002 14 1 71 75 10.1179/joc.2002.14.1.71 11892903,535,50,PMC5225941.txt
6.20.4.201,...pato-Biliary-Pancreatic Surgery 10.14701/ahbps.2016.20.4.201Case ReportCholangiocarcinoma in choledo...,3,203,PMC5325150.txt
6.20.4.187,...pato-Biliary-Pancreatic Surgery 10.14701/ahbps.2016.20.4.187Original ArticlePediatric cholecystectom...,3,203,PMC5325154.txt
6.20.4.167,...pato-Biliary-Pancreatic Surgery 10.14701/ahbps.2016.20.4.167Original ArticleLaparoscopic combined co...,3,203,PMC5325152.txt
6.20.4.159,...pato-Biliary-Pancreatic Surgery 10.14701/ahbps.2016.20.4.159Original ArticleImpact of clinically sig...,3,203,PMC5325151.txt
6.20.4.204,...pato-Biliary-Pancreatic Surgery 10.14701/ahbps.2016.20.4.204Case ReportPseudoaneurysm of the splenic...,3,203,PMC5325145.txt
6.20.4.197,...pato-Biliary-Pancreatic Surgery 10.14701/ahbps.2016.20.4.197How-I-Do-ItFibrin glue-infiltrating hemo...,3,203,PMC5325153.txt
6.20.4.153,...pato-Biliary-Pancreatic Surgery 10.14701/ahbps.2016.20.4.153Original ArticleRisk factors of postoper...,3,203,PMC5325146.txt
6.20.4.180,...pato-Biliary-Pancreatic Surgery 10.14701/ahbps.2016.20.4.180Original ArticlePreoperative predictive ...,3,203,PMC5325147.txt
6.20.4.173,...pato-Biliary-Pancreatic Surgery 10.14701/ahbps.2016.20.4.173Original ArticleIncidence of underlying ...,3,203,PMC5325148.txt
6.20.4.191,...pato-Biliary-Pancreatic Surgery 10.14701/ahbps.2016.20.4.191Original ArticleEffect of polylactic fil...,3,203,PMC5325149.txt
EC 3.2.1.108,"... human lactase (lactase–phlorizin hydrolase, LPH, EC 3.2.1.108) in adults is regulated at the level ...",28,104,Ann_Hum_Genet_2016_Nov_7_80(6)_307-318.txt
2.7.10.2,...ncogene tyrosine-protein kinase protein Src; EC = 2.7.10.2 in linking neuronal apoptosis and amyloid...,10,75,Ann_Indian_Acad_Neurol_2014_Jan-Mar_17(1)_48-54.txt
3.98.6.122,...hage J Neurosurg 2003 98 1227 1234 10.3171/jns.2003.98.6.1227 12816269,119,214,Ann_Intensive_Care_2011_May_24_1_12.txt
6.8.2.237,...t Opin Pharmacother 2007 8 237 256 10.1517/14656566.8.2.237 17257093,196,174,Ann_Intensive_Care_2012_Jul_28_2_35.txt
6.14.3.181,...ce J Perinat Med 1986 3 3 181 187 10.1515/jpme.1986.14.3.181 3537267,213,185,Ann_Intensive_Care_2013_Aug_22_3_28.txt
5.5.2.163,...ning J Healthc Eng 2014 5 163 184 10.1260/2040-2295.5.2.163 24918182,174,208,Ann_Intensive_Care_2014_Dec_21_4(1)_40.txt
5.66.2.175,...verdo it Hosp Med. 2005 66 73 75 10.12968/hmed.2005.66.2.17548 15739696,163,111,Ann_Intensive_Care_2015_Nov_19_5_42.txt
2.3.1.1,"2.3.1.1 In intermittent RRT, systemic anticoagulat...",144,1,Ann_Intensive_Care_2015_Dec_30_5_58.txt
2.3.1.2,"2.3.1.2 In continuous RRT, regional citrate antico...",146,1,Ann_Intensive_Care_2015_Dec_30_5_58.txt
2.3.1.3,"2.3.1.3 In continuous RRT, no anticoagulation shou...",148,1,Ann_Intensive_Care_2015_Dec_30_5_58.txt
